data_1fh3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fh3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.139 0.495 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.474 HH21 ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.2 -178.79 6.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -128.9 132.06 47.66 Favored 'General case' 0 CA--C 1.494 -1.175 1 N-CA-C 99.008 -4.441 . . . . 0.0 99.008 171.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 175.41 38.17 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -77.26 128.04 33.66 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -91.0 139.93 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.6 -129.13 0.24 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.443 -1.708 . . . . 0.0 107.915 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -145.34 154.47 53.46 Favored Pre-proline 0 N--CA 1.415 -2.206 1 N-CA-C 95.337 -5.801 . . . . 0.0 95.337 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -68.64 110.14 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.837 2.358 . . . . 0.0 110.551 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -145.64 162.16 38.15 Favored 'General case' 0 CA--C 1.484 -1.564 1 N-CA-C 98.039 -4.8 . . . . 0.0 98.039 4.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.17 27.05 0.91 Allowed 'General case' 0 C--N 1.359 0.985 0 CA-C-O 123.169 1.462 . . . . 0.0 108.887 162.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.9 m -118.99 -158.19 0.72 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.06 168.07 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 1 N-CA-C 95.594 -5.706 . . . . 0.0 95.594 161.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.15 -170.3 2.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -131.76 151.65 51.5 Favored 'General case' 0 CA--C 1.478 -1.799 1 N-CA-C 97.244 -5.095 . . . . 0.0 97.244 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -116.65 163.4 16.18 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -113.43 112.87 48.67 Favored Pre-proline 0 N--CA 1.419 -2.017 1 N-CA-C 98.034 -4.802 . . . . 0.0 98.034 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.74 130.72 40.04 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.293 1.996 . . . . 0.0 111.88 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.56 -56.72 0.73 Allowed Glycine 0 CA--C 1.484 -1.852 1 N-CA-C 101.659 -4.576 . . . . 0.0 101.659 -163.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m 119.42 -23.87 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.98 2.912 . . . . 0.0 107.134 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -61.77 0.74 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.381 2.272 . . . . 0.0 115.763 -154.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.56 -39.68 60.46 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.916 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -29.29 51.83 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 117.643 0.721 . . . . 0.0 109.593 -168.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.55 -49.41 77.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.63 1.172 . . . . 0.0 109.861 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -63.87 -34.34 77.72 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.75 -0.594 . . . . 0.0 112.228 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.16 -40.84 94.87 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.043 0.925 . . . . 0.0 110.685 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.03 -44.63 94.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.592 0.757 . . . . 0.0 110.612 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.36 -21.44 56.09 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 119.239 0.927 . . . . 0.0 111.567 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -84.13 -41.3 17.23 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.605 -0.685 . . . . 0.0 109.39 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.08 48.0 0.1 OUTLIER Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.6 137.81 13.88 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 104.781 -3.328 . . . . 0.0 104.781 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -0.07 56.79 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.323 1.049 . . . . 0.0 110.768 -168.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 m -159.38 164.2 34.89 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 100.012 -4.07 . . . . 0.0 100.012 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.05 169.66 39.02 Favored Glycine 0 N--CA 1.424 -2.16 1 N-CA-C 98.043 -6.023 . . . . 0.0 98.043 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -164.55 -171.42 2.33 Favored 'General case' 0 N--CA 1.438 -1.072 1 N-CA-C 100.043 -4.058 . . . . 0.0 100.043 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.8 m -98.9 174.58 6.3 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 166.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.05 43.28 Favored Glycine 0 N--CA 1.427 -1.933 1 N-CA-C 102.025 -4.43 . . . . 0.0 102.025 168.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -134.84 142.45 46.64 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.741 -4.54 . . . . 0.0 98.741 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -126.22 107.36 10.29 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.14 124.04 25.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.9 -81.27 0.22 Allowed Glycine 0 CA--C 1.482 -2.003 1 N-CA-C 100.92 -4.872 . . . . 0.0 100.92 -164.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -87.34 -59.25 2.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.99 -140.38 7.23 Favored Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.69 143.57 57.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.974 2.109 . . . . 0.0 106.271 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.25 -174.58 4.86 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.71 -179.99 4.91 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -132.43 151.24 51.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 -175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.44 136.4 33.0 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -105.96 135.7 46.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.03 40.58 3.96 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.934 1.693 . . . . 0.0 112.031 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 tp -81.92 138.89 46.31 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 165.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -70.19 165.53 31.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.262 1.975 . . . . 0.0 110.833 170.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.41 -5.2 57.65 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 123.93 0.892 . . . . 0.0 110.989 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.66 16.73 10.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.244 1.017 . . . . 0.0 109.837 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.57 162.21 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 N-CA-C 95.134 -5.876 . . . . 0.0 95.134 170.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.99 -177.41 35.96 Favored Glycine 0 CA--C 1.475 -2.44 0 C-N-CA 115.877 -3.059 . . . . 0.0 107.699 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.474 ' CG2' HH21 ' A' ' 2' ' ' ARG . 46.7 pt -142.26 -152.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 114.694 -0.753 . . . . 0.0 110.873 -141.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mm -75.25 132.56 33.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 N--CA 1.423 -1.802 1 N-CA-C 94.813 -5.995 . . . . 0.0 94.813 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 175.89 12.51 Favored 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.274 -5.454 . . . . 0.0 96.274 169.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -125.15 141.81 51.88 Favored 'General case' 0 CA--C 1.487 -1.475 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -176.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.26 179.02 36.96 Favored Glycine 0 CA--C 1.47 -2.766 0 N-CA-C 103.996 -3.642 . . . . 0.0 103.996 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -81.8 129.79 34.85 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.0 tt -79.25 129.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.88 -169.63 1.49 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 112.055 -2.339 . . . . 0.0 107.615 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.75 151.94 37.64 Favored Pre-proline 0 N--CA 1.434 -1.243 1 N-CA-C 99.601 -4.222 . . . . 0.0 99.601 167.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.34 140.83 78.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 162.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.49 -42.31 10.34 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 121.604 2.002 . . . . 0.0 108.744 12.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -151.97 142.74 22.9 Favored 'General case' 0 N--CA 1.417 -2.077 1 N-CA-C 93.663 -6.421 . . . . 0.0 93.663 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.2 m -179.79 -155.41 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.269 -4.345 . . . . 0.0 99.269 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.42 167.96 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 1 N-CA-C 97.011 -5.181 . . . . 0.0 97.011 160.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.93 -166.37 1.37 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 163.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.29 166.95 20.07 Favored 'General case' 0 CA--C 1.484 -1.595 1 N-CA-C 98.067 -4.79 . . . . 0.0 98.067 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.15 167.24 28.36 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -128.7 129.7 23.5 Favored Pre-proline 0 N--CA 1.423 -1.818 1 N-CA-C 99.835 -4.135 . . . . 0.0 99.835 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -54.59 123.68 14.27 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.778 2.319 . . . . 0.0 112.696 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.48 -46.69 1.06 Allowed Glycine 0 CA--C 1.488 -1.61 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 -166.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m 92.11 0.09 0.13 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 127.492 2.317 . . . . 0.0 113.238 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -44.43 81.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.563 1.945 . . . . 0.0 112.905 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.18 -46.27 44.07 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -79.31 -22.03 45.15 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.823 1.312 . . . . 0.0 110.717 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -55.17 -41.51 71.98 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.229 0.922 . . . . 0.0 109.829 166.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 m -63.35 -45.7 89.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.816 -0.553 . . . . 0.0 110.205 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.29 -41.23 96.99 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 122.717 1.246 . . . . 0.0 110.039 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.62 -41.27 98.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 109.946 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -71.77 -37.15 70.53 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.14 -31.16 62.62 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.719 -0.613 . . . . 0.0 111.267 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -85.91 -16.9 37.02 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.537 -0.727 . . . . 0.0 111.073 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 43.07 2.24 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 165.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.57 142.74 16.19 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 167.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -34.01 66.86 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 129.123 2.969 . . . . 0.0 110.504 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 m -160.12 165.95 30.72 Favored 'General case' 0 N--CA 1.421 -1.922 1 N-CA-C 97.944 -4.836 . . . . 0.0 97.944 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.31 165.47 37.02 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.945 -6.062 . . . . 0.0 97.945 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -166.91 178.95 5.52 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.576 -4.602 . . . . 0.0 98.576 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.14 161.4 26.49 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.71 40.48 Favored Glycine 0 N--CA 1.421 -2.321 1 N-CA-C 98.463 -5.855 . . . . 0.0 98.463 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.85 165.46 32.22 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 96.932 -5.21 . . . . 0.0 96.932 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -114.36 -9.28 12.79 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.216 1.006 . . . . 0.0 108.998 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t 73.38 132.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 107.126 -160.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.06 -104.98 0.29 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -69.51 -77.27 0.08 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.076 0.951 . . . . 0.0 112.909 -169.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.39 -50.61 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.516 0 O-C-N 120.285 -1.509 . . . . 0.0 109.769 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -158.78 -167.47 2.13 Favored 'General case' 0 N--CA 1.43 -1.447 1 N-CA-C 95.481 -5.748 . . . . 0.0 95.481 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 -165.62 1.85 Allowed 'General case' 0 CA--C 1.486 -1.484 1 N-CA-C 97.961 -4.829 . . . . 0.0 97.961 167.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 -176.5 4.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 102.128 -3.286 . . . . 0.0 102.128 158.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -117.48 155.38 29.82 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 m -146.44 139.85 25.84 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 100.375 -3.935 . . . . 0.0 100.375 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 30.19 6.59 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.287 0.565 . . . . 0.0 110.073 -168.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 177.5 151.02 0.2 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 93.979 -6.304 . . . . 0.0 93.979 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -153.36 151.92 26.61 Favored Pre-proline 0 CA--C 1.487 -1.47 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 149.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.72 170.95 16.48 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.08 1.853 . . . . 0.0 110.515 171.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.37 16.93 1.16 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -98.55 -6.25 30.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 120.51 -1.369 . . . . 0.0 108.287 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.73 168.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.41 177.36 27.65 Favored Glycine 0 CA--C 1.483 -1.952 1 N-CA-C 102.033 -4.427 . . . . 0.0 102.033 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 6' ' ' ILE . 6.4 pt -154.82 -171.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -158.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.76 133.05 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.431 -1.379 0 N-CA-C 101.792 -3.411 . . . . 0.0 101.792 171.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.063 0.459 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -100.99 157.82 16.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -127.53 125.9 41.23 Favored 'General case' 0 CA--C 1.486 -1.482 1 N-CA-C 94.315 -6.18 . . . . 0.0 94.315 159.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.38 29.01 Favored Glycine 0 CA--C 1.474 -2.512 0 N-CA-C 104.021 -3.632 . . . . 0.0 104.021 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -83.54 140.35 32.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.87 148.23 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.3 -177.17 6.07 Favored 'General case' 0 N--CA 1.415 -2.204 1 N-CA-C 98.329 -4.693 . . . . 0.0 98.329 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -105.06 157.54 34.04 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -66.56 144.62 73.46 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.654 2.236 . . . . 0.0 109.226 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -103.14 80.02 1.8 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 128.027 2.531 . . . . 0.0 106.336 -5.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.8 t30 84.66 44.19 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 124.932 1.293 . . . . 0.0 108.392 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.85 127.76 47.64 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 15' ' ' HIS 0.254 5.4 m -70.64 165.04 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 141.87 51.36 Favored 'General case' 0 N--CA 1.423 -1.817 1 N-CA-C 94.455 -6.128 . . . . 0.0 94.455 -176.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.416 ' CE1' HG23 ' A' ' 13' ' ' VAL . 46.9 m80 -117.31 160.73 20.65 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -167.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 t -115.18 169.27 9.24 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.53 124.68 23.61 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 98.423 -4.658 . . . . 0.0 98.423 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -57.59 111.84 0.95 Allowed 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.965 2.443 . . . . 0.0 113.261 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.79 -51.37 0.52 Allowed Glycine 0 CA--C 1.484 -1.85 1 N-CA-C 100.367 -5.093 . . . . 0.0 100.367 -168.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 6.8 m 106.12 -0.84 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 127.984 2.513 . . . . 0.0 111.852 169.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -46.97 -45.4 20.83 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.567 1.547 . . . . 0.0 113.806 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.37 -59.99 7.65 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.904 0.764 . . . . 0.0 111.955 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.3 m -70.68 -27.56 64.11 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.869 -1.371 . . . . 0.0 113.263 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.84 -45.19 93.74 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.4 m -66.08 -40.97 91.28 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.748 0.819 . . . . 0.0 110.4 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.21 -42.33 94.9 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.703 0.801 . . . . 0.0 109.74 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -38.64 82.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.541 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.24 -42.25 84.3 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.925 -0.484 . . . . 0.0 111.455 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.35 -30.3 37.98 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.726 -0.609 . . . . 0.0 111.019 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -84.66 -22.29 29.92 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 118.363 0.529 . . . . 0.0 109.949 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.49 45.95 1.61 Allowed Glycine 0 CA--C 1.488 -1.594 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 162.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.26 172.8 17.38 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 104.26 -3.536 . . . . 0.0 104.26 167.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 p -75.39 -56.71 4.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.987 0.899 . . . . 0.0 108.651 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -160.65 -176.76 5.75 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 98.832 -4.506 . . . . 0.0 98.832 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.19 -176.73 41.93 Favored Glycine 0 N--CA 1.414 -2.769 1 N-CA-C 98.612 -5.795 . . . . 0.0 98.612 -168.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -166.79 178.08 6.1 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 -172.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.34 168.09 20.66 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.773 0.797 . . . . 0.0 110.465 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.84 -171.01 37.9 Favored Glycine 0 N--CA 1.419 -2.463 1 N-CA-C 97.05 -6.42 . . . . 0.0 97.05 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -146.54 161.91 39.46 Favored 'General case' 0 N--CA 1.422 -1.828 1 N-CA-C 95.325 -5.805 . . . . 0.0 95.325 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -152.44 167.08 29.93 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 97.458 -5.015 . . . . 0.0 97.458 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.76 149.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 1 N-CA-C 96.152 -5.499 . . . . 0.0 96.152 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 -23.02 23.29 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 106.274 -2.731 . . . . 0.0 106.274 -168.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -135.62 -76.36 0.44 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 167.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.41 -150.76 22.13 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 98.289 -5.924 . . . . 0.0 98.289 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.28 115.26 2.37 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.339 2.656 . . . . 0.0 108.689 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.99 158.35 44.07 Favored 'General case' 0 CA--C 1.482 -1.657 1 N-CA-C 96.871 -5.233 . . . . 0.0 96.871 -166.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.8 p -138.61 174.36 10.62 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 116.349 -2.141 . . . . 0.0 108.548 -167.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -104.86 156.64 17.83 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -164.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -152.12 151.1 30.64 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 167.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -113.17 145.71 40.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 104.475 -2.416 . . . . 0.0 104.475 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.94 46.43 0.25 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.098 2.159 . . . . 0.0 112.227 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.33 130.97 33.88 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.95 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.071 1.847 . . . . 0.0 110.656 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -60.69 -20.15 60.31 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.77 1.628 . . . . 0.0 114.762 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -82.29 -12.76 57.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.652 -0.655 . . . . 0.0 110.414 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.52 112.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.46 143.74 17.45 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 104.894 -3.282 . . . . 0.0 104.894 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.9 pt -143.66 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 -160.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mm -68.08 122.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -161.431 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.27 162.5 14.02 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 164.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -125.59 131.85 52.63 Favored 'General case' 0 CA--C 1.486 -1.501 1 N-CA-C 94.287 -6.19 . . . . 0.0 94.287 161.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.81 29.57 Favored Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 100.912 -4.875 . . . . 0.0 100.912 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.91 137.24 33.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.01 142.52 12.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -135.53 -129.78 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.88 2.872 . . . . 0.0 106.385 175.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -154.16 166.51 15.67 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -172.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -65.39 139.14 58.19 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.346 2.697 . . . . 0.0 111.017 166.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -109.4 -16.26 14.05 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.571 2.348 . . . . 0.0 108.768 9.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -160.22 146.67 15.69 Favored 'General case' 0 CA--C 1.48 -1.72 1 N-CA-C 94.154 -6.239 . . . . 0.0 94.154 165.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.08 -161.97 0.29 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 169.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.74 166.78 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 1 N-CA-C 97.536 -4.987 . . . . 0.0 97.536 157.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -166.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 163.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -127.46 161.89 27.67 Favored 'General case' 0 CA--C 1.473 -1.99 1 N-CA-C 99.245 -4.354 . . . . 0.0 99.245 169.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.0 t -124.83 147.87 48.51 Favored 'General case' 0 N--CA 1.419 -1.996 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -102.41 119.72 55.37 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 96.935 -5.209 . . . . 0.0 96.935 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -57.34 103.97 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 CA-C-N 124.491 2.64 . . . . 0.0 114.726 -165.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.68 -175.8 37.36 Favored Glycine 0 N--CA 1.419 -2.455 1 N-CA-C 97.248 -6.341 . . . . 0.0 97.248 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -92.0 -30.75 15.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.627 0.713 . . . . 0.0 109.276 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -43.97 91.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.561 2.344 . . . . 0.0 115.319 -157.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.25 -50.46 45.04 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -68.96 -41.76 77.53 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.057 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -48.2 -54.11 14.61 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.437 1.495 . . . . 0.0 110.291 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 m -58.72 -54.08 51.07 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.967 0.907 . . . . 0.0 111.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -67.14 -40.77 86.79 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-O 122.36 1.076 . . . . 0.0 110.339 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -64.93 -45.09 87.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.334 1.054 . . . . 0.0 110.304 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -68.56 -40.41 80.62 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 121.27 -0.894 . . . . 0.0 110.945 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -68.26 -14.89 63.32 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.49 7.84 20.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 118.344 0.52 . . . . 0.0 110.433 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 32.75 8.27 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.395 165.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.71 142.05 16.06 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -85.64 -21.63 28.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.461 1.504 . . . . 0.0 109.063 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 m -157.06 156.26 32.53 Favored 'General case' 0 N--CA 1.424 -1.761 1 N-CA-C 98.782 -4.525 . . . . 0.0 98.782 169.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.41 141.81 9.43 Favored Glycine 0 CA--C 1.468 -2.885 1 N-CA-C 99.681 -5.368 . . . . 0.0 99.681 -170.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -145.83 -167.65 2.77 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 101.373 -3.565 . . . . 0.0 101.373 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.81 168.36 27.44 Favored 'General case' 0 N--CA 1.427 -1.582 1 N-CA-C 96.882 -5.229 . . . . 0.0 96.882 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.55 91.57 1.06 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 103.112 -3.995 . . . . 0.0 103.112 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.61 156.55 33.72 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 171.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -138.88 18.87 2.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 42' ' ' GLY . 1.6 t -146.69 -157.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 101.686 -3.45 . . . . 0.0 101.686 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 98.68 -95.1 1.54 Allowed Glycine 0 CA--C 1.474 -2.475 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -129.49 -54.34 1.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.236 -3.616 . . . . 0.0 101.236 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.09 64.68 0.24 Allowed Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 173.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.57 0.0 OUTLIER 73.36 171.75 0.3 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.513 1.925 . . . . 0.0 110.306 -171.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.67 -173.17 3.62 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -109.97 156.33 20.61 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -106.64 148.58 28.17 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -138.74 148.85 44.39 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.73 128.11 49.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.88 76.89 0.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 126.94 2.096 . . . . 0.0 111.557 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.47 141.97 23.75 Favored Pre-proline 0 CA--C 1.496 -1.128 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.15 166.33 23.52 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.603 2.202 . . . . 0.0 110.648 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -86.68 15.19 5.91 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.926 -1.109 . . . . 0.0 111.485 -165.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.11 11.17 21.96 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.09 140.61 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 101.637 -3.468 . . . . 0.0 101.637 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.36 143.28 15.65 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.16 -156.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -164.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 7' ' ' ALA . 8.7 mm -70.52 125.01 27.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.437 -1.116 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 174.093 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -101.73 157.65 16.68 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.44 127.44 45.42 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 94.201 -6.222 . . . . 0.0 94.201 157.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -173.73 30.98 Favored Glycine 0 CA--C 1.475 -2.444 0 N-CA-C 103.532 -3.827 . . . . 0.0 103.532 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -78.98 140.92 37.9 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 163.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tt -90.98 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.62 171.54 14.24 Favored 'General case' 0 N--CA 1.42 -1.964 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.78 158.24 68.26 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.89 111.17 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.681 2.921 . . . . 0.0 110.633 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -125.69 132.07 52.47 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 1.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.9 t30 63.47 33.99 13.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 162.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.45 121.65 24.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.16 153.96 4.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -163.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.22 120.35 41.62 Favored 'General case' 0 N--CA 1.424 -1.732 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -89.18 128.33 35.8 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.5 t -80.01 159.31 26.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.59 115.18 46.92 Favored Pre-proline 0 N--CA 1.426 -1.659 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.8 113.19 1.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 123.048 2.499 . . . . 0.0 113.117 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.23 -49.54 0.69 Allowed Glycine 0 CA--C 1.489 -1.592 1 N-CA-C 101.045 -4.822 . . . . 0.0 101.045 -164.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m 99.64 -12.77 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 129.073 2.949 . . . . 0.0 109.662 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -50.75 -48.9 59.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.275 2.23 . . . . 0.0 115.213 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.13 -31.47 59.58 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.0 t -75.12 -24.53 58.06 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -49.63 77.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.635 -0.665 . . . . 0.0 111.865 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.8 -42.87 97.61 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 122.559 1.171 . . . . 0.0 111.148 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.0 t -63.2 -44.01 96.56 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 125.371 1.469 . . . . 0.0 108.899 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.61 -45.93 90.62 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 122.965 0.506 . . . . 0.0 110.557 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.95 -23.69 55.42 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -81.57 -21.08 38.67 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.62 38.39 2.23 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 164.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.51 134.72 12.11 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 103.315 -3.914 . . . . 0.0 103.315 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.3 p -102.83 4.95 38.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.859 0.838 . . . . 0.0 109.499 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 m -160.38 164.63 32.26 Favored 'General case' 0 CA--C 1.478 -1.804 1 N-CA-C 97.99 -4.819 . . . . 0.0 97.99 167.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.34 171.75 36.62 Favored Glycine 0 N--CA 1.414 -2.821 1 N-CA-C 99.261 -5.536 . . . . 0.0 99.261 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -160.92 -167.65 1.88 Allowed 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 96.609 -5.33 . . . . 0.0 96.609 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.5 m -154.75 176.1 12.88 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 97.487 -5.005 . . . . 0.0 97.487 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.99 -169.0 41.21 Favored Glycine 0 N--CA 1.42 -2.406 1 N-CA-C 96.805 -6.518 . . . . 0.0 96.805 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.84 173.48 6.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 101.702 -3.444 . . . . 0.0 101.702 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -157.31 163.04 39.11 Favored 'General case' 0 N--CA 1.42 -1.967 1 N-CA-C 95.81 -5.626 . . . . 0.0 95.81 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.31 158.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 1 N-CA-C 97.607 -4.961 . . . . 0.0 97.607 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 -43.89 1.6 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -118.61 -83.41 0.65 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.85 -148.69 18.09 Favored Glycine 0 CA--C 1.478 -2.278 1 N-CA-C 99.384 -5.487 . . . . 0.0 99.384 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.95 131.33 48.32 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 126.597 1.959 . . . . 0.0 107.936 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.75 175.76 11.31 Favored 'General case' 0 CA--C 1.482 -1.646 1 N-CA-C 98.846 -4.501 . . . . 0.0 98.846 -162.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.67 168.4 15.09 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -119.9 150.06 41.1 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.0 m -141.05 149.1 41.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 101.178 -3.638 . . . . 0.0 101.178 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.27 130.48 53.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 103.171 -2.9 . . . . 0.0 103.171 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.44 54.79 0.16 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.674 1.989 . . . . 0.0 110.998 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.26 132.8 32.95 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.18 172.46 13.0 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.436 2.091 . . . . 0.0 110.003 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.11 23.99 1.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.602 -0.686 . . . . 0.0 111.948 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.46 -7.48 28.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.23 143.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.78 146.41 17.94 Favored Glycine 0 CA--C 1.476 -2.368 1 N-CA-C 101.44 -4.664 . . . . 0.0 101.44 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.4 pt -142.31 -146.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 -165.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -69.68 123.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.259 1.0 OUTLIER . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 -167.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.537 0.684 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 171.68 8.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -136.11 140.26 43.58 Favored 'General case' 0 CA--C 1.488 -1.44 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -177.31 34.78 Favored Glycine 0 CA--C 1.475 -2.419 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -79.27 134.25 36.64 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 102.04 -3.319 . . . . 0.0 102.04 157.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -90.16 133.83 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.5 -147.94 0.36 Allowed 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 111.057 -2.792 . . . . 0.0 108.978 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -138.09 148.76 61.35 Favored Pre-proline 0 N--CA 1.42 -1.937 1 N-CA-C 94.691 -6.04 . . . . 0.0 94.691 170.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -76.01 151.77 35.46 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 122.052 1.769 . . . . 0.0 108.428 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.16 -12.18 19.82 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 127.446 2.299 . . . . 0.0 108.204 9.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -160.96 141.89 11.57 Favored 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 95.647 -5.686 . . . . 0.0 95.647 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.05 -159.79 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.14 165.09 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 N-CA-C 98.597 -4.594 . . . . 0.0 98.597 160.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 -157.44 0.46 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -138.97 -177.86 5.08 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 98.673 -4.566 . . . . 0.0 98.673 168.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.44 163.54 35.34 Favored 'General case' 0 N--CA 1.419 -1.999 1 N-CA-C 95.913 -5.588 . . . . 0.0 95.913 -175.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.28 119.26 31.97 Favored Pre-proline 0 N--CA 1.421 -1.883 1 N-CA-C 98.584 -4.599 . . . . 0.0 98.584 172.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -57.37 111.49 0.83 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.905 2.403 . . . . 0.0 113.14 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.6 -37.87 1.25 Allowed Glycine 0 CA--C 1.49 -1.506 1 N-CA-C 101.148 -4.781 . . . . 0.0 101.148 -162.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m 86.09 -5.43 0.79 Allowed 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 125.678 1.591 . . . . 0.0 112.242 158.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -61.79 -42.38 98.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.156 1.782 . . . . 0.0 112.531 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.22 -31.97 63.26 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -71.57 -50.04 34.89 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.96 -38.12 89.81 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 118.766 0.712 . . . . 0.0 110.602 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.5 m -59.58 -50.04 75.44 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.367 -0.833 . . . . 0.0 111.674 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.82 -43.96 91.39 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.861 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.1 t -54.1 -46.41 72.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.391 1.076 . . . . 0.0 110.91 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -65.5 -49.15 70.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.483 0.713 . . . . 0.0 110.596 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.96 -20.22 61.77 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.774 -0.579 . . . . 0.0 112.56 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -87.66 -6.61 58.17 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 118.615 0.643 . . . . 0.0 110.24 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 27.82 9.43 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.32 146.74 18.34 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 p -75.57 -37.23 60.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.511 -0.993 . . . . 0.0 110.726 -164.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 m -160.88 -177.5 6.18 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.723 -4.918 . . . . 0.0 97.723 165.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.39 -176.72 41.34 Favored Glycine 0 N--CA 1.414 -2.805 1 N-CA-C 98.614 -5.794 . . . . 0.0 98.614 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.57 180.0 6.84 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 97.015 -5.18 . . . . 0.0 97.015 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.2 m -103.52 165.41 11.05 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.5 171.42 39.98 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 97.923 -6.071 . . . . 0.0 97.923 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -103.39 145.43 30.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -116.99 96.15 5.32 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.32 127.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -42.45 1.43 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -169.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -119.27 -68.68 0.9 Allowed 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.31 -160.36 33.98 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 -172.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.64 136.51 51.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 -173.94 3.82 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.35 158.77 27.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 101.166 -3.642 . . . . 0.0 101.166 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -120.57 153.06 37.28 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -146.87 155.38 42.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -118.76 143.94 46.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 166.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.24 56.96 0.11 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 127.237 2.215 . . . . 0.0 111.197 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -96.23 133.37 25.11 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -71.84 174.94 10.38 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 122.206 1.824 . . . . 0.0 111.43 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.32 16.34 1.66 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -98.34 -5.27 33.2 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.87 169.68 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.35 160.23 27.84 Favored Glycine 0 CA--C 1.48 -2.106 1 N-CA-C 99.414 -5.475 . . . . 0.0 99.414 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 pt -144.88 -164.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 -163.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.89 128.54 34.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.002 0.429 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.97 162.67 12.84 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -132.08 130.45 41.28 Favored 'General case' 0 CA--C 1.489 -1.375 1 N-CA-C 95.077 -5.897 . . . . 0.0 95.077 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.95 -169.16 24.89 Favored Glycine 0 CA--C 1.477 -2.306 0 N-CA-C 104.025 -3.63 . . . . 0.0 104.025 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.28 140.26 30.97 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 159.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.71 150.3 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.23 174.74 14.79 Favored 'General case' 0 N--CA 1.415 -2.221 1 N-CA-C 98.535 -4.617 . . . . 0.0 98.535 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -85.67 158.54 56.7 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.54 113.46 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.019 2.479 . . . . 0.0 110.785 164.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -126.64 114.04 17.51 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 127.45 2.3 . . . . 0.0 106.636 1.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.4 t30 80.63 31.99 0.16 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.582 1.153 . . . . 0.0 109.126 156.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -123.04 123.03 39.95 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.82 158.26 6.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 CA-C-N 120.106 1.321 . . . . 0.0 114.028 -159.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 135.9 42.74 Favored 'General case' 0 CA--C 1.483 -1.604 1 N-CA-C 97.291 -5.077 . . . . 0.0 97.291 178.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -90.96 165.9 13.31 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -164.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 175.95 11.92 Favored 'General case' 0 N--CA 1.406 -2.647 1 N-CA-C 94.815 -5.994 . . . . 0.0 94.815 -170.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -149.43 176.56 2.2 Favored Pre-proline 0 N--CA 1.408 -2.573 1 N-CA-C 95.026 -5.916 . . . . 0.0 95.026 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.46 55.0 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.122 2.865 . . . . 0.0 110.607 161.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.96 150.43 11.77 Favored Glycine 0 CA--C 1.481 -2.032 1 N-CA-C 99.391 -5.484 . . . . 0.0 99.391 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -106.91 15.09 25.8 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 117.533 0.667 . . . . 0.0 111.239 -161.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -62.11 -61.0 2.78 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.934 1.293 . . . . 0.0 111.759 -166.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.56 -41.14 77.04 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 t -57.89 -58.41 8.51 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.585 1.154 . . . . 0.0 111.288 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.63 -33.57 75.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.066 0.546 . . . . 0.0 109.806 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.0 m -61.2 -50.02 74.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.402 0.681 . . . . 0.0 110.869 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.45 -37.5 68.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.643 0.777 . . . . 0.0 110.04 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.26 -46.26 83.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 110.112 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -62.28 -49.2 76.63 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.133 0.573 . . . . 0.0 110.995 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.28 -21.07 60.68 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.527 -0.733 . . . . 0.0 112.687 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -94.28 3.04 55.76 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.793 -0.567 . . . . 0.0 110.083 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.96 33.06 7.54 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 161.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.91 147.22 18.53 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 104.326 -3.51 . . . . 0.0 104.326 167.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -78.37 -37.14 44.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 117.99 0.895 . . . . 0.0 110.277 -166.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 m -160.52 -179.64 7.82 Favored 'General case' 0 N--CA 1.426 -1.655 1 N-CA-C 99.06 -4.422 . . . . 0.0 99.06 169.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.59 178.7 43.76 Favored Glycine 0 N--CA 1.423 -2.23 1 N-CA-C 99.52 -5.432 . . . . 0.0 99.52 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -167.19 -179.81 4.74 Favored 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 99.287 -4.338 . . . . 0.0 99.287 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.5 m -126.64 158.42 36.36 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.18 102.75 0.34 Allowed Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 105.015 -3.234 . . . . 0.0 105.015 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 174.07 5.31 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.07 26.04 0.01 OUTLIER 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.76 132.41 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -160.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.28 -95.44 2.1 Favored Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -83.58 -51.43 7.32 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.47 46.43 Favored Glycine 0 N--CA 1.42 -2.432 1 N-CA-C 97.694 -6.162 . . . . 0.0 97.694 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.377 0.2 OUTLIER -76.64 143.17 40.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.977 0.388 . . . . 0.0 110.755 173.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.0 9.06 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 101.956 -3.35 . . . . 0.0 101.956 -163.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 t -113.2 153.59 28.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -97.64 155.65 16.89 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.72 148.85 32.41 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.03 142.62 46.73 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 101.883 -3.376 . . . . 0.0 101.883 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.19 59.21 1.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.356 2.262 . . . . 0.0 112.11 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.6 mt -93.55 133.34 28.32 Favored Pre-proline 0 CA--C 1.495 -1.163 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.92 170.9 15.68 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.403 2.069 . . . . 0.0 110.611 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.86 32.59 0.59 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.726 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.19 -3.37 14.66 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.43 162.66 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 -175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.52 150.71 21.53 Favored Glycine 0 CA--C 1.481 -2.038 1 N-CA-C 98.552 -5.819 . . . . 0.0 98.552 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.6 pt -150.55 -150.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -159.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.04 128.02 31.84 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 167.69 21.58 Favored 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 164.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -127.99 132.04 49.2 Favored 'General case' 0 CA--C 1.48 -1.731 1 N-CA-C 94.017 -6.29 . . . . 0.0 94.017 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.77 36.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 105.551 -3.019 . . . . 0.0 105.551 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.46 134.15 40.92 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.39 148.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' VAL . . . -160.22 -176.88 5.89 Favored 'General case' 0 N--CA 1.413 -2.294 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 -173.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -101.74 168.31 9.26 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.33 130.33 31.66 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.37 2.046 . . . . 0.0 110.395 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -128.47 117.98 22.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 -7.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 70.91 19.54 5.71 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.385 1.074 . . . . 0.0 109.837 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.3 m -103.63 91.77 4.16 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.405 ' HA ' ' CB ' ' A' ' 7' ' ' ALA 0.287 27.2 m -59.4 154.86 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -165.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.56 175.58 5.43 Favored 'General case' 0 N--CA 1.421 -1.903 1 N-CA-C 98.175 -4.75 . . . . 0.0 98.175 175.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -136.39 152.81 51.02 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 97.128 -5.138 . . . . 0.0 97.128 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.05 175.58 6.06 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.32 119.45 33.14 Favored Pre-proline 0 N--CA 1.426 -1.654 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 173.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.47 101.24 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.819 2.346 . . . . 0.0 111.497 -170.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.89 -44.92 0.51 Allowed Glycine 0 CA--C 1.481 -2.092 1 N-CA-C 102.504 -4.238 . . . . 0.0 102.504 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m 121.75 -48.48 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 129.006 2.922 . . . . 0.0 107.299 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -39.94 -45.41 1.86 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.068 2.947 . . . . 0.0 118.097 -155.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -41.57 49.46 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 121.235 -0.916 . . . . 0.0 111.33 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 t -82.92 -25.73 32.12 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.81 -29.16 69.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.742 0.817 . . . . 0.0 110.396 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.7 m -70.52 -43.44 69.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.119 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.73 -39.91 95.55 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 122.075 0.941 . . . . 0.0 109.9 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -54.14 -45.68 72.05 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.531 1.132 . . . . 0.0 110.743 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -61.7 -48.97 78.36 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.31 -18.87 59.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.49 -22.7 24.74 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.634 0.652 . . . . 0.0 109.756 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.9 28.13 3.51 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 167.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.44 121.96 7.18 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.04 -2.824 . . . . 0.0 106.04 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -93.59 1.57 56.64 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 122.046 0.927 . . . . 0.0 109.959 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -160.19 160.69 33.12 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 98.121 -4.77 . . . . 0.0 98.121 169.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.83 178.57 46.55 Favored Glycine 0 CA--C 1.481 -2.089 1 N-CA-C 101.318 -4.713 . . . . 0.0 101.318 -171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -166.71 179.95 5.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.663 -3.829 . . . . 0.0 100.663 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.9 m -93.87 173.81 7.48 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.25 -172.72 31.08 Favored Glycine 0 CA--C 1.482 -2.019 1 N-CA-C 98.32 -5.912 . . . . 0.0 98.32 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -127.65 149.21 50.3 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.21 -4.367 . . . . 0.0 99.21 170.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -126.72 101.2 6.52 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.44 120.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.59 -42.03 1.38 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -118.05 -64.51 1.28 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.43 -138.09 5.9 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 105.254 -3.138 . . . . 0.0 105.254 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp -81.23 133.41 35.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.8 162.83 37.08 Favored 'General case' 0 N--CA 1.433 -1.288 1 N-CA-C 97.975 -4.824 . . . . 0.0 97.975 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -113.02 -176.49 2.91 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 121.162 1.801 . . . . 0.0 106.494 -169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -126.47 147.88 49.75 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 m -141.86 142.18 33.11 Favored 'General case' 0 N--CA 1.433 -1.278 1 N-CA-C 100.096 -4.039 . . . . 0.0 100.096 170.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.1 22.35 16.07 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -165.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.8 2.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 94.542 -6.095 . . . . 0.0 94.542 173.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.22 154.14 35.95 Favored Pre-proline 0 N--CA 1.427 -1.602 1 N-CA-C 96.024 -5.547 . . . . 0.0 96.024 152.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.09 166.3 30.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 122.156 1.806 . . . . 0.0 109.165 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.64 -10.92 56.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -86.09 -1.34 57.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.517 0.727 . . . . 0.0 110.082 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -100.28 142.52 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.13 13.25 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 99.65 -5.38 . . . . 0.0 99.65 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -130.09 -129.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -163.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -72.89 118.78 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 166.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -166.472 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 162.71 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -128.6 134.16 48.51 Favored 'General case' 0 CA--C 1.487 -1.463 1 N-CA-C 94.955 -5.943 . . . . 0.0 94.955 165.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.19 -175.14 32.9 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 105.576 -3.009 . . . . 0.0 105.576 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -76.06 132.89 40.38 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.8 137.17 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.52 -150.52 0.42 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.64 -2.527 . . . . 0.0 108.872 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -135.1 152.35 76.92 Favored Pre-proline 0 N--CA 1.421 -1.902 1 N-CA-C 94.612 -6.07 . . . . 0.0 94.612 161.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -67.41 157.55 61.21 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 CA-C-N 123.391 2.247 . . . . 0.0 108.439 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.74 -25.12 17.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 128.153 2.581 . . . . 0.0 110.278 5.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.76 106.1 2.25 Favored 'General case' 0 N--CA 1.434 -1.241 1 N-CA-C 99.612 -4.218 . . . . 0.0 99.612 -173.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.06 -168.23 1.69 Allowed 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 120.092 1.315 . . . . 0.0 107.648 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.18 164.6 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 160.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 -164.59 1.01 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.9 167.92 20.3 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 96.314 -5.439 . . . . 0.0 96.314 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.42 156.41 48.59 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 98.231 -4.729 . . . . 0.0 98.231 -167.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.05 116.15 45.01 Favored Pre-proline 0 N--CA 1.424 -1.752 1 N-CA-C 96.304 -5.443 . . . . 0.0 96.304 164.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -63.59 102.41 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 125.025 2.83 . . . . 0.0 114.788 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.98 -172.47 45.47 Favored Glycine 0 N--CA 1.418 -2.507 1 N-CA-C 96.184 -6.767 . . . . 0.0 96.184 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -38.24 23.86 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 118.437 1.119 . . . . 0.0 108.675 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.51 -60.02 2.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.337 2.655 . . . . 0.0 116.124 -165.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.56 -54.37 10.51 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -166.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.29 -47.52 79.17 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 122.292 -0.534 . . . . 0.0 110.971 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -64.69 -40.98 96.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 m -64.8 -44.62 89.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.492 -0.755 . . . . 0.0 111.035 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.88 -38.53 91.27 Favored 'General case' 0 C--N 1.358 0.964 0 CA-C-O 122.342 1.068 . . . . 0.0 109.985 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -58.93 -50.24 74.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.512 1.125 . . . . 0.0 110.572 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -68.76 -35.8 77.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.12 -29.29 54.7 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.264 -0.897 . . . . 0.0 111.806 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -77.29 -35.06 55.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.739 0.7 . . . . 0.0 109.419 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.61 43.32 0.82 Allowed Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.07 157.09 21.0 Favored Glycine 0 CA--C 1.484 -1.897 1 N-CA-C 102.263 -4.335 . . . . 0.0 102.263 159.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.8 m -81.3 -38.05 27.4 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -168.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.2 m -160.5 168.79 24.33 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 99.929 -4.1 . . . . 0.0 99.929 175.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.11 178.55 45.92 Favored Glycine 0 N--CA 1.421 -2.355 1 N-CA-C 99.969 -5.252 . . . . 0.0 99.969 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -169.66 -175.49 2.15 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -171.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.89 145.98 29.12 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.84 167.96 38.84 Favored Glycine 0 N--CA 1.419 -2.486 1 N-CA-C 99.18 -5.568 . . . . 0.0 99.18 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -164.37 -168.04 1.44 Allowed 'General case' 0 N--CA 1.42 -1.971 1 N-CA-C 95.997 -5.557 . . . . 0.0 95.997 170.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 99.59 61.4 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 131.324 3.85 . . . . 0.0 102.244 -167.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.7 t -141.41 166.95 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 1 N-CA-C 99.627 -4.212 . . . . 0.0 99.627 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.32 80.23 0.27 Allowed Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.54 -3.024 . . . . 0.0 105.54 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -173.34 -145.16 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 94.47 -6.122 . . . . 0.0 94.47 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.86 120.15 1.87 Allowed Glycine 0 CA--C 1.484 -1.902 1 N-CA-C 101.349 -4.701 . . . . 0.0 101.349 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tp 73.88 175.53 0.26 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.608 1.963 . . . . 0.0 108.962 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.79 -173.78 0.42 Allowed 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 98.183 -4.747 . . . . 0.0 98.183 171.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.3 m -125.83 176.48 6.92 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 100.499 -3.889 . . . . 0.0 100.499 159.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -113.94 152.52 30.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -145.63 149.94 35.43 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -116.47 137.73 51.94 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.25 61.05 0.23 Allowed 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.345 2.258 . . . . 0.0 110.517 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.36 131.0 26.99 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.61 178.02 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.986 2.457 . . . . 0.0 110.714 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -74.61 -1.54 22.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -89.81 -1.22 57.94 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 120.937 -1.102 . . . . 0.0 109.761 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.93 170.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.98 152.01 24.11 Favored Glycine 0 CA--C 1.478 -2.269 1 N-CA-C 97.719 -6.152 . . . . 0.0 97.719 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.46 -149.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -68.28 134.98 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.421 -1.924 1 N-CA-C 93.188 -6.597 . . . . 0.0 93.188 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.031 0.443 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 169.3 9.08 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -128.2 144.38 51.12 Favored 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 94.587 -6.079 . . . . 0.0 94.587 166.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 178.06 37.52 Favored Glycine 0 CA--C 1.475 -2.409 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -81.7 129.91 34.88 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 159.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 14.6 tt -90.52 140.16 16.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.48 -149.76 0.42 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 127.097 2.159 . . . . 0.0 108.285 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.59 165.58 24.22 Favored Pre-proline 0 N--CA 1.418 -2.07 1 N-CA-C 95.229 -5.841 . . . . 0.0 95.229 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.01 152.17 83.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.22 1.947 . . . . 0.0 108.706 167.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -88.27 -51.76 5.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.21 2.204 . . . . 0.0 108.095 1.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.84 121.85 14.6 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 89.567 -7.938 . . . . 0.0 89.567 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 m -163.57 -166.32 1.19 Allowed 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 102.252 -3.24 . . . . 0.0 102.252 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.03 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 97.796 -4.89 . . . . 0.0 97.796 160.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -161.62 0.66 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 162.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -137.76 167.36 21.87 Favored 'General case' 0 CA--C 1.484 -1.581 1 N-CA-C 97.257 -5.09 . . . . 0.0 97.257 164.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.3 t -108.42 163.58 13.09 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -110.29 106.0 57.64 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 97.712 -4.921 . . . . 0.0 97.712 162.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -53.14 104.62 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 124.045 2.48 . . . . 0.0 118.245 -161.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.01 -162.64 33.77 Favored Glycine 0 N--CA 1.423 -2.193 1 N-CA-C 97.569 -6.212 . . . . 0.0 97.569 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -88.86 -34.03 17.14 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -39.47 -59.64 1.06 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 128.568 2.747 . . . . 0.0 116.643 -160.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -53.65 11.08 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.71 -43.04 98.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 122.115 -0.638 . . . . 0.0 111.621 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -44.5 97.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.818 0.847 . . . . 0.0 109.988 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -63.09 -43.88 97.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.395 -0.815 . . . . 0.0 110.515 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.08 -40.61 90.97 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 122.422 1.106 . . . . 0.0 110.215 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.31 -44.39 95.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.817 1.247 . . . . 0.0 109.658 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -74.98 -28.79 60.69 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -78.39 -24.33 46.38 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.971 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -78.0 -58.18 3.4 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.82 45.52 0.07 OUTLIER Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.85 159.07 14.15 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 104.215 -3.554 . . . . 0.0 104.215 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 m -91.97 -31.14 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.653 0.74 . . . . 0.0 109.757 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -146.22 154.78 42.13 Favored 'General case' 0 CA--C 1.476 -1.896 1 N-CA-C 99.837 -4.134 . . . . 0.0 99.837 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.97 155.69 26.57 Favored Glycine 0 N--CA 1.417 -2.591 1 N-CA-C 98.427 -5.869 . . . . 0.0 98.427 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -166.51 -172.99 2.34 Favored 'General case' 0 N--CA 1.424 -1.736 1 N-CA-C 96.863 -5.236 . . . . 0.0 96.863 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.2 m -72.86 179.57 3.63 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 122.699 1.237 . . . . 0.0 110.817 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.24 174.08 39.48 Favored Glycine 0 N--CA 1.41 -3.07 1 N-CA-C 98.17 -5.972 . . . . 0.0 98.17 168.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -137.45 132.74 33.82 Favored 'General case' 0 N--CA 1.427 -1.584 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 172.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -117.23 105.28 12.04 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.98 125.18 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.35 -32.07 3.47 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -124.35 -67.55 0.91 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.6 -148.92 19.49 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.295 -3.122 . . . . 0.0 105.295 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 tp -58.87 143.76 46.61 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.648 2.379 . . . . 0.0 107.942 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.11 -172.66 4.18 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -170.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.6 m -117.46 170.81 8.43 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 165.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.8 t-105 -124.32 156.83 36.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.2 m -145.03 147.54 32.72 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -113.6 136.73 52.5 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.55 69.73 0.46 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.358 2.663 . . . . 0.0 111.644 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 mt -105.06 139.11 19.79 Favored Pre-proline 0 CA--C 1.503 -0.837 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -68.52 167.44 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.657 2.238 . . . . 0.0 111.596 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -67.49 -21.0 65.53 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.342 1.057 . . . . 0.0 113.742 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -84.02 2.37 39.38 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 110.847 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.29 125.89 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.36 152.27 20.15 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 105.842 -2.903 . . . . 0.0 105.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.1 pt -140.46 -147.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 -166.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mm -72.71 135.5 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.412 -2.349 1 N-CA-C 93.569 -6.456 . . . . 0.0 93.569 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.3 0.571 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.4 171.29 7.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -131.71 144.14 50.77 Favored 'General case' 0 CA--C 1.485 -1.549 1 N-CA-C 95.694 -5.669 . . . . 0.0 95.694 165.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.78 36.6 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.709 -2.956 . . . . 0.0 105.709 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.37 133.41 35.91 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.37 135.17 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.21 -150.0 0.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 111.328 -2.669 . . . . 0.0 107.026 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 9.2 pt20 -142.14 164.36 34.16 Favored Pre-proline 0 N--CA 1.42 -1.926 1 N-CA-C 96.017 -5.549 . . . . 0.0 96.017 169.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -66.97 149.27 82.88 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 CA-C-N 122.4 1.893 . . . . 0.0 109.698 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -81.86 -22.72 36.78 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.491 2.316 . . . . 0.0 107.844 -1.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -177.49 155.53 1.09 Allowed 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 94.094 -6.261 . . . . 0.0 94.094 -171.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 73.2 m 161.22 -149.33 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.116 1 N-CA-C 97.971 -4.825 . . . . 0.0 97.971 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.57 164.7 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 1 N-CA-C 98.802 -4.518 . . . . 0.0 98.802 160.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -155.46 0.24 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 161.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -134.82 -179.5 5.65 Favored 'General case' 0 CA--C 1.482 -1.641 1 N-CA-C 98.919 -4.474 . . . . 0.0 98.919 164.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.2 t -139.1 174.01 10.96 Favored 'General case' 0 N--CA 1.416 -2.127 1 N-CA-C 96.817 -5.253 . . . . 0.0 96.817 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -128.04 132.67 24.47 Favored Pre-proline 0 N--CA 1.416 -2.174 1 N-CA-C 97.639 -4.948 . . . . 0.0 97.639 173.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -55.38 118.37 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.109 2.54 . . . . 0.0 112.773 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.81 -44.16 1.21 Allowed Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 25.4 m 91.87 -13.78 0.2 Allowed 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 127.784 2.434 . . . . 0.0 112.917 175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -47.14 -48.28 23.34 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.54 -28.89 56.67 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 111.241 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.21 -45.47 60.15 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.25 -47.49 78.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.854 1.262 . . . . 0.0 109.163 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -59.78 -45.67 91.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.606 0.762 . . . . 0.0 112.07 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 mt -66.65 -40.13 88.53 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.887 -1.133 . . . . 0.0 110.54 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.29 -43.45 83.18 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.648 1.179 . . . . 0.0 110.779 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -59.37 -53.31 59.67 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.35 0.66 . . . . 0.0 110.679 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.31 -16.97 61.36 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.622 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -91.22 -5.2 55.19 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.794 -0.566 . . . . 0.0 109.895 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.18 27.92 7.95 Favored Glycine 0 CA--C 1.49 -1.5 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.036 166.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.9 146.29 17.42 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -78.87 -27.93 44.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.318 -1.107 . . . . 0.0 111.06 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 m -161.07 174.73 13.3 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 99.674 -4.195 . . . . 0.0 99.674 166.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.06 172.56 43.91 Favored Glycine 0 N--CA 1.423 -2.222 1 N-CA-C 98.82 -5.712 . . . . 0.0 98.82 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -159.63 174.76 14.09 Favored 'General case' 0 CA--C 1.491 -1.3 1 N-CA-C 99.521 -4.252 . . . . 0.0 99.521 -173.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.8 m -71.82 163.4 27.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 119.818 1.19 . . . . 0.0 110.429 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.25 171.81 37.35 Favored Glycine 0 N--CA 1.424 -2.139 1 N-CA-C 99.568 -5.413 . . . . 0.0 99.568 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -120.79 134.59 55.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -110.85 106.42 15.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.34 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.4 -21.87 10.51 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -132.07 -74.02 0.51 Allowed 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.34 -160.62 34.0 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.68 135.54 57.66 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 127.253 2.221 . . . . 0.0 107.167 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.47 -173.45 3.77 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -170.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.7 t -122.58 155.56 36.04 Favored 'General case' 0 CA--C 1.494 -1.181 1 N-CA-C 99.986 -4.079 . . . . 0.0 99.986 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -114.24 151.29 33.05 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.7 m -146.3 149.15 33.28 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.77 138.89 53.06 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 103.385 -2.82 . . . . 0.0 103.385 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.65 58.54 0.1 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 127.67 2.388 . . . . 0.0 111.473 171.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.17 132.68 23.02 Favored Pre-proline 0 CA--C 1.501 -0.911 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.34 171.68 17.79 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.283 1.851 . . . . 0.0 110.965 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.76 -18.23 62.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.672 1.989 . . . . 0.0 114.753 -169.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -86.73 -5.72 59.04 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.278 0.631 . . . . 0.0 109.842 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.17 138.54 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.3 152.52 17.19 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 pt -131.37 -150.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -160.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.0 mm -76.39 113.49 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 176.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 165.87 26.14 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -134.17 130.07 36.74 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 94.465 -6.124 . . . . 0.0 94.465 166.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.99 -174.1 31.47 Favored Glycine 0 CA--C 1.471 -2.695 0 N-CA-C 103.278 -3.929 . . . . 0.0 103.278 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.94 134.91 37.79 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 163.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tt -90.9 143.56 10.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.25 -153.66 0.51 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 126.842 2.057 . . . . 0.0 105.618 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.83 66.02 Favored Pre-proline 0 N--CA 1.424 -1.764 1 N-CA-C 94.199 -6.223 . . . . 0.0 94.199 165.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.16 150.57 59.94 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.277 1.984 . . . . 0.0 108.407 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -85.98 -35.59 20.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.914 1.686 . . . . 0.0 109.402 10.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -159.26 145.31 16.38 Favored 'General case' 0 N--CA 1.419 -2.02 1 N-CA-C 94.773 -6.01 . . . . 0.0 94.773 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.4 m 175.37 -155.3 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.433 1 N-CA-C 96.642 -5.318 . . . . 0.0 96.642 172.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.07 165.38 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 1 N-CA-C 96.913 -5.217 . . . . 0.0 96.913 161.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.78 -166.91 1.55 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 164.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -135.73 151.19 49.9 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 101.619 -3.474 . . . . 0.0 101.619 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.0 t -124.31 156.94 36.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.36 118.29 47.73 Favored Pre-proline 0 N--CA 1.42 -1.927 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -176.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 108.28 0.45 Allowed 'Trans proline' 0 CA--C 1.506 -0.914 0 C-N-CA 122.999 2.466 . . . . 0.0 111.892 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.78 0.54 Allowed Glycine 0 CA--C 1.482 -1.97 1 N-CA-C 100.374 -5.09 . . . . 0.0 100.374 -164.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.252 6.8 m 114.49 -35.79 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 108.714 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -39.46 -52.06 2.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.999 2.519 . . . . 0.0 117.118 -157.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.62 -41.51 75.16 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 121.033 -1.042 . . . . 0.0 112.066 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -90.14 -21.76 22.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.934 -1.333 . . . . 0.0 109.176 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.6 -43.08 93.82 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 166.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.59 -47.21 87.2 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.572 -0.705 . . . . 0.0 110.763 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.3 mt -58.87 -43.97 90.98 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 123.676 0.79 . . . . 0.0 111.027 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.7 t -54.07 -47.51 71.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.997 1.319 . . . . 0.0 110.863 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -69.24 -40.62 77.79 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.48 0.312 . . . . 0.0 111.391 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.82 -25.32 48.75 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 118.01 0.368 . . . . 0.0 111.469 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -72.76 -54.37 9.08 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.03 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 167.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.66 136.75 13.82 Favored Glycine 0 CA--C 1.49 -1.515 1 N-CA-C 102.696 -4.162 . . . . 0.0 102.696 165.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -101.58 11.1 39.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.778 0.799 . . . . 0.0 110.098 -163.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.5 m -160.01 159.97 32.71 Favored 'General case' 0 CA--C 1.484 -1.582 1 N-CA-C 98.032 -4.803 . . . . 0.0 98.032 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.58 42.57 Favored Glycine 0 CA--C 1.479 -2.184 1 N-CA-C 99.672 -5.371 . . . . 0.0 99.672 -168.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -167.34 -167.26 0.88 Allowed 'General case' 0 N--CA 1.435 -1.195 1 N-CA-C 98.055 -4.794 . . . . 0.0 98.055 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.9 m -99.19 177.25 5.27 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.22 179.73 42.86 Favored Glycine 0 N--CA 1.423 -2.207 1 N-CA-C 102.569 -4.213 . . . . 0.0 102.569 -175.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -143.95 148.52 35.46 Favored 'General case' 0 CA--C 1.486 -1.505 1 N-CA-C 97.248 -5.093 . . . . 0.0 97.248 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -133.39 112.79 11.89 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.34 124.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.82 -31.56 3.89 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 104.702 -3.359 . . . . 0.0 104.702 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -113.47 -70.88 0.78 Allowed 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.3 -153.15 24.33 Favored Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tt -72.39 144.38 48.22 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.3 -168.96 2.4 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 m -123.61 -179.87 4.52 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 165.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -130.78 152.98 49.53 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.9 m -148.25 150.89 34.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.33 140.58 49.38 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 170.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.53 0.82 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.331 2.253 . . . . 0.0 111.03 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -91.17 146.52 33.71 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -66.53 162.83 35.05 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.521 2.147 . . . . 0.0 111.001 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.64 -19.1 62.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.381 0.672 . . . . 0.0 112.449 -168.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -82.2 -1.26 48.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.865 1.266 . . . . 0.0 110.975 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.56 129.22 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.02 20.83 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.62 -154.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 -167.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.4 139.69 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.422 -1.852 1 N-CA-C 95.266 -5.828 . . . . 0.0 95.266 -173.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -102.51 152.74 20.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -120.76 119.87 34.01 Favored 'General case' 0 CA--C 1.487 -1.473 1 N-CA-C 95.336 -5.801 . . . . 0.0 95.336 159.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.67 -177.88 35.12 Favored Glycine 0 CA--C 1.472 -2.607 1 N-CA-C 102.747 -4.141 . . . . 0.0 102.747 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.79 144.36 27.79 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -90.76 148.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.87 -164.14 1.48 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 146.94 32.17 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 101.429 -3.545 . . . . 0.0 101.429 161.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.91 113.39 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.176 2.584 . . . . 0.0 107.754 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.96 162.54 35.2 Favored 'General case' 0 CA--C 1.473 -2.011 1 N-CA-C 99.407 -4.294 . . . . 0.0 99.407 5.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.471 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER 83.14 -5.51 1.24 Allowed 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.087 0.867 . . . . 0.0 110.922 162.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -90.65 -143.83 0.17 Allowed 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 125.366 1.466 . . . . 0.0 107.715 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 43' ' ' HIS . 34.8 m -141.75 -179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 1 N-CA-C 98.366 -4.679 . . . . 0.0 98.366 160.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.7 156.28 39.58 Favored 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 94.494 -6.113 . . . . 0.0 94.494 162.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -96.0 123.14 39.48 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 t -94.36 143.3 26.52 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -111.82 121.22 40.31 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.94 120.6 8.49 Favored 'Trans proline' 0 CA--C 1.506 -0.901 0 CA-C-N 123.565 2.309 . . . . 0.0 111.454 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.73 -55.61 0.68 Allowed Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.819 -5.312 . . . . 0.0 99.819 -160.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 m 113.27 -27.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 129.676 3.19 . . . . 0.0 109.839 167.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.29 -49.65 2.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.673 2.389 . . . . 0.0 117.147 -160.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.2 -49.01 69.07 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 121.669 -0.644 . . . . 0.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.7 t -85.91 -23.9 26.83 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.621 -0.929 . . . . 0.0 110.026 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.82 -36.92 85.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.572 -0.705 . . . . 0.0 109.124 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.8 m -66.41 -41.04 89.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.947 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.83 -44.5 95.99 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.632 0.773 . . . . 0.0 109.833 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 t -52.6 -50.14 63.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.406 1.482 . . . . 0.0 110.272 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -60.73 -47.69 85.17 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.721 0.409 . . . . 0.0 112.04 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.09 -31.79 66.39 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.487 -0.758 . . . . 0.0 112.783 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -78.48 -25.23 45.68 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.788 0.722 . . . . 0.0 109.784 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.97 42.57 0.77 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 161.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.68 135.37 12.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.879 -2.888 . . . . 0.0 105.879 170.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -84.02 -16.14 45.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.648 0.779 . . . . 0.0 109.928 -166.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t -158.8 169.98 23.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.99 175.39 46.64 Favored Glycine 0 N--CA 1.425 -2.046 1 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 p80 179.2 -176.45 0.26 Allowed 'General case' 0 N--CA 1.435 -1.193 1 N-CA-C 99.513 -4.255 . . . . 0.0 99.513 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.67 173.84 7.49 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.02 -171.05 40.99 Favored Glycine 0 CA--C 1.483 -1.953 1 N-CA-C 97.322 -6.311 . . . . 0.0 97.322 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.29 160.86 40.28 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 97.256 -5.09 . . . . 0.0 97.256 171.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -160.01 36.88 0.18 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.263 2.2 t 58.53 -143.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -157.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.92 -126.19 6.38 Favored Glycine 0 CA--C 1.48 -2.133 1 N-CA-C 99.548 -5.421 . . . . 0.0 99.548 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.471 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 66.9 m80 -121.13 -20.32 6.83 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 125.611 1.565 . . . . 0.0 108.192 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.39 -173.89 45.78 Favored Glycine 0 N--CA 1.421 -2.318 1 N-CA-C 96.481 -6.647 . . . . 0.0 96.481 -165.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.03 102.07 10.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 118.271 1.035 . . . . 0.0 108.232 -168.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.99 -179.83 7.54 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 125.231 1.413 . . . . 0.0 109.005 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 155.64 39.47 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 -170.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -90.95 154.36 19.52 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.9 m -141.95 144.02 33.52 Favored 'General case' 0 CA--C 1.479 -1.783 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 161.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -112.5 121.93 46.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.17 75.94 0.16 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 126.424 1.89 . . . . 0.0 110.085 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.5 mt -99.74 140.19 21.39 Favored Pre-proline 0 CA--C 1.497 -1.088 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.66 171.3 17.52 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.502 2.135 . . . . 0.0 109.943 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -78.56 -3.88 45.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -163.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -91.14 1.31 57.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.939 0.896 . . . . 0.0 109.917 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.95 140.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.56 148.58 18.91 Favored Glycine 0 CA--C 1.482 -1.997 1 N-CA-C 102.598 -4.201 . . . . 0.0 102.598 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.53 -153.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -161.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 mm -72.53 139.46 19.59 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.423 -1.824 1 N-CA-C 92.91 -6.7 . . . . 0.0 92.91 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.698 0.761 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.71 157.15 34.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -132.52 127.84 36.03 Favored 'General case' 0 CA--C 1.488 -1.423 1 N-CA-C 98.113 -4.773 . . . . 0.0 98.113 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -167.23 22.25 Favored Glycine 0 CA--C 1.475 -2.421 1 N-CA-C 102.017 -4.433 . . . . 0.0 102.017 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.47 135.34 39.37 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 161.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -85.16 135.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -138.24 0.09 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.492 -2.595 . . . . 0.0 106.577 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -151.56 164.03 21.63 Favored Pre-proline 0 N--CA 1.422 -1.829 1 N-CA-C 95.329 -5.804 . . . . 0.0 95.329 162.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -65.22 148.4 88.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.845 2.052 . . . . 0.0 109.328 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.53 -51.01 6.15 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 127.97 2.508 . . . . 0.0 109.463 5.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -142.3 143.38 32.77 Favored 'General case' 0 CA--C 1.479 -1.767 1 N-CA-C 92.615 -6.809 . . . . 0.0 92.615 169.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.2 m -172.83 -158.85 0.11 Allowed 'General case' 0 N--CA 1.435 -1.179 1 N-CA-C 100.133 -4.025 . . . . 0.0 100.133 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.26 166.37 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 96.612 -5.329 . . . . 0.0 96.612 159.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.16 -170.48 3.06 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -130.09 145.21 51.67 Favored 'General case' 0 CA--C 1.472 -2.027 1 N-CA-C 93.075 -6.639 . . . . 0.0 93.075 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -160.44 -165.37 1.42 Allowed 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 94.863 -5.977 . . . . 0.0 94.863 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -144.42 171.91 6.12 Favored Pre-proline 0 N--CA 1.416 -2.154 1 N-CA-C 99.821 -4.14 . . . . 0.0 99.821 -161.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.88 60.3 2.26 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.304 2.669 . . . . 0.0 110.049 164.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.59 124.43 0.81 Allowed Glycine 0 N--CA 1.422 -2.251 1 N-CA-C 100.948 -4.861 . . . . 0.0 100.948 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.37 38.21 0.35 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.088 1.755 . . . . 0.0 112.276 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -70.08 -63.96 0.98 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.369 1.468 . . . . 0.0 110.127 -161.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -23.46 61.93 Favored Glycine 0 CA--C 1.495 -1.19 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -79.65 -14.66 58.63 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.724 -0.655 . . . . 0.0 111.4 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.7 -55.35 23.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 119.714 1.143 . . . . 0.0 109.735 168.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.32 90.88 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.004 1.322 . . . . 0.0 112.767 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.53 -40.49 89.16 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.574 0.702 . . . . 0.0 111.219 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.6 -42.87 98.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -64.1 -46.38 84.49 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 122.465 0.306 . . . . 0.0 110.935 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.32 -15.94 61.89 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.128 -0.982 . . . . 0.0 112.495 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -92.67 -6.87 48.36 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.02 0.528 . . . . 0.0 109.878 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 32.11 11.14 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.81 18.92 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 103.858 -3.697 . . . . 0.0 103.858 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -82.13 -43.33 17.93 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 121.828 -0.807 . . . . 0.0 109.761 -167.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -160.71 -179.76 7.88 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.72 -4.548 . . . . 0.0 98.72 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.01 -176.39 42.39 Favored Glycine 0 N--CA 1.418 -2.503 1 N-CA-C 99.313 -5.515 . . . . 0.0 99.313 -167.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -160.33 -176.6 5.71 Favored 'General case' 0 CA--C 1.488 -1.409 1 N-CA-C 98.511 -4.625 . . . . 0.0 98.511 -174.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.7 m -140.32 161.64 37.2 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.06 109.73 0.95 Allowed Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 104.571 -3.411 . . . . 0.0 104.571 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -171.84 -179.75 2.53 Favored 'General case' 0 N--CA 1.43 -1.425 1 N-CA-C 98.138 -4.764 . . . . 0.0 98.138 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -153.78 148.74 26.68 Favored 'General case' 0 N--CA 1.433 -1.319 1 N-CA-C 95.849 -5.612 . . . . 0.0 95.849 163.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.52 173.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 N-CA-C 97.814 -4.884 . . . . 0.0 97.814 173.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.29 75.89 1.98 Allowed Glycine 0 C--N 1.351 1.372 0 N-CA-C 105.163 -3.175 . . . . 0.0 105.163 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.38 -50.29 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.35 1 N-CA-C 99.928 -4.101 . . . . 0.0 99.928 -170.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.02 -92.41 0.12 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.59 174.16 8.01 Favored 'General case' 0 N--CA 1.427 -1.597 1 N-CA-C 95.838 -5.616 . . . . 0.0 95.838 -173.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.44 -174.62 4.57 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.9 t -118.01 158.3 25.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 101.742 -3.429 . . . . 0.0 101.742 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -97.17 153.98 17.65 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 m -145.63 152.17 39.22 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 101.444 -3.539 . . . . 0.0 101.444 163.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.87 143.15 48.08 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.84 51.58 0.57 Allowed 'General case' 0 CA--C 1.498 -1.019 0 C-N-CA 126.928 2.091 . . . . 0.0 111.986 171.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -93.0 133.04 29.49 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.97 172.94 11.91 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.542 2.161 . . . . 0.0 110.283 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.71 26.33 1.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -97.31 -7.91 30.94 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG11 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -101.81 -176.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.438 ' H ' HG11 ' A' ' 56' ' ' VAL . . . -151.17 166.65 30.57 Favored Glycine 0 CA--C 1.479 -2.181 1 N-CA-C 98.11 -5.996 . . . . 0.0 98.11 -174.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.3 pt -153.8 -168.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.478 -1.807 1 N-CA-C 99.282 -4.34 . . . . 0.0 99.282 -168.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -64.17 111.65 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.118 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -104.47 166.42 10.41 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -130.46 134.33 47.01 Favored 'General case' 0 CA--C 1.491 -1.289 1 N-CA-C 94.574 -6.084 . . . . 0.0 94.574 158.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 -179.69 36.78 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -79.21 132.38 36.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 159.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.62 138.06 20.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.84 -156.88 0.57 Allowed 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 127.71 2.404 . . . . 0.0 107.913 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -121.89 142.94 37.36 Favored Pre-proline 0 N--CA 1.424 -1.774 1 N-CA-C 94.846 -5.983 . . . . 0.0 94.846 165.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -63.36 138.03 63.72 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.034 2.489 . . . . 0.0 107.592 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -79.97 -49.45 11.83 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 127.291 2.236 . . . . 0.0 111.469 12.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -156.58 145.08 19.86 Favored 'General case' 0 N--CA 1.417 -2.08 1 N-CA-C 94.538 -6.097 . . . . 0.0 94.538 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 m 172.11 -157.65 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 43' ' ' HIS . 5.6 m -125.83 159.04 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 1 N-CA-C 97.143 -5.132 . . . . 0.0 97.143 162.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.85 -175.74 5.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 162.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -132.03 170.62 14.68 Favored 'General case' 0 CA--C 1.481 -1.682 1 N-CA-C 96.638 -5.319 . . . . 0.0 96.638 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -160.42 169.04 23.89 Favored 'General case' 0 N--CA 1.412 -2.364 1 N-CA-C 98.754 -4.535 . . . . 0.0 98.754 -170.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.27 104.21 22.42 Favored Pre-proline 0 N--CA 1.416 -2.136 1 N-CA-C 93.085 -6.635 . . . . 0.0 93.085 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.95 101.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.306 0 CA-C-N 124.987 2.817 . . . . 0.0 118.138 -141.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.97 8.33 79.32 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -91.87 170.65 9.7 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -49.57 -36.69 24.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.704 2.002 . . . . 0.0 115.209 -169.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.33 -59.84 10.01 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 123.115 0.388 . . . . 0.0 112.642 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -79.57 -13.71 59.34 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 118.792 1.296 . . . . 0.0 109.611 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.21 -49.53 76.79 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -42.84 99.43 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.65 -38.86 90.54 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.856 1.207 . . . . 0.0 110.597 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -62.57 -48.78 77.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -57.76 -50.05 74.52 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.896 0.878 . . . . 0.0 112.268 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.4 -10.33 57.5 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -4.07 28.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.634 0.774 . . . . 0.0 110.016 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.14 37.91 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.51 114.99 4.28 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 m -101.9 -5.59 24.55 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.85 169.32 24.62 Favored 'General case' 0 N--CA 1.435 -1.197 1 N-CA-C 97.462 -5.014 . . . . 0.0 97.462 163.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.88 -177.8 42.45 Favored Glycine 0 CA--C 1.479 -2.181 0 N-CA-C 103.797 -3.721 . . . . 0.0 103.797 -174.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -163.48 -166.56 1.25 Allowed 'General case' 0 N--CA 1.433 -1.286 1 N-CA-C 97.229 -5.1 . . . . 0.0 97.229 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.8 m -154.71 163.28 40.47 Favored 'General case' 0 CA--C 1.484 -1.568 1 N-CA-C 98.938 -4.468 . . . . 0.0 98.938 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.55 -176.48 47.68 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 103.274 -3.93 . . . . 0.0 103.274 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.42 143.11 29.87 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 97.178 -5.119 . . . . 0.0 97.178 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -164.42 53.84 0.14 Allowed 'General case' 0 CA--C 1.491 -1.312 1 N-CA-C 97.357 -5.053 . . . . 0.0 97.357 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.301 1.5 t 57.76 -146.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 C-N-CA 125.628 1.571 . . . . 0.0 107.95 -160.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.04 -127.63 6.9 Favored Glycine 0 N--CA 1.424 -2.111 1 N-CA-C 98.915 -5.674 . . . . 0.0 98.915 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.473 ' H ' HG11 ' A' ' 13' ' ' VAL . 31.9 m170 -119.23 -10.02 9.83 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.19 -169.86 42.93 Favored Glycine 0 N--CA 1.423 -2.196 1 N-CA-C 98.168 -5.973 . . . . 0.0 98.168 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.59 128.63 36.86 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.91 171.37 8.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.1 t -113.46 166.91 11.04 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 100.856 -3.757 . . . . 0.0 100.856 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -132.15 148.78 52.49 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.4 m -142.18 154.05 44.52 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -120.25 136.03 54.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.72 56.19 0.18 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.588 2.355 . . . . 0.0 109.896 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.95 135.98 25.31 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -66.5 169.1 14.82 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.112 1.875 . . . . 0.0 112.098 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.8 -6.71 50.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -93.6 1.97 56.51 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 123.01 0.524 . . . . 0.0 110.061 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.06 133.85 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.04 151.55 19.49 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 105.766 -2.934 . . . . 0.0 105.766 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 pt -140.7 -166.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.47 140.56 17.79 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -172.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.421 -1.879 1 N-CA-C 94.982 -5.933 . . . . 0.0 94.982 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.426 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -140.59 178.19 7.5 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -135.83 131.77 35.81 Favored 'General case' 0 CA--C 1.492 -1.274 1 N-CA-C 96.781 -5.266 . . . . 0.0 96.781 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -177.89 35.21 Favored Glycine 0 CA--C 1.479 -2.204 0 N-CA-C 103.909 -3.677 . . . . 0.0 103.909 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -74.73 131.71 41.05 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.5 130.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.22 -153.0 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 111.418 -2.628 . . . . 0.0 108.275 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -130.79 152.27 80.26 Favored Pre-proline 0 N--CA 1.422 -1.873 1 N-CA-C 95.834 -5.617 . . . . 0.0 95.834 174.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -70.87 151.39 62.7 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 CA-C-N 122.338 1.871 . . . . 0.0 109.841 -171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -96.31 -20.64 18.35 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 127.771 2.428 . . . . 0.0 106.662 3.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -154.01 148.11 25.74 Favored 'General case' 0 N--CA 1.407 -2.585 1 N-CA-C 95.509 -5.737 . . . . 0.0 95.509 172.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.78 -154.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -136.53 173.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 N-CA-C 97.566 -4.976 . . . . 0.0 97.566 166.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -161.39 0.81 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 167.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -136.75 151.87 49.7 Favored 'General case' 0 N--CA 1.418 -2.057 1 N-CA-C 95.023 -5.918 . . . . 0.0 95.023 167.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -160.77 -167.6 1.89 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.74 -5.652 . . . . 0.0 95.74 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.6 166.35 17.85 Favored Pre-proline 0 N--CA 1.415 -2.204 1 N-CA-C 98.05 -4.796 . . . . 0.0 98.05 -161.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -68.34 68.68 1.02 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 CA-C-N 124.094 2.498 . . . . 0.0 112.199 165.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.1 -179.83 46.98 Favored Glycine 0 N--CA 1.417 -2.567 1 N-CA-C 97.661 -6.176 . . . . 0.0 97.661 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -128.82 9.02 5.8 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -55.03 -43.53 73.81 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.891 1.676 . . . . 0.0 114.205 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.95 -49.69 5.52 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -50.36 -43.23 54.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.042 1.737 . . . . 0.0 113.177 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.9 -32.23 70.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.695 0.798 . . . . 0.0 110.593 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -78.97 -45.8 19.6 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 109.004 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.24 -41.15 86.1 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -63.06 -41.8 99.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.464 -0.773 . . . . 0.0 110.684 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.86 -35.17 67.14 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.277 -0.889 . . . . 0.0 111.49 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.59 -30.35 61.66 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.564 -0.71 . . . . 0.0 111.077 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -90.37 -6.82 54.56 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.213 0.605 . . . . 0.0 110.534 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.7 37.18 4.55 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 160.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.29 163.7 16.81 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 104.653 -3.379 . . . . 0.0 104.653 164.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.4 p -68.53 -56.13 9.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.515 1.15 . . . . 0.0 109.854 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -160.67 -172.62 3.59 Favored 'General case' 0 N--CA 1.424 -1.775 1 N-CA-C 98.904 -4.48 . . . . 0.0 98.904 168.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.04 -178.83 40.2 Favored Glycine 0 N--CA 1.415 -2.764 1 N-CA-C 98.529 -5.828 . . . . 0.0 98.529 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -161.56 -175.74 4.93 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.726 -4.916 . . . . 0.0 97.726 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -139.19 157.77 45.35 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 103.811 -2.662 . . . . 0.0 103.811 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.55 166.44 34.24 Favored Glycine 0 N--CA 1.429 -1.774 1 N-CA-C 95.847 -6.901 . . . . 0.0 95.847 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.95 132.08 56.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -129.67 36.08 4.12 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 42' ' ' GLY 0.284 11.5 t 70.1 -171.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -163.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 147.34 -130.37 3.54 Favored Glycine 0 N--CA 1.42 -2.386 1 N-CA-C 97.122 -6.391 . . . . 0.0 97.122 -168.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -114.5 -48.7 2.86 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.45 -178.74 23.83 Favored Glycine 0 N--CA 1.425 -2.083 1 N-CA-C 97.895 -6.082 . . . . 0.0 97.895 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 103.37 7.43 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.423 1.489 . . . . 0.0 107.294 -171.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.11 -166.46 1.5 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -117.49 151.79 36.39 Favored 'General case' 0 CA--C 1.489 -1.386 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -101.32 158.74 15.83 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.8 m -145.78 143.41 29.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.8 123.6 50.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 172.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.23 65.26 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.778 2.431 . . . . 0.0 109.315 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.95 138.68 20.67 Favored Pre-proline 0 CA--C 1.492 -1.271 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.534 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -66.48 161.3 41.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.749 2.299 . . . . 0.0 110.606 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.6 -15.21 59.89 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.059 0.543 . . . . 0.0 111.127 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -92.27 12.36 22.71 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 110.391 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.08 -158.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 101.439 -3.541 . . . . 0.0 101.439 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -160.03 163.39 33.75 Favored Glycine 0 CA--C 1.466 -3.001 1 N-CA-C 102.539 -4.224 . . . . 0.0 102.539 -179.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -152.78 -170.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 101.168 -3.641 . . . . 0.0 101.168 -163.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mm -71.22 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.427 -1.583 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 174.87 5.73 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.54 145.77 51.02 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 95.451 -5.759 . . . . 0.0 95.451 165.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 175.66 38.13 Favored Glycine 0 CA--C 1.479 -2.215 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -80.4 131.64 35.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 155.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.87 138.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.75 -138.18 0.37 Allowed 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 127.493 2.317 . . . . 0.0 107.085 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -141.34 148.82 52.54 Favored Pre-proline 0 N--CA 1.415 -2.196 1 N-CA-C 94.553 -6.092 . . . . 0.0 94.553 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -67.52 143.8 64.4 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.641 2.228 . . . . 0.0 107.548 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -84.29 -33.06 24.05 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 127.897 2.479 . . . . 0.0 109.332 9.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -160.42 158.32 29.26 Favored 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 94.312 -6.181 . . . . 0.0 94.312 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 171.18 -152.5 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 1 N-CA-C 98.382 -4.673 . . . . 0.0 98.382 167.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.32 167.72 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 N-CA-C 96.287 -5.449 . . . . 0.0 96.287 158.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.87 -150.48 0.11 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -139.29 -175.36 4.15 Favored 'General case' 0 CA--C 1.484 -1.571 1 N-CA-C 96.619 -5.326 . . . . 0.0 96.619 163.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -147.93 173.81 12.5 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 96.608 -5.33 . . . . 0.0 96.608 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -129.65 126.11 22.55 Favored Pre-proline 0 N--CA 1.413 -2.317 1 N-CA-C 92.376 -6.898 . . . . 0.0 92.376 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -60.13 98.33 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 125.164 2.88 . . . . 0.0 114.855 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -167.01 35.33 Favored Glycine 0 N--CA 1.422 -2.249 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 p -91.44 -45.36 8.59 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -39.68 -70.62 0.1 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.218 2.207 . . . . 0.0 116.912 -151.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.58 -37.35 62.07 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.799 -1.188 . . . . 0.0 111.068 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -64.88 -51.47 61.77 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.914 1.286 . . . . 0.0 108.795 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.16 -41.39 96.68 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.896 0.878 . . . . 0.0 109.587 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.6 m -59.0 -47.7 84.24 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 121.333 -0.854 . . . . 0.0 111.756 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 mt -65.98 -42.3 90.03 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 123.387 0.675 . . . . 0.0 110.476 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.13 -49.53 73.65 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.38 1.472 . . . . 0.0 109.902 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -69.72 -35.57 75.14 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.27 -0.894 . . . . 0.0 111.339 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -74.76 -2.69 27.6 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.319 -0.863 . . . . 0.0 112.884 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.5 7.53 28.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.379 -0.825 . . . . 0.0 109.212 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.39 26.38 18.3 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.82 132.97 11.43 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 m -94.05 -15.88 24.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -166.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -160.61 179.19 8.78 Favored 'General case' 0 CA--C 1.493 -1.248 1 N-CA-C 99.337 -4.32 . . . . 0.0 99.337 168.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.5 -173.87 39.4 Favored Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 103.104 -3.998 . . . . 0.0 103.104 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -161.08 -162.31 0.9 Allowed 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 -174.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.9 t -136.17 164.92 26.92 Favored 'General case' 0 CA--C 1.489 -1.374 1 N-CA-C 96.202 -5.481 . . . . 0.0 96.202 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.04 -168.19 37.75 Favored Glycine 0 N--CA 1.425 -2.099 1 N-CA-C 102.053 -4.419 . . . . 0.0 102.053 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -148.14 144.68 27.95 Favored 'General case' 0 N--CA 1.428 -1.546 1 N-CA-C 96.368 -5.419 . . . . 0.0 96.368 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -126.89 109.96 12.53 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.73 136.12 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.57 -34.16 4.2 Favored Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 105.414 -3.074 . . . . 0.0 105.414 -170.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.34 -70.62 0.78 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.95 -153.03 23.81 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 106.819 -2.512 . . . . 0.0 106.819 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.64 137.89 55.95 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.164 2.186 . . . . 0.0 106.273 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.35 178.21 8.08 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 101.349 -3.574 . . . . 0.0 101.349 -168.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.22 165.94 13.2 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.651 -4.203 . . . . 0.0 99.651 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -127.89 146.87 50.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -134.98 149.22 50.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.67 136.63 53.81 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 172.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.7 76.37 0.28 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 126.799 2.039 . . . . 0.0 111.522 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.16 141.22 22.11 Favored Pre-proline 0 CA--C 1.501 -0.913 0 N-CA-C 101.819 -3.4 . . . . 0.0 101.819 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.7 165.16 31.84 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.38 2.054 . . . . 0.0 109.595 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.8 -1.65 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.438 -0.789 . . . . 0.0 112.726 -160.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.49 -1.99 58.35 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.051 0.94 . . . . 0.0 109.533 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.65 134.41 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.96 148.44 16.55 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 104.295 -3.522 . . . . 0.0 104.295 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 pt -132.27 -150.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mm -73.64 131.37 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 99.313 -4.329 . . . . 0.0 99.313 172.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -174.57 4.56 Favored 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 98.192 -4.744 . . . . 0.0 98.192 172.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -133.74 143.17 48.3 Favored 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.143 -4.762 . . . . 0.0 98.143 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.32 23.86 Favored Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -81.87 136.65 35.34 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 163.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 tt -90.55 146.83 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.333 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.09 178.19 10.3 Favored 'General case' 0 N--CA 1.401 -2.88 1 N-CA-C 96.949 -5.204 . . . . 0.0 96.949 -163.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -93.21 161.01 32.24 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -64.07 116.85 3.95 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.089 1.859 . . . . 0.0 109.812 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -145.52 139.2 26.6 Favored 'General case' 0 CA--C 1.481 -1.703 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 2.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.1 -26.95 0.09 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 127.162 2.185 . . . . 0.0 110.138 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.2 m -87.24 111.63 21.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -157.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.04 171.97 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-O 124.544 2.116 . . . . 0.0 114.654 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.76 -154.78 0.49 Allowed 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.533 -2.576 . . . . 0.0 104.337 -173.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.9 177.61 8.23 Favored 'General case' 0 N--CA 1.417 -2.12 1 N-CA-C 95.756 -5.646 . . . . 0.0 95.756 162.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.5 t -142.7 159.21 42.68 Favored 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 95.153 -5.869 . . . . 0.0 95.153 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.0 121.42 25.44 Favored Pre-proline 0 N--CA 1.415 -2.18 1 N-CA-C 93.235 -6.58 . . . . 0.0 93.235 168.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -68.29 67.69 1.03 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 CA-C-N 123.604 2.323 . . . . 0.0 114.787 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.93 161.5 32.73 Favored Glycine 0 N--CA 1.424 -2.159 1 N-CA-C 100.031 -5.228 . . . . 0.0 100.031 175.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 m -63.3 -39.76 95.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.919 0.887 . . . . 0.0 112.156 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -62.33 -27.16 68.85 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -168.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -77.19 1.33 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 168.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.19 -37.29 79.79 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.855 0.862 . . . . 0.0 113.238 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -73.26 -46.79 47.97 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 m -54.86 -46.0 74.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.829 0.851 . . . . 0.0 111.383 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.13 -35.23 79.28 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 123.49 0.716 . . . . 0.0 111.637 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -69.98 -48.85 56.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 109.207 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -60.95 -45.59 94.12 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 121.822 -0.549 . . . . 0.0 110.865 -174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.572 ' HG3' ' HZ3' ' A' ' 30' ' ' LYS . 26.3 pt-20 -68.73 -13.84 62.64 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.572 ' HZ3' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.86 -0.1 37.53 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.66 26.42 13.28 Favored Glycine 0 CA--C 1.491 -1.442 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.012 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.78 138.53 14.43 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.7 p -84.46 -29.67 25.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.764 0.793 . . . . 0.0 109.589 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.45 158.53 29.55 Favored 'General case' 0 N--CA 1.421 -1.889 1 N-CA-C 98.726 -4.546 . . . . 0.0 98.726 -166.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.33 -177.43 47.85 Favored Glycine 0 N--CA 1.424 -2.104 1 N-CA-C 100.346 -5.102 . . . . 0.0 100.346 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -173.17 -176.73 1.42 Allowed 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 100.311 -3.959 . . . . 0.0 100.311 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.3 t -90.22 163.46 14.79 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.77 -175.04 37.93 Favored Glycine 0 CA--C 1.479 -2.168 1 N-CA-C 99.308 -5.517 . . . . 0.0 99.308 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -131.0 148.25 52.73 Favored 'General case' 0 N--CA 1.433 -1.289 1 N-CA-C 99.437 -4.282 . . . . 0.0 99.437 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -115.65 94.38 4.67 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.81 120.2 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.63 -22.83 7.66 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -121.83 -72.11 0.7 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.03 -159.54 32.64 Favored Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 105.706 -2.958 . . . . 0.0 105.706 -169.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mt -78.26 150.73 33.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.385 -2.821 . . . . 0.0 103.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.33 173.84 15.66 Favored 'General case' 0 CA--C 1.485 -1.554 1 N-CA-C 98.69 -4.559 . . . . 0.0 98.69 -174.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -116.14 164.6 14.23 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -106.34 146.56 30.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 m -141.92 147.44 37.07 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.7 138.8 47.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.43 68.98 0.77 Allowed 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.788 2.035 . . . . 0.0 112.326 169.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mt -99.57 148.86 35.3 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -66.64 167.97 17.82 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.591 2.194 . . . . 0.0 112.366 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -81.76 4.08 23.37 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -103.21 13.4 34.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.83 152.77 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 167.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.41 158.26 27.61 Favored Glycine 0 CA--C 1.48 -2.099 1 N-CA-C 98.304 -5.918 . . . . 0.0 98.304 -176.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.19 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 -151.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.26 131.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.415 -2.2 1 N-CA-C 90.335 -7.654 . . . . 0.0 90.335 -174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.185 0.517 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 179.12 7.05 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 169.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -133.09 140.51 47.7 Favored 'General case' 0 CA--C 1.49 -1.335 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -176.18 33.77 Favored Glycine 0 CA--C 1.482 -2.008 0 N-CA-C 106.547 -2.621 . . . . 0.0 106.547 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -77.36 130.7 37.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 161.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.254 15.5 tt -90.41 136.2 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.41 -168.39 2.09 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 129.149 2.98 . . . . 0.0 109.383 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -145.91 158.63 48.69 Favored Pre-proline 0 N--CA 1.423 -1.819 1 N-CA-C 95.85 -5.611 . . . . 0.0 95.85 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.18 146.59 90.73 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 123.065 2.13 . . . . 0.0 112.26 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.63 -53.22 4.9 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 126.621 1.968 . . . . 0.0 107.721 7.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -142.74 137.67 29.96 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 91.947 -7.057 . . . . 0.0 91.947 168.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.6 m -177.47 -162.76 0.07 Allowed 'General case' 0 CA--C 1.483 -1.628 1 N-CA-C 98.735 -4.543 . . . . 0.0 98.735 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.92 163.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 1 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 166.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -169.21 1.95 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 159.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -135.01 167.53 20.78 Favored 'General case' 0 CA--C 1.477 -1.86 1 N-CA-C 97.104 -5.147 . . . . 0.0 97.104 173.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -136.58 160.94 37.28 Favored 'General case' 0 N--CA 1.421 -1.92 1 N-CA-C 96.517 -5.364 . . . . 0.0 96.517 -165.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -112.73 116.54 47.76 Favored Pre-proline 0 N--CA 1.422 -1.858 1 N-CA-C 95.067 -5.901 . . . . 0.0 95.067 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -59.37 101.76 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.676 0 CA-C-N 125.004 2.823 . . . . 0.0 115.32 -161.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.15 -171.3 37.15 Favored Glycine 0 N--CA 1.42 -2.387 1 N-CA-C 98.308 -5.917 . . . . 0.0 98.308 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 -35.99 14.6 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.445 0.622 . . . . 0.0 110.499 -172.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -53.25 35.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.496 2.319 . . . . 0.0 116.034 -159.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.75 -42.38 31.73 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.5 -42.79 86.82 Favored 'General case' 0 CA--C 1.482 -1.644 0 O-C-N 122.148 -0.619 . . . . 0.0 110.988 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.36 -39.33 93.67 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.2 m -63.05 -47.21 83.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.818 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -40.07 95.78 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.783 0.801 . . . . 0.0 110.1 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.39 -42.81 82.94 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.26 1.024 . . . . 0.0 110.823 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.86 -47.79 84.77 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 122.878 0.471 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.95 -14.9 60.24 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -96.26 -6.84 37.03 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.733 -0.605 . . . . 0.0 111.061 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.44 27.25 12.03 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.51 151.87 19.09 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.726 -3.349 . . . . 0.0 104.726 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.0 p -84.85 -34.42 22.67 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -169.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.55 152.84 34.75 Favored 'General case' 0 N--CA 1.423 -1.8 1 N-CA-C 99.992 -4.077 . . . . 0.0 99.992 -161.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.89 42.18 Favored Glycine 0 CA--C 1.475 -2.444 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.489 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 26.1 p-80 -166.49 -158.74 0.33 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 101.49 -3.522 . . . . 0.0 101.49 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.98 161.18 21.35 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -178.86 41.91 Favored Glycine 0 N--CA 1.422 -2.246 1 N-CA-C 102.214 -4.354 . . . . 0.0 102.214 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -138.07 139.64 39.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 100.389 -3.93 . . . . 0.0 100.389 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -115.48 99.02 7.06 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.82 120.05 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.14 -32.22 3.16 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.782 -2.927 . . . . 0.0 105.782 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.21 -70.3 0.81 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.15 -159.81 32.69 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 104.973 -3.251 . . . . 0.0 104.973 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.53 140.64 58.89 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.453 2.301 . . . . 0.0 106.849 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.86 -179.77 6.13 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -171.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.4 m -113.24 168.2 9.93 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 101.451 -3.537 . . . . 0.0 101.451 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 13.2 t-105 -121.93 148.38 44.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.07 150.02 45.25 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.14 147.2 43.57 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 103.233 -2.876 . . . . 0.0 103.233 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.02 51.47 0.95 Allowed 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 126.953 2.101 . . . . 0.0 110.972 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.84 133.71 28.69 Favored Pre-proline 0 CA--C 1.499 -0.984 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.0 175.5 11.32 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.266 1.978 . . . . 0.0 110.444 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.08 4.63 16.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -95.86 3.62 53.5 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.182 -0.948 . . . . 0.0 108.813 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.58 178.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.58 164.13 31.96 Favored Glycine 0 CA--C 1.482 -1.974 1 N-CA-C 98.412 -5.875 . . . . 0.0 98.412 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 pt -155.62 -172.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -163.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.9 118.87 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 CA-C-O 122.077 0.942 . . . . 0.0 111.937 -160.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.427 -1.58 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 166.235 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.627 0.727 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -116.96 154.6 30.59 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -137.89 128.59 26.81 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 97.425 -5.028 . . . . 0.0 97.425 168.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -170.99 27.45 Favored Glycine 0 CA--C 1.476 -2.363 1 N-CA-C 102.306 -4.318 . . . . 0.0 102.306 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.57 135.46 39.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 160.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.51 141.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.44 -138.89 0.36 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.582 -2.099 . . . . 0.0 107.029 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -140.93 161.19 55.19 Favored Pre-proline 0 N--CA 1.423 -1.783 1 N-CA-C 95.526 -5.731 . . . . 0.0 95.526 169.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -67.31 144.5 68.41 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 122.765 2.023 . . . . 0.0 108.588 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.62 -42.36 8.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.455 2.302 . . . . 0.0 107.744 7.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.62 146.02 37.41 Favored 'General case' 0 N--CA 1.419 -1.986 1 N-CA-C 92.92 -6.696 . . . . 0.0 92.92 173.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -177.75 -163.98 0.08 Allowed 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 43' ' ' HIS . 3.5 m -128.65 164.11 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.729 1 N-CA-C 96.789 -5.263 . . . . 0.0 96.789 156.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -173.47 4.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 160.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -134.96 147.1 49.66 Favored 'General case' 0 CA--C 1.466 -2.256 1 N-CA-C 93.823 -6.362 . . . . 0.0 93.823 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -160.57 -165.82 1.5 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.081 -5.896 . . . . 0.0 95.081 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -141.22 173.18 5.11 Favored Pre-proline 0 N--CA 1.418 -2.04 1 N-CA-C 99.974 -4.084 . . . . 0.0 99.974 -161.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.52 55.51 3.7 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 C-N-CA 123.035 2.49 . . . . 0.0 110.754 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.69 141.11 4.57 Favored Glycine 0 N--CA 1.42 -2.375 1 N-CA-C 99.363 -5.495 . . . . 0.0 99.363 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 24.93 0.5 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.809 1.644 . . . . 0.0 112.667 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -59.16 -49.46 77.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.663 1.985 . . . . 0.0 112.492 -161.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.87 -25.83 26.12 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -82.85 -8.94 59.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.538 -0.977 . . . . 0.0 110.853 -167.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.46 -57.21 10.61 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.324 1.05 . . . . 0.0 108.98 166.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -52.1 67.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.465 1.106 . . . . 0.0 112.419 171.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.89 -43.25 93.52 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.801 0.81 . . . . 0.0 111.856 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.0 t -62.8 -43.13 99.6 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 108.957 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -78.59 -27.48 45.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.398 -0.814 . . . . 0.0 111.601 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.85 -20.13 53.61 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.182 -0.949 . . . . 0.0 111.334 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -88.06 -22.48 24.16 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.76 33.48 2.42 Favored Glycine 0 CA--C 1.488 -1.595 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 163.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.21 150.83 19.74 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -96.96 -17.92 19.78 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.671 0.748 . . . . 0.0 109.833 -165.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 m -160.75 168.27 25.14 Favored 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 98.979 -4.452 . . . . 0.0 98.979 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.37 176.66 44.57 Favored Glycine 0 N--CA 1.419 -2.452 1 N-CA-C 100.855 -4.898 . . . . 0.0 100.855 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -168.93 -168.77 0.89 Allowed 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 97.35 -5.056 . . . . 0.0 97.35 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -142.43 166.05 25.74 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.44 -176.61 44.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 103.135 -3.986 . . . . 0.0 103.135 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -130.95 121.96 26.05 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 99.539 -4.245 . . . . 0.0 99.539 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -139.33 59.81 1.59 Allowed 'General case' 0 CA--C 1.487 -1.444 1 N-CA-C 99.404 -4.295 . . . . 0.0 99.404 171.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 42' ' ' GLY 0.293 1.5 t 56.47 -152.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 127.512 2.325 . . . . 0.0 108.204 -165.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 119.82 -128.76 7.69 Favored Glycine 0 N--CA 1.425 -2.072 1 N-CA-C 100.065 -5.214 . . . . 0.0 100.065 -170.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.526 ' H ' HG12 ' A' ' 13' ' ' VAL . 35.5 m170 -118.55 -19.65 8.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 125.452 1.501 . . . . 0.0 107.307 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.86 -174.14 46.59 Favored Glycine 0 N--CA 1.426 -1.995 1 N-CA-C 97.625 -6.19 . . . . 0.0 97.625 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -69.16 132.71 46.97 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.06 -169.7 2.03 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -163.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.6 t -123.25 159.51 28.56 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -113.41 151.43 31.37 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.8 m -144.5 150.87 38.3 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -110.53 144.15 39.81 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.79 54.96 4.88 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.748 2.419 . . . . 0.0 112.682 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.18 144.62 38.84 Favored Pre-proline 0 CA--C 1.499 -0.991 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -64.9 162.82 30.62 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.576 2.184 . . . . 0.0 112.209 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.97 -28.03 63.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.103 1.761 . . . . 0.0 114.101 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -98.24 15.82 23.32 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.23 1.012 . . . . 0.0 110.652 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 138.83 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 151.53 18.21 Favored Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 104.31 -3.516 . . . . 0.0 104.31 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.82 -159.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mm -72.54 130.78 35.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.147 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 100.86 -3.756 . . . . 0.0 100.86 178.883 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.59 165.38 11.86 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 171.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.15 137.91 53.62 Favored 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 94.305 -6.183 . . . . 0.0 94.305 153.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -176.7 34.23 Favored Glycine 0 CA--C 1.474 -2.496 1 N-CA-C 102.956 -4.058 . . . . 0.0 102.956 177.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -76.86 135.52 38.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 161.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -90.4 138.44 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -176.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.57 -135.91 0.34 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.425 -1.716 . . . . 0.0 106.931 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -136.34 159.08 72.11 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 96.156 -5.498 . . . . 0.0 96.156 169.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -69.14 148.57 69.37 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.011 1.807 . . . . 0.0 109.421 174.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -82.15 -29.19 31.74 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 127.42 2.288 . . . . 0.0 108.315 -3.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -155.57 165.34 36.88 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 178.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 157.62 -147.0 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.58 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.571 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.0 166.9 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 1 N-CA-C 98.352 -4.684 . . . . 0.0 98.352 161.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -170.9 2.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 165.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -136.24 149.54 48.57 Favored 'General case' 0 CA--C 1.479 -1.757 1 N-CA-C 98.53 -4.618 . . . . 0.0 98.53 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -125.59 162.65 24.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 101.922 -3.362 . . . . 0.0 101.922 -168.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -114.06 112.81 46.96 Favored Pre-proline 0 N--CA 1.421 -1.898 1 N-CA-C 98.765 -4.531 . . . . 0.0 98.765 168.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.53 118.53 5.46 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 CA-C-N 123.314 2.219 . . . . 0.0 111.47 -171.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.28 -45.73 0.57 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 99.874 -5.291 . . . . 0.0 99.874 -165.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m 115.17 -35.33 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 129.362 3.065 . . . . 0.0 107.003 168.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -40.15 -53.78 2.4 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.326 2.65 . . . . 0.0 116.459 -156.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.16 -36.7 56.05 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 121.369 -0.832 . . . . 0.0 111.607 -176.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -86.29 -26.13 25.11 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 120.963 -1.316 . . . . 0.0 109.072 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.65 -36.48 84.38 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.999 0.919 . . . . 0.0 108.83 170.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 m -66.23 -42.21 88.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.382 -0.824 . . . . 0.0 110.336 173.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.46 -38.97 92.89 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 121.002 -1.061 . . . . 0.0 110.869 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 t -54.28 -42.78 70.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.515 1.126 . . . . 0.0 111.009 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.71 -44.85 92.42 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 122.022 -0.424 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.22 -28.39 63.14 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.487 0.585 . . . . 0.0 111.91 -176.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.91 -19.04 49.04 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.853 -0.53 . . . . 0.0 110.435 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.47 35.46 2.86 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 164.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.22 138.45 13.91 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 167.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 p -98.05 3.14 49.36 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.851 -0.794 . . . . 0.0 110.036 -168.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -160.36 166.46 29.33 Favored 'General case' 0 CA--C 1.48 -1.716 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.98 175.75 46.48 Favored Glycine 0 CA--C 1.469 -2.831 1 N-CA-C 99.73 -5.348 . . . . 0.0 99.73 -177.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -168.91 -153.78 0.12 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 96.269 -5.456 . . . . 0.0 96.269 -172.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -149.98 166.15 30.51 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.57 -4.974 . . . . 0.0 97.57 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.2 171.41 41.92 Favored Glycine 0 CA--C 1.48 -2.126 1 N-CA-C 96.154 -6.778 . . . . 0.0 96.154 176.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -146.5 137.32 24.12 Favored 'General case' 0 CA--C 1.483 -1.607 1 N-CA-C 99.251 -4.352 . . . . 0.0 99.251 -175.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -158.57 56.18 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.32 1.4 t 55.62 -144.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 125.859 1.664 . . . . 0.0 108.215 -158.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.41 -131.04 5.36 Favored Glycine 0 CA--C 1.474 -2.492 1 N-CA-C 94.86 -7.296 . . . . 0.0 94.86 -169.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -123.34 10.82 9.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.98 -49.18 0.29 Allowed Glycine 0 CA--C 1.486 -1.737 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -171.33 -176.52 1.89 Allowed 'General case' 0 N--CA 1.437 -1.096 1 N-CA-C 95.848 -5.612 . . . . 0.0 95.848 -175.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.92 174.98 4.59 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 99.089 -4.412 . . . . 0.0 99.089 174.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 29.6 m -123.31 -174.16 2.89 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 171.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -132.01 152.62 51.04 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.7 m -145.13 155.11 43.11 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -119.27 140.77 49.72 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 172.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.19 55.77 1.07 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 127.356 2.262 . . . . 0.0 111.38 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.35 130.99 37.68 Favored Pre-proline 0 CA--C 1.496 -1.123 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -70.69 176.2 7.81 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.339 2.026 . . . . 0.0 111.069 177.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -84.68 19.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -99.53 -6.16 27.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.06 173.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 -174.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.58 156.86 27.15 Favored Glycine 0 CA--C 1.48 -2.141 1 N-CA-C 97.914 -6.075 . . . . 0.0 97.914 -175.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 pt -150.76 -167.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 101.926 -3.361 . . . . 0.0 101.926 -166.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.03 133.97 30.92 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -171.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.434 -1.263 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 162.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.139 0.495 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.88 171.39 7.93 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 172.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -135.82 133.72 38.15 Favored 'General case' 0 CA--C 1.489 -1.379 1 N-CA-C 96.421 -5.399 . . . . 0.0 96.421 168.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.8 -177.26 34.71 Favored Glycine 0 CA--C 1.478 -2.277 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 36.2 m-85 -73.91 133.75 43.14 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.19 136.89 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.81 -146.14 0.3 Allowed 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 126.718 2.007 . . . . 0.0 107.295 178.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -133.86 147.14 63.02 Favored Pre-proline 0 N--CA 1.423 -1.8 1 N-CA-C 94.408 -6.145 . . . . 0.0 94.408 164.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.54 145.1 63.27 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 CA-C-N 123.21 2.182 . . . . 0.0 108.089 177.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.57 -44.43 15.87 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 120.902 1.683 . . . . 0.0 111.79 7.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -152.92 149.59 28.39 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 94.489 -6.115 . . . . 0.0 94.489 177.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.32 -158.9 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.437 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 -179.006 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.76 161.1 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 1 N-CA-C 98.739 -4.541 . . . . 0.0 98.739 161.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -162.36 0.6 Allowed 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 162.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -137.87 166.49 23.9 Favored 'General case' 0 N--CA 1.426 -1.669 1 N-CA-C 96.89 -5.226 . . . . 0.0 96.89 162.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.4 t -119.95 169.82 9.83 Favored 'General case' 0 N--CA 1.419 -1.978 1 N-CA-C 99.041 -4.429 . . . . 0.0 99.041 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.24 131.0 24.02 Favored Pre-proline 0 N--CA 1.421 -1.911 1 N-CA-C 98.03 -4.804 . . . . 0.0 98.03 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -69.08 37.62 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 123.145 2.563 . . . . 0.0 114.715 174.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.86 142.8 9.45 Favored Glycine 0 N--CA 1.426 -2.007 1 N-CA-C 96.084 -6.806 . . . . 0.0 96.084 177.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.1 -41.69 98.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.928 1.291 . . . . 0.0 113.962 -157.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -53.38 9.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 128.407 2.683 . . . . 0.0 115.592 -163.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -50.78 32.21 Favored Glycine 0 C--N 1.349 1.288 0 O-C-N 121.945 -0.472 . . . . 0.0 112.14 -166.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.12 -18.91 55.05 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -58.34 -53.72 55.16 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -39.31 93.99 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.32 -37.95 86.55 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.922 0.783 . . . . 0.0 111.261 -179.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -65.9 -45.78 80.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.614 -0.679 . . . . 0.0 109.98 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -65.15 -41.32 94.85 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.957 -0.464 . . . . 0.0 111.916 -178.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.9 -17.35 63.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.166 -0.959 . . . . 0.0 112.188 -175.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -95.72 -6.29 40.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.66 0.784 . . . . 0.0 110.046 176.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.89 32.7 17.3 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.0 151.15 17.96 Favored Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 104.066 -3.614 . . . . 0.0 104.066 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.7 p -73.45 -55.07 6.83 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.029 0.919 . . . . 0.0 109.999 -168.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -160.63 -177.03 5.91 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 98.184 -4.746 . . . . 0.0 98.184 166.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.56 176.44 44.1 Favored Glycine 0 N--CA 1.416 -2.684 1 N-CA-C 99.838 -5.305 . . . . 0.0 99.838 -171.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -146.31 178.49 8.2 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 100.466 -3.902 . . . . 0.0 100.466 -172.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.6 m -83.79 171.76 12.84 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 119.14 0.882 . . . . 0.0 109.771 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.12 -179.07 45.45 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 103.13 -3.988 . . . . 0.0 103.13 -172.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -147.72 152.71 38.23 Favored 'General case' 0 N--CA 1.427 -1.598 1 N-CA-C 97.298 -5.075 . . . . 0.0 97.298 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -136.84 106.07 6.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 172.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.43 122.29 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.72 -40.69 1.43 Allowed Glycine 0 CA--C 1.482 -2.005 1 N-CA-C 102.62 -4.192 . . . . 0.0 102.62 -166.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -123.76 -67.6 0.92 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.95 -157.51 30.02 Favored Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 -169.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -70.71 139.03 51.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.3 -173.46 3.34 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -167.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -129.4 177.3 7.29 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.815 -3.772 . . . . 0.0 100.815 169.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 30.1 t-105 -122.3 160.48 25.23 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.5 m -148.65 151.77 35.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 167.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.97 129.92 56.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.31 66.89 0.1 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 127.64 2.376 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.5 mt -103.11 137.96 19.41 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.12 170.86 18.81 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.745 2.296 . . . . 0.0 110.402 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.75 -5.68 42.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 124.164 0.986 . . . . 0.0 113.583 -168.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -88.91 3.7 50.49 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.288 -0.883 . . . . 0.0 109.551 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.05 136.05 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.33 154.94 18.54 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.347 -2.301 . . . . 0.0 107.347 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.89 -171.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 -172.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.86 141.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 123.395 0.678 . . . . 0.0 109.581 -169.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.424 -1.731 1 N-CA-C 98.089 -4.782 . . . . 0.0 98.089 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.254 0.55 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 178.8 4.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 167.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -128.74 148.02 50.81 Favored 'General case' 0 N--CA 1.431 -1.397 1 N-CA-C 95.245 -5.835 . . . . 0.0 95.245 166.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.31 170.59 37.13 Favored Glycine 0 CA--C 1.48 -2.133 0 C-N-CA 117.845 -2.121 . . . . 0.0 109.017 -175.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -82.11 121.82 27.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 159.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 tt -90.5 143.27 11.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.089 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -174.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.59 -154.52 0.55 Allowed 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 128.995 2.918 . . . . 0.0 108.858 -175.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.32 165.58 30.72 Favored Pre-proline 0 N--CA 1.425 -1.708 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 170.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -62.19 126.49 18.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.748 2.965 . . . . 0.0 112.871 -173.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -133.77 138.07 45.52 Favored 'General case' 0 CA--C 1.467 -2.24 1 N-CA-C 96.33 -5.433 . . . . 0.0 96.33 -10.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 48.6 t30 68.36 30.25 5.54 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 119.351 0.978 . . . . 0.0 111.626 175.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.23 -159.9 0.76 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 168.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.95 162.84 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 1 N-CA-C 96.55 -5.352 . . . . 0.0 96.55 170.563 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -168.02 2.09 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 162.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -138.08 146.09 42.51 Favored 'General case' 0 CA--C 1.469 -2.161 1 N-CA-C 96.214 -5.476 . . . . 0.0 96.214 168.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.55 175.2 6.84 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -112.29 130.49 23.28 Favored Pre-proline 0 N--CA 1.421 -1.882 1 N-CA-C 93.976 -6.305 . . . . 0.0 93.976 165.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.92 37.98 0.11 Allowed 'Trans proline' 0 C--N 1.331 -0.369 0 CA-C-N 125.679 3.064 . . . . 0.0 116.024 177.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.55 108.97 0.49 Allowed Glycine 0 N--CA 1.422 -2.243 1 N-CA-C 94.734 -7.346 . . . . 0.0 94.734 170.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -52.42 -36.8 55.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.313 2.245 . . . . 0.0 115.042 -157.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -44.79 -39.35 5.18 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.854 2.462 . . . . 0.0 116.659 -170.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.41 -46.13 87.31 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 120.776 -1.202 . . . . 0.0 112.05 -177.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.65 -25.09 28.75 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 122.18 -0.6 . . . . 0.0 109.621 -175.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.82 -39.25 91.12 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.096 0.558 . . . . 0.0 109.971 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -63.81 -41.97 97.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.464 175.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.0 mt -63.94 -40.44 96.43 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 121.953 0.883 . . . . 0.0 110.667 177.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.6 t -57.86 -47.38 82.88 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.208 1.403 . . . . 0.0 110.575 175.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.04 -42.41 80.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 122.681 0.393 . . . . 0.0 111.024 -176.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.02 -23.6 60.63 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.727 -0.608 . . . . 0.0 111.928 -175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.95 -49.21 11.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.92 48.81 0.16 Allowed Glycine 0 CA--C 1.49 -1.518 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 168.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.13 143.55 15.79 Favored Glycine 0 CA--C 1.487 -1.673 1 N-CA-C 101.35 -4.7 . . . . 0.0 101.35 157.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 p -75.12 -28.6 60.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 118.385 1.092 . . . . 0.0 110.77 -164.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.9 m -160.56 173.42 15.55 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.92 -176.96 42.75 Favored Glycine 0 N--CA 1.418 -2.542 1 N-CA-C 98.786 -5.726 . . . . 0.0 98.786 -172.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -171.16 -174.71 1.54 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 -170.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.4 m -81.03 169.71 17.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 119.153 0.888 . . . . 0.0 109.134 -178.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.88 164.51 34.25 Favored Glycine 0 N--CA 1.416 -2.693 1 N-CA-C 98.465 -5.854 . . . . 0.0 98.465 175.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -135.8 154.77 51.1 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 97.21 -5.108 . . . . 0.0 97.21 177.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.92 179.21 9.29 Favored 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 97.503 -4.999 . . . . 0.0 97.503 174.935 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.63 163.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 1 N-CA-C 97.968 -4.827 . . . . 0.0 97.968 178.173 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.39 -46.85 1.1 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 102.564 -4.214 . . . . 0.0 102.564 -170.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 35.1 m170 -119.46 -79.65 0.6 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 170.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.22 -147.26 12.82 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 103.28 -3.928 . . . . 0.0 103.28 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.59 132.91 54.64 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.51 2.324 . . . . 0.0 108.066 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.11 -173.34 3.7 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 102.201 -3.259 . . . . 0.0 102.201 -164.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.31 172.05 9.41 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 169.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -129.31 147.9 51.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.7 m -143.28 146.97 34.06 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -114.69 145.46 42.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.5 55.44 0.5 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 126.578 1.951 . . . . 0.0 111.064 172.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.05 138.69 20.35 Favored Pre-proline 0 CA--C 1.501 -0.908 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -66.42 165.95 23.23 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.45 2.1 . . . . 0.0 111.773 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -73.86 -19.1 60.83 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.328 0.651 . . . . 0.0 112.27 -169.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -92.29 18.55 8.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 109.73 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.05 133.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 100.533 -3.877 . . . . 0.0 100.533 167.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.92 146.57 18.64 Favored Glycine 0 CA--C 1.479 -2.172 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.69 -141.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -156.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.8 120.62 28.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 169.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -163.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.115 0.483 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.29 167.7 12.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 171.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -130.46 140.03 50.55 Favored 'General case' 0 CA--C 1.485 -1.545 1 N-CA-C 94.703 -6.036 . . . . 0.0 94.703 165.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.45 29.27 Favored Glycine 0 CA--C 1.472 -2.608 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 178.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 39' ' ' PHE . 25.5 m-85 -82.58 138.72 34.15 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 101.453 -3.536 . . . . 0.0 101.453 157.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -89.99 132.82 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -177.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.26 -148.86 0.43 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 111.949 -2.387 . . . . 0.0 107.09 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.94 148.46 65.06 Favored Pre-proline 0 N--CA 1.424 -1.773 1 N-CA-C 95.509 -5.738 . . . . 0.0 95.509 174.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.64 149.86 39.18 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.787 2.031 . . . . 0.0 107.847 -177.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 -5.33 16.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.468 2.307 . . . . 0.0 109.263 13.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -162.38 146.55 12.0 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 94.417 -6.142 . . . . 0.0 94.417 163.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.08 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 177.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.15 170.42 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 97.164 -5.124 . . . . 0.0 97.164 163.048 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.85 -168.16 1.59 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -125.72 163.64 22.39 Favored 'General case' 0 CA--C 1.474 -1.96 1 N-CA-C 99.603 -4.221 . . . . 0.0 99.603 171.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.28 152.71 47.47 Favored 'General case' 0 N--CA 1.417 -2.076 1 N-CA-C 96.158 -5.497 . . . . 0.0 96.158 -166.07 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.52 115.76 39.47 Favored Pre-proline 0 N--CA 1.419 -1.996 1 N-CA-C 97.36 -5.052 . . . . 0.0 97.36 171.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.3 107.49 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 123.347 2.231 . . . . 0.0 112.043 -176.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.81 -41.26 0.83 Allowed Glycine 0 CA--C 1.491 -1.455 1 N-CA-C 101.472 -4.651 . . . . 0.0 101.472 -161.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m 84.76 3.81 0.68 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 125.351 1.46 . . . . 0.0 113.222 157.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.75 -40.82 80.6 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.417 1.887 . . . . 0.0 110.752 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.91 -41.29 93.47 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.906 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.5 m -68.89 -42.94 76.26 Favored 'General case' 0 CA--C 1.484 -1.559 0 CA-C-N 117.959 0.879 . . . . 0.0 110.164 -175.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.98 -49.69 74.97 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.905 0.882 . . . . 0.0 109.255 176.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -57.5 -50.11 74.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 111.443 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.7 -43.78 98.19 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.035 0.921 . . . . 0.0 110.152 -178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.1 -43.05 95.86 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.284 0.634 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.86 -39.74 83.72 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.802 -0.561 . . . . 0.0 111.477 -178.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.71 -21.21 52.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.613 -0.679 . . . . 0.0 111.702 -175.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -89.51 -28.78 19.4 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.592 -0.693 . . . . 0.0 109.691 175.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.21 44.62 0.85 Allowed Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 164.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.73 141.23 16.32 Favored Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 p -99.62 7.42 45.24 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 123.488 0.715 . . . . 0.0 110.034 -167.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.3 m -160.18 150.89 18.77 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 100.28 -3.97 . . . . 0.0 100.28 166.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.94 162.67 36.45 Favored Glycine 0 CA--C 1.463 -3.205 1 N-CA-C 99.537 -5.425 . . . . 0.0 99.537 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -162.34 -157.68 0.48 Allowed 'General case' 0 N--CA 1.428 -1.529 1 N-CA-C 99.714 -4.18 . . . . 0.0 99.714 -168.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.4 t -155.6 167.04 31.68 Favored 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 95.954 -5.573 . . . . 0.0 95.954 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.82 73.95 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.568 1 N-CA-C 100.27 -5.132 . . . . 0.0 100.27 -176.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.6 t80 -157.84 157.39 33.18 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 176.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -148.39 166.76 27.13 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 94.16 -6.237 . . . . 0.0 94.16 159.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 42' ' ' GLY 0.332 50.1 t 84.19 -167.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -172.132 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' H ' ' CG1' ' A' ' 41' ' ' VAL . . . 89.67 -93.24 1.86 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 107.174 -2.371 . . . . 0.0 107.174 -177.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -137.96 -52.47 0.62 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 100.589 -3.856 . . . . 0.0 100.589 178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.8 61.95 0.22 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 172.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.461 0.0 OUTLIER 76.36 167.82 0.26 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 109.164 -175.717 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.55 -179.65 8.37 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -175.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.78 160.97 15.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 176.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 t-105 -107.79 150.52 26.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -147.55 150.92 35.42 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.38 143.15 48.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.21 54.13 0.43 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 126.544 1.938 . . . . 0.0 110.602 168.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.6 mt -95.7 135.34 23.07 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 175.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.99 171.8 16.79 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.432 2.088 . . . . 0.0 110.434 177.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -67.61 -17.17 64.52 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -79.37 -6.78 57.56 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.818 -0.551 . . . . 0.0 110.448 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.61 127.3 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.71 157.09 17.54 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 105.16 -3.176 . . . . 0.0 105.16 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -136.75 -158.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 105.925 -1.879 . . . . 0.0 105.925 -163.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -74.76 123.09 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -173.896 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.395 0.617 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 173.08 6.95 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.33 137.92 39.42 Favored 'General case' 0 N--CA 1.431 -1.405 1 N-CA-C 95.412 -5.773 . . . . 0.0 95.412 170.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.94 -177.58 35.12 Favored Glycine 0 CA--C 1.471 -2.662 1 N-CA-C 103.06 -4.016 . . . . 0.0 103.06 176.042 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -77.44 134.39 38.39 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 159.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.48 138.28 19.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -157.18 0.56 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 129.045 2.938 . . . . 0.0 110.557 178.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -148.65 165.74 17.21 Favored Pre-proline 0 N--CA 1.426 -1.664 1 N-CA-C 97.116 -5.142 . . . . 0.0 97.116 176.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -68.96 149.9 72.46 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.688 2.259 . . . . 0.0 109.974 176.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -82.21 -47.37 12.55 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 127.48 2.312 . . . . 0.0 107.231 -1.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -150.26 140.38 22.1 Favored 'General case' 0 N--CA 1.42 -1.972 1 N-CA-C 92.332 -6.914 . . . . 0.0 92.332 173.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.8 m 179.9 -161.05 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 97.336 -5.061 . . . . 0.0 97.336 -174.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.77 163.55 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 100.365 -3.939 . . . . 0.0 100.365 167.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.6 -165.63 1.01 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 158.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -138.34 168.52 19.57 Favored 'General case' 0 N--CA 1.415 -2.179 1 N-CA-C 96.399 -5.408 . . . . 0.0 96.399 167.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -129.55 -176.41 3.89 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 96.68 -5.304 . . . . 0.0 96.68 -176.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.77 131.17 23.67 Favored Pre-proline 0 N--CA 1.42 -1.95 1 N-CA-C 95.385 -5.783 . . . . 0.0 95.385 174.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.79 40.71 0.17 Allowed 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.298 3.332 . . . . 0.0 116.401 -174.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.13 92.9 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 93.609 -7.796 . . . . 0.0 93.609 174.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -78.79 30.86 0.2 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -148.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -70.18 -35.98 74.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 110.32 -170.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.19 -33.44 69.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -81.69 -11.83 58.9 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.189 -0.595 . . . . 0.0 109.969 -177.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.01 -50.08 75.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -50.58 73.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.867 0.867 . . . . 0.0 112.466 170.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.63 -41.52 99.06 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 121.593 0.711 . . . . 0.0 112.135 -173.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 t -65.12 -45.83 83.51 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -67.86 -37.17 81.48 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.669 -0.644 . . . . 0.0 112.358 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.16 -7.86 53.27 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.054 -1.029 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -106.22 1.61 26.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.98 29.67 37.39 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 140.83 15.27 Favored Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -92.94 -54.73 3.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -164.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 m -106.46 147.63 29.11 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 102.895 -3.002 . . . . 0.0 102.895 174.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.64 154.76 25.81 Favored Glycine 0 CA--C 1.469 -2.785 1 N-CA-C 100.468 -5.053 . . . . 0.0 100.468 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -171.97 179.02 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 98.016 -4.809 . . . . 0.0 98.016 -175.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.7 m -78.05 173.93 11.67 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 119.796 1.18 . . . . 0.0 111.044 -177.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.92 164.17 37.75 Favored Glycine 0 N--CA 1.418 -2.528 1 N-CA-C 98.688 -5.765 . . . . 0.0 98.688 175.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -126.72 131.57 51.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -115.76 105.49 12.78 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.72 140.23 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -172.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.09 -36.14 4.6 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -104.17 -66.39 0.96 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -177.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.33 -150.31 22.23 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 104.963 -3.255 . . . . 0.0 104.963 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.43 136.48 54.75 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.84 -162.48 1.1 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 101.998 -3.334 . . . . 0.0 101.998 -176.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.8 171.55 11.64 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 158.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -129.7 148.76 51.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.2 m -142.36 146.67 35.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -116.64 140.63 49.18 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 170.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 63.98 0.31 Allowed 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 126.342 1.857 . . . . 0.0 109.893 176.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 mt -103.09 133.88 20.09 Favored Pre-proline 0 CA--C 1.503 -0.833 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 169.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -72.52 174.64 11.31 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.624 2.216 . . . . 0.0 111.248 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -76.03 -2.08 28.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -165.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -90.49 -5.89 55.49 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.266 -0.896 . . . . 0.0 110.065 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.03 138.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -174.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.72 149.92 17.8 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 pt -146.78 -175.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -168.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.42 127.75 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 121.723 0.773 . . . . 0.0 111.74 -159.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 100.833 -3.766 . . . . 0.0 100.833 168.808 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.33 163.27 13.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -130.76 127.93 39.74 Favored 'General case' 0 CA--C 1.491 -1.301 1 N-CA-C 95.564 -5.717 . . . . 0.0 95.564 158.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.05 -169.83 25.95 Favored Glycine 0 CA--C 1.478 -2.261 1 N-CA-C 102.808 -4.117 . . . . 0.0 102.808 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.55 142.33 34.23 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 163.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.92 141.64 14.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.971 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.77 -153.25 0.53 Allowed 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 128.029 2.531 . . . . 0.0 106.701 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -128.84 147.46 64.65 Favored Pre-proline 0 N--CA 1.419 -1.992 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 173.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.98 146.8 59.89 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.614 1.969 . . . . 0.0 107.31 175.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -80.93 -41.67 22.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.403 2.281 . . . . 0.0 109.845 11.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -154.02 151.87 29.85 Favored 'General case' 0 N--CA 1.417 -2.095 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 -176.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.7 m 173.97 -154.01 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 97.091 -5.151 . . . . 0.0 97.091 169.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.15 170.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 1 N-CA-C 97.412 -5.032 . . . . 0.0 97.412 161.536 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -161.77 0.72 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 164.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -142.35 163.54 32.58 Favored 'General case' 0 N--CA 1.417 -2.101 1 N-CA-C 94.463 -6.125 . . . . 0.0 94.463 165.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -160.64 -156.89 0.5 Allowed 'General case' 0 N--CA 1.414 -2.257 1 N-CA-C 94.656 -6.053 . . . . 0.0 94.656 -174.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -145.61 169.71 9.28 Favored Pre-proline 0 N--CA 1.414 -2.25 1 N-CA-C 97.837 -4.875 . . . . 0.0 97.837 -167.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -77.33 68.4 7.49 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 CA-C-N 124.14 2.514 . . . . 0.0 111.873 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.82 165.94 34.59 Favored Glycine 0 CA--C 1.479 -2.166 1 N-CA-C 99.778 -5.329 . . . . 0.0 99.778 171.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -83.25 11.17 6.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 118.085 0.942 . . . . 0.0 111.32 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.91 -57.02 8.32 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 128.56 2.744 . . . . 0.0 114.485 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.51 -29.66 18.38 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -85.03 -5.06 59.36 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.779 -0.836 . . . . 0.0 110.873 -165.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.96 -53.04 62.89 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -52.63 64.65 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.486 1.115 . . . . 0.0 112.423 171.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.88 -41.08 97.83 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 118.603 0.638 . . . . 0.0 110.998 -173.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -65.47 -42.3 92.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 121.231 -0.918 . . . . 0.0 108.78 -177.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -69.61 -40.28 76.71 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.896 -0.502 . . . . 0.0 111.136 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -72.65 -30.13 64.03 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 118.535 0.607 . . . . 0.0 112.324 -178.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.69 -24.56 36.13 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.216 0.462 . . . . 0.0 109.89 176.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.61 37.92 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 159.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.89 136.86 13.87 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 104.773 -3.331 . . . . 0.0 104.773 173.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -106.34 9.64 31.84 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.74 0.781 . . . . 0.0 108.978 -165.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.6 m -160.21 157.83 28.96 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 98.886 -4.487 . . . . 0.0 98.886 163.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 170.98 44.04 Favored Glycine 0 N--CA 1.421 -2.339 1 N-CA-C 100.799 -4.92 . . . . 0.0 100.799 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -168.12 -174.44 2.33 Favored 'General case' 0 N--CA 1.432 -1.334 1 N-CA-C 97.303 -5.073 . . . . 0.0 97.303 -179.377 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.45 159.89 33.99 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.75 -179.22 48.49 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 100.721 -4.951 . . . . 0.0 100.721 -173.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -102.9 146.97 27.51 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -171.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -119.17 113.27 20.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 101.458 -3.534 . . . . 0.0 101.458 171.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.03 132.3 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -173.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.83 15.65 33.27 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -171.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -152.4 -79.48 0.11 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.66 -168.88 39.78 Favored Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 -165.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.96 142.15 42.04 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.87 -164.08 1.43 Allowed 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -166.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.6 t -127.62 165.93 19.03 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.2 -4.0 . . . . 0.0 100.2 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -123.33 148.04 46.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 178.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.51 152.3 40.38 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 175.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -115.99 140.84 48.86 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 172.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.1 42.29 0.14 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.145 2.178 . . . . 0.0 111.197 166.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 mt -85.11 134.76 40.38 Favored Pre-proline 0 CA--C 1.5 -0.97 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.32 172.92 15.36 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.127 1.885 . . . . 0.0 110.135 -178.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.66 -9.38 58.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -167.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -91.24 5.3 49.69 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -178.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -103.81 147.79 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 176.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.01 143.83 18.21 Favored Glycine 0 CA--C 1.478 -2.274 1 N-CA-C 101.111 -4.796 . . . . 0.0 101.111 175.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 -149.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -167.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.4 119.78 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 174.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.581 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.122 0.487 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -112.59 167.92 10.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 164.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.85 123.79 33.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 94.856 -5.979 . . . . 0.0 94.856 159.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.69 -169.75 25.44 Favored Glycine 0 CA--C 1.485 -1.791 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -172.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HH ' ' C ' ' A' ' 38' ' ' GLY . 2.8 m-85 -94.01 138.8 31.7 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 164.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 tt -90.93 144.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB1' HD13 ' A' ' 59' ' ' ILE . . . -105.71 -138.16 0.36 Allowed 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 127.874 2.47 . . . . 0.0 107.115 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -139.62 154.04 70.88 Favored Pre-proline 0 N--CA 1.426 -1.647 1 N-CA-C 95.597 -5.705 . . . . 0.0 95.597 166.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.87 155.4 53.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 122.836 2.049 . . . . 0.0 109.016 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -83.71 -27.63 28.84 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 126.764 2.025 . . . . 0.0 107.824 -1.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -158.61 152.91 24.08 Favored 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 95.123 -5.881 . . . . 0.0 95.123 175.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m 170.27 -153.55 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.662 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.32 170.4 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 1 N-CA-C 96.715 -5.291 . . . . 0.0 96.715 166.67 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -156.95 0.34 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 161.453 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -138.4 143.07 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 167.02 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 t -160.1 -174.44 4.55 Favored 'General case' 0 N--CA 1.419 -2.011 1 N-CA-C 96.878 -5.23 . . . . 0.0 96.878 178.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.17 173.52 5.53 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 -159.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.79 61.74 2.31 Favored 'Trans proline' 0 C--N 1.328 -0.552 0 C-N-CA 123.117 2.545 . . . . 0.0 110.108 161.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.86 138.56 2.7 Favored Glycine 0 N--CA 1.428 -1.843 1 N-CA-C 100.024 -5.231 . . . . 0.0 100.024 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -85.9 -11.48 53.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 123.918 0.887 . . . . 0.0 112.976 -165.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -39.29 -53.42 1.94 Allowed 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 127.963 2.505 . . . . 0.0 117.632 -153.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.94 -40.94 7.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -174.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -82.09 -14.81 55.24 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.586 -0.949 . . . . 0.0 110.306 -169.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.66 -45.11 93.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.792 0.837 . . . . 0.0 109.253 169.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -46.82 86.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.299 1.039 . . . . 0.0 111.513 172.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.32 -39.29 89.18 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-O 121.801 0.81 . . . . 0.0 111.435 -176.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.91 -44.57 67.06 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.116 1.766 . . . . 0.0 110.776 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.8 -54.26 47.37 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 123.196 0.598 . . . . 0.0 110.961 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.95 -20.42 62.45 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -88.74 -7.68 55.83 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.581 0.628 . . . . 0.0 110.413 172.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.99 5.2 Favored Glycine 0 CA--C 1.486 -1.758 0 CA-C-O 119.192 -0.782 . . . . 0.0 111.81 160.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.72 20.33 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 p -86.94 -84.2 0.18 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.5 m -81.54 161.26 23.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.27 168.35 35.83 Favored Glycine 0 N--CA 1.42 -2.416 1 N-CA-C 99.172 -5.571 . . . . 0.0 99.172 -177.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -165.03 -179.8 5.94 Favored 'General case' 0 N--CA 1.433 -1.318 1 N-CA-C 97.758 -4.904 . . . . 0.0 97.758 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.6 m -143.92 161.22 39.27 Favored 'General case' 0 CA--C 1.487 -1.45 1 N-CA-C 98.376 -4.676 . . . . 0.0 98.376 165.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.402 ' C ' ' HH ' ' A' ' 5' ' ' TYR . . . 162.52 177.43 35.53 Favored Glycine 0 CA--C 1.488 -1.629 1 N-CA-C 97.081 -6.408 . . . . 0.0 97.081 -175.033 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -113.43 103.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 120.374 2.087 . . . . 0.0 108.559 -174.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -130.38 81.9 2.03 Favored 'General case' 0 CA--C 1.497 -1.091 1 N-CA-C 99.215 -4.365 . . . . 0.0 99.215 156.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.39 -177.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 1 N-CA-C 100.177 -4.008 . . . . 0.0 100.177 -174.65 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.51 54.61 0.37 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -157.47 -67.18 0.1 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 -178.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.85 42.47 Favored Glycine 0 CA--C 1.477 -2.285 1 N-CA-C 98.533 -5.827 . . . . 0.0 98.533 -178.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -76.69 140.88 41.05 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -175.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.91 -172.75 4.12 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 100.882 -3.747 . . . . 0.0 100.882 -162.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.39 155.33 32.16 Favored 'General case' 0 CA--C 1.479 -1.773 0 C-N-CA 117.542 -1.663 . . . . 0.0 106.658 -165.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -97.49 150.4 21.11 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 176.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 46.8 m -145.14 146.69 31.89 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 168.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.64 145.47 33.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 170.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.64 38.04 1.33 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 126.065 1.746 . . . . 0.0 111.85 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.57 133.97 62.33 Favored Pre-proline 0 CA--C 1.5 -0.952 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -65.22 166.75 18.11 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.5 2.134 . . . . 0.0 111.331 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.45 -5.49 52.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.969 -0.457 . . . . 0.0 112.16 -168.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -90.38 -0.57 57.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.69 -0.631 . . . . 0.0 109.861 177.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 t -95.74 123.74 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 177.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.86 145.75 16.82 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -147.13 -171.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -158.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 HD13 ' HB1' ' A' ' 7' ' ' ALA . 35.1 mm -54.44 111.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.939 0 C-N-CA 126.912 2.085 . . . . 0.0 112.562 -170.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.434 -1.272 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 166.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.27 0.557 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -179.55 6.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 172.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -130.95 146.17 52.27 Favored 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 99.33 -4.322 . . . . 0.0 99.33 -174.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.63 -179.65 36.44 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -177.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.51 123.34 28.0 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 11.9 tt -90.67 140.9 15.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 120.752 1.615 . . . . 0.0 109.453 -176.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.98 169.07 10.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 110.95 -2.841 . . . . 0.0 112.092 177.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.252 26.6 tt0 -95.9 151.22 38.21 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 174.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -63.03 132.34 36.34 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.978 2.452 . . . . 0.0 109.336 165.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.94 -50.86 9.83 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 122.001 2.182 . . . . 0.0 110.843 14.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -168.06 156.28 8.79 Favored 'General case' 0 N--CA 1.425 -1.708 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 167.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 m 158.52 -144.84 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.428 1 N-CA-C 97.985 -4.821 . . . . 0.0 97.985 -176.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.02 165.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 165.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -167.93 1.94 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 162.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -136.73 161.75 35.07 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 168.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.9 t -132.41 163.97 27.54 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 101.341 -3.577 . . . . 0.0 101.341 -160.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -109.43 126.95 28.1 Favored Pre-proline 0 N--CA 1.423 -1.775 1 N-CA-C 99.554 -4.239 . . . . 0.0 99.554 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.91 41.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.485 0 C-N-CA 123.843 3.029 . . . . 0.0 116.617 174.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.93 115.41 0.66 Allowed Glycine 0 N--CA 1.423 -2.217 1 N-CA-C 94.436 -7.466 . . . . 0.0 94.436 171.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -60.48 -32.76 71.73 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 m -41.18 -43.88 2.43 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 127.807 2.443 . . . . 0.0 116.373 -168.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -55.89 26.91 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 121.116 -0.99 . . . . 0.0 112.017 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -21.61 36.55 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.642 -0.916 . . . . 0.0 110.091 -173.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.11 -35.32 78.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.542 0.737 . . . . 0.0 109.641 169.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 m -70.61 -40.1 73.37 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 177.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.75 -39.61 94.71 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -57.17 -42.57 81.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.652 1.181 . . . . 0.0 111.176 177.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.55 -51.85 67.68 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.833 0.453 . . . . 0.0 110.821 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.88 -18.94 62.67 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.31 -2.32 57.99 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.802 -0.561 . . . . 0.0 111.325 174.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 24.91 12.74 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 121.601 -0.687 . . . . 0.0 111.754 170.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.03 157.89 21.15 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 172.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 p -81.43 -40.86 22.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.41 157.5 27.87 Favored 'General case' 0 N--CA 1.418 -2.028 1 N-CA-C 98.524 -4.621 . . . . 0.0 98.524 -164.025 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.14 173.87 45.29 Favored Glycine 0 CA--C 1.475 -2.449 1 N-CA-C 102.085 -4.406 . . . . 0.0 102.085 -176.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -170.72 -143.98 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.5 m -121.36 -175.37 3.06 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 -170.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.49 -168.58 33.29 Favored Glycine 0 N--CA 1.417 -2.624 1 N-CA-C 96.845 -6.502 . . . . 0.0 96.845 172.594 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -141.97 157.87 44.44 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 96.884 -5.228 . . . . 0.0 96.884 172.328 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -162.55 177.84 9.1 Favored 'General case' 0 N--CA 1.423 -1.784 1 N-CA-C 96.036 -5.542 . . . . 0.0 96.036 172.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.41 171.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 1 N-CA-C 96.283 -5.451 . . . . 0.0 96.283 179.119 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.03 -49.53 0.85 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 104.005 -3.638 . . . . 0.0 104.005 -173.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -115.43 -70.19 0.81 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.33 -159.9 32.98 Favored Glycine 0 CA--C 1.482 -1.979 0 N-CA-C 103.367 -3.893 . . . . 0.0 103.367 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.06 136.27 58.03 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.761 2.024 . . . . 0.0 106.831 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.49 168.32 20.06 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -161.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.79 179.05 4.39 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -140.37 146.82 38.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.845 -3.02 . . . . 0.0 102.845 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.73 151.18 49.89 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -112.12 137.69 49.83 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 173.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 56.9 71.88 0.55 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 127.753 2.421 . . . . 0.0 113.253 174.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.6 mt -103.77 143.59 26.95 Favored Pre-proline 0 CA--C 1.504 -0.809 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 172.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -69.21 173.39 10.55 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.251 1.967 . . . . 0.0 113.288 174.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.06 -17.64 61.4 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.067 1.347 . . . . 0.0 111.549 -174.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -94.3 18.91 10.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.592 0.757 . . . . 0.0 109.485 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.97 164.74 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 1 N-CA-C 98.773 -4.528 . . . . 0.0 98.773 167.025 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.06 175.1 30.91 Favored Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.783 -5.327 . . . . 0.0 99.783 -175.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 pt -159.22 -170.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 -156.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 mm -38.9 -43.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 129.844 3.258 . . . . 0.0 118.908 -147.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.487 -1.472 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.93 0.871 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -117.73 164.44 14.98 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -139.91 136.51 33.96 Favored 'General case' 0 CA--C 1.485 -1.536 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 167.296 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.13 35.57 Favored Glycine 0 CA--C 1.476 -2.399 0 N-CA-C 104.165 -3.574 . . . . 0.0 104.165 174.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -75.02 130.8 39.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.359 -3.201 . . . . 0.0 102.359 157.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -84.1 135.84 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.68 -136.61 0.34 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 110.711 -2.949 . . . . 0.0 109.256 175.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -146.43 159.24 45.5 Favored Pre-proline 0 N--CA 1.423 -1.79 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 172.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.11 141.89 44.99 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.37 2.047 . . . . 0.0 108.484 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.22 -32.42 13.04 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 127.962 2.505 . . . . 0.0 107.601 7.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -150.34 147.21 27.32 Favored 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 94.126 -6.25 . . . . 0.0 94.126 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -159.47 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.58 157.8 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 162.273 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 -155.16 0.27 Allowed 'General case' 0 C--N 1.358 0.936 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 161.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -138.63 154.97 48.68 Favored 'General case' 0 CA--C 1.473 -2.004 1 N-CA-C 97.496 -5.002 . . . . 0.0 97.496 177.364 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.25 175.31 6.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -158.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.89 85.58 57.42 Favored Pre-proline 0 N--CA 1.411 -2.419 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -175.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -78.0 -4.39 14.36 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.133 1.889 . . . . 0.0 109.63 165.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.27 141.09 10.84 Favored Glycine 0 CA--C 1.484 -1.901 1 N-CA-C 96.815 -6.514 . . . . 0.0 96.815 174.169 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -68.06 -55.13 13.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -153.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -63.47 5.95 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -155.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.17 -93.05 1.31 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 169.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.92 -17.86 62.06 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.521 1.128 . . . . 0.0 111.61 -166.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -62.31 -49.84 74.04 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 121.082 1.765 . . . . 0.0 109.499 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.72 89.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.812 2.045 . . . . 0.0 111.884 173.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.33 -44.09 88.91 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.815 0.817 . . . . 0.0 110.968 -178.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.9 t -58.67 -43.88 90.01 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 125.182 1.393 . . . . 0.0 109.03 177.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -53.51 54.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.099 0.96 . . . . 0.0 111.262 -178.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.28 -26.39 66.52 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.785 -0.572 . . . . 0.0 112.474 -175.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -79.86 -13.12 59.63 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 123.39 0.676 . . . . 0.0 110.498 177.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.31 23.87 8.74 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.87 119.87 6.13 Favored Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.134 -3.187 . . . . 0.0 105.134 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 p -82.45 -11.97 58.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.695 0.759 . . . . 0.0 110.087 -172.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.97 149.01 17.54 Favored 'General case' 0 N--CA 1.415 -2.207 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -160.094 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.62 47.24 Favored Glycine 0 CA--C 1.476 -2.397 1 N-CA-C 97.963 -6.055 . . . . 0.0 97.963 -178.024 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.457 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 12.7 p-80 -165.79 168.54 15.92 Favored 'General case' 0 N--CA 1.425 -1.676 1 N-CA-C 98.191 -4.744 . . . . 0.0 98.191 179.377 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.8 t -100.33 166.16 11.11 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.1 -170.27 40.05 Favored Glycine 0 N--CA 1.425 -2.054 1 N-CA-C 97.754 -6.138 . . . . 0.0 97.754 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.77 154.39 51.61 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 100.237 -3.986 . . . . 0.0 100.237 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -150.29 149.82 30.65 Favored 'General case' 0 N--CA 1.426 -1.652 1 N-CA-C 94.231 -6.211 . . . . 0.0 94.231 172.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.97 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.57 -71.64 1.12 Allowed Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 108.204 -1.959 . . . . 0.0 108.204 171.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 m170 -99.59 -42.31 6.96 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.87 -70.79 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.942 0 C-N-CA 118.274 -1.917 . . . . 0.0 108.74 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 tp -158.68 161.95 37.17 Favored 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 95.535 -5.728 . . . . 0.0 95.535 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.35 172.99 16.33 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 -171.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -128.55 167.41 17.15 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 100.98 -3.711 . . . . 0.0 100.98 -175.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.457 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 27.4 t-105 -116.7 145.2 43.61 Favored 'General case' 0 C--N 1.364 1.2 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 176.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.6 m -133.94 143.82 48.44 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 170.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -127.38 121.7 31.67 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 -172.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.43 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 127.942 2.497 . . . . 0.0 108.076 -177.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.49 135.44 20.64 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-O 117.084 -1.436 . . . . 0.0 107.433 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.88 165.91 26.34 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.434 2.089 . . . . 0.0 112.653 176.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.84 -13.94 62.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.252 1.021 . . . . 0.0 112.484 -174.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -91.44 5.58 48.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.85 0.86 . . . . 0.0 110.995 -179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -108.38 -174.96 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.71 169.22 33.97 Favored Glycine 0 CA--C 1.482 -2.022 1 N-CA-C 101.877 -4.489 . . . . 0.0 101.877 -170.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 pt -155.53 -168.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 101.722 -3.436 . . . . 0.0 101.722 -162.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mm -70.79 131.25 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 101.176 -3.639 . . . . 0.0 101.176 176.113 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.7 169.6 9.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 162.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -125.44 146.34 49.67 Favored 'General case' 0 CA--C 1.487 -1.443 1 N-CA-C 93.329 -6.545 . . . . 0.0 93.329 156.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 179.31 36.95 Favored Glycine 0 CA--C 1.468 -2.879 0 C-N-CA 116.542 -2.742 . . . . 0.0 107.55 -177.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.34 132.7 33.86 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 100.832 -3.766 . . . . 0.0 100.832 157.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.62 140.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.64 -138.46 0.36 Allowed 'General case' 0 N--CA 1.426 -1.673 0 O-C-N 126.849 2.593 . . . . 0.0 106.982 -178.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -133.27 153.39 80.62 Favored Pre-proline 0 N--CA 1.421 -1.912 1 N-CA-C 94.915 -5.957 . . . . 0.0 94.915 166.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -64.19 135.31 46.36 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.12 2.15 . . . . 0.0 106.571 163.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -94.9 -37.61 11.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 121.952 2.16 . . . . 0.0 109.648 17.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -158.74 148.43 19.28 Favored 'General case' 0 N--CA 1.422 -1.853 1 N-CA-C 94.639 -6.06 . . . . 0.0 94.639 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.3 m 170.73 -158.55 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.939 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.92 165.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 N-CA-C 99.515 -4.254 . . . . 0.0 99.515 157.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -155.48 0.21 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.052 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -139.35 179.31 6.61 Favored 'General case' 0 CA--C 1.482 -1.651 1 N-CA-C 97.853 -4.869 . . . . 0.0 97.853 160.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.56 171.17 14.42 Favored 'General case' 0 N--CA 1.415 -2.194 1 N-CA-C 97.276 -5.083 . . . . 0.0 97.276 -177.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -125.75 121.74 24.52 Favored Pre-proline 0 N--CA 1.415 -2.202 1 N-CA-C 97.762 -4.903 . . . . 0.0 97.762 176.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.28 113.96 1.65 Allowed 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.262 2.641 . . . . 0.0 112.661 176.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.22 -43.51 1.05 Allowed Glycine 0 CA--C 1.489 -1.57 1 N-CA-C 101.86 -4.496 . . . . 0.0 101.86 -163.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.254 67.6 m 85.47 -7.84 0.84 Allowed 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 127.448 2.299 . . . . 0.0 113.101 172.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -51.32 -49.6 61.04 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.479 1.512 . . . . 0.0 113.595 -171.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -38.98 62.0 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.32 -47.16 77.5 Favored 'General case' 0 CA--C 1.488 -1.437 0 O-C-N 121.757 -0.849 . . . . 0.0 109.698 -177.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.9 -40.1 94.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.485 0.66 . . . . 0.0 109.792 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 m -63.05 -48.63 77.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.438 0.695 . . . . 0.0 110.929 175.016 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.05 -36.13 83.37 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.132 0.973 . . . . 0.0 111.055 -177.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.4 t -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.724 1.21 . . . . 0.0 110.448 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -68.55 -41.38 79.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.784 -0.573 . . . . 0.0 111.966 -175.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.89 -11.77 60.95 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.457 -0.777 . . . . 0.0 112.45 -178.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -99.55 -0.69 40.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.443 0.697 . . . . 0.0 109.75 174.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.09 28.36 18.1 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 170.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.48 152.4 20.17 Favored Glycine 0 C--N 1.356 1.66 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 170.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -80.9 -38.74 27.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.451 -1.029 . . . . 0.0 110.635 -166.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 m -160.54 173.36 15.65 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 98.805 -4.517 . . . . 0.0 98.805 166.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.31 168.88 41.19 Favored Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 99.386 -5.486 . . . . 0.0 99.386 -172.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -163.72 172.53 14.06 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -172.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.49 156.18 39.3 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 119.412 1.006 . . . . 0.0 110.831 -177.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 -179.39 40.63 Favored Glycine 0 N--CA 1.42 -2.378 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 168.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -145.14 154.45 42.46 Favored 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.082 -5.525 . . . . 0.0 96.082 -175.206 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 18.84 2.91 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 2.3 t 61.75 -142.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -167.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.0 -74.53 1.61 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 124.071 0.843 . . . . 0.0 111.709 168.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.08 -76.14 0.59 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.78 -174.28 41.33 Favored Glycine 0 CA--C 1.478 -2.236 1 N-CA-C 100.582 -5.007 . . . . 0.0 100.582 -168.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.0 tp -52.3 134.89 33.55 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 127.245 2.218 . . . . 0.0 108.561 177.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.69 -167.67 1.84 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 -167.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.02 153.73 48.12 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.076 -4.416 . . . . 0.0 99.076 172.449 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -105.65 152.01 23.66 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.52 144.65 33.05 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -103.31 142.26 34.51 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 167.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.68 74.37 0.44 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.013 2.525 . . . . 0.0 112.602 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.2 mt -108.29 134.83 20.06 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.8 170.02 20.61 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.24 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.77 -17.35 64.57 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.213 1.405 . . . . 0.0 114.008 -166.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -84.37 -7.67 59.24 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 124.205 1.002 . . . . 0.0 110.907 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.55 125.95 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 -176.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 143.8 16.74 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 104.486 -3.445 . . . . 0.0 104.486 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.9 pt -130.41 -150.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -165.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -74.3 117.37 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 177.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 -176.932 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.467 0.651 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -104.72 155.21 19.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 165.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -120.36 126.14 49.75 Favored 'General case' 0 CA--C 1.485 -1.552 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 157.265 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -162.45 13.09 Favored Glycine 0 CA--C 1.481 -2.061 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -174.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.58 141.37 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.268 -3.975 . . . . 0.0 100.268 163.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tt -90.42 147.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 173.094 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.62 177.0 10.47 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 98.482 -4.636 . . . . 0.0 98.482 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -86.53 158.37 54.45 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.079 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -62.31 118.06 4.94 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.467 2.111 . . . . 0.0 109.589 168.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -130.87 114.22 15.02 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 127.74 2.416 . . . . 0.0 105.365 2.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 65.74 40.15 4.47 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 110.279 169.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.66 125.03 43.46 Favored 'General case' 0 CA--C 1.479 -1.751 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 168.268 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.269 35.0 m -69.58 169.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 122.637 1.208 . . . . 0.0 113.832 -161.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.2 131.21 50.71 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 92.062 -7.014 . . . . 0.0 92.062 -178.478 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -92.88 -146.32 0.23 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -170.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -151.09 155.45 39.0 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 93.821 -6.363 . . . . 0.0 93.821 -174.539 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -108.98 112.8 59.87 Favored Pre-proline 0 N--CA 1.43 -1.431 1 N-CA-C 99.037 -4.431 . . . . 0.0 99.037 168.366 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.92 106.12 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.448 2.765 . . . . 0.0 117.665 -166.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.57 -166.46 38.48 Favored Glycine 0 N--CA 1.421 -2.343 1 N-CA-C 94.561 -7.416 . . . . 0.0 94.561 179.258 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 m -79.56 -29.19 41.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.722 1.761 . . . . 0.0 107.778 170.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -40.28 -57.44 1.74 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.505 3.922 . . . . 0.0 115.414 -168.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.92 -34.94 55.11 Favored Glycine 0 CA--C 1.492 -1.39 0 O-C-N 120.767 -1.208 . . . . 0.0 112.132 -168.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.86 -36.93 35.95 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.36 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.4 -49.76 71.51 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 123.79 0.836 . . . . 0.0 109.207 173.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 m -58.17 -54.96 41.12 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.456 0.702 . . . . 0.0 111.35 175.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.97 -46.52 90.4 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.669 1.188 . . . . 0.0 111.51 -174.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.39 -42.95 92.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -175.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.35 -42.77 74.81 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.171 0.442 . . . . 0.0 111.706 -179.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -72.11 -22.79 61.28 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.42 -0.8 . . . . 0.0 111.973 -173.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -46.62 9.18 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.676 -0.64 . . . . 0.0 109.558 172.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.01 48.66 0.18 Allowed Glycine 0 CA--C 1.487 -1.711 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 168.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.24 149.9 18.53 Favored Glycine 0 CA--C 1.488 -1.626 1 N-CA-C 102.114 -4.394 . . . . 0.0 102.114 163.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -89.16 -62.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.011 0.906 . . . . 0.0 109.129 -169.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -94.34 150.57 20.16 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.13 167.24 39.71 Favored Glycine 0 CA--C 1.478 -2.225 1 N-CA-C 100.826 -4.909 . . . . 0.0 100.826 176.902 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -170.04 172.76 6.3 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 100.249 -3.982 . . . . 0.0 100.249 -178.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 m -113.15 145.26 41.26 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.052 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.8 90.92 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.739 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -174.14 176.93 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 97.933 -4.839 . . . . 0.0 97.933 178.197 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp 170.25 49.96 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 170.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.49 140.31 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -172.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.66 -63.64 3.55 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.525 -0.734 . . . . 0.0 111.304 161.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -107.59 -52.51 2.75 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -176.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.25 -146.88 11.14 Favored Glycine 0 N--CA 1.42 -2.401 1 N-CA-C 95.024 -7.23 . . . . 0.0 95.024 -174.582 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 162.92 20.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.155 0.977 . . . . 0.0 108.63 171.386 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.16 169.57 17.36 Favored 'General case' 0 CA--C 1.485 -1.555 1 N-CA-C 98.395 -4.668 . . . . 0.0 98.395 -178.096 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 141.0 42.51 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 -170.202 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -88.37 150.07 23.39 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.9 m -149.23 138.5 21.5 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -108.27 136.49 47.84 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 170.246 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.67 56.36 0.14 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 126.187 1.795 . . . . 0.0 110.559 168.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.33 132.81 34.55 Favored Pre-proline 0 CA--C 1.498 -1.023 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 170.193 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 172.42 14.2 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.116 2.544 . . . . 0.0 110.169 177.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.0 -20.06 63.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.694 1.598 . . . . 0.0 113.824 -169.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -82.77 -4.45 57.96 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.511 -0.743 . . . . 0.0 111.486 -172.014 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -101.3 126.73 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -175.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.27 148.8 18.52 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 103.204 -3.958 . . . . 0.0 103.204 176.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.7 pt -148.03 -146.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 -159.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -71.27 118.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -159.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.192 0.52 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -101.08 159.31 15.34 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 165.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -126.33 122.77 36.39 Favored 'General case' 0 CA--C 1.484 -1.588 1 N-CA-C 94.19 -6.226 . . . . 0.0 94.19 159.793 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.63 38.15 Favored Glycine 0 CA--C 1.473 -2.581 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -173.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -79.64 131.4 35.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 165.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.4 tt -90.39 141.57 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -176.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.22 -141.81 0.37 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -178.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -131.95 150.9 77.45 Favored Pre-proline 0 N--CA 1.419 -2.02 1 N-CA-C 94.586 -6.079 . . . . 0.0 94.586 166.011 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.7 144.01 58.31 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 N-CA-C 106.629 -2.104 . . . . 0.0 106.629 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.57 -36.64 13.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.635 1.974 . . . . 0.0 109.165 12.795 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.88 150.08 28.93 Favored 'General case' 0 N--CA 1.418 -2.056 1 N-CA-C 94.707 -6.034 . . . . 0.0 94.707 175.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.55 -160.66 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -176.316 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.33 165.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 96.568 -5.345 . . . . 0.0 96.568 152.64 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.32 158.41 19.68 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 100.235 -3.987 . . . . 0.0 100.235 163.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -107.71 147.22 31.04 Favored 'General case' 0 CA--C 1.47 -2.103 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 -177.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -159.41 -177.99 6.83 Favored 'General case' 0 N--CA 1.409 -2.484 1 N-CA-C 95.763 -5.643 . . . . 0.0 95.763 -168.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -139.76 171.46 7.89 Favored Pre-proline 0 N--CA 1.414 -2.227 1 N-CA-C 98.867 -4.494 . . . . 0.0 98.867 -156.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.15 42.92 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 123.967 3.112 . . . . 0.0 114.308 169.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.83 129.52 1.49 Allowed Glycine 0 N--CA 1.423 -2.229 1 N-CA-C 100.203 -5.159 . . . . 0.0 100.203 -176.398 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.25 33.69 1.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.673 1.589 . . . . 0.0 111.083 -171.063 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -56.48 -43.63 79.81 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 126.437 1.895 . . . . 0.0 113.133 -173.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -33.29 8.97 Favored Glycine 0 C--N 1.352 1.431 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.0 t -61.72 -36.71 81.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.018 1.327 . . . . 0.0 111.408 -170.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.97 -53.84 43.92 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.121 0.968 . . . . 0.0 110.588 176.379 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -36.84 84.89 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.629 1.172 . . . . 0.0 112.884 177.061 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.02 -39.78 87.1 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 122.076 0.941 . . . . 0.0 109.733 -179.602 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -61.36 -42.87 99.4 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.444 0.697 . . . . 0.0 110.792 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -60.65 -47.79 84.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.785 0.834 . . . . 0.0 111.033 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.37 -17.55 62.41 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.211 -0.931 . . . . 0.0 112.739 -174.003 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -96.3 -5.17 40.75 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.208 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.35 11.85 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.009 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.35 159.48 19.29 Favored Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 105.721 -2.951 . . . . 0.0 105.721 168.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -71.51 -60.74 2.07 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.758 1.266 . . . . 0.0 108.747 -170.7 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.96 -171.05 2.92 Favored 'General case' 0 N--CA 1.425 -1.711 1 N-CA-C 97.323 -5.065 . . . . 0.0 97.323 169.438 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.99 -158.18 16.68 Favored Glycine 0 N--CA 1.419 -2.453 1 N-CA-C 101.732 -4.547 . . . . 0.0 101.732 -175.769 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -163.11 -170.2 2.24 Favored 'General case' 0 N--CA 1.429 -1.501 1 N-CA-C 97.467 -5.012 . . . . 0.0 97.467 -171.188 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.9 m -128.61 165.58 20.52 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 174.171 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.72 -170.92 43.03 Favored Glycine 0 N--CA 1.42 -2.383 1 N-CA-C 96.847 -6.501 . . . . 0.0 96.847 -176.353 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -139.46 161.85 36.48 Favored 'General case' 0 N--CA 1.431 -1.406 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 -174.485 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 150.4 40.54 Favored 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 94.237 -6.208 . . . . 0.0 94.237 159.88 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 t -75.99 126.57 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 119.539 1.063 . . . . 0.0 108.326 -165.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.87 -78.23 0.05 OUTLIER Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 104.382 -3.487 . . . . 0.0 104.382 178.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -108.3 -105.32 0.35 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.6 98.21 0.18 Allowed Glycine 0 CA--C 1.489 -1.58 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 -171.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.333 0.2 OUTLIER 59.33 -166.91 0.17 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.764 2.425 . . . . 0.0 110.712 -170.322 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -164.98 -179.47 5.77 Favored 'General case' 0 N--CA 1.427 -1.605 1 N-CA-C 99.878 -4.119 . . . . 0.0 99.878 168.661 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -122.55 152.99 39.83 Favored 'General case' 0 CA--C 1.494 -1.186 1 N-CA-C 98.078 -4.786 . . . . 0.0 98.078 175.282 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -104.87 156.01 18.4 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 176.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.01 141.78 32.87 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 165.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -108.18 122.31 46.65 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 177.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.62 82.3 0.14 Allowed 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 127.188 2.195 . . . . 0.0 109.924 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.8 mt -106.67 135.12 19.56 Favored Pre-proline 0 CA--C 1.49 -1.342 0 N-CA-C 103.417 -2.809 . . . . 0.0 103.417 170.155 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.88 170.49 16.6 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.078 1.852 . . . . 0.0 110.385 171.216 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -82.1 7.06 14.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -162.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -90.08 -8.03 52.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.737 0.815 . . . . 0.0 108.961 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 t -99.13 138.17 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -174.171 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.43 148.11 16.65 Favored Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 103.976 -3.649 . . . . 0.0 103.976 178.7 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 pt -134.6 -156.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -167.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mm -72.59 128.51 35.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.155 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 178.527 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 170.7 9.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 171.14 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -130.32 133.74 46.67 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 95.862 -5.607 . . . . 0.0 95.862 168.433 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -176.07 33.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 118.527 -1.797 . . . . 0.0 109.627 -175.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -86.74 125.03 33.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 169.334 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.66 146.26 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 119.348 0.977 . . . . 0.0 108.44 -174.594 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.64 -163.98 0.89 Allowed 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 127.477 2.311 . . . . 0.0 105.998 -175.82 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -128.51 159.01 69.99 Favored Pre-proline 0 N--CA 1.422 -1.846 1 N-CA-C 96.44 -5.393 . . . . 0.0 96.44 169.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -68.57 155.77 67.85 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 CA-C-N 122.621 1.972 . . . . 0.0 109.189 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -99.21 -19.97 16.85 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 128.901 2.88 . . . . 0.0 108.502 4.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -149.72 151.57 33.87 Favored 'General case' 0 CA--C 1.479 -1.761 1 N-CA-C 92.592 -6.818 . . . . 0.0 92.592 158.079 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.07 -163.69 0.11 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 171.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.505 HG11 ' HD1' ' A' ' 43' ' ' HIS . 5.7 m -128.75 160.3 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 1 N-CA-C 95.904 -5.591 . . . . 0.0 95.904 160.648 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -164.47 0.7 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.513 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -137.86 168.62 19.32 Favored 'General case' 0 N--CA 1.418 -2.063 1 N-CA-C 95.186 -5.857 . . . . 0.0 95.186 176.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -142.85 155.88 44.84 Favored 'General case' 0 CA--C 1.474 -1.966 1 N-CA-C 96.973 -5.195 . . . . 0.0 96.973 -166.277 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -114.46 119.35 40.12 Favored Pre-proline 0 N--CA 1.421 -1.921 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 167.21 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.91 95.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 124.728 2.724 . . . . 0.0 117.444 -162.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.19 -173.15 41.69 Favored Glycine 0 N--CA 1.422 -2.293 1 N-CA-C 97.787 -6.125 . . . . 0.0 97.787 -179.388 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -89.67 -13.9 35.98 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 118.173 0.987 . . . . 0.0 109.455 178.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.41 -60.56 1.89 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.557 3.143 . . . . 0.0 116.566 -161.32 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 -36.49 23.09 Favored Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.4 m -80.47 -16.1 55.16 Favored 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 123.141 0.576 . . . . 0.0 110.793 -174.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.89 -51.68 68.61 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.955 0.798 . . . . 0.0 108.951 168.451 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.49 81.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.73 0.812 . . . . 0.0 112.661 174.077 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.23 -38.69 85.65 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.129 0.966 . . . . 0.0 111.645 -174.191 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.4 -34.7 78.54 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.311 -0.868 . . . . 0.0 110.28 178.56 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -40.54 89.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.374 0.669 . . . . 0.0 111.477 -177.177 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.54 -28.77 59.17 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 122.159 -0.338 . . . . 0.0 110.978 -177.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.02 -27.41 24.82 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.951 -0.468 . . . . 0.0 110.768 179.422 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.28 42.62 1.06 Allowed Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 163.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.96 157.33 15.06 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 162.224 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -94.08 -9.9 35.12 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 122.178 -0.601 . . . . 0.0 110.559 -163.662 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 m -149.5 149.62 31.04 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.78 138.61 9.94 Favored Glycine 0 CA--C 1.475 -2.409 1 N-CA-C 98.847 -5.701 . . . . 0.0 98.847 -178.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -141.45 -162.64 1.41 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 -177.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.77 169.15 9.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 -170.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.65 -177.97 41.69 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 102.469 -4.252 . . . . 0.0 102.469 -177.094 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -152.16 159.74 43.54 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 97.665 -4.939 . . . . 0.0 97.665 178.03 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -151.96 171.01 18.47 Favored 'General case' 0 CA--C 1.491 -1.309 1 N-CA-C 98.974 -4.454 . . . . 0.0 98.974 167.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.92 168.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -177.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.92 29.22 52.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -169.011 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.505 ' HD1' HG11 ' A' ' 13' ' ' VAL . 27.7 m170 163.45 -154.13 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 94.471 -6.122 . . . . 0.0 94.471 -174.963 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.08 150.16 21.39 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 98.715 -5.754 . . . . 0.0 98.715 170.41 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tp 74.16 176.84 0.24 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.003 1.721 . . . . 0.0 108.519 175.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -178.46 -169.35 0.18 Allowed 'General case' 0 CA--C 1.483 -1.62 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 173.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.35 178.25 6.96 Favored 'General case' 0 CA--C 1.484 -1.559 1 N-CA-C 100.137 -4.023 . . . . 0.0 100.137 154.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -126.85 146.59 50.22 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.06 156.09 46.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 179.665 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -125.65 142.44 51.51 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.97 55.67 1.13 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 128.542 2.737 . . . . 0.0 111.783 172.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.52 132.85 25.58 Favored Pre-proline 0 CA--C 1.505 -0.777 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.042 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -73.54 174.76 11.66 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.513 2.142 . . . . 0.0 111.75 174.015 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.15 -19.07 62.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 126.548 1.939 . . . . 0.0 114.787 -173.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -79.62 -15.26 57.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 121.686 -0.634 . . . . 0.0 109.704 -177.23 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.55 129.92 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -178.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.84 149.53 18.73 Favored Glycine 0 CA--C 1.48 -2.153 1 N-CA-C 101.402 -4.679 . . . . 0.0 101.402 -179.481 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -133.18 -143.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -162.051 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.19 120.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 CA--C 1.496 -1.111 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.2 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.686 0.755 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 161.83 34.65 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.78 137.67 51.66 Favored 'General case' 0 CA--C 1.485 -1.548 1 N-CA-C 94.977 -5.934 . . . . 0.0 94.977 171.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.84 -172.56 29.39 Favored Glycine 0 CA--C 1.472 -2.618 0 N-CA-C 104.866 -3.294 . . . . 0.0 104.866 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.03 138.69 32.96 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 102.051 -3.314 . . . . 0.0 102.051 158.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.0 tt -90.84 141.33 14.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.31 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -112.46 -160.31 0.71 Allowed 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 128.395 2.678 . . . . 0.0 108.099 -176.213 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -136.17 164.78 40.53 Favored Pre-proline 0 N--CA 1.419 -1.977 1 N-CA-C 96.601 -5.333 . . . . 0.0 96.601 174.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -65.32 151.53 84.95 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.67 2.246 . . . . 0.0 109.764 169.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.52 -54.58 4.1 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 127.75 2.42 . . . . 0.0 107.917 5.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -133.35 135.69 44.91 Favored 'General case' 0 N--CA 1.42 -1.925 1 N-CA-C 90.729 -7.508 . . . . 0.0 90.729 169.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 m -168.19 -166.41 0.7 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 178.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.06 164.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 165.804 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.34 -158.42 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 162.079 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -137.45 168.7 19.13 Favored 'General case' 0 CA--C 1.476 -1.9 1 N-CA-C 96.668 -5.308 . . . . 0.0 96.668 165.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.5 t -130.86 158.59 39.78 Favored 'General case' 0 CA--C 1.478 -1.818 1 N-CA-C 97.402 -5.036 . . . . 0.0 97.402 -170.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -109.84 112.43 58.17 Favored Pre-proline 0 N--CA 1.425 -1.694 1 N-CA-C 96.596 -5.335 . . . . 0.0 96.596 167.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.3 101.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.543 0 CA-C-N 124.491 2.64 . . . . 0.0 116.177 -161.175 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -172.57 36.9 Favored Glycine 0 N--CA 1.427 -1.935 1 N-CA-C 97.092 -6.403 . . . . 0.0 97.092 -172.628 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p -92.58 -28.75 16.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 118.993 1.396 . . . . 0.0 109.893 -177.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.16 -63.92 0.56 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.775 2.43 . . . . 0.0 116.152 -161.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.65 -45.45 52.93 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -176.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 m -64.47 -45.77 85.98 Favored 'General case' 0 CA--C 1.486 -1.495 0 O-C-N 122.229 -0.571 . . . . 0.0 111.776 -174.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.36 -35.97 78.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -60.85 -48.43 81.82 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.713 173.764 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.38 -41.95 99.04 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-O 121.799 0.809 . . . . 0.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -60.69 -45.3 94.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.87 0.868 . . . . 0.0 110.432 179.395 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.81 -42.37 81.64 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.392 0.277 . . . . 0.0 110.792 -176.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.44 -27.08 56.09 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.799 -0.563 . . . . 0.0 111.552 -176.049 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -76.49 -49.23 17.06 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.22 51.6 0.18 Allowed Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 169.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.04 16.15 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 104.913 -3.275 . . . . 0.0 104.913 159.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.4 p -92.92 -3.59 54.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 117.777 0.788 . . . . 0.0 110.7 -166.091 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.479 -1.778 1 N-CA-C 98.427 -4.657 . . . . 0.0 98.427 174.096 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.17 163.71 37.33 Favored Glycine 0 CA--C 1.465 -3.058 1 N-CA-C 101.065 -4.814 . . . . 0.0 101.065 -173.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -156.66 -155.34 0.53 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.814 -3.772 . . . . 0.0 100.814 -170.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 t -145.03 161.71 38.74 Favored 'General case' 0 N--CA 1.429 -1.51 1 N-CA-C 96.534 -5.358 . . . . 0.0 96.534 -173.825 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.92 -172.57 45.18 Favored Glycine 0 N--CA 1.42 -2.409 1 N-CA-C 99.024 -5.63 . . . . 0.0 99.024 -176.439 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -135.38 142.47 45.7 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 97.048 -5.168 . . . . 0.0 97.048 -177.426 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -112.46 108.82 18.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.1 121.38 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.553 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -13.54 8.09 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -168.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -136.68 -77.26 0.41 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.04 -163.45 36.82 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 -165.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.8 141.26 57.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.79 2.436 . . . . 0.0 106.044 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.32 178.3 8.52 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 -168.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 m -110.44 162.16 14.95 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 170.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -119.23 146.56 45.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.6 m -141.8 150.91 42.3 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -120.71 142.09 49.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 173.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 60.05 62.44 1.64 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 127.495 2.318 . . . . 0.0 111.374 174.277 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.18 145.5 30.17 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 171.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -64.73 160.58 39.8 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.973 2.448 . . . . 0.0 110.886 174.353 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -66.51 -24.53 66.41 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.867 0.867 . . . . 0.0 112.626 -168.087 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -81.48 -2.75 50.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.473 1.109 . . . . 0.0 111.162 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.87 122.88 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 177.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.75 145.57 17.71 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -136.72 -153.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -165.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -66.65 131.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.365 1.265 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.426 -1.65 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 177.409 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 159.91 15.92 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.37 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -130.69 130.09 43.42 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.558 -6.09 . . . . 0.0 94.558 159.457 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.07 -170.31 26.64 Favored Glycine 0 CA--C 1.473 -2.567 1 N-CA-C 101.607 -4.597 . . . . 0.0 101.607 179.146 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -83.54 143.4 30.2 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 159.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.27 143.57 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.45 -137.05 0.35 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.498 1.919 . . . . 0.0 106.507 179.782 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -136.88 155.23 76.53 Favored Pre-proline 0 N--CA 1.421 -1.907 1 N-CA-C 95.185 -5.858 . . . . 0.0 95.185 159.822 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -66.3 150.77 84.5 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 0.0 108.423 174.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.34 -30.07 33.92 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 128.389 2.676 . . . . 0.0 108.992 6.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -164.67 159.36 18.78 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 94.237 -6.209 . . . . 0.0 94.237 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m 167.51 -147.69 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 98.82 -4.511 . . . . 0.0 98.82 174.395 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.91 170.01 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 1 N-CA-C 95.661 -5.681 . . . . 0.0 95.661 170.15 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.39 179.85 6.79 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 167.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -119.17 78.06 1.26 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 -179.11 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.3 t -98.77 -170.37 1.93 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -142.63 172.87 5.19 Favored Pre-proline 0 N--CA 1.42 -1.971 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -164.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -66.69 50.54 0.32 Allowed 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 123.595 2.864 . . . . 0.0 112.829 162.628 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.46 139.93 5.62 Favored Glycine 0 N--CA 1.423 -2.191 1 N-CA-C 100.437 -5.065 . . . . 0.0 100.437 -178.452 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -94.83 30.37 2.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 -171.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -65.86 -57.12 8.64 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.969 1.708 . . . . 0.0 110.836 -166.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.17 -28.91 47.7 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.048 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.91 -30.52 71.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.651 1.181 . . . . 0.0 110.859 -172.542 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.45 -58.62 6.5 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.744 0.818 . . . . 0.0 109.945 173.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -44.59 96.76 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.157 0.983 . . . . 0.0 113.014 175.833 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.35 -41.85 88.91 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.287 0.565 . . . . 0.0 111.094 -173.283 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -64.25 -40.56 96.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 121.948 -0.47 . . . . 0.0 109.934 179.553 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -66.08 -47.29 74.77 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 122.071 -0.393 . . . . 0.0 111.625 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.18 -20.49 63.12 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.654 -0.654 . . . . 0.0 112.292 -173.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.55 -3.23 50.15 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.248 0.619 . . . . 0.0 110.199 176.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.32 32.56 8.18 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 165.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.82 163.05 13.03 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 105.546 -3.021 . . . . 0.0 105.546 168.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -83.72 -43.6 15.33 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.244 1.021 . . . . 0.0 110.038 -169.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -160.12 150.92 18.91 Favored 'General case' 0 N--CA 1.418 -2.068 1 N-CA-C 98.759 -4.534 . . . . 0.0 98.759 -157.954 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.9 169.24 38.03 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 100.286 -5.126 . . . . 0.0 100.286 -171.157 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -162.55 -177.98 5.95 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 98.258 -4.719 . . . . 0.0 98.258 -179.494 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.1 m -139.26 162.42 35.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -178.804 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.83 109.1 0.73 Allowed Glycine 0 CA--C 1.487 -1.681 1 N-CA-C 101.748 -4.541 . . . . 0.0 101.748 -178.359 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 41' ' ' VAL . 72.1 t80 -161.14 149.07 15.55 Favored 'General case' 0 CA--C 1.483 -1.617 1 N-CA-C 97.216 -5.105 . . . . 0.0 97.216 -165.595 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -151.12 75.38 1.19 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 39' ' ' PHE . 49.1 t -126.07 138.52 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 95.671 -5.678 . . . . 0.0 95.671 167.129 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.91 62.99 4.52 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 119.016 0.826 . . . . 0.0 111.621 -163.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.5 -51.52 2.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.53 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 -164.19 35.5 Favored Glycine 0 N--CA 1.426 -2.019 1 N-CA-C 96.029 -6.828 . . . . 0.0 96.029 -164.372 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.65 118.63 22.23 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -172.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.84 -178.2 5.69 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.068 0.947 . . . . 0.0 110.703 -166.706 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.98 149.62 40.63 Favored 'General case' 0 CA--C 1.489 -1.377 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -174.616 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -96.87 155.17 16.89 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 178.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.4 m -147.64 152.14 37.37 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 168.248 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -115.91 144.55 43.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 169.023 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.45 57.3 0.57 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 128.059 2.543 . . . . 0.0 111.651 170.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.09 124.8 48.28 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.574 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 167.04 28.09 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.184 1.923 . . . . 0.0 109.43 174.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.77 46.97 1.44 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.52 -0.737 . . . . 0.0 111.618 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -111.91 -6.53 14.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 163.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.87 140.86 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 -172.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.65 147.59 18.0 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 103.399 -3.88 . . . . 0.0 103.399 179.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.97 -159.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -165.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.75 133.12 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -174.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.422 -1.834 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 176.806 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.428 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -148.81 179.77 7.59 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 171.558 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -137.02 142.0 42.5 Favored 'General case' 0 CA--C 1.485 -1.532 1 N-CA-C 96.666 -5.309 . . . . 0.0 96.666 179.667 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.53 12.15 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 99.653 -5.379 . . . . 0.0 99.653 165.41 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.53 144.03 30.67 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 165.035 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -91.11 139.98 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.401 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.11 -168.14 1.5 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.099 2.959 . . . . 0.0 108.549 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -113.7 161.67 26.41 Favored Pre-proline 0 N--CA 1.428 -1.53 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 170.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.2 134.64 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 N-CA-C 106.843 -2.022 . . . . 0.0 106.843 158.205 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -79.31 -58.16 3.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.05 2.14 . . . . 0.0 111.251 14.479 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -166.6 146.24 5.75 Favored 'General case' 0 N--CA 1.426 -1.638 1 N-CA-C 92.384 -6.895 . . . . 0.0 92.384 -178.357 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.9 m 159.92 -141.4 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.528 1 N-CA-C 97.771 -4.9 . . . . 0.0 97.771 179.131 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.26 165.34 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 176.203 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -154.83 0.29 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 162.976 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -141.17 177.37 8.13 Favored 'General case' 0 N--CA 1.425 -1.68 1 N-CA-C 97.177 -5.119 . . . . 0.0 97.177 167.818 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.81 158.81 43.83 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.816 -5.624 . . . . 0.0 95.816 -179.263 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -115.6 113.57 42.67 Favored Pre-proline 0 N--CA 1.422 -1.839 1 N-CA-C 96.197 -5.483 . . . . 0.0 96.197 177.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.83 99.2 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 CA-C-N 124.019 2.471 . . . . 0.0 116.082 -156.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.93 -166.9 36.42 Favored Glycine 0 N--CA 1.423 -2.219 1 N-CA-C 96.716 -6.554 . . . . 0.0 96.716 -173.746 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -85.97 -41.53 14.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.199 1.0 . . . . 0.0 109.6 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.43 -70.56 0.1 Allowed 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -147.352 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.11 -31.68 54.59 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 121.092 -1.005 . . . . 0.0 111.42 -172.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.95 -49.54 44.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.415 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.5 -33.66 76.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.22 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 m -61.48 -50.19 73.73 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.892 172.5 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -42.6 99.76 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.905 0.882 . . . . 0.0 109.968 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -56.48 -47.13 79.86 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.566 1.146 . . . . 0.0 110.714 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.8 -45.5 89.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.886 0.874 . . . . 0.0 110.585 -175.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.39 -28.93 62.29 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.845 -0.534 . . . . 0.0 112.163 -176.015 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.6 -18.2 45.59 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.589 -0.694 . . . . 0.0 110.144 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.91 38.16 2.99 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 163.717 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.29 139.25 14.39 Favored Glycine 0 CA--C 1.486 -1.776 1 N-CA-C 101.153 -4.779 . . . . 0.0 101.153 164.099 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -81.84 -29.06 32.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 118.032 0.916 . . . . 0.0 110.065 -162.629 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.47 -176.86 5.84 Favored 'General case' 0 N--CA 1.423 -1.783 1 N-CA-C 98.313 -4.699 . . . . 0.0 98.313 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.25 -160.97 24.99 Favored Glycine 0 N--CA 1.414 -2.783 1 N-CA-C 100.618 -4.993 . . . . 0.0 100.618 -167.378 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -163.62 -159.73 0.53 Allowed 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 96.899 -5.223 . . . . 0.0 96.899 -172.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -136.11 170.26 16.29 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 100.584 -3.858 . . . . 0.0 100.584 173.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 -177.31 47.92 Favored Glycine 0 N--CA 1.422 -2.283 1 N-CA-C 101.32 -4.712 . . . . 0.0 101.32 177.695 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -113.56 139.97 48.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -177.435 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -110.71 91.09 3.52 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.679 -3.082 . . . . 0.0 102.679 173.054 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 t -68.27 124.98 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -171.168 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -47.53 1.01 Allowed Glycine 0 CA--C 1.483 -1.922 0 N-CA-C 104.539 -3.424 . . . . 0.0 104.539 -173.019 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -100.44 -60.3 1.55 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.001 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.43 -170.63 39.67 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.633 -2.587 . . . . 0.0 106.633 -174.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.15 137.68 35.92 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 102.904 -2.998 . . . . 0.0 102.904 177.493 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.93 -174.51 3.68 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -164.165 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.9 t -114.62 153.84 29.43 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 178.3 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -119.48 149.78 41.32 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -177.299 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -143.15 156.13 44.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.73 144.2 50.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 102.691 -3.078 . . . . 0.0 102.691 170.021 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.64 52.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.758 2.023 . . . . 0.0 111.415 171.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.65 130.66 36.18 Favored Pre-proline 0 CA--C 1.501 -0.934 0 N-CA-C 104.951 -2.241 . . . . 0.0 104.951 173.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -74.22 176.07 10.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.451 2.1 . . . . 0.0 110.741 175.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -86.15 19.69 2.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.988 -174.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -95.15 -7.01 40.51 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.446 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.01 169.0 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -179.155 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -148.68 151.26 23.47 Favored Glycine 0 CA--C 1.479 -2.179 1 N-CA-C 97.533 -6.227 . . . . 0.0 97.533 173.755 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.3 -147.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -155.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.38 -27.71 43.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 126.173 1.789 . . . . 0.0 113.312 -169.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.613 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.539 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.279 0.562 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.36 170.95 9.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 160.489 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -129.96 132.69 46.4 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 93.509 -6.478 . . . . 0.0 93.509 158.314 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -178.01 35.39 Favored Glycine 0 CA--C 1.47 -2.736 0 N-CA-C 104.015 -3.634 . . . . 0.0 104.015 -175.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -83.71 140.65 31.99 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 162.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -90.39 137.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.005 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.31 -145.03 0.3 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.198 174.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.7 142.8 45.11 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 92.939 -6.689 . . . . 0.0 92.939 166.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.82 146.34 47.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.693 1.998 . . . . 0.0 107.974 -177.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.23 -21.69 17.71 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 126.098 1.759 . . . . 0.0 108.504 13.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -158.48 151.68 22.81 Favored 'General case' 0 N--CA 1.415 -2.2 1 N-CA-C 95.945 -5.576 . . . . 0.0 95.945 172.182 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 166.54 -155.93 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 -177.707 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.4 164.81 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 1 N-CA-C 96.798 -5.26 . . . . 0.0 96.798 161.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.11 171.75 8.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 161.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -108.56 116.33 31.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -177.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 t -92.39 150.43 20.82 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.44 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.36 122.02 28.98 Favored Pre-proline 0 N--CA 1.422 -1.855 1 N-CA-C 97.65 -4.945 . . . . 0.0 97.65 -179.341 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.57 137.49 74.04 Favored 'Trans proline' 0 CA--C 1.505 -0.962 0 CA-C-N 123.456 2.27 . . . . 0.0 110.987 -176.371 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.36 -57.95 0.57 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -158.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m 105.51 -14.72 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 128.901 2.881 . . . . 0.0 110.533 173.137 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -46.44 -51.05 15.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.685 1.994 . . . . 0.0 114.806 -162.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.84 -39.77 75.56 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 121.507 -0.746 . . . . 0.0 111.517 -177.231 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.04 -22.1 22.02 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.068 -1.254 . . . . 0.0 110.748 -169.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.47 94.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -62.49 -45.05 94.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.161 -0.962 . . . . 0.0 110.983 172.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.94 -41.24 97.73 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.518 -0.739 . . . . 0.0 111.926 177.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.22 -44.39 75.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.35 1.46 . . . . 0.0 110.345 174.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.59 -45.85 88.52 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.853 -0.529 . . . . 0.0 111.554 -177.322 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.75 -7.63 51.52 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.36 -0.837 . . . . 0.0 112.669 -177.096 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -102.79 -3.78 25.89 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 121.704 -0.622 . . . . 0.0 109.813 174.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.56 28.35 11.53 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 169.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.34 129.71 9.99 Favored Glycine 0 CA--C 1.483 -1.917 0 N-CA-C 104.259 -3.536 . . . . 0.0 104.259 169.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -36.25 74.19 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.509 -165.763 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -160.56 175.33 12.83 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 170.642 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.49 -178.72 48.78 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 98.516 -5.833 . . . . 0.0 98.516 -169.694 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -164.08 -175.82 4.2 Favored 'General case' 0 N--CA 1.434 -1.24 1 N-CA-C 99.067 -4.42 . . . . 0.0 99.067 -177.946 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.4 m -84.4 168.67 15.33 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.317 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.47 -178.35 41.82 Favored Glycine 0 CA--C 1.487 -1.671 1 N-CA-C 96.9 -6.48 . . . . 0.0 96.9 172.562 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -152.6 132.72 13.48 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 100.478 -3.897 . . . . 0.0 100.478 179.629 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -139.66 40.25 2.02 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.261 2.2 t 57.11 -134.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.17 1.788 . . . . 0.0 107.606 -172.328 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -122.48 7.58 Favored Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 179.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -118.15 5.12 11.97 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.126 0.57 . . . . 0.0 109.711 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.22 -172.87 34.74 Favored Glycine 0 CA--C 1.483 -1.947 1 N-CA-C 100.413 -5.075 . . . . 0.0 100.413 -178.046 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.25 98.46 11.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.028 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.38 177.71 7.74 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 125.634 1.574 . . . . 0.0 110.93 -172.791 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -126.69 160.03 31.96 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.411 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -96.61 154.66 17.15 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 177.69 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.0 m -142.37 140.68 32.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.764 -3.791 . . . . 0.0 100.764 165.53 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.75 27.97 8.9 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.482 0.658 . . . . 0.0 109.631 -170.026 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.27 147.95 0.74 Allowed 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 93.605 -6.443 . . . . 0.0 93.605 167.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -150.86 142.83 15.77 Favored Pre-proline 0 CA--C 1.487 -1.468 1 N-CA-C 97.711 -4.922 . . . . 0.0 97.711 153.076 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.86 171.73 17.28 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.265 1.977 . . . . 0.0 109.598 176.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.54 -4.97 37.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -92.98 3.65 55.37 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 -178.135 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 t -107.76 138.5 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 103.557 -2.756 . . . . 0.0 103.557 -176.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.75 147.37 16.41 Favored Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 103.786 -3.726 . . . . 0.0 103.786 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.9 -160.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -164.342 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.33 137.46 23.3 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -172.883 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.421 -1.881 1 N-CA-C 95.046 -5.909 . . . . 0.0 95.046 173.54 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 177.71 7.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 172.704 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -129.58 139.76 51.39 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 97.621 -4.955 . . . . 0.0 97.621 171.556 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 179.16 37.5 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 177.58 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -78.04 128.67 34.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 162.411 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 tt -90.76 140.76 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.385 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.65 -162.47 0.96 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.229 3.012 . . . . 0.0 107.755 174.54 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -144.05 170.37 8.51 Favored Pre-proline 0 N--CA 1.42 -1.953 1 N-CA-C 96.886 -5.227 . . . . 0.0 96.886 175.364 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -64.28 152.58 80.76 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.221 1.948 . . . . 0.0 111.314 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.61 -49.21 9.42 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 127.1 2.16 . . . . 0.0 107.544 -1.203 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -146.2 139.49 25.9 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 92.096 -7.002 . . . . 0.0 92.096 169.153 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.2 m -175.83 -158.44 0.06 Allowed 'General case' 0 CA--C 1.488 -1.408 1 N-CA-C 100.024 -4.065 . . . . 0.0 100.024 -174.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.14 155.14 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 N-CA-C 97.509 -4.997 . . . . 0.0 97.509 164.992 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.27 153.22 20.63 Favored 'General case' 0 CA--C 1.494 -1.191 1 N-CA-C 100.136 -4.024 . . . . 0.0 100.136 166.044 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -102.07 -173.13 2.27 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.4 t -140.24 154.37 46.85 Favored 'General case' 0 N--CA 1.417 -2.093 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 -171.125 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -115.93 121.39 34.08 Favored Pre-proline 0 N--CA 1.419 -1.988 1 N-CA-C 96.816 -5.253 . . . . 0.0 96.816 167.561 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -56.86 129.2 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 122.972 2.097 . . . . 0.0 112.846 -174.429 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.31 -46.78 1.04 Allowed Glycine 0 CA--C 1.491 -1.424 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -164.41 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 m 92.69 2.41 0.08 Allowed 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 127.496 2.318 . . . . 0.0 112.093 171.289 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -34.65 77.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.835 1.198 . . . . 0.0 111.469 -173.795 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.09 -48.89 50.79 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 175.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.21 -49.78 76.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.378 1.471 . . . . 0.0 109.182 179.418 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.52 -45.37 73.34 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.345 1.458 . . . . 0.0 111.751 177.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 m -63.88 -43.87 94.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.72 -36.47 67.79 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.769 0.795 . . . . 0.0 109.953 -176.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -62.61 -46.5 88.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.739 1.216 . . . . 0.0 110.448 173.358 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.18 -45.78 86.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 123.969 0.908 . . . . 0.0 110.051 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -95.33 -4.29 45.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.145 0.978 . . . . 0.0 109.972 179.425 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.02 12.53 31.53 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 168.139 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.91 127.38 8.39 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 177.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 p -97.0 5.04 51.18 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.879 -0.777 . . . . 0.0 110.041 -169.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -160.48 158.1 28.74 Favored 'General case' 0 CA--C 1.479 -1.752 1 N-CA-C 99.159 -4.385 . . . . 0.0 99.159 166.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.31 168.4 41.41 Favored Glycine 0 N--CA 1.417 -2.633 1 N-CA-C 98.628 -5.789 . . . . 0.0 98.628 -178.541 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 8.1 p-80 -166.77 173.83 9.18 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 97.064 -5.162 . . . . 0.0 97.064 -179.871 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.0 m -94.95 162.28 13.8 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.548 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.11 174.09 40.98 Favored Glycine 0 N--CA 1.421 -2.304 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 178.533 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -117.79 138.14 52.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 101.544 -3.502 . . . . 0.0 101.544 -177.156 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -98.47 -29.14 13.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.18 0.99 . . . . 0.0 109.483 -175.349 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t 70.62 176.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 105.468 -165.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.76 -65.42 3.92 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 120.137 -1.602 . . . . 0.0 109.931 172.572 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -91.36 -53.33 4.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 172.131 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.84 -128.46 3.46 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 171.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.47 127.42 32.67 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.435 2.694 . . . . 0.0 106.665 -177.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.36 176.88 7.6 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -166.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.8 t -117.55 158.96 23.66 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 100.301 -3.962 . . . . 0.0 100.301 174.038 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 19.4 t-105 -124.07 150.34 45.11 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.444 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.2 m -140.07 152.75 46.43 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.623 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.17 138.35 51.34 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 169.671 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.71 50.13 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.942 2.097 . . . . 0.0 111.072 166.852 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.1 133.29 32.14 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.95 176.12 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.321 2.014 . . . . 0.0 110.715 176.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.4 2.44 25.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.075 0.95 . . . . 0.0 112.732 -170.734 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -95.93 5.26 51.66 Favored 'General case' 0 CA--C 1.503 -0.849 0 O-C-N 121.098 -1.001 . . . . 0.0 108.847 175.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.49 167.39 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 175.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.61 163.1 29.54 Favored Glycine 0 CA--C 1.485 -1.827 1 N-CA-C 98.319 -5.912 . . . . 0.0 98.319 -177.039 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -154.12 -164.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 -161.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 mm -65.4 121.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 123.979 0.912 . . . . 0.0 111.013 -163.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.308 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.223 0.535 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 176.68 5.28 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 159.294 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -129.75 144.34 51.25 Favored 'General case' 0 CA--C 1.481 -1.675 1 N-CA-C 95.169 -5.863 . . . . 0.0 95.169 171.903 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 -178.24 35.47 Favored Glycine 0 CA--C 1.473 -2.593 0 N-CA-C 103.957 -3.657 . . . . 0.0 103.957 175.879 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -76.73 137.75 39.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 156.68 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 tt -90.52 137.82 20.79 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.357 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.36 -154.62 0.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 127.245 2.218 . . . . 0.0 107.946 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -122.7 148.77 54.3 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 95.604 -5.702 . . . . 0.0 95.604 170.138 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -68.96 145.57 62.22 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 122.691 1.997 . . . . 0.0 109.025 -176.761 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -89.07 -42.52 11.68 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.881 2.472 . . . . 0.0 110.085 12.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -153.97 140.09 18.41 Favored 'General case' 0 N--CA 1.424 -1.746 1 N-CA-C 92.212 -6.959 . . . . 0.0 92.212 178.459 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -178.35 -151.53 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 95.515 -5.735 . . . . 0.0 95.515 178.321 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.91 -178.34 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 163.177 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -152.67 0.32 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 166.758 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -143.18 161.2 38.85 Favored 'General case' 0 N--CA 1.422 -1.846 1 N-CA-C 94.601 -6.074 . . . . 0.0 94.601 153.005 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -160.54 -157.7 0.56 Allowed 'General case' 0 N--CA 1.42 -1.974 1 N-CA-C 96.077 -5.527 . . . . 0.0 96.077 -176.682 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -147.1 172.4 5.24 Favored Pre-proline 0 N--CA 1.418 -2.045 1 N-CA-C 99.865 -4.124 . . . . 0.0 99.865 -161.317 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.92 63.55 4.03 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 124.311 2.575 . . . . 0.0 111.386 170.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.87 148.65 5.68 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 101.578 -4.609 . . . . 0.0 101.578 174.181 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -83.98 60.97 6.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 118.166 0.983 . . . . 0.0 108.675 178.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -69.94 -65.21 0.75 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -173.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.8 -22.42 57.95 Favored Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 177.084 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -79.48 -10.74 59.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.261 -1.141 . . . . 0.0 110.992 -174.139 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.4 -51.99 67.53 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 120.428 1.467 . . . . 0.0 108.649 174.746 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -72.28 -40.76 67.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.151 -177.405 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.27 -42.93 96.42 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 118.659 0.663 . . . . 0.0 112.565 179.055 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.31 -44.39 91.72 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -69.29 -43.47 73.75 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 121.439 -0.788 . . . . 0.0 111.679 -178.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -69.42 -28.49 66.18 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 119.544 1.065 . . . . 0.0 112.829 -177.675 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -87.51 -4.01 58.99 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.664 0.665 . . . . 0.0 110.558 175.609 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.91 29.4 8.11 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 162.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.21 149.32 17.89 Favored Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 171.1 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 p -79.33 -50.45 10.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.174 0.988 . . . . 0.0 109.88 -167.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -160.17 176.83 11.32 Favored 'General case' 0 N--CA 1.422 -1.844 1 N-CA-C 98.699 -4.556 . . . . 0.0 98.699 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.27 46.22 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 103.68 -3.768 . . . . 0.0 103.68 -169.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -146.98 -177.77 5.84 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.754 -4.906 . . . . 0.0 97.754 -169.252 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.3 m -136.96 160.75 37.97 Favored 'General case' 0 CA--C 1.479 -1.766 1 N-CA-C 99.549 -4.241 . . . . 0.0 99.549 171.529 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.09 179.26 47.37 Favored Glycine 0 N--CA 1.424 -2.136 1 N-CA-C 99.841 -5.304 . . . . 0.0 99.841 -174.318 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -93.18 150.58 20.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 -172.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -118.15 116.09 26.13 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 170.838 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.36 128.57 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -16.57 26.09 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -175.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -127.52 -85.49 0.59 Allowed 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.8 -162.56 34.9 Favored Glycine 0 N--CA 1.426 -1.971 1 N-CA-C 102.91 -4.076 . . . . 0.0 102.91 -169.685 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.18 147.73 52.9 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.152 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.79 -176.08 5.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -165.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -128.18 166.13 19.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 175.869 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -125.71 143.27 51.11 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.3 m -135.83 139.9 43.79 Favored 'General case' 0 CA--C 1.487 -1.465 1 N-CA-C 99.898 -4.112 . . . . 0.0 99.898 175.045 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -104.49 30.98 4.95 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.105 0.955 . . . . 0.0 108.929 -168.054 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.62 146.95 1.75 Allowed 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 94.036 -6.283 . . . . 0.0 94.036 165.911 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.53 151.67 64.3 Favored Pre-proline 0 N--CA 1.427 -1.591 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 141.79 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.41 174.01 13.28 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 122.158 1.905 . . . . 0.0 110.168 164.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -65.04 -11.66 41.73 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 126.454 1.902 . . . . 0.0 115.116 -172.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.3 -0.08 57.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.255 -0.903 . . . . 0.0 111.036 -175.543 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.29 142.51 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 -176.488 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.49 155.19 16.5 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 104.679 -3.368 . . . . 0.0 104.679 -176.668 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 pt -143.44 -155.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -161.583 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -83.57 154.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -172.88 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.628 1 N-CA-C 96.763 -5.273 . . . . 0.0 96.763 171.208 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.34 169.68 10.36 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 176.109 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -134.83 137.0 42.91 Favored 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 96.437 -5.394 . . . . 0.0 96.437 169.735 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.49 23.03 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 105.312 -3.115 . . . . 0.0 105.312 172.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 72.2 m-85 -82.38 137.41 34.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 163.272 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -91.65 140.89 15.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.7 -155.09 0.46 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.215 3.406 . . . . 0.0 110.406 -177.766 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -132.92 154.03 81.24 Favored Pre-proline 0 N--CA 1.429 -1.512 1 N-CA-C 96.211 -5.478 . . . . 0.0 96.211 165.511 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -67.25 135.12 35.9 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.889 2.393 . . . . 0.0 107.884 168.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -90.57 -55.14 3.7 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 121.881 2.128 . . . . 0.0 110.752 20.227 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -149.3 132.6 16.5 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 92.971 -6.678 . . . . 0.0 92.971 177.667 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -169.01 0.26 Allowed 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 -174.799 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.75 160.95 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 167.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -161.26 0.32 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 162.522 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.79 158.7 43.37 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.39 -5.411 . . . . 0.0 96.39 165.11 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.39 168.06 18.23 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 -167.908 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -114.02 114.18 46.37 Favored Pre-proline 0 N--CA 1.42 -1.942 1 N-CA-C 99.576 -4.231 . . . . 0.0 99.576 174.309 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -57.89 125.72 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.576 2.184 . . . . 0.0 112.268 -176.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.15 -56.93 0.67 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 100.357 -5.097 . . . . 0.0 100.357 -162.419 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m 117.7 -34.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 129.48 3.112 . . . . 0.0 107.676 173.466 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.37 -51.22 2.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.86 2.864 . . . . 0.0 116.238 -159.375 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.48 -43.94 75.28 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.559 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.34 -23.08 26.35 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -170.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.79 -37.65 85.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.353 1.061 . . . . 0.0 108.522 168.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.9 m -69.46 -40.21 77.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.799 -0.563 . . . . 0.0 109.981 174.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.89 -38.03 89.63 Favored 'General case' 0 C--N 1.359 1.012 0 O-C-N 121.277 -0.889 . . . . 0.0 111.404 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -52.85 -48.56 66.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.01 1.324 . . . . 0.0 110.357 170.008 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -65.15 -41.85 94.36 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.463 -0.773 . . . . 0.0 112.446 -175.05 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.34 -9.44 58.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.137 -0.977 . . . . 0.0 111.906 -177.301 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -103.43 7.3 38.02 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.245 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.7 20.26 34.88 Favored Glycine 0 CA--C 1.491 -1.466 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.922 167.238 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.37 148.26 22.87 Favored Glycine 0 CA--C 1.49 -1.531 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 170.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.5 m -88.79 -32.72 17.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -168.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.7 m -160.69 -177.88 6.48 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 98.783 -4.525 . . . . 0.0 98.783 170.357 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.42 -169.87 37.67 Favored Glycine 0 CA--C 1.466 -3.031 1 N-CA-C 102.247 -4.341 . . . . 0.0 102.247 -172.471 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.41 -160.43 0.77 Allowed 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 98.835 -4.506 . . . . 0.0 98.835 -169.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.04 170.96 17.65 Favored 'General case' 0 CA--C 1.472 -2.047 1 N-CA-C 99.085 -4.413 . . . . 0.0 99.085 175.328 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.45 -170.8 41.02 Favored Glycine 0 N--CA 1.419 -2.487 1 N-CA-C 98.031 -6.027 . . . . 0.0 98.031 -173.751 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -124.08 150.04 45.46 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 100.765 -3.791 . . . . 0.0 100.765 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -123.05 98.99 6.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 173.763 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.86 122.93 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.69 -40.57 1.53 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -165.385 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -124.43 -63.59 1.18 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.508 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.24 -158.91 31.04 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -172.239 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.43 146.62 53.02 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.566 2.347 . . . . 0.0 105.523 176.748 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.66 -177.22 6.23 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -170.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.9 m -122.66 173.73 7.54 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 102.115 -3.291 . . . . 0.0 102.115 170.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 7.6 t-105 -131.33 148.17 52.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -175.104 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.4 m -134.11 149.06 51.07 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.248 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.6 134.15 55.17 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 171.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.26 71.82 0.54 Allowed 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.345 2.258 . . . . 0.0 111.514 174.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.9 135.56 19.41 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 170.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -72.78 176.86 8.35 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 122.65 1.982 . . . . 0.0 112.253 177.01 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.61 9.84 3.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.743 0.817 . . . . 0.0 112.752 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -95.89 -0.81 50.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 121.241 -0.912 . . . . 0.0 108.566 176.025 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.2 170.37 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 -178.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.02 163.14 28.37 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.009 -6.036 . . . . 0.0 98.009 177.233 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 pt -159.28 -170.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.391 -3.929 . . . . 0.0 100.391 -160.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.15 116.32 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 126.28 1.832 . . . . 0.0 111.517 -162.975 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 160.546 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.468 0.651 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.6 165.93 12.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.161 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -137.02 132.47 34.29 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 97.452 -5.018 . . . . 0.0 97.452 171.988 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -168.5 24.01 Favored Glycine 0 CA--C 1.48 -2.098 1 N-CA-C 102.755 -4.138 . . . . 0.0 102.755 175.015 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.06 142.42 34.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 159.182 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.45 150.92 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.232 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.32 176.39 12.21 Favored 'General case' 0 N--CA 1.421 -1.887 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 179.12 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -84.2 159.93 58.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 171.009 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -61.76 110.98 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.468 2.779 . . . . 0.0 110.594 171.416 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -131.76 131.21 42.77 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 129.178 2.991 . . . . 0.0 104.378 2.539 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 67.39 16.43 10.04 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.905 1.336 . . . . 0.0 111.573 171.451 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.1 m -96.19 88.99 4.98 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 179.654 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.29 159.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -159.899 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -166.57 1.49 Allowed 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.628 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -150.45 177.47 9.97 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 96.31 -5.441 . . . . 0.0 96.31 172.456 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -157.25 157.59 34.55 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.626 -5.694 . . . . 0.0 95.626 -175.038 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -118.61 122.08 30.29 Favored Pre-proline 0 N--CA 1.426 -1.674 0 N-CA-C 100.424 -3.917 . . . . 0.0 100.424 -175.654 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.95 130.05 38.2 Favored 'Trans proline' 0 CA--C 1.507 -0.837 0 C-N-CA 122.474 2.116 . . . . 0.0 112.994 -174.723 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.06 -48.61 0.95 Allowed Glycine 0 CA--C 1.492 -1.402 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -159.941 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.253 15.0 m 96.26 -12.43 0.09 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 128.551 2.74 . . . . 0.0 111.603 172.577 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -44.85 -48.12 11.09 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 127.377 2.271 . . . . 0.0 115.904 -166.793 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.87 -38.36 41.88 Favored Glycine 0 C--N 1.351 1.389 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -174.913 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.39 -23.92 50.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.137 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.11 -47.6 80.67 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.785 0.834 . . . . 0.0 109.35 173.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -47.2 86.7 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.034 -1.041 . . . . 0.0 112.77 172.104 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.03 -42.36 97.11 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 122.039 0.923 . . . . 0.0 111.297 -175.169 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.38 -42.99 97.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.19 0.996 . . . . 0.0 109.998 178.831 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -63.9 -43.5 95.77 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 117.954 0.343 . . . . 0.0 111.449 -179.474 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -76.61 -20.5 56.69 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 118.554 0.616 . . . . 0.0 111.888 -175.779 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -84.53 -14.5 48.78 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.243 0.617 . . . . 0.0 110.499 172.962 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 27.29 5.97 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 166.575 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.66 134.73 12.31 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 175.053 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 p -103.99 12.94 33.59 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 -167.15 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.38 156.44 26.16 Favored 'General case' 0 CA--C 1.482 -1.644 1 N-CA-C 98.929 -4.471 . . . . 0.0 98.929 161.1 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.41 162.51 32.8 Favored Glycine 0 CA--C 1.47 -2.772 1 N-CA-C 98.675 -5.77 . . . . 0.0 98.675 -179.056 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -174.83 175.36 2.4 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 -174.479 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.3 m -87.0 160.0 18.79 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.333 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.95 172.0 44.81 Favored Glycine 0 N--CA 1.425 -2.035 1 N-CA-C 96.73 -6.548 . . . . 0.0 96.73 176.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -154.73 148.64 25.65 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 98.098 -4.778 . . . . 0.0 98.098 174.208 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -179.01 47.84 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 100.367 -3.938 . . . . 0.0 100.367 163.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -171.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -164.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.14 64.93 0.39 Allowed Glycine 0 CA--C 1.489 -1.569 1 N-CA-C 102.126 -4.389 . . . . 0.0 102.126 179.011 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -160.7 -165.72 1.46 Allowed 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.391 -5.411 . . . . 0.0 96.391 -177.434 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.94 -48.32 33.95 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -177.486 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -174.29 1.65 Allowed 'General case' 0 N--CA 1.432 -1.351 1 N-CA-C 96.748 -5.278 . . . . 0.0 96.748 171.709 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.2 168.28 20.91 Favored 'General case' 0 CA--C 1.49 -1.332 1 N-CA-C 96.554 -5.35 . . . . 0.0 96.554 177.701 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.5 t -125.1 157.97 35.01 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 -171.353 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -93.82 148.9 21.7 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.378 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 m -141.31 148.76 40.27 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 167.35 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 137.55 54.0 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 -176.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.57 55.38 0.63 Allowed 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.677 1.591 . . . . 0.0 110.741 174.16 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 mt -92.58 135.77 26.07 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.393 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.45 166.27 30.3 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.803 2.336 . . . . 0.0 108.965 177.318 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -87.42 41.29 0.97 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -171.979 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.83 -0.12 12.36 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 169.666 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.47 151.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 -178.228 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.78 147.66 18.99 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 98.282 -5.927 . . . . 0.0 98.282 -179.772 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 pt -145.3 -138.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -156.961 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.44 146.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.459 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.431 -1.387 2 N-CA-C 94.158 -6.238 . . . . 0.0 94.158 172.521 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.894 0.378 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.554 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -137.62 -176.87 4.56 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.803 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -133.61 143.51 48.68 Favored 'General case' 0 CA--C 1.49 -1.354 1 N-CA-C 97.492 -5.003 . . . . 0.0 97.492 176.454 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 177.45 37.88 Favored Glycine 0 CA--C 1.48 -2.107 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 178.233 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -79.28 127.91 32.66 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 156.601 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -89.67 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -172.599 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.1 -146.49 0.27 Allowed 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 126.824 2.577 . . . . 0.0 109.438 178.111 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -149.81 167.75 12.39 Favored Pre-proline 0 N--CA 1.424 -1.761 1 N-CA-C 95.989 -5.56 . . . . 0.0 95.989 175.153 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.96 151.14 86.84 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.298 2.666 . . . . 0.0 107.686 158.187 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.87 -51.13 8.41 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 128.12 2.568 . . . . 0.0 109.033 7.181 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -145.66 147.59 32.17 Favored 'General case' 0 N--CA 1.421 -1.914 1 N-CA-C 92.149 -6.982 . . . . 0.0 92.149 162.598 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.49 -164.41 0.22 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -173.641 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.75 161.76 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 1 N-CA-C 96.718 -5.29 . . . . 0.0 96.718 161.509 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -151.93 0.07 Allowed 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 163.501 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -139.35 177.72 7.72 Favored 'General case' 0 CA--C 1.478 -1.813 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 163.825 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.9 t -138.14 162.4 34.33 Favored 'General case' 0 N--CA 1.415 -2.198 1 N-CA-C 97.347 -5.057 . . . . 0.0 97.347 -174.424 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -116.1 112.67 41.97 Favored Pre-proline 0 N--CA 1.418 -2.053 1 N-CA-C 96.031 -5.544 . . . . 0.0 96.031 172.296 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -70.45 49.53 0.87 Allowed 'Trans proline' 0 CA--C 1.517 -0.374 0 CA-C-N 124.402 2.608 . . . . 0.0 115.351 -173.663 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.31 16.78 6.67 Favored Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 168.607 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m 74.24 -52.82 0.69 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 127.362 2.265 . . . . 0.0 112.12 172.42 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.05 -41.52 59.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.317 2.247 . . . . 0.0 115.815 -170.955 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.82 60.88 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.154 -0.966 . . . . 0.0 111.496 -176.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.76 -47.87 24.13 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.128 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -56.58 -43.21 79.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.255 0.622 . . . . 0.0 110.193 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -57.14 -47.71 80.46 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.077 -1.014 . . . . 0.0 112.164 176.333 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.3 mt -65.38 -43.03 91.97 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-O 121.834 0.826 . . . . 0.0 110.206 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -57.42 -45.98 84.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.162 0.985 . . . . 0.0 110.762 176.422 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.95 -44.33 80.87 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 122.717 0.407 . . . . 0.0 110.322 -176.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.31 -30.51 66.32 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 118.381 0.537 . . . . 0.0 111.96 -177.049 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -77.74 -33.51 52.87 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.515 -0.741 . . . . 0.0 109.965 176.219 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.22 43.05 0.49 Allowed Glycine 0 CA--C 1.489 -1.589 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 161.492 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.31 139.94 14.67 Favored Glycine 0 C--N 1.353 1.528 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 164.778 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 p -96.24 -1.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.038 0.923 . . . . 0.0 109.96 -168.04 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -160.34 168.19 25.81 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 97.528 -4.99 . . . . 0.0 97.528 171.404 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.36 -177.83 37.35 Favored Glycine 0 CA--C 1.468 -2.869 1 N-CA-C 100.329 -5.108 . . . . 0.0 100.329 -175.655 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -159.0 -176.78 6.06 Favored 'General case' 0 N--CA 1.423 -1.799 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 -175.885 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -139.91 150.29 44.39 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 95.853 -5.61 . . . . 0.0 95.853 -176.755 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.97 -176.89 46.32 Favored Glycine 0 N--CA 1.423 -2.177 1 N-CA-C 102.127 -4.389 . . . . 0.0 102.127 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -118.16 141.48 48.45 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 99.803 -4.147 . . . . 0.0 99.803 -178.24 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -94.83 -28.98 14.96 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.692 1.234 . . . . 0.0 108.915 -177.574 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 42' ' ' GLY . 2.6 t 72.04 -166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 129.895 3.278 . . . . 0.0 103.372 -165.158 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 75.74 -69.98 2.04 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 120.387 -1.446 . . . . 0.0 110.505 176.818 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -99.65 -57.33 2.17 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.047 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.09 -138.83 5.54 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 118.576 -1.773 . . . . 0.0 110.588 -178.047 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 tp -80.74 144.36 32.22 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -177.477 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.14 -179.9 7.39 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 102.9 -3.0 . . . . 0.0 102.9 -170.118 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -115.88 165.49 13.03 Favored 'General case' 0 CA--C 1.496 -1.1 1 N-CA-C 98.945 -4.465 . . . . 0.0 98.945 175.49 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -129.67 150.87 50.8 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 54.4 m -142.57 149.53 39.17 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.24 138.99 51.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 172.283 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.17 67.65 0.72 Allowed 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.884 2.473 . . . . 0.0 110.539 179.164 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.91 139.64 21.42 Favored Pre-proline 0 CA--C 1.496 -1.112 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 171.108 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -70.32 162.38 42.57 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.279 1.986 . . . . 0.0 110.567 165.166 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.16 -37.54 72.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.9 2.08 . . . . 0.0 115.164 -163.966 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -83.61 -5.86 59.29 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.869 -1.144 . . . . 0.0 110.591 -172.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.54 99.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 178.061 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.554 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -83.49 166.27 43.5 Favored Glycine 0 CA--C 1.489 -1.569 0 CA-C-O 122.036 0.798 . . . . 0.0 112.163 -161.823 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.9 pt -147.35 -178.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 -164.67 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mm -69.29 103.91 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 124.819 1.248 . . . . 0.0 110.216 -166.841 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 101.527 -3.509 . . . . 0.0 101.527 167.163 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.139 0.495 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.474 HH21 ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.2 -178.79 6.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -128.9 132.06 47.66 Favored 'General case' 0 CA--C 1.494 -1.175 1 N-CA-C 99.008 -4.441 . . . . 0.0 99.008 171.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 175.41 38.17 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -77.26 128.04 33.66 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -91.0 139.93 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.6 -129.13 0.24 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.443 -1.708 . . . . 0.0 107.915 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -145.34 154.47 53.46 Favored Pre-proline 0 N--CA 1.415 -2.206 1 N-CA-C 95.337 -5.801 . . . . 0.0 95.337 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -68.64 110.14 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.837 2.358 . . . . 0.0 110.551 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -145.64 162.16 38.15 Favored 'General case' 0 CA--C 1.484 -1.564 1 N-CA-C 98.039 -4.8 . . . . 0.0 98.039 4.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.17 27.05 0.91 Allowed 'General case' 0 C--N 1.359 0.985 0 CA-C-O 123.169 1.462 . . . . 0.0 108.887 162.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.9 m -118.99 -158.19 0.72 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.06 168.07 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 1 N-CA-C 95.594 -5.706 . . . . 0.0 95.594 161.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.15 -170.3 2.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -131.76 151.65 51.5 Favored 'General case' 0 CA--C 1.478 -1.799 1 N-CA-C 97.244 -5.095 . . . . 0.0 97.244 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -116.65 163.4 16.18 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -113.43 112.87 48.67 Favored Pre-proline 0 N--CA 1.419 -2.017 1 N-CA-C 98.034 -4.802 . . . . 0.0 98.034 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.74 130.72 40.04 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.293 1.996 . . . . 0.0 111.88 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.56 -56.72 0.73 Allowed Glycine 0 CA--C 1.484 -1.852 1 N-CA-C 101.659 -4.576 . . . . 0.0 101.659 -163.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m 119.42 -23.87 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.98 2.912 . . . . 0.0 107.134 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -61.77 0.74 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.381 2.272 . . . . 0.0 115.763 -154.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.56 -39.68 60.46 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.916 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -29.29 51.83 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 117.643 0.721 . . . . 0.0 109.593 -168.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.55 -49.41 77.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.63 1.172 . . . . 0.0 109.861 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -63.87 -34.34 77.72 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.75 -0.594 . . . . 0.0 112.228 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.16 -40.84 94.87 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.043 0.925 . . . . 0.0 110.685 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.03 -44.63 94.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.592 0.757 . . . . 0.0 110.612 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.36 -21.44 56.09 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 119.239 0.927 . . . . 0.0 111.567 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -84.13 -41.3 17.23 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.605 -0.685 . . . . 0.0 109.39 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.08 48.0 0.1 OUTLIER Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.6 137.81 13.88 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 104.781 -3.328 . . . . 0.0 104.781 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -0.07 56.79 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.323 1.049 . . . . 0.0 110.768 -168.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 m -159.38 164.2 34.89 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 100.012 -4.07 . . . . 0.0 100.012 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.05 169.66 39.02 Favored Glycine 0 N--CA 1.424 -2.16 1 N-CA-C 98.043 -6.023 . . . . 0.0 98.043 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -164.55 -171.42 2.33 Favored 'General case' 0 N--CA 1.438 -1.072 1 N-CA-C 100.043 -4.058 . . . . 0.0 100.043 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.8 m -98.9 174.58 6.3 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 166.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.05 43.28 Favored Glycine 0 N--CA 1.427 -1.933 1 N-CA-C 102.025 -4.43 . . . . 0.0 102.025 168.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -134.84 142.45 46.64 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.741 -4.54 . . . . 0.0 98.741 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -126.22 107.36 10.29 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.14 124.04 25.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.9 -81.27 0.22 Allowed Glycine 0 CA--C 1.482 -2.003 1 N-CA-C 100.92 -4.872 . . . . 0.0 100.92 -164.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -87.34 -59.25 2.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.99 -140.38 7.23 Favored Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.69 143.57 57.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.974 2.109 . . . . 0.0 106.271 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.25 -174.58 4.86 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.71 -179.99 4.91 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -132.43 151.24 51.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 -175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.44 136.4 33.0 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -105.96 135.7 46.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.03 40.58 3.96 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.934 1.693 . . . . 0.0 112.031 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 tp -81.92 138.89 46.31 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 165.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -70.19 165.53 31.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.262 1.975 . . . . 0.0 110.833 170.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.41 -5.2 57.65 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 123.93 0.892 . . . . 0.0 110.989 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.66 16.73 10.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.244 1.017 . . . . 0.0 109.837 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.57 162.21 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 N-CA-C 95.134 -5.876 . . . . 0.0 95.134 170.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.99 -177.41 35.96 Favored Glycine 0 CA--C 1.475 -2.44 0 C-N-CA 115.877 -3.059 . . . . 0.0 107.699 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.474 ' CG2' HH21 ' A' ' 2' ' ' ARG . 46.7 pt -142.26 -152.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 114.694 -0.753 . . . . 0.0 110.873 -141.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mm -75.25 132.56 33.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t -145.76 160.82 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 1 N-CA-C 94.813 -5.995 . . . . 0.0 94.813 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -142.66 151.15 41.1 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 98.114 -4.773 . . . . 0.0 98.114 160.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.23 -42.86 0.68 Allowed Glycine 0 N--CA 1.428 -1.894 1 N-CA-C 102.115 -4.394 . . . . 0.0 102.115 -166.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -104.71 -92.95 0.36 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.3 tptt 165.77 177.78 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.221 1 N-CA-C 95.918 -5.586 . . . . 0.0 95.918 -172.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.9 t -80.74 152.2 28.46 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -110.54 -132.59 0.33 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 135.85 57.84 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 127.586 2.354 . . . . 0.0 109.723 170.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.273 0 O-C-N 123.444 0.465 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 175.89 12.51 Favored 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.274 -5.454 . . . . 0.0 96.274 169.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -125.15 141.81 51.88 Favored 'General case' 0 CA--C 1.487 -1.475 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -176.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.26 179.02 36.96 Favored Glycine 0 CA--C 1.47 -2.766 0 N-CA-C 103.996 -3.642 . . . . 0.0 103.996 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -81.8 129.79 34.85 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.0 tt -79.25 129.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.88 -169.63 1.49 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 112.055 -2.339 . . . . 0.0 107.615 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.75 151.94 37.64 Favored Pre-proline 0 N--CA 1.434 -1.243 1 N-CA-C 99.601 -4.222 . . . . 0.0 99.601 167.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.34 140.83 78.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 162.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.49 -42.31 10.34 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 121.604 2.002 . . . . 0.0 108.744 12.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -151.97 142.74 22.9 Favored 'General case' 0 N--CA 1.417 -2.077 1 N-CA-C 93.663 -6.421 . . . . 0.0 93.663 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.2 m -179.79 -155.41 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.269 -4.345 . . . . 0.0 99.269 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.42 167.96 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 1 N-CA-C 97.011 -5.181 . . . . 0.0 97.011 160.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.93 -166.37 1.37 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 163.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.29 166.95 20.07 Favored 'General case' 0 CA--C 1.484 -1.595 1 N-CA-C 98.067 -4.79 . . . . 0.0 98.067 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.15 167.24 28.36 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -128.7 129.7 23.5 Favored Pre-proline 0 N--CA 1.423 -1.818 1 N-CA-C 99.835 -4.135 . . . . 0.0 99.835 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -54.59 123.68 14.27 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.778 2.319 . . . . 0.0 112.696 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.48 -46.69 1.06 Allowed Glycine 0 CA--C 1.488 -1.61 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 -166.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m 92.11 0.09 0.13 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 127.492 2.317 . . . . 0.0 113.238 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -44.43 81.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.563 1.945 . . . . 0.0 112.905 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.18 -46.27 44.07 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -79.31 -22.03 45.15 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.823 1.312 . . . . 0.0 110.717 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -55.17 -41.51 71.98 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.229 0.922 . . . . 0.0 109.829 166.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 m -63.35 -45.7 89.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.816 -0.553 . . . . 0.0 110.205 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.29 -41.23 96.99 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 122.717 1.246 . . . . 0.0 110.039 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.62 -41.27 98.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 109.946 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -71.77 -37.15 70.53 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.14 -31.16 62.62 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.719 -0.613 . . . . 0.0 111.267 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -85.91 -16.9 37.02 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.537 -0.727 . . . . 0.0 111.073 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 43.07 2.24 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 165.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.57 142.74 16.19 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 167.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -34.01 66.86 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 129.123 2.969 . . . . 0.0 110.504 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 m -160.12 165.95 30.72 Favored 'General case' 0 N--CA 1.421 -1.922 1 N-CA-C 97.944 -4.836 . . . . 0.0 97.944 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.31 165.47 37.02 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.945 -6.062 . . . . 0.0 97.945 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -166.91 178.95 5.52 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.576 -4.602 . . . . 0.0 98.576 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.14 161.4 26.49 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.71 40.48 Favored Glycine 0 N--CA 1.421 -2.321 1 N-CA-C 98.463 -5.855 . . . . 0.0 98.463 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.85 165.46 32.22 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 96.932 -5.21 . . . . 0.0 96.932 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -114.36 -9.28 12.79 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.216 1.006 . . . . 0.0 108.998 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t 73.38 132.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 107.126 -160.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.06 -104.98 0.29 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -69.51 -77.27 0.08 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.076 0.951 . . . . 0.0 112.909 -169.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.39 -50.61 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.516 0 O-C-N 120.285 -1.509 . . . . 0.0 109.769 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -158.78 -167.47 2.13 Favored 'General case' 0 N--CA 1.43 -1.447 1 N-CA-C 95.481 -5.748 . . . . 0.0 95.481 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 -165.62 1.85 Allowed 'General case' 0 CA--C 1.486 -1.484 1 N-CA-C 97.961 -4.829 . . . . 0.0 97.961 167.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 -176.5 4.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 102.128 -3.286 . . . . 0.0 102.128 158.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -117.48 155.38 29.82 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 m -146.44 139.85 25.84 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 100.375 -3.935 . . . . 0.0 100.375 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 30.19 6.59 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.287 0.565 . . . . 0.0 110.073 -168.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 177.5 151.02 0.2 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 93.979 -6.304 . . . . 0.0 93.979 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -153.36 151.92 26.61 Favored Pre-proline 0 CA--C 1.487 -1.47 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 149.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.72 170.95 16.48 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.08 1.853 . . . . 0.0 110.515 171.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.37 16.93 1.16 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -98.55 -6.25 30.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 120.51 -1.369 . . . . 0.0 108.287 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.73 168.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.41 177.36 27.65 Favored Glycine 0 CA--C 1.483 -1.952 1 N-CA-C 102.033 -4.427 . . . . 0.0 102.033 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 6' ' ' ILE . 6.4 pt -154.82 -171.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -158.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.76 133.05 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 t -113.95 115.21 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 101.792 -3.411 . . . . 0.0 101.792 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 61.83 -117.63 0.65 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.457 1.503 . . . . 0.0 109.672 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.71 59.61 0.1 Allowed Glycine 0 CA--C 1.485 -1.841 1 N-CA-C 99.334 -5.506 . . . . 0.0 99.334 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 -74.2 0.62 Allowed 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.451 -161.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -126.26 171.97 10.48 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -162.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.3 t -137.35 134.9 36.52 Favored 'General case' 0 N--CA 1.422 -1.826 1 N-CA-C 97.624 -4.954 . . . . 0.0 97.624 170.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.87 109.53 4.04 Favored 'General case' 0 N--CA 1.427 -1.599 1 N-CA-C 100.114 -4.032 . . . . 0.0 100.114 169.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -81.51 119.3 23.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.017 0 O-C-N 123.463 0.477 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.063 0.459 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -100.99 157.82 16.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -127.53 125.9 41.23 Favored 'General case' 0 CA--C 1.486 -1.482 1 N-CA-C 94.315 -6.18 . . . . 0.0 94.315 159.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.38 29.01 Favored Glycine 0 CA--C 1.474 -2.512 0 N-CA-C 104.021 -3.632 . . . . 0.0 104.021 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -83.54 140.35 32.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.87 148.23 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.3 -177.17 6.07 Favored 'General case' 0 N--CA 1.415 -2.204 1 N-CA-C 98.329 -4.693 . . . . 0.0 98.329 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -105.06 157.54 34.04 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -66.56 144.62 73.46 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.654 2.236 . . . . 0.0 109.226 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -103.14 80.02 1.8 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 128.027 2.531 . . . . 0.0 106.336 -5.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.8 t30 84.66 44.19 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 124.932 1.293 . . . . 0.0 108.392 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.85 127.76 47.64 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 15' ' ' HIS 0.254 5.4 m -70.64 165.04 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 141.87 51.36 Favored 'General case' 0 N--CA 1.423 -1.817 1 N-CA-C 94.455 -6.128 . . . . 0.0 94.455 -176.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.416 ' CE1' HG23 ' A' ' 13' ' ' VAL . 46.9 m80 -117.31 160.73 20.65 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -167.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 t -115.18 169.27 9.24 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.53 124.68 23.61 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 98.423 -4.658 . . . . 0.0 98.423 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -57.59 111.84 0.95 Allowed 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.965 2.443 . . . . 0.0 113.261 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.79 -51.37 0.52 Allowed Glycine 0 CA--C 1.484 -1.85 1 N-CA-C 100.367 -5.093 . . . . 0.0 100.367 -168.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 6.8 m 106.12 -0.84 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 127.984 2.513 . . . . 0.0 111.852 169.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -46.97 -45.4 20.83 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.567 1.547 . . . . 0.0 113.806 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.37 -59.99 7.65 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.904 0.764 . . . . 0.0 111.955 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.3 m -70.68 -27.56 64.11 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.869 -1.371 . . . . 0.0 113.263 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.84 -45.19 93.74 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.4 m -66.08 -40.97 91.28 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.748 0.819 . . . . 0.0 110.4 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.21 -42.33 94.9 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.703 0.801 . . . . 0.0 109.74 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -38.64 82.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.541 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.24 -42.25 84.3 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.925 -0.484 . . . . 0.0 111.455 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.35 -30.3 37.98 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.726 -0.609 . . . . 0.0 111.019 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -84.66 -22.29 29.92 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 118.363 0.529 . . . . 0.0 109.949 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.49 45.95 1.61 Allowed Glycine 0 CA--C 1.488 -1.594 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 162.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.26 172.8 17.38 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 104.26 -3.536 . . . . 0.0 104.26 167.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 p -75.39 -56.71 4.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.987 0.899 . . . . 0.0 108.651 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -160.65 -176.76 5.75 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 98.832 -4.506 . . . . 0.0 98.832 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.19 -176.73 41.93 Favored Glycine 0 N--CA 1.414 -2.769 1 N-CA-C 98.612 -5.795 . . . . 0.0 98.612 -168.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -166.79 178.08 6.1 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 -172.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.34 168.09 20.66 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.773 0.797 . . . . 0.0 110.465 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.84 -171.01 37.9 Favored Glycine 0 N--CA 1.419 -2.463 1 N-CA-C 97.05 -6.42 . . . . 0.0 97.05 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -146.54 161.91 39.46 Favored 'General case' 0 N--CA 1.422 -1.828 1 N-CA-C 95.325 -5.805 . . . . 0.0 95.325 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -152.44 167.08 29.93 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 97.458 -5.015 . . . . 0.0 97.458 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.76 149.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 1 N-CA-C 96.152 -5.499 . . . . 0.0 96.152 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 -23.02 23.29 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 106.274 -2.731 . . . . 0.0 106.274 -168.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -135.62 -76.36 0.44 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 167.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.41 -150.76 22.13 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 98.289 -5.924 . . . . 0.0 98.289 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.28 115.26 2.37 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.339 2.656 . . . . 0.0 108.689 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.99 158.35 44.07 Favored 'General case' 0 CA--C 1.482 -1.657 1 N-CA-C 96.871 -5.233 . . . . 0.0 96.871 -166.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.8 p -138.61 174.36 10.62 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 116.349 -2.141 . . . . 0.0 108.548 -167.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -104.86 156.64 17.83 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -164.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -152.12 151.1 30.64 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 167.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -113.17 145.71 40.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 104.475 -2.416 . . . . 0.0 104.475 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.94 46.43 0.25 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.098 2.159 . . . . 0.0 112.227 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.33 130.97 33.88 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.95 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.071 1.847 . . . . 0.0 110.656 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -60.69 -20.15 60.31 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.77 1.628 . . . . 0.0 114.762 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -82.29 -12.76 57.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.652 -0.655 . . . . 0.0 110.414 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.52 112.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.46 143.74 17.45 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 104.894 -3.282 . . . . 0.0 104.894 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.9 pt -143.66 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 -160.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mm -68.08 122.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t -132.49 164.29 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -161.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 60.61 -129.96 0.89 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.162 1.785 . . . . 0.0 110.562 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.13 53.67 0.1 OUTLIER Glycine 0 CA--C 1.485 -1.821 1 N-CA-C 97.971 -6.052 . . . . 0.0 97.971 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' A' ' 64' ' ' LYS . 70.1 tt0 -165.7 -174.56 3.13 Favored 'General case' 0 N--CA 1.423 -1.776 1 N-CA-C 96.251 -5.462 . . . . 0.0 96.251 -168.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 53.0 tttt -106.74 -150.74 0.45 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.81 158.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -169.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.74 174.57 11.47 Favored 'General case' 0 N--CA 1.425 -1.7 1 N-CA-C 96.881 -5.229 . . . . 0.0 96.881 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -177.61 176.16 1.29 Allowed 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.943 0 O-C-N 124.256 0.973 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.27 162.5 14.02 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 164.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -125.59 131.85 52.63 Favored 'General case' 0 CA--C 1.486 -1.501 1 N-CA-C 94.287 -6.19 . . . . 0.0 94.287 161.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.81 29.57 Favored Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 100.912 -4.875 . . . . 0.0 100.912 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.91 137.24 33.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.01 142.52 12.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -135.53 -129.78 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.88 2.872 . . . . 0.0 106.385 175.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -154.16 166.51 15.67 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -172.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -65.39 139.14 58.19 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.346 2.697 . . . . 0.0 111.017 166.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -109.4 -16.26 14.05 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.571 2.348 . . . . 0.0 108.768 9.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -160.22 146.67 15.69 Favored 'General case' 0 CA--C 1.48 -1.72 1 N-CA-C 94.154 -6.239 . . . . 0.0 94.154 165.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.08 -161.97 0.29 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 169.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.74 166.78 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 1 N-CA-C 97.536 -4.987 . . . . 0.0 97.536 157.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -166.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 163.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -127.46 161.89 27.67 Favored 'General case' 0 CA--C 1.473 -1.99 1 N-CA-C 99.245 -4.354 . . . . 0.0 99.245 169.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.0 t -124.83 147.87 48.51 Favored 'General case' 0 N--CA 1.419 -1.996 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -102.41 119.72 55.37 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 96.935 -5.209 . . . . 0.0 96.935 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -57.34 103.97 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 CA-C-N 124.491 2.64 . . . . 0.0 114.726 -165.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.68 -175.8 37.36 Favored Glycine 0 N--CA 1.419 -2.455 1 N-CA-C 97.248 -6.341 . . . . 0.0 97.248 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -92.0 -30.75 15.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.627 0.713 . . . . 0.0 109.276 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -43.97 91.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.561 2.344 . . . . 0.0 115.319 -157.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.25 -50.46 45.04 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -68.96 -41.76 77.53 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.057 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -48.2 -54.11 14.61 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.437 1.495 . . . . 0.0 110.291 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 m -58.72 -54.08 51.07 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.967 0.907 . . . . 0.0 111.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -67.14 -40.77 86.79 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-O 122.36 1.076 . . . . 0.0 110.339 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -64.93 -45.09 87.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.334 1.054 . . . . 0.0 110.304 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -68.56 -40.41 80.62 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 121.27 -0.894 . . . . 0.0 110.945 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -68.26 -14.89 63.32 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.49 7.84 20.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 118.344 0.52 . . . . 0.0 110.433 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 32.75 8.27 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.395 165.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.71 142.05 16.06 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -85.64 -21.63 28.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.461 1.504 . . . . 0.0 109.063 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 m -157.06 156.26 32.53 Favored 'General case' 0 N--CA 1.424 -1.761 1 N-CA-C 98.782 -4.525 . . . . 0.0 98.782 169.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.41 141.81 9.43 Favored Glycine 0 CA--C 1.468 -2.885 1 N-CA-C 99.681 -5.368 . . . . 0.0 99.681 -170.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -145.83 -167.65 2.77 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 101.373 -3.565 . . . . 0.0 101.373 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.81 168.36 27.44 Favored 'General case' 0 N--CA 1.427 -1.582 1 N-CA-C 96.882 -5.229 . . . . 0.0 96.882 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.55 91.57 1.06 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 103.112 -3.995 . . . . 0.0 103.112 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -156.61 156.55 33.72 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 171.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -138.88 18.87 2.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 42' ' ' GLY . 1.6 t -146.69 -157.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 101.686 -3.45 . . . . 0.0 101.686 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 98.68 -95.1 1.54 Allowed Glycine 0 CA--C 1.474 -2.475 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -129.49 -54.34 1.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.236 -3.616 . . . . 0.0 101.236 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.09 64.68 0.24 Allowed Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 173.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.57 0.0 OUTLIER 73.36 171.75 0.3 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.513 1.925 . . . . 0.0 110.306 -171.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.67 -173.17 3.62 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -109.97 156.33 20.61 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -106.64 148.58 28.17 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -138.74 148.85 44.39 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.73 128.11 49.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.88 76.89 0.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 126.94 2.096 . . . . 0.0 111.557 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.47 141.97 23.75 Favored Pre-proline 0 CA--C 1.496 -1.128 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.15 166.33 23.52 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.603 2.202 . . . . 0.0 110.648 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -86.68 15.19 5.91 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.926 -1.109 . . . . 0.0 111.485 -165.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.11 11.17 21.96 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.09 140.61 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 101.637 -3.468 . . . . 0.0 101.637 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.36 143.28 15.65 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.16 -156.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -164.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 7' ' ' ALA . 8.7 mm -70.52 125.01 27.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.2 t -90.66 -54.54 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.76 154.13 34.58 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 66.89 3.82 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 106.949 -2.46 . . . . 0.0 106.949 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -123.87 -95.63 0.47 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -143.96 149.63 37.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 -167.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 30.4 t -85.79 154.62 21.46 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 126.694 1.998 . . . . 0.0 106.231 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -165.94 169.62 14.57 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -152.98 164.24 38.32 Favored 'General case' 0 N--CA 1.423 -1.82 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.881 0 O-C-N 124.247 0.967 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -101.73 157.65 16.68 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.44 127.44 45.42 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 94.201 -6.222 . . . . 0.0 94.201 157.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -173.73 30.98 Favored Glycine 0 CA--C 1.475 -2.444 0 N-CA-C 103.532 -3.827 . . . . 0.0 103.532 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -78.98 140.92 37.9 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 163.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tt -90.98 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.62 171.54 14.24 Favored 'General case' 0 N--CA 1.42 -1.964 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.78 158.24 68.26 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.89 111.17 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.681 2.921 . . . . 0.0 110.633 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -125.69 132.07 52.47 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 1.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.488 HD22 ' HA ' ' A' ' 61' ' ' GLU . 43.9 t30 63.47 33.99 13.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 162.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.45 121.65 24.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.16 153.96 4.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -163.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.22 120.35 41.62 Favored 'General case' 0 N--CA 1.424 -1.732 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -89.18 128.33 35.8 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.5 t -80.01 159.31 26.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.59 115.18 46.92 Favored Pre-proline 0 N--CA 1.426 -1.659 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.8 113.19 1.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 123.048 2.499 . . . . 0.0 113.117 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.23 -49.54 0.69 Allowed Glycine 0 CA--C 1.489 -1.592 1 N-CA-C 101.045 -4.822 . . . . 0.0 101.045 -164.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m 99.64 -12.77 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 129.073 2.949 . . . . 0.0 109.662 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -50.75 -48.9 59.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.275 2.23 . . . . 0.0 115.213 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.13 -31.47 59.58 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.0 t -75.12 -24.53 58.06 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -49.63 77.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.635 -0.665 . . . . 0.0 111.865 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.8 -42.87 97.61 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 122.559 1.171 . . . . 0.0 111.148 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.0 t -63.2 -44.01 96.56 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 125.371 1.469 . . . . 0.0 108.899 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.61 -45.93 90.62 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 122.965 0.506 . . . . 0.0 110.557 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.95 -23.69 55.42 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -81.57 -21.08 38.67 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.62 38.39 2.23 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 164.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.51 134.72 12.11 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 103.315 -3.914 . . . . 0.0 103.315 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.3 p -102.83 4.95 38.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.859 0.838 . . . . 0.0 109.499 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 m -160.38 164.63 32.26 Favored 'General case' 0 CA--C 1.478 -1.804 1 N-CA-C 97.99 -4.819 . . . . 0.0 97.99 167.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.34 171.75 36.62 Favored Glycine 0 N--CA 1.414 -2.821 1 N-CA-C 99.261 -5.536 . . . . 0.0 99.261 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -160.92 -167.65 1.88 Allowed 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 96.609 -5.33 . . . . 0.0 96.609 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.5 m -154.75 176.1 12.88 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 97.487 -5.005 . . . . 0.0 97.487 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.99 -169.0 41.21 Favored Glycine 0 N--CA 1.42 -2.406 1 N-CA-C 96.805 -6.518 . . . . 0.0 96.805 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.84 173.48 6.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 101.702 -3.444 . . . . 0.0 101.702 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -157.31 163.04 39.11 Favored 'General case' 0 N--CA 1.42 -1.967 1 N-CA-C 95.81 -5.626 . . . . 0.0 95.81 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.31 158.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 1 N-CA-C 97.607 -4.961 . . . . 0.0 97.607 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 -43.89 1.6 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -118.61 -83.41 0.65 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.85 -148.69 18.09 Favored Glycine 0 CA--C 1.478 -2.278 1 N-CA-C 99.384 -5.487 . . . . 0.0 99.384 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.95 131.33 48.32 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 126.597 1.959 . . . . 0.0 107.936 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.75 175.76 11.31 Favored 'General case' 0 CA--C 1.482 -1.646 1 N-CA-C 98.846 -4.501 . . . . 0.0 98.846 -162.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.67 168.4 15.09 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -119.9 150.06 41.1 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.0 m -141.05 149.1 41.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 101.178 -3.638 . . . . 0.0 101.178 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.27 130.48 53.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 103.171 -2.9 . . . . 0.0 103.171 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.44 54.79 0.16 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.674 1.989 . . . . 0.0 110.998 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.26 132.8 32.95 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.18 172.46 13.0 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.436 2.091 . . . . 0.0 110.003 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.11 23.99 1.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.602 -0.686 . . . . 0.0 111.948 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.46 -7.48 28.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.23 143.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.78 146.41 17.94 Favored Glycine 0 CA--C 1.476 -2.368 1 N-CA-C 101.44 -4.664 . . . . 0.0 101.44 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.4 pt -142.31 -146.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 -165.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -69.68 123.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.259 1.0 OUTLIER -135.93 22.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 -167.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HA ' HD22 ' A' ' 11' ' ' ASN . 33.5 tt0 -65.92 127.41 31.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 127.331 2.252 . . . . 0.0 109.496 -175.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.64 -46.92 0.99 Allowed Glycine 0 N--CA 1.433 -1.524 1 N-CA-C 98.318 -5.913 . . . . 0.0 98.318 -150.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 13.5 tp10 -95.26 -153.3 0.39 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 157.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 41.7 tptt -149.98 -170.73 3.72 Favored 'General case' 0 N--CA 1.434 -1.252 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 -178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.411 ' H ' ' HG3' ' A' ' 64' ' ' LYS . 41.8 t -59.0 128.47 37.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.675 2.39 . . . . 0.0 111.966 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.331 91.4 m-70 66.76 -147.31 0.17 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 127.965 2.506 . . . . 0.0 111.913 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -77.95 58.92 2.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 124.09 0.956 . . . . 0.0 111.736 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.081 0 CA-C-N 116.366 -0.379 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.537 0.684 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 171.68 8.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -136.11 140.26 43.58 Favored 'General case' 0 CA--C 1.488 -1.44 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -177.31 34.78 Favored Glycine 0 CA--C 1.475 -2.419 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -79.27 134.25 36.64 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 102.04 -3.319 . . . . 0.0 102.04 157.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -90.16 133.83 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.5 -147.94 0.36 Allowed 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 111.057 -2.792 . . . . 0.0 108.978 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -138.09 148.76 61.35 Favored Pre-proline 0 N--CA 1.42 -1.937 1 N-CA-C 94.691 -6.04 . . . . 0.0 94.691 170.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -76.01 151.77 35.46 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 122.052 1.769 . . . . 0.0 108.428 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.16 -12.18 19.82 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 127.446 2.299 . . . . 0.0 108.204 9.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -160.96 141.89 11.57 Favored 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 95.647 -5.686 . . . . 0.0 95.647 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.05 -159.79 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.14 165.09 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 N-CA-C 98.597 -4.594 . . . . 0.0 98.597 160.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 -157.44 0.46 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -138.97 -177.86 5.08 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 98.673 -4.566 . . . . 0.0 98.673 168.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.44 163.54 35.34 Favored 'General case' 0 N--CA 1.419 -1.999 1 N-CA-C 95.913 -5.588 . . . . 0.0 95.913 -175.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.28 119.26 31.97 Favored Pre-proline 0 N--CA 1.421 -1.883 1 N-CA-C 98.584 -4.599 . . . . 0.0 98.584 172.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -57.37 111.49 0.83 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.905 2.403 . . . . 0.0 113.14 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.6 -37.87 1.25 Allowed Glycine 0 CA--C 1.49 -1.506 1 N-CA-C 101.148 -4.781 . . . . 0.0 101.148 -162.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m 86.09 -5.43 0.79 Allowed 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 125.678 1.591 . . . . 0.0 112.242 158.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -61.79 -42.38 98.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.156 1.782 . . . . 0.0 112.531 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.22 -31.97 63.26 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -71.57 -50.04 34.89 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.96 -38.12 89.81 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 118.766 0.712 . . . . 0.0 110.602 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.5 m -59.58 -50.04 75.44 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.367 -0.833 . . . . 0.0 111.674 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.82 -43.96 91.39 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.861 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.1 t -54.1 -46.41 72.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.391 1.076 . . . . 0.0 110.91 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -65.5 -49.15 70.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.483 0.713 . . . . 0.0 110.596 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.96 -20.22 61.77 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.774 -0.579 . . . . 0.0 112.56 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -87.66 -6.61 58.17 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 118.615 0.643 . . . . 0.0 110.24 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 27.82 9.43 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.32 146.74 18.34 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 p -75.57 -37.23 60.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.511 -0.993 . . . . 0.0 110.726 -164.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 m -160.88 -177.5 6.18 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.723 -4.918 . . . . 0.0 97.723 165.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.39 -176.72 41.34 Favored Glycine 0 N--CA 1.414 -2.805 1 N-CA-C 98.614 -5.794 . . . . 0.0 98.614 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.57 180.0 6.84 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 97.015 -5.18 . . . . 0.0 97.015 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.2 m -103.52 165.41 11.05 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.5 171.42 39.98 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 97.923 -6.071 . . . . 0.0 97.923 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -103.39 145.43 30.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -116.99 96.15 5.32 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.32 127.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -42.45 1.43 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -169.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -119.27 -68.68 0.9 Allowed 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.31 -160.36 33.98 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 -172.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.64 136.51 51.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 -173.94 3.82 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.35 158.77 27.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 101.166 -3.642 . . . . 0.0 101.166 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -120.57 153.06 37.28 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -146.87 155.38 42.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -118.76 143.94 46.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 166.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.24 56.96 0.11 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 127.237 2.215 . . . . 0.0 111.197 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -96.23 133.37 25.11 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -71.84 174.94 10.38 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 122.206 1.824 . . . . 0.0 111.43 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.32 16.34 1.66 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -98.34 -5.27 33.2 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.87 169.68 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.35 160.23 27.84 Favored Glycine 0 CA--C 1.48 -2.106 1 N-CA-C 99.414 -5.475 . . . . 0.0 99.414 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 pt -144.88 -164.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 -163.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.89 128.54 34.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.44 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.24 -124.15 0.72 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.402 1.881 . . . . 0.0 108.569 -171.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.84 42.13 0.32 Allowed Glycine 0 CA--C 1.486 -1.775 1 N-CA-C 102.216 -4.353 . . . . 0.0 102.216 169.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -85.64 -51.82 6.22 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.487 0.715 . . . . 0.0 109.499 -168.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -163.23 -168.64 1.77 Allowed 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 101.35 -3.574 . . . . 0.0 101.35 -171.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.26 148.93 42.58 Favored 'General case' 0 N--CA 1.429 -1.477 1 N-CA-C 96.887 -5.227 . . . . 0.0 96.887 171.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -141.36 103.52 4.43 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 99.93 -4.1 . . . . 0.0 99.93 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 m -65.0 128.26 35.0 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.331 1.052 . . . . 0.0 110.263 -172.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.362 1.125 0 O-C-N 123.115 0.26 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.002 0.429 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.97 162.67 12.84 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -132.08 130.45 41.28 Favored 'General case' 0 CA--C 1.489 -1.375 1 N-CA-C 95.077 -5.897 . . . . 0.0 95.077 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.95 -169.16 24.89 Favored Glycine 0 CA--C 1.477 -2.306 0 N-CA-C 104.025 -3.63 . . . . 0.0 104.025 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.28 140.26 30.97 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 159.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.71 150.3 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.23 174.74 14.79 Favored 'General case' 0 N--CA 1.415 -2.221 1 N-CA-C 98.535 -4.617 . . . . 0.0 98.535 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -85.67 158.54 56.7 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.54 113.46 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.019 2.479 . . . . 0.0 110.785 164.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -126.64 114.04 17.51 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 127.45 2.3 . . . . 0.0 106.636 1.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.545 HD22 ' HA ' ' A' ' 61' ' ' GLU . 61.4 t30 80.63 31.99 0.16 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.582 1.153 . . . . 0.0 109.126 156.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -123.04 123.03 39.95 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.82 158.26 6.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 CA-C-N 120.106 1.321 . . . . 0.0 114.028 -159.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 135.9 42.74 Favored 'General case' 0 CA--C 1.483 -1.604 1 N-CA-C 97.291 -5.077 . . . . 0.0 97.291 178.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -90.96 165.9 13.31 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -164.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 175.95 11.92 Favored 'General case' 0 N--CA 1.406 -2.647 1 N-CA-C 94.815 -5.994 . . . . 0.0 94.815 -170.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -149.43 176.56 2.2 Favored Pre-proline 0 N--CA 1.408 -2.573 1 N-CA-C 95.026 -5.916 . . . . 0.0 95.026 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.46 55.0 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.122 2.865 . . . . 0.0 110.607 161.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.96 150.43 11.77 Favored Glycine 0 CA--C 1.481 -2.032 1 N-CA-C 99.391 -5.484 . . . . 0.0 99.391 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -106.91 15.09 25.8 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 117.533 0.667 . . . . 0.0 111.239 -161.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -62.11 -61.0 2.78 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.934 1.293 . . . . 0.0 111.759 -166.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.56 -41.14 77.04 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 t -57.89 -58.41 8.51 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.585 1.154 . . . . 0.0 111.288 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.63 -33.57 75.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.066 0.546 . . . . 0.0 109.806 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.0 m -61.2 -50.02 74.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.402 0.681 . . . . 0.0 110.869 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.45 -37.5 68.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.643 0.777 . . . . 0.0 110.04 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.26 -46.26 83.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 110.112 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -62.28 -49.2 76.63 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.133 0.573 . . . . 0.0 110.995 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.28 -21.07 60.68 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.527 -0.733 . . . . 0.0 112.687 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -94.28 3.04 55.76 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.793 -0.567 . . . . 0.0 110.083 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.96 33.06 7.54 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 161.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.91 147.22 18.53 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 104.326 -3.51 . . . . 0.0 104.326 167.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -78.37 -37.14 44.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 117.99 0.895 . . . . 0.0 110.277 -166.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 m -160.52 -179.64 7.82 Favored 'General case' 0 N--CA 1.426 -1.655 1 N-CA-C 99.06 -4.422 . . . . 0.0 99.06 169.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.59 178.7 43.76 Favored Glycine 0 N--CA 1.423 -2.23 1 N-CA-C 99.52 -5.432 . . . . 0.0 99.52 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -167.19 -179.81 4.74 Favored 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 99.287 -4.338 . . . . 0.0 99.287 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.5 m -126.64 158.42 36.36 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.18 102.75 0.34 Allowed Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 105.015 -3.234 . . . . 0.0 105.015 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 174.07 5.31 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.07 26.04 0.01 OUTLIER 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.76 132.41 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -160.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.28 -95.44 2.1 Favored Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -83.58 -51.43 7.32 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.47 46.43 Favored Glycine 0 N--CA 1.42 -2.432 1 N-CA-C 97.694 -6.162 . . . . 0.0 97.694 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.377 0.2 OUTLIER -76.64 143.17 40.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.977 0.388 . . . . 0.0 110.755 173.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.0 9.06 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 101.956 -3.35 . . . . 0.0 101.956 -163.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 t -113.2 153.59 28.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 -170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -97.64 155.65 16.89 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.72 148.85 32.41 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.03 142.62 46.73 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 101.883 -3.376 . . . . 0.0 101.883 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.19 59.21 1.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.356 2.262 . . . . 0.0 112.11 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.6 mt -93.55 133.34 28.32 Favored Pre-proline 0 CA--C 1.495 -1.163 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.92 170.9 15.68 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.403 2.069 . . . . 0.0 110.611 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.86 32.59 0.59 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.726 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.19 -3.37 14.66 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.43 162.66 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 -175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.52 150.71 21.53 Favored Glycine 0 CA--C 1.481 -2.038 1 N-CA-C 98.552 -5.819 . . . . 0.0 98.552 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.6 pt -150.55 -150.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -159.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.04 128.02 31.84 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.92 18.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -170.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' HA ' HD22 ' A' ' 11' ' ' ASN . 78.0 tt0 -62.5 133.2 54.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 125.585 1.554 . . . . 0.0 112.184 -168.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.73 -46.42 0.77 Allowed Glycine 0 N--CA 1.432 -1.6 1 N-CA-C 98.69 -5.764 . . . . 0.0 98.69 -157.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -94.4 -149.32 0.28 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 154.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -149.85 -172.98 4.29 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 101.277 -3.601 . . . . 0.0 101.277 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.2 135.7 55.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.909 1.684 . . . . 0.0 109.077 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -157.52 174.34 15.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -67.78 122.55 18.35 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.964 1.306 . . . . 0.0 107.993 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 122.989 0.18 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 167.69 21.58 Favored 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 164.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -127.99 132.04 49.2 Favored 'General case' 0 CA--C 1.48 -1.731 1 N-CA-C 94.017 -6.29 . . . . 0.0 94.017 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.77 36.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 105.551 -3.019 . . . . 0.0 105.551 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.46 134.15 40.92 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.39 148.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' VAL . . . -160.22 -176.88 5.89 Favored 'General case' 0 N--CA 1.413 -2.294 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 -173.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -101.74 168.31 9.26 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.33 130.33 31.66 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.37 2.046 . . . . 0.0 110.395 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -128.47 117.98 22.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 -7.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 70.91 19.54 5.71 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.385 1.074 . . . . 0.0 109.837 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.3 m -103.63 91.77 4.16 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.405 ' HA ' ' CB ' ' A' ' 7' ' ' ALA 0.287 27.2 m -59.4 154.86 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -165.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.56 175.58 5.43 Favored 'General case' 0 N--CA 1.421 -1.903 1 N-CA-C 98.175 -4.75 . . . . 0.0 98.175 175.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -136.39 152.81 51.02 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 97.128 -5.138 . . . . 0.0 97.128 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.05 175.58 6.06 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.32 119.45 33.14 Favored Pre-proline 0 N--CA 1.426 -1.654 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 173.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.47 101.24 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.819 2.346 . . . . 0.0 111.497 -170.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.89 -44.92 0.51 Allowed Glycine 0 CA--C 1.481 -2.092 1 N-CA-C 102.504 -4.238 . . . . 0.0 102.504 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m 121.75 -48.48 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 129.006 2.922 . . . . 0.0 107.299 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -39.94 -45.41 1.86 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.068 2.947 . . . . 0.0 118.097 -155.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -41.57 49.46 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 121.235 -0.916 . . . . 0.0 111.33 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 t -82.92 -25.73 32.12 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.81 -29.16 69.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.742 0.817 . . . . 0.0 110.396 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.7 m -70.52 -43.44 69.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.119 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.73 -39.91 95.55 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 122.075 0.941 . . . . 0.0 109.9 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -54.14 -45.68 72.05 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.531 1.132 . . . . 0.0 110.743 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -61.7 -48.97 78.36 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.31 -18.87 59.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.49 -22.7 24.74 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.634 0.652 . . . . 0.0 109.756 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.9 28.13 3.51 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 167.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.44 121.96 7.18 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.04 -2.824 . . . . 0.0 106.04 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -93.59 1.57 56.64 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 122.046 0.927 . . . . 0.0 109.959 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -160.19 160.69 33.12 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 98.121 -4.77 . . . . 0.0 98.121 169.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.83 178.57 46.55 Favored Glycine 0 CA--C 1.481 -2.089 1 N-CA-C 101.318 -4.713 . . . . 0.0 101.318 -171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -166.71 179.95 5.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.663 -3.829 . . . . 0.0 100.663 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.9 m -93.87 173.81 7.48 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.25 -172.72 31.08 Favored Glycine 0 CA--C 1.482 -2.019 1 N-CA-C 98.32 -5.912 . . . . 0.0 98.32 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -127.65 149.21 50.3 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.21 -4.367 . . . . 0.0 99.21 170.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -126.72 101.2 6.52 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.44 120.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.59 -42.03 1.38 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -118.05 -64.51 1.28 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.43 -138.09 5.9 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 105.254 -3.138 . . . . 0.0 105.254 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp -81.23 133.41 35.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.8 162.83 37.08 Favored 'General case' 0 N--CA 1.433 -1.288 1 N-CA-C 97.975 -4.824 . . . . 0.0 97.975 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -113.02 -176.49 2.91 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 121.162 1.801 . . . . 0.0 106.494 -169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -126.47 147.88 49.75 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 m -141.86 142.18 33.11 Favored 'General case' 0 N--CA 1.433 -1.278 1 N-CA-C 100.096 -4.039 . . . . 0.0 100.096 170.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.1 22.35 16.07 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -165.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.8 2.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 94.542 -6.095 . . . . 0.0 94.542 173.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.22 154.14 35.95 Favored Pre-proline 0 N--CA 1.427 -1.602 1 N-CA-C 96.024 -5.547 . . . . 0.0 96.024 152.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.09 166.3 30.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 122.156 1.806 . . . . 0.0 109.165 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.64 -10.92 56.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -86.09 -1.34 57.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.517 0.727 . . . . 0.0 110.082 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -100.28 142.52 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.13 13.25 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 99.65 -5.38 . . . . 0.0 99.65 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -130.09 -129.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -163.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mm -72.89 118.78 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 166.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.39 112.18 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 9.4 tp10 73.48 -178.3 0.19 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 128.037 2.535 . . . . 0.0 109.544 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -107.99 79.12 0.25 Allowed Glycine 0 CA--C 1.486 -1.777 1 N-CA-C 100.983 -4.847 . . . . 0.0 100.983 169.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -137.37 -124.14 0.14 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 101.408 -3.553 . . . . 0.0 101.408 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -157.16 -174.97 5.16 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 97.835 -4.876 . . . . 0.0 97.835 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.38 123.37 19.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 126.044 1.738 . . . . 0.0 107.61 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -144.02 179.88 6.92 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -171.27 172.29 5.32 Favored 'General case' 0 N--CA 1.428 -1.544 1 N-CA-C 96.226 -5.472 . . . . 0.0 96.226 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.032 0 CA-C-N 119.345 0.975 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 162.71 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -128.6 134.16 48.51 Favored 'General case' 0 CA--C 1.487 -1.463 1 N-CA-C 94.955 -5.943 . . . . 0.0 94.955 165.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.19 -175.14 32.9 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 105.576 -3.009 . . . . 0.0 105.576 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -76.06 132.89 40.38 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.8 137.17 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.52 -150.52 0.42 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.64 -2.527 . . . . 0.0 108.872 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -135.1 152.35 76.92 Favored Pre-proline 0 N--CA 1.421 -1.902 1 N-CA-C 94.612 -6.07 . . . . 0.0 94.612 161.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -67.41 157.55 61.21 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 CA-C-N 123.391 2.247 . . . . 0.0 108.439 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.401 ' H ' ' CE1' ' A' ' 66' ' ' HIS . 45.2 mt-10 -93.74 -25.12 17.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 128.153 2.581 . . . . 0.0 110.278 5.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.76 106.1 2.25 Favored 'General case' 0 N--CA 1.434 -1.241 1 N-CA-C 99.612 -4.218 . . . . 0.0 99.612 -173.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -163.06 -168.23 1.69 Allowed 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 120.092 1.315 . . . . 0.0 107.648 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.18 164.6 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 160.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 -164.59 1.01 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.9 167.92 20.3 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 96.314 -5.439 . . . . 0.0 96.314 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.42 156.41 48.59 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 98.231 -4.729 . . . . 0.0 98.231 -167.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.05 116.15 45.01 Favored Pre-proline 0 N--CA 1.424 -1.752 1 N-CA-C 96.304 -5.443 . . . . 0.0 96.304 164.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -63.59 102.41 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 125.025 2.83 . . . . 0.0 114.788 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.98 -172.47 45.47 Favored Glycine 0 N--CA 1.418 -2.507 1 N-CA-C 96.184 -6.767 . . . . 0.0 96.184 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -38.24 23.86 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 118.437 1.119 . . . . 0.0 108.675 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.51 -60.02 2.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.337 2.655 . . . . 0.0 116.124 -165.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.56 -54.37 10.51 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -166.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.29 -47.52 79.17 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 122.292 -0.534 . . . . 0.0 110.971 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -64.69 -40.98 96.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 m -64.8 -44.62 89.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.492 -0.755 . . . . 0.0 111.035 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.88 -38.53 91.27 Favored 'General case' 0 C--N 1.358 0.964 0 CA-C-O 122.342 1.068 . . . . 0.0 109.985 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -58.93 -50.24 74.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.512 1.125 . . . . 0.0 110.572 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -68.76 -35.8 77.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.12 -29.29 54.7 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.264 -0.897 . . . . 0.0 111.806 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -77.29 -35.06 55.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.739 0.7 . . . . 0.0 109.419 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.61 43.32 0.82 Allowed Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.07 157.09 21.0 Favored Glycine 0 CA--C 1.484 -1.897 1 N-CA-C 102.263 -4.335 . . . . 0.0 102.263 159.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.8 m -81.3 -38.05 27.4 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -168.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.2 m -160.5 168.79 24.33 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 99.929 -4.1 . . . . 0.0 99.929 175.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.11 178.55 45.92 Favored Glycine 0 N--CA 1.421 -2.355 1 N-CA-C 99.969 -5.252 . . . . 0.0 99.969 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -169.66 -175.49 2.15 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -171.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.89 145.98 29.12 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.84 167.96 38.84 Favored Glycine 0 N--CA 1.419 -2.486 1 N-CA-C 99.18 -5.568 . . . . 0.0 99.18 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -164.37 -168.04 1.44 Allowed 'General case' 0 N--CA 1.42 -1.971 1 N-CA-C 95.997 -5.557 . . . . 0.0 95.997 170.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 99.59 61.4 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 131.324 3.85 . . . . 0.0 102.244 -167.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.7 t -141.41 166.95 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 1 N-CA-C 99.627 -4.212 . . . . 0.0 99.627 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.32 80.23 0.27 Allowed Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.54 -3.024 . . . . 0.0 105.54 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -173.34 -145.16 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 94.47 -6.122 . . . . 0.0 94.47 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.86 120.15 1.87 Allowed Glycine 0 CA--C 1.484 -1.902 1 N-CA-C 101.349 -4.701 . . . . 0.0 101.349 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tp 73.88 175.53 0.26 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.608 1.963 . . . . 0.0 108.962 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.79 -173.78 0.42 Allowed 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 98.183 -4.747 . . . . 0.0 98.183 171.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.3 m -125.83 176.48 6.92 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 100.499 -3.889 . . . . 0.0 100.499 159.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -113.94 152.52 30.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -145.63 149.94 35.43 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -116.47 137.73 51.94 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.25 61.05 0.23 Allowed 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.345 2.258 . . . . 0.0 110.517 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.36 131.0 26.99 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.61 178.02 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.986 2.457 . . . . 0.0 110.714 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -74.61 -1.54 22.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -89.81 -1.22 57.94 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 120.937 -1.102 . . . . 0.0 109.761 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.93 170.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.98 152.01 24.11 Favored Glycine 0 CA--C 1.478 -2.269 1 N-CA-C 97.719 -6.152 . . . . 0.0 97.719 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.46 -149.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mm -68.28 134.98 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.15 158.16 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 1 N-CA-C 93.188 -6.597 . . . . 0.0 93.188 169.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -148.89 158.69 44.36 Favored 'General case' 0 CA--C 1.477 -1.839 1 N-CA-C 96.606 -5.331 . . . . 0.0 96.606 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.19 -39.63 1.11 Allowed Glycine 0 CA--C 1.485 -1.817 1 N-CA-C 102.255 -4.338 . . . . 0.0 102.255 -163.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -104.29 -98.63 0.31 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -174.01 -161.66 0.13 Allowed 'General case' 0 N--CA 1.427 -1.583 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 -169.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 10.4 t -79.89 119.58 22.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 162.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.401 ' CE1' ' H ' ' A' ' 10' ' ' GLU . 3.3 p-80 -75.13 174.12 9.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.557 1.17 . . . . 0.0 110.574 -167.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.7 m -170.81 -179.4 2.83 Favored 'General case' 0 N--CA 1.421 -1.891 1 N-CA-C 95.778 -5.638 . . . . 0.0 95.778 173.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.928 0 O-C-N 124.438 1.086 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.031 0.443 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 169.3 9.08 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -128.2 144.38 51.12 Favored 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 94.587 -6.079 . . . . 0.0 94.587 166.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 178.06 37.52 Favored Glycine 0 CA--C 1.475 -2.409 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -81.7 129.91 34.88 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 159.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 14.6 tt -90.52 140.16 16.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.48 -149.76 0.42 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 127.097 2.159 . . . . 0.0 108.285 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.59 165.58 24.22 Favored Pre-proline 0 N--CA 1.418 -2.07 1 N-CA-C 95.229 -5.841 . . . . 0.0 95.229 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.01 152.17 83.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.22 1.947 . . . . 0.0 108.706 167.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -88.27 -51.76 5.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.21 2.204 . . . . 0.0 108.095 1.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.84 121.85 14.6 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 89.567 -7.938 . . . . 0.0 89.567 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 m -163.57 -166.32 1.19 Allowed 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 102.252 -3.24 . . . . 0.0 102.252 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.03 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 97.796 -4.89 . . . . 0.0 97.796 160.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -161.62 0.66 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 162.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -137.76 167.36 21.87 Favored 'General case' 0 CA--C 1.484 -1.581 1 N-CA-C 97.257 -5.09 . . . . 0.0 97.257 164.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.3 t -108.42 163.58 13.09 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -110.29 106.0 57.64 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 97.712 -4.921 . . . . 0.0 97.712 162.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -53.14 104.62 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 124.045 2.48 . . . . 0.0 118.245 -161.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.01 -162.64 33.77 Favored Glycine 0 N--CA 1.423 -2.193 1 N-CA-C 97.569 -6.212 . . . . 0.0 97.569 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -88.86 -34.03 17.14 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -39.47 -59.64 1.06 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 128.568 2.747 . . . . 0.0 116.643 -160.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -53.65 11.08 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.71 -43.04 98.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 122.115 -0.638 . . . . 0.0 111.621 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -44.5 97.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.818 0.847 . . . . 0.0 109.988 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -63.09 -43.88 97.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.395 -0.815 . . . . 0.0 110.515 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.08 -40.61 90.97 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 122.422 1.106 . . . . 0.0 110.215 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.31 -44.39 95.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.817 1.247 . . . . 0.0 109.658 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -74.98 -28.79 60.69 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -78.39 -24.33 46.38 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.971 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -78.0 -58.18 3.4 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.82 45.52 0.07 OUTLIER Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.85 159.07 14.15 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 104.215 -3.554 . . . . 0.0 104.215 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 m -91.97 -31.14 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.653 0.74 . . . . 0.0 109.757 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -146.22 154.78 42.13 Favored 'General case' 0 CA--C 1.476 -1.896 1 N-CA-C 99.837 -4.134 . . . . 0.0 99.837 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.97 155.69 26.57 Favored Glycine 0 N--CA 1.417 -2.591 1 N-CA-C 98.427 -5.869 . . . . 0.0 98.427 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -166.51 -172.99 2.34 Favored 'General case' 0 N--CA 1.424 -1.736 1 N-CA-C 96.863 -5.236 . . . . 0.0 96.863 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.2 m -72.86 179.57 3.63 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 122.699 1.237 . . . . 0.0 110.817 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.24 174.08 39.48 Favored Glycine 0 N--CA 1.41 -3.07 1 N-CA-C 98.17 -5.972 . . . . 0.0 98.17 168.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -137.45 132.74 33.82 Favored 'General case' 0 N--CA 1.427 -1.584 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 172.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -117.23 105.28 12.04 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.98 125.18 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.35 -32.07 3.47 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -124.35 -67.55 0.91 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.6 -148.92 19.49 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.295 -3.122 . . . . 0.0 105.295 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 tp -58.87 143.76 46.61 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.648 2.379 . . . . 0.0 107.942 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.11 -172.66 4.18 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -170.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.6 m -117.46 170.81 8.43 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 165.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.8 t-105 -124.32 156.83 36.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.2 m -145.03 147.54 32.72 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -113.6 136.73 52.5 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.55 69.73 0.46 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.358 2.663 . . . . 0.0 111.644 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 mt -105.06 139.11 19.79 Favored Pre-proline 0 CA--C 1.503 -0.837 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -68.52 167.44 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.657 2.238 . . . . 0.0 111.596 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -67.49 -21.0 65.53 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.342 1.057 . . . . 0.0 113.742 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -84.02 2.37 39.38 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 110.847 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.29 125.89 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.36 152.27 20.15 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 105.842 -2.903 . . . . 0.0 105.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.1 pt -140.46 -147.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 -166.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mm -72.71 135.5 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.06 149.04 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 1 N-CA-C 93.569 -6.456 . . . . 0.0 93.569 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 46.26 -117.18 0.69 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.615 1.966 . . . . 0.0 112.422 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.88 48.82 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -86.46 -60.04 2.11 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -166.89 -171.68 1.88 Allowed 'General case' 0 N--CA 1.424 -1.734 1 N-CA-C 99.14 -4.392 . . . . 0.0 99.14 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.6 t -107.18 119.75 40.25 Favored 'General case' 0 N--CA 1.426 -1.656 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 165.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.256 83.7 m-70 78.55 -164.45 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 128.183 2.593 . . . . 0.0 108.189 -170.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 p -87.42 107.78 18.7 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -170.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.048 0 O-C-N 123.533 0.52 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.3 0.571 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.4 171.29 7.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -131.71 144.14 50.77 Favored 'General case' 0 CA--C 1.485 -1.549 1 N-CA-C 95.694 -5.669 . . . . 0.0 95.694 165.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.78 36.6 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.709 -2.956 . . . . 0.0 105.709 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.37 133.41 35.91 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.37 135.17 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.21 -150.0 0.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 111.328 -2.669 . . . . 0.0 107.026 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 9.2 pt20 -142.14 164.36 34.16 Favored Pre-proline 0 N--CA 1.42 -1.926 1 N-CA-C 96.017 -5.549 . . . . 0.0 96.017 169.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -66.97 149.27 82.88 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 CA-C-N 122.4 1.893 . . . . 0.0 109.698 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -81.86 -22.72 36.78 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.491 2.316 . . . . 0.0 107.844 -1.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -177.49 155.53 1.09 Allowed 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 94.094 -6.261 . . . . 0.0 94.094 -171.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 73.2 m 161.22 -149.33 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.116 1 N-CA-C 97.971 -4.825 . . . . 0.0 97.971 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.57 164.7 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 1 N-CA-C 98.802 -4.518 . . . . 0.0 98.802 160.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -155.46 0.24 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 161.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -134.82 -179.5 5.65 Favored 'General case' 0 CA--C 1.482 -1.641 1 N-CA-C 98.919 -4.474 . . . . 0.0 98.919 164.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.2 t -139.1 174.01 10.96 Favored 'General case' 0 N--CA 1.416 -2.127 1 N-CA-C 96.817 -5.253 . . . . 0.0 96.817 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -128.04 132.67 24.47 Favored Pre-proline 0 N--CA 1.416 -2.174 1 N-CA-C 97.639 -4.948 . . . . 0.0 97.639 173.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -55.38 118.37 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.109 2.54 . . . . 0.0 112.773 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.81 -44.16 1.21 Allowed Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 25.4 m 91.87 -13.78 0.2 Allowed 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 127.784 2.434 . . . . 0.0 112.917 175.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -47.14 -48.28 23.34 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.54 -28.89 56.67 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 111.241 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.21 -45.47 60.15 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.25 -47.49 78.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.854 1.262 . . . . 0.0 109.163 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -59.78 -45.67 91.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.606 0.762 . . . . 0.0 112.07 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 mt -66.65 -40.13 88.53 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.887 -1.133 . . . . 0.0 110.54 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.29 -43.45 83.18 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.648 1.179 . . . . 0.0 110.779 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -59.37 -53.31 59.67 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.35 0.66 . . . . 0.0 110.679 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.31 -16.97 61.36 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.622 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -91.22 -5.2 55.19 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.794 -0.566 . . . . 0.0 109.895 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.18 27.92 7.95 Favored Glycine 0 CA--C 1.49 -1.5 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.036 166.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.9 146.29 17.42 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -78.87 -27.93 44.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.318 -1.107 . . . . 0.0 111.06 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 m -161.07 174.73 13.3 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 99.674 -4.195 . . . . 0.0 99.674 166.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.06 172.56 43.91 Favored Glycine 0 N--CA 1.423 -2.222 1 N-CA-C 98.82 -5.712 . . . . 0.0 98.82 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -159.63 174.76 14.09 Favored 'General case' 0 CA--C 1.491 -1.3 1 N-CA-C 99.521 -4.252 . . . . 0.0 99.521 -173.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.8 m -71.82 163.4 27.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 119.818 1.19 . . . . 0.0 110.429 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.25 171.81 37.35 Favored Glycine 0 N--CA 1.424 -2.139 1 N-CA-C 99.568 -5.413 . . . . 0.0 99.568 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -120.79 134.59 55.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -110.85 106.42 15.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.34 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.4 -21.87 10.51 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.405 ' HE1' ' O ' ' A' ' 64' ' ' LYS . 9.6 m170 -132.07 -74.02 0.51 Allowed 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.34 -160.62 34.0 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.68 135.54 57.66 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 127.253 2.221 . . . . 0.0 107.167 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.47 -173.45 3.77 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -170.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.7 t -122.58 155.56 36.04 Favored 'General case' 0 CA--C 1.494 -1.181 1 N-CA-C 99.986 -4.079 . . . . 0.0 99.986 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -114.24 151.29 33.05 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.7 m -146.3 149.15 33.28 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.77 138.89 53.06 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 103.385 -2.82 . . . . 0.0 103.385 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.65 58.54 0.1 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 127.67 2.388 . . . . 0.0 111.473 171.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.17 132.68 23.02 Favored Pre-proline 0 CA--C 1.501 -0.911 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.34 171.68 17.79 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.283 1.851 . . . . 0.0 110.965 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.76 -18.23 62.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.672 1.989 . . . . 0.0 114.753 -169.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -86.73 -5.72 59.04 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.278 0.631 . . . . 0.0 109.842 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.17 138.54 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.3 152.52 17.19 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 pt -131.37 -150.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -160.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.0 mm -76.39 113.49 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.79 95.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -81.01 141.2 34.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.14 -38.44 3.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -83.63 -29.67 27.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.917 0.887 . . . . 0.0 109.049 -175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' O ' ' HE1' ' A' ' 43' ' ' HIS 0.311 51.1 tttm 94.83 -117.31 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 125.095 1.358 . . . . 0.0 108.718 173.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.0 t -133.63 128.85 35.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.95 -142.73 0.56 Allowed 'General case' 0 CA--C 1.498 -1.058 0 C-N-CA 126.033 1.733 . . . . 0.0 110.135 -170.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -76.25 56.36 1.04 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.554 1.542 . . . . 0.0 110.995 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.053 0 CA-C-N 115.621 -0.718 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 165.87 26.14 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -134.17 130.07 36.74 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 94.465 -6.124 . . . . 0.0 94.465 166.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.99 -174.1 31.47 Favored Glycine 0 CA--C 1.471 -2.695 0 N-CA-C 103.278 -3.929 . . . . 0.0 103.278 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.94 134.91 37.79 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 163.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tt -90.9 143.56 10.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.25 -153.66 0.51 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 126.842 2.057 . . . . 0.0 105.618 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.83 66.02 Favored Pre-proline 0 N--CA 1.424 -1.764 1 N-CA-C 94.199 -6.223 . . . . 0.0 94.199 165.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.16 150.57 59.94 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.277 1.984 . . . . 0.0 108.407 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -85.98 -35.59 20.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.914 1.686 . . . . 0.0 109.402 10.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -159.26 145.31 16.38 Favored 'General case' 0 N--CA 1.419 -2.02 1 N-CA-C 94.773 -6.01 . . . . 0.0 94.773 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.4 m 175.37 -155.3 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.433 1 N-CA-C 96.642 -5.318 . . . . 0.0 96.642 172.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -127.07 165.38 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 1 N-CA-C 96.913 -5.217 . . . . 0.0 96.913 161.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.78 -166.91 1.55 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 164.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -135.73 151.19 49.9 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 101.619 -3.474 . . . . 0.0 101.619 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.0 t -124.31 156.94 36.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.36 118.29 47.73 Favored Pre-proline 0 N--CA 1.42 -1.927 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -176.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 108.28 0.45 Allowed 'Trans proline' 0 CA--C 1.506 -0.914 0 C-N-CA 122.999 2.466 . . . . 0.0 111.892 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.78 0.54 Allowed Glycine 0 CA--C 1.482 -1.97 1 N-CA-C 100.374 -5.09 . . . . 0.0 100.374 -164.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.252 6.8 m 114.49 -35.79 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 108.714 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -39.46 -52.06 2.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.999 2.519 . . . . 0.0 117.118 -157.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.62 -41.51 75.16 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 121.033 -1.042 . . . . 0.0 112.066 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -90.14 -21.76 22.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.934 -1.333 . . . . 0.0 109.176 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.6 -43.08 93.82 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 166.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.59 -47.21 87.2 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.572 -0.705 . . . . 0.0 110.763 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.3 mt -58.87 -43.97 90.98 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 123.676 0.79 . . . . 0.0 111.027 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.7 t -54.07 -47.51 71.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.997 1.319 . . . . 0.0 110.863 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -69.24 -40.62 77.79 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.48 0.312 . . . . 0.0 111.391 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.82 -25.32 48.75 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 118.01 0.368 . . . . 0.0 111.469 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -72.76 -54.37 9.08 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.03 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 167.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.66 136.75 13.82 Favored Glycine 0 CA--C 1.49 -1.515 1 N-CA-C 102.696 -4.162 . . . . 0.0 102.696 165.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -101.58 11.1 39.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.778 0.799 . . . . 0.0 110.098 -163.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.5 m -160.01 159.97 32.71 Favored 'General case' 0 CA--C 1.484 -1.582 1 N-CA-C 98.032 -4.803 . . . . 0.0 98.032 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.58 42.57 Favored Glycine 0 CA--C 1.479 -2.184 1 N-CA-C 99.672 -5.371 . . . . 0.0 99.672 -168.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -167.34 -167.26 0.88 Allowed 'General case' 0 N--CA 1.435 -1.195 1 N-CA-C 98.055 -4.794 . . . . 0.0 98.055 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.9 m -99.19 177.25 5.27 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.22 179.73 42.86 Favored Glycine 0 N--CA 1.423 -2.207 1 N-CA-C 102.569 -4.213 . . . . 0.0 102.569 -175.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -143.95 148.52 35.46 Favored 'General case' 0 CA--C 1.486 -1.505 1 N-CA-C 97.248 -5.093 . . . . 0.0 97.248 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -133.39 112.79 11.89 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.34 124.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.82 -31.56 3.89 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 104.702 -3.359 . . . . 0.0 104.702 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -113.47 -70.88 0.78 Allowed 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.3 -153.15 24.33 Favored Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tt -72.39 144.38 48.22 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.3 -168.96 2.4 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 m -123.61 -179.87 4.52 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 165.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -130.78 152.98 49.53 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.9 m -148.25 150.89 34.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.33 140.58 49.38 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 170.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.53 0.82 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.331 2.253 . . . . 0.0 111.03 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -91.17 146.52 33.71 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -66.53 162.83 35.05 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.521 2.147 . . . . 0.0 111.001 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.64 -19.1 62.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.381 0.672 . . . . 0.0 112.449 -168.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -82.2 -1.26 48.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.865 1.266 . . . . 0.0 110.975 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.56 129.22 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.02 20.83 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.62 -154.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 -167.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.4 139.69 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 t -147.67 164.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 1 N-CA-C 95.266 -5.828 . . . . 0.0 95.266 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -158.39 157.49 32.42 Favored 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 96.812 -5.255 . . . . 0.0 96.812 166.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.88 -42.87 1.49 Allowed Glycine 0 CA--C 1.494 -1.243 1 N-CA-C 101.249 -4.741 . . . . 0.0 101.249 -163.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -96.56 -147.79 0.3 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 155.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -167.79 -162.75 0.45 Allowed 'General case' 0 N--CA 1.425 -1.718 1 N-CA-C 96.216 -5.476 . . . . 0.0 96.216 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.8 127.49 31.68 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 127.0 2.12 . . . . 0.0 110.374 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -149.97 93.94 2.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 m -78.38 118.54 20.65 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.052 0 O-C-N 123.0 0.188 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -102.51 152.74 20.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -120.76 119.87 34.01 Favored 'General case' 0 CA--C 1.487 -1.473 1 N-CA-C 95.336 -5.801 . . . . 0.0 95.336 159.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.67 -177.88 35.12 Favored Glycine 0 CA--C 1.472 -2.607 1 N-CA-C 102.747 -4.141 . . . . 0.0 102.747 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.79 144.36 27.79 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -90.76 148.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.87 -164.14 1.48 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 146.94 32.17 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 101.429 -3.545 . . . . 0.0 101.429 161.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.91 113.39 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.176 2.584 . . . . 0.0 107.754 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -142.96 162.54 35.2 Favored 'General case' 0 CA--C 1.473 -2.011 1 N-CA-C 99.407 -4.294 . . . . 0.0 99.407 5.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.471 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER 83.14 -5.51 1.24 Allowed 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.087 0.867 . . . . 0.0 110.922 162.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -90.65 -143.83 0.17 Allowed 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 125.366 1.466 . . . . 0.0 107.715 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 43' ' ' HIS . 34.8 m -141.75 -179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 1 N-CA-C 98.366 -4.679 . . . . 0.0 98.366 160.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.7 156.28 39.58 Favored 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 94.494 -6.113 . . . . 0.0 94.494 162.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -96.0 123.14 39.48 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 t -94.36 143.3 26.52 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -111.82 121.22 40.31 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.94 120.6 8.49 Favored 'Trans proline' 0 CA--C 1.506 -0.901 0 CA-C-N 123.565 2.309 . . . . 0.0 111.454 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.73 -55.61 0.68 Allowed Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.819 -5.312 . . . . 0.0 99.819 -160.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 m 113.27 -27.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 129.676 3.19 . . . . 0.0 109.839 167.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.29 -49.65 2.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.673 2.389 . . . . 0.0 117.147 -160.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.2 -49.01 69.07 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 121.669 -0.644 . . . . 0.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.7 t -85.91 -23.9 26.83 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.621 -0.929 . . . . 0.0 110.026 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.82 -36.92 85.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.572 -0.705 . . . . 0.0 109.124 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.8 m -66.41 -41.04 89.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.947 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.83 -44.5 95.99 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.632 0.773 . . . . 0.0 109.833 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 t -52.6 -50.14 63.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.406 1.482 . . . . 0.0 110.272 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -60.73 -47.69 85.17 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.721 0.409 . . . . 0.0 112.04 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.09 -31.79 66.39 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.487 -0.758 . . . . 0.0 112.783 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -78.48 -25.23 45.68 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.788 0.722 . . . . 0.0 109.784 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.97 42.57 0.77 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 161.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.68 135.37 12.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.879 -2.888 . . . . 0.0 105.879 170.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -84.02 -16.14 45.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.648 0.779 . . . . 0.0 109.928 -166.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t -158.8 169.98 23.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.99 175.39 46.64 Favored Glycine 0 N--CA 1.425 -2.046 1 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 p80 179.2 -176.45 0.26 Allowed 'General case' 0 N--CA 1.435 -1.193 1 N-CA-C 99.513 -4.255 . . . . 0.0 99.513 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.67 173.84 7.49 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.02 -171.05 40.99 Favored Glycine 0 CA--C 1.483 -1.953 1 N-CA-C 97.322 -6.311 . . . . 0.0 97.322 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.29 160.86 40.28 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 97.256 -5.09 . . . . 0.0 97.256 171.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -160.01 36.88 0.18 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.263 2.2 t 58.53 -143.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -157.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.92 -126.19 6.38 Favored Glycine 0 CA--C 1.48 -2.133 1 N-CA-C 99.548 -5.421 . . . . 0.0 99.548 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.471 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 66.9 m80 -121.13 -20.32 6.83 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 125.611 1.565 . . . . 0.0 108.192 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.39 -173.89 45.78 Favored Glycine 0 N--CA 1.421 -2.318 1 N-CA-C 96.481 -6.647 . . . . 0.0 96.481 -165.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.03 102.07 10.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 118.271 1.035 . . . . 0.0 108.232 -168.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.99 -179.83 7.54 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 125.231 1.413 . . . . 0.0 109.005 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 155.64 39.47 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 -170.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -90.95 154.36 19.52 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.9 m -141.95 144.02 33.52 Favored 'General case' 0 CA--C 1.479 -1.783 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 161.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -112.5 121.93 46.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.17 75.94 0.16 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 126.424 1.89 . . . . 0.0 110.085 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.5 mt -99.74 140.19 21.39 Favored Pre-proline 0 CA--C 1.497 -1.088 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.66 171.3 17.52 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.502 2.135 . . . . 0.0 109.943 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -78.56 -3.88 45.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -163.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -91.14 1.31 57.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.939 0.896 . . . . 0.0 109.917 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.95 140.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.56 148.58 18.91 Favored Glycine 0 CA--C 1.482 -1.997 1 N-CA-C 102.598 -4.201 . . . . 0.0 102.598 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 pt -144.53 -153.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -161.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.2 mm -72.53 139.46 19.59 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -148.36 141.01 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 1 N-CA-C 92.91 -6.7 . . . . 0.0 92.91 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 41.18 -108.86 0.1 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 126.238 1.815 . . . . 0.0 111.612 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.95 70.45 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 104.127 -3.589 . . . . 0.0 104.127 164.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.42 -66.6 0.31 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 -168.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -96.7 163.87 12.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.57 130.53 55.3 Favored 'General case' 0 CA--C 1.496 -1.111 1 N-CA-C 100.048 -4.056 . . . . 0.0 100.048 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.277 41.6 m-70 69.48 -168.33 0.17 Allowed 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.841 1.656 . . . . 0.0 110.356 -163.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 m -68.71 105.35 2.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 1.214 0 O-C-N 123.031 0.207 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.698 0.761 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.71 157.15 34.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -132.52 127.84 36.03 Favored 'General case' 0 CA--C 1.488 -1.423 1 N-CA-C 98.113 -4.773 . . . . 0.0 98.113 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -167.23 22.25 Favored Glycine 0 CA--C 1.475 -2.421 1 N-CA-C 102.017 -4.433 . . . . 0.0 102.017 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.47 135.34 39.37 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 161.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -85.16 135.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -138.24 0.09 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.492 -2.595 . . . . 0.0 106.577 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -151.56 164.03 21.63 Favored Pre-proline 0 N--CA 1.422 -1.829 1 N-CA-C 95.329 -5.804 . . . . 0.0 95.329 162.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -65.22 148.4 88.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.845 2.052 . . . . 0.0 109.328 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.53 -51.01 6.15 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 127.97 2.508 . . . . 0.0 109.463 5.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -142.3 143.38 32.77 Favored 'General case' 0 CA--C 1.479 -1.767 1 N-CA-C 92.615 -6.809 . . . . 0.0 92.615 169.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.2 m -172.83 -158.85 0.11 Allowed 'General case' 0 N--CA 1.435 -1.179 1 N-CA-C 100.133 -4.025 . . . . 0.0 100.133 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.26 166.37 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 96.612 -5.329 . . . . 0.0 96.612 159.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.16 -170.48 3.06 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -130.09 145.21 51.67 Favored 'General case' 0 CA--C 1.472 -2.027 1 N-CA-C 93.075 -6.639 . . . . 0.0 93.075 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -160.44 -165.37 1.42 Allowed 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 94.863 -5.977 . . . . 0.0 94.863 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -144.42 171.91 6.12 Favored Pre-proline 0 N--CA 1.416 -2.154 1 N-CA-C 99.821 -4.14 . . . . 0.0 99.821 -161.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.88 60.3 2.26 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.304 2.669 . . . . 0.0 110.049 164.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.59 124.43 0.81 Allowed Glycine 0 N--CA 1.422 -2.251 1 N-CA-C 100.948 -4.861 . . . . 0.0 100.948 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.37 38.21 0.35 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.088 1.755 . . . . 0.0 112.276 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -70.08 -63.96 0.98 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.369 1.468 . . . . 0.0 110.127 -161.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -23.46 61.93 Favored Glycine 0 CA--C 1.495 -1.19 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -79.65 -14.66 58.63 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.724 -0.655 . . . . 0.0 111.4 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.7 -55.35 23.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 119.714 1.143 . . . . 0.0 109.735 168.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.32 90.88 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.004 1.322 . . . . 0.0 112.767 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.53 -40.49 89.16 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.574 0.702 . . . . 0.0 111.219 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.6 -42.87 98.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -64.1 -46.38 84.49 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 122.465 0.306 . . . . 0.0 110.935 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.32 -15.94 61.89 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.128 -0.982 . . . . 0.0 112.495 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -92.67 -6.87 48.36 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.02 0.528 . . . . 0.0 109.878 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 32.11 11.14 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.81 18.92 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 103.858 -3.697 . . . . 0.0 103.858 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -82.13 -43.33 17.93 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 121.828 -0.807 . . . . 0.0 109.761 -167.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -160.71 -179.76 7.88 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.72 -4.548 . . . . 0.0 98.72 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.01 -176.39 42.39 Favored Glycine 0 N--CA 1.418 -2.503 1 N-CA-C 99.313 -5.515 . . . . 0.0 99.313 -167.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -160.33 -176.6 5.71 Favored 'General case' 0 CA--C 1.488 -1.409 1 N-CA-C 98.511 -4.625 . . . . 0.0 98.511 -174.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.7 m -140.32 161.64 37.2 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.06 109.73 0.95 Allowed Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 104.571 -3.411 . . . . 0.0 104.571 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -171.84 -179.75 2.53 Favored 'General case' 0 N--CA 1.43 -1.425 1 N-CA-C 98.138 -4.764 . . . . 0.0 98.138 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -153.78 148.74 26.68 Favored 'General case' 0 N--CA 1.433 -1.319 1 N-CA-C 95.849 -5.612 . . . . 0.0 95.849 163.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.52 173.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 N-CA-C 97.814 -4.884 . . . . 0.0 97.814 173.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.29 75.89 1.98 Allowed Glycine 0 C--N 1.351 1.372 0 N-CA-C 105.163 -3.175 . . . . 0.0 105.163 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.38 -50.29 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.35 1 N-CA-C 99.928 -4.101 . . . . 0.0 99.928 -170.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.02 -92.41 0.12 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.59 174.16 8.01 Favored 'General case' 0 N--CA 1.427 -1.597 1 N-CA-C 95.838 -5.616 . . . . 0.0 95.838 -173.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.44 -174.62 4.57 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.9 t -118.01 158.3 25.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 101.742 -3.429 . . . . 0.0 101.742 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -97.17 153.98 17.65 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 m -145.63 152.17 39.22 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 101.444 -3.539 . . . . 0.0 101.444 163.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.87 143.15 48.08 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.84 51.58 0.57 Allowed 'General case' 0 CA--C 1.498 -1.019 0 C-N-CA 126.928 2.091 . . . . 0.0 111.986 171.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -93.0 133.04 29.49 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.97 172.94 11.91 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.542 2.161 . . . . 0.0 110.283 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.71 26.33 1.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -97.31 -7.91 30.94 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG11 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -101.81 -176.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' H ' HG11 ' A' ' 56' ' ' VAL . . . -151.17 166.65 30.57 Favored Glycine 0 CA--C 1.479 -2.181 1 N-CA-C 98.11 -5.996 . . . . 0.0 98.11 -174.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.3 pt -153.8 -168.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.478 -1.807 1 N-CA-C 99.282 -4.34 . . . . 0.0 99.282 -168.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 mm -64.17 111.65 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -83.89 -45.17 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -162.49 168.2 22.29 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 95.583 -5.71 . . . . 0.0 95.583 172.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.72 45.37 1.73 Allowed Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.81 -48.5 9.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.923 -167.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -153.24 167.28 29.86 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 28.6 t -133.63 136.6 44.92 Favored 'General case' 0 CA--C 1.482 -1.671 1 N-CA-C 97.769 -4.9 . . . . 0.0 97.769 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -158.31 144.77 17.38 Favored 'General case' 0 CA--C 1.479 -1.758 1 N-CA-C 98.858 -4.497 . . . . 0.0 98.858 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -159.5 167.7 28.0 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 95.435 -5.765 . . . . 0.0 95.435 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.09 0.869 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -104.47 166.42 10.41 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -130.46 134.33 47.01 Favored 'General case' 0 CA--C 1.491 -1.289 1 N-CA-C 94.574 -6.084 . . . . 0.0 94.574 158.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 -179.69 36.78 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -79.21 132.38 36.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 159.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.62 138.06 20.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.84 -156.88 0.57 Allowed 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 127.71 2.404 . . . . 0.0 107.913 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -121.89 142.94 37.36 Favored Pre-proline 0 N--CA 1.424 -1.774 1 N-CA-C 94.846 -5.983 . . . . 0.0 94.846 165.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -63.36 138.03 63.72 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.034 2.489 . . . . 0.0 107.592 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -79.97 -49.45 11.83 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 127.291 2.236 . . . . 0.0 111.469 12.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -156.58 145.08 19.86 Favored 'General case' 0 N--CA 1.417 -2.08 1 N-CA-C 94.538 -6.097 . . . . 0.0 94.538 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 m 172.11 -157.65 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 43' ' ' HIS . 5.6 m -125.83 159.04 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 1 N-CA-C 97.143 -5.132 . . . . 0.0 97.143 162.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.85 -175.74 5.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 162.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -132.03 170.62 14.68 Favored 'General case' 0 CA--C 1.481 -1.682 1 N-CA-C 96.638 -5.319 . . . . 0.0 96.638 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -160.42 169.04 23.89 Favored 'General case' 0 N--CA 1.412 -2.364 1 N-CA-C 98.754 -4.535 . . . . 0.0 98.754 -170.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.27 104.21 22.42 Favored Pre-proline 0 N--CA 1.416 -2.136 1 N-CA-C 93.085 -6.635 . . . . 0.0 93.085 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.95 101.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.306 0 CA-C-N 124.987 2.817 . . . . 0.0 118.138 -141.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.97 8.33 79.32 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -91.87 170.65 9.7 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -49.57 -36.69 24.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.704 2.002 . . . . 0.0 115.209 -169.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.33 -59.84 10.01 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 123.115 0.388 . . . . 0.0 112.642 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -79.57 -13.71 59.34 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 118.792 1.296 . . . . 0.0 109.611 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.21 -49.53 76.79 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -42.84 99.43 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.65 -38.86 90.54 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.856 1.207 . . . . 0.0 110.597 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -62.57 -48.78 77.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -57.76 -50.05 74.52 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.896 0.878 . . . . 0.0 112.268 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.4 -10.33 57.5 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -4.07 28.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.634 0.774 . . . . 0.0 110.016 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.14 37.91 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.51 114.99 4.28 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 m -101.9 -5.59 24.55 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.85 169.32 24.62 Favored 'General case' 0 N--CA 1.435 -1.197 1 N-CA-C 97.462 -5.014 . . . . 0.0 97.462 163.482 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.88 -177.8 42.45 Favored Glycine 0 CA--C 1.479 -2.181 0 N-CA-C 103.797 -3.721 . . . . 0.0 103.797 -174.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -163.48 -166.56 1.25 Allowed 'General case' 0 N--CA 1.433 -1.286 1 N-CA-C 97.229 -5.1 . . . . 0.0 97.229 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.8 m -154.71 163.28 40.47 Favored 'General case' 0 CA--C 1.484 -1.568 1 N-CA-C 98.938 -4.468 . . . . 0.0 98.938 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.55 -176.48 47.68 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 103.274 -3.93 . . . . 0.0 103.274 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.42 143.11 29.87 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 97.178 -5.119 . . . . 0.0 97.178 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -164.42 53.84 0.14 Allowed 'General case' 0 CA--C 1.491 -1.312 1 N-CA-C 97.357 -5.053 . . . . 0.0 97.357 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.301 1.5 t 57.76 -146.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 C-N-CA 125.628 1.571 . . . . 0.0 107.95 -160.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.04 -127.63 6.9 Favored Glycine 0 N--CA 1.424 -2.111 1 N-CA-C 98.915 -5.674 . . . . 0.0 98.915 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.473 ' H ' HG11 ' A' ' 13' ' ' VAL . 31.9 m170 -119.23 -10.02 9.83 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.19 -169.86 42.93 Favored Glycine 0 N--CA 1.423 -2.196 1 N-CA-C 98.168 -5.973 . . . . 0.0 98.168 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.59 128.63 36.86 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.91 171.37 8.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.1 t -113.46 166.91 11.04 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 100.856 -3.757 . . . . 0.0 100.856 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -132.15 148.78 52.49 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.4 m -142.18 154.05 44.52 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -120.25 136.03 54.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.72 56.19 0.18 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.588 2.355 . . . . 0.0 109.896 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.95 135.98 25.31 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -66.5 169.1 14.82 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.112 1.875 . . . . 0.0 112.098 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.8 -6.71 50.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -93.6 1.97 56.51 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 123.01 0.524 . . . . 0.0 110.061 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.06 133.85 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.04 151.55 19.49 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 105.766 -2.934 . . . . 0.0 105.766 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 pt -140.7 -166.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.47 140.56 17.79 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -172.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.26 160.8 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 1 N-CA-C 94.982 -5.933 . . . . 0.0 94.982 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.44 157.13 36.51 Favored 'General case' 0 N--CA 1.425 -1.696 1 N-CA-C 97.151 -5.129 . . . . 0.0 97.151 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.27 -45.05 1.17 Allowed Glycine 0 CA--C 1.491 -1.439 1 N-CA-C 100.132 -5.187 . . . . 0.0 100.132 -163.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -97.92 -143.74 0.3 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 101.18 -3.637 . . . . 0.0 101.18 155.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -169.06 -155.27 0.14 Allowed 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.266 -5.457 . . . . 0.0 96.266 173.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.05 134.64 57.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 125.762 1.625 . . . . 0.0 110.067 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -82.58 -163.26 0.67 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.083 0.944 . . . . 0.0 108.691 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.2 m -167.66 171.83 9.84 Favored 'General case' 0 N--CA 1.424 -1.759 1 N-CA-C 96.215 -5.476 . . . . 0.0 96.215 172.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.923 0 O-C-N 124.426 1.078 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.426 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -140.59 178.19 7.5 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -135.83 131.77 35.81 Favored 'General case' 0 CA--C 1.492 -1.274 1 N-CA-C 96.781 -5.266 . . . . 0.0 96.781 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -177.89 35.21 Favored Glycine 0 CA--C 1.479 -2.204 0 N-CA-C 103.909 -3.677 . . . . 0.0 103.909 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -74.73 131.71 41.05 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.5 130.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.22 -153.0 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 111.418 -2.628 . . . . 0.0 108.275 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -130.79 152.27 80.26 Favored Pre-proline 0 N--CA 1.422 -1.873 1 N-CA-C 95.834 -5.617 . . . . 0.0 95.834 174.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -70.87 151.39 62.7 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 CA-C-N 122.338 1.871 . . . . 0.0 109.841 -171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -96.31 -20.64 18.35 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 127.771 2.428 . . . . 0.0 106.662 3.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -154.01 148.11 25.74 Favored 'General case' 0 N--CA 1.407 -2.585 1 N-CA-C 95.509 -5.737 . . . . 0.0 95.509 172.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.78 -154.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -136.53 173.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 N-CA-C 97.566 -4.976 . . . . 0.0 97.566 166.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -161.39 0.81 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 167.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -136.75 151.87 49.7 Favored 'General case' 0 N--CA 1.418 -2.057 1 N-CA-C 95.023 -5.918 . . . . 0.0 95.023 167.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -160.77 -167.6 1.89 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.74 -5.652 . . . . 0.0 95.74 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.6 166.35 17.85 Favored Pre-proline 0 N--CA 1.415 -2.204 1 N-CA-C 98.05 -4.796 . . . . 0.0 98.05 -161.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -68.34 68.68 1.02 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 CA-C-N 124.094 2.498 . . . . 0.0 112.199 165.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.1 -179.83 46.98 Favored Glycine 0 N--CA 1.417 -2.567 1 N-CA-C 97.661 -6.176 . . . . 0.0 97.661 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -128.82 9.02 5.8 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -55.03 -43.53 73.81 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.891 1.676 . . . . 0.0 114.205 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.95 -49.69 5.52 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -50.36 -43.23 54.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.042 1.737 . . . . 0.0 113.177 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.9 -32.23 70.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.695 0.798 . . . . 0.0 110.593 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -78.97 -45.8 19.6 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 109.004 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.24 -41.15 86.1 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -63.06 -41.8 99.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.464 -0.773 . . . . 0.0 110.684 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.86 -35.17 67.14 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.277 -0.889 . . . . 0.0 111.49 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.59 -30.35 61.66 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.564 -0.71 . . . . 0.0 111.077 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -90.37 -6.82 54.56 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.213 0.605 . . . . 0.0 110.534 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.7 37.18 4.55 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 160.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.29 163.7 16.81 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 104.653 -3.379 . . . . 0.0 104.653 164.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.4 p -68.53 -56.13 9.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.515 1.15 . . . . 0.0 109.854 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -160.67 -172.62 3.59 Favored 'General case' 0 N--CA 1.424 -1.775 1 N-CA-C 98.904 -4.48 . . . . 0.0 98.904 168.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.04 -178.83 40.2 Favored Glycine 0 N--CA 1.415 -2.764 1 N-CA-C 98.529 -5.828 . . . . 0.0 98.529 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -161.56 -175.74 4.93 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.726 -4.916 . . . . 0.0 97.726 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -139.19 157.77 45.35 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 103.811 -2.662 . . . . 0.0 103.811 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.55 166.44 34.24 Favored Glycine 0 N--CA 1.429 -1.774 1 N-CA-C 95.847 -6.901 . . . . 0.0 95.847 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.95 132.08 56.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -129.67 36.08 4.12 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' ' 42' ' ' GLY 0.284 11.5 t 70.1 -171.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -163.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 147.34 -130.37 3.54 Favored Glycine 0 N--CA 1.42 -2.386 1 N-CA-C 97.122 -6.391 . . . . 0.0 97.122 -168.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -114.5 -48.7 2.86 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.45 -178.74 23.83 Favored Glycine 0 N--CA 1.425 -2.083 1 N-CA-C 97.895 -6.082 . . . . 0.0 97.895 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 103.37 7.43 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.423 1.489 . . . . 0.0 107.294 -171.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.11 -166.46 1.5 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -117.49 151.79 36.39 Favored 'General case' 0 CA--C 1.489 -1.386 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -101.32 158.74 15.83 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.8 m -145.78 143.41 29.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.8 123.6 50.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 172.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.23 65.26 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.778 2.431 . . . . 0.0 109.315 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.95 138.68 20.67 Favored Pre-proline 0 CA--C 1.492 -1.271 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.534 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -66.48 161.3 41.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.749 2.299 . . . . 0.0 110.606 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.6 -15.21 59.89 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.059 0.543 . . . . 0.0 111.127 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -92.27 12.36 22.71 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 110.391 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.08 -158.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 101.439 -3.541 . . . . 0.0 101.439 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -160.03 163.39 33.75 Favored Glycine 0 CA--C 1.466 -3.001 1 N-CA-C 102.539 -4.224 . . . . 0.0 102.539 -179.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -152.78 -170.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 101.168 -3.641 . . . . 0.0 101.168 -163.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mm -71.22 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.95 159.51 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -160.71 171.27 19.17 Favored 'General case' 0 N--CA 1.432 -1.347 1 N-CA-C 96.874 -5.232 . . . . 0.0 96.874 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.3 29.72 48.73 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 105.342 -3.103 . . . . 0.0 105.342 -152.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 175.07 -170.18 0.05 OUTLIER 'General case' 0 N--CA 1.423 -1.807 1 N-CA-C 95.293 -5.817 . . . . 0.0 95.293 -158.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -156.49 -176.67 6.09 Favored 'General case' 0 N--CA 1.435 -1.18 1 N-CA-C 96.94 -5.207 . . . . 0.0 96.94 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.83 130.71 48.12 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.68 1.582 . . . . 0.0 108.076 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -149.93 150.12 31.42 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 t -171.7 -179.93 2.64 Favored 'General case' 0 N--CA 1.421 -1.923 1 N-CA-C 96.316 -5.439 . . . . 0.0 96.316 -174.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 0.981 0 O-C-N 125.171 1.545 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 174.87 5.73 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.54 145.77 51.02 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 95.451 -5.759 . . . . 0.0 95.451 165.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 175.66 38.13 Favored Glycine 0 CA--C 1.479 -2.215 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -80.4 131.64 35.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 155.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.87 138.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.75 -138.18 0.37 Allowed 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 127.493 2.317 . . . . 0.0 107.085 176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -141.34 148.82 52.54 Favored Pre-proline 0 N--CA 1.415 -2.196 1 N-CA-C 94.553 -6.092 . . . . 0.0 94.553 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -67.52 143.8 64.4 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.641 2.228 . . . . 0.0 107.548 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -84.29 -33.06 24.05 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 127.897 2.479 . . . . 0.0 109.332 9.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -160.42 158.32 29.26 Favored 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 94.312 -6.181 . . . . 0.0 94.312 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 171.18 -152.5 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 1 N-CA-C 98.382 -4.673 . . . . 0.0 98.382 167.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.32 167.72 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 N-CA-C 96.287 -5.449 . . . . 0.0 96.287 158.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.87 -150.48 0.11 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -139.29 -175.36 4.15 Favored 'General case' 0 CA--C 1.484 -1.571 1 N-CA-C 96.619 -5.326 . . . . 0.0 96.619 163.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -147.93 173.81 12.5 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 96.608 -5.33 . . . . 0.0 96.608 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -129.65 126.11 22.55 Favored Pre-proline 0 N--CA 1.413 -2.317 1 N-CA-C 92.376 -6.898 . . . . 0.0 92.376 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -60.13 98.33 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 125.164 2.88 . . . . 0.0 114.855 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -167.01 35.33 Favored Glycine 0 N--CA 1.422 -2.249 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 p -91.44 -45.36 8.59 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -39.68 -70.62 0.1 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.218 2.207 . . . . 0.0 116.912 -151.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.58 -37.35 62.07 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.799 -1.188 . . . . 0.0 111.068 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -64.88 -51.47 61.77 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.914 1.286 . . . . 0.0 108.795 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.16 -41.39 96.68 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.896 0.878 . . . . 0.0 109.587 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.6 m -59.0 -47.7 84.24 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 121.333 -0.854 . . . . 0.0 111.756 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 mt -65.98 -42.3 90.03 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 123.387 0.675 . . . . 0.0 110.476 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.13 -49.53 73.65 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.38 1.472 . . . . 0.0 109.902 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -69.72 -35.57 75.14 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.27 -0.894 . . . . 0.0 111.339 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -74.76 -2.69 27.6 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.319 -0.863 . . . . 0.0 112.884 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.5 7.53 28.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.379 -0.825 . . . . 0.0 109.212 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.39 26.38 18.3 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.82 132.97 11.43 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 m -94.05 -15.88 24.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -166.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -160.61 179.19 8.78 Favored 'General case' 0 CA--C 1.493 -1.248 1 N-CA-C 99.337 -4.32 . . . . 0.0 99.337 168.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.5 -173.87 39.4 Favored Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 103.104 -3.998 . . . . 0.0 103.104 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -161.08 -162.31 0.9 Allowed 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 -174.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.9 t -136.17 164.92 26.92 Favored 'General case' 0 CA--C 1.489 -1.374 1 N-CA-C 96.202 -5.481 . . . . 0.0 96.202 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.04 -168.19 37.75 Favored Glycine 0 N--CA 1.425 -2.099 1 N-CA-C 102.053 -4.419 . . . . 0.0 102.053 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -148.14 144.68 27.95 Favored 'General case' 0 N--CA 1.428 -1.546 1 N-CA-C 96.368 -5.419 . . . . 0.0 96.368 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -126.89 109.96 12.53 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.73 136.12 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.57 -34.16 4.2 Favored Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 105.414 -3.074 . . . . 0.0 105.414 -170.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.34 -70.62 0.78 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.95 -153.03 23.81 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 106.819 -2.512 . . . . 0.0 106.819 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.64 137.89 55.95 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.164 2.186 . . . . 0.0 106.273 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.35 178.21 8.08 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 101.349 -3.574 . . . . 0.0 101.349 -168.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.22 165.94 13.2 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.651 -4.203 . . . . 0.0 99.651 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.4 t-105 -127.89 146.87 50.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -134.98 149.22 50.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.67 136.63 53.81 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 172.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.7 76.37 0.28 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 126.799 2.039 . . . . 0.0 111.522 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.16 141.22 22.11 Favored Pre-proline 0 CA--C 1.501 -0.913 0 N-CA-C 101.819 -3.4 . . . . 0.0 101.819 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.7 165.16 31.84 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.38 2.054 . . . . 0.0 109.595 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.8 -1.65 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.438 -0.789 . . . . 0.0 112.726 -160.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.49 -1.99 58.35 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.051 0.94 . . . . 0.0 109.533 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.65 134.41 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.96 148.44 16.55 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 104.295 -3.522 . . . . 0.0 104.295 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 pt -132.27 -150.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 mm -73.64 131.37 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.7 t -120.5 155.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 99.313 -4.329 . . . . 0.0 99.313 172.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -160.14 161.61 33.74 Favored 'General case' 0 CA--C 1.483 -1.615 1 N-CA-C 98.604 -4.591 . . . . 0.0 98.604 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.52 32.84 45.31 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 -147.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -178.07 -172.32 0.32 Allowed 'General case' 0 N--CA 1.424 -1.727 1 N-CA-C 96.167 -5.494 . . . . 0.0 96.167 -161.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.41 176.15 9.31 Favored 'General case' 0 N--CA 1.428 -1.557 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 -175.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 30.1 t -60.11 133.01 55.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 128.338 2.655 . . . . 0.0 111.14 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.321 96.4 m-70 60.68 -137.27 0.62 Allowed 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.942 2.097 . . . . 0.0 109.731 -164.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -77.56 59.79 2.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.326 0.65 . . . . 0.0 111.09 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.062 0 CA-C-N 116.022 -0.535 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -174.57 4.56 Favored 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 98.192 -4.744 . . . . 0.0 98.192 172.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -133.74 143.17 48.3 Favored 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.143 -4.762 . . . . 0.0 98.143 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.32 23.86 Favored Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -81.87 136.65 35.34 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 163.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 tt -90.55 146.83 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.333 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.09 178.19 10.3 Favored 'General case' 0 N--CA 1.401 -2.88 1 N-CA-C 96.949 -5.204 . . . . 0.0 96.949 -163.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -93.21 161.01 32.24 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -64.07 116.85 3.95 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.089 1.859 . . . . 0.0 109.812 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -145.52 139.2 26.6 Favored 'General case' 0 CA--C 1.481 -1.703 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 2.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 65' ' ' CYS . 27.8 t-20 86.1 -26.95 0.09 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 127.162 2.185 . . . . 0.0 110.138 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.2 m -87.24 111.63 21.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -157.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.04 171.97 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-O 124.544 2.116 . . . . 0.0 114.654 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.76 -154.78 0.49 Allowed 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.533 -2.576 . . . . 0.0 104.337 -173.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.9 177.61 8.23 Favored 'General case' 0 N--CA 1.417 -2.12 1 N-CA-C 95.756 -5.646 . . . . 0.0 95.756 162.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.5 t -142.7 159.21 42.68 Favored 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 95.153 -5.869 . . . . 0.0 95.153 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.0 121.42 25.44 Favored Pre-proline 0 N--CA 1.415 -2.18 1 N-CA-C 93.235 -6.58 . . . . 0.0 93.235 168.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -68.29 67.69 1.03 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 CA-C-N 123.604 2.323 . . . . 0.0 114.787 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.93 161.5 32.73 Favored Glycine 0 N--CA 1.424 -2.159 1 N-CA-C 100.031 -5.228 . . . . 0.0 100.031 175.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 m -63.3 -39.76 95.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.919 0.887 . . . . 0.0 112.156 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -62.33 -27.16 68.85 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -168.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -77.19 1.33 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 168.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.19 -37.29 79.79 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.855 0.862 . . . . 0.0 113.238 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -73.26 -46.79 47.97 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 m -54.86 -46.0 74.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.829 0.851 . . . . 0.0 111.383 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.13 -35.23 79.28 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 123.49 0.716 . . . . 0.0 111.637 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -69.98 -48.85 56.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 109.207 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -60.95 -45.59 94.12 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 121.822 -0.549 . . . . 0.0 110.865 -174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.572 ' HG3' ' HZ3' ' A' ' 30' ' ' LYS . 26.3 pt-20 -68.73 -13.84 62.64 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.572 ' HZ3' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -100.86 -0.1 37.53 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.66 26.42 13.28 Favored Glycine 0 CA--C 1.491 -1.442 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.012 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.78 138.53 14.43 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.7 p -84.46 -29.67 25.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.764 0.793 . . . . 0.0 109.589 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.45 158.53 29.55 Favored 'General case' 0 N--CA 1.421 -1.889 1 N-CA-C 98.726 -4.546 . . . . 0.0 98.726 -166.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.33 -177.43 47.85 Favored Glycine 0 N--CA 1.424 -2.104 1 N-CA-C 100.346 -5.102 . . . . 0.0 100.346 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -173.17 -176.73 1.42 Allowed 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 100.311 -3.959 . . . . 0.0 100.311 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.3 t -90.22 163.46 14.79 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.77 -175.04 37.93 Favored Glycine 0 CA--C 1.479 -2.168 1 N-CA-C 99.308 -5.517 . . . . 0.0 99.308 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -131.0 148.25 52.73 Favored 'General case' 0 N--CA 1.433 -1.289 1 N-CA-C 99.437 -4.282 . . . . 0.0 99.437 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -115.65 94.38 4.67 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.81 120.2 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.63 -22.83 7.66 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -121.83 -72.11 0.7 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.03 -159.54 32.64 Favored Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 105.706 -2.958 . . . . 0.0 105.706 -169.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mt -78.26 150.73 33.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.385 -2.821 . . . . 0.0 103.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.33 173.84 15.66 Favored 'General case' 0 CA--C 1.485 -1.554 1 N-CA-C 98.69 -4.559 . . . . 0.0 98.69 -174.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -116.14 164.6 14.23 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -106.34 146.56 30.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 m -141.92 147.44 37.07 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.7 138.8 47.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.43 68.98 0.77 Allowed 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.788 2.035 . . . . 0.0 112.326 169.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mt -99.57 148.86 35.3 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -66.64 167.97 17.82 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.591 2.194 . . . . 0.0 112.366 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -81.76 4.08 23.37 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -103.21 13.4 34.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.83 152.77 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 167.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.41 158.26 27.61 Favored Glycine 0 CA--C 1.48 -2.099 1 N-CA-C 98.304 -5.918 . . . . 0.0 98.304 -176.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.19 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 -151.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mm -68.26 131.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.62 136.87 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 1 N-CA-C 90.335 -7.654 . . . . 0.0 90.335 -174.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -164.2 166.22 21.3 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 98.771 -4.529 . . . . 0.0 98.771 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.42 27.71 42.58 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 104.879 -3.288 . . . . 0.0 104.879 -146.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -176.21 -169.93 0.34 Allowed 'General case' 0 N--CA 1.424 -1.769 1 N-CA-C 95.879 -5.6 . . . . 0.0 95.879 -168.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -156.05 -179.69 8.39 Favored 'General case' 0 N--CA 1.427 -1.619 1 N-CA-C 96.87 -5.233 . . . . 0.0 96.87 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.1 t -55.39 129.4 38.45 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 127.333 2.253 . . . . 0.0 111.779 -170.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -154.27 160.63 41.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 m -78.11 56.98 1.72 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.07 1.348 . . . . 0.0 112.996 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.001 0 CA-C-N 116.435 -0.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.185 0.517 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 179.12 7.05 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 169.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -133.09 140.51 47.7 Favored 'General case' 0 CA--C 1.49 -1.335 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -176.18 33.77 Favored Glycine 0 CA--C 1.482 -2.008 0 N-CA-C 106.547 -2.621 . . . . 0.0 106.547 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -77.36 130.7 37.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 161.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.254 15.5 tt -90.41 136.2 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.41 -168.39 2.09 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 129.149 2.98 . . . . 0.0 109.383 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -145.91 158.63 48.69 Favored Pre-proline 0 N--CA 1.423 -1.819 1 N-CA-C 95.85 -5.611 . . . . 0.0 95.85 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.18 146.59 90.73 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 123.065 2.13 . . . . 0.0 112.26 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.63 -53.22 4.9 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 126.621 1.968 . . . . 0.0 107.721 7.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -142.74 137.67 29.96 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 91.947 -7.057 . . . . 0.0 91.947 168.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.6 m -177.47 -162.76 0.07 Allowed 'General case' 0 CA--C 1.483 -1.628 1 N-CA-C 98.735 -4.543 . . . . 0.0 98.735 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.92 163.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 1 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 166.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -169.21 1.95 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 159.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -135.01 167.53 20.78 Favored 'General case' 0 CA--C 1.477 -1.86 1 N-CA-C 97.104 -5.147 . . . . 0.0 97.104 173.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -136.58 160.94 37.28 Favored 'General case' 0 N--CA 1.421 -1.92 1 N-CA-C 96.517 -5.364 . . . . 0.0 96.517 -165.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -112.73 116.54 47.76 Favored Pre-proline 0 N--CA 1.422 -1.858 1 N-CA-C 95.067 -5.901 . . . . 0.0 95.067 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -59.37 101.76 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.676 0 CA-C-N 125.004 2.823 . . . . 0.0 115.32 -161.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.15 -171.3 37.15 Favored Glycine 0 N--CA 1.42 -2.387 1 N-CA-C 98.308 -5.917 . . . . 0.0 98.308 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 -35.99 14.6 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.445 0.622 . . . . 0.0 110.499 -172.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -53.25 35.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.496 2.319 . . . . 0.0 116.034 -159.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.75 -42.38 31.73 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.5 -42.79 86.82 Favored 'General case' 0 CA--C 1.482 -1.644 0 O-C-N 122.148 -0.619 . . . . 0.0 110.988 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.36 -39.33 93.67 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.2 m -63.05 -47.21 83.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.818 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -40.07 95.78 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.783 0.801 . . . . 0.0 110.1 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.39 -42.81 82.94 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.26 1.024 . . . . 0.0 110.823 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.86 -47.79 84.77 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 122.878 0.471 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.95 -14.9 60.24 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -96.26 -6.84 37.03 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.733 -0.605 . . . . 0.0 111.061 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.44 27.25 12.03 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.51 151.87 19.09 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.726 -3.349 . . . . 0.0 104.726 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.0 p -84.85 -34.42 22.67 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -169.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.55 152.84 34.75 Favored 'General case' 0 N--CA 1.423 -1.8 1 N-CA-C 99.992 -4.077 . . . . 0.0 99.992 -161.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.89 42.18 Favored Glycine 0 CA--C 1.475 -2.444 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.489 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 26.1 p-80 -166.49 -158.74 0.33 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 101.49 -3.522 . . . . 0.0 101.49 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.98 161.18 21.35 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -178.86 41.91 Favored Glycine 0 N--CA 1.422 -2.246 1 N-CA-C 102.214 -4.354 . . . . 0.0 102.214 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -138.07 139.64 39.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 100.389 -3.93 . . . . 0.0 100.389 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -115.48 99.02 7.06 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.82 120.05 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.14 -32.22 3.16 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.782 -2.927 . . . . 0.0 105.782 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.21 -70.3 0.81 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.15 -159.81 32.69 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 104.973 -3.251 . . . . 0.0 104.973 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.53 140.64 58.89 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.453 2.301 . . . . 0.0 106.849 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.86 -179.77 6.13 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -171.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.4 m -113.24 168.2 9.93 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 101.451 -3.537 . . . . 0.0 101.451 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 13.2 t-105 -121.93 148.38 44.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.07 150.02 45.25 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.14 147.2 43.57 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 103.233 -2.876 . . . . 0.0 103.233 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.02 51.47 0.95 Allowed 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 126.953 2.101 . . . . 0.0 110.972 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.84 133.71 28.69 Favored Pre-proline 0 CA--C 1.499 -0.984 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.0 175.5 11.32 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.266 1.978 . . . . 0.0 110.444 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.08 4.63 16.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -95.86 3.62 53.5 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.182 -0.948 . . . . 0.0 108.813 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.58 178.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.58 164.13 31.96 Favored Glycine 0 CA--C 1.482 -1.974 1 N-CA-C 98.412 -5.875 . . . . 0.0 98.412 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 pt -155.62 -172.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -163.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.9 118.87 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 CA-C-O 122.077 0.942 . . . . 0.0 111.937 -160.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.76 155.18 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 166.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -147.87 153.63 39.37 Favored 'General case' 0 N--CA 1.426 -1.651 1 N-CA-C 96.686 -5.301 . . . . 0.0 96.686 171.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.41 -43.74 1.31 Allowed Glycine 0 CA--C 1.489 -1.551 1 N-CA-C 100.145 -5.182 . . . . 0.0 100.145 -161.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.81 -143.76 0.32 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 155.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -162.98 -141.69 0.06 Allowed 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 98.22 -4.733 . . . . 0.0 98.22 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.4 t -84.34 125.36 32.21 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -138.69 143.14 39.01 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 171.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 t -173.49 -179.98 1.98 Allowed 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 96.357 -5.423 . . . . 0.0 96.357 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.884 0 O-C-N 124.767 1.292 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.627 0.727 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -116.96 154.6 30.59 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -137.89 128.59 26.81 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 97.425 -5.028 . . . . 0.0 97.425 168.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -170.99 27.45 Favored Glycine 0 CA--C 1.476 -2.363 1 N-CA-C 102.306 -4.318 . . . . 0.0 102.306 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.57 135.46 39.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 160.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.51 141.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.44 -138.89 0.36 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.582 -2.099 . . . . 0.0 107.029 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -140.93 161.19 55.19 Favored Pre-proline 0 N--CA 1.423 -1.783 1 N-CA-C 95.526 -5.731 . . . . 0.0 95.526 169.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -67.31 144.5 68.41 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 122.765 2.023 . . . . 0.0 108.588 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.62 -42.36 8.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.455 2.302 . . . . 0.0 107.744 7.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.62 146.02 37.41 Favored 'General case' 0 N--CA 1.419 -1.986 1 N-CA-C 92.92 -6.696 . . . . 0.0 92.92 173.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -177.75 -163.98 0.08 Allowed 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 43' ' ' HIS . 3.5 m -128.65 164.11 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.729 1 N-CA-C 96.789 -5.263 . . . . 0.0 96.789 156.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -173.47 4.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 160.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -134.96 147.1 49.66 Favored 'General case' 0 CA--C 1.466 -2.256 1 N-CA-C 93.823 -6.362 . . . . 0.0 93.823 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -160.57 -165.82 1.5 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.081 -5.896 . . . . 0.0 95.081 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -141.22 173.18 5.11 Favored Pre-proline 0 N--CA 1.418 -2.04 1 N-CA-C 99.974 -4.084 . . . . 0.0 99.974 -161.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.52 55.51 3.7 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 C-N-CA 123.035 2.49 . . . . 0.0 110.754 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.69 141.11 4.57 Favored Glycine 0 N--CA 1.42 -2.375 1 N-CA-C 99.363 -5.495 . . . . 0.0 99.363 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 24.93 0.5 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.809 1.644 . . . . 0.0 112.667 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -59.16 -49.46 77.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.663 1.985 . . . . 0.0 112.492 -161.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.87 -25.83 26.12 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -82.85 -8.94 59.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.538 -0.977 . . . . 0.0 110.853 -167.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.46 -57.21 10.61 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.324 1.05 . . . . 0.0 108.98 166.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -52.1 67.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.465 1.106 . . . . 0.0 112.419 171.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.89 -43.25 93.52 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.801 0.81 . . . . 0.0 111.856 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.0 t -62.8 -43.13 99.6 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 108.957 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -78.59 -27.48 45.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.398 -0.814 . . . . 0.0 111.601 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.85 -20.13 53.61 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.182 -0.949 . . . . 0.0 111.334 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -88.06 -22.48 24.16 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.76 33.48 2.42 Favored Glycine 0 CA--C 1.488 -1.595 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 163.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.21 150.83 19.74 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -96.96 -17.92 19.78 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.671 0.748 . . . . 0.0 109.833 -165.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 m -160.75 168.27 25.14 Favored 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 98.979 -4.452 . . . . 0.0 98.979 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.37 176.66 44.57 Favored Glycine 0 N--CA 1.419 -2.452 1 N-CA-C 100.855 -4.898 . . . . 0.0 100.855 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -168.93 -168.77 0.89 Allowed 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 97.35 -5.056 . . . . 0.0 97.35 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -142.43 166.05 25.74 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.44 -176.61 44.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 103.135 -3.986 . . . . 0.0 103.135 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -130.95 121.96 26.05 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 99.539 -4.245 . . . . 0.0 99.539 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -139.33 59.81 1.59 Allowed 'General case' 0 CA--C 1.487 -1.444 1 N-CA-C 99.404 -4.295 . . . . 0.0 99.404 171.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 42' ' ' GLY 0.293 1.5 t 56.47 -152.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 127.512 2.325 . . . . 0.0 108.204 -165.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 119.82 -128.76 7.69 Favored Glycine 0 N--CA 1.425 -2.072 1 N-CA-C 100.065 -5.214 . . . . 0.0 100.065 -170.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.526 ' H ' HG12 ' A' ' 13' ' ' VAL . 35.5 m170 -118.55 -19.65 8.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 125.452 1.501 . . . . 0.0 107.307 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.86 -174.14 46.59 Favored Glycine 0 N--CA 1.426 -1.995 1 N-CA-C 97.625 -6.19 . . . . 0.0 97.625 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -69.16 132.71 46.97 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.06 -169.7 2.03 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -163.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.6 t -123.25 159.51 28.56 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -113.41 151.43 31.37 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.8 m -144.5 150.87 38.3 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -110.53 144.15 39.81 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.79 54.96 4.88 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.748 2.419 . . . . 0.0 112.682 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.18 144.62 38.84 Favored Pre-proline 0 CA--C 1.499 -0.991 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -64.9 162.82 30.62 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.576 2.184 . . . . 0.0 112.209 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.97 -28.03 63.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.103 1.761 . . . . 0.0 114.101 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -98.24 15.82 23.32 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.23 1.012 . . . . 0.0 110.652 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 138.83 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 151.53 18.21 Favored Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 104.31 -3.516 . . . . 0.0 104.31 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.82 -159.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mm -72.54 130.78 35.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.147 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.13 134.93 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 100.86 -3.756 . . . . 0.0 100.86 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 58.6 -129.72 1.31 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.904 1.281 . . . . 0.0 108.811 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -157.96 55.58 0.37 Allowed Glycine 0 CA--C 1.482 -2.017 1 N-CA-C 98.986 -5.646 . . . . 0.0 98.986 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -98.48 -103.92 0.2 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -166.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -155.37 170.31 22.2 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 -164.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 54.0 t -96.3 150.38 20.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -154.47 153.22 31.15 Favored 'General case' 0 CA--C 1.486 -1.511 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 168.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.3 m -152.47 163.38 39.66 Favored 'General case' 0 N--CA 1.421 -1.876 1 N-CA-C 95.662 -5.681 . . . . 0.0 95.662 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.923 0 O-C-N 124.402 1.064 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.59 165.38 11.86 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 171.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.15 137.91 53.62 Favored 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 94.305 -6.183 . . . . 0.0 94.305 153.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -176.7 34.23 Favored Glycine 0 CA--C 1.474 -2.496 1 N-CA-C 102.956 -4.058 . . . . 0.0 102.956 177.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -76.86 135.52 38.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 161.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -90.4 138.44 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -176.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.57 -135.91 0.34 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.425 -1.716 . . . . 0.0 106.931 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -136.34 159.08 72.11 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 96.156 -5.498 . . . . 0.0 96.156 169.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -69.14 148.57 69.37 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.011 1.807 . . . . 0.0 109.421 174.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -82.15 -29.19 31.74 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 127.42 2.288 . . . . 0.0 108.315 -3.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -155.57 165.34 36.88 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 178.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 157.62 -147.0 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.58 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.571 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.0 166.9 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 1 N-CA-C 98.352 -4.684 . . . . 0.0 98.352 161.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -170.9 2.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 165.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -136.24 149.54 48.57 Favored 'General case' 0 CA--C 1.479 -1.757 1 N-CA-C 98.53 -4.618 . . . . 0.0 98.53 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -125.59 162.65 24.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 101.922 -3.362 . . . . 0.0 101.922 -168.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -114.06 112.81 46.96 Favored Pre-proline 0 N--CA 1.421 -1.898 1 N-CA-C 98.765 -4.531 . . . . 0.0 98.765 168.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.53 118.53 5.46 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 CA-C-N 123.314 2.219 . . . . 0.0 111.47 -171.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.28 -45.73 0.57 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 99.874 -5.291 . . . . 0.0 99.874 -165.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m 115.17 -35.33 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 129.362 3.065 . . . . 0.0 107.003 168.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -40.15 -53.78 2.4 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.326 2.65 . . . . 0.0 116.459 -156.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.16 -36.7 56.05 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 121.369 -0.832 . . . . 0.0 111.607 -176.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -86.29 -26.13 25.11 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 120.963 -1.316 . . . . 0.0 109.072 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.65 -36.48 84.38 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.999 0.919 . . . . 0.0 108.83 170.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 m -66.23 -42.21 88.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.382 -0.824 . . . . 0.0 110.336 173.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.46 -38.97 92.89 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 121.002 -1.061 . . . . 0.0 110.869 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 t -54.28 -42.78 70.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.515 1.126 . . . . 0.0 111.009 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.71 -44.85 92.42 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 122.022 -0.424 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.22 -28.39 63.14 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.487 0.585 . . . . 0.0 111.91 -176.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.91 -19.04 49.04 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.853 -0.53 . . . . 0.0 110.435 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.47 35.46 2.86 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 164.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.22 138.45 13.91 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 167.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 p -98.05 3.14 49.36 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.851 -0.794 . . . . 0.0 110.036 -168.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -160.36 166.46 29.33 Favored 'General case' 0 CA--C 1.48 -1.716 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.98 175.75 46.48 Favored Glycine 0 CA--C 1.469 -2.831 1 N-CA-C 99.73 -5.348 . . . . 0.0 99.73 -177.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -168.91 -153.78 0.12 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 96.269 -5.456 . . . . 0.0 96.269 -172.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -149.98 166.15 30.51 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.57 -4.974 . . . . 0.0 97.57 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.2 171.41 41.92 Favored Glycine 0 CA--C 1.48 -2.126 1 N-CA-C 96.154 -6.778 . . . . 0.0 96.154 176.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -146.5 137.32 24.12 Favored 'General case' 0 CA--C 1.483 -1.607 1 N-CA-C 99.251 -4.352 . . . . 0.0 99.251 -175.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -158.57 56.18 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.32 1.4 t 55.62 -144.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 125.859 1.664 . . . . 0.0 108.215 -158.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.41 -131.04 5.36 Favored Glycine 0 CA--C 1.474 -2.492 1 N-CA-C 94.86 -7.296 . . . . 0.0 94.86 -169.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -123.34 10.82 9.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.98 -49.18 0.29 Allowed Glycine 0 CA--C 1.486 -1.737 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -171.33 -176.52 1.89 Allowed 'General case' 0 N--CA 1.437 -1.096 1 N-CA-C 95.848 -5.612 . . . . 0.0 95.848 -175.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.92 174.98 4.59 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 99.089 -4.412 . . . . 0.0 99.089 174.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 29.6 m -123.31 -174.16 2.89 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 171.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -132.01 152.62 51.04 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.7 m -145.13 155.11 43.11 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -119.27 140.77 49.72 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 172.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.19 55.77 1.07 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 127.356 2.262 . . . . 0.0 111.38 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.35 130.99 37.68 Favored Pre-proline 0 CA--C 1.496 -1.123 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -70.69 176.2 7.81 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.339 2.026 . . . . 0.0 111.069 177.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -84.68 19.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -99.53 -6.16 27.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.06 173.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 -174.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.58 156.86 27.15 Favored Glycine 0 CA--C 1.48 -2.141 1 N-CA-C 97.914 -6.075 . . . . 0.0 97.914 -175.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 pt -150.76 -167.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 101.926 -3.361 . . . . 0.0 101.926 -166.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mm -70.03 133.97 30.92 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -171.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.92 126.4 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 162.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -96.47 -44.12 7.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 118.646 0.657 . . . . 0.0 111.515 -168.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 62.32 4.37 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -170.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -162.23 -66.28 0.05 Allowed 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 -176.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.8 tptt 127.92 -139.79 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 96.545 -5.354 . . . . 0.0 96.545 -170.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.75 148.18 24.67 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.67 130.05 39.61 Favored 'General case' 0 CA--C 1.483 -1.601 1 N-CA-C 92.975 -6.676 . . . . 0.0 92.975 168.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 p -88.12 -67.21 0.84 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 1.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.139 0.495 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.88 171.39 7.93 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 172.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -135.82 133.72 38.15 Favored 'General case' 0 CA--C 1.489 -1.379 1 N-CA-C 96.421 -5.399 . . . . 0.0 96.421 168.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.8 -177.26 34.71 Favored Glycine 0 CA--C 1.478 -2.277 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 36.2 m-85 -73.91 133.75 43.14 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.19 136.89 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.81 -146.14 0.3 Allowed 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 126.718 2.007 . . . . 0.0 107.295 178.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -133.86 147.14 63.02 Favored Pre-proline 0 N--CA 1.423 -1.8 1 N-CA-C 94.408 -6.145 . . . . 0.0 94.408 164.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.54 145.1 63.27 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 CA-C-N 123.21 2.182 . . . . 0.0 108.089 177.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.57 -44.43 15.87 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 120.902 1.683 . . . . 0.0 111.79 7.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -152.92 149.59 28.39 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 94.489 -6.115 . . . . 0.0 94.489 177.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.32 -158.9 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.437 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 -179.006 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.76 161.1 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 1 N-CA-C 98.739 -4.541 . . . . 0.0 98.739 161.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -162.36 0.6 Allowed 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 162.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -137.87 166.49 23.9 Favored 'General case' 0 N--CA 1.426 -1.669 1 N-CA-C 96.89 -5.226 . . . . 0.0 96.89 162.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.4 t -119.95 169.82 9.83 Favored 'General case' 0 N--CA 1.419 -1.978 1 N-CA-C 99.041 -4.429 . . . . 0.0 99.041 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.24 131.0 24.02 Favored Pre-proline 0 N--CA 1.421 -1.911 1 N-CA-C 98.03 -4.804 . . . . 0.0 98.03 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -69.08 37.62 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 123.145 2.563 . . . . 0.0 114.715 174.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.86 142.8 9.45 Favored Glycine 0 N--CA 1.426 -2.007 1 N-CA-C 96.084 -6.806 . . . . 0.0 96.084 177.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.1 -41.69 98.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.928 1.291 . . . . 0.0 113.962 -157.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -53.38 9.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 128.407 2.683 . . . . 0.0 115.592 -163.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -50.78 32.21 Favored Glycine 0 C--N 1.349 1.288 0 O-C-N 121.945 -0.472 . . . . 0.0 112.14 -166.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.12 -18.91 55.05 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -58.34 -53.72 55.16 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -39.31 93.99 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.32 -37.95 86.55 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.922 0.783 . . . . 0.0 111.261 -179.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -65.9 -45.78 80.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.614 -0.679 . . . . 0.0 109.98 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -65.15 -41.32 94.85 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.957 -0.464 . . . . 0.0 111.916 -178.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.9 -17.35 63.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.166 -0.959 . . . . 0.0 112.188 -175.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -95.72 -6.29 40.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.66 0.784 . . . . 0.0 110.046 176.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.89 32.7 17.3 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.0 151.15 17.96 Favored Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 104.066 -3.614 . . . . 0.0 104.066 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.7 p -73.45 -55.07 6.83 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.029 0.919 . . . . 0.0 109.999 -168.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -160.63 -177.03 5.91 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 98.184 -4.746 . . . . 0.0 98.184 166.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.56 176.44 44.1 Favored Glycine 0 N--CA 1.416 -2.684 1 N-CA-C 99.838 -5.305 . . . . 0.0 99.838 -171.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -146.31 178.49 8.2 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 100.466 -3.902 . . . . 0.0 100.466 -172.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.6 m -83.79 171.76 12.84 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 119.14 0.882 . . . . 0.0 109.771 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.12 -179.07 45.45 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 103.13 -3.988 . . . . 0.0 103.13 -172.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -147.72 152.71 38.23 Favored 'General case' 0 N--CA 1.427 -1.598 1 N-CA-C 97.298 -5.075 . . . . 0.0 97.298 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -136.84 106.07 6.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 172.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.43 122.29 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.72 -40.69 1.43 Allowed Glycine 0 CA--C 1.482 -2.005 1 N-CA-C 102.62 -4.192 . . . . 0.0 102.62 -166.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -123.76 -67.6 0.92 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.95 -157.51 30.02 Favored Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 -169.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -70.71 139.03 51.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.3 -173.46 3.34 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -167.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -129.4 177.3 7.29 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.815 -3.772 . . . . 0.0 100.815 169.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 30.1 t-105 -122.3 160.48 25.23 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.5 m -148.65 151.77 35.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 167.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.97 129.92 56.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.31 66.89 0.1 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 127.64 2.376 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.5 mt -103.11 137.96 19.41 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.12 170.86 18.81 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.745 2.296 . . . . 0.0 110.402 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.75 -5.68 42.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 124.164 0.986 . . . . 0.0 113.583 -168.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -88.91 3.7 50.49 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.288 -0.883 . . . . 0.0 109.551 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.05 136.05 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.33 154.94 18.54 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.347 -2.301 . . . . 0.0 107.347 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.89 -171.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 -172.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.86 141.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 123.395 0.678 . . . . 0.0 109.581 -169.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.45 155.11 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 1 N-CA-C 98.089 -4.782 . . . . 0.0 98.089 178.69 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -144.14 152.92 41.56 Favored 'General case' 0 N--CA 1.426 -1.663 1 N-CA-C 95.3 -5.815 . . . . 0.0 95.3 166.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.96 -42.0 1.6 Allowed Glycine 0 CA--C 1.489 -1.586 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -163.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -99.36 -136.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 153.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -163.66 -165.2 1.0 Allowed 'General case' 0 N--CA 1.427 -1.61 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.74 125.17 22.6 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -143.72 154.22 43.25 Favored 'General case' 0 CA--C 1.475 -1.928 1 N-CA-C 97.19 -5.115 . . . . 0.0 97.19 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m 179.78 174.53 0.84 Allowed 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 96.132 -5.507 . . . . 0.0 96.132 179.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.903 0 CA-C-N 119.341 0.973 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.254 0.55 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 178.8 4.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 167.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -128.74 148.02 50.81 Favored 'General case' 0 N--CA 1.431 -1.397 1 N-CA-C 95.245 -5.835 . . . . 0.0 95.245 166.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.31 170.59 37.13 Favored Glycine 0 CA--C 1.48 -2.133 0 C-N-CA 117.845 -2.121 . . . . 0.0 109.017 -175.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -82.11 121.82 27.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 159.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 tt -90.5 143.27 11.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.089 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -174.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.59 -154.52 0.55 Allowed 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 128.995 2.918 . . . . 0.0 108.858 -175.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.32 165.58 30.72 Favored Pre-proline 0 N--CA 1.425 -1.708 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 170.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' O ' ' HE1' ' A' ' 66' ' ' HIS . 44.0 Cg_exo -62.19 126.49 18.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.748 2.965 . . . . 0.0 112.871 -173.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -133.77 138.07 45.52 Favored 'General case' 0 CA--C 1.467 -2.24 1 N-CA-C 96.33 -5.433 . . . . 0.0 96.33 -10.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 48.6 t30 68.36 30.25 5.54 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 119.351 0.978 . . . . 0.0 111.626 175.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.23 -159.9 0.76 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 168.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.95 162.84 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 1 N-CA-C 96.55 -5.352 . . . . 0.0 96.55 170.563 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -168.02 2.09 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 162.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -138.08 146.09 42.51 Favored 'General case' 0 CA--C 1.469 -2.161 1 N-CA-C 96.214 -5.476 . . . . 0.0 96.214 168.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.55 175.2 6.84 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -112.29 130.49 23.28 Favored Pre-proline 0 N--CA 1.421 -1.882 1 N-CA-C 93.976 -6.305 . . . . 0.0 93.976 165.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.92 37.98 0.11 Allowed 'Trans proline' 0 C--N 1.331 -0.369 0 CA-C-N 125.679 3.064 . . . . 0.0 116.024 177.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.55 108.97 0.49 Allowed Glycine 0 N--CA 1.422 -2.243 1 N-CA-C 94.734 -7.346 . . . . 0.0 94.734 170.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -52.42 -36.8 55.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.313 2.245 . . . . 0.0 115.042 -157.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -44.79 -39.35 5.18 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.854 2.462 . . . . 0.0 116.659 -170.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.41 -46.13 87.31 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 120.776 -1.202 . . . . 0.0 112.05 -177.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.65 -25.09 28.75 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 122.18 -0.6 . . . . 0.0 109.621 -175.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.82 -39.25 91.12 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.096 0.558 . . . . 0.0 109.971 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -63.81 -41.97 97.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.464 175.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.0 mt -63.94 -40.44 96.43 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 121.953 0.883 . . . . 0.0 110.667 177.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.6 t -57.86 -47.38 82.88 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.208 1.403 . . . . 0.0 110.575 175.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.04 -42.41 80.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 122.681 0.393 . . . . 0.0 111.024 -176.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.02 -23.6 60.63 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.727 -0.608 . . . . 0.0 111.928 -175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.95 -49.21 11.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.92 48.81 0.16 Allowed Glycine 0 CA--C 1.49 -1.518 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 168.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.13 143.55 15.79 Favored Glycine 0 CA--C 1.487 -1.673 1 N-CA-C 101.35 -4.7 . . . . 0.0 101.35 157.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 p -75.12 -28.6 60.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 118.385 1.092 . . . . 0.0 110.77 -164.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.9 m -160.56 173.42 15.55 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.92 -176.96 42.75 Favored Glycine 0 N--CA 1.418 -2.542 1 N-CA-C 98.786 -5.726 . . . . 0.0 98.786 -172.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -171.16 -174.71 1.54 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 -170.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.4 m -81.03 169.71 17.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 119.153 0.888 . . . . 0.0 109.134 -178.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.88 164.51 34.25 Favored Glycine 0 N--CA 1.416 -2.693 1 N-CA-C 98.465 -5.854 . . . . 0.0 98.465 175.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -135.8 154.77 51.1 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 97.21 -5.108 . . . . 0.0 97.21 177.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.92 179.21 9.29 Favored 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 97.503 -4.999 . . . . 0.0 97.503 174.935 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.63 163.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 1 N-CA-C 97.968 -4.827 . . . . 0.0 97.968 178.173 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.39 -46.85 1.1 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 102.564 -4.214 . . . . 0.0 102.564 -170.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 35.1 m170 -119.46 -79.65 0.6 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 170.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.22 -147.26 12.82 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 103.28 -3.928 . . . . 0.0 103.28 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.59 132.91 54.64 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.51 2.324 . . . . 0.0 108.066 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.11 -173.34 3.7 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 102.201 -3.259 . . . . 0.0 102.201 -164.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.31 172.05 9.41 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 169.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -129.31 147.9 51.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.7 m -143.28 146.97 34.06 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -114.69 145.46 42.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.5 55.44 0.5 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 126.578 1.951 . . . . 0.0 111.064 172.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.05 138.69 20.35 Favored Pre-proline 0 CA--C 1.501 -0.908 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -66.42 165.95 23.23 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.45 2.1 . . . . 0.0 111.773 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -73.86 -19.1 60.83 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.328 0.651 . . . . 0.0 112.27 -169.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -92.29 18.55 8.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 109.73 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.05 133.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 100.533 -3.877 . . . . 0.0 100.533 167.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.92 146.57 18.64 Favored Glycine 0 CA--C 1.479 -2.172 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.69 -141.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -156.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.8 120.62 28.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 169.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.9 -33.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -163.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 35.0 tt0 -155.43 -136.98 0.06 Allowed 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 96.542 -5.355 . . . . 0.0 96.542 176.178 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . -168.55 52.08 0.22 Allowed Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 103.535 -3.826 . . . . 0.0 103.535 171.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.73 -57.51 2.02 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -172.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -158.14 157.04 31.98 Favored 'General case' 0 N--CA 1.423 -1.788 1 N-CA-C 97.195 -5.113 . . . . 0.0 97.195 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.8 t -86.7 149.83 24.61 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.422 ' HE1' ' O ' ' A' ' 9' ' ' PRO 0.334 75.0 m-70 85.09 -163.31 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.517 0 C-N-CA 130.01 3.324 . . . . 0.0 106.273 -173.351 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -84.31 67.04 9.67 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 119.158 0.89 . . . . 0.0 108.959 -170.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.093 0 CA-C-N 115.949 -0.569 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.115 0.483 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.29 167.7 12.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 171.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -130.46 140.03 50.55 Favored 'General case' 0 CA--C 1.485 -1.545 1 N-CA-C 94.703 -6.036 . . . . 0.0 94.703 165.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.45 29.27 Favored Glycine 0 CA--C 1.472 -2.608 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 178.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 39' ' ' PHE . 25.5 m-85 -82.58 138.72 34.15 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 101.453 -3.536 . . . . 0.0 101.453 157.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -89.99 132.82 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -177.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.26 -148.86 0.43 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 111.949 -2.387 . . . . 0.0 107.09 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.94 148.46 65.06 Favored Pre-proline 0 N--CA 1.424 -1.773 1 N-CA-C 95.509 -5.738 . . . . 0.0 95.509 174.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.64 149.86 39.18 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.787 2.031 . . . . 0.0 107.847 -177.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.492 ' HB2' ' HD1' ' A' ' 66' ' ' HIS . 40.9 mt-10 -108.82 -5.33 16.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.468 2.307 . . . . 0.0 109.263 13.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -162.38 146.55 12.0 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 94.417 -6.142 . . . . 0.0 94.417 163.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.08 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 177.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.15 170.42 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 97.164 -5.124 . . . . 0.0 97.164 163.048 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.85 -168.16 1.59 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -125.72 163.64 22.39 Favored 'General case' 0 CA--C 1.474 -1.96 1 N-CA-C 99.603 -4.221 . . . . 0.0 99.603 171.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.28 152.71 47.47 Favored 'General case' 0 N--CA 1.417 -2.076 1 N-CA-C 96.158 -5.497 . . . . 0.0 96.158 -166.07 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.52 115.76 39.47 Favored Pre-proline 0 N--CA 1.419 -1.996 1 N-CA-C 97.36 -5.052 . . . . 0.0 97.36 171.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.3 107.49 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 123.347 2.231 . . . . 0.0 112.043 -176.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.81 -41.26 0.83 Allowed Glycine 0 CA--C 1.491 -1.455 1 N-CA-C 101.472 -4.651 . . . . 0.0 101.472 -161.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m 84.76 3.81 0.68 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 125.351 1.46 . . . . 0.0 113.222 157.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.75 -40.82 80.6 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.417 1.887 . . . . 0.0 110.752 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.91 -41.29 93.47 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.906 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.5 m -68.89 -42.94 76.26 Favored 'General case' 0 CA--C 1.484 -1.559 0 CA-C-N 117.959 0.879 . . . . 0.0 110.164 -175.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.98 -49.69 74.97 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.905 0.882 . . . . 0.0 109.255 176.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -57.5 -50.11 74.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 111.443 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.7 -43.78 98.19 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.035 0.921 . . . . 0.0 110.152 -178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.1 -43.05 95.86 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.284 0.634 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.86 -39.74 83.72 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.802 -0.561 . . . . 0.0 111.477 -178.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.71 -21.21 52.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.613 -0.679 . . . . 0.0 111.702 -175.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -89.51 -28.78 19.4 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.592 -0.693 . . . . 0.0 109.691 175.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.21 44.62 0.85 Allowed Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 164.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.73 141.23 16.32 Favored Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 p -99.62 7.42 45.24 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 123.488 0.715 . . . . 0.0 110.034 -167.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.3 m -160.18 150.89 18.77 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 100.28 -3.97 . . . . 0.0 100.28 166.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.94 162.67 36.45 Favored Glycine 0 CA--C 1.463 -3.205 1 N-CA-C 99.537 -5.425 . . . . 0.0 99.537 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -162.34 -157.68 0.48 Allowed 'General case' 0 N--CA 1.428 -1.529 1 N-CA-C 99.714 -4.18 . . . . 0.0 99.714 -168.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.4 t -155.6 167.04 31.68 Favored 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 95.954 -5.573 . . . . 0.0 95.954 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.82 73.95 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.568 1 N-CA-C 100.27 -5.132 . . . . 0.0 100.27 -176.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.6 t80 -157.84 157.39 33.18 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 176.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -148.39 166.76 27.13 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 94.16 -6.237 . . . . 0.0 94.16 159.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 42' ' ' GLY 0.332 50.1 t 84.19 -167.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -172.132 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' H ' ' CG1' ' A' ' 41' ' ' VAL . . . 89.67 -93.24 1.86 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 107.174 -2.371 . . . . 0.0 107.174 -177.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -137.96 -52.47 0.62 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 100.589 -3.856 . . . . 0.0 100.589 178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.8 61.95 0.22 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 172.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.461 0.0 OUTLIER 76.36 167.82 0.26 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 109.164 -175.717 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.55 -179.65 8.37 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -175.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.78 160.97 15.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 176.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 t-105 -107.79 150.52 26.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -147.55 150.92 35.42 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.38 143.15 48.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.21 54.13 0.43 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 126.544 1.938 . . . . 0.0 110.602 168.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.6 mt -95.7 135.34 23.07 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 175.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.99 171.8 16.79 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.432 2.088 . . . . 0.0 110.434 177.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -67.61 -17.17 64.52 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -79.37 -6.78 57.56 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.818 -0.551 . . . . 0.0 110.448 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.61 127.3 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.71 157.09 17.54 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 105.16 -3.176 . . . . 0.0 105.16 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -136.75 -158.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 105.925 -1.879 . . . . 0.0 105.925 -163.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -74.76 123.09 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.86 -47.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -173.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -159.94 158.83 31.46 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 98.666 -4.568 . . . . 0.0 98.666 -176.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.27 55.54 4.93 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 174.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -92.49 -68.65 0.79 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -172.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -171.53 -164.72 0.34 Allowed 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.188 -4.745 . . . . 0.0 98.188 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 38.3 t -115.82 157.43 24.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -178.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.492 ' HD1' ' HB2' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -154.17 138.56 16.72 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 166.09 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 m -83.07 120.41 25.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -169.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.007 0 O-C-N 123.242 0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.395 0.617 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 173.08 6.95 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.33 137.92 39.42 Favored 'General case' 0 N--CA 1.431 -1.405 1 N-CA-C 95.412 -5.773 . . . . 0.0 95.412 170.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.94 -177.58 35.12 Favored Glycine 0 CA--C 1.471 -2.662 1 N-CA-C 103.06 -4.016 . . . . 0.0 103.06 176.042 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -77.44 134.39 38.39 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 159.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.48 138.28 19.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.14 -157.18 0.56 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 129.045 2.938 . . . . 0.0 110.557 178.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -148.65 165.74 17.21 Favored Pre-proline 0 N--CA 1.426 -1.664 1 N-CA-C 97.116 -5.142 . . . . 0.0 97.116 176.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -68.96 149.9 72.46 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.688 2.259 . . . . 0.0 109.974 176.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -82.21 -47.37 12.55 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 127.48 2.312 . . . . 0.0 107.231 -1.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -150.26 140.38 22.1 Favored 'General case' 0 N--CA 1.42 -1.972 1 N-CA-C 92.332 -6.914 . . . . 0.0 92.332 173.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.8 m 179.9 -161.05 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 97.336 -5.061 . . . . 0.0 97.336 -174.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.77 163.55 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 100.365 -3.939 . . . . 0.0 100.365 167.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.6 -165.63 1.01 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 158.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -138.34 168.52 19.57 Favored 'General case' 0 N--CA 1.415 -2.179 1 N-CA-C 96.399 -5.408 . . . . 0.0 96.399 167.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -129.55 -176.41 3.89 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 96.68 -5.304 . . . . 0.0 96.68 -176.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.77 131.17 23.67 Favored Pre-proline 0 N--CA 1.42 -1.95 1 N-CA-C 95.385 -5.783 . . . . 0.0 95.385 174.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.79 40.71 0.17 Allowed 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.298 3.332 . . . . 0.0 116.401 -174.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.13 92.9 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 93.609 -7.796 . . . . 0.0 93.609 174.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -78.79 30.86 0.2 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -148.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -70.18 -35.98 74.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 110.32 -170.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.19 -33.44 69.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -81.69 -11.83 58.9 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.189 -0.595 . . . . 0.0 109.969 -177.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.01 -50.08 75.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -50.58 73.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.867 0.867 . . . . 0.0 112.466 170.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.63 -41.52 99.06 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 121.593 0.711 . . . . 0.0 112.135 -173.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 t -65.12 -45.83 83.51 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -67.86 -37.17 81.48 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.669 -0.644 . . . . 0.0 112.358 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.16 -7.86 53.27 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.054 -1.029 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -106.22 1.61 26.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.98 29.67 37.39 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 140.83 15.27 Favored Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -92.94 -54.73 3.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -164.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 m -106.46 147.63 29.11 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 102.895 -3.002 . . . . 0.0 102.895 174.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.64 154.76 25.81 Favored Glycine 0 CA--C 1.469 -2.785 1 N-CA-C 100.468 -5.053 . . . . 0.0 100.468 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -171.97 179.02 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 98.016 -4.809 . . . . 0.0 98.016 -175.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.7 m -78.05 173.93 11.67 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 119.796 1.18 . . . . 0.0 111.044 -177.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.92 164.17 37.75 Favored Glycine 0 N--CA 1.418 -2.528 1 N-CA-C 98.688 -5.765 . . . . 0.0 98.688 175.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -126.72 131.57 51.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -115.76 105.49 12.78 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.72 140.23 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -172.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.09 -36.14 4.6 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -104.17 -66.39 0.96 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -177.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.33 -150.31 22.23 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 104.963 -3.255 . . . . 0.0 104.963 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.43 136.48 54.75 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.84 -162.48 1.1 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 101.998 -3.334 . . . . 0.0 101.998 -176.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.8 171.55 11.64 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 158.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -129.7 148.76 51.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.2 m -142.36 146.67 35.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -116.64 140.63 49.18 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 170.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 63.98 0.31 Allowed 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 126.342 1.857 . . . . 0.0 109.893 176.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 mt -103.09 133.88 20.09 Favored Pre-proline 0 CA--C 1.503 -0.833 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 169.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -72.52 174.64 11.31 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.624 2.216 . . . . 0.0 111.248 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -76.03 -2.08 28.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -165.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -90.49 -5.89 55.49 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.266 -0.896 . . . . 0.0 110.065 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.03 138.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -174.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.72 149.92 17.8 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 pt -146.78 -175.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -168.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.42 127.75 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 121.723 0.773 . . . . 0.0 111.74 -159.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.07 159.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 100.833 -3.766 . . . . 0.0 100.833 168.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -143.93 158.61 43.59 Favored 'General case' 0 N--CA 1.426 -1.653 1 N-CA-C 96.208 -5.479 . . . . 0.0 96.208 164.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.03 -33.47 3.86 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -167.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -93.8 -101.74 0.14 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 172.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 tptm 175.16 -167.86 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.527 1 N-CA-C 97.677 -4.934 . . . . 0.0 97.677 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -94.97 134.66 37.4 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 168.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -157.47 150.61 23.53 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 102.129 -3.286 . . . . 0.0 102.129 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -153.97 162.07 41.49 Favored 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 96.155 -5.498 . . . . 0.0 96.155 -177.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.437 1.086 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.33 163.27 13.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -130.76 127.93 39.74 Favored 'General case' 0 CA--C 1.491 -1.301 1 N-CA-C 95.564 -5.717 . . . . 0.0 95.564 158.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.05 -169.83 25.95 Favored Glycine 0 CA--C 1.478 -2.261 1 N-CA-C 102.808 -4.117 . . . . 0.0 102.808 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.55 142.33 34.23 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 163.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.92 141.64 14.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.971 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.77 -153.25 0.53 Allowed 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 128.029 2.531 . . . . 0.0 106.701 -175.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -128.84 147.46 64.65 Favored Pre-proline 0 N--CA 1.419 -1.992 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 173.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.98 146.8 59.89 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.614 1.969 . . . . 0.0 107.31 175.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -80.93 -41.67 22.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.403 2.281 . . . . 0.0 109.845 11.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -154.02 151.87 29.85 Favored 'General case' 0 N--CA 1.417 -2.095 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 -176.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.7 m 173.97 -154.01 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 97.091 -5.151 . . . . 0.0 97.091 169.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.15 170.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 1 N-CA-C 97.412 -5.032 . . . . 0.0 97.412 161.536 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -161.77 0.72 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 164.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -142.35 163.54 32.58 Favored 'General case' 0 N--CA 1.417 -2.101 1 N-CA-C 94.463 -6.125 . . . . 0.0 94.463 165.355 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -160.64 -156.89 0.5 Allowed 'General case' 0 N--CA 1.414 -2.257 1 N-CA-C 94.656 -6.053 . . . . 0.0 94.656 -174.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -145.61 169.71 9.28 Favored Pre-proline 0 N--CA 1.414 -2.25 1 N-CA-C 97.837 -4.875 . . . . 0.0 97.837 -167.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -77.33 68.4 7.49 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 CA-C-N 124.14 2.514 . . . . 0.0 111.873 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.82 165.94 34.59 Favored Glycine 0 CA--C 1.479 -2.166 1 N-CA-C 99.778 -5.329 . . . . 0.0 99.778 171.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -83.25 11.17 6.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 118.085 0.942 . . . . 0.0 111.32 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.91 -57.02 8.32 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 128.56 2.744 . . . . 0.0 114.485 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.51 -29.66 18.38 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -85.03 -5.06 59.36 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.779 -0.836 . . . . 0.0 110.873 -165.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.96 -53.04 62.89 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -52.63 64.65 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.486 1.115 . . . . 0.0 112.423 171.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.88 -41.08 97.83 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 118.603 0.638 . . . . 0.0 110.998 -173.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -65.47 -42.3 92.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 121.231 -0.918 . . . . 0.0 108.78 -177.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -69.61 -40.28 76.71 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.896 -0.502 . . . . 0.0 111.136 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -72.65 -30.13 64.03 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 118.535 0.607 . . . . 0.0 112.324 -178.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.69 -24.56 36.13 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.216 0.462 . . . . 0.0 109.89 176.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.61 37.92 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 159.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.89 136.86 13.87 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 104.773 -3.331 . . . . 0.0 104.773 173.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -106.34 9.64 31.84 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.74 0.781 . . . . 0.0 108.978 -165.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.6 m -160.21 157.83 28.96 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 98.886 -4.487 . . . . 0.0 98.886 163.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 170.98 44.04 Favored Glycine 0 N--CA 1.421 -2.339 1 N-CA-C 100.799 -4.92 . . . . 0.0 100.799 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -168.12 -174.44 2.33 Favored 'General case' 0 N--CA 1.432 -1.334 1 N-CA-C 97.303 -5.073 . . . . 0.0 97.303 -179.377 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.45 159.89 33.99 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.75 -179.22 48.49 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 100.721 -4.951 . . . . 0.0 100.721 -173.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -102.9 146.97 27.51 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -171.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -119.17 113.27 20.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 101.458 -3.534 . . . . 0.0 101.458 171.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.03 132.3 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -173.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.83 15.65 33.27 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -171.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -152.4 -79.48 0.11 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.66 -168.88 39.78 Favored Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 -165.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.96 142.15 42.04 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.87 -164.08 1.43 Allowed 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -166.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.6 t -127.62 165.93 19.03 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.2 -4.0 . . . . 0.0 100.2 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -123.33 148.04 46.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 178.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.51 152.3 40.38 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 175.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -115.99 140.84 48.86 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 172.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.1 42.29 0.14 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.145 2.178 . . . . 0.0 111.197 166.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 mt -85.11 134.76 40.38 Favored Pre-proline 0 CA--C 1.5 -0.97 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.32 172.92 15.36 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.127 1.885 . . . . 0.0 110.135 -178.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.66 -9.38 58.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -167.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -91.24 5.3 49.69 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -178.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -103.81 147.79 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 176.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.01 143.83 18.21 Favored Glycine 0 CA--C 1.478 -2.274 1 N-CA-C 101.111 -4.796 . . . . 0.0 101.111 175.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 -149.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -167.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.4 119.78 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 174.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -91.51 -48.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -162.43 164.31 27.22 Favored 'General case' 0 CA--C 1.486 -1.517 1 N-CA-C 100.146 -4.02 . . . . 0.0 100.146 174.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.15 68.29 3.55 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 172.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -113.93 -61.8 1.69 Allowed 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -172.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -157.84 -155.03 0.47 Allowed 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -172.023 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.31 133.91 25.02 Favored 'General case' 0 N--CA 1.417 -2.083 1 N-CA-C 93.604 -6.443 . . . . 0.0 93.604 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 54.76 29.88 12.57 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 127.762 2.425 . . . . 0.0 114.535 -169.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -172.87 167.93 5.07 Favored 'General case' 0 N--CA 1.428 -1.548 1 N-CA-C 96.766 -5.272 . . . . 0.0 96.766 172.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.968 0 O-C-N 124.27 0.981 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.122 0.487 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -112.59 167.92 10.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 164.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.85 123.79 33.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 94.856 -5.979 . . . . 0.0 94.856 159.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.69 -169.75 25.44 Favored Glycine 0 CA--C 1.485 -1.791 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -172.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HH ' ' C ' ' A' ' 38' ' ' GLY . 2.8 m-85 -94.01 138.8 31.7 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 164.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 tt -90.93 144.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB1' HD13 ' A' ' 59' ' ' ILE . . . -105.71 -138.16 0.36 Allowed 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 127.874 2.47 . . . . 0.0 107.115 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -139.62 154.04 70.88 Favored Pre-proline 0 N--CA 1.426 -1.647 1 N-CA-C 95.597 -5.705 . . . . 0.0 95.597 166.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.87 155.4 53.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 122.836 2.049 . . . . 0.0 109.016 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -83.71 -27.63 28.84 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 126.764 2.025 . . . . 0.0 107.824 -1.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -158.61 152.91 24.08 Favored 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 95.123 -5.881 . . . . 0.0 95.123 175.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m 170.27 -153.55 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.662 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.32 170.4 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 1 N-CA-C 96.715 -5.291 . . . . 0.0 96.715 166.67 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -156.95 0.34 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 161.453 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -138.4 143.07 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 167.02 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 t -160.1 -174.44 4.55 Favored 'General case' 0 N--CA 1.419 -2.011 1 N-CA-C 96.878 -5.23 . . . . 0.0 96.878 178.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.17 173.52 5.53 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 -159.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.79 61.74 2.31 Favored 'Trans proline' 0 C--N 1.328 -0.552 0 C-N-CA 123.117 2.545 . . . . 0.0 110.108 161.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.86 138.56 2.7 Favored Glycine 0 N--CA 1.428 -1.843 1 N-CA-C 100.024 -5.231 . . . . 0.0 100.024 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -85.9 -11.48 53.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 123.918 0.887 . . . . 0.0 112.976 -165.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -39.29 -53.42 1.94 Allowed 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 127.963 2.505 . . . . 0.0 117.632 -153.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.94 -40.94 7.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -174.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -82.09 -14.81 55.24 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.586 -0.949 . . . . 0.0 110.306 -169.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.66 -45.11 93.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.792 0.837 . . . . 0.0 109.253 169.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -46.82 86.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.299 1.039 . . . . 0.0 111.513 172.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.32 -39.29 89.18 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-O 121.801 0.81 . . . . 0.0 111.435 -176.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.91 -44.57 67.06 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.116 1.766 . . . . 0.0 110.776 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.8 -54.26 47.37 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 123.196 0.598 . . . . 0.0 110.961 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.95 -20.42 62.45 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -88.74 -7.68 55.83 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.581 0.628 . . . . 0.0 110.413 172.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.99 5.2 Favored Glycine 0 CA--C 1.486 -1.758 0 CA-C-O 119.192 -0.782 . . . . 0.0 111.81 160.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.72 20.33 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 p -86.94 -84.2 0.18 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.5 m -81.54 161.26 23.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.27 168.35 35.83 Favored Glycine 0 N--CA 1.42 -2.416 1 N-CA-C 99.172 -5.571 . . . . 0.0 99.172 -177.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -165.03 -179.8 5.94 Favored 'General case' 0 N--CA 1.433 -1.318 1 N-CA-C 97.758 -4.904 . . . . 0.0 97.758 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.6 m -143.92 161.22 39.27 Favored 'General case' 0 CA--C 1.487 -1.45 1 N-CA-C 98.376 -4.676 . . . . 0.0 98.376 165.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.402 ' C ' ' HH ' ' A' ' 5' ' ' TYR . . . 162.52 177.43 35.53 Favored Glycine 0 CA--C 1.488 -1.629 1 N-CA-C 97.081 -6.408 . . . . 0.0 97.081 -175.033 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -113.43 103.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 120.374 2.087 . . . . 0.0 108.559 -174.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -130.38 81.9 2.03 Favored 'General case' 0 CA--C 1.497 -1.091 1 N-CA-C 99.215 -4.365 . . . . 0.0 99.215 156.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.39 -177.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 1 N-CA-C 100.177 -4.008 . . . . 0.0 100.177 -174.65 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.51 54.61 0.37 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -157.47 -67.18 0.1 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 -178.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.85 42.47 Favored Glycine 0 CA--C 1.477 -2.285 1 N-CA-C 98.533 -5.827 . . . . 0.0 98.533 -178.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -76.69 140.88 41.05 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -175.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.91 -172.75 4.12 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 100.882 -3.747 . . . . 0.0 100.882 -162.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.39 155.33 32.16 Favored 'General case' 0 CA--C 1.479 -1.773 0 C-N-CA 117.542 -1.663 . . . . 0.0 106.658 -165.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -97.49 150.4 21.11 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 176.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 46.8 m -145.14 146.69 31.89 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 168.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.64 145.47 33.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 170.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.64 38.04 1.33 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 126.065 1.746 . . . . 0.0 111.85 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.57 133.97 62.33 Favored Pre-proline 0 CA--C 1.5 -0.952 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -65.22 166.75 18.11 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.5 2.134 . . . . 0.0 111.331 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.45 -5.49 52.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.969 -0.457 . . . . 0.0 112.16 -168.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -90.38 -0.57 57.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.69 -0.631 . . . . 0.0 109.861 177.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 t -95.74 123.74 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 177.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.86 145.75 16.82 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -147.13 -171.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -158.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 HD13 ' HB1' ' A' ' 7' ' ' ALA . 35.1 mm -54.44 111.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.939 0 C-N-CA 126.912 2.085 . . . . 0.0 112.562 -170.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.15 162.12 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 166.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.82 162.69 38.43 Favored 'General case' 0 N--CA 1.428 -1.571 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 -175.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.18 -1.31 76.88 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -172.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -119.18 -92.89 0.53 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -171.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -174.18 -169.36 0.46 Allowed 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -161.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.73 146.01 45.34 Favored 'General case' 0 N--CA 1.432 -1.328 1 N-CA-C 93.099 -6.63 . . . . 0.0 93.099 169.678 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -103.68 177.18 4.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.832 1.301 . . . . 0.0 108.698 -171.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 m -177.16 173.97 1.72 Allowed 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 95.355 -5.794 . . . . 0.0 95.355 -178.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.865 0 O-C-N 124.478 1.111 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.27 0.557 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -179.55 6.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 172.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -130.95 146.17 52.27 Favored 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 99.33 -4.322 . . . . 0.0 99.33 -174.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.63 -179.65 36.44 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -177.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.51 123.34 28.0 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 11.9 tt -90.67 140.9 15.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 120.752 1.615 . . . . 0.0 109.453 -176.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.98 169.07 10.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 110.95 -2.841 . . . . 0.0 112.092 177.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.252 26.6 tt0 -95.9 151.22 38.21 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 174.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -63.03 132.34 36.34 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.978 2.452 . . . . 0.0 109.336 165.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.94 -50.86 9.83 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 122.001 2.182 . . . . 0.0 110.843 14.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -168.06 156.28 8.79 Favored 'General case' 0 N--CA 1.425 -1.708 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 167.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 18.7 m 158.52 -144.84 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.428 1 N-CA-C 97.985 -4.821 . . . . 0.0 97.985 -176.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.02 165.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 165.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 -167.93 1.94 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 162.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -136.73 161.75 35.07 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 168.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.9 t -132.41 163.97 27.54 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 101.341 -3.577 . . . . 0.0 101.341 -160.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -109.43 126.95 28.1 Favored Pre-proline 0 N--CA 1.423 -1.775 1 N-CA-C 99.554 -4.239 . . . . 0.0 99.554 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.91 41.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.485 0 C-N-CA 123.843 3.029 . . . . 0.0 116.617 174.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.93 115.41 0.66 Allowed Glycine 0 N--CA 1.423 -2.217 1 N-CA-C 94.436 -7.466 . . . . 0.0 94.436 171.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -60.48 -32.76 71.73 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 m -41.18 -43.88 2.43 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 127.807 2.443 . . . . 0.0 116.373 -168.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -55.89 26.91 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 121.116 -0.99 . . . . 0.0 112.017 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -21.61 36.55 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.642 -0.916 . . . . 0.0 110.091 -173.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.11 -35.32 78.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.542 0.737 . . . . 0.0 109.641 169.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 m -70.61 -40.1 73.37 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 177.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.75 -39.61 94.71 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -57.17 -42.57 81.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.652 1.181 . . . . 0.0 111.176 177.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.55 -51.85 67.68 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.833 0.453 . . . . 0.0 110.821 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.88 -18.94 62.67 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.31 -2.32 57.99 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.802 -0.561 . . . . 0.0 111.325 174.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 24.91 12.74 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 121.601 -0.687 . . . . 0.0 111.754 170.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.03 157.89 21.15 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 172.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 p -81.43 -40.86 22.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.41 157.5 27.87 Favored 'General case' 0 N--CA 1.418 -2.028 1 N-CA-C 98.524 -4.621 . . . . 0.0 98.524 -164.025 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.14 173.87 45.29 Favored Glycine 0 CA--C 1.475 -2.449 1 N-CA-C 102.085 -4.406 . . . . 0.0 102.085 -176.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -170.72 -143.98 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.5 m -121.36 -175.37 3.06 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 -170.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.49 -168.58 33.29 Favored Glycine 0 N--CA 1.417 -2.624 1 N-CA-C 96.845 -6.502 . . . . 0.0 96.845 172.594 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -141.97 157.87 44.44 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 96.884 -5.228 . . . . 0.0 96.884 172.328 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -162.55 177.84 9.1 Favored 'General case' 0 N--CA 1.423 -1.784 1 N-CA-C 96.036 -5.542 . . . . 0.0 96.036 172.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.41 171.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 1 N-CA-C 96.283 -5.451 . . . . 0.0 96.283 179.119 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.03 -49.53 0.85 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 104.005 -3.638 . . . . 0.0 104.005 -173.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -115.43 -70.19 0.81 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.33 -159.9 32.98 Favored Glycine 0 CA--C 1.482 -1.979 0 N-CA-C 103.367 -3.893 . . . . 0.0 103.367 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.06 136.27 58.03 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.761 2.024 . . . . 0.0 106.831 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.49 168.32 20.06 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -161.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.79 179.05 4.39 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -140.37 146.82 38.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.845 -3.02 . . . . 0.0 102.845 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.73 151.18 49.89 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -112.12 137.69 49.83 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 173.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 56.9 71.88 0.55 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 127.753 2.421 . . . . 0.0 113.253 174.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.6 mt -103.77 143.59 26.95 Favored Pre-proline 0 CA--C 1.504 -0.809 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 172.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -69.21 173.39 10.55 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.251 1.967 . . . . 0.0 113.288 174.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.06 -17.64 61.4 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.067 1.347 . . . . 0.0 111.549 -174.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -94.3 18.91 10.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.592 0.757 . . . . 0.0 109.485 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.97 164.74 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 1 N-CA-C 98.773 -4.528 . . . . 0.0 98.773 167.025 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.06 175.1 30.91 Favored Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.783 -5.327 . . . . 0.0 99.783 -175.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 pt -159.22 -170.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 -156.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 mm -38.9 -43.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 129.844 3.258 . . . . 0.0 118.908 -147.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.84 -57.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.472 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 75.63 -95.88 0.02 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -154.1 33.38 0.72 Allowed Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 103.209 -3.957 . . . . 0.0 103.209 168.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -123.14 -105.66 0.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.9 tttp 179.33 -157.24 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.419 -3.178 . . . . 0.0 102.419 -169.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.55 135.35 36.61 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 94.775 -6.009 . . . . 0.0 94.775 -176.072 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -167.26 156.52 10.35 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -176.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -179.32 176.82 0.81 Allowed 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 95.915 -5.587 . . . . 0.0 95.915 -176.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.901 0 O-C-N 124.112 0.883 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.93 0.871 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -117.73 164.44 14.98 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -139.91 136.51 33.96 Favored 'General case' 0 CA--C 1.485 -1.536 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 167.296 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.13 35.57 Favored Glycine 0 CA--C 1.476 -2.399 0 N-CA-C 104.165 -3.574 . . . . 0.0 104.165 174.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -75.02 130.8 39.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.359 -3.201 . . . . 0.0 102.359 157.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -84.1 135.84 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.68 -136.61 0.34 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 110.711 -2.949 . . . . 0.0 109.256 175.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -146.43 159.24 45.5 Favored Pre-proline 0 N--CA 1.423 -1.79 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 172.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.11 141.89 44.99 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.37 2.047 . . . . 0.0 108.484 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.22 -32.42 13.04 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 127.962 2.505 . . . . 0.0 107.601 7.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -150.34 147.21 27.32 Favored 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 94.126 -6.25 . . . . 0.0 94.126 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -159.47 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.58 157.8 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 162.273 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 -155.16 0.27 Allowed 'General case' 0 C--N 1.358 0.936 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 161.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -138.63 154.97 48.68 Favored 'General case' 0 CA--C 1.473 -2.004 1 N-CA-C 97.496 -5.002 . . . . 0.0 97.496 177.364 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.25 175.31 6.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -158.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.89 85.58 57.42 Favored Pre-proline 0 N--CA 1.411 -2.419 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -175.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -78.0 -4.39 14.36 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.133 1.889 . . . . 0.0 109.63 165.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.27 141.09 10.84 Favored Glycine 0 CA--C 1.484 -1.901 1 N-CA-C 96.815 -6.514 . . . . 0.0 96.815 174.169 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -68.06 -55.13 13.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -153.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -63.47 5.95 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -155.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.17 -93.05 1.31 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 169.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.92 -17.86 62.06 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.521 1.128 . . . . 0.0 111.61 -166.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -62.31 -49.84 74.04 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 121.082 1.765 . . . . 0.0 109.499 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.72 89.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.812 2.045 . . . . 0.0 111.884 173.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.33 -44.09 88.91 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.815 0.817 . . . . 0.0 110.968 -178.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.9 t -58.67 -43.88 90.01 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 125.182 1.393 . . . . 0.0 109.03 177.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -53.51 54.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.099 0.96 . . . . 0.0 111.262 -178.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.28 -26.39 66.52 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.785 -0.572 . . . . 0.0 112.474 -175.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -79.86 -13.12 59.63 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 123.39 0.676 . . . . 0.0 110.498 177.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.31 23.87 8.74 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.87 119.87 6.13 Favored Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.134 -3.187 . . . . 0.0 105.134 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 p -82.45 -11.97 58.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.695 0.759 . . . . 0.0 110.087 -172.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.97 149.01 17.54 Favored 'General case' 0 N--CA 1.415 -2.207 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -160.094 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.62 47.24 Favored Glycine 0 CA--C 1.476 -2.397 1 N-CA-C 97.963 -6.055 . . . . 0.0 97.963 -178.024 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.457 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 12.7 p-80 -165.79 168.54 15.92 Favored 'General case' 0 N--CA 1.425 -1.676 1 N-CA-C 98.191 -4.744 . . . . 0.0 98.191 179.377 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.8 t -100.33 166.16 11.11 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.1 -170.27 40.05 Favored Glycine 0 N--CA 1.425 -2.054 1 N-CA-C 97.754 -6.138 . . . . 0.0 97.754 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.77 154.39 51.61 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 100.237 -3.986 . . . . 0.0 100.237 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -150.29 149.82 30.65 Favored 'General case' 0 N--CA 1.426 -1.652 1 N-CA-C 94.231 -6.211 . . . . 0.0 94.231 172.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.97 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.57 -71.64 1.12 Allowed Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 108.204 -1.959 . . . . 0.0 108.204 171.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 m170 -99.59 -42.31 6.96 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.87 -70.79 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.942 0 C-N-CA 118.274 -1.917 . . . . 0.0 108.74 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 tp -158.68 161.95 37.17 Favored 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 95.535 -5.728 . . . . 0.0 95.535 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.35 172.99 16.33 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 -171.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -128.55 167.41 17.15 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 100.98 -3.711 . . . . 0.0 100.98 -175.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.457 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 27.4 t-105 -116.7 145.2 43.61 Favored 'General case' 0 C--N 1.364 1.2 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 176.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.6 m -133.94 143.82 48.44 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 170.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -127.38 121.7 31.67 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 -172.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.43 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 127.942 2.497 . . . . 0.0 108.076 -177.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.49 135.44 20.64 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-O 117.084 -1.436 . . . . 0.0 107.433 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.88 165.91 26.34 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.434 2.089 . . . . 0.0 112.653 176.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.84 -13.94 62.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.252 1.021 . . . . 0.0 112.484 -174.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -91.44 5.58 48.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.85 0.86 . . . . 0.0 110.995 -179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -108.38 -174.96 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.71 169.22 33.97 Favored Glycine 0 CA--C 1.482 -2.022 1 N-CA-C 101.877 -4.489 . . . . 0.0 101.877 -170.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 pt -155.53 -168.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 101.722 -3.436 . . . . 0.0 101.722 -162.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mm -70.79 131.25 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.5 t -111.65 109.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 101.176 -3.639 . . . . 0.0 101.176 176.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 62.77 -117.86 0.56 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.188 1.395 . . . . 0.0 107.879 -170.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.1 47.05 0.32 Allowed Glycine 0 N--CA 1.428 -1.896 1 N-CA-C 98.795 -5.722 . . . . 0.0 98.795 165.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.09 -59.99 2.5 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.57 0.7 . . . . 0.0 110.341 -162.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -161.09 -178.44 6.76 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.774 -3.787 . . . . 0.0 100.774 -171.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.0 t -123.73 148.04 46.95 Favored 'General case' 0 N--CA 1.427 -1.587 1 N-CA-C 98.594 -4.595 . . . . 0.0 98.594 172.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -167.24 159.81 13.1 Favored 'General case' 0 CA--C 1.482 -1.637 1 N-CA-C 99.662 -4.199 . . . . 0.0 99.662 175.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -150.17 165.08 33.96 Favored 'General case' 0 N--CA 1.423 -1.781 1 N-CA-C 96.598 -5.334 . . . . 0.0 96.598 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.53 1.144 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.7 169.6 9.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 162.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -125.44 146.34 49.67 Favored 'General case' 0 CA--C 1.487 -1.443 1 N-CA-C 93.329 -6.545 . . . . 0.0 93.329 156.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 179.31 36.95 Favored Glycine 0 CA--C 1.468 -2.879 0 C-N-CA 116.542 -2.742 . . . . 0.0 107.55 -177.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.34 132.7 33.86 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 100.832 -3.766 . . . . 0.0 100.832 157.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.62 140.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.64 -138.46 0.36 Allowed 'General case' 0 N--CA 1.426 -1.673 0 O-C-N 126.849 2.593 . . . . 0.0 106.982 -178.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -133.27 153.39 80.62 Favored Pre-proline 0 N--CA 1.421 -1.912 1 N-CA-C 94.915 -5.957 . . . . 0.0 94.915 166.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -64.19 135.31 46.36 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.12 2.15 . . . . 0.0 106.571 163.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -94.9 -37.61 11.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 121.952 2.16 . . . . 0.0 109.648 17.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -158.74 148.43 19.28 Favored 'General case' 0 N--CA 1.422 -1.853 1 N-CA-C 94.639 -6.06 . . . . 0.0 94.639 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.3 m 170.73 -158.55 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.939 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.92 165.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 N-CA-C 99.515 -4.254 . . . . 0.0 99.515 157.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -155.48 0.21 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.052 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -139.35 179.31 6.61 Favored 'General case' 0 CA--C 1.482 -1.651 1 N-CA-C 97.853 -4.869 . . . . 0.0 97.853 160.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.56 171.17 14.42 Favored 'General case' 0 N--CA 1.415 -2.194 1 N-CA-C 97.276 -5.083 . . . . 0.0 97.276 -177.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -125.75 121.74 24.52 Favored Pre-proline 0 N--CA 1.415 -2.202 1 N-CA-C 97.762 -4.903 . . . . 0.0 97.762 176.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.28 113.96 1.65 Allowed 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.262 2.641 . . . . 0.0 112.661 176.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.22 -43.51 1.05 Allowed Glycine 0 CA--C 1.489 -1.57 1 N-CA-C 101.86 -4.496 . . . . 0.0 101.86 -163.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.254 67.6 m 85.47 -7.84 0.84 Allowed 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 127.448 2.299 . . . . 0.0 113.101 172.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -51.32 -49.6 61.04 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.479 1.512 . . . . 0.0 113.595 -171.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -38.98 62.0 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.32 -47.16 77.5 Favored 'General case' 0 CA--C 1.488 -1.437 0 O-C-N 121.757 -0.849 . . . . 0.0 109.698 -177.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.9 -40.1 94.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.485 0.66 . . . . 0.0 109.792 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 m -63.05 -48.63 77.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.438 0.695 . . . . 0.0 110.929 175.016 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.05 -36.13 83.37 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.132 0.973 . . . . 0.0 111.055 -177.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.4 t -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.724 1.21 . . . . 0.0 110.448 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -68.55 -41.38 79.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.784 -0.573 . . . . 0.0 111.966 -175.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.89 -11.77 60.95 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.457 -0.777 . . . . 0.0 112.45 -178.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -99.55 -0.69 40.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.443 0.697 . . . . 0.0 109.75 174.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.09 28.36 18.1 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 170.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.48 152.4 20.17 Favored Glycine 0 C--N 1.356 1.66 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 170.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -80.9 -38.74 27.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.451 -1.029 . . . . 0.0 110.635 -166.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 m -160.54 173.36 15.65 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 98.805 -4.517 . . . . 0.0 98.805 166.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.31 168.88 41.19 Favored Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 99.386 -5.486 . . . . 0.0 99.386 -172.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -163.72 172.53 14.06 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -172.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.49 156.18 39.3 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 119.412 1.006 . . . . 0.0 110.831 -177.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 -179.39 40.63 Favored Glycine 0 N--CA 1.42 -2.378 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 168.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -145.14 154.45 42.46 Favored 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.082 -5.525 . . . . 0.0 96.082 -175.206 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 18.84 2.91 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 2.3 t 61.75 -142.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -167.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.0 -74.53 1.61 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 124.071 0.843 . . . . 0.0 111.709 168.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.08 -76.14 0.59 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.78 -174.28 41.33 Favored Glycine 0 CA--C 1.478 -2.236 1 N-CA-C 100.582 -5.007 . . . . 0.0 100.582 -168.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.0 tp -52.3 134.89 33.55 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 127.245 2.218 . . . . 0.0 108.561 177.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.69 -167.67 1.84 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 -167.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.02 153.73 48.12 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.076 -4.416 . . . . 0.0 99.076 172.449 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -105.65 152.01 23.66 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.52 144.65 33.05 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -103.31 142.26 34.51 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 167.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.68 74.37 0.44 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.013 2.525 . . . . 0.0 112.602 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.2 mt -108.29 134.83 20.06 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.8 170.02 20.61 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.24 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.77 -17.35 64.57 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.213 1.405 . . . . 0.0 114.008 -166.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -84.37 -7.67 59.24 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 124.205 1.002 . . . . 0.0 110.907 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.55 125.95 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 -176.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 143.8 16.74 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 104.486 -3.445 . . . . 0.0 104.486 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.9 pt -130.41 -150.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -165.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -74.3 117.37 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 177.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.39 108.83 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 -176.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 62.5 -125.9 0.68 Allowed 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.46 46.71 0.55 Allowed Glycine 0 CA--C 1.485 -1.807 1 N-CA-C 101.606 -4.598 . . . . 0.0 101.606 165.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -99.08 -61.2 1.4 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -164.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -122.42 165.87 15.64 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -160.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.5 t -141.12 136.02 31.49 Favored 'General case' 0 N--CA 1.425 -1.72 1 N-CA-C 96.571 -5.344 . . . . 0.0 96.571 167.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.05 118.52 2.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 169.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -83.2 118.07 23.36 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.363 1.155 0 O-C-N 123.384 0.428 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.467 0.651 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -104.72 155.21 19.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 165.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -120.36 126.14 49.75 Favored 'General case' 0 CA--C 1.485 -1.552 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 157.265 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -162.45 13.09 Favored Glycine 0 CA--C 1.481 -2.061 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -174.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.58 141.37 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.268 -3.975 . . . . 0.0 100.268 163.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tt -90.42 147.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 173.094 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.62 177.0 10.47 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 98.482 -4.636 . . . . 0.0 98.482 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -86.53 158.37 54.45 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.079 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -62.31 118.06 4.94 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.467 2.111 . . . . 0.0 109.589 168.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -130.87 114.22 15.02 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 127.74 2.416 . . . . 0.0 105.365 2.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 65.74 40.15 4.47 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 110.279 169.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.66 125.03 43.46 Favored 'General case' 0 CA--C 1.479 -1.751 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 168.268 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.269 35.0 m -69.58 169.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 122.637 1.208 . . . . 0.0 113.832 -161.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.2 131.21 50.71 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 92.062 -7.014 . . . . 0.0 92.062 -178.478 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -92.88 -146.32 0.23 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -170.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -151.09 155.45 39.0 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 93.821 -6.363 . . . . 0.0 93.821 -174.539 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -108.98 112.8 59.87 Favored Pre-proline 0 N--CA 1.43 -1.431 1 N-CA-C 99.037 -4.431 . . . . 0.0 99.037 168.366 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.92 106.12 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.448 2.765 . . . . 0.0 117.665 -166.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.57 -166.46 38.48 Favored Glycine 0 N--CA 1.421 -2.343 1 N-CA-C 94.561 -7.416 . . . . 0.0 94.561 179.258 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 m -79.56 -29.19 41.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.722 1.761 . . . . 0.0 107.778 170.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -40.28 -57.44 1.74 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.505 3.922 . . . . 0.0 115.414 -168.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.92 -34.94 55.11 Favored Glycine 0 CA--C 1.492 -1.39 0 O-C-N 120.767 -1.208 . . . . 0.0 112.132 -168.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.86 -36.93 35.95 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.36 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.4 -49.76 71.51 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 123.79 0.836 . . . . 0.0 109.207 173.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 m -58.17 -54.96 41.12 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.456 0.702 . . . . 0.0 111.35 175.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.97 -46.52 90.4 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.669 1.188 . . . . 0.0 111.51 -174.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.39 -42.95 92.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -175.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.35 -42.77 74.81 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.171 0.442 . . . . 0.0 111.706 -179.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -72.11 -22.79 61.28 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.42 -0.8 . . . . 0.0 111.973 -173.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -46.62 9.18 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.676 -0.64 . . . . 0.0 109.558 172.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.01 48.66 0.18 Allowed Glycine 0 CA--C 1.487 -1.711 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 168.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.24 149.9 18.53 Favored Glycine 0 CA--C 1.488 -1.626 1 N-CA-C 102.114 -4.394 . . . . 0.0 102.114 163.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -89.16 -62.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.011 0.906 . . . . 0.0 109.129 -169.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -94.34 150.57 20.16 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.13 167.24 39.71 Favored Glycine 0 CA--C 1.478 -2.225 1 N-CA-C 100.826 -4.909 . . . . 0.0 100.826 176.902 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -170.04 172.76 6.3 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 100.249 -3.982 . . . . 0.0 100.249 -178.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 m -113.15 145.26 41.26 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.052 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.8 90.92 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.739 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -174.14 176.93 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 97.933 -4.839 . . . . 0.0 97.933 178.197 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp 170.25 49.96 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 170.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.49 140.31 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -172.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.66 -63.64 3.55 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.525 -0.734 . . . . 0.0 111.304 161.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -107.59 -52.51 2.75 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -176.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.25 -146.88 11.14 Favored Glycine 0 N--CA 1.42 -2.401 1 N-CA-C 95.024 -7.23 . . . . 0.0 95.024 -174.582 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 162.92 20.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.155 0.977 . . . . 0.0 108.63 171.386 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.16 169.57 17.36 Favored 'General case' 0 CA--C 1.485 -1.555 1 N-CA-C 98.395 -4.668 . . . . 0.0 98.395 -178.096 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 141.0 42.51 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 -170.202 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -88.37 150.07 23.39 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.9 m -149.23 138.5 21.5 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -108.27 136.49 47.84 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 170.246 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.67 56.36 0.14 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 126.187 1.795 . . . . 0.0 110.559 168.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.33 132.81 34.55 Favored Pre-proline 0 CA--C 1.498 -1.023 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 170.193 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 172.42 14.2 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.116 2.544 . . . . 0.0 110.169 177.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.0 -20.06 63.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.694 1.598 . . . . 0.0 113.824 -169.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -82.77 -4.45 57.96 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.511 -0.743 . . . . 0.0 111.486 -172.014 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -101.3 126.73 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -175.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.27 148.8 18.52 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 103.204 -3.958 . . . . 0.0 103.204 176.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.7 pt -148.03 -146.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 -159.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mm -71.27 118.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.32 162.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -159.303 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 77.89 -112.27 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 127.895 2.478 . . . . 0.0 106.52 -173.104 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.53 59.58 0.04 OUTLIER Glycine 0 CA--C 1.479 -2.18 1 N-CA-C 97.672 -6.171 . . . . 0.0 97.672 -177.508 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 10.7 tp10 -170.06 -162.36 0.31 Allowed 'General case' 0 N--CA 1.421 -1.909 1 N-CA-C 98.262 -4.718 . . . . 0.0 98.262 -162.341 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.501 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 32.7 tttp -113.56 -146.32 0.41 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.8 t -79.93 146.28 32.2 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 125.725 1.61 . . . . 0.0 109.403 -169.022 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -151.86 167.8 27.14 Favored 'General case' 0 N--CA 1.423 -1.819 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 174.527 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 m -75.51 58.08 1.0 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.054 1.342 . . . . 0.0 112.424 -171.31 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.944 0 CA-C-N 116.543 -0.299 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.192 0.52 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -101.08 159.31 15.34 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 165.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -126.33 122.77 36.39 Favored 'General case' 0 CA--C 1.484 -1.588 1 N-CA-C 94.19 -6.226 . . . . 0.0 94.19 159.793 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.63 38.15 Favored Glycine 0 CA--C 1.473 -2.581 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -173.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -79.64 131.4 35.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 165.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.4 tt -90.39 141.57 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -176.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.22 -141.81 0.37 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -178.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -131.95 150.9 77.45 Favored Pre-proline 0 N--CA 1.419 -2.02 1 N-CA-C 94.586 -6.079 . . . . 0.0 94.586 166.011 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.7 144.01 58.31 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 N-CA-C 106.629 -2.104 . . . . 0.0 106.629 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.57 -36.64 13.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.635 1.974 . . . . 0.0 109.165 12.795 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.88 150.08 28.93 Favored 'General case' 0 N--CA 1.418 -2.056 1 N-CA-C 94.707 -6.034 . . . . 0.0 94.707 175.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.55 -160.66 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -176.316 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.33 165.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 96.568 -5.345 . . . . 0.0 96.568 152.64 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.32 158.41 19.68 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 100.235 -3.987 . . . . 0.0 100.235 163.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -107.71 147.22 31.04 Favored 'General case' 0 CA--C 1.47 -2.103 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 -177.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -159.41 -177.99 6.83 Favored 'General case' 0 N--CA 1.409 -2.484 1 N-CA-C 95.763 -5.643 . . . . 0.0 95.763 -168.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -139.76 171.46 7.89 Favored Pre-proline 0 N--CA 1.414 -2.227 1 N-CA-C 98.867 -4.494 . . . . 0.0 98.867 -156.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.15 42.92 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 123.967 3.112 . . . . 0.0 114.308 169.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.83 129.52 1.49 Allowed Glycine 0 N--CA 1.423 -2.229 1 N-CA-C 100.203 -5.159 . . . . 0.0 100.203 -176.398 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.25 33.69 1.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.673 1.589 . . . . 0.0 111.083 -171.063 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -56.48 -43.63 79.81 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 126.437 1.895 . . . . 0.0 113.133 -173.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -33.29 8.97 Favored Glycine 0 C--N 1.352 1.431 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.0 t -61.72 -36.71 81.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.018 1.327 . . . . 0.0 111.408 -170.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.97 -53.84 43.92 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.121 0.968 . . . . 0.0 110.588 176.379 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -36.84 84.89 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.629 1.172 . . . . 0.0 112.884 177.061 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.02 -39.78 87.1 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 122.076 0.941 . . . . 0.0 109.733 -179.602 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -61.36 -42.87 99.4 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.444 0.697 . . . . 0.0 110.792 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -60.65 -47.79 84.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.785 0.834 . . . . 0.0 111.033 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.37 -17.55 62.41 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.211 -0.931 . . . . 0.0 112.739 -174.003 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -96.3 -5.17 40.75 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.208 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.35 11.85 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.009 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.35 159.48 19.29 Favored Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 105.721 -2.951 . . . . 0.0 105.721 168.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -71.51 -60.74 2.07 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.758 1.266 . . . . 0.0 108.747 -170.7 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.96 -171.05 2.92 Favored 'General case' 0 N--CA 1.425 -1.711 1 N-CA-C 97.323 -5.065 . . . . 0.0 97.323 169.438 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.99 -158.18 16.68 Favored Glycine 0 N--CA 1.419 -2.453 1 N-CA-C 101.732 -4.547 . . . . 0.0 101.732 -175.769 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -163.11 -170.2 2.24 Favored 'General case' 0 N--CA 1.429 -1.501 1 N-CA-C 97.467 -5.012 . . . . 0.0 97.467 -171.188 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.9 m -128.61 165.58 20.52 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 174.171 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.72 -170.92 43.03 Favored Glycine 0 N--CA 1.42 -2.383 1 N-CA-C 96.847 -6.501 . . . . 0.0 96.847 -176.353 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -139.46 161.85 36.48 Favored 'General case' 0 N--CA 1.431 -1.406 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 -174.485 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 150.4 40.54 Favored 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 94.237 -6.208 . . . . 0.0 94.237 159.88 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 t -75.99 126.57 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 119.539 1.063 . . . . 0.0 108.326 -165.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.87 -78.23 0.05 OUTLIER Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 104.382 -3.487 . . . . 0.0 104.382 178.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -108.3 -105.32 0.35 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.6 98.21 0.18 Allowed Glycine 0 CA--C 1.489 -1.58 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 -171.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.333 0.2 OUTLIER 59.33 -166.91 0.17 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.764 2.425 . . . . 0.0 110.712 -170.322 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -164.98 -179.47 5.77 Favored 'General case' 0 N--CA 1.427 -1.605 1 N-CA-C 99.878 -4.119 . . . . 0.0 99.878 168.661 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -122.55 152.99 39.83 Favored 'General case' 0 CA--C 1.494 -1.186 1 N-CA-C 98.078 -4.786 . . . . 0.0 98.078 175.282 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -104.87 156.01 18.4 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 176.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.01 141.78 32.87 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 165.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -108.18 122.31 46.65 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 177.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.62 82.3 0.14 Allowed 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 127.188 2.195 . . . . 0.0 109.924 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.8 mt -106.67 135.12 19.56 Favored Pre-proline 0 CA--C 1.49 -1.342 0 N-CA-C 103.417 -2.809 . . . . 0.0 103.417 170.155 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.88 170.49 16.6 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.078 1.852 . . . . 0.0 110.385 171.216 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -82.1 7.06 14.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -162.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -90.08 -8.03 52.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.737 0.815 . . . . 0.0 108.961 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 t -99.13 138.17 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -174.171 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.43 148.11 16.65 Favored Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 103.976 -3.649 . . . . 0.0 103.976 178.7 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 pt -134.6 -156.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -167.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mm -72.59 128.51 35.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.155 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -121.34 114.01 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 178.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 60.3 -128.67 1.0 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.513 1.125 . . . . 0.0 108.167 -174.183 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -159.9 45.98 0.42 Allowed Glycine 0 N--CA 1.432 -1.608 1 N-CA-C 101.135 -4.786 . . . . 0.0 101.135 164.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -76.56 -58.5 3.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 -164.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -165.01 -168.36 1.41 Allowed 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 100.096 -4.038 . . . . 0.0 100.096 -176.174 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 t -127.3 153.53 46.04 Favored 'General case' 0 N--CA 1.424 -1.751 1 N-CA-C 99.266 -4.346 . . . . 0.0 99.266 178.42 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 119.72 5.51 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 164.103 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 m -75.97 117.45 17.7 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.742 0.817 . . . . 0.0 108.837 -174.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.059 0 CA-C-N 116.236 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 170.7 9.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 171.14 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -130.32 133.74 46.67 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 95.862 -5.607 . . . . 0.0 95.862 168.433 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -176.07 33.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 118.527 -1.797 . . . . 0.0 109.627 -175.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -86.74 125.03 33.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 169.334 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.66 146.26 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 119.348 0.977 . . . . 0.0 108.44 -174.594 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.64 -163.98 0.89 Allowed 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 127.477 2.311 . . . . 0.0 105.998 -175.82 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -128.51 159.01 69.99 Favored Pre-proline 0 N--CA 1.422 -1.846 1 N-CA-C 96.44 -5.393 . . . . 0.0 96.44 169.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -68.57 155.77 67.85 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 CA-C-N 122.621 1.972 . . . . 0.0 109.189 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -99.21 -19.97 16.85 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 128.901 2.88 . . . . 0.0 108.502 4.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -149.72 151.57 33.87 Favored 'General case' 0 CA--C 1.479 -1.761 1 N-CA-C 92.592 -6.818 . . . . 0.0 92.592 158.079 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.07 -163.69 0.11 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 171.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.505 HG11 ' HD1' ' A' ' 43' ' ' HIS . 5.7 m -128.75 160.3 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 1 N-CA-C 95.904 -5.591 . . . . 0.0 95.904 160.648 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -164.47 0.7 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.513 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -137.86 168.62 19.32 Favored 'General case' 0 N--CA 1.418 -2.063 1 N-CA-C 95.186 -5.857 . . . . 0.0 95.186 176.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -142.85 155.88 44.84 Favored 'General case' 0 CA--C 1.474 -1.966 1 N-CA-C 96.973 -5.195 . . . . 0.0 96.973 -166.277 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -114.46 119.35 40.12 Favored Pre-proline 0 N--CA 1.421 -1.921 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 167.21 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.91 95.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 124.728 2.724 . . . . 0.0 117.444 -162.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.19 -173.15 41.69 Favored Glycine 0 N--CA 1.422 -2.293 1 N-CA-C 97.787 -6.125 . . . . 0.0 97.787 -179.388 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -89.67 -13.9 35.98 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 118.173 0.987 . . . . 0.0 109.455 178.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.41 -60.56 1.89 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.557 3.143 . . . . 0.0 116.566 -161.32 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 -36.49 23.09 Favored Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.4 m -80.47 -16.1 55.16 Favored 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 123.141 0.576 . . . . 0.0 110.793 -174.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.89 -51.68 68.61 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.955 0.798 . . . . 0.0 108.951 168.451 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.49 81.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.73 0.812 . . . . 0.0 112.661 174.077 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.23 -38.69 85.65 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.129 0.966 . . . . 0.0 111.645 -174.191 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.4 -34.7 78.54 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.311 -0.868 . . . . 0.0 110.28 178.56 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -40.54 89.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.374 0.669 . . . . 0.0 111.477 -177.177 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.54 -28.77 59.17 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 122.159 -0.338 . . . . 0.0 110.978 -177.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.02 -27.41 24.82 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.951 -0.468 . . . . 0.0 110.768 179.422 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.28 42.62 1.06 Allowed Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 163.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.96 157.33 15.06 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 162.224 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -94.08 -9.9 35.12 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 122.178 -0.601 . . . . 0.0 110.559 -163.662 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 m -149.5 149.62 31.04 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.78 138.61 9.94 Favored Glycine 0 CA--C 1.475 -2.409 1 N-CA-C 98.847 -5.701 . . . . 0.0 98.847 -178.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -141.45 -162.64 1.41 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 -177.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.77 169.15 9.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 -170.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.65 -177.97 41.69 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 102.469 -4.252 . . . . 0.0 102.469 -177.094 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -152.16 159.74 43.54 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 97.665 -4.939 . . . . 0.0 97.665 178.03 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -151.96 171.01 18.47 Favored 'General case' 0 CA--C 1.491 -1.309 1 N-CA-C 98.974 -4.454 . . . . 0.0 98.974 167.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.92 168.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -177.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.92 29.22 52.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -169.011 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.505 ' HD1' HG11 ' A' ' 13' ' ' VAL . 27.7 m170 163.45 -154.13 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 94.471 -6.122 . . . . 0.0 94.471 -174.963 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.08 150.16 21.39 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 98.715 -5.754 . . . . 0.0 98.715 170.41 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tp 74.16 176.84 0.24 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.003 1.721 . . . . 0.0 108.519 175.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -178.46 -169.35 0.18 Allowed 'General case' 0 CA--C 1.483 -1.62 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 173.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.35 178.25 6.96 Favored 'General case' 0 CA--C 1.484 -1.559 1 N-CA-C 100.137 -4.023 . . . . 0.0 100.137 154.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -126.85 146.59 50.22 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.06 156.09 46.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 179.665 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -125.65 142.44 51.51 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.97 55.67 1.13 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 128.542 2.737 . . . . 0.0 111.783 172.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.52 132.85 25.58 Favored Pre-proline 0 CA--C 1.505 -0.777 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.042 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -73.54 174.76 11.66 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.513 2.142 . . . . 0.0 111.75 174.015 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.15 -19.07 62.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 126.548 1.939 . . . . 0.0 114.787 -173.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -79.62 -15.26 57.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 121.686 -0.634 . . . . 0.0 109.704 -177.23 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.55 129.92 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -178.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.84 149.53 18.73 Favored Glycine 0 CA--C 1.48 -2.153 1 N-CA-C 101.402 -4.679 . . . . 0.0 101.402 -179.481 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -133.18 -143.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -162.051 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.19 120.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.13 -51.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -162.72 163.08 27.03 Favored 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 98.402 -4.666 . . . . 0.0 98.402 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 74.17 2.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 173.115 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -121.64 -67.11 0.99 Allowed 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -165.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -162.99 172.58 14.81 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 98.633 -4.58 . . . . 0.0 98.633 -169.434 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.4 t -129.41 153.3 48.05 Favored 'General case' 0 CA--C 1.485 -1.531 1 N-CA-C 97.15 -5.13 . . . . 0.0 97.15 178.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.31 152.37 23.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 94.975 -5.935 . . . . 0.0 94.975 176.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -154.9 163.28 40.51 Favored 'General case' 0 N--CA 1.421 -1.894 1 N-CA-C 95.599 -5.704 . . . . 0.0 95.599 -177.991 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.929 0 O-C-N 124.419 1.074 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.686 0.755 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 161.83 34.65 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.78 137.67 51.66 Favored 'General case' 0 CA--C 1.485 -1.548 1 N-CA-C 94.977 -5.934 . . . . 0.0 94.977 171.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.84 -172.56 29.39 Favored Glycine 0 CA--C 1.472 -2.618 0 N-CA-C 104.866 -3.294 . . . . 0.0 104.866 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.03 138.69 32.96 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 102.051 -3.314 . . . . 0.0 102.051 158.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.0 tt -90.84 141.33 14.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.31 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -112.46 -160.31 0.71 Allowed 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 128.395 2.678 . . . . 0.0 108.099 -176.213 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -136.17 164.78 40.53 Favored Pre-proline 0 N--CA 1.419 -1.977 1 N-CA-C 96.601 -5.333 . . . . 0.0 96.601 174.86 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -65.32 151.53 84.95 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.67 2.246 . . . . 0.0 109.764 169.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.52 -54.58 4.1 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 127.75 2.42 . . . . 0.0 107.917 5.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -133.35 135.69 44.91 Favored 'General case' 0 N--CA 1.42 -1.925 1 N-CA-C 90.729 -7.508 . . . . 0.0 90.729 169.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 m -168.19 -166.41 0.7 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 178.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.06 164.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 165.804 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.34 -158.42 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 162.079 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -137.45 168.7 19.13 Favored 'General case' 0 CA--C 1.476 -1.9 1 N-CA-C 96.668 -5.308 . . . . 0.0 96.668 165.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.5 t -130.86 158.59 39.78 Favored 'General case' 0 CA--C 1.478 -1.818 1 N-CA-C 97.402 -5.036 . . . . 0.0 97.402 -170.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -109.84 112.43 58.17 Favored Pre-proline 0 N--CA 1.425 -1.694 1 N-CA-C 96.596 -5.335 . . . . 0.0 96.596 167.915 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.3 101.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.543 0 CA-C-N 124.491 2.64 . . . . 0.0 116.177 -161.175 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -172.57 36.9 Favored Glycine 0 N--CA 1.427 -1.935 1 N-CA-C 97.092 -6.403 . . . . 0.0 97.092 -172.628 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p -92.58 -28.75 16.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 118.993 1.396 . . . . 0.0 109.893 -177.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.16 -63.92 0.56 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.775 2.43 . . . . 0.0 116.152 -161.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.65 -45.45 52.93 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -176.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 m -64.47 -45.77 85.98 Favored 'General case' 0 CA--C 1.486 -1.495 0 O-C-N 122.229 -0.571 . . . . 0.0 111.776 -174.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.36 -35.97 78.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -60.85 -48.43 81.82 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.713 173.764 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.38 -41.95 99.04 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-O 121.799 0.809 . . . . 0.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -60.69 -45.3 94.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.87 0.868 . . . . 0.0 110.432 179.395 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.81 -42.37 81.64 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.392 0.277 . . . . 0.0 110.792 -176.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.44 -27.08 56.09 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.799 -0.563 . . . . 0.0 111.552 -176.049 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -76.49 -49.23 17.06 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.22 51.6 0.18 Allowed Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 169.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.04 16.15 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 104.913 -3.275 . . . . 0.0 104.913 159.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.4 p -92.92 -3.59 54.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 117.777 0.788 . . . . 0.0 110.7 -166.091 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.479 -1.778 1 N-CA-C 98.427 -4.657 . . . . 0.0 98.427 174.096 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.17 163.71 37.33 Favored Glycine 0 CA--C 1.465 -3.058 1 N-CA-C 101.065 -4.814 . . . . 0.0 101.065 -173.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -156.66 -155.34 0.53 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.814 -3.772 . . . . 0.0 100.814 -170.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 t -145.03 161.71 38.74 Favored 'General case' 0 N--CA 1.429 -1.51 1 N-CA-C 96.534 -5.358 . . . . 0.0 96.534 -173.825 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.92 -172.57 45.18 Favored Glycine 0 N--CA 1.42 -2.409 1 N-CA-C 99.024 -5.63 . . . . 0.0 99.024 -176.439 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -135.38 142.47 45.7 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 97.048 -5.168 . . . . 0.0 97.048 -177.426 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -112.46 108.82 18.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.1 121.38 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.553 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -13.54 8.09 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -168.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -136.68 -77.26 0.41 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.04 -163.45 36.82 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 -165.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.8 141.26 57.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.79 2.436 . . . . 0.0 106.044 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.32 178.3 8.52 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 -168.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 m -110.44 162.16 14.95 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 170.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -119.23 146.56 45.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.6 m -141.8 150.91 42.3 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -120.71 142.09 49.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 173.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 60.05 62.44 1.64 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 127.495 2.318 . . . . 0.0 111.374 174.277 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.18 145.5 30.17 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 171.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -64.73 160.58 39.8 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.973 2.448 . . . . 0.0 110.886 174.353 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -66.51 -24.53 66.41 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.867 0.867 . . . . 0.0 112.626 -168.087 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -81.48 -2.75 50.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.473 1.109 . . . . 0.0 111.162 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.87 122.88 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 177.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.75 145.57 17.71 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -136.72 -153.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -165.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -66.65 131.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.365 1.265 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 t -119.55 151.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 177.409 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 7.5 tp10 51.11 -142.16 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.796 2.038 . . . . 0.0 112.191 168.678 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -150.66 110.79 0.48 Allowed Glycine 0 CA--C 1.479 -2.196 1 N-CA-C 92.352 -8.299 . . . . 0.0 92.352 158.079 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -147.61 -82.33 0.12 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -165.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 35.6 tttm -165.4 -175.25 3.5 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 99.559 -4.237 . . . . 0.0 99.559 -173.186 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.419 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 1.7 t -132.15 134.19 45.13 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 95.879 -5.601 . . . . 0.0 95.879 177.931 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -162.06 158.56 25.06 Favored 'General case' 0 CA--C 1.485 -1.54 1 N-CA-C 99.356 -4.312 . . . . 0.0 99.356 -176.161 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -153.4 164.03 38.89 Favored 'General case' 0 N--CA 1.423 -1.807 1 N-CA-C 95.811 -5.626 . . . . 0.0 95.811 -177.253 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.926 0 O-C-N 124.435 1.085 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 159.91 15.92 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.37 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -130.69 130.09 43.42 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.558 -6.09 . . . . 0.0 94.558 159.457 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.07 -170.31 26.64 Favored Glycine 0 CA--C 1.473 -2.567 1 N-CA-C 101.607 -4.597 . . . . 0.0 101.607 179.146 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -83.54 143.4 30.2 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 159.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.27 143.57 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.45 -137.05 0.35 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.498 1.919 . . . . 0.0 106.507 179.782 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -136.88 155.23 76.53 Favored Pre-proline 0 N--CA 1.421 -1.907 1 N-CA-C 95.185 -5.858 . . . . 0.0 95.185 159.822 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -66.3 150.77 84.5 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 0.0 108.423 174.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.34 -30.07 33.92 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 128.389 2.676 . . . . 0.0 108.992 6.572 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -164.67 159.36 18.78 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 94.237 -6.209 . . . . 0.0 94.237 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m 167.51 -147.69 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 98.82 -4.511 . . . . 0.0 98.82 174.395 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.91 170.01 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 1 N-CA-C 95.661 -5.681 . . . . 0.0 95.661 170.15 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.39 179.85 6.79 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 167.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -119.17 78.06 1.26 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 -179.11 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.3 t -98.77 -170.37 1.93 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -142.63 172.87 5.19 Favored Pre-proline 0 N--CA 1.42 -1.971 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -164.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -66.69 50.54 0.32 Allowed 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 123.595 2.864 . . . . 0.0 112.829 162.628 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.46 139.93 5.62 Favored Glycine 0 N--CA 1.423 -2.191 1 N-CA-C 100.437 -5.065 . . . . 0.0 100.437 -178.452 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -94.83 30.37 2.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 -171.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -65.86 -57.12 8.64 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.969 1.708 . . . . 0.0 110.836 -166.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.17 -28.91 47.7 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.048 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.91 -30.52 71.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.651 1.181 . . . . 0.0 110.859 -172.542 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.45 -58.62 6.5 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.744 0.818 . . . . 0.0 109.945 173.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -44.59 96.76 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.157 0.983 . . . . 0.0 113.014 175.833 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.35 -41.85 88.91 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.287 0.565 . . . . 0.0 111.094 -173.283 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -64.25 -40.56 96.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 121.948 -0.47 . . . . 0.0 109.934 179.553 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -66.08 -47.29 74.77 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 122.071 -0.393 . . . . 0.0 111.625 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.18 -20.49 63.12 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.654 -0.654 . . . . 0.0 112.292 -173.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.55 -3.23 50.15 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.248 0.619 . . . . 0.0 110.199 176.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.32 32.56 8.18 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 165.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.82 163.05 13.03 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 105.546 -3.021 . . . . 0.0 105.546 168.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -83.72 -43.6 15.33 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.244 1.021 . . . . 0.0 110.038 -169.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -160.12 150.92 18.91 Favored 'General case' 0 N--CA 1.418 -2.068 1 N-CA-C 98.759 -4.534 . . . . 0.0 98.759 -157.954 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.9 169.24 38.03 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 100.286 -5.126 . . . . 0.0 100.286 -171.157 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -162.55 -177.98 5.95 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 98.258 -4.719 . . . . 0.0 98.258 -179.494 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.1 m -139.26 162.42 35.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -178.804 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.83 109.1 0.73 Allowed Glycine 0 CA--C 1.487 -1.681 1 N-CA-C 101.748 -4.541 . . . . 0.0 101.748 -178.359 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 41' ' ' VAL . 72.1 t80 -161.14 149.07 15.55 Favored 'General case' 0 CA--C 1.483 -1.617 1 N-CA-C 97.216 -5.105 . . . . 0.0 97.216 -165.595 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -151.12 75.38 1.19 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 39' ' ' PHE . 49.1 t -126.07 138.52 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 95.671 -5.678 . . . . 0.0 95.671 167.129 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.91 62.99 4.52 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 119.016 0.826 . . . . 0.0 111.621 -163.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.5 -51.52 2.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.53 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 -164.19 35.5 Favored Glycine 0 N--CA 1.426 -2.019 1 N-CA-C 96.029 -6.828 . . . . 0.0 96.029 -164.372 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.65 118.63 22.23 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -172.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.84 -178.2 5.69 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.068 0.947 . . . . 0.0 110.703 -166.706 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.98 149.62 40.63 Favored 'General case' 0 CA--C 1.489 -1.377 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -174.616 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -96.87 155.17 16.89 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 178.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.4 m -147.64 152.14 37.37 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 168.248 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -115.91 144.55 43.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 169.023 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.45 57.3 0.57 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 128.059 2.543 . . . . 0.0 111.651 170.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.09 124.8 48.28 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.574 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 167.04 28.09 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.184 1.923 . . . . 0.0 109.43 174.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.77 46.97 1.44 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.52 -0.737 . . . . 0.0 111.618 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -111.91 -6.53 14.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 163.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.87 140.86 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 -172.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.65 147.59 18.0 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 103.399 -3.88 . . . . 0.0 103.399 179.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.97 -159.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -165.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.75 133.12 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -174.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.58 160.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 176.806 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -161.76 162.8 29.75 Favored 'General case' 0 N--CA 1.428 -1.543 1 N-CA-C 96.754 -5.276 . . . . 0.0 96.754 171.733 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.07 35.59 26.94 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 104.841 -3.304 . . . . 0.0 104.841 -150.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -179.04 -163.61 0.06 Allowed 'General case' 0 N--CA 1.424 -1.731 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 -166.292 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 21.1 ttpp -156.98 -169.01 2.82 Favored 'General case' 0 N--CA 1.43 -1.431 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 179.707 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.44 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 8.7 t -72.52 134.32 45.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.881 2.072 . . . . 0.0 106.086 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.293 98.2 m-70 57.91 -132.68 1.23 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 126.089 1.756 . . . . 0.0 109.535 -161.41 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.5 m -79.65 55.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 177.101 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.081 0 CA-C-N 116.23 -0.441 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.428 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -148.81 179.77 7.59 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 171.558 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -137.02 142.0 42.5 Favored 'General case' 0 CA--C 1.485 -1.532 1 N-CA-C 96.666 -5.309 . . . . 0.0 96.666 179.667 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.53 12.15 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 99.653 -5.379 . . . . 0.0 99.653 165.41 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.53 144.03 30.67 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 165.035 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -91.11 139.98 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.401 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.11 -168.14 1.5 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.099 2.959 . . . . 0.0 108.549 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -113.7 161.67 26.41 Favored Pre-proline 0 N--CA 1.428 -1.53 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 170.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.2 134.64 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 N-CA-C 106.843 -2.022 . . . . 0.0 106.843 158.205 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -79.31 -58.16 3.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.05 2.14 . . . . 0.0 111.251 14.479 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -166.6 146.24 5.75 Favored 'General case' 0 N--CA 1.426 -1.638 1 N-CA-C 92.384 -6.895 . . . . 0.0 92.384 -178.357 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.9 m 159.92 -141.4 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.528 1 N-CA-C 97.771 -4.9 . . . . 0.0 97.771 179.131 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.26 165.34 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 176.203 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -154.83 0.29 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 162.976 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -141.17 177.37 8.13 Favored 'General case' 0 N--CA 1.425 -1.68 1 N-CA-C 97.177 -5.119 . . . . 0.0 97.177 167.818 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.81 158.81 43.83 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.816 -5.624 . . . . 0.0 95.816 -179.263 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -115.6 113.57 42.67 Favored Pre-proline 0 N--CA 1.422 -1.839 1 N-CA-C 96.197 -5.483 . . . . 0.0 96.197 177.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.83 99.2 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 CA-C-N 124.019 2.471 . . . . 0.0 116.082 -156.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.93 -166.9 36.42 Favored Glycine 0 N--CA 1.423 -2.219 1 N-CA-C 96.716 -6.554 . . . . 0.0 96.716 -173.746 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -85.97 -41.53 14.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.199 1.0 . . . . 0.0 109.6 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.43 -70.56 0.1 Allowed 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -147.352 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.11 -31.68 54.59 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 121.092 -1.005 . . . . 0.0 111.42 -172.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.95 -49.54 44.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.415 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.5 -33.66 76.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.22 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 m -61.48 -50.19 73.73 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.892 172.5 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -42.6 99.76 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.905 0.882 . . . . 0.0 109.968 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -56.48 -47.13 79.86 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.566 1.146 . . . . 0.0 110.714 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.8 -45.5 89.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.886 0.874 . . . . 0.0 110.585 -175.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.39 -28.93 62.29 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.845 -0.534 . . . . 0.0 112.163 -176.015 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.6 -18.2 45.59 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.589 -0.694 . . . . 0.0 110.144 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.91 38.16 2.99 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 163.717 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.29 139.25 14.39 Favored Glycine 0 CA--C 1.486 -1.776 1 N-CA-C 101.153 -4.779 . . . . 0.0 101.153 164.099 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -81.84 -29.06 32.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 118.032 0.916 . . . . 0.0 110.065 -162.629 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.47 -176.86 5.84 Favored 'General case' 0 N--CA 1.423 -1.783 1 N-CA-C 98.313 -4.699 . . . . 0.0 98.313 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.25 -160.97 24.99 Favored Glycine 0 N--CA 1.414 -2.783 1 N-CA-C 100.618 -4.993 . . . . 0.0 100.618 -167.378 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -163.62 -159.73 0.53 Allowed 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 96.899 -5.223 . . . . 0.0 96.899 -172.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -136.11 170.26 16.29 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 100.584 -3.858 . . . . 0.0 100.584 173.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 -177.31 47.92 Favored Glycine 0 N--CA 1.422 -2.283 1 N-CA-C 101.32 -4.712 . . . . 0.0 101.32 177.695 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -113.56 139.97 48.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -177.435 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -110.71 91.09 3.52 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.679 -3.082 . . . . 0.0 102.679 173.054 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 t -68.27 124.98 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -171.168 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -47.53 1.01 Allowed Glycine 0 CA--C 1.483 -1.922 0 N-CA-C 104.539 -3.424 . . . . 0.0 104.539 -173.019 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -100.44 -60.3 1.55 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.001 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.43 -170.63 39.67 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.633 -2.587 . . . . 0.0 106.633 -174.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.15 137.68 35.92 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 102.904 -2.998 . . . . 0.0 102.904 177.493 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.93 -174.51 3.68 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -164.165 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.9 t -114.62 153.84 29.43 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 178.3 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -119.48 149.78 41.32 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -177.299 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -143.15 156.13 44.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.73 144.2 50.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 102.691 -3.078 . . . . 0.0 102.691 170.021 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.64 52.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.758 2.023 . . . . 0.0 111.415 171.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.65 130.66 36.18 Favored Pre-proline 0 CA--C 1.501 -0.934 0 N-CA-C 104.951 -2.241 . . . . 0.0 104.951 173.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -74.22 176.07 10.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.451 2.1 . . . . 0.0 110.741 175.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -86.15 19.69 2.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.988 -174.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -95.15 -7.01 40.51 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.446 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.01 169.0 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -179.155 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -148.68 151.26 23.47 Favored Glycine 0 CA--C 1.479 -2.179 1 N-CA-C 97.533 -6.227 . . . . 0.0 97.533 173.755 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.3 -147.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -155.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.38 -27.71 43.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 126.173 1.789 . . . . 0.0 113.312 -169.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 167.4 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.539 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -171.98 -173.84 1.2 Allowed 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 94.978 -5.934 . . . . 0.0 94.978 -170.061 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.42 69.92 2.9 Favored Glycine 0 CA--C 1.495 -1.195 0 N-CA-C 105.007 -3.237 . . . . 0.0 105.007 164.334 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -169.5 -170.91 1.14 Allowed 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 96.739 -5.282 . . . . 0.0 96.739 -172.033 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -164.19 172.1 14.11 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.73 -4.544 . . . . 0.0 98.73 -175.125 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 18.2 t -73.16 125.48 27.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 127.506 2.322 . . . . 0.0 109.106 -172.168 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -165.04 172.92 12.09 Favored 'General case' 0 N--CA 1.426 -1.659 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 173.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m 177.47 178.69 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 95.746 -5.649 . . . . 0.0 95.746 171.221 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.937 0 CA-C-N 119.022 0.828 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.279 0.562 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.36 170.95 9.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 160.489 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -129.96 132.69 46.4 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 93.509 -6.478 . . . . 0.0 93.509 158.314 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -178.01 35.39 Favored Glycine 0 CA--C 1.47 -2.736 0 N-CA-C 104.015 -3.634 . . . . 0.0 104.015 -175.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -83.71 140.65 31.99 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 162.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -90.39 137.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.005 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.31 -145.03 0.3 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.198 174.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.7 142.8 45.11 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 92.939 -6.689 . . . . 0.0 92.939 166.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.82 146.34 47.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.693 1.998 . . . . 0.0 107.974 -177.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.559 ' HB2' ' HD1' ' A' ' 66' ' ' HIS . 48.6 mt-10 -96.23 -21.69 17.71 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 126.098 1.759 . . . . 0.0 108.504 13.404 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -158.48 151.68 22.81 Favored 'General case' 0 N--CA 1.415 -2.2 1 N-CA-C 95.945 -5.576 . . . . 0.0 95.945 172.182 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 166.54 -155.93 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 -177.707 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.4 164.81 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 1 N-CA-C 96.798 -5.26 . . . . 0.0 96.798 161.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.11 171.75 8.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 161.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -108.56 116.33 31.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -177.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 t -92.39 150.43 20.82 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.44 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.36 122.02 28.98 Favored Pre-proline 0 N--CA 1.422 -1.855 1 N-CA-C 97.65 -4.945 . . . . 0.0 97.65 -179.341 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.57 137.49 74.04 Favored 'Trans proline' 0 CA--C 1.505 -0.962 0 CA-C-N 123.456 2.27 . . . . 0.0 110.987 -176.371 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.36 -57.95 0.57 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -158.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m 105.51 -14.72 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 128.901 2.881 . . . . 0.0 110.533 173.137 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -46.44 -51.05 15.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.685 1.994 . . . . 0.0 114.806 -162.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.84 -39.77 75.56 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 121.507 -0.746 . . . . 0.0 111.517 -177.231 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.04 -22.1 22.02 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.068 -1.254 . . . . 0.0 110.748 -169.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.47 94.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -62.49 -45.05 94.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.161 -0.962 . . . . 0.0 110.983 172.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.94 -41.24 97.73 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.518 -0.739 . . . . 0.0 111.926 177.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.22 -44.39 75.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.35 1.46 . . . . 0.0 110.345 174.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.59 -45.85 88.52 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.853 -0.529 . . . . 0.0 111.554 -177.322 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.75 -7.63 51.52 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.36 -0.837 . . . . 0.0 112.669 -177.096 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -102.79 -3.78 25.89 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 121.704 -0.622 . . . . 0.0 109.813 174.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.56 28.35 11.53 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 169.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.34 129.71 9.99 Favored Glycine 0 CA--C 1.483 -1.917 0 N-CA-C 104.259 -3.536 . . . . 0.0 104.259 169.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -36.25 74.19 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.509 -165.763 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -160.56 175.33 12.83 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 170.642 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.49 -178.72 48.78 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 98.516 -5.833 . . . . 0.0 98.516 -169.694 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -164.08 -175.82 4.2 Favored 'General case' 0 N--CA 1.434 -1.24 1 N-CA-C 99.067 -4.42 . . . . 0.0 99.067 -177.946 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.4 m -84.4 168.67 15.33 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.317 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.47 -178.35 41.82 Favored Glycine 0 CA--C 1.487 -1.671 1 N-CA-C 96.9 -6.48 . . . . 0.0 96.9 172.562 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -152.6 132.72 13.48 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 100.478 -3.897 . . . . 0.0 100.478 179.629 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -139.66 40.25 2.02 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.261 2.2 t 57.11 -134.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.17 1.788 . . . . 0.0 107.606 -172.328 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -122.48 7.58 Favored Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 179.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -118.15 5.12 11.97 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.126 0.57 . . . . 0.0 109.711 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.22 -172.87 34.74 Favored Glycine 0 CA--C 1.483 -1.947 1 N-CA-C 100.413 -5.075 . . . . 0.0 100.413 -178.046 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.25 98.46 11.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.028 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.38 177.71 7.74 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 125.634 1.574 . . . . 0.0 110.93 -172.791 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -126.69 160.03 31.96 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.411 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -96.61 154.66 17.15 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 177.69 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.0 m -142.37 140.68 32.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.764 -3.791 . . . . 0.0 100.764 165.53 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.75 27.97 8.9 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.482 0.658 . . . . 0.0 109.631 -170.026 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.27 147.95 0.74 Allowed 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 93.605 -6.443 . . . . 0.0 93.605 167.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -150.86 142.83 15.77 Favored Pre-proline 0 CA--C 1.487 -1.468 1 N-CA-C 97.711 -4.922 . . . . 0.0 97.711 153.076 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.86 171.73 17.28 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.265 1.977 . . . . 0.0 109.598 176.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.54 -4.97 37.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -92.98 3.65 55.37 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 -178.135 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 t -107.76 138.5 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 103.557 -2.756 . . . . 0.0 103.557 -176.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.75 147.37 16.41 Favored Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 103.786 -3.726 . . . . 0.0 103.786 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.9 -160.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -164.342 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.33 137.46 23.3 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -172.883 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.88 153.41 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 1 N-CA-C 95.046 -5.909 . . . . 0.0 95.046 173.54 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.73 153.04 30.62 Favored 'General case' 0 N--CA 1.427 -1.62 1 N-CA-C 96.717 -5.29 . . . . 0.0 96.717 168.251 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.94 -42.87 1.43 Allowed Glycine 0 CA--C 1.49 -1.529 1 N-CA-C 100.651 -4.98 . . . . 0.0 100.651 -160.786 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.94 -145.19 0.28 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.159 -3.274 . . . . 0.0 102.159 157.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 51.9 tttm -157.48 -170.77 3.34 Favored 'General case' 0 N--CA 1.428 -1.554 1 N-CA-C 97.513 -4.995 . . . . 0.0 97.513 -174.378 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 34.7 t -65.52 147.35 53.56 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 126.284 1.834 . . . . 0.0 110.031 -178.486 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.559 ' HD1' ' HB2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -156.03 102.69 2.17 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 167.688 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -66.63 125.09 24.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 124.693 1.197 . . . . 0.0 110.137 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.062 0 O-C-N 123.424 0.453 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 177.71 7.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 172.704 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -129.58 139.76 51.39 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 97.621 -4.955 . . . . 0.0 97.621 171.556 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 179.16 37.5 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 177.58 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -78.04 128.67 34.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 162.411 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 tt -90.76 140.76 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.385 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.65 -162.47 0.96 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.229 3.012 . . . . 0.0 107.755 174.54 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -144.05 170.37 8.51 Favored Pre-proline 0 N--CA 1.42 -1.953 1 N-CA-C 96.886 -5.227 . . . . 0.0 96.886 175.364 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -64.28 152.58 80.76 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.221 1.948 . . . . 0.0 111.314 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.61 -49.21 9.42 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 127.1 2.16 . . . . 0.0 107.544 -1.203 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -146.2 139.49 25.9 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 92.096 -7.002 . . . . 0.0 92.096 169.153 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.2 m -175.83 -158.44 0.06 Allowed 'General case' 0 CA--C 1.488 -1.408 1 N-CA-C 100.024 -4.065 . . . . 0.0 100.024 -174.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.14 155.14 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 N-CA-C 97.509 -4.997 . . . . 0.0 97.509 164.992 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.27 153.22 20.63 Favored 'General case' 0 CA--C 1.494 -1.191 1 N-CA-C 100.136 -4.024 . . . . 0.0 100.136 166.044 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -102.07 -173.13 2.27 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.4 t -140.24 154.37 46.85 Favored 'General case' 0 N--CA 1.417 -2.093 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 -171.125 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -115.93 121.39 34.08 Favored Pre-proline 0 N--CA 1.419 -1.988 1 N-CA-C 96.816 -5.253 . . . . 0.0 96.816 167.561 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -56.86 129.2 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 122.972 2.097 . . . . 0.0 112.846 -174.429 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.31 -46.78 1.04 Allowed Glycine 0 CA--C 1.491 -1.424 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -164.41 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 m 92.69 2.41 0.08 Allowed 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 127.496 2.318 . . . . 0.0 112.093 171.289 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -34.65 77.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.835 1.198 . . . . 0.0 111.469 -173.795 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.09 -48.89 50.79 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 175.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.21 -49.78 76.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.378 1.471 . . . . 0.0 109.182 179.418 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.52 -45.37 73.34 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.345 1.458 . . . . 0.0 111.751 177.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 m -63.88 -43.87 94.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.72 -36.47 67.79 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.769 0.795 . . . . 0.0 109.953 -176.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -62.61 -46.5 88.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.739 1.216 . . . . 0.0 110.448 173.358 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.18 -45.78 86.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 123.969 0.908 . . . . 0.0 110.051 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -95.33 -4.29 45.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.145 0.978 . . . . 0.0 109.972 179.425 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.02 12.53 31.53 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 168.139 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.91 127.38 8.39 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 177.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 p -97.0 5.04 51.18 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.879 -0.777 . . . . 0.0 110.041 -169.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -160.48 158.1 28.74 Favored 'General case' 0 CA--C 1.479 -1.752 1 N-CA-C 99.159 -4.385 . . . . 0.0 99.159 166.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.31 168.4 41.41 Favored Glycine 0 N--CA 1.417 -2.633 1 N-CA-C 98.628 -5.789 . . . . 0.0 98.628 -178.541 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 8.1 p-80 -166.77 173.83 9.18 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 97.064 -5.162 . . . . 0.0 97.064 -179.871 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.0 m -94.95 162.28 13.8 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.548 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.11 174.09 40.98 Favored Glycine 0 N--CA 1.421 -2.304 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 178.533 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -117.79 138.14 52.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 101.544 -3.502 . . . . 0.0 101.544 -177.156 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -98.47 -29.14 13.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.18 0.99 . . . . 0.0 109.483 -175.349 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t 70.62 176.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 105.468 -165.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.76 -65.42 3.92 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 120.137 -1.602 . . . . 0.0 109.931 172.572 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -91.36 -53.33 4.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 172.131 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.84 -128.46 3.46 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 171.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.47 127.42 32.67 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.435 2.694 . . . . 0.0 106.665 -177.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.36 176.88 7.6 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -166.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.8 t -117.55 158.96 23.66 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 100.301 -3.962 . . . . 0.0 100.301 174.038 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 19.4 t-105 -124.07 150.34 45.11 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.444 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.2 m -140.07 152.75 46.43 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.623 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.17 138.35 51.34 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 169.671 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.71 50.13 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.942 2.097 . . . . 0.0 111.072 166.852 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.1 133.29 32.14 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.95 176.12 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.321 2.014 . . . . 0.0 110.715 176.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.4 2.44 25.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.075 0.95 . . . . 0.0 112.732 -170.734 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -95.93 5.26 51.66 Favored 'General case' 0 CA--C 1.503 -0.849 0 O-C-N 121.098 -1.001 . . . . 0.0 108.847 175.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.49 167.39 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 175.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.61 163.1 29.54 Favored Glycine 0 CA--C 1.485 -1.827 1 N-CA-C 98.319 -5.912 . . . . 0.0 98.319 -177.039 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -154.12 -164.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 -161.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 mm -65.4 121.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 123.979 0.912 . . . . 0.0 111.013 -163.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.64 155.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.308 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -157.41 167.93 28.82 Favored 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 96.855 -5.239 . . . . 0.0 96.855 177.624 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 24.68 52.43 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -151.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 176.48 -165.33 0.03 OUTLIER 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 94.276 -6.194 . . . . 0.0 94.276 -167.392 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -165.81 -153.3 0.17 Allowed 'General case' 0 N--CA 1.432 -1.374 1 N-CA-C 99.079 -4.415 . . . . 0.0 99.079 177.967 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.9 t -82.34 142.74 31.78 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 125.832 1.653 . . . . 0.0 107.202 -176.064 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -157.61 153.31 26.62 Favored 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 172.548 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.5 m 1.67 68.14 0.0 OUTLIER 'General case' 0 C--N 1.358 0.961 0 C-N-CA 130.646 3.579 . . . . 0.0 117.353 -169.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.362 1.13 0 CA-C-N 116.766 -0.197 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.223 0.535 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 176.68 5.28 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 159.294 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -129.75 144.34 51.25 Favored 'General case' 0 CA--C 1.481 -1.675 1 N-CA-C 95.169 -5.863 . . . . 0.0 95.169 171.903 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 -178.24 35.47 Favored Glycine 0 CA--C 1.473 -2.593 0 N-CA-C 103.957 -3.657 . . . . 0.0 103.957 175.879 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -76.73 137.75 39.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 156.68 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 tt -90.52 137.82 20.79 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.357 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.36 -154.62 0.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 127.245 2.218 . . . . 0.0 107.946 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -122.7 148.77 54.3 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 95.604 -5.702 . . . . 0.0 95.604 170.138 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -68.96 145.57 62.22 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 122.691 1.997 . . . . 0.0 109.025 -176.761 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -89.07 -42.52 11.68 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.881 2.472 . . . . 0.0 110.085 12.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -153.97 140.09 18.41 Favored 'General case' 0 N--CA 1.424 -1.746 1 N-CA-C 92.212 -6.959 . . . . 0.0 92.212 178.459 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -178.35 -151.53 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 95.515 -5.735 . . . . 0.0 95.515 178.321 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.91 -178.34 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 163.177 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -152.67 0.32 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 166.758 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -143.18 161.2 38.85 Favored 'General case' 0 N--CA 1.422 -1.846 1 N-CA-C 94.601 -6.074 . . . . 0.0 94.601 153.005 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -160.54 -157.7 0.56 Allowed 'General case' 0 N--CA 1.42 -1.974 1 N-CA-C 96.077 -5.527 . . . . 0.0 96.077 -176.682 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -147.1 172.4 5.24 Favored Pre-proline 0 N--CA 1.418 -2.045 1 N-CA-C 99.865 -4.124 . . . . 0.0 99.865 -161.317 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.92 63.55 4.03 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 124.311 2.575 . . . . 0.0 111.386 170.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.87 148.65 5.68 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 101.578 -4.609 . . . . 0.0 101.578 174.181 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -83.98 60.97 6.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 118.166 0.983 . . . . 0.0 108.675 178.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -69.94 -65.21 0.75 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -173.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.8 -22.42 57.95 Favored Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 177.084 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -79.48 -10.74 59.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.261 -1.141 . . . . 0.0 110.992 -174.139 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.4 -51.99 67.53 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 120.428 1.467 . . . . 0.0 108.649 174.746 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -72.28 -40.76 67.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.151 -177.405 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.27 -42.93 96.42 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 118.659 0.663 . . . . 0.0 112.565 179.055 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.31 -44.39 91.72 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -69.29 -43.47 73.75 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 121.439 -0.788 . . . . 0.0 111.679 -178.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -69.42 -28.49 66.18 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 119.544 1.065 . . . . 0.0 112.829 -177.675 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -87.51 -4.01 58.99 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.664 0.665 . . . . 0.0 110.558 175.609 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.91 29.4 8.11 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 162.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.21 149.32 17.89 Favored Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 171.1 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 p -79.33 -50.45 10.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.174 0.988 . . . . 0.0 109.88 -167.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -160.17 176.83 11.32 Favored 'General case' 0 N--CA 1.422 -1.844 1 N-CA-C 98.699 -4.556 . . . . 0.0 98.699 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.27 46.22 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 103.68 -3.768 . . . . 0.0 103.68 -169.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -146.98 -177.77 5.84 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.754 -4.906 . . . . 0.0 97.754 -169.252 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.3 m -136.96 160.75 37.97 Favored 'General case' 0 CA--C 1.479 -1.766 1 N-CA-C 99.549 -4.241 . . . . 0.0 99.549 171.529 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.09 179.26 47.37 Favored Glycine 0 N--CA 1.424 -2.136 1 N-CA-C 99.841 -5.304 . . . . 0.0 99.841 -174.318 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -93.18 150.58 20.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 -172.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -118.15 116.09 26.13 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 170.838 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.36 128.57 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -16.57 26.09 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -175.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -127.52 -85.49 0.59 Allowed 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.8 -162.56 34.9 Favored Glycine 0 N--CA 1.426 -1.971 1 N-CA-C 102.91 -4.076 . . . . 0.0 102.91 -169.685 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.18 147.73 52.9 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.152 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.79 -176.08 5.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -165.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -128.18 166.13 19.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 175.869 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -125.71 143.27 51.11 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 177.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.3 m -135.83 139.9 43.79 Favored 'General case' 0 CA--C 1.487 -1.465 1 N-CA-C 99.898 -4.112 . . . . 0.0 99.898 175.045 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -104.49 30.98 4.95 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.105 0.955 . . . . 0.0 108.929 -168.054 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.62 146.95 1.75 Allowed 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 94.036 -6.283 . . . . 0.0 94.036 165.911 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.53 151.67 64.3 Favored Pre-proline 0 N--CA 1.427 -1.591 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 141.79 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.41 174.01 13.28 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 122.158 1.905 . . . . 0.0 110.168 164.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -65.04 -11.66 41.73 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 126.454 1.902 . . . . 0.0 115.116 -172.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.3 -0.08 57.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.255 -0.903 . . . . 0.0 111.036 -175.543 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.29 142.51 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 -176.488 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.49 155.19 16.5 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 104.679 -3.368 . . . . 0.0 104.679 -176.668 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 pt -143.44 -155.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -161.583 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -83.57 154.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -172.88 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.2 173.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.628 1 N-CA-C 96.763 -5.273 . . . . 0.0 96.763 171.208 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -156.91 158.7 37.16 Favored 'General case' 0 N--CA 1.43 -1.472 1 N-CA-C 98.108 -4.775 . . . . 0.0 98.108 168.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 -40.61 2.42 Favored Glycine 0 CA--C 1.495 -1.197 1 N-CA-C 102.211 -4.356 . . . . 0.0 102.211 -162.989 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' CE1' ' A' ' 66' ' ' HIS . 7.0 tp10 -91.74 -153.39 0.33 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 157.752 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -168.85 -167.75 0.79 Allowed 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 98.748 -4.538 . . . . 0.0 98.748 -175.677 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.5 t -71.41 125.27 26.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.553 1.541 . . . . 0.0 107.77 -176.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.425 ' CE1' ' HG2' ' A' ' 63' ' ' GLU . 8.2 p-80 -155.51 145.96 21.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 m -160.72 175.57 12.48 Favored 'General case' 0 N--CA 1.428 -1.564 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 -176.012 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.037 0 O-C-N 124.007 0.817 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.34 169.68 10.36 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 176.109 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -134.83 137.0 42.91 Favored 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 96.437 -5.394 . . . . 0.0 96.437 169.735 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.49 23.03 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 105.312 -3.115 . . . . 0.0 105.312 172.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 72.2 m-85 -82.38 137.41 34.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 163.272 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -91.65 140.89 15.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.7 -155.09 0.46 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.215 3.406 . . . . 0.0 110.406 -177.766 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -132.92 154.03 81.24 Favored Pre-proline 0 N--CA 1.429 -1.512 1 N-CA-C 96.211 -5.478 . . . . 0.0 96.211 165.511 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -67.25 135.12 35.9 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.889 2.393 . . . . 0.0 107.884 168.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -90.57 -55.14 3.7 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 121.881 2.128 . . . . 0.0 110.752 20.227 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -149.3 132.6 16.5 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 92.971 -6.678 . . . . 0.0 92.971 177.667 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -169.01 0.26 Allowed 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 -174.799 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.75 160.95 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 167.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -161.26 0.32 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 162.522 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.79 158.7 43.37 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.39 -5.411 . . . . 0.0 96.39 165.11 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.39 168.06 18.23 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 -167.908 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -114.02 114.18 46.37 Favored Pre-proline 0 N--CA 1.42 -1.942 1 N-CA-C 99.576 -4.231 . . . . 0.0 99.576 174.309 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -57.89 125.72 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.576 2.184 . . . . 0.0 112.268 -176.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.15 -56.93 0.67 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 100.357 -5.097 . . . . 0.0 100.357 -162.419 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m 117.7 -34.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 129.48 3.112 . . . . 0.0 107.676 173.466 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.37 -51.22 2.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.86 2.864 . . . . 0.0 116.238 -159.375 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.48 -43.94 75.28 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.559 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.34 -23.08 26.35 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -170.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.79 -37.65 85.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.353 1.061 . . . . 0.0 108.522 168.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.9 m -69.46 -40.21 77.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.799 -0.563 . . . . 0.0 109.981 174.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.89 -38.03 89.63 Favored 'General case' 0 C--N 1.359 1.012 0 O-C-N 121.277 -0.889 . . . . 0.0 111.404 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -52.85 -48.56 66.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.01 1.324 . . . . 0.0 110.357 170.008 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -65.15 -41.85 94.36 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.463 -0.773 . . . . 0.0 112.446 -175.05 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.34 -9.44 58.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.137 -0.977 . . . . 0.0 111.906 -177.301 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -103.43 7.3 38.02 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.245 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.7 20.26 34.88 Favored Glycine 0 CA--C 1.491 -1.466 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.922 167.238 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.37 148.26 22.87 Favored Glycine 0 CA--C 1.49 -1.531 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 170.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.5 m -88.79 -32.72 17.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -168.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.7 m -160.69 -177.88 6.48 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 98.783 -4.525 . . . . 0.0 98.783 170.357 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.42 -169.87 37.67 Favored Glycine 0 CA--C 1.466 -3.031 1 N-CA-C 102.247 -4.341 . . . . 0.0 102.247 -172.471 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.41 -160.43 0.77 Allowed 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 98.835 -4.506 . . . . 0.0 98.835 -169.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.04 170.96 17.65 Favored 'General case' 0 CA--C 1.472 -2.047 1 N-CA-C 99.085 -4.413 . . . . 0.0 99.085 175.328 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.45 -170.8 41.02 Favored Glycine 0 N--CA 1.419 -2.487 1 N-CA-C 98.031 -6.027 . . . . 0.0 98.031 -173.751 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -124.08 150.04 45.46 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 100.765 -3.791 . . . . 0.0 100.765 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -123.05 98.99 6.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 173.763 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.86 122.93 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.69 -40.57 1.53 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -165.385 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -124.43 -63.59 1.18 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.508 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.24 -158.91 31.04 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -172.239 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.43 146.62 53.02 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.566 2.347 . . . . 0.0 105.523 176.748 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.66 -177.22 6.23 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -170.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.9 m -122.66 173.73 7.54 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 102.115 -3.291 . . . . 0.0 102.115 170.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 7.6 t-105 -131.33 148.17 52.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -175.104 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.4 m -134.11 149.06 51.07 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.248 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.6 134.15 55.17 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 171.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.26 71.82 0.54 Allowed 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.345 2.258 . . . . 0.0 111.514 174.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.9 135.56 19.41 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 170.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -72.78 176.86 8.35 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 122.65 1.982 . . . . 0.0 112.253 177.01 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.61 9.84 3.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.743 0.817 . . . . 0.0 112.752 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -95.89 -0.81 50.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 121.241 -0.912 . . . . 0.0 108.566 176.025 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.2 170.37 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 -178.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.02 163.14 28.37 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.009 -6.036 . . . . 0.0 98.009 177.233 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 pt -159.28 -170.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.391 -3.929 . . . . 0.0 100.391 -160.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.5 mt -76.15 116.32 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 126.28 1.832 . . . . 0.0 111.517 -162.975 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.7 163.85 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 160.546 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.04 158.62 43.59 Favored 'General case' 0 CA--C 1.484 -1.591 1 N-CA-C 97.906 -4.85 . . . . 0.0 97.906 173.539 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.77 -30.85 5.57 Favored Glycine 0 CA--C 1.493 -1.323 0 N-CA-C 104.835 -3.306 . . . . 0.0 104.835 -163.236 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -96.96 -106.68 0.17 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -169.18 -163.97 0.44 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 -171.678 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 39.4 t -123.89 120.76 33.48 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 98.722 -4.548 . . . . 0.0 98.722 178.736 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 106.46 3.76 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 179.435 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 m -83.08 137.59 34.04 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.876 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.468 0.651 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.6 165.93 12.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.161 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -137.02 132.47 34.29 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 97.452 -5.018 . . . . 0.0 97.452 171.988 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -168.5 24.01 Favored Glycine 0 CA--C 1.48 -2.098 1 N-CA-C 102.755 -4.138 . . . . 0.0 102.755 175.015 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.06 142.42 34.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 159.182 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.45 150.92 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.232 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.32 176.39 12.21 Favored 'General case' 0 N--CA 1.421 -1.887 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 179.12 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -84.2 159.93 58.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 171.009 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -61.76 110.98 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.468 2.779 . . . . 0.0 110.594 171.416 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -131.76 131.21 42.77 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 129.178 2.991 . . . . 0.0 104.378 2.539 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 67.39 16.43 10.04 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.905 1.336 . . . . 0.0 111.573 171.451 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.1 m -96.19 88.99 4.98 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 179.654 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.29 159.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -159.899 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -166.57 1.49 Allowed 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.628 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -150.45 177.47 9.97 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 96.31 -5.441 . . . . 0.0 96.31 172.456 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -157.25 157.59 34.55 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.626 -5.694 . . . . 0.0 95.626 -175.038 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -118.61 122.08 30.29 Favored Pre-proline 0 N--CA 1.426 -1.674 0 N-CA-C 100.424 -3.917 . . . . 0.0 100.424 -175.654 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.95 130.05 38.2 Favored 'Trans proline' 0 CA--C 1.507 -0.837 0 C-N-CA 122.474 2.116 . . . . 0.0 112.994 -174.723 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.06 -48.61 0.95 Allowed Glycine 0 CA--C 1.492 -1.402 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -159.941 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.253 15.0 m 96.26 -12.43 0.09 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 128.551 2.74 . . . . 0.0 111.603 172.577 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -44.85 -48.12 11.09 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 127.377 2.271 . . . . 0.0 115.904 -166.793 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.87 -38.36 41.88 Favored Glycine 0 C--N 1.351 1.389 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -174.913 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.39 -23.92 50.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.137 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.11 -47.6 80.67 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.785 0.834 . . . . 0.0 109.35 173.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -47.2 86.7 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.034 -1.041 . . . . 0.0 112.77 172.104 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.03 -42.36 97.11 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 122.039 0.923 . . . . 0.0 111.297 -175.169 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.38 -42.99 97.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.19 0.996 . . . . 0.0 109.998 178.831 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -63.9 -43.5 95.77 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 117.954 0.343 . . . . 0.0 111.449 -179.474 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -76.61 -20.5 56.69 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 118.554 0.616 . . . . 0.0 111.888 -175.779 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -84.53 -14.5 48.78 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.243 0.617 . . . . 0.0 110.499 172.962 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 27.29 5.97 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 166.575 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.66 134.73 12.31 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 175.053 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 p -103.99 12.94 33.59 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 -167.15 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.38 156.44 26.16 Favored 'General case' 0 CA--C 1.482 -1.644 1 N-CA-C 98.929 -4.471 . . . . 0.0 98.929 161.1 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.41 162.51 32.8 Favored Glycine 0 CA--C 1.47 -2.772 1 N-CA-C 98.675 -5.77 . . . . 0.0 98.675 -179.056 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -174.83 175.36 2.4 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 -174.479 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.3 m -87.0 160.0 18.79 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.333 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.95 172.0 44.81 Favored Glycine 0 N--CA 1.425 -2.035 1 N-CA-C 96.73 -6.548 . . . . 0.0 96.73 176.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -154.73 148.64 25.65 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 98.098 -4.778 . . . . 0.0 98.098 174.208 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -179.01 47.84 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 100.367 -3.938 . . . . 0.0 100.367 163.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -171.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -164.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.14 64.93 0.39 Allowed Glycine 0 CA--C 1.489 -1.569 1 N-CA-C 102.126 -4.389 . . . . 0.0 102.126 179.011 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -160.7 -165.72 1.46 Allowed 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.391 -5.411 . . . . 0.0 96.391 -177.434 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.94 -48.32 33.95 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -177.486 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -174.29 1.65 Allowed 'General case' 0 N--CA 1.432 -1.351 1 N-CA-C 96.748 -5.278 . . . . 0.0 96.748 171.709 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.2 168.28 20.91 Favored 'General case' 0 CA--C 1.49 -1.332 1 N-CA-C 96.554 -5.35 . . . . 0.0 96.554 177.701 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.5 t -125.1 157.97 35.01 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 -171.353 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -93.82 148.9 21.7 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.378 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 m -141.31 148.76 40.27 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 167.35 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 137.55 54.0 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 -176.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.57 55.38 0.63 Allowed 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.677 1.591 . . . . 0.0 110.741 174.16 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 mt -92.58 135.77 26.07 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.393 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.45 166.27 30.3 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.803 2.336 . . . . 0.0 108.965 177.318 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -87.42 41.29 0.97 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -171.979 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.83 -0.12 12.36 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 169.666 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.47 151.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 -178.228 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.78 147.66 18.99 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 98.282 -5.927 . . . . 0.0 98.282 -179.772 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 pt -145.3 -138.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -156.961 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.44 146.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.459 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG12 ' HE1' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -146.07 160.7 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 2 N-CA-C 94.158 -6.238 . . . . 0.0 94.158 172.521 . . . . . . . . 4 4 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 24.7 tt0 -164.36 178.03 7.79 Favored 'General case' 0 CA--C 1.488 -1.439 1 N-CA-C 99.597 -4.223 . . . . 0.0 99.597 169.978 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . 88.35 23.45 37.16 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 105.428 -3.069 . . . . 0.0 105.428 -153.266 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -176.83 -159.61 0.06 Allowed 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 97.43 -5.026 . . . . 0.0 97.43 -166.798 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.75 -167.23 2.53 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.732 -4.544 . . . . 0.0 98.732 -176.3 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.38 127.84 33.75 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 126.384 1.873 . . . . 0.0 108.807 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.433 ' HE1' HG12 ' A' ' 60' ' ' VAL . 38.9 p-80 -149.32 159.06 44.6 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 101.669 -3.456 . . . . 0.0 101.669 176.917 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 t -169.16 -176.98 2.74 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 178.182 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.894 0 O-C-N 124.937 1.398 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.894 0.378 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.554 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -137.62 -176.87 4.56 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.803 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -133.61 143.51 48.68 Favored 'General case' 0 CA--C 1.49 -1.354 1 N-CA-C 97.492 -5.003 . . . . 0.0 97.492 176.454 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 177.45 37.88 Favored Glycine 0 CA--C 1.48 -2.107 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 178.233 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -79.28 127.91 32.66 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 156.601 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -89.67 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -172.599 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.1 -146.49 0.27 Allowed 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 126.824 2.577 . . . . 0.0 109.438 178.111 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -149.81 167.75 12.39 Favored Pre-proline 0 N--CA 1.424 -1.761 1 N-CA-C 95.989 -5.56 . . . . 0.0 95.989 175.153 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.96 151.14 86.84 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.298 2.666 . . . . 0.0 107.686 158.187 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HG3' ' CE1' ' A' ' 66' ' ' HIS . 57.3 mm-40 -81.87 -51.13 8.41 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 128.12 2.568 . . . . 0.0 109.033 7.181 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -145.66 147.59 32.17 Favored 'General case' 0 N--CA 1.421 -1.914 1 N-CA-C 92.149 -6.982 . . . . 0.0 92.149 162.598 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.49 -164.41 0.22 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -173.641 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.75 161.76 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 1 N-CA-C 96.718 -5.29 . . . . 0.0 96.718 161.509 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -151.93 0.07 Allowed 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 163.501 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -139.35 177.72 7.72 Favored 'General case' 0 CA--C 1.478 -1.813 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 163.825 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.9 t -138.14 162.4 34.33 Favored 'General case' 0 N--CA 1.415 -2.198 1 N-CA-C 97.347 -5.057 . . . . 0.0 97.347 -174.424 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -116.1 112.67 41.97 Favored Pre-proline 0 N--CA 1.418 -2.053 1 N-CA-C 96.031 -5.544 . . . . 0.0 96.031 172.296 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -70.45 49.53 0.87 Allowed 'Trans proline' 0 CA--C 1.517 -0.374 0 CA-C-N 124.402 2.608 . . . . 0.0 115.351 -173.663 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.31 16.78 6.67 Favored Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 168.607 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m 74.24 -52.82 0.69 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 127.362 2.265 . . . . 0.0 112.12 172.42 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.05 -41.52 59.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.317 2.247 . . . . 0.0 115.815 -170.955 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.82 60.88 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.154 -0.966 . . . . 0.0 111.496 -176.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.76 -47.87 24.13 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.128 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -56.58 -43.21 79.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.255 0.622 . . . . 0.0 110.193 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -57.14 -47.71 80.46 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.077 -1.014 . . . . 0.0 112.164 176.333 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.3 mt -65.38 -43.03 91.97 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-O 121.834 0.826 . . . . 0.0 110.206 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -57.42 -45.98 84.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.162 0.985 . . . . 0.0 110.762 176.422 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.95 -44.33 80.87 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 122.717 0.407 . . . . 0.0 110.322 -176.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.31 -30.51 66.32 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 118.381 0.537 . . . . 0.0 111.96 -177.049 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -77.74 -33.51 52.87 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.515 -0.741 . . . . 0.0 109.965 176.219 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.22 43.05 0.49 Allowed Glycine 0 CA--C 1.489 -1.589 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 161.492 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.31 139.94 14.67 Favored Glycine 0 C--N 1.353 1.528 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 164.778 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 p -96.24 -1.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.038 0.923 . . . . 0.0 109.96 -168.04 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -160.34 168.19 25.81 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 97.528 -4.99 . . . . 0.0 97.528 171.404 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.36 -177.83 37.35 Favored Glycine 0 CA--C 1.468 -2.869 1 N-CA-C 100.329 -5.108 . . . . 0.0 100.329 -175.655 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -159.0 -176.78 6.06 Favored 'General case' 0 N--CA 1.423 -1.799 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 -175.885 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -139.91 150.29 44.39 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 95.853 -5.61 . . . . 0.0 95.853 -176.755 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.97 -176.89 46.32 Favored Glycine 0 N--CA 1.423 -2.177 1 N-CA-C 102.127 -4.389 . . . . 0.0 102.127 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -118.16 141.48 48.45 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 99.803 -4.147 . . . . 0.0 99.803 -178.24 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -94.83 -28.98 14.96 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.692 1.234 . . . . 0.0 108.915 -177.574 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 42' ' ' GLY . 2.6 t 72.04 -166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 129.895 3.278 . . . . 0.0 103.372 -165.158 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 75.74 -69.98 2.04 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 120.387 -1.446 . . . . 0.0 110.505 176.818 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -99.65 -57.33 2.17 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.047 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.09 -138.83 5.54 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 118.576 -1.773 . . . . 0.0 110.588 -178.047 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 tp -80.74 144.36 32.22 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -177.477 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.14 -179.9 7.39 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 102.9 -3.0 . . . . 0.0 102.9 -170.118 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -115.88 165.49 13.03 Favored 'General case' 0 CA--C 1.496 -1.1 1 N-CA-C 98.945 -4.465 . . . . 0.0 98.945 175.49 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -129.67 150.87 50.8 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 54.4 m -142.57 149.53 39.17 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.24 138.99 51.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 172.283 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.17 67.65 0.72 Allowed 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.884 2.473 . . . . 0.0 110.539 179.164 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.91 139.64 21.42 Favored Pre-proline 0 CA--C 1.496 -1.112 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 171.108 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -70.32 162.38 42.57 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.279 1.986 . . . . 0.0 110.567 165.166 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.16 -37.54 72.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.9 2.08 . . . . 0.0 115.164 -163.966 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -83.61 -5.86 59.29 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.869 -1.144 . . . . 0.0 110.591 -172.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.54 99.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 178.061 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.554 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -83.49 166.27 43.5 Favored Glycine 0 CA--C 1.489 -1.569 0 CA-C-O 122.036 0.798 . . . . 0.0 112.163 -161.823 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.9 pt -147.35 -178.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 -164.67 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 mm -69.29 103.91 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 124.819 1.248 . . . . 0.0 110.216 -166.841 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.05 170.92 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 101.527 -3.509 . . . . 0.0 101.527 167.163 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.2 163.67 39.87 Favored 'General case' 0 N--CA 1.427 -1.601 1 N-CA-C 97.768 -4.901 . . . . 0.0 97.768 174.833 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.87 -33.87 4.42 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 103.923 -3.671 . . . . 0.0 103.923 -162.385 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.02 -115.54 0.22 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 175.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -176.47 -153.8 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.475 1 N-CA-C 97.48 -5.007 . . . . 0.0 97.48 -171.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 34.8 t -120.39 123.6 43.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 -179.896 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.436 ' CE1' ' HG3' ' A' ' 10' ' ' GLU . 14.8 p80 -149.77 150.2 31.67 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 171.177 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t -170.46 -175.6 1.94 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 96.08 -5.526 . . . . 0.0 96.08 -172.17 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.906 0 O-C-N 125.062 1.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.139 0.495 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.487 HH21 ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.2 -178.79 6.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -128.9 132.06 47.66 Favored 'General case' 0 CA--C 1.494 -1.175 1 N-CA-C 99.008 -4.441 . . . . 0.0 99.008 171.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 175.41 38.17 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -77.26 128.04 33.66 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -91.0 139.93 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.6 -129.13 0.24 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.443 -1.708 . . . . 0.0 107.915 169.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -145.34 154.47 53.46 Favored Pre-proline 0 N--CA 1.415 -2.206 1 N-CA-C 95.337 -5.801 . . . . 0.0 95.337 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 82.2 Cg_exo -68.64 110.14 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.837 2.358 . . . . 0.0 110.551 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 52.9 mm-40 -145.64 162.16 38.15 Favored 'General case' 0 CA--C 1.484 -1.564 1 N-CA-C 98.039 -4.8 . . . . 0.0 98.039 4.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.17 27.05 0.91 Allowed 'General case' 0 C--N 1.359 0.985 0 CA-C-O 123.169 1.462 . . . . 0.0 108.887 162.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.9 m -118.99 -158.19 0.72 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.06 168.07 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 1 N-CA-C 95.594 -5.706 . . . . 0.0 95.594 161.161 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.15 -170.3 2.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -131.76 151.65 51.5 Favored 'General case' 0 CA--C 1.478 -1.799 1 N-CA-C 97.244 -5.095 . . . . 0.0 97.244 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' H ' HD22 ' A' ' 45' ' ' LEU . 9.1 t -116.65 163.4 16.18 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 -171.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -113.43 112.87 48.67 Favored Pre-proline 0 N--CA 1.419 -2.017 1 N-CA-C 98.034 -4.802 . . . . 0.0 98.034 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.74 130.72 40.04 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.293 1.996 . . . . 0.0 111.88 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.56 -56.72 0.73 Allowed Glycine 0 CA--C 1.484 -1.852 1 N-CA-C 101.659 -4.576 . . . . 0.0 101.659 -163.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m 119.42 -23.87 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.98 2.912 . . . . 0.0 107.134 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -61.77 0.74 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.381 2.272 . . . . 0.0 115.763 -154.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.56 -39.68 60.46 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.916 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -29.29 51.83 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 117.643 0.721 . . . . 0.0 109.593 -168.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.55 -49.41 77.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.63 1.172 . . . . 0.0 109.861 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -63.87 -34.34 77.72 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.75 -0.594 . . . . 0.0 112.228 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.16 -40.84 94.87 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.043 0.925 . . . . 0.0 110.685 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.03 -44.63 94.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.592 0.757 . . . . 0.0 110.612 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.36 -21.44 56.09 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 119.239 0.927 . . . . 0.0 111.567 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -84.13 -41.3 17.23 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.605 -0.685 . . . . 0.0 109.39 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.08 48.0 0.1 OUTLIER Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.6 137.81 13.88 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 104.781 -3.328 . . . . 0.0 104.781 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -0.07 56.79 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.323 1.049 . . . . 0.0 110.768 -168.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 m -159.38 164.2 34.89 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 100.012 -4.07 . . . . 0.0 100.012 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.05 169.66 39.02 Favored Glycine 0 N--CA 1.424 -2.16 1 N-CA-C 98.043 -6.023 . . . . 0.0 98.043 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -164.55 -171.42 2.33 Favored 'General case' 0 N--CA 1.438 -1.072 1 N-CA-C 100.043 -4.058 . . . . 0.0 100.043 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.8 m -98.9 174.58 6.3 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 166.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.05 43.28 Favored Glycine 0 N--CA 1.427 -1.933 1 N-CA-C 102.025 -4.43 . . . . 0.0 102.025 168.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -134.84 142.45 46.64 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.741 -4.54 . . . . 0.0 98.741 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -126.22 107.36 10.29 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.14 124.04 25.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.9 -81.27 0.22 Allowed Glycine 0 CA--C 1.482 -2.003 1 N-CA-C 100.92 -4.872 . . . . 0.0 100.92 -164.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -87.34 -59.25 2.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.99 -140.38 7.23 Favored Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -65.69 143.57 57.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.974 2.109 . . . . 0.0 106.271 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.25 -174.58 4.86 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.71 -179.99 4.91 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -132.43 151.24 51.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 -175.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.44 136.4 33.0 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -105.96 135.7 46.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.03 40.58 3.96 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.934 1.693 . . . . 0.0 112.031 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 tp -81.92 138.89 46.31 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 165.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -70.19 165.53 31.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.262 1.975 . . . . 0.0 110.833 170.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.41 -5.2 57.65 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 123.93 0.892 . . . . 0.0 110.989 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.66 16.73 10.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.244 1.017 . . . . 0.0 109.837 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.57 162.21 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 N-CA-C 95.134 -5.876 . . . . 0.0 95.134 170.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.99 -177.41 35.96 Favored Glycine 0 CA--C 1.475 -2.44 0 C-N-CA 115.877 -3.059 . . . . 0.0 107.699 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.487 ' CG2' HH21 ' A' ' 2' ' ' ARG . 46.7 pt -142.26 -152.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 114.694 -0.753 . . . . 0.0 110.873 -141.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -75.25 132.56 33.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 N--CA 1.423 -1.802 1 N-CA-C 94.813 -5.995 . . . . 0.0 94.813 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 175.89 12.51 Favored 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.274 -5.454 . . . . 0.0 96.274 169.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -125.15 141.81 51.88 Favored 'General case' 0 CA--C 1.487 -1.475 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -176.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.26 179.02 36.96 Favored Glycine 0 CA--C 1.47 -2.766 0 N-CA-C 103.996 -3.642 . . . . 0.0 103.996 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -81.8 129.79 34.85 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.0 tt -79.25 129.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.88 -169.63 1.49 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 112.055 -2.339 . . . . 0.0 107.615 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.75 151.94 37.64 Favored Pre-proline 0 N--CA 1.434 -1.243 1 N-CA-C 99.601 -4.222 . . . . 0.0 99.601 167.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.34 140.83 78.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 162.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.49 -42.31 10.34 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 121.604 2.002 . . . . 0.0 108.744 12.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -151.97 142.74 22.9 Favored 'General case' 0 N--CA 1.417 -2.077 1 N-CA-C 93.663 -6.421 . . . . 0.0 93.663 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.2 m -179.79 -155.41 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.269 -4.345 . . . . 0.0 99.269 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.72 HG12 HD12 ' A' ' 59' ' ' ILE . 15.9 m -131.42 167.96 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 1 N-CA-C 97.011 -5.181 . . . . 0.0 97.011 160.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.93 -166.37 1.37 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 163.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.29 166.95 20.07 Favored 'General case' 0 CA--C 1.484 -1.595 1 N-CA-C 98.067 -4.79 . . . . 0.0 98.067 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.15 167.24 28.36 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -128.7 129.7 23.5 Favored Pre-proline 0 N--CA 1.423 -1.818 1 N-CA-C 99.835 -4.135 . . . . 0.0 99.835 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -54.59 123.68 14.27 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.778 2.319 . . . . 0.0 112.696 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.48 -46.69 1.06 Allowed Glycine 0 CA--C 1.488 -1.61 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 -166.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m 92.11 0.09 0.13 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 127.492 2.317 . . . . 0.0 113.238 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -44.43 81.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.563 1.945 . . . . 0.0 112.905 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.18 -46.27 44.07 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -79.31 -22.03 45.15 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.823 1.312 . . . . 0.0 110.717 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -55.17 -41.51 71.98 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.229 0.922 . . . . 0.0 109.829 166.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 m -63.35 -45.7 89.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.816 -0.553 . . . . 0.0 110.205 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.29 -41.23 96.99 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 122.717 1.246 . . . . 0.0 110.039 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.62 -41.27 98.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 109.946 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -71.77 -37.15 70.53 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.14 -31.16 62.62 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.719 -0.613 . . . . 0.0 111.267 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -85.91 -16.9 37.02 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.537 -0.727 . . . . 0.0 111.073 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 43.07 2.24 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 165.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.57 142.74 16.19 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 167.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -34.01 66.86 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 129.123 2.969 . . . . 0.0 110.504 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 m -160.12 165.95 30.72 Favored 'General case' 0 N--CA 1.421 -1.922 1 N-CA-C 97.944 -4.836 . . . . 0.0 97.944 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.31 165.47 37.02 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.945 -6.062 . . . . 0.0 97.945 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -166.91 178.95 5.52 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.576 -4.602 . . . . 0.0 98.576 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.14 161.4 26.49 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.71 40.48 Favored Glycine 0 N--CA 1.421 -2.321 1 N-CA-C 98.463 -5.855 . . . . 0.0 98.463 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.85 165.46 32.22 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 96.932 -5.21 . . . . 0.0 96.932 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -114.36 -9.28 12.79 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.216 1.006 . . . . 0.0 108.998 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t 73.38 132.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 107.126 -160.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.06 -104.98 0.29 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -69.51 -77.27 0.08 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.076 0.951 . . . . 0.0 112.909 -169.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.39 -50.61 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.516 0 O-C-N 120.285 -1.509 . . . . 0.0 109.769 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -158.78 -167.47 2.13 Favored 'General case' 0 N--CA 1.43 -1.447 1 N-CA-C 95.481 -5.748 . . . . 0.0 95.481 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 -165.62 1.85 Allowed 'General case' 0 CA--C 1.486 -1.484 1 N-CA-C 97.961 -4.829 . . . . 0.0 97.961 167.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 -176.5 4.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 102.128 -3.286 . . . . 0.0 102.128 158.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -117.48 155.38 29.82 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 m -146.44 139.85 25.84 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 100.375 -3.935 . . . . 0.0 100.375 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 30.19 6.59 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.287 0.565 . . . . 0.0 110.073 -168.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 177.5 151.02 0.2 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 93.979 -6.304 . . . . 0.0 93.979 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -153.36 151.92 26.61 Favored Pre-proline 0 CA--C 1.487 -1.47 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 149.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.72 170.95 16.48 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.08 1.853 . . . . 0.0 110.515 171.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.37 16.93 1.16 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -98.55 -6.25 30.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 120.51 -1.369 . . . . 0.0 108.287 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.73 168.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.41 177.36 27.65 Favored Glycine 0 CA--C 1.483 -1.952 1 N-CA-C 102.033 -4.427 . . . . 0.0 102.033 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 6' ' ' ILE . 6.4 pt -154.82 -171.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -158.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.721 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.3 mm -68.76 133.05 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.431 -1.379 0 N-CA-C 101.792 -3.411 . . . . 0.0 101.792 171.845 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.063 0.459 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -100.99 157.82 16.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -127.53 125.9 41.23 Favored 'General case' 0 CA--C 1.486 -1.482 1 N-CA-C 94.315 -6.18 . . . . 0.0 94.315 159.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.38 29.01 Favored Glycine 0 CA--C 1.474 -2.512 0 N-CA-C 104.021 -3.632 . . . . 0.0 104.021 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -83.54 140.35 32.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.87 148.23 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.3 -177.17 6.07 Favored 'General case' 0 N--CA 1.415 -2.204 1 N-CA-C 98.329 -4.693 . . . . 0.0 98.329 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -105.06 157.54 34.04 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -66.56 144.62 73.46 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.654 2.236 . . . . 0.0 109.226 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -103.14 80.02 1.8 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 128.027 2.531 . . . . 0.0 106.336 -5.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.8 t30 84.66 44.19 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 124.932 1.293 . . . . 0.0 108.392 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.85 127.76 47.64 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.445 ' HA ' ' HB1' ' A' ' 7' ' ' ALA 0.254 5.4 m -70.64 165.04 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 141.87 51.36 Favored 'General case' 0 N--CA 1.423 -1.817 1 N-CA-C 94.455 -6.128 . . . . 0.0 94.455 -176.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -117.31 160.73 20.65 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -167.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 t -115.18 169.27 9.24 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.53 124.68 23.61 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 98.423 -4.658 . . . . 0.0 98.423 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -57.59 111.84 0.95 Allowed 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.965 2.443 . . . . 0.0 113.261 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.79 -51.37 0.52 Allowed Glycine 0 CA--C 1.484 -1.85 1 N-CA-C 100.367 -5.093 . . . . 0.0 100.367 -168.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 6.8 m 106.12 -0.84 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 127.984 2.513 . . . . 0.0 111.852 169.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -46.97 -45.4 20.83 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.567 1.547 . . . . 0.0 113.806 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.37 -59.99 7.65 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.904 0.764 . . . . 0.0 111.955 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.3 m -70.68 -27.56 64.11 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.869 -1.371 . . . . 0.0 113.263 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.84 -45.19 93.74 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.4 m -66.08 -40.97 91.28 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.748 0.819 . . . . 0.0 110.4 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.21 -42.33 94.9 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.703 0.801 . . . . 0.0 109.74 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -38.64 82.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.541 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.24 -42.25 84.3 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.925 -0.484 . . . . 0.0 111.455 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.35 -30.3 37.98 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.726 -0.609 . . . . 0.0 111.019 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -84.66 -22.29 29.92 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 118.363 0.529 . . . . 0.0 109.949 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.49 45.95 1.61 Allowed Glycine 0 CA--C 1.488 -1.594 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 162.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.26 172.8 17.38 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 104.26 -3.536 . . . . 0.0 104.26 167.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 p -75.39 -56.71 4.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.987 0.899 . . . . 0.0 108.651 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -160.65 -176.76 5.75 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 98.832 -4.506 . . . . 0.0 98.832 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.19 -176.73 41.93 Favored Glycine 0 N--CA 1.414 -2.769 1 N-CA-C 98.612 -5.795 . . . . 0.0 98.612 -168.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -166.79 178.08 6.1 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 -172.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.34 168.09 20.66 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.773 0.797 . . . . 0.0 110.465 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.84 -171.01 37.9 Favored Glycine 0 N--CA 1.419 -2.463 1 N-CA-C 97.05 -6.42 . . . . 0.0 97.05 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -146.54 161.91 39.46 Favored 'General case' 0 N--CA 1.422 -1.828 1 N-CA-C 95.325 -5.805 . . . . 0.0 95.325 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -152.44 167.08 29.93 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 97.458 -5.015 . . . . 0.0 97.458 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.76 149.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 1 N-CA-C 96.152 -5.499 . . . . 0.0 96.152 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 -23.02 23.29 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 106.274 -2.731 . . . . 0.0 106.274 -168.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -135.62 -76.36 0.44 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 167.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.41 -150.76 22.13 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 98.289 -5.924 . . . . 0.0 98.289 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.28 115.26 2.37 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.339 2.656 . . . . 0.0 108.689 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.99 158.35 44.07 Favored 'General case' 0 CA--C 1.482 -1.657 1 N-CA-C 96.871 -5.233 . . . . 0.0 96.871 -166.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.8 p -138.61 174.36 10.62 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 116.349 -2.141 . . . . 0.0 108.548 -167.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -104.86 156.64 17.83 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -164.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -152.12 151.1 30.64 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 167.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -113.17 145.71 40.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 104.475 -2.416 . . . . 0.0 104.475 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.94 46.43 0.25 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.098 2.159 . . . . 0.0 112.227 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.33 130.97 33.88 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.95 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.071 1.847 . . . . 0.0 110.656 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -60.69 -20.15 60.31 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.77 1.628 . . . . 0.0 114.762 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -82.29 -12.76 57.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.652 -0.655 . . . . 0.0 110.414 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.52 112.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.46 143.74 17.45 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 104.894 -3.282 . . . . 0.0 104.894 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.9 pt -143.66 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 -160.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mm -68.08 122.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -161.431 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.27 162.5 14.02 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 164.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -125.59 131.85 52.63 Favored 'General case' 0 CA--C 1.486 -1.501 1 N-CA-C 94.287 -6.19 . . . . 0.0 94.287 161.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.81 29.57 Favored Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 100.912 -4.875 . . . . 0.0 100.912 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.91 137.24 33.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.01 142.52 12.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -135.53 -129.78 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.88 2.872 . . . . 0.0 106.385 175.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -154.16 166.51 15.67 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -172.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -65.39 139.14 58.19 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.346 2.697 . . . . 0.0 111.017 166.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -109.4 -16.26 14.05 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.571 2.348 . . . . 0.0 108.768 9.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -160.22 146.67 15.69 Favored 'General case' 0 CA--C 1.48 -1.72 1 N-CA-C 94.154 -6.239 . . . . 0.0 94.154 165.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.08 -161.97 0.29 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 169.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.74 166.78 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 1 N-CA-C 97.536 -4.987 . . . . 0.0 97.536 157.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -166.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 163.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -127.46 161.89 27.67 Favored 'General case' 0 CA--C 1.473 -1.99 1 N-CA-C 99.245 -4.354 . . . . 0.0 99.245 169.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.0 t -124.83 147.87 48.51 Favored 'General case' 0 N--CA 1.419 -1.996 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -102.41 119.72 55.37 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 96.935 -5.209 . . . . 0.0 96.935 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -57.34 103.97 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 CA-C-N 124.491 2.64 . . . . 0.0 114.726 -165.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.68 -175.8 37.36 Favored Glycine 0 N--CA 1.419 -2.455 1 N-CA-C 97.248 -6.341 . . . . 0.0 97.248 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -92.0 -30.75 15.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.627 0.713 . . . . 0.0 109.276 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -43.97 91.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.561 2.344 . . . . 0.0 115.319 -157.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.25 -50.46 45.04 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -68.96 -41.76 77.53 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.057 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -48.2 -54.11 14.61 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.437 1.495 . . . . 0.0 110.291 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 m -58.72 -54.08 51.07 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.967 0.907 . . . . 0.0 111.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -67.14 -40.77 86.79 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-O 122.36 1.076 . . . . 0.0 110.339 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -64.93 -45.09 87.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.334 1.054 . . . . 0.0 110.304 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -68.56 -40.41 80.62 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 121.27 -0.894 . . . . 0.0 110.945 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -68.26 -14.89 63.32 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.49 7.84 20.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 118.344 0.52 . . . . 0.0 110.433 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 32.75 8.27 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.395 165.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.71 142.05 16.06 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -85.64 -21.63 28.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.461 1.504 . . . . 0.0 109.063 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 m -157.06 156.26 32.53 Favored 'General case' 0 N--CA 1.424 -1.761 1 N-CA-C 98.782 -4.525 . . . . 0.0 98.782 169.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -148.41 141.81 9.43 Favored Glycine 0 CA--C 1.468 -2.885 1 N-CA-C 99.681 -5.368 . . . . 0.0 99.681 -170.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -145.83 -167.65 2.77 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 101.373 -3.565 . . . . 0.0 101.373 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.81 168.36 27.44 Favored 'General case' 0 N--CA 1.427 -1.582 1 N-CA-C 96.882 -5.229 . . . . 0.0 96.882 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.55 91.57 1.06 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 103.112 -3.995 . . . . 0.0 103.112 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -156.61 156.55 33.72 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 171.71 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -138.88 18.87 2.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 42' ' ' GLY . 1.6 t -146.69 -157.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 101.686 -3.45 . . . . 0.0 101.686 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 98.68 -95.1 1.54 Allowed Glycine 0 CA--C 1.474 -2.475 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.49 -54.34 1.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.236 -3.616 . . . . 0.0 101.236 175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.09 64.68 0.24 Allowed Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 173.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE 0.57 0.0 OUTLIER 73.36 171.75 0.3 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.513 1.925 . . . . 0.0 110.306 -171.511 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.67 -173.17 3.62 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -109.97 156.33 20.61 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -106.64 148.58 28.17 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 32.0 m -138.74 148.85 44.39 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 172.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.73 128.11 49.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.88 76.89 0.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 126.94 2.096 . . . . 0.0 111.557 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.47 141.97 23.75 Favored Pre-proline 0 CA--C 1.496 -1.128 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.15 166.33 23.52 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.603 2.202 . . . . 0.0 110.648 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -86.68 15.19 5.91 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.926 -1.109 . . . . 0.0 111.485 -165.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.11 11.17 21.96 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.09 140.61 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 101.637 -3.468 . . . . 0.0 101.637 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.36 143.28 15.65 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.16 -156.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -164.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.7 mm -70.52 125.01 27.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.437 -1.116 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 174.093 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -101.73 157.65 16.68 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.44 127.44 45.42 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 94.201 -6.222 . . . . 0.0 94.201 157.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -173.73 30.98 Favored Glycine 0 CA--C 1.475 -2.444 0 N-CA-C 103.532 -3.827 . . . . 0.0 103.532 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 35.4 m-85 -78.98 140.92 37.9 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 163.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tt -90.98 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.859 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -144.62 171.54 14.24 Favored 'General case' 0 N--CA 1.42 -1.964 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 177.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.78 158.24 68.26 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 92.3 Cg_exo -61.89 111.17 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.681 2.921 . . . . 0.0 110.633 170.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 68.9 mm-40 -125.69 132.07 52.47 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 1.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.9 t30 63.47 33.99 13.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 162.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.45 121.65 24.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.16 153.96 4.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -163.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.22 120.35 41.62 Favored 'General case' 0 N--CA 1.424 -1.732 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -89.18 128.33 35.8 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.5 t -80.01 159.31 26.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.59 115.18 46.92 Favored Pre-proline 0 N--CA 1.426 -1.659 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.8 113.19 1.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 123.048 2.499 . . . . 0.0 113.117 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.23 -49.54 0.69 Allowed Glycine 0 CA--C 1.489 -1.592 1 N-CA-C 101.045 -4.822 . . . . 0.0 101.045 -164.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m 99.64 -12.77 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 129.073 2.949 . . . . 0.0 109.662 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -50.75 -48.9 59.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.275 2.23 . . . . 0.0 115.213 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.13 -31.47 59.58 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.0 t -75.12 -24.53 58.06 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -49.63 77.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.635 -0.665 . . . . 0.0 111.865 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.8 -42.87 97.61 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 122.559 1.171 . . . . 0.0 111.148 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.0 t -63.2 -44.01 96.56 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 125.371 1.469 . . . . 0.0 108.899 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.61 -45.93 90.62 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 122.965 0.506 . . . . 0.0 110.557 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.95 -23.69 55.42 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -81.57 -21.08 38.67 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.62 38.39 2.23 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 164.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.51 134.72 12.11 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 103.315 -3.914 . . . . 0.0 103.315 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.3 p -102.83 4.95 38.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.859 0.838 . . . . 0.0 109.499 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 m -160.38 164.63 32.26 Favored 'General case' 0 CA--C 1.478 -1.804 1 N-CA-C 97.99 -4.819 . . . . 0.0 97.99 167.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.34 171.75 36.62 Favored Glycine 0 N--CA 1.414 -2.821 1 N-CA-C 99.261 -5.536 . . . . 0.0 99.261 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -160.92 -167.65 1.88 Allowed 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 96.609 -5.33 . . . . 0.0 96.609 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.5 m -154.75 176.1 12.88 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 97.487 -5.005 . . . . 0.0 97.487 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.99 -169.0 41.21 Favored Glycine 0 N--CA 1.42 -2.406 1 N-CA-C 96.805 -6.518 . . . . 0.0 96.805 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.84 173.48 6.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 101.702 -3.444 . . . . 0.0 101.702 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -157.31 163.04 39.11 Favored 'General case' 0 N--CA 1.42 -1.967 1 N-CA-C 95.81 -5.626 . . . . 0.0 95.81 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.31 158.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 1 N-CA-C 97.607 -4.961 . . . . 0.0 97.607 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 -43.89 1.6 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -118.61 -83.41 0.65 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.85 -148.69 18.09 Favored Glycine 0 CA--C 1.478 -2.278 1 N-CA-C 99.384 -5.487 . . . . 0.0 99.384 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.95 131.33 48.32 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 126.597 1.959 . . . . 0.0 107.936 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.75 175.76 11.31 Favored 'General case' 0 CA--C 1.482 -1.646 1 N-CA-C 98.846 -4.501 . . . . 0.0 98.846 -162.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.67 168.4 15.09 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 28.1 t-105 -119.9 150.06 41.1 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.0 m -141.05 149.1 41.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 101.178 -3.638 . . . . 0.0 101.178 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.27 130.48 53.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 103.171 -2.9 . . . . 0.0 103.171 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.44 54.79 0.16 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.674 1.989 . . . . 0.0 110.998 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.26 132.8 32.95 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.18 172.46 13.0 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.436 2.091 . . . . 0.0 110.003 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.11 23.99 1.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.602 -0.686 . . . . 0.0 111.948 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.46 -7.48 28.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.23 143.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.78 146.41 17.94 Favored Glycine 0 CA--C 1.476 -2.368 1 N-CA-C 101.44 -4.664 . . . . 0.0 101.44 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.4 pt -142.31 -146.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 -165.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 7' ' ' ALA . 14.5 mm -69.68 123.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.259 1.0 OUTLIER . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 -167.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.537 0.684 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 171.68 8.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -136.11 140.26 43.58 Favored 'General case' 0 CA--C 1.488 -1.44 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -177.31 34.78 Favored Glycine 0 CA--C 1.475 -2.419 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -79.27 134.25 36.64 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 102.04 -3.319 . . . . 0.0 102.04 157.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -90.16 133.83 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.5 -147.94 0.36 Allowed 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 111.057 -2.792 . . . . 0.0 108.978 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -138.09 148.76 61.35 Favored Pre-proline 0 N--CA 1.42 -1.937 1 N-CA-C 94.691 -6.04 . . . . 0.0 94.691 170.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -76.01 151.77 35.46 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 122.052 1.769 . . . . 0.0 108.428 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.16 -12.18 19.82 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 127.446 2.299 . . . . 0.0 108.204 9.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -160.96 141.89 11.57 Favored 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 95.647 -5.686 . . . . 0.0 95.647 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.05 -159.79 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -128.14 165.09 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 N-CA-C 98.597 -4.594 . . . . 0.0 98.597 160.98 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 -157.44 0.46 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -138.97 -177.86 5.08 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 98.673 -4.566 . . . . 0.0 98.673 168.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.44 163.54 35.34 Favored 'General case' 0 N--CA 1.419 -1.999 1 N-CA-C 95.913 -5.588 . . . . 0.0 95.913 -175.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.28 119.26 31.97 Favored Pre-proline 0 N--CA 1.421 -1.883 1 N-CA-C 98.584 -4.599 . . . . 0.0 98.584 172.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -57.37 111.49 0.83 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.905 2.403 . . . . 0.0 113.14 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.6 -37.87 1.25 Allowed Glycine 0 CA--C 1.49 -1.506 1 N-CA-C 101.148 -4.781 . . . . 0.0 101.148 -162.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m 86.09 -5.43 0.79 Allowed 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 125.678 1.591 . . . . 0.0 112.242 158.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -61.79 -42.38 98.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.156 1.782 . . . . 0.0 112.531 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.22 -31.97 63.26 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -71.57 -50.04 34.89 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.96 -38.12 89.81 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 118.766 0.712 . . . . 0.0 110.602 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.5 m -59.58 -50.04 75.44 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.367 -0.833 . . . . 0.0 111.674 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.82 -43.96 91.39 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.861 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.1 t -54.1 -46.41 72.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.391 1.076 . . . . 0.0 110.91 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -65.5 -49.15 70.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.483 0.713 . . . . 0.0 110.596 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.96 -20.22 61.77 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.774 -0.579 . . . . 0.0 112.56 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -87.66 -6.61 58.17 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 118.615 0.643 . . . . 0.0 110.24 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 27.82 9.43 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.32 146.74 18.34 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 p -75.57 -37.23 60.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.511 -0.993 . . . . 0.0 110.726 -164.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 m -160.88 -177.5 6.18 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.723 -4.918 . . . . 0.0 97.723 165.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.39 -176.72 41.34 Favored Glycine 0 N--CA 1.414 -2.805 1 N-CA-C 98.614 -5.794 . . . . 0.0 98.614 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.57 180.0 6.84 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 97.015 -5.18 . . . . 0.0 97.015 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.2 m -103.52 165.41 11.05 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.5 171.42 39.98 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 97.923 -6.071 . . . . 0.0 97.923 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -103.39 145.43 30.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -116.99 96.15 5.32 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.32 127.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -42.45 1.43 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -169.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -119.27 -68.68 0.9 Allowed 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.31 -160.36 33.98 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 -172.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.64 136.51 51.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 -173.94 3.82 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.35 158.77 27.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 101.166 -3.642 . . . . 0.0 101.166 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -120.57 153.06 37.28 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -146.87 155.38 42.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -118.76 143.94 46.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 166.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.24 56.96 0.11 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 127.237 2.215 . . . . 0.0 111.197 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -96.23 133.37 25.11 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -71.84 174.94 10.38 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 122.206 1.824 . . . . 0.0 111.43 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.32 16.34 1.66 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -98.34 -5.27 33.2 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.87 169.68 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.35 160.23 27.84 Favored Glycine 0 CA--C 1.48 -2.106 1 N-CA-C 99.414 -5.475 . . . . 0.0 99.414 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 pt -144.88 -164.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 -163.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -70.89 128.54 34.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.002 0.429 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.97 162.67 12.84 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -132.08 130.45 41.28 Favored 'General case' 0 CA--C 1.489 -1.375 1 N-CA-C 95.077 -5.897 . . . . 0.0 95.077 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.95 -169.16 24.89 Favored Glycine 0 CA--C 1.477 -2.306 0 N-CA-C 104.025 -3.63 . . . . 0.0 104.025 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.28 140.26 30.97 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 159.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.71 150.3 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -155.23 174.74 14.79 Favored 'General case' 0 N--CA 1.415 -2.221 1 N-CA-C 98.535 -4.617 . . . . 0.0 98.535 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -85.67 158.54 56.7 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 34.7 Cg_exo -64.54 113.46 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.019 2.479 . . . . 0.0 110.785 164.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.7 mm-40 -126.64 114.04 17.51 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 127.45 2.3 . . . . 0.0 106.636 1.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.4 t30 80.63 31.99 0.16 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.582 1.153 . . . . 0.0 109.126 156.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -123.04 123.03 39.95 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.82 158.26 6.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 CA-C-N 120.106 1.321 . . . . 0.0 114.028 -159.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 135.9 42.74 Favored 'General case' 0 CA--C 1.483 -1.604 1 N-CA-C 97.291 -5.077 . . . . 0.0 97.291 178.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -90.96 165.9 13.31 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -164.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -151.8 175.95 11.92 Favored 'General case' 0 N--CA 1.406 -2.647 1 N-CA-C 94.815 -5.994 . . . . 0.0 94.815 -170.202 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -149.43 176.56 2.2 Favored Pre-proline 0 N--CA 1.408 -2.573 1 N-CA-C 95.026 -5.916 . . . . 0.0 95.026 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.46 55.0 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.122 2.865 . . . . 0.0 110.607 161.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.96 150.43 11.77 Favored Glycine 0 CA--C 1.481 -2.032 1 N-CA-C 99.391 -5.484 . . . . 0.0 99.391 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -106.91 15.09 25.8 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 117.533 0.667 . . . . 0.0 111.239 -161.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -62.11 -61.0 2.78 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.934 1.293 . . . . 0.0 111.759 -166.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.56 -41.14 77.04 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 t -57.89 -58.41 8.51 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.585 1.154 . . . . 0.0 111.288 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.63 -33.57 75.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.066 0.546 . . . . 0.0 109.806 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.0 m -61.2 -50.02 74.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.402 0.681 . . . . 0.0 110.869 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.45 -37.5 68.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.643 0.777 . . . . 0.0 110.04 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.26 -46.26 83.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 110.112 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -62.28 -49.2 76.63 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.133 0.573 . . . . 0.0 110.995 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.28 -21.07 60.68 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.527 -0.733 . . . . 0.0 112.687 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -94.28 3.04 55.76 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.793 -0.567 . . . . 0.0 110.083 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.96 33.06 7.54 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 161.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.91 147.22 18.53 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 104.326 -3.51 . . . . 0.0 104.326 167.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -78.37 -37.14 44.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 117.99 0.895 . . . . 0.0 110.277 -166.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 m -160.52 -179.64 7.82 Favored 'General case' 0 N--CA 1.426 -1.655 1 N-CA-C 99.06 -4.422 . . . . 0.0 99.06 169.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.59 178.7 43.76 Favored Glycine 0 N--CA 1.423 -2.23 1 N-CA-C 99.52 -5.432 . . . . 0.0 99.52 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -167.19 -179.81 4.74 Favored 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 99.287 -4.338 . . . . 0.0 99.287 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.5 m -126.64 158.42 36.36 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.18 102.75 0.34 Allowed Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 105.015 -3.234 . . . . 0.0 105.015 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 174.07 5.31 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.07 26.04 0.01 OUTLIER 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.76 132.41 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -160.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.28 -95.44 2.1 Favored Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -83.58 -51.43 7.32 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.47 46.43 Favored Glycine 0 N--CA 1.42 -2.432 1 N-CA-C 97.694 -6.162 . . . . 0.0 97.694 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.377 0.2 OUTLIER -76.64 143.17 40.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.977 0.388 . . . . 0.0 110.755 173.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.0 9.06 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 101.956 -3.35 . . . . 0.0 101.956 -163.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.48 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 1.9 t -113.2 153.59 28.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 -170.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -97.64 155.65 16.89 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.72 148.85 32.41 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.03 142.62 46.73 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 101.883 -3.376 . . . . 0.0 101.883 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.19 59.21 1.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.356 2.262 . . . . 0.0 112.11 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.6 mt -93.55 133.34 28.32 Favored Pre-proline 0 CA--C 1.495 -1.163 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.92 170.9 15.68 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.403 2.069 . . . . 0.0 110.611 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.86 32.59 0.59 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.726 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.19 -3.37 14.66 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.43 162.66 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 -175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.52 150.71 21.53 Favored Glycine 0 CA--C 1.481 -2.038 1 N-CA-C 98.552 -5.819 . . . . 0.0 98.552 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.6 pt -150.55 -150.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -159.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.6 mm -69.04 128.02 31.84 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -170.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 167.69 21.58 Favored 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 164.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -127.99 132.04 49.2 Favored 'General case' 0 CA--C 1.48 -1.731 1 N-CA-C 94.017 -6.29 . . . . 0.0 94.017 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.77 36.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 105.551 -3.019 . . . . 0.0 105.551 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.46 134.15 40.92 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.39 148.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.22 -176.88 5.89 Favored 'General case' 0 N--CA 1.413 -2.294 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 -173.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -101.74 168.31 9.26 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 41.1 Cg_exo -61.33 130.33 31.66 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.37 2.046 . . . . 0.0 110.395 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 43.6 mt-10 -128.47 117.98 22.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 -7.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 70.91 19.54 5.71 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.385 1.074 . . . . 0.0 109.837 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.3 m -103.63 91.77 4.16 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 7' ' ' ALA 0.287 27.2 m -59.4 154.86 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -165.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.56 175.58 5.43 Favored 'General case' 0 N--CA 1.421 -1.903 1 N-CA-C 98.175 -4.75 . . . . 0.0 98.175 175.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -136.39 152.81 51.02 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 97.128 -5.138 . . . . 0.0 97.128 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.05 175.58 6.06 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.32 119.45 33.14 Favored Pre-proline 0 N--CA 1.426 -1.654 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 173.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.47 101.24 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.819 2.346 . . . . 0.0 111.497 -170.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.89 -44.92 0.51 Allowed Glycine 0 CA--C 1.481 -2.092 1 N-CA-C 102.504 -4.238 . . . . 0.0 102.504 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m 121.75 -48.48 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 129.006 2.922 . . . . 0.0 107.299 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -39.94 -45.41 1.86 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.068 2.947 . . . . 0.0 118.097 -155.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -41.57 49.46 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 121.235 -0.916 . . . . 0.0 111.33 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 t -82.92 -25.73 32.12 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.81 -29.16 69.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.742 0.817 . . . . 0.0 110.396 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.7 m -70.52 -43.44 69.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.119 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.73 -39.91 95.55 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 122.075 0.941 . . . . 0.0 109.9 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -54.14 -45.68 72.05 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.531 1.132 . . . . 0.0 110.743 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -61.7 -48.97 78.36 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.31 -18.87 59.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.49 -22.7 24.74 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.634 0.652 . . . . 0.0 109.756 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.9 28.13 3.51 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 167.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.44 121.96 7.18 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.04 -2.824 . . . . 0.0 106.04 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -93.59 1.57 56.64 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 122.046 0.927 . . . . 0.0 109.959 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -160.19 160.69 33.12 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 98.121 -4.77 . . . . 0.0 98.121 169.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.83 178.57 46.55 Favored Glycine 0 CA--C 1.481 -2.089 1 N-CA-C 101.318 -4.713 . . . . 0.0 101.318 -171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -166.71 179.95 5.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.663 -3.829 . . . . 0.0 100.663 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.9 m -93.87 173.81 7.48 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.25 -172.72 31.08 Favored Glycine 0 CA--C 1.482 -2.019 1 N-CA-C 98.32 -5.912 . . . . 0.0 98.32 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -127.65 149.21 50.3 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.21 -4.367 . . . . 0.0 99.21 170.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -126.72 101.2 6.52 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.44 120.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.59 -42.03 1.38 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -118.05 -64.51 1.28 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.43 -138.09 5.9 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 105.254 -3.138 . . . . 0.0 105.254 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp -81.23 133.41 35.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.8 162.83 37.08 Favored 'General case' 0 N--CA 1.433 -1.288 1 N-CA-C 97.975 -4.824 . . . . 0.0 97.975 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -113.02 -176.49 2.91 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 121.162 1.801 . . . . 0.0 106.494 -169.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -126.47 147.88 49.75 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 m -141.86 142.18 33.11 Favored 'General case' 0 N--CA 1.433 -1.278 1 N-CA-C 100.096 -4.039 . . . . 0.0 100.096 170.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.1 22.35 16.07 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -165.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.8 2.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 94.542 -6.095 . . . . 0.0 94.542 173.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -150.22 154.14 35.95 Favored Pre-proline 0 N--CA 1.427 -1.602 1 N-CA-C 96.024 -5.547 . . . . 0.0 96.024 152.102 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.09 166.3 30.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 122.156 1.806 . . . . 0.0 109.165 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.64 -10.92 56.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -86.09 -1.34 57.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.517 0.727 . . . . 0.0 110.082 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG11 ' HG ' ' A' ' 52' ' ' LEU . 6.0 t -100.28 142.52 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.13 13.25 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 99.65 -5.38 . . . . 0.0 99.65 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.401 HG21 HD23 ' A' ' 52' ' ' LEU . 15.1 pt -130.09 -129.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -163.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 7' ' ' ALA . 6.1 mm -72.89 118.78 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -166.472 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 162.71 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -128.6 134.16 48.51 Favored 'General case' 0 CA--C 1.487 -1.463 1 N-CA-C 94.955 -5.943 . . . . 0.0 94.955 165.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.19 -175.14 32.9 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 105.576 -3.009 . . . . 0.0 105.576 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -76.06 132.89 40.38 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.8 137.17 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.52 -150.52 0.42 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.64 -2.527 . . . . 0.0 108.872 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -135.1 152.35 76.92 Favored Pre-proline 0 N--CA 1.421 -1.902 1 N-CA-C 94.612 -6.07 . . . . 0.0 94.612 161.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -67.41 157.55 61.21 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 CA-C-N 123.391 2.247 . . . . 0.0 108.439 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.74 -25.12 17.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 128.153 2.581 . . . . 0.0 110.278 5.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.76 106.1 2.25 Favored 'General case' 0 N--CA 1.434 -1.241 1 N-CA-C 99.612 -4.218 . . . . 0.0 99.612 -173.011 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.06 -168.23 1.69 Allowed 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 120.092 1.315 . . . . 0.0 107.648 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -129.18 164.6 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 160.536 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 -164.59 1.01 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.9 167.92 20.3 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 96.314 -5.439 . . . . 0.0 96.314 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.42 156.41 48.59 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 98.231 -4.729 . . . . 0.0 98.231 -167.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.05 116.15 45.01 Favored Pre-proline 0 N--CA 1.424 -1.752 1 N-CA-C 96.304 -5.443 . . . . 0.0 96.304 164.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -63.59 102.41 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 125.025 2.83 . . . . 0.0 114.788 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.98 -172.47 45.47 Favored Glycine 0 N--CA 1.418 -2.507 1 N-CA-C 96.184 -6.767 . . . . 0.0 96.184 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -38.24 23.86 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 118.437 1.119 . . . . 0.0 108.675 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.51 -60.02 2.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.337 2.655 . . . . 0.0 116.124 -165.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.56 -54.37 10.51 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -166.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.29 -47.52 79.17 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 122.292 -0.534 . . . . 0.0 110.971 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -64.69 -40.98 96.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 m -64.8 -44.62 89.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.492 -0.755 . . . . 0.0 111.035 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.88 -38.53 91.27 Favored 'General case' 0 C--N 1.358 0.964 0 CA-C-O 122.342 1.068 . . . . 0.0 109.985 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -58.93 -50.24 74.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.512 1.125 . . . . 0.0 110.572 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -68.76 -35.8 77.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.12 -29.29 54.7 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.264 -0.897 . . . . 0.0 111.806 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -77.29 -35.06 55.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.739 0.7 . . . . 0.0 109.419 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.61 43.32 0.82 Allowed Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.07 157.09 21.0 Favored Glycine 0 CA--C 1.484 -1.897 1 N-CA-C 102.263 -4.335 . . . . 0.0 102.263 159.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.8 m -81.3 -38.05 27.4 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -168.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.2 m -160.5 168.79 24.33 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 99.929 -4.1 . . . . 0.0 99.929 175.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.11 178.55 45.92 Favored Glycine 0 N--CA 1.421 -2.355 1 N-CA-C 99.969 -5.252 . . . . 0.0 99.969 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -169.66 -175.49 2.15 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -171.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.89 145.98 29.12 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.84 167.96 38.84 Favored Glycine 0 N--CA 1.419 -2.486 1 N-CA-C 99.18 -5.568 . . . . 0.0 99.18 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -164.37 -168.04 1.44 Allowed 'General case' 0 N--CA 1.42 -1.971 1 N-CA-C 95.997 -5.557 . . . . 0.0 95.997 170.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 99.59 61.4 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 131.324 3.85 . . . . 0.0 102.244 -167.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.7 t -141.41 166.95 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 1 N-CA-C 99.627 -4.212 . . . . 0.0 99.627 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.32 80.23 0.27 Allowed Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.54 -3.024 . . . . 0.0 105.54 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -173.34 -145.16 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 94.47 -6.122 . . . . 0.0 94.47 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.86 120.15 1.87 Allowed Glycine 0 CA--C 1.484 -1.902 1 N-CA-C 101.349 -4.701 . . . . 0.0 101.349 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tp 73.88 175.53 0.26 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.608 1.963 . . . . 0.0 108.962 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.79 -173.78 0.42 Allowed 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 98.183 -4.747 . . . . 0.0 98.183 171.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.3 m -125.83 176.48 6.92 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 100.499 -3.889 . . . . 0.0 100.499 159.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -113.94 152.52 30.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -145.63 149.94 35.43 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -116.47 137.73 51.94 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.25 61.05 0.23 Allowed 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.345 2.258 . . . . 0.0 110.517 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.36 131.0 26.99 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.61 178.02 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.986 2.457 . . . . 0.0 110.714 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -74.61 -1.54 22.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -89.81 -1.22 57.94 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 120.937 -1.102 . . . . 0.0 109.761 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.93 170.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.98 152.01 24.11 Favored Glycine 0 CA--C 1.478 -2.269 1 N-CA-C 97.719 -6.152 . . . . 0.0 97.719 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.46 -149.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 10.8 mm -68.28 134.98 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.421 -1.924 1 N-CA-C 93.188 -6.597 . . . . 0.0 93.188 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.031 0.443 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 169.3 9.08 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -128.2 144.38 51.12 Favored 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 94.587 -6.079 . . . . 0.0 94.587 166.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 178.06 37.52 Favored Glycine 0 CA--C 1.475 -2.409 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -81.7 129.91 34.88 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 159.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 14.6 tt -90.52 140.16 16.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.48 -149.76 0.42 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 127.097 2.159 . . . . 0.0 108.285 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.59 165.58 24.22 Favored Pre-proline 0 N--CA 1.418 -2.07 1 N-CA-C 95.229 -5.841 . . . . 0.0 95.229 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.01 152.17 83.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.22 1.947 . . . . 0.0 108.706 167.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -88.27 -51.76 5.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.21 2.204 . . . . 0.0 108.095 1.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.84 121.85 14.6 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 89.567 -7.938 . . . . 0.0 89.567 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 m -163.57 -166.32 1.19 Allowed 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 102.252 -3.24 . . . . 0.0 102.252 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.07 166.03 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 97.796 -4.89 . . . . 0.0 97.796 160.96 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -161.62 0.66 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 162.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -137.76 167.36 21.87 Favored 'General case' 0 CA--C 1.484 -1.581 1 N-CA-C 97.257 -5.09 . . . . 0.0 97.257 164.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.3 t -108.42 163.58 13.09 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -110.29 106.0 57.64 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 97.712 -4.921 . . . . 0.0 97.712 162.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -53.14 104.62 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 124.045 2.48 . . . . 0.0 118.245 -161.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.01 -162.64 33.77 Favored Glycine 0 N--CA 1.423 -2.193 1 N-CA-C 97.569 -6.212 . . . . 0.0 97.569 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 4.6 p -88.86 -34.03 17.14 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -39.47 -59.64 1.06 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 128.568 2.747 . . . . 0.0 116.643 -160.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -53.65 11.08 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.71 -43.04 98.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 122.115 -0.638 . . . . 0.0 111.621 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -44.5 97.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.818 0.847 . . . . 0.0 109.988 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -63.09 -43.88 97.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.395 -0.815 . . . . 0.0 110.515 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.08 -40.61 90.97 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 122.422 1.106 . . . . 0.0 110.215 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.31 -44.39 95.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.817 1.247 . . . . 0.0 109.658 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -74.98 -28.79 60.69 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -78.39 -24.33 46.38 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.971 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -78.0 -58.18 3.4 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.82 45.52 0.07 OUTLIER Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.85 159.07 14.15 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 104.215 -3.554 . . . . 0.0 104.215 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 m -91.97 -31.14 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.653 0.74 . . . . 0.0 109.757 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -146.22 154.78 42.13 Favored 'General case' 0 CA--C 1.476 -1.896 1 N-CA-C 99.837 -4.134 . . . . 0.0 99.837 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.97 155.69 26.57 Favored Glycine 0 N--CA 1.417 -2.591 1 N-CA-C 98.427 -5.869 . . . . 0.0 98.427 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 8.3 p80 -166.51 -172.99 2.34 Favored 'General case' 0 N--CA 1.424 -1.736 1 N-CA-C 96.863 -5.236 . . . . 0.0 96.863 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 18' ' ' PRO . 28.2 m -72.86 179.57 3.63 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 122.699 1.237 . . . . 0.0 110.817 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.24 174.08 39.48 Favored Glycine 0 N--CA 1.41 -3.07 1 N-CA-C 98.17 -5.972 . . . . 0.0 98.17 168.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -137.45 132.74 33.82 Favored 'General case' 0 N--CA 1.427 -1.584 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 172.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -117.23 105.28 12.04 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.98 125.18 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.35 -32.07 3.47 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -124.35 -67.55 0.91 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.6 -148.92 19.49 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.295 -3.122 . . . . 0.0 105.295 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 tp -58.87 143.76 46.61 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.648 2.379 . . . . 0.0 107.942 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.11 -172.66 4.18 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -170.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.6 m -117.46 170.81 8.43 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 165.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.8 t-105 -124.32 156.83 36.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.2 m -145.03 147.54 32.72 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -113.6 136.73 52.5 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.55 69.73 0.46 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.358 2.663 . . . . 0.0 111.644 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 mt -105.06 139.11 19.79 Favored Pre-proline 0 CA--C 1.503 -0.837 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -68.52 167.44 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.657 2.238 . . . . 0.0 111.596 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -67.49 -21.0 65.53 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.342 1.057 . . . . 0.0 113.742 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -84.02 2.37 39.38 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 110.847 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.29 125.89 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.36 152.27 20.15 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 105.842 -2.903 . . . . 0.0 105.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.1 pt -140.46 -147.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 -166.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.2 mm -72.71 135.5 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.412 -2.349 1 N-CA-C 93.569 -6.456 . . . . 0.0 93.569 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.3 0.571 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.4 171.29 7.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -131.71 144.14 50.77 Favored 'General case' 0 CA--C 1.485 -1.549 1 N-CA-C 95.694 -5.669 . . . . 0.0 95.694 165.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.78 36.6 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.709 -2.956 . . . . 0.0 105.709 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.37 133.41 35.91 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.37 135.17 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.21 -150.0 0.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 111.328 -2.669 . . . . 0.0 107.026 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 9.2 pt20 -142.14 164.36 34.16 Favored Pre-proline 0 N--CA 1.42 -1.926 1 N-CA-C 96.017 -5.549 . . . . 0.0 96.017 169.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -66.97 149.27 82.88 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 CA-C-N 122.4 1.893 . . . . 0.0 109.698 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -81.86 -22.72 36.78 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.491 2.316 . . . . 0.0 107.844 -1.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -177.49 155.53 1.09 Allowed 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 94.094 -6.261 . . . . 0.0 94.094 -171.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.419 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 73.2 m 161.22 -149.33 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.116 1 N-CA-C 97.971 -4.825 . . . . 0.0 97.971 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -117.57 164.7 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 1 N-CA-C 98.802 -4.518 . . . . 0.0 98.802 160.646 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -155.46 0.24 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 161.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -134.82 -179.5 5.65 Favored 'General case' 0 CA--C 1.482 -1.641 1 N-CA-C 98.919 -4.474 . . . . 0.0 98.919 164.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.2 t -139.1 174.01 10.96 Favored 'General case' 0 N--CA 1.416 -2.127 1 N-CA-C 96.817 -5.253 . . . . 0.0 96.817 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -128.04 132.67 24.47 Favored Pre-proline 0 N--CA 1.416 -2.174 1 N-CA-C 97.639 -4.948 . . . . 0.0 97.639 173.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -55.38 118.37 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.109 2.54 . . . . 0.0 112.773 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.81 -44.16 1.21 Allowed Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 25.4 m 91.87 -13.78 0.2 Allowed 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 127.784 2.434 . . . . 0.0 112.917 175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -47.14 -48.28 23.34 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.54 -28.89 56.67 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 111.241 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.21 -45.47 60.15 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.25 -47.49 78.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.854 1.262 . . . . 0.0 109.163 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -59.78 -45.67 91.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.606 0.762 . . . . 0.0 112.07 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 mt -66.65 -40.13 88.53 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.887 -1.133 . . . . 0.0 110.54 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.29 -43.45 83.18 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.648 1.179 . . . . 0.0 110.779 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -59.37 -53.31 59.67 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.35 0.66 . . . . 0.0 110.679 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.31 -16.97 61.36 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.622 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -91.22 -5.2 55.19 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.794 -0.566 . . . . 0.0 109.895 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.18 27.92 7.95 Favored Glycine 0 CA--C 1.49 -1.5 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.036 166.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.9 146.29 17.42 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -78.87 -27.93 44.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.318 -1.107 . . . . 0.0 111.06 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 m -161.07 174.73 13.3 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 99.674 -4.195 . . . . 0.0 99.674 166.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.06 172.56 43.91 Favored Glycine 0 N--CA 1.423 -2.222 1 N-CA-C 98.82 -5.712 . . . . 0.0 98.82 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -159.63 174.76 14.09 Favored 'General case' 0 CA--C 1.491 -1.3 1 N-CA-C 99.521 -4.252 . . . . 0.0 99.521 -173.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.8 m -71.82 163.4 27.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 119.818 1.19 . . . . 0.0 110.429 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.25 171.81 37.35 Favored Glycine 0 N--CA 1.424 -2.139 1 N-CA-C 99.568 -5.413 . . . . 0.0 99.568 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -120.79 134.59 55.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -110.85 106.42 15.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.34 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.4 -21.87 10.51 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -132.07 -74.02 0.51 Allowed 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.34 -160.62 34.0 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.68 135.54 57.66 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 127.253 2.221 . . . . 0.0 107.167 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.47 -173.45 3.77 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -170.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.7 t -122.58 155.56 36.04 Favored 'General case' 0 CA--C 1.494 -1.181 1 N-CA-C 99.986 -4.079 . . . . 0.0 99.986 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -114.24 151.29 33.05 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.7 m -146.3 149.15 33.28 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.77 138.89 53.06 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 103.385 -2.82 . . . . 0.0 103.385 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.65 58.54 0.1 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 127.67 2.388 . . . . 0.0 111.473 171.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.17 132.68 23.02 Favored Pre-proline 0 CA--C 1.501 -0.911 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.34 171.68 17.79 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.283 1.851 . . . . 0.0 110.965 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.76 -18.23 62.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.672 1.989 . . . . 0.0 114.753 -169.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -86.73 -5.72 59.04 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.278 0.631 . . . . 0.0 109.842 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.17 138.54 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.3 152.52 17.19 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 pt -131.37 -150.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -160.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 HD12 HG12 ' A' ' 13' ' ' VAL . 6.0 mm -76.39 113.49 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 176.561 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 165.87 26.14 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -134.17 130.07 36.74 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 94.465 -6.124 . . . . 0.0 94.465 166.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.99 -174.1 31.47 Favored Glycine 0 CA--C 1.471 -2.695 0 N-CA-C 103.278 -3.929 . . . . 0.0 103.278 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.94 134.91 37.79 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 163.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 47' ' ' CYS . 8.2 tt -90.9 143.56 10.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.25 -153.66 0.51 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 126.842 2.057 . . . . 0.0 105.618 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.83 66.02 Favored Pre-proline 0 N--CA 1.424 -1.764 1 N-CA-C 94.199 -6.223 . . . . 0.0 94.199 165.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.16 150.57 59.94 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.277 1.984 . . . . 0.0 108.407 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -85.98 -35.59 20.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.914 1.686 . . . . 0.0 109.402 10.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -159.26 145.31 16.38 Favored 'General case' 0 N--CA 1.419 -2.02 1 N-CA-C 94.773 -6.01 . . . . 0.0 94.773 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.4 m 175.37 -155.3 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.433 1 N-CA-C 96.642 -5.318 . . . . 0.0 96.642 172.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.641 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -127.07 165.38 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 1 N-CA-C 96.913 -5.217 . . . . 0.0 96.913 161.042 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.78 -166.91 1.55 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 164.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -135.73 151.19 49.9 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 101.619 -3.474 . . . . 0.0 101.619 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.0 t -124.31 156.94 36.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.36 118.29 47.73 Favored Pre-proline 0 N--CA 1.42 -1.927 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -176.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 108.28 0.45 Allowed 'Trans proline' 0 CA--C 1.506 -0.914 0 C-N-CA 122.999 2.466 . . . . 0.0 111.892 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.78 0.54 Allowed Glycine 0 CA--C 1.482 -1.97 1 N-CA-C 100.374 -5.09 . . . . 0.0 100.374 -164.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.252 6.8 m 114.49 -35.79 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 108.714 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -39.46 -52.06 2.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.999 2.519 . . . . 0.0 117.118 -157.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.62 -41.51 75.16 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 121.033 -1.042 . . . . 0.0 112.066 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -90.14 -21.76 22.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.934 -1.333 . . . . 0.0 109.176 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.6 -43.08 93.82 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 166.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.59 -47.21 87.2 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.572 -0.705 . . . . 0.0 110.763 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.3 mt -58.87 -43.97 90.98 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 123.676 0.79 . . . . 0.0 111.027 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.7 t -54.07 -47.51 71.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.997 1.319 . . . . 0.0 110.863 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -69.24 -40.62 77.79 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.48 0.312 . . . . 0.0 111.391 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.82 -25.32 48.75 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 118.01 0.368 . . . . 0.0 111.469 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -72.76 -54.37 9.08 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.03 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 167.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.66 136.75 13.82 Favored Glycine 0 CA--C 1.49 -1.515 1 N-CA-C 102.696 -4.162 . . . . 0.0 102.696 165.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -101.58 11.1 39.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.778 0.799 . . . . 0.0 110.098 -163.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.5 m -160.01 159.97 32.71 Favored 'General case' 0 CA--C 1.484 -1.582 1 N-CA-C 98.032 -4.803 . . . . 0.0 98.032 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.58 42.57 Favored Glycine 0 CA--C 1.479 -2.184 1 N-CA-C 99.672 -5.371 . . . . 0.0 99.672 -168.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -167.34 -167.26 0.88 Allowed 'General case' 0 N--CA 1.435 -1.195 1 N-CA-C 98.055 -4.794 . . . . 0.0 98.055 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.9 m -99.19 177.25 5.27 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.22 179.73 42.86 Favored Glycine 0 N--CA 1.423 -2.207 1 N-CA-C 102.569 -4.213 . . . . 0.0 102.569 -175.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 37.9 t80 -143.95 148.52 35.46 Favored 'General case' 0 CA--C 1.486 -1.505 1 N-CA-C 97.248 -5.093 . . . . 0.0 97.248 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -133.39 112.79 11.89 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.34 124.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.82 -31.56 3.89 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 104.702 -3.359 . . . . 0.0 104.702 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -113.47 -70.88 0.78 Allowed 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.3 -153.15 24.33 Favored Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 2.9 tt -72.39 144.38 48.22 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.3 -168.96 2.4 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.2 m -123.61 -179.87 4.52 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -130.78 152.98 49.53 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.9 m -148.25 150.89 34.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.33 140.58 49.38 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 170.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.53 0.82 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.331 2.253 . . . . 0.0 111.03 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -91.17 146.52 33.71 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -66.53 162.83 35.05 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.521 2.147 . . . . 0.0 111.001 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.64 -19.1 62.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.381 0.672 . . . . 0.0 112.449 -168.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -82.2 -1.26 48.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.865 1.266 . . . . 0.0 110.975 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.56 129.22 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.02 20.83 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.62 -154.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 -167.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -77.4 139.69 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.422 -1.852 1 N-CA-C 95.266 -5.828 . . . . 0.0 95.266 -173.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -102.51 152.74 20.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -120.76 119.87 34.01 Favored 'General case' 0 CA--C 1.487 -1.473 1 N-CA-C 95.336 -5.801 . . . . 0.0 95.336 159.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.67 -177.88 35.12 Favored Glycine 0 CA--C 1.472 -2.607 1 N-CA-C 102.747 -4.141 . . . . 0.0 102.747 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.79 144.36 27.79 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -90.76 148.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.809 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -164.14 1.48 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 146.94 32.17 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 101.429 -3.545 . . . . 0.0 101.429 161.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.6 Cg_endo -64.91 113.39 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.176 2.584 . . . . 0.0 107.754 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.3 tt0 -142.96 162.54 35.2 Favored 'General case' 0 CA--C 1.473 -2.011 1 N-CA-C 99.407 -4.294 . . . . 0.0 99.407 5.487 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 83.14 -5.51 1.24 Allowed 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.087 0.867 . . . . 0.0 110.922 162.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -90.65 -143.83 0.17 Allowed 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 125.366 1.466 . . . . 0.0 107.715 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.514 HG11 ' H ' ' A' ' 43' ' ' HIS . 34.8 m -141.75 -179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 1 N-CA-C 98.366 -4.679 . . . . 0.0 98.366 160.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.7 156.28 39.58 Favored 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 94.494 -6.113 . . . . 0.0 94.494 162.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -96.0 123.14 39.48 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 t -94.36 143.3 26.52 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -111.82 121.22 40.31 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.94 120.6 8.49 Favored 'Trans proline' 0 CA--C 1.506 -0.901 0 CA-C-N 123.565 2.309 . . . . 0.0 111.454 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.73 -55.61 0.68 Allowed Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.819 -5.312 . . . . 0.0 99.819 -160.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 m 113.27 -27.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 129.676 3.19 . . . . 0.0 109.839 167.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.29 -49.65 2.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.673 2.389 . . . . 0.0 117.147 -160.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.2 -49.01 69.07 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 121.669 -0.644 . . . . 0.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.7 t -85.91 -23.9 26.83 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.621 -0.929 . . . . 0.0 110.026 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.82 -36.92 85.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.572 -0.705 . . . . 0.0 109.124 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.8 m -66.41 -41.04 89.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.947 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.83 -44.5 95.99 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.632 0.773 . . . . 0.0 109.833 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 t -52.6 -50.14 63.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.406 1.482 . . . . 0.0 110.272 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -60.73 -47.69 85.17 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.721 0.409 . . . . 0.0 112.04 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.09 -31.79 66.39 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.487 -0.758 . . . . 0.0 112.783 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -78.48 -25.23 45.68 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.788 0.722 . . . . 0.0 109.784 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.97 42.57 0.77 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 161.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.68 135.37 12.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.879 -2.888 . . . . 0.0 105.879 170.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -84.02 -16.14 45.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.648 0.779 . . . . 0.0 109.928 -166.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t -158.8 169.98 23.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.99 175.39 46.64 Favored Glycine 0 N--CA 1.425 -2.046 1 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 p80 179.2 -176.45 0.26 Allowed 'General case' 0 N--CA 1.435 -1.193 1 N-CA-C 99.513 -4.255 . . . . 0.0 99.513 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.67 173.84 7.49 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.02 -171.05 40.99 Favored Glycine 0 CA--C 1.483 -1.953 1 N-CA-C 97.322 -6.311 . . . . 0.0 97.322 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.29 160.86 40.28 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 97.256 -5.09 . . . . 0.0 97.256 171.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -160.01 36.88 0.18 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.263 2.2 t 58.53 -143.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -157.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.92 -126.19 6.38 Favored Glycine 0 CA--C 1.48 -2.133 1 N-CA-C 99.548 -5.421 . . . . 0.0 99.548 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' H ' HG11 ' A' ' 13' ' ' VAL . 57.1 m-70 -121.13 -20.32 6.83 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 125.611 1.565 . . . . 0.0 108.192 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.39 -173.89 45.78 Favored Glycine 0 N--CA 1.421 -2.318 1 N-CA-C 96.481 -6.647 . . . . 0.0 96.481 -165.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.03 102.07 10.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 118.271 1.035 . . . . 0.0 108.232 -168.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.99 -179.83 7.54 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 125.231 1.413 . . . . 0.0 109.005 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 155.64 39.47 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 -170.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -90.95 154.36 19.52 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.9 m -141.95 144.02 33.52 Favored 'General case' 0 CA--C 1.479 -1.783 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 161.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -112.5 121.93 46.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.17 75.94 0.16 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 126.424 1.89 . . . . 0.0 110.085 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.5 mt -99.74 140.19 21.39 Favored Pre-proline 0 CA--C 1.497 -1.088 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.66 171.3 17.52 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.502 2.135 . . . . 0.0 109.943 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -78.56 -3.88 45.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -163.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -91.14 1.31 57.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.939 0.896 . . . . 0.0 109.917 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.95 140.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.56 148.58 18.91 Favored Glycine 0 CA--C 1.482 -1.997 1 N-CA-C 102.598 -4.201 . . . . 0.0 102.598 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HB ' ' H ' ' A' ' 59' ' ' ILE . 19.1 pt -144.53 -153.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -161.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.2 mm -72.53 139.46 19.59 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.423 -1.824 1 N-CA-C 92.91 -6.7 . . . . 0.0 92.91 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.698 0.761 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HE ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -123.71 157.15 34.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 174.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -132.52 127.84 36.03 Favored 'General case' 0 CA--C 1.488 -1.423 1 N-CA-C 98.113 -4.773 . . . . 0.0 98.113 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -167.23 22.25 Favored Glycine 0 CA--C 1.475 -2.421 1 N-CA-C 102.017 -4.433 . . . . 0.0 102.017 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.47 135.34 39.37 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 161.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -85.16 135.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -138.24 0.09 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.492 -2.595 . . . . 0.0 106.577 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -151.56 164.03 21.63 Favored Pre-proline 0 N--CA 1.422 -1.829 1 N-CA-C 95.329 -5.804 . . . . 0.0 95.329 162.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -65.22 148.4 88.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.845 2.052 . . . . 0.0 109.328 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.53 -51.01 6.15 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 127.97 2.508 . . . . 0.0 109.463 5.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -142.3 143.38 32.77 Favored 'General case' 0 CA--C 1.479 -1.767 1 N-CA-C 92.615 -6.809 . . . . 0.0 92.615 169.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.2 m -172.83 -158.85 0.11 Allowed 'General case' 0 N--CA 1.435 -1.179 1 N-CA-C 100.133 -4.025 . . . . 0.0 100.133 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 59' ' ' ILE . 2.9 m -124.26 166.37 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 96.612 -5.329 . . . . 0.0 96.612 159.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.16 -170.48 3.06 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -130.09 145.21 51.67 Favored 'General case' 0 CA--C 1.472 -2.027 1 N-CA-C 93.075 -6.639 . . . . 0.0 93.075 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -160.44 -165.37 1.42 Allowed 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 94.863 -5.977 . . . . 0.0 94.863 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -144.42 171.91 6.12 Favored Pre-proline 0 N--CA 1.416 -2.154 1 N-CA-C 99.821 -4.14 . . . . 0.0 99.821 -161.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.88 60.3 2.26 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.304 2.669 . . . . 0.0 110.049 164.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.59 124.43 0.81 Allowed Glycine 0 N--CA 1.422 -2.251 1 N-CA-C 100.948 -4.861 . . . . 0.0 100.948 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.37 38.21 0.35 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.088 1.755 . . . . 0.0 112.276 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -70.08 -63.96 0.98 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.369 1.468 . . . . 0.0 110.127 -161.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -23.46 61.93 Favored Glycine 0 CA--C 1.495 -1.19 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -79.65 -14.66 58.63 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.724 -0.655 . . . . 0.0 111.4 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.7 -55.35 23.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 119.714 1.143 . . . . 0.0 109.735 168.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.32 90.88 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.004 1.322 . . . . 0.0 112.767 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.53 -40.49 89.16 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.574 0.702 . . . . 0.0 111.219 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.6 -42.87 98.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -64.1 -46.38 84.49 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 122.465 0.306 . . . . 0.0 110.935 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.32 -15.94 61.89 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.128 -0.982 . . . . 0.0 112.495 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -92.67 -6.87 48.36 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.02 0.528 . . . . 0.0 109.878 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 32.11 11.14 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.81 18.92 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 103.858 -3.697 . . . . 0.0 103.858 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -82.13 -43.33 17.93 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 121.828 -0.807 . . . . 0.0 109.761 -167.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -160.71 -179.76 7.88 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.72 -4.548 . . . . 0.0 98.72 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.01 -176.39 42.39 Favored Glycine 0 N--CA 1.418 -2.503 1 N-CA-C 99.313 -5.515 . . . . 0.0 99.313 -167.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -160.33 -176.6 5.71 Favored 'General case' 0 CA--C 1.488 -1.409 1 N-CA-C 98.511 -4.625 . . . . 0.0 98.511 -174.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.7 m -140.32 161.64 37.2 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.06 109.73 0.95 Allowed Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 104.571 -3.411 . . . . 0.0 104.571 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -171.84 -179.75 2.53 Favored 'General case' 0 N--CA 1.43 -1.425 1 N-CA-C 98.138 -4.764 . . . . 0.0 98.138 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -153.78 148.74 26.68 Favored 'General case' 0 N--CA 1.433 -1.319 1 N-CA-C 95.849 -5.612 . . . . 0.0 95.849 163.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.52 173.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 N-CA-C 97.814 -4.884 . . . . 0.0 97.814 173.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.29 75.89 1.98 Allowed Glycine 0 C--N 1.351 1.372 0 N-CA-C 105.163 -3.175 . . . . 0.0 105.163 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.38 -50.29 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.35 1 N-CA-C 99.928 -4.101 . . . . 0.0 99.928 -170.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.02 -92.41 0.12 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.59 174.16 8.01 Favored 'General case' 0 N--CA 1.427 -1.597 1 N-CA-C 95.838 -5.616 . . . . 0.0 95.838 -173.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.44 -174.62 4.57 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.9 t -118.01 158.3 25.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 101.742 -3.429 . . . . 0.0 101.742 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -97.17 153.98 17.65 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 m -145.63 152.17 39.22 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 101.444 -3.539 . . . . 0.0 101.444 163.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.87 143.15 48.08 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.84 51.58 0.57 Allowed 'General case' 0 CA--C 1.498 -1.019 0 C-N-CA 126.928 2.091 . . . . 0.0 111.986 171.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -93.0 133.04 29.49 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.97 172.94 11.91 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.542 2.161 . . . . 0.0 110.283 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.71 26.33 1.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -97.31 -7.91 30.94 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -101.81 -176.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -151.17 166.65 30.57 Favored Glycine 0 CA--C 1.479 -2.181 1 N-CA-C 98.11 -5.996 . . . . 0.0 98.11 -174.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.416 HG12 ' HE ' ' A' ' 2' ' ' ARG . 23.3 pt -153.8 -168.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.478 -1.807 1 N-CA-C 99.282 -4.34 . . . . 0.0 99.282 -168.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.429 HD12 HG12 ' A' ' 13' ' ' VAL . 14.5 mm -64.17 111.65 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.118 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -104.47 166.42 10.41 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -130.46 134.33 47.01 Favored 'General case' 0 CA--C 1.491 -1.289 1 N-CA-C 94.574 -6.084 . . . . 0.0 94.574 158.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 -179.69 36.78 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -79.21 132.38 36.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 159.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.62 138.06 20.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.84 -156.88 0.57 Allowed 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 127.71 2.404 . . . . 0.0 107.913 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -121.89 142.94 37.36 Favored Pre-proline 0 N--CA 1.424 -1.774 1 N-CA-C 94.846 -5.983 . . . . 0.0 94.846 165.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -63.36 138.03 63.72 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.034 2.489 . . . . 0.0 107.592 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -79.97 -49.45 11.83 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 127.291 2.236 . . . . 0.0 111.469 12.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -156.58 145.08 19.86 Favored 'General case' 0 N--CA 1.417 -2.08 1 N-CA-C 94.538 -6.097 . . . . 0.0 94.538 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 m 172.11 -157.65 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 59' ' ' ILE . 5.6 m -125.83 159.04 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 1 N-CA-C 97.143 -5.132 . . . . 0.0 97.143 162.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.85 -175.74 5.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 162.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.03 170.62 14.68 Favored 'General case' 0 CA--C 1.481 -1.682 1 N-CA-C 96.638 -5.319 . . . . 0.0 96.638 176.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -160.42 169.04 23.89 Favored 'General case' 0 N--CA 1.412 -2.364 1 N-CA-C 98.754 -4.535 . . . . 0.0 98.754 -170.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.27 104.21 22.42 Favored Pre-proline 0 N--CA 1.416 -2.136 1 N-CA-C 93.085 -6.635 . . . . 0.0 93.085 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.95 101.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.306 0 CA-C-N 124.987 2.817 . . . . 0.0 118.138 -141.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.97 8.33 79.32 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -91.87 170.65 9.7 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -49.57 -36.69 24.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.704 2.002 . . . . 0.0 115.209 -169.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.33 -59.84 10.01 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 123.115 0.388 . . . . 0.0 112.642 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -79.57 -13.71 59.34 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 118.792 1.296 . . . . 0.0 109.611 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.21 -49.53 76.79 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -42.84 99.43 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.65 -38.86 90.54 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.856 1.207 . . . . 0.0 110.597 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -62.57 -48.78 77.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -57.76 -50.05 74.52 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.896 0.878 . . . . 0.0 112.268 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.4 -10.33 57.5 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -4.07 28.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.634 0.774 . . . . 0.0 110.016 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.14 37.91 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.51 114.99 4.28 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 m -101.9 -5.59 24.55 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.85 169.32 24.62 Favored 'General case' 0 N--CA 1.435 -1.197 1 N-CA-C 97.462 -5.014 . . . . 0.0 97.462 163.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.88 -177.8 42.45 Favored Glycine 0 CA--C 1.479 -2.181 0 N-CA-C 103.797 -3.721 . . . . 0.0 103.797 -174.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -163.48 -166.56 1.25 Allowed 'General case' 0 N--CA 1.433 -1.286 1 N-CA-C 97.229 -5.1 . . . . 0.0 97.229 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.8 m -154.71 163.28 40.47 Favored 'General case' 0 CA--C 1.484 -1.568 1 N-CA-C 98.938 -4.468 . . . . 0.0 98.938 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.55 -176.48 47.68 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 103.274 -3.93 . . . . 0.0 103.274 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.42 143.11 29.87 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 97.178 -5.119 . . . . 0.0 97.178 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -164.42 53.84 0.14 Allowed 'General case' 0 CA--C 1.491 -1.312 1 N-CA-C 97.357 -5.053 . . . . 0.0 97.357 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.301 1.5 t 57.76 -146.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 C-N-CA 125.628 1.571 . . . . 0.0 107.95 -160.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.04 -127.63 6.9 Favored Glycine 0 N--CA 1.424 -2.111 1 N-CA-C 98.915 -5.674 . . . . 0.0 98.915 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.484 ' H ' HG11 ' A' ' 13' ' ' VAL . 31.9 m170 -119.23 -10.02 9.83 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.19 -169.86 42.93 Favored Glycine 0 N--CA 1.423 -2.196 1 N-CA-C 98.168 -5.973 . . . . 0.0 98.168 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.59 128.63 36.86 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.91 171.37 8.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.1 t -113.46 166.91 11.04 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 100.856 -3.757 . . . . 0.0 100.856 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -132.15 148.78 52.49 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.4 m -142.18 154.05 44.52 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -120.25 136.03 54.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.72 56.19 0.18 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.588 2.355 . . . . 0.0 109.896 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.95 135.98 25.31 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -66.5 169.1 14.82 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.112 1.875 . . . . 0.0 112.098 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.8 -6.71 50.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -93.6 1.97 56.51 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 123.01 0.524 . . . . 0.0 110.061 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.06 133.85 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.04 151.55 19.49 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 105.766 -2.934 . . . . 0.0 105.766 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 pt -140.7 -166.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -72.47 140.56 17.79 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -172.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.421 -1.879 1 N-CA-C 94.982 -5.933 . . . . 0.0 94.982 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 178.19 7.5 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -135.83 131.77 35.81 Favored 'General case' 0 CA--C 1.492 -1.274 1 N-CA-C 96.781 -5.266 . . . . 0.0 96.781 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -177.89 35.21 Favored Glycine 0 CA--C 1.479 -2.204 0 N-CA-C 103.909 -3.677 . . . . 0.0 103.909 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -74.73 131.71 41.05 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.5 130.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -99.22 -153.0 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 111.418 -2.628 . . . . 0.0 108.275 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -130.79 152.27 80.26 Favored Pre-proline 0 N--CA 1.422 -1.873 1 N-CA-C 95.834 -5.617 . . . . 0.0 95.834 174.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -70.87 151.39 62.7 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 CA-C-N 122.338 1.871 . . . . 0.0 109.841 -171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -96.31 -20.64 18.35 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 127.771 2.428 . . . . 0.0 106.662 3.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -154.01 148.11 25.74 Favored 'General case' 0 N--CA 1.407 -2.585 1 N-CA-C 95.509 -5.737 . . . . 0.0 95.509 172.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.78 -154.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.605 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -136.53 173.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 N-CA-C 97.566 -4.976 . . . . 0.0 97.566 166.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -161.39 0.81 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 167.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -136.75 151.87 49.7 Favored 'General case' 0 N--CA 1.418 -2.057 1 N-CA-C 95.023 -5.918 . . . . 0.0 95.023 167.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -160.77 -167.6 1.89 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.74 -5.652 . . . . 0.0 95.74 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.6 166.35 17.85 Favored Pre-proline 0 N--CA 1.415 -2.204 1 N-CA-C 98.05 -4.796 . . . . 0.0 98.05 -161.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -68.34 68.68 1.02 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 CA-C-N 124.094 2.498 . . . . 0.0 112.199 165.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.1 -179.83 46.98 Favored Glycine 0 N--CA 1.417 -2.567 1 N-CA-C 97.661 -6.176 . . . . 0.0 97.661 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -128.82 9.02 5.8 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -55.03 -43.53 73.81 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.891 1.676 . . . . 0.0 114.205 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.95 -49.69 5.52 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -50.36 -43.23 54.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.042 1.737 . . . . 0.0 113.177 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.9 -32.23 70.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.695 0.798 . . . . 0.0 110.593 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -78.97 -45.8 19.6 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 109.004 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.24 -41.15 86.1 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -63.06 -41.8 99.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.464 -0.773 . . . . 0.0 110.684 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.86 -35.17 67.14 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.277 -0.889 . . . . 0.0 111.49 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.59 -30.35 61.66 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.564 -0.71 . . . . 0.0 111.077 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -90.37 -6.82 54.56 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.213 0.605 . . . . 0.0 110.534 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.7 37.18 4.55 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 160.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.29 163.7 16.81 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 104.653 -3.379 . . . . 0.0 104.653 164.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.4 p -68.53 -56.13 9.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.515 1.15 . . . . 0.0 109.854 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -160.67 -172.62 3.59 Favored 'General case' 0 N--CA 1.424 -1.775 1 N-CA-C 98.904 -4.48 . . . . 0.0 98.904 168.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.04 -178.83 40.2 Favored Glycine 0 N--CA 1.415 -2.764 1 N-CA-C 98.529 -5.828 . . . . 0.0 98.529 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -161.56 -175.74 4.93 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.726 -4.916 . . . . 0.0 97.726 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -139.19 157.77 45.35 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 103.811 -2.662 . . . . 0.0 103.811 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.55 166.44 34.24 Favored Glycine 0 N--CA 1.429 -1.774 1 N-CA-C 95.847 -6.901 . . . . 0.0 95.847 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.95 132.08 56.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -129.67 36.08 4.12 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 42' ' ' GLY 0.284 11.5 t 70.1 -171.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -163.25 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.751 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 147.34 -130.37 3.54 Favored Glycine 0 N--CA 1.42 -2.386 1 N-CA-C 97.122 -6.391 . . . . 0.0 97.122 -168.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -114.5 -48.7 2.86 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.45 -178.74 23.83 Favored Glycine 0 N--CA 1.425 -2.083 1 N-CA-C 97.895 -6.082 . . . . 0.0 97.895 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 103.37 7.43 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.423 1.489 . . . . 0.0 107.294 -171.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.11 -166.46 1.5 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -117.49 151.79 36.39 Favored 'General case' 0 CA--C 1.489 -1.386 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -101.32 158.74 15.83 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.8 m -145.78 143.41 29.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.8 123.6 50.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 172.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.23 65.26 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.778 2.431 . . . . 0.0 109.315 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.95 138.68 20.67 Favored Pre-proline 0 CA--C 1.492 -1.271 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.534 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -66.48 161.3 41.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.749 2.299 . . . . 0.0 110.606 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.6 -15.21 59.89 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.059 0.543 . . . . 0.0 111.127 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -92.27 12.36 22.71 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 110.391 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.08 -158.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 101.439 -3.541 . . . . 0.0 101.439 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.03 163.39 33.75 Favored Glycine 0 CA--C 1.466 -3.001 1 N-CA-C 102.539 -4.224 . . . . 0.0 102.539 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -152.78 -170.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 101.168 -3.641 . . . . 0.0 101.168 -163.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 13' ' ' VAL . 4.0 mm -71.22 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.427 -1.583 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 174.87 5.73 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.54 145.77 51.02 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 95.451 -5.759 . . . . 0.0 95.451 165.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 175.66 38.13 Favored Glycine 0 CA--C 1.479 -2.215 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 66.5 m-85 -80.4 131.64 35.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 155.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.87 138.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -106.75 -138.18 0.37 Allowed 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 127.493 2.317 . . . . 0.0 107.085 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -141.34 148.82 52.54 Favored Pre-proline 0 N--CA 1.415 -2.196 1 N-CA-C 94.553 -6.092 . . . . 0.0 94.553 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -67.52 143.8 64.4 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.641 2.228 . . . . 0.0 107.548 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -84.29 -33.06 24.05 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 127.897 2.479 . . . . 0.0 109.332 9.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -160.42 158.32 29.26 Favored 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 94.312 -6.181 . . . . 0.0 94.312 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 171.18 -152.5 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 1 N-CA-C 98.382 -4.673 . . . . 0.0 98.382 167.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.32 167.72 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 N-CA-C 96.287 -5.449 . . . . 0.0 96.287 158.891 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.87 -150.48 0.11 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -139.29 -175.36 4.15 Favored 'General case' 0 CA--C 1.484 -1.571 1 N-CA-C 96.619 -5.326 . . . . 0.0 96.619 163.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -147.93 173.81 12.5 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 96.608 -5.33 . . . . 0.0 96.608 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -129.65 126.11 22.55 Favored Pre-proline 0 N--CA 1.413 -2.317 1 N-CA-C 92.376 -6.898 . . . . 0.0 92.376 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -60.13 98.33 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 125.164 2.88 . . . . 0.0 114.855 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -167.01 35.33 Favored Glycine 0 N--CA 1.422 -2.249 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 p -91.44 -45.36 8.59 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -39.68 -70.62 0.1 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.218 2.207 . . . . 0.0 116.912 -151.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.58 -37.35 62.07 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.799 -1.188 . . . . 0.0 111.068 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -64.88 -51.47 61.77 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.914 1.286 . . . . 0.0 108.795 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.16 -41.39 96.68 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.896 0.878 . . . . 0.0 109.587 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.6 m -59.0 -47.7 84.24 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 121.333 -0.854 . . . . 0.0 111.756 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 mt -65.98 -42.3 90.03 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 123.387 0.675 . . . . 0.0 110.476 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.13 -49.53 73.65 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.38 1.472 . . . . 0.0 109.902 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -69.72 -35.57 75.14 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.27 -0.894 . . . . 0.0 111.339 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -74.76 -2.69 27.6 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.319 -0.863 . . . . 0.0 112.884 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.5 7.53 28.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.379 -0.825 . . . . 0.0 109.212 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.39 26.38 18.3 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.82 132.97 11.43 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 m -94.05 -15.88 24.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -166.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -160.61 179.19 8.78 Favored 'General case' 0 CA--C 1.493 -1.248 1 N-CA-C 99.337 -4.32 . . . . 0.0 99.337 168.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.5 -173.87 39.4 Favored Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 103.104 -3.998 . . . . 0.0 103.104 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -161.08 -162.31 0.9 Allowed 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 -174.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.9 t -136.17 164.92 26.92 Favored 'General case' 0 CA--C 1.489 -1.374 1 N-CA-C 96.202 -5.481 . . . . 0.0 96.202 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.04 -168.19 37.75 Favored Glycine 0 N--CA 1.425 -2.099 1 N-CA-C 102.053 -4.419 . . . . 0.0 102.053 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -148.14 144.68 27.95 Favored 'General case' 0 N--CA 1.428 -1.546 1 N-CA-C 96.368 -5.419 . . . . 0.0 96.368 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -126.89 109.96 12.53 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.73 136.12 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.57 -34.16 4.2 Favored Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 105.414 -3.074 . . . . 0.0 105.414 -170.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.34 -70.62 0.78 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.95 -153.03 23.81 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 106.819 -2.512 . . . . 0.0 106.819 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.64 137.89 55.95 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.164 2.186 . . . . 0.0 106.273 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.35 178.21 8.08 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 101.349 -3.574 . . . . 0.0 101.349 -168.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.22 165.94 13.2 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.651 -4.203 . . . . 0.0 99.651 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 6.4 t-105 -127.89 146.87 50.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -134.98 149.22 50.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.67 136.63 53.81 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 172.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.7 76.37 0.28 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 126.799 2.039 . . . . 0.0 111.522 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.16 141.22 22.11 Favored Pre-proline 0 CA--C 1.501 -0.913 0 N-CA-C 101.819 -3.4 . . . . 0.0 101.819 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.7 165.16 31.84 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.38 2.054 . . . . 0.0 109.595 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.8 -1.65 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.438 -0.789 . . . . 0.0 112.726 -160.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.49 -1.99 58.35 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.051 0.94 . . . . 0.0 109.533 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.65 134.41 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.96 148.44 16.55 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 104.295 -3.522 . . . . 0.0 104.295 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 pt -132.27 -150.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.6 mm -73.64 131.37 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 99.313 -4.329 . . . . 0.0 99.313 172.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -174.57 4.56 Favored 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 98.192 -4.744 . . . . 0.0 98.192 172.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -133.74 143.17 48.3 Favored 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.143 -4.762 . . . . 0.0 98.143 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.32 23.86 Favored Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -81.87 136.65 35.34 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 163.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 tt -90.55 146.83 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.333 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.09 178.19 10.3 Favored 'General case' 0 N--CA 1.401 -2.88 1 N-CA-C 96.949 -5.204 . . . . 0.0 96.949 -163.158 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -93.21 161.01 32.24 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -64.07 116.85 3.95 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.089 1.859 . . . . 0.0 109.812 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -145.52 139.2 26.6 Favored 'General case' 0 CA--C 1.481 -1.703 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 2.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.1 -26.95 0.09 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 127.162 2.185 . . . . 0.0 110.138 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.2 m -87.24 111.63 21.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -157.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.04 171.97 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-O 124.544 2.116 . . . . 0.0 114.654 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.76 -154.78 0.49 Allowed 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.533 -2.576 . . . . 0.0 104.337 -173.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.9 177.61 8.23 Favored 'General case' 0 N--CA 1.417 -2.12 1 N-CA-C 95.756 -5.646 . . . . 0.0 95.756 162.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' HD22 ' A' ' 45' ' ' LEU . 11.5 t -142.7 159.21 42.68 Favored 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 95.153 -5.869 . . . . 0.0 95.153 -174.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.0 121.42 25.44 Favored Pre-proline 0 N--CA 1.415 -2.18 1 N-CA-C 93.235 -6.58 . . . . 0.0 93.235 168.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -68.29 67.69 1.03 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 CA-C-N 123.604 2.323 . . . . 0.0 114.787 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.93 161.5 32.73 Favored Glycine 0 N--CA 1.424 -2.159 1 N-CA-C 100.031 -5.228 . . . . 0.0 100.031 175.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 m -63.3 -39.76 95.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.919 0.887 . . . . 0.0 112.156 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -62.33 -27.16 68.85 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -168.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -77.19 1.33 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 168.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.19 -37.29 79.79 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.855 0.862 . . . . 0.0 113.238 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -73.26 -46.79 47.97 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 m -54.86 -46.0 74.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.829 0.851 . . . . 0.0 111.383 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.13 -35.23 79.28 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 123.49 0.716 . . . . 0.0 111.637 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -69.98 -48.85 56.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 109.207 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -60.95 -45.59 94.12 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 121.822 -0.549 . . . . 0.0 110.865 -174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.73 -13.84 62.64 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -0.1 37.53 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.66 26.42 13.28 Favored Glycine 0 CA--C 1.491 -1.442 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.012 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.78 138.53 14.43 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.7 p -84.46 -29.67 25.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.764 0.793 . . . . 0.0 109.589 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.45 158.53 29.55 Favored 'General case' 0 N--CA 1.421 -1.889 1 N-CA-C 98.726 -4.546 . . . . 0.0 98.726 -166.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.33 -177.43 47.85 Favored Glycine 0 N--CA 1.424 -2.104 1 N-CA-C 100.346 -5.102 . . . . 0.0 100.346 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -173.17 -176.73 1.42 Allowed 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 100.311 -3.959 . . . . 0.0 100.311 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.3 t -90.22 163.46 14.79 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.77 -175.04 37.93 Favored Glycine 0 CA--C 1.479 -2.168 1 N-CA-C 99.308 -5.517 . . . . 0.0 99.308 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -131.0 148.25 52.73 Favored 'General case' 0 N--CA 1.433 -1.289 1 N-CA-C 99.437 -4.282 . . . . 0.0 99.437 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -115.65 94.38 4.67 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.81 120.2 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.63 -22.83 7.66 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -121.83 -72.11 0.7 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.03 -159.54 32.64 Favored Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 105.706 -2.958 . . . . 0.0 105.706 -169.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 16' ' ' CYS . 1.8 mt -78.26 150.73 33.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.385 -2.821 . . . . 0.0 103.385 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.33 173.84 15.66 Favored 'General case' 0 CA--C 1.485 -1.554 1 N-CA-C 98.69 -4.559 . . . . 0.0 98.69 -174.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -116.14 164.6 14.23 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -106.34 146.56 30.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 m -141.92 147.44 37.07 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.7 138.8 47.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.43 68.98 0.77 Allowed 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.788 2.035 . . . . 0.0 112.326 169.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mt -99.57 148.86 35.3 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -66.64 167.97 17.82 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.591 2.194 . . . . 0.0 112.366 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -81.76 4.08 23.37 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -103.21 13.4 34.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.83 152.77 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 167.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.41 158.26 27.61 Favored Glycine 0 CA--C 1.48 -2.099 1 N-CA-C 98.304 -5.918 . . . . 0.0 98.304 -176.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.19 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 -151.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.8 mm -68.26 131.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.415 -2.2 1 N-CA-C 90.335 -7.654 . . . . 0.0 90.335 -174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.185 0.517 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 179.12 7.05 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 169.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -133.09 140.51 47.7 Favored 'General case' 0 CA--C 1.49 -1.335 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -176.18 33.77 Favored Glycine 0 CA--C 1.482 -2.008 0 N-CA-C 106.547 -2.621 . . . . 0.0 106.547 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -77.36 130.7 37.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 161.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.254 15.5 tt -90.41 136.2 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.41 -168.39 2.09 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 129.149 2.98 . . . . 0.0 109.383 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -145.91 158.63 48.69 Favored Pre-proline 0 N--CA 1.423 -1.819 1 N-CA-C 95.85 -5.611 . . . . 0.0 95.85 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.18 146.59 90.73 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 123.065 2.13 . . . . 0.0 112.26 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.63 -53.22 4.9 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 126.621 1.968 . . . . 0.0 107.721 7.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -142.74 137.67 29.96 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 91.947 -7.057 . . . . 0.0 91.947 168.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.6 m -177.47 -162.76 0.07 Allowed 'General case' 0 CA--C 1.483 -1.628 1 N-CA-C 98.735 -4.543 . . . . 0.0 98.735 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -117.92 163.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 1 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 166.45 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -169.21 1.95 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 159.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -135.01 167.53 20.78 Favored 'General case' 0 CA--C 1.477 -1.86 1 N-CA-C 97.104 -5.147 . . . . 0.0 97.104 173.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -136.58 160.94 37.28 Favored 'General case' 0 N--CA 1.421 -1.92 1 N-CA-C 96.517 -5.364 . . . . 0.0 96.517 -165.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -112.73 116.54 47.76 Favored Pre-proline 0 N--CA 1.422 -1.858 1 N-CA-C 95.067 -5.901 . . . . 0.0 95.067 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -59.37 101.76 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.676 0 CA-C-N 125.004 2.823 . . . . 0.0 115.32 -161.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.15 -171.3 37.15 Favored Glycine 0 N--CA 1.42 -2.387 1 N-CA-C 98.308 -5.917 . . . . 0.0 98.308 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 -35.99 14.6 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.445 0.622 . . . . 0.0 110.499 -172.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -53.25 35.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.496 2.319 . . . . 0.0 116.034 -159.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.75 -42.38 31.73 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.5 -42.79 86.82 Favored 'General case' 0 CA--C 1.482 -1.644 0 O-C-N 122.148 -0.619 . . . . 0.0 110.988 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.36 -39.33 93.67 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.2 m -63.05 -47.21 83.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.818 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -40.07 95.78 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.783 0.801 . . . . 0.0 110.1 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.39 -42.81 82.94 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.26 1.024 . . . . 0.0 110.823 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.86 -47.79 84.77 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 122.878 0.471 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.95 -14.9 60.24 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -96.26 -6.84 37.03 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.733 -0.605 . . . . 0.0 111.061 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.44 27.25 12.03 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.51 151.87 19.09 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.726 -3.349 . . . . 0.0 104.726 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.0 p -84.85 -34.42 22.67 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -169.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.55 152.84 34.75 Favored 'General case' 0 N--CA 1.423 -1.8 1 N-CA-C 99.992 -4.077 . . . . 0.0 99.992 -161.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.89 42.18 Favored Glycine 0 CA--C 1.475 -2.444 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -166.49 -158.74 0.33 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 101.49 -3.522 . . . . 0.0 101.49 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.98 161.18 21.35 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -178.86 41.91 Favored Glycine 0 N--CA 1.422 -2.246 1 N-CA-C 102.214 -4.354 . . . . 0.0 102.214 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -138.07 139.64 39.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 100.389 -3.93 . . . . 0.0 100.389 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -115.48 99.02 7.06 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.82 120.05 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.14 -32.22 3.16 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.782 -2.927 . . . . 0.0 105.782 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.21 -70.3 0.81 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.15 -159.81 32.69 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 104.973 -3.251 . . . . 0.0 104.973 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.53 140.64 58.89 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.453 2.301 . . . . 0.0 106.849 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.86 -179.77 6.13 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -171.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.4 m -113.24 168.2 9.93 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 101.451 -3.537 . . . . 0.0 101.451 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.2 t-105 -121.93 148.38 44.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.07 150.02 45.25 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.14 147.2 43.57 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 103.233 -2.876 . . . . 0.0 103.233 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.02 51.47 0.95 Allowed 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 126.953 2.101 . . . . 0.0 110.972 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.84 133.71 28.69 Favored Pre-proline 0 CA--C 1.499 -0.984 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.0 175.5 11.32 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.266 1.978 . . . . 0.0 110.444 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.08 4.63 16.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -95.86 3.62 53.5 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.182 -0.948 . . . . 0.0 108.813 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -104.58 178.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -155.58 164.13 31.96 Favored Glycine 0 CA--C 1.482 -1.974 1 N-CA-C 98.412 -5.875 . . . . 0.0 98.412 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 pt -155.62 -172.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -163.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER -68.9 118.87 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 CA-C-O 122.077 0.942 . . . . 0.0 111.937 -160.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.427 -1.58 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 166.235 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.627 0.727 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -116.96 154.6 30.59 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -137.89 128.59 26.81 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 97.425 -5.028 . . . . 0.0 97.425 168.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -170.99 27.45 Favored Glycine 0 CA--C 1.476 -2.363 1 N-CA-C 102.306 -4.318 . . . . 0.0 102.306 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.57 135.46 39.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 160.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.51 141.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.44 -138.89 0.36 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.582 -2.099 . . . . 0.0 107.029 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.432 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 64.0 mt-30 -140.93 161.19 55.19 Favored Pre-proline 0 N--CA 1.423 -1.783 1 N-CA-C 95.526 -5.731 . . . . 0.0 95.526 169.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -67.31 144.5 68.41 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 122.765 2.023 . . . . 0.0 108.588 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.62 -42.36 8.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.455 2.302 . . . . 0.0 107.744 7.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.62 146.02 37.41 Favored 'General case' 0 N--CA 1.419 -1.986 1 N-CA-C 92.92 -6.696 . . . . 0.0 92.92 173.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -177.75 -163.98 0.08 Allowed 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.561 HG11 ' H ' ' A' ' 43' ' ' HIS . 3.5 m -128.65 164.11 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.729 1 N-CA-C 96.789 -5.263 . . . . 0.0 96.789 156.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -173.47 4.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 160.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -134.96 147.1 49.66 Favored 'General case' 0 CA--C 1.466 -2.256 1 N-CA-C 93.823 -6.362 . . . . 0.0 93.823 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -160.57 -165.82 1.5 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.081 -5.896 . . . . 0.0 95.081 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -141.22 173.18 5.11 Favored Pre-proline 0 N--CA 1.418 -2.04 1 N-CA-C 99.974 -4.084 . . . . 0.0 99.974 -161.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.52 55.51 3.7 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 C-N-CA 123.035 2.49 . . . . 0.0 110.754 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.69 141.11 4.57 Favored Glycine 0 N--CA 1.42 -2.375 1 N-CA-C 99.363 -5.495 . . . . 0.0 99.363 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 24.93 0.5 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.809 1.644 . . . . 0.0 112.667 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -59.16 -49.46 77.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.663 1.985 . . . . 0.0 112.492 -161.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.87 -25.83 26.12 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -82.85 -8.94 59.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.538 -0.977 . . . . 0.0 110.853 -167.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.46 -57.21 10.61 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.324 1.05 . . . . 0.0 108.98 166.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -52.1 67.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.465 1.106 . . . . 0.0 112.419 171.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.89 -43.25 93.52 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.801 0.81 . . . . 0.0 111.856 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.0 t -62.8 -43.13 99.6 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 108.957 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -78.59 -27.48 45.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.398 -0.814 . . . . 0.0 111.601 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.85 -20.13 53.61 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.182 -0.949 . . . . 0.0 111.334 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -88.06 -22.48 24.16 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.76 33.48 2.42 Favored Glycine 0 CA--C 1.488 -1.595 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 163.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.21 150.83 19.74 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -96.96 -17.92 19.78 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.671 0.748 . . . . 0.0 109.833 -165.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 m -160.75 168.27 25.14 Favored 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 98.979 -4.452 . . . . 0.0 98.979 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.37 176.66 44.57 Favored Glycine 0 N--CA 1.419 -2.452 1 N-CA-C 100.855 -4.898 . . . . 0.0 100.855 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -168.93 -168.77 0.89 Allowed 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 97.35 -5.056 . . . . 0.0 97.35 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -142.43 166.05 25.74 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.44 -176.61 44.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 103.135 -3.986 . . . . 0.0 103.135 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -130.95 121.96 26.05 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 99.539 -4.245 . . . . 0.0 99.539 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -139.33 59.81 1.59 Allowed 'General case' 0 CA--C 1.487 -1.444 1 N-CA-C 99.404 -4.295 . . . . 0.0 99.404 171.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 42' ' ' GLY 0.293 1.5 t 56.47 -152.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 127.512 2.325 . . . . 0.0 108.204 -165.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 119.82 -128.76 7.69 Favored Glycine 0 N--CA 1.425 -2.072 1 N-CA-C 100.065 -5.214 . . . . 0.0 100.065 -170.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.561 ' H ' HG11 ' A' ' 13' ' ' VAL . 35.5 m170 -118.55 -19.65 8.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 125.452 1.501 . . . . 0.0 107.307 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.86 -174.14 46.59 Favored Glycine 0 N--CA 1.426 -1.995 1 N-CA-C 97.625 -6.19 . . . . 0.0 97.625 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -69.16 132.71 46.97 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.06 -169.7 2.03 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -163.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.6 t -123.25 159.51 28.56 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -113.41 151.43 31.37 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.8 m -144.5 150.87 38.3 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -110.53 144.15 39.81 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.79 54.96 4.88 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.748 2.419 . . . . 0.0 112.682 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.18 144.62 38.84 Favored Pre-proline 0 CA--C 1.499 -0.991 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -64.9 162.82 30.62 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.576 2.184 . . . . 0.0 112.209 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.97 -28.03 63.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.103 1.761 . . . . 0.0 114.101 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -98.24 15.82 23.32 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.23 1.012 . . . . 0.0 110.652 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 138.83 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 151.53 18.21 Favored Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 104.31 -3.516 . . . . 0.0 104.31 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.82 -159.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 13' ' ' VAL . 2.0 mm -72.54 130.78 35.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.147 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 100.86 -3.756 . . . . 0.0 100.86 178.883 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.59 165.38 11.86 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 171.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.15 137.91 53.62 Favored 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 94.305 -6.183 . . . . 0.0 94.305 153.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -176.7 34.23 Favored Glycine 0 CA--C 1.474 -2.496 1 N-CA-C 102.956 -4.058 . . . . 0.0 102.956 177.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 41.9 m-85 -76.86 135.52 38.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 161.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -90.4 138.44 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -176.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.57 -135.91 0.34 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.425 -1.716 . . . . 0.0 106.931 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -136.34 159.08 72.11 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 96.156 -5.498 . . . . 0.0 96.156 169.065 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -69.14 148.57 69.37 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.011 1.807 . . . . 0.0 109.421 174.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -82.15 -29.19 31.74 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 127.42 2.288 . . . . 0.0 108.315 -3.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -155.57 165.34 36.88 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 178.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 157.62 -147.0 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.58 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.571 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 59' ' ' ILE . 17.3 m -135.0 166.9 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 1 N-CA-C 98.352 -4.684 . . . . 0.0 98.352 161.842 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -170.9 2.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 165.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -136.24 149.54 48.57 Favored 'General case' 0 CA--C 1.479 -1.757 1 N-CA-C 98.53 -4.618 . . . . 0.0 98.53 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -125.59 162.65 24.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 101.922 -3.362 . . . . 0.0 101.922 -168.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -114.06 112.81 46.96 Favored Pre-proline 0 N--CA 1.421 -1.898 1 N-CA-C 98.765 -4.531 . . . . 0.0 98.765 168.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.53 118.53 5.46 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 CA-C-N 123.314 2.219 . . . . 0.0 111.47 -171.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.28 -45.73 0.57 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 99.874 -5.291 . . . . 0.0 99.874 -165.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m 115.17 -35.33 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 129.362 3.065 . . . . 0.0 107.003 168.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -40.15 -53.78 2.4 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.326 2.65 . . . . 0.0 116.459 -156.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.16 -36.7 56.05 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 121.369 -0.832 . . . . 0.0 111.607 -176.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -86.29 -26.13 25.11 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 120.963 -1.316 . . . . 0.0 109.072 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.65 -36.48 84.38 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.999 0.919 . . . . 0.0 108.83 170.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 m -66.23 -42.21 88.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.382 -0.824 . . . . 0.0 110.336 173.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.46 -38.97 92.89 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 121.002 -1.061 . . . . 0.0 110.869 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 t -54.28 -42.78 70.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.515 1.126 . . . . 0.0 111.009 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.71 -44.85 92.42 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 122.022 -0.424 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.22 -28.39 63.14 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.487 0.585 . . . . 0.0 111.91 -176.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.91 -19.04 49.04 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.853 -0.53 . . . . 0.0 110.435 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.47 35.46 2.86 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 164.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.22 138.45 13.91 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 167.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 p -98.05 3.14 49.36 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.851 -0.794 . . . . 0.0 110.036 -168.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -160.36 166.46 29.33 Favored 'General case' 0 CA--C 1.48 -1.716 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.98 175.75 46.48 Favored Glycine 0 CA--C 1.469 -2.831 1 N-CA-C 99.73 -5.348 . . . . 0.0 99.73 -177.272 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -168.91 -153.78 0.12 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 96.269 -5.456 . . . . 0.0 96.269 -172.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -149.98 166.15 30.51 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.57 -4.974 . . . . 0.0 97.57 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.2 171.41 41.92 Favored Glycine 0 CA--C 1.48 -2.126 1 N-CA-C 96.154 -6.778 . . . . 0.0 96.154 176.287 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -146.5 137.32 24.12 Favored 'General case' 0 CA--C 1.483 -1.607 1 N-CA-C 99.251 -4.352 . . . . 0.0 99.251 -175.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -158.57 56.18 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.32 1.4 t 55.62 -144.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 125.859 1.664 . . . . 0.0 108.215 -158.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.41 -131.04 5.36 Favored Glycine 0 CA--C 1.474 -2.492 1 N-CA-C 94.86 -7.296 . . . . 0.0 94.86 -169.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.54 ' H ' HG11 ' A' ' 13' ' ' VAL . 51.2 m170 -123.34 10.82 9.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.98 -49.18 0.29 Allowed Glycine 0 CA--C 1.486 -1.737 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -171.33 -176.52 1.89 Allowed 'General case' 0 N--CA 1.437 -1.096 1 N-CA-C 95.848 -5.612 . . . . 0.0 95.848 -175.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.92 174.98 4.59 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 99.089 -4.412 . . . . 0.0 99.089 174.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 29.6 m -123.31 -174.16 2.89 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 171.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 18.4 t-105 -132.01 152.62 51.04 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -177.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.7 m -145.13 155.11 43.11 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -119.27 140.77 49.72 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 172.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.19 55.77 1.07 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 127.356 2.262 . . . . 0.0 111.38 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.35 130.99 37.68 Favored Pre-proline 0 CA--C 1.496 -1.123 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -70.69 176.2 7.81 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.339 2.026 . . . . 0.0 111.069 177.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -84.68 19.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -99.53 -6.16 27.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.2 t -99.06 173.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -145.58 156.86 27.15 Favored Glycine 0 CA--C 1.48 -2.141 1 N-CA-C 97.914 -6.075 . . . . 0.0 97.914 -175.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 pt -150.76 -167.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 101.926 -3.361 . . . . 0.0 101.926 -166.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.738 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -70.03 133.97 30.92 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -171.14 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.434 -1.263 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 162.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.139 0.495 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.88 171.39 7.93 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 172.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -135.82 133.72 38.15 Favored 'General case' 0 CA--C 1.489 -1.379 1 N-CA-C 96.421 -5.399 . . . . 0.0 96.421 168.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.8 -177.26 34.71 Favored Glycine 0 CA--C 1.478 -2.277 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 36.2 m-85 -73.91 133.75 43.14 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.19 136.89 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.81 -146.14 0.3 Allowed 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 126.718 2.007 . . . . 0.0 107.295 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -133.86 147.14 63.02 Favored Pre-proline 0 N--CA 1.423 -1.8 1 N-CA-C 94.408 -6.145 . . . . 0.0 94.408 164.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.54 145.1 63.27 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 CA-C-N 123.21 2.182 . . . . 0.0 108.089 177.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.57 -44.43 15.87 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 120.902 1.683 . . . . 0.0 111.79 7.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -152.92 149.59 28.39 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 94.489 -6.115 . . . . 0.0 94.489 177.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.32 -158.9 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.437 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 -179.006 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -123.76 161.1 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 1 N-CA-C 98.739 -4.541 . . . . 0.0 98.739 161.758 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -162.36 0.6 Allowed 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 162.143 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -137.87 166.49 23.9 Favored 'General case' 0 N--CA 1.426 -1.669 1 N-CA-C 96.89 -5.226 . . . . 0.0 96.89 162.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.4 t -119.95 169.82 9.83 Favored 'General case' 0 N--CA 1.419 -1.978 1 N-CA-C 99.041 -4.429 . . . . 0.0 99.041 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.24 131.0 24.02 Favored Pre-proline 0 N--CA 1.421 -1.911 1 N-CA-C 98.03 -4.804 . . . . 0.0 98.03 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -69.08 37.62 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 123.145 2.563 . . . . 0.0 114.715 174.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.86 142.8 9.45 Favored Glycine 0 N--CA 1.426 -2.007 1 N-CA-C 96.084 -6.806 . . . . 0.0 96.084 177.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.1 -41.69 98.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.928 1.291 . . . . 0.0 113.962 -157.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -53.38 9.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 128.407 2.683 . . . . 0.0 115.592 -163.214 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -50.78 32.21 Favored Glycine 0 C--N 1.349 1.288 0 O-C-N 121.945 -0.472 . . . . 0.0 112.14 -166.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.12 -18.91 55.05 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -58.34 -53.72 55.16 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -39.31 93.99 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.32 -37.95 86.55 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.922 0.783 . . . . 0.0 111.261 -179.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -65.9 -45.78 80.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.614 -0.679 . . . . 0.0 109.98 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -65.15 -41.32 94.85 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.957 -0.464 . . . . 0.0 111.916 -178.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.9 -17.35 63.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.166 -0.959 . . . . 0.0 112.188 -175.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -95.72 -6.29 40.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.66 0.784 . . . . 0.0 110.046 176.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.89 32.7 17.3 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.0 151.15 17.96 Favored Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 104.066 -3.614 . . . . 0.0 104.066 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.7 p -73.45 -55.07 6.83 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.029 0.919 . . . . 0.0 109.999 -168.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -160.63 -177.03 5.91 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 98.184 -4.746 . . . . 0.0 98.184 166.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.56 176.44 44.1 Favored Glycine 0 N--CA 1.416 -2.684 1 N-CA-C 99.838 -5.305 . . . . 0.0 99.838 -171.079 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -146.31 178.49 8.2 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 100.466 -3.902 . . . . 0.0 100.466 -172.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.6 m -83.79 171.76 12.84 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 119.14 0.882 . . . . 0.0 109.771 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.12 -179.07 45.45 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 103.13 -3.988 . . . . 0.0 103.13 -172.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -147.72 152.71 38.23 Favored 'General case' 0 N--CA 1.427 -1.598 1 N-CA-C 97.298 -5.075 . . . . 0.0 97.298 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -136.84 106.07 6.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 172.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.43 122.29 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.72 -40.69 1.43 Allowed Glycine 0 CA--C 1.482 -2.005 1 N-CA-C 102.62 -4.192 . . . . 0.0 102.62 -166.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -123.76 -67.6 0.92 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.95 -157.51 30.02 Favored Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 -169.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -70.71 139.03 51.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.3 -173.46 3.34 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -167.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -129.4 177.3 7.29 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.815 -3.772 . . . . 0.0 100.815 169.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 30.1 t-105 -122.3 160.48 25.23 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.5 m -148.65 151.77 35.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 167.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.97 129.92 56.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.31 66.89 0.1 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 127.64 2.376 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.5 mt -103.11 137.96 19.41 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.12 170.86 18.81 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.745 2.296 . . . . 0.0 110.402 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.75 -5.68 42.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 124.164 0.986 . . . . 0.0 113.583 -168.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -88.91 3.7 50.49 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.288 -0.883 . . . . 0.0 109.551 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.05 136.05 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.33 154.94 18.54 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.347 -2.301 . . . . 0.0 107.347 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.89 -171.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 -172.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -73.86 141.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 123.395 0.678 . . . . 0.0 109.581 -169.222 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.424 -1.731 1 N-CA-C 98.089 -4.782 . . . . 0.0 98.089 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.254 0.55 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 178.8 4.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 167.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -128.74 148.02 50.81 Favored 'General case' 0 N--CA 1.431 -1.397 1 N-CA-C 95.245 -5.835 . . . . 0.0 95.245 166.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.31 170.59 37.13 Favored Glycine 0 CA--C 1.48 -2.133 0 C-N-CA 117.845 -2.121 . . . . 0.0 109.017 -175.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -82.11 121.82 27.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 159.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 tt -90.5 143.27 11.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.089 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -174.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -115.59 -154.52 0.55 Allowed 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 128.995 2.918 . . . . 0.0 108.858 -175.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.32 165.58 30.72 Favored Pre-proline 0 N--CA 1.425 -1.708 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 170.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 44.0 Cg_exo -62.19 126.49 18.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.748 2.965 . . . . 0.0 112.871 -173.1 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 3.2 mm-40 -133.77 138.07 45.52 Favored 'General case' 0 CA--C 1.467 -2.24 1 N-CA-C 96.33 -5.433 . . . . 0.0 96.33 -10.685 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.6 t30 68.36 30.25 5.54 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 119.351 0.978 . . . . 0.0 111.626 175.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.23 -159.9 0.76 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 168.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -133.95 162.84 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 1 N-CA-C 96.55 -5.352 . . . . 0.0 96.55 170.563 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -168.02 2.09 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 162.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -138.08 146.09 42.51 Favored 'General case' 0 CA--C 1.469 -2.161 1 N-CA-C 96.214 -5.476 . . . . 0.0 96.214 168.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.55 175.2 6.84 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -112.29 130.49 23.28 Favored Pre-proline 0 N--CA 1.421 -1.882 1 N-CA-C 93.976 -6.305 . . . . 0.0 93.976 165.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.92 37.98 0.11 Allowed 'Trans proline' 0 C--N 1.331 -0.369 0 CA-C-N 125.679 3.064 . . . . 0.0 116.024 177.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.55 108.97 0.49 Allowed Glycine 0 N--CA 1.422 -2.243 1 N-CA-C 94.734 -7.346 . . . . 0.0 94.734 170.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -52.42 -36.8 55.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.313 2.245 . . . . 0.0 115.042 -157.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -44.79 -39.35 5.18 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.854 2.462 . . . . 0.0 116.659 -170.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.41 -46.13 87.31 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 120.776 -1.202 . . . . 0.0 112.05 -177.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.65 -25.09 28.75 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 122.18 -0.6 . . . . 0.0 109.621 -175.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.82 -39.25 91.12 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.096 0.558 . . . . 0.0 109.971 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -63.81 -41.97 97.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.464 175.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.0 mt -63.94 -40.44 96.43 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 121.953 0.883 . . . . 0.0 110.667 177.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.6 t -57.86 -47.38 82.88 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.208 1.403 . . . . 0.0 110.575 175.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.04 -42.41 80.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 122.681 0.393 . . . . 0.0 111.024 -176.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.02 -23.6 60.63 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.727 -0.608 . . . . 0.0 111.928 -175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.95 -49.21 11.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.073 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.92 48.81 0.16 Allowed Glycine 0 CA--C 1.49 -1.518 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 168.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.13 143.55 15.79 Favored Glycine 0 CA--C 1.487 -1.673 1 N-CA-C 101.35 -4.7 . . . . 0.0 101.35 157.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 p -75.12 -28.6 60.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 118.385 1.092 . . . . 0.0 110.77 -164.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.9 m -160.56 173.42 15.55 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.92 -176.96 42.75 Favored Glycine 0 N--CA 1.418 -2.542 1 N-CA-C 98.786 -5.726 . . . . 0.0 98.786 -172.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -171.16 -174.71 1.54 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 -170.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.4 m -81.03 169.71 17.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 119.153 0.888 . . . . 0.0 109.134 -178.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.88 164.51 34.25 Favored Glycine 0 N--CA 1.416 -2.693 1 N-CA-C 98.465 -5.854 . . . . 0.0 98.465 175.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -135.8 154.77 51.1 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 97.21 -5.108 . . . . 0.0 97.21 177.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.92 179.21 9.29 Favored 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 97.503 -4.999 . . . . 0.0 97.503 174.935 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.63 163.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 1 N-CA-C 97.968 -4.827 . . . . 0.0 97.968 178.173 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.39 -46.85 1.1 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 102.564 -4.214 . . . . 0.0 102.564 -170.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -119.46 -79.65 0.6 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 170.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.22 -147.26 12.82 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 103.28 -3.928 . . . . 0.0 103.28 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.59 132.91 54.64 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.51 2.324 . . . . 0.0 108.066 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.11 -173.34 3.7 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 102.201 -3.259 . . . . 0.0 102.201 -164.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.31 172.05 9.41 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 169.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -129.31 147.9 51.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.7 m -143.28 146.97 34.06 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -114.69 145.46 42.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.5 55.44 0.5 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 126.578 1.951 . . . . 0.0 111.064 172.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.05 138.69 20.35 Favored Pre-proline 0 CA--C 1.501 -0.908 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -66.42 165.95 23.23 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.45 2.1 . . . . 0.0 111.773 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -73.86 -19.1 60.83 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.328 0.651 . . . . 0.0 112.27 -169.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -92.29 18.55 8.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 109.73 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.05 133.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 100.533 -3.877 . . . . 0.0 100.533 167.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.92 146.57 18.64 Favored Glycine 0 CA--C 1.479 -2.172 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.69 -141.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -156.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.8 120.62 28.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 169.14 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -163.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.115 0.483 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.29 167.7 12.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 171.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -130.46 140.03 50.55 Favored 'General case' 0 CA--C 1.485 -1.545 1 N-CA-C 94.703 -6.036 . . . . 0.0 94.703 165.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.45 29.27 Favored Glycine 0 CA--C 1.472 -2.608 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 178.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.58 138.72 34.15 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 101.453 -3.536 . . . . 0.0 101.453 157.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -89.99 132.82 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -177.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.26 -148.86 0.43 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 111.949 -2.387 . . . . 0.0 107.09 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.94 148.46 65.06 Favored Pre-proline 0 N--CA 1.424 -1.773 1 N-CA-C 95.509 -5.738 . . . . 0.0 95.509 174.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.64 149.86 39.18 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.787 2.031 . . . . 0.0 107.847 -177.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 -5.33 16.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.468 2.307 . . . . 0.0 109.263 13.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -162.38 146.55 12.0 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 94.417 -6.142 . . . . 0.0 94.417 163.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.08 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 177.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 59' ' ' ILE . 16.2 m -135.15 170.42 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 97.164 -5.124 . . . . 0.0 97.164 163.048 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.85 -168.16 1.59 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -125.72 163.64 22.39 Favored 'General case' 0 CA--C 1.474 -1.96 1 N-CA-C 99.603 -4.221 . . . . 0.0 99.603 171.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.28 152.71 47.47 Favored 'General case' 0 N--CA 1.417 -2.076 1 N-CA-C 96.158 -5.497 . . . . 0.0 96.158 -166.07 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.52 115.76 39.47 Favored Pre-proline 0 N--CA 1.419 -1.996 1 N-CA-C 97.36 -5.052 . . . . 0.0 97.36 171.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.3 107.49 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 123.347 2.231 . . . . 0.0 112.043 -176.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.81 -41.26 0.83 Allowed Glycine 0 CA--C 1.491 -1.455 1 N-CA-C 101.472 -4.651 . . . . 0.0 101.472 -161.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m 84.76 3.81 0.68 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 125.351 1.46 . . . . 0.0 113.222 157.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.75 -40.82 80.6 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.417 1.887 . . . . 0.0 110.752 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.91 -41.29 93.47 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.906 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.5 m -68.89 -42.94 76.26 Favored 'General case' 0 CA--C 1.484 -1.559 0 CA-C-N 117.959 0.879 . . . . 0.0 110.164 -175.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.98 -49.69 74.97 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.905 0.882 . . . . 0.0 109.255 176.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -57.5 -50.11 74.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 111.443 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.7 -43.78 98.19 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.035 0.921 . . . . 0.0 110.152 -178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.1 -43.05 95.86 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.284 0.634 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.86 -39.74 83.72 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.802 -0.561 . . . . 0.0 111.477 -178.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.71 -21.21 52.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.613 -0.679 . . . . 0.0 111.702 -175.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -89.51 -28.78 19.4 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.592 -0.693 . . . . 0.0 109.691 175.07 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.21 44.62 0.85 Allowed Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 164.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.73 141.23 16.32 Favored Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 p -99.62 7.42 45.24 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 123.488 0.715 . . . . 0.0 110.034 -167.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.3 m -160.18 150.89 18.77 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 100.28 -3.97 . . . . 0.0 100.28 166.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -166.94 162.67 36.45 Favored Glycine 0 CA--C 1.463 -3.205 1 N-CA-C 99.537 -5.425 . . . . 0.0 99.537 -177.415 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -162.34 -157.68 0.48 Allowed 'General case' 0 N--CA 1.428 -1.529 1 N-CA-C 99.714 -4.18 . . . . 0.0 99.714 -168.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.4 t -155.6 167.04 31.68 Favored 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 95.954 -5.573 . . . . 0.0 95.954 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.82 73.95 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.568 1 N-CA-C 100.27 -5.132 . . . . 0.0 100.27 -176.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -157.84 157.39 33.18 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 176.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -148.39 166.76 27.13 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 94.16 -6.237 . . . . 0.0 94.16 159.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 42' ' ' GLY 0.332 50.1 t 84.19 -167.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -172.132 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.775 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 89.67 -93.24 1.86 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 107.174 -2.371 . . . . 0.0 107.174 -177.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -137.96 -52.47 0.62 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 100.589 -3.856 . . . . 0.0 100.589 178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.8 61.95 0.22 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 172.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.461 0.0 OUTLIER 76.36 167.82 0.26 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 109.164 -175.717 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.55 -179.65 8.37 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -175.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.78 160.97 15.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 176.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 t-105 -107.79 150.52 26.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 9.4 m -147.55 150.92 35.42 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.38 143.15 48.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.21 54.13 0.43 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 126.544 1.938 . . . . 0.0 110.602 168.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.6 mt -95.7 135.34 23.07 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 175.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.99 171.8 16.79 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.432 2.088 . . . . 0.0 110.434 177.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -67.61 -17.17 64.52 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -79.37 -6.78 57.56 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.818 -0.551 . . . . 0.0 110.448 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.61 127.3 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.71 157.09 17.54 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 105.16 -3.176 . . . . 0.0 105.16 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -136.75 -158.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 105.925 -1.879 . . . . 0.0 105.925 -163.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -74.76 123.09 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -178.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -173.896 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.395 0.617 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 173.08 6.95 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.33 137.92 39.42 Favored 'General case' 0 N--CA 1.431 -1.405 1 N-CA-C 95.412 -5.773 . . . . 0.0 95.412 170.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.94 -177.58 35.12 Favored Glycine 0 CA--C 1.471 -2.662 1 N-CA-C 103.06 -4.016 . . . . 0.0 103.06 176.042 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -77.44 134.39 38.39 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 159.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.48 138.28 19.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.14 -157.18 0.56 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 129.045 2.938 . . . . 0.0 110.557 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.42 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 36.9 mt-30 -148.65 165.74 17.21 Favored Pre-proline 0 N--CA 1.426 -1.664 1 N-CA-C 97.116 -5.142 . . . . 0.0 97.116 176.782 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -68.96 149.9 72.46 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.688 2.259 . . . . 0.0 109.974 176.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -82.21 -47.37 12.55 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 127.48 2.312 . . . . 0.0 107.231 -1.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -150.26 140.38 22.1 Favored 'General case' 0 N--CA 1.42 -1.972 1 N-CA-C 92.332 -6.914 . . . . 0.0 92.332 173.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.8 m 179.9 -161.05 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 97.336 -5.061 . . . . 0.0 97.336 -174.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 59' ' ' ILE . 1.2 m -119.77 163.55 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 100.365 -3.939 . . . . 0.0 100.365 167.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.6 -165.63 1.01 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 158.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -138.34 168.52 19.57 Favored 'General case' 0 N--CA 1.415 -2.179 1 N-CA-C 96.399 -5.408 . . . . 0.0 96.399 167.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -129.55 -176.41 3.89 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 96.68 -5.304 . . . . 0.0 96.68 -176.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.77 131.17 23.67 Favored Pre-proline 0 N--CA 1.42 -1.95 1 N-CA-C 95.385 -5.783 . . . . 0.0 95.385 174.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.79 40.71 0.17 Allowed 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.298 3.332 . . . . 0.0 116.401 -174.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.13 92.9 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 93.609 -7.796 . . . . 0.0 93.609 174.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -78.79 30.86 0.2 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -148.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -70.18 -35.98 74.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 110.32 -170.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.19 -33.44 69.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -81.69 -11.83 58.9 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.189 -0.595 . . . . 0.0 109.969 -177.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.01 -50.08 75.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.039 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -50.58 73.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.867 0.867 . . . . 0.0 112.466 170.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.63 -41.52 99.06 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 121.593 0.711 . . . . 0.0 112.135 -173.202 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 t -65.12 -45.83 83.51 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -67.86 -37.17 81.48 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.669 -0.644 . . . . 0.0 112.358 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.16 -7.86 53.27 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.054 -1.029 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -106.22 1.61 26.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.98 29.67 37.39 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 140.83 15.27 Favored Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -92.94 -54.73 3.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -164.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 m -106.46 147.63 29.11 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 102.895 -3.002 . . . . 0.0 102.895 174.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.64 154.76 25.81 Favored Glycine 0 CA--C 1.469 -2.785 1 N-CA-C 100.468 -5.053 . . . . 0.0 100.468 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -171.97 179.02 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 98.016 -4.809 . . . . 0.0 98.016 -175.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.7 m -78.05 173.93 11.67 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 119.796 1.18 . . . . 0.0 111.044 -177.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.92 164.17 37.75 Favored Glycine 0 N--CA 1.418 -2.528 1 N-CA-C 98.688 -5.765 . . . . 0.0 98.688 175.69 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -126.72 131.57 51.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -115.76 105.49 12.78 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.72 140.23 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -172.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.09 -36.14 4.6 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -104.17 -66.39 0.96 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -177.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.33 -150.31 22.23 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 104.963 -3.255 . . . . 0.0 104.963 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.43 136.48 54.75 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.84 -162.48 1.1 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 101.998 -3.334 . . . . 0.0 101.998 -176.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.8 171.55 11.64 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 158.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -129.7 148.76 51.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.2 m -142.36 146.67 35.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -116.64 140.63 49.18 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 170.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 63.98 0.31 Allowed 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 126.342 1.857 . . . . 0.0 109.893 176.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 mt -103.09 133.88 20.09 Favored Pre-proline 0 CA--C 1.503 -0.833 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 169.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -72.52 174.64 11.31 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.624 2.216 . . . . 0.0 111.248 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -76.03 -2.08 28.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -165.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -90.49 -5.89 55.49 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.266 -0.896 . . . . 0.0 110.065 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.03 138.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -174.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.72 149.92 17.8 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 pt -146.78 -175.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -168.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.0 OUTLIER -72.42 127.75 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 121.723 0.773 . . . . 0.0 111.74 -159.637 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 100.833 -3.766 . . . . 0.0 100.833 168.808 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.33 163.27 13.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -130.76 127.93 39.74 Favored 'General case' 0 CA--C 1.491 -1.301 1 N-CA-C 95.564 -5.717 . . . . 0.0 95.564 158.11 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.05 -169.83 25.95 Favored Glycine 0 CA--C 1.478 -2.261 1 N-CA-C 102.808 -4.117 . . . . 0.0 102.808 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 76.0 m-85 -80.55 142.33 34.23 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 163.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.92 141.64 14.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.971 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.702 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -119.77 -153.25 0.53 Allowed 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 128.029 2.531 . . . . 0.0 106.701 -175.376 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -128.84 147.46 64.65 Favored Pre-proline 0 N--CA 1.419 -1.992 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 173.656 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.98 146.8 59.89 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.614 1.969 . . . . 0.0 107.31 175.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -80.93 -41.67 22.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.403 2.281 . . . . 0.0 109.845 11.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -154.02 151.87 29.85 Favored 'General case' 0 N--CA 1.417 -2.095 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 -176.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.7 m 173.97 -154.01 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 97.091 -5.151 . . . . 0.0 97.091 169.704 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.15 170.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 1 N-CA-C 97.412 -5.032 . . . . 0.0 97.412 161.536 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -161.77 0.72 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 164.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -142.35 163.54 32.58 Favored 'General case' 0 N--CA 1.417 -2.101 1 N-CA-C 94.463 -6.125 . . . . 0.0 94.463 165.355 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -160.64 -156.89 0.5 Allowed 'General case' 0 N--CA 1.414 -2.257 1 N-CA-C 94.656 -6.053 . . . . 0.0 94.656 -174.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -145.61 169.71 9.28 Favored Pre-proline 0 N--CA 1.414 -2.25 1 N-CA-C 97.837 -4.875 . . . . 0.0 97.837 -167.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -77.33 68.4 7.49 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 CA-C-N 124.14 2.514 . . . . 0.0 111.873 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.82 165.94 34.59 Favored Glycine 0 CA--C 1.479 -2.166 1 N-CA-C 99.778 -5.329 . . . . 0.0 99.778 171.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -83.25 11.17 6.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 118.085 0.942 . . . . 0.0 111.32 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.91 -57.02 8.32 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 128.56 2.744 . . . . 0.0 114.485 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.51 -29.66 18.38 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -85.03 -5.06 59.36 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.779 -0.836 . . . . 0.0 110.873 -165.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.96 -53.04 62.89 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -52.63 64.65 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.486 1.115 . . . . 0.0 112.423 171.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.88 -41.08 97.83 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 118.603 0.638 . . . . 0.0 110.998 -173.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -65.47 -42.3 92.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 121.231 -0.918 . . . . 0.0 108.78 -177.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -69.61 -40.28 76.71 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.896 -0.502 . . . . 0.0 111.136 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -72.65 -30.13 64.03 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 118.535 0.607 . . . . 0.0 112.324 -178.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.69 -24.56 36.13 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.216 0.462 . . . . 0.0 109.89 176.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.61 37.92 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 159.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.89 136.86 13.87 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 104.773 -3.331 . . . . 0.0 104.773 173.031 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -106.34 9.64 31.84 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.74 0.781 . . . . 0.0 108.978 -165.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.6 m -160.21 157.83 28.96 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 98.886 -4.487 . . . . 0.0 98.886 163.292 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 170.98 44.04 Favored Glycine 0 N--CA 1.421 -2.339 1 N-CA-C 100.799 -4.92 . . . . 0.0 100.799 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -168.12 -174.44 2.33 Favored 'General case' 0 N--CA 1.432 -1.334 1 N-CA-C 97.303 -5.073 . . . . 0.0 97.303 -179.377 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.45 159.89 33.99 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.75 -179.22 48.49 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 100.721 -4.951 . . . . 0.0 100.721 -173.147 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -102.9 146.97 27.51 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -171.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -119.17 113.27 20.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 101.458 -3.534 . . . . 0.0 101.458 171.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.03 132.3 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -173.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.83 15.65 33.27 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -171.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -152.4 -79.48 0.11 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.66 -168.88 39.78 Favored Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 -165.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.96 142.15 42.04 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.87 -164.08 1.43 Allowed 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -166.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.6 t -127.62 165.93 19.03 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.2 -4.0 . . . . 0.0 100.2 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 13.6 t-105 -123.33 148.04 46.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 178.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.51 152.3 40.38 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 175.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -115.99 140.84 48.86 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 172.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.1 42.29 0.14 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.145 2.178 . . . . 0.0 111.197 166.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 mt -85.11 134.76 40.38 Favored Pre-proline 0 CA--C 1.5 -0.97 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.32 172.92 15.36 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.127 1.885 . . . . 0.0 110.135 -178.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.66 -9.38 58.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -167.459 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -91.24 5.3 49.69 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -178.202 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -103.81 147.79 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 176.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.01 143.83 18.21 Favored Glycine 0 CA--C 1.478 -2.274 1 N-CA-C 101.111 -4.796 . . . . 0.0 101.111 175.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 -149.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -167.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.3 mp -67.4 119.78 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 174.389 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.581 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.122 0.487 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -112.59 167.92 10.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 164.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.85 123.79 33.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 94.856 -5.979 . . . . 0.0 94.856 159.596 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.69 -169.75 25.44 Favored Glycine 0 CA--C 1.485 -1.791 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -172.066 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.01 138.8 31.7 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 164.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 tt -90.93 144.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.71 -138.16 0.36 Allowed 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 127.874 2.47 . . . . 0.0 107.115 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -139.62 154.04 70.88 Favored Pre-proline 0 N--CA 1.426 -1.647 1 N-CA-C 95.597 -5.705 . . . . 0.0 95.597 166.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.87 155.4 53.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 122.836 2.049 . . . . 0.0 109.016 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -83.71 -27.63 28.84 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 126.764 2.025 . . . . 0.0 107.824 -1.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -158.61 152.91 24.08 Favored 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 95.123 -5.881 . . . . 0.0 95.123 175.316 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m 170.27 -153.55 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.662 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.32 170.4 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 1 N-CA-C 96.715 -5.291 . . . . 0.0 96.715 166.67 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -156.95 0.34 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 161.453 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -138.4 143.07 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 167.02 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 t -160.1 -174.44 4.55 Favored 'General case' 0 N--CA 1.419 -2.011 1 N-CA-C 96.878 -5.23 . . . . 0.0 96.878 178.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.17 173.52 5.53 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 -159.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.79 61.74 2.31 Favored 'Trans proline' 0 C--N 1.328 -0.552 0 C-N-CA 123.117 2.545 . . . . 0.0 110.108 161.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.86 138.56 2.7 Favored Glycine 0 N--CA 1.428 -1.843 1 N-CA-C 100.024 -5.231 . . . . 0.0 100.024 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -85.9 -11.48 53.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 123.918 0.887 . . . . 0.0 112.976 -165.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -39.29 -53.42 1.94 Allowed 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 127.963 2.505 . . . . 0.0 117.632 -153.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.94 -40.94 7.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -174.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -82.09 -14.81 55.24 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.586 -0.949 . . . . 0.0 110.306 -169.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.66 -45.11 93.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.792 0.837 . . . . 0.0 109.253 169.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -46.82 86.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.299 1.039 . . . . 0.0 111.513 172.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.32 -39.29 89.18 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-O 121.801 0.81 . . . . 0.0 111.435 -176.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.91 -44.57 67.06 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.116 1.766 . . . . 0.0 110.776 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.8 -54.26 47.37 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 123.196 0.598 . . . . 0.0 110.961 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.95 -20.42 62.45 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.323 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -88.74 -7.68 55.83 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.581 0.628 . . . . 0.0 110.413 172.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.99 5.2 Favored Glycine 0 CA--C 1.486 -1.758 0 CA-C-O 119.192 -0.782 . . . . 0.0 111.81 160.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.72 20.33 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 p -86.94 -84.2 0.18 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.5 m -81.54 161.26 23.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.27 168.35 35.83 Favored Glycine 0 N--CA 1.42 -2.416 1 N-CA-C 99.172 -5.571 . . . . 0.0 99.172 -177.596 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -165.03 -179.8 5.94 Favored 'General case' 0 N--CA 1.433 -1.318 1 N-CA-C 97.758 -4.904 . . . . 0.0 97.758 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.6 m -143.92 161.22 39.27 Favored 'General case' 0 CA--C 1.487 -1.45 1 N-CA-C 98.376 -4.676 . . . . 0.0 98.376 165.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.52 177.43 35.53 Favored Glycine 0 CA--C 1.488 -1.629 1 N-CA-C 97.081 -6.408 . . . . 0.0 97.081 -175.033 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -113.43 103.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 120.374 2.087 . . . . 0.0 108.559 -174.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -130.38 81.9 2.03 Favored 'General case' 0 CA--C 1.497 -1.091 1 N-CA-C 99.215 -4.365 . . . . 0.0 99.215 156.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.39 -177.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 1 N-CA-C 100.177 -4.008 . . . . 0.0 100.177 -174.65 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.51 54.61 0.37 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -157.47 -67.18 0.1 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 -178.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.85 42.47 Favored Glycine 0 CA--C 1.477 -2.285 1 N-CA-C 98.533 -5.827 . . . . 0.0 98.533 -178.105 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -76.69 140.88 41.05 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -175.273 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.91 -172.75 4.12 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 100.882 -3.747 . . . . 0.0 100.882 -162.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.39 155.33 32.16 Favored 'General case' 0 CA--C 1.479 -1.773 0 C-N-CA 117.542 -1.663 . . . . 0.0 106.658 -165.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -97.49 150.4 21.11 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 176.365 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 46.8 m -145.14 146.69 31.89 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 168.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.64 145.47 33.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 170.087 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.64 38.04 1.33 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 126.065 1.746 . . . . 0.0 111.85 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.57 133.97 62.33 Favored Pre-proline 0 CA--C 1.5 -0.952 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -65.22 166.75 18.11 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.5 2.134 . . . . 0.0 111.331 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.45 -5.49 52.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.969 -0.457 . . . . 0.0 112.16 -168.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -90.38 -0.57 57.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.69 -0.631 . . . . 0.0 109.861 177.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 t -95.74 123.74 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 177.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.86 145.75 16.82 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -147.13 -171.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -158.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 7' ' ' ALA . 35.1 mm -54.44 111.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.939 0 C-N-CA 126.912 2.085 . . . . 0.0 112.562 -170.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.434 -1.272 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 166.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.27 0.557 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -179.55 6.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 172.204 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -130.95 146.17 52.27 Favored 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 99.33 -4.322 . . . . 0.0 99.33 -174.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.63 -179.65 36.44 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -177.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.51 123.34 28.0 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 58' ' ' ILE 0.273 11.9 tt -90.67 140.9 15.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 120.752 1.615 . . . . 0.0 109.453 -176.413 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.98 169.07 10.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 110.95 -2.841 . . . . 0.0 112.092 177.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 14' ' ' TYR 0.252 26.6 tt0 -95.9 151.22 38.21 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 174.745 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -63.03 132.34 36.34 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.978 2.452 . . . . 0.0 109.336 165.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.94 -50.86 9.83 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 122.001 2.182 . . . . 0.0 110.843 14.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -168.06 156.28 8.79 Favored 'General case' 0 N--CA 1.425 -1.708 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 167.356 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 18.7 m 158.52 -144.84 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.428 1 N-CA-C 97.985 -4.821 . . . . 0.0 97.985 -176.968 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 59' ' ' ILE . 3.6 m -106.02 165.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 165.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -91.0 -167.93 1.94 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 162.787 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -136.73 161.75 35.07 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 168.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.9 t -132.41 163.97 27.54 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 101.341 -3.577 . . . . 0.0 101.341 -160.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -109.43 126.95 28.1 Favored Pre-proline 0 N--CA 1.423 -1.775 1 N-CA-C 99.554 -4.239 . . . . 0.0 99.554 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.91 41.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.485 0 C-N-CA 123.843 3.029 . . . . 0.0 116.617 174.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.93 115.41 0.66 Allowed Glycine 0 N--CA 1.423 -2.217 1 N-CA-C 94.436 -7.466 . . . . 0.0 94.436 171.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -60.48 -32.76 71.73 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 m -41.18 -43.88 2.43 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 127.807 2.443 . . . . 0.0 116.373 -168.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -55.89 26.91 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 121.116 -0.99 . . . . 0.0 112.017 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -21.61 36.55 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.642 -0.916 . . . . 0.0 110.091 -173.583 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.11 -35.32 78.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.542 0.737 . . . . 0.0 109.641 169.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 m -70.61 -40.1 73.37 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 177.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.75 -39.61 94.71 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.242 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -57.17 -42.57 81.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.652 1.181 . . . . 0.0 111.176 177.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.55 -51.85 67.68 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.833 0.453 . . . . 0.0 110.821 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.88 -18.94 62.67 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.31 -2.32 57.99 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.802 -0.561 . . . . 0.0 111.325 174.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 24.91 12.74 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 121.601 -0.687 . . . . 0.0 111.754 170.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.03 157.89 21.15 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 172.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 p -81.43 -40.86 22.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.41 157.5 27.87 Favored 'General case' 0 N--CA 1.418 -2.028 1 N-CA-C 98.524 -4.621 . . . . 0.0 98.524 -164.025 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.14 173.87 45.29 Favored Glycine 0 CA--C 1.475 -2.449 1 N-CA-C 102.085 -4.406 . . . . 0.0 102.085 -176.082 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -170.72 -143.98 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.5 m -121.36 -175.37 3.06 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 -170.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.49 -168.58 33.29 Favored Glycine 0 N--CA 1.417 -2.624 1 N-CA-C 96.845 -6.502 . . . . 0.0 96.845 172.594 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -141.97 157.87 44.44 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 96.884 -5.228 . . . . 0.0 96.884 172.328 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -162.55 177.84 9.1 Favored 'General case' 0 N--CA 1.423 -1.784 1 N-CA-C 96.036 -5.542 . . . . 0.0 96.036 172.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.41 171.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 1 N-CA-C 96.283 -5.451 . . . . 0.0 96.283 179.119 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.03 -49.53 0.85 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 104.005 -3.638 . . . . 0.0 104.005 -173.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.43 -70.19 0.81 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.33 -159.9 32.98 Favored Glycine 0 CA--C 1.482 -1.979 0 N-CA-C 103.367 -3.893 . . . . 0.0 103.367 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.06 136.27 58.03 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.761 2.024 . . . . 0.0 106.831 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.49 168.32 20.06 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -161.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.79 179.05 4.39 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -140.37 146.82 38.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.845 -3.02 . . . . 0.0 102.845 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.73 151.18 49.89 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -112.12 137.69 49.83 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 173.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 56.9 71.88 0.55 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 127.753 2.421 . . . . 0.0 113.253 174.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.6 mt -103.77 143.59 26.95 Favored Pre-proline 0 CA--C 1.504 -0.809 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 172.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -69.21 173.39 10.55 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.251 1.967 . . . . 0.0 113.288 174.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.06 -17.64 61.4 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.067 1.347 . . . . 0.0 111.549 -174.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -94.3 18.91 10.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.592 0.757 . . . . 0.0 109.485 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.97 164.74 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 1 N-CA-C 98.773 -4.528 . . . . 0.0 98.773 167.025 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.06 175.1 30.91 Favored Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.783 -5.327 . . . . 0.0 99.783 -175.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -159.22 -170.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 -156.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 13' ' ' VAL . 17.5 mm -38.9 -43.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 129.844 3.258 . . . . 0.0 118.908 -147.27 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.487 -1.472 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.93 0.871 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -117.73 164.44 14.98 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.245 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -139.91 136.51 33.96 Favored 'General case' 0 CA--C 1.485 -1.536 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 167.296 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.13 35.57 Favored Glycine 0 CA--C 1.476 -2.399 0 N-CA-C 104.165 -3.574 . . . . 0.0 104.165 174.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -75.02 130.8 39.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.359 -3.201 . . . . 0.0 102.359 157.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -84.1 135.84 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.68 -136.61 0.34 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 110.711 -2.949 . . . . 0.0 109.256 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -146.43 159.24 45.5 Favored Pre-proline 0 N--CA 1.423 -1.79 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 172.678 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.11 141.89 44.99 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.37 2.047 . . . . 0.0 108.484 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.22 -32.42 13.04 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 127.962 2.505 . . . . 0.0 107.601 7.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -150.34 147.21 27.32 Favored 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 94.126 -6.25 . . . . 0.0 94.126 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -159.47 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.606 HG12 HD12 ' A' ' 59' ' ' ILE . 2.4 m -133.58 157.8 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 162.273 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 -155.16 0.27 Allowed 'General case' 0 C--N 1.358 0.936 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 161.776 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -138.63 154.97 48.68 Favored 'General case' 0 CA--C 1.473 -2.004 1 N-CA-C 97.496 -5.002 . . . . 0.0 97.496 177.364 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.25 175.31 6.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -158.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.89 85.58 57.42 Favored Pre-proline 0 N--CA 1.411 -2.419 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -175.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -78.0 -4.39 14.36 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.133 1.889 . . . . 0.0 109.63 165.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.27 141.09 10.84 Favored Glycine 0 CA--C 1.484 -1.901 1 N-CA-C 96.815 -6.514 . . . . 0.0 96.815 174.169 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -68.06 -55.13 13.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -153.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -63.47 5.95 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -155.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.17 -93.05 1.31 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 169.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.92 -17.86 62.06 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.521 1.128 . . . . 0.0 111.61 -166.003 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -62.31 -49.84 74.04 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 121.082 1.765 . . . . 0.0 109.499 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.72 89.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.812 2.045 . . . . 0.0 111.884 173.112 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.33 -44.09 88.91 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.815 0.817 . . . . 0.0 110.968 -178.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.9 t -58.67 -43.88 90.01 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 125.182 1.393 . . . . 0.0 109.03 177.216 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -53.51 54.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.099 0.96 . . . . 0.0 111.262 -178.583 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.28 -26.39 66.52 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.785 -0.572 . . . . 0.0 112.474 -175.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -79.86 -13.12 59.63 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 123.39 0.676 . . . . 0.0 110.498 177.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.31 23.87 8.74 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.87 119.87 6.13 Favored Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.134 -3.187 . . . . 0.0 105.134 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 p -82.45 -11.97 58.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.695 0.759 . . . . 0.0 110.087 -172.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.97 149.01 17.54 Favored 'General case' 0 N--CA 1.415 -2.207 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -160.094 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.62 47.24 Favored Glycine 0 CA--C 1.476 -2.397 1 N-CA-C 97.963 -6.055 . . . . 0.0 97.963 -178.024 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -165.79 168.54 15.92 Favored 'General case' 0 N--CA 1.425 -1.676 1 N-CA-C 98.191 -4.744 . . . . 0.0 98.191 179.377 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.8 t -100.33 166.16 11.11 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.1 -170.27 40.05 Favored Glycine 0 N--CA 1.425 -2.054 1 N-CA-C 97.754 -6.138 . . . . 0.0 97.754 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.77 154.39 51.61 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 100.237 -3.986 . . . . 0.0 100.237 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -150.29 149.82 30.65 Favored 'General case' 0 N--CA 1.426 -1.652 1 N-CA-C 94.231 -6.211 . . . . 0.0 94.231 172.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.97 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.57 -71.64 1.12 Allowed Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 108.204 -1.959 . . . . 0.0 108.204 171.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 m170 -99.59 -42.31 6.96 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.87 -70.79 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.942 0 C-N-CA 118.274 -1.917 . . . . 0.0 108.74 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 tp -158.68 161.95 37.17 Favored 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 95.535 -5.728 . . . . 0.0 95.535 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.35 172.99 16.33 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 -171.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -128.55 167.41 17.15 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 100.98 -3.711 . . . . 0.0 100.98 -175.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -116.7 145.2 43.61 Favored 'General case' 0 C--N 1.364 1.2 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 176.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.6 m -133.94 143.82 48.44 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 170.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -127.38 121.7 31.67 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 -172.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.43 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 127.942 2.497 . . . . 0.0 108.076 -177.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.49 135.44 20.64 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-O 117.084 -1.436 . . . . 0.0 107.433 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.88 165.91 26.34 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.434 2.089 . . . . 0.0 112.653 176.444 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.84 -13.94 62.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.252 1.021 . . . . 0.0 112.484 -174.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -91.44 5.58 48.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.85 0.86 . . . . 0.0 110.995 -179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -108.38 -174.96 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.71 169.22 33.97 Favored Glycine 0 CA--C 1.482 -2.022 1 N-CA-C 101.877 -4.489 . . . . 0.0 101.877 -170.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 pt -155.53 -168.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 101.722 -3.436 . . . . 0.0 101.722 -162.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.606 HD12 HG12 ' A' ' 13' ' ' VAL . 1.2 mm -70.79 131.25 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 101.176 -3.639 . . . . 0.0 101.176 176.113 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.7 169.6 9.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 162.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -125.44 146.34 49.67 Favored 'General case' 0 CA--C 1.487 -1.443 1 N-CA-C 93.329 -6.545 . . . . 0.0 93.329 156.092 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 179.31 36.95 Favored Glycine 0 CA--C 1.468 -2.879 0 C-N-CA 116.542 -2.742 . . . . 0.0 107.55 -177.119 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 40' ' ' LYS . 41.8 m-85 -87.34 132.7 33.86 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 100.832 -3.766 . . . . 0.0 100.832 157.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.62 140.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.64 -138.46 0.36 Allowed 'General case' 0 N--CA 1.426 -1.673 0 O-C-N 126.849 2.593 . . . . 0.0 106.982 -178.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -133.27 153.39 80.62 Favored Pre-proline 0 N--CA 1.421 -1.912 1 N-CA-C 94.915 -5.957 . . . . 0.0 94.915 166.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -64.19 135.31 46.36 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.12 2.15 . . . . 0.0 106.571 163.154 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -94.9 -37.61 11.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 121.952 2.16 . . . . 0.0 109.648 17.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -158.74 148.43 19.28 Favored 'General case' 0 N--CA 1.422 -1.853 1 N-CA-C 94.639 -6.06 . . . . 0.0 94.639 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.3 m 170.73 -158.55 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.939 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 59' ' ' ILE . 1.2 m -122.92 165.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 N-CA-C 99.515 -4.254 . . . . 0.0 99.515 157.859 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -155.48 0.21 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.052 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -139.35 179.31 6.61 Favored 'General case' 0 CA--C 1.482 -1.651 1 N-CA-C 97.853 -4.869 . . . . 0.0 97.853 160.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.56 171.17 14.42 Favored 'General case' 0 N--CA 1.415 -2.194 1 N-CA-C 97.276 -5.083 . . . . 0.0 97.276 -177.658 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -125.75 121.74 24.52 Favored Pre-proline 0 N--CA 1.415 -2.202 1 N-CA-C 97.762 -4.903 . . . . 0.0 97.762 176.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.28 113.96 1.65 Allowed 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.262 2.641 . . . . 0.0 112.661 176.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.22 -43.51 1.05 Allowed Glycine 0 CA--C 1.489 -1.57 1 N-CA-C 101.86 -4.496 . . . . 0.0 101.86 -163.278 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.254 67.6 m 85.47 -7.84 0.84 Allowed 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 127.448 2.299 . . . . 0.0 113.101 172.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -51.32 -49.6 61.04 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.479 1.512 . . . . 0.0 113.595 -171.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -38.98 62.0 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.331 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.32 -47.16 77.5 Favored 'General case' 0 CA--C 1.488 -1.437 0 O-C-N 121.757 -0.849 . . . . 0.0 109.698 -177.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.9 -40.1 94.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.485 0.66 . . . . 0.0 109.792 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 m -63.05 -48.63 77.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.438 0.695 . . . . 0.0 110.929 175.016 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.05 -36.13 83.37 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.132 0.973 . . . . 0.0 111.055 -177.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.4 t -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.724 1.21 . . . . 0.0 110.448 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -68.55 -41.38 79.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.784 -0.573 . . . . 0.0 111.966 -175.495 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.89 -11.77 60.95 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.457 -0.777 . . . . 0.0 112.45 -178.458 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -99.55 -0.69 40.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.443 0.697 . . . . 0.0 109.75 174.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.09 28.36 18.1 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 170.224 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.48 152.4 20.17 Favored Glycine 0 C--N 1.356 1.66 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 170.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -80.9 -38.74 27.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.451 -1.029 . . . . 0.0 110.635 -166.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 m -160.54 173.36 15.65 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 98.805 -4.517 . . . . 0.0 98.805 166.539 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.31 168.88 41.19 Favored Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 99.386 -5.486 . . . . 0.0 99.386 -172.711 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.72 172.53 14.06 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -172.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.49 156.18 39.3 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 119.412 1.006 . . . . 0.0 110.831 -177.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 -179.39 40.63 Favored Glycine 0 N--CA 1.42 -2.378 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 168.517 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -145.14 154.45 42.46 Favored 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.082 -5.525 . . . . 0.0 96.082 -175.206 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -137.49 18.84 2.91 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.976 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 42' ' ' GLY 0.27 2.3 t 61.75 -142.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -167.746 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 76.0 -74.53 1.61 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 124.071 0.843 . . . . 0.0 111.709 168.063 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.08 -76.14 0.59 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.78 -174.28 41.33 Favored Glycine 0 CA--C 1.478 -2.236 1 N-CA-C 100.582 -5.007 . . . . 0.0 100.582 -168.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.0 tp -52.3 134.89 33.55 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 127.245 2.218 . . . . 0.0 108.561 177.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.69 -167.67 1.84 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 -167.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.02 153.73 48.12 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.076 -4.416 . . . . 0.0 99.076 172.449 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -105.65 152.01 23.66 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.52 144.65 33.05 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -103.31 142.26 34.51 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 167.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.68 74.37 0.44 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.013 2.525 . . . . 0.0 112.602 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.2 mt -108.29 134.83 20.06 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.8 170.02 20.61 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.24 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.77 -17.35 64.57 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.213 1.405 . . . . 0.0 114.008 -166.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -84.37 -7.67 59.24 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 124.205 1.002 . . . . 0.0 110.907 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.55 125.95 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 -176.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 143.8 16.74 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 104.486 -3.445 . . . . 0.0 104.486 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.9 pt -130.41 -150.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -165.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.588 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -74.3 117.37 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 177.133 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 -176.932 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.467 0.651 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -104.72 155.21 19.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 165.564 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -120.36 126.14 49.75 Favored 'General case' 0 CA--C 1.485 -1.552 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 157.265 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -162.45 13.09 Favored Glycine 0 CA--C 1.481 -2.061 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -174.399 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.58 141.37 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.268 -3.975 . . . . 0.0 100.268 163.926 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tt -90.42 147.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 173.094 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.826 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -150.62 177.0 10.47 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 98.482 -4.636 . . . . 0.0 98.482 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -86.53 158.37 54.45 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.079 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 61.6 Cg_exo -62.31 118.06 4.94 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.467 2.111 . . . . 0.0 109.589 168.916 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.0 mm-40 -130.87 114.22 15.02 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 127.74 2.416 . . . . 0.0 105.365 2.483 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 65.74 40.15 4.47 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 110.279 169.968 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.66 125.03 43.46 Favored 'General case' 0 CA--C 1.479 -1.751 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 168.268 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.269 35.0 m -69.58 169.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 122.637 1.208 . . . . 0.0 113.832 -161.799 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.2 131.21 50.71 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 92.062 -7.014 . . . . 0.0 92.062 -178.478 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 16' ' ' CYS . 59.4 m80 -92.88 -146.32 0.23 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -170.389 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 15' ' ' HIS . 3.8 t -151.09 155.45 39.0 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 93.821 -6.363 . . . . 0.0 93.821 -174.539 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -108.98 112.8 59.87 Favored Pre-proline 0 N--CA 1.43 -1.431 1 N-CA-C 99.037 -4.431 . . . . 0.0 99.037 168.366 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.92 106.12 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.448 2.765 . . . . 0.0 117.665 -166.343 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.57 -166.46 38.48 Favored Glycine 0 N--CA 1.421 -2.343 1 N-CA-C 94.561 -7.416 . . . . 0.0 94.561 179.258 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 m -79.56 -29.19 41.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.722 1.761 . . . . 0.0 107.778 170.461 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -40.28 -57.44 1.74 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.505 3.922 . . . . 0.0 115.414 -168.711 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.92 -34.94 55.11 Favored Glycine 0 CA--C 1.492 -1.39 0 O-C-N 120.767 -1.208 . . . . 0.0 112.132 -168.452 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.86 -36.93 35.95 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.36 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.4 -49.76 71.51 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 123.79 0.836 . . . . 0.0 109.207 173.076 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 m -58.17 -54.96 41.12 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.456 0.702 . . . . 0.0 111.35 175.831 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.97 -46.52 90.4 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.669 1.188 . . . . 0.0 111.51 -174.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.39 -42.95 92.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -175.827 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.35 -42.77 74.81 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.171 0.442 . . . . 0.0 111.706 -179.19 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -72.11 -22.79 61.28 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.42 -0.8 . . . . 0.0 111.973 -173.801 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -46.62 9.18 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.676 -0.64 . . . . 0.0 109.558 172.779 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.01 48.66 0.18 Allowed Glycine 0 CA--C 1.487 -1.711 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 168.759 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.24 149.9 18.53 Favored Glycine 0 CA--C 1.488 -1.626 1 N-CA-C 102.114 -4.394 . . . . 0.0 102.114 163.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -89.16 -62.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.011 0.906 . . . . 0.0 109.129 -169.241 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -94.34 150.57 20.16 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.269 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.13 167.24 39.71 Favored Glycine 0 CA--C 1.478 -2.225 1 N-CA-C 100.826 -4.909 . . . . 0.0 100.826 176.902 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -170.04 172.76 6.3 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 100.249 -3.982 . . . . 0.0 100.249 -178.087 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 m -113.15 145.26 41.26 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.052 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.8 90.92 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.739 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -174.14 176.93 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 97.933 -4.839 . . . . 0.0 97.933 178.197 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp 170.25 49.96 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 170.57 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.49 140.31 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -172.812 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.66 -63.64 3.55 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.525 -0.734 . . . . 0.0 111.304 161.496 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -107.59 -52.51 2.75 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -176.85 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.25 -146.88 11.14 Favored Glycine 0 N--CA 1.42 -2.401 1 N-CA-C 95.024 -7.23 . . . . 0.0 95.024 -174.582 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 162.92 20.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.155 0.977 . . . . 0.0 108.63 171.386 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.16 169.57 17.36 Favored 'General case' 0 CA--C 1.485 -1.555 1 N-CA-C 98.395 -4.668 . . . . 0.0 98.395 -178.096 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 141.0 42.51 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 -170.202 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -88.37 150.07 23.39 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.886 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.9 m -149.23 138.5 21.5 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.894 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -108.27 136.49 47.84 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 170.246 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.67 56.36 0.14 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 126.187 1.795 . . . . 0.0 110.559 168.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.33 132.81 34.55 Favored Pre-proline 0 CA--C 1.498 -1.023 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 170.193 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 172.42 14.2 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.116 2.544 . . . . 0.0 110.169 177.944 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.0 -20.06 63.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.694 1.598 . . . . 0.0 113.824 -169.554 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -82.77 -4.45 57.96 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.511 -0.743 . . . . 0.0 111.486 -172.014 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -101.3 126.73 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -175.132 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.27 148.8 18.52 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 103.204 -3.958 . . . . 0.0 103.204 176.146 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.7 pt -148.03 -146.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 -159.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.826 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.6 mm -71.27 118.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.144 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -159.303 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.192 0.52 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -101.08 159.31 15.34 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 165.845 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -126.33 122.77 36.39 Favored 'General case' 0 CA--C 1.484 -1.588 1 N-CA-C 94.19 -6.226 . . . . 0.0 94.19 159.793 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.63 38.15 Favored Glycine 0 CA--C 1.473 -2.581 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -173.915 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -79.64 131.4 35.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 165.511 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.4 tt -90.39 141.57 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -176.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.22 -141.81 0.37 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -178.493 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -131.95 150.9 77.45 Favored Pre-proline 0 N--CA 1.419 -2.02 1 N-CA-C 94.586 -6.079 . . . . 0.0 94.586 166.011 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.7 144.01 58.31 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 N-CA-C 106.629 -2.104 . . . . 0.0 106.629 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.57 -36.64 13.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.635 1.974 . . . . 0.0 109.165 12.795 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.88 150.08 28.93 Favored 'General case' 0 N--CA 1.418 -2.056 1 N-CA-C 94.707 -6.034 . . . . 0.0 94.707 175.816 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.55 -160.66 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -176.316 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.638 HG12 HD12 ' A' ' 59' ' ' ILE . 16.0 m -129.33 165.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 96.568 -5.345 . . . . 0.0 96.568 152.64 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.32 158.41 19.68 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 100.235 -3.987 . . . . 0.0 100.235 163.341 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.71 147.22 31.04 Favored 'General case' 0 CA--C 1.47 -2.103 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 -177.997 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -159.41 -177.99 6.83 Favored 'General case' 0 N--CA 1.409 -2.484 1 N-CA-C 95.763 -5.643 . . . . 0.0 95.763 -168.865 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -139.76 171.46 7.89 Favored Pre-proline 0 N--CA 1.414 -2.227 1 N-CA-C 98.867 -4.494 . . . . 0.0 98.867 -156.964 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.15 42.92 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 123.967 3.112 . . . . 0.0 114.308 169.962 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.83 129.52 1.49 Allowed Glycine 0 N--CA 1.423 -2.229 1 N-CA-C 100.203 -5.159 . . . . 0.0 100.203 -176.398 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.25 33.69 1.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.673 1.589 . . . . 0.0 111.083 -171.063 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -56.48 -43.63 79.81 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 126.437 1.895 . . . . 0.0 113.133 -173.237 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -33.29 8.97 Favored Glycine 0 C--N 1.352 1.431 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.691 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.0 t -61.72 -36.71 81.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.018 1.327 . . . . 0.0 111.408 -170.826 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.97 -53.84 43.92 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.121 0.968 . . . . 0.0 110.588 176.379 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -36.84 84.89 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.629 1.172 . . . . 0.0 112.884 177.061 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.02 -39.78 87.1 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 122.076 0.941 . . . . 0.0 109.733 -179.602 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -61.36 -42.87 99.4 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.444 0.697 . . . . 0.0 110.792 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -60.65 -47.79 84.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.785 0.834 . . . . 0.0 111.033 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.37 -17.55 62.41 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.211 -0.931 . . . . 0.0 112.739 -174.003 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -96.3 -5.17 40.75 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.208 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.35 11.85 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.009 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.35 159.48 19.29 Favored Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 105.721 -2.951 . . . . 0.0 105.721 168.907 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -71.51 -60.74 2.07 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.758 1.266 . . . . 0.0 108.747 -170.7 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.96 -171.05 2.92 Favored 'General case' 0 N--CA 1.425 -1.711 1 N-CA-C 97.323 -5.065 . . . . 0.0 97.323 169.438 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.99 -158.18 16.68 Favored Glycine 0 N--CA 1.419 -2.453 1 N-CA-C 101.732 -4.547 . . . . 0.0 101.732 -175.769 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -163.11 -170.2 2.24 Favored 'General case' 0 N--CA 1.429 -1.501 1 N-CA-C 97.467 -5.012 . . . . 0.0 97.467 -171.188 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.9 m -128.61 165.58 20.52 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 174.171 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.72 -170.92 43.03 Favored Glycine 0 N--CA 1.42 -2.383 1 N-CA-C 96.847 -6.501 . . . . 0.0 96.847 -176.353 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -139.46 161.85 36.48 Favored 'General case' 0 N--CA 1.431 -1.406 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 -174.485 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 150.4 40.54 Favored 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 94.237 -6.208 . . . . 0.0 94.237 159.88 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 t -75.99 126.57 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 119.539 1.063 . . . . 0.0 108.326 -165.005 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.87 -78.23 0.05 OUTLIER Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 104.382 -3.487 . . . . 0.0 104.382 178.348 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -108.3 -105.32 0.35 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.375 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.6 98.21 0.18 Allowed Glycine 0 CA--C 1.489 -1.58 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 -171.741 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.333 0.2 OUTLIER 59.33 -166.91 0.17 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.764 2.425 . . . . 0.0 110.712 -170.322 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -164.98 -179.47 5.77 Favored 'General case' 0 N--CA 1.427 -1.605 1 N-CA-C 99.878 -4.119 . . . . 0.0 99.878 168.661 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -122.55 152.99 39.83 Favored 'General case' 0 CA--C 1.494 -1.186 1 N-CA-C 98.078 -4.786 . . . . 0.0 98.078 175.282 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -104.87 156.01 18.4 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 176.688 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.01 141.78 32.87 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 165.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -108.18 122.31 46.65 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 177.317 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.62 82.3 0.14 Allowed 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 127.188 2.195 . . . . 0.0 109.924 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.8 mt -106.67 135.12 19.56 Favored Pre-proline 0 CA--C 1.49 -1.342 0 N-CA-C 103.417 -2.809 . . . . 0.0 103.417 170.155 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.88 170.49 16.6 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.078 1.852 . . . . 0.0 110.385 171.216 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -82.1 7.06 14.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -162.053 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -90.08 -8.03 52.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.737 0.815 . . . . 0.0 108.961 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 t -99.13 138.17 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -174.171 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.43 148.11 16.65 Favored Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 103.976 -3.649 . . . . 0.0 103.976 178.7 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 pt -134.6 -156.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -167.861 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -72.59 128.51 35.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 178.527 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 170.7 9.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 171.14 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -130.32 133.74 46.67 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 95.862 -5.607 . . . . 0.0 95.862 168.433 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -176.07 33.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 118.527 -1.797 . . . . 0.0 109.627 -175.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -86.74 125.03 33.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 169.334 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.66 146.26 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 119.348 0.977 . . . . 0.0 108.44 -174.594 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.64 -163.98 0.89 Allowed 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 127.477 2.311 . . . . 0.0 105.998 -175.82 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -128.51 159.01 69.99 Favored Pre-proline 0 N--CA 1.422 -1.846 1 N-CA-C 96.44 -5.393 . . . . 0.0 96.44 169.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -68.57 155.77 67.85 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 CA-C-N 122.621 1.972 . . . . 0.0 109.189 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -99.21 -19.97 16.85 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 128.901 2.88 . . . . 0.0 108.502 4.596 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -149.72 151.57 33.87 Favored 'General case' 0 CA--C 1.479 -1.761 1 N-CA-C 92.592 -6.818 . . . . 0.0 92.592 158.079 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.07 -163.69 0.11 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 171.442 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 HD12 ' A' ' 59' ' ' ILE . 5.7 m -128.75 160.3 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 1 N-CA-C 95.904 -5.591 . . . . 0.0 95.904 160.648 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -164.47 0.7 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.513 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -137.86 168.62 19.32 Favored 'General case' 0 N--CA 1.418 -2.063 1 N-CA-C 95.186 -5.857 . . . . 0.0 95.186 176.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -142.85 155.88 44.84 Favored 'General case' 0 CA--C 1.474 -1.966 1 N-CA-C 96.973 -5.195 . . . . 0.0 96.973 -166.277 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -114.46 119.35 40.12 Favored Pre-proline 0 N--CA 1.421 -1.921 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 167.21 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.91 95.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 124.728 2.724 . . . . 0.0 117.444 -162.795 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.19 -173.15 41.69 Favored Glycine 0 N--CA 1.422 -2.293 1 N-CA-C 97.787 -6.125 . . . . 0.0 97.787 -179.388 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -89.67 -13.9 35.98 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 118.173 0.987 . . . . 0.0 109.455 178.636 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.41 -60.56 1.89 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.557 3.143 . . . . 0.0 116.566 -161.32 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 -36.49 23.09 Favored Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.4 m -80.47 -16.1 55.16 Favored 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 123.141 0.576 . . . . 0.0 110.793 -174.124 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.89 -51.68 68.61 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.955 0.798 . . . . 0.0 108.951 168.451 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.49 81.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.73 0.812 . . . . 0.0 112.661 174.077 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.23 -38.69 85.65 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.129 0.966 . . . . 0.0 111.645 -174.191 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.4 -34.7 78.54 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.311 -0.868 . . . . 0.0 110.28 178.56 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -40.54 89.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.374 0.669 . . . . 0.0 111.477 -177.177 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.54 -28.77 59.17 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 122.159 -0.338 . . . . 0.0 110.978 -177.883 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.02 -27.41 24.82 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.951 -0.468 . . . . 0.0 110.768 179.422 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.28 42.62 1.06 Allowed Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 163.729 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.96 157.33 15.06 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 162.224 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -94.08 -9.9 35.12 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 122.178 -0.601 . . . . 0.0 110.559 -163.662 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 m -149.5 149.62 31.04 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.78 138.61 9.94 Favored Glycine 0 CA--C 1.475 -2.409 1 N-CA-C 98.847 -5.701 . . . . 0.0 98.847 -178.048 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -141.45 -162.64 1.41 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 -177.328 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.77 169.15 9.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 -170.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.65 -177.97 41.69 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 102.469 -4.252 . . . . 0.0 102.469 -177.094 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -152.16 159.74 43.54 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 97.665 -4.939 . . . . 0.0 97.665 178.03 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -151.96 171.01 18.47 Favored 'General case' 0 CA--C 1.491 -1.309 1 N-CA-C 98.974 -4.454 . . . . 0.0 98.974 167.909 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.92 168.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -177.768 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.92 29.22 52.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -169.011 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m170 163.45 -154.13 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 94.471 -6.122 . . . . 0.0 94.471 -174.963 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.08 150.16 21.39 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 98.715 -5.754 . . . . 0.0 98.715 170.41 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tp 74.16 176.84 0.24 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.003 1.721 . . . . 0.0 108.519 175.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -178.46 -169.35 0.18 Allowed 'General case' 0 CA--C 1.483 -1.62 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 173.922 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.35 178.25 6.96 Favored 'General case' 0 CA--C 1.484 -1.559 1 N-CA-C 100.137 -4.023 . . . . 0.0 100.137 154.524 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -126.85 146.59 50.22 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.06 156.09 46.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 179.665 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -125.65 142.44 51.51 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.735 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.97 55.67 1.13 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 128.542 2.737 . . . . 0.0 111.783 172.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.52 132.85 25.58 Favored Pre-proline 0 CA--C 1.505 -0.777 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.042 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -73.54 174.76 11.66 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.513 2.142 . . . . 0.0 111.75 174.015 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.15 -19.07 62.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 126.548 1.939 . . . . 0.0 114.787 -173.885 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -79.62 -15.26 57.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 121.686 -0.634 . . . . 0.0 109.704 -177.23 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.55 129.92 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -178.537 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.84 149.53 18.73 Favored Glycine 0 CA--C 1.48 -2.153 1 N-CA-C 101.402 -4.679 . . . . 0.0 101.402 -179.481 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -133.18 -143.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -162.051 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG12 ' A' ' 13' ' ' VAL . 3.9 mm -67.19 120.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.659 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 CA--C 1.496 -1.111 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.2 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.686 0.755 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 161.83 34.65 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.415 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.78 137.67 51.66 Favored 'General case' 0 CA--C 1.485 -1.548 1 N-CA-C 94.977 -5.934 . . . . 0.0 94.977 171.992 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.84 -172.56 29.39 Favored Glycine 0 CA--C 1.472 -2.618 0 N-CA-C 104.866 -3.294 . . . . 0.0 104.866 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.03 138.69 32.96 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 102.051 -3.314 . . . . 0.0 102.051 158.352 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.0 tt -90.84 141.33 14.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.31 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -112.46 -160.31 0.71 Allowed 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 128.395 2.678 . . . . 0.0 108.099 -176.213 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.44 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 53.5 mt-30 -136.17 164.78 40.53 Favored Pre-proline 0 N--CA 1.419 -1.977 1 N-CA-C 96.601 -5.333 . . . . 0.0 96.601 174.86 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -65.32 151.53 84.95 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.67 2.246 . . . . 0.0 109.764 169.291 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.52 -54.58 4.1 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 127.75 2.42 . . . . 0.0 107.917 5.266 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -133.35 135.69 44.91 Favored 'General case' 0 N--CA 1.42 -1.925 1 N-CA-C 90.729 -7.508 . . . . 0.0 90.729 169.928 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 m -168.19 -166.41 0.7 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 178.748 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.06 164.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 165.804 . . . . . . . . 4 4 . 1 . 034 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.34 -158.42 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 162.079 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -137.45 168.7 19.13 Favored 'General case' 0 CA--C 1.476 -1.9 1 N-CA-C 96.668 -5.308 . . . . 0.0 96.668 165.852 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.5 t -130.86 158.59 39.78 Favored 'General case' 0 CA--C 1.478 -1.818 1 N-CA-C 97.402 -5.036 . . . . 0.0 97.402 -170.374 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -109.84 112.43 58.17 Favored Pre-proline 0 N--CA 1.425 -1.694 1 N-CA-C 96.596 -5.335 . . . . 0.0 96.596 167.915 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.3 101.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.543 0 CA-C-N 124.491 2.64 . . . . 0.0 116.177 -161.175 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -172.57 36.9 Favored Glycine 0 N--CA 1.427 -1.935 1 N-CA-C 97.092 -6.403 . . . . 0.0 97.092 -172.628 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p -92.58 -28.75 16.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 118.993 1.396 . . . . 0.0 109.893 -177.933 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.16 -63.92 0.56 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.775 2.43 . . . . 0.0 116.152 -161.899 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.65 -45.45 52.93 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -176.142 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 m -64.47 -45.77 85.98 Favored 'General case' 0 CA--C 1.486 -1.495 0 O-C-N 122.229 -0.571 . . . . 0.0 111.776 -174.162 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.36 -35.97 78.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -60.85 -48.43 81.82 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.713 173.764 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.38 -41.95 99.04 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-O 121.799 0.809 . . . . 0.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -60.69 -45.3 94.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.87 0.868 . . . . 0.0 110.432 179.395 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.81 -42.37 81.64 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.392 0.277 . . . . 0.0 110.792 -176.781 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.44 -27.08 56.09 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.799 -0.563 . . . . 0.0 111.552 -176.049 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -76.49 -49.23 17.06 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.868 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.22 51.6 0.18 Allowed Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 169.318 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.04 16.15 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 104.913 -3.275 . . . . 0.0 104.913 159.636 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.4 p -92.92 -3.59 54.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 117.777 0.788 . . . . 0.0 110.7 -166.091 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.479 -1.778 1 N-CA-C 98.427 -4.657 . . . . 0.0 98.427 174.096 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -167.17 163.71 37.33 Favored Glycine 0 CA--C 1.465 -3.058 1 N-CA-C 101.065 -4.814 . . . . 0.0 101.065 -173.539 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -156.66 -155.34 0.53 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.814 -3.772 . . . . 0.0 100.814 -170.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 t -145.03 161.71 38.74 Favored 'General case' 0 N--CA 1.429 -1.51 1 N-CA-C 96.534 -5.358 . . . . 0.0 96.534 -173.825 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.92 -172.57 45.18 Favored Glycine 0 N--CA 1.42 -2.409 1 N-CA-C 99.024 -5.63 . . . . 0.0 99.024 -176.439 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -135.38 142.47 45.7 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 97.048 -5.168 . . . . 0.0 97.048 -177.426 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -112.46 108.82 18.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.1 121.38 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.553 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -13.54 8.09 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -168.1 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -136.68 -77.26 0.41 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.528 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.04 -163.45 36.82 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 -165.1 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.8 141.26 57.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.79 2.436 . . . . 0.0 106.044 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.32 178.3 8.52 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 -168.223 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 m -110.44 162.16 14.95 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 170.886 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -119.23 146.56 45.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 14.6 m -141.8 150.91 42.3 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -120.71 142.09 49.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 173.043 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 60.05 62.44 1.64 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 127.495 2.318 . . . . 0.0 111.374 174.277 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.18 145.5 30.17 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 171.428 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -64.73 160.58 39.8 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.973 2.448 . . . . 0.0 110.886 174.353 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -66.51 -24.53 66.41 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.867 0.867 . . . . 0.0 112.626 -168.087 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -81.48 -2.75 50.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.473 1.109 . . . . 0.0 111.162 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.87 122.88 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 177.776 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.75 145.57 17.71 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -136.72 -153.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -165.538 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -66.65 131.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.365 1.265 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.107 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.426 -1.65 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 177.409 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 159.91 15.92 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.37 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -130.69 130.09 43.42 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.558 -6.09 . . . . 0.0 94.558 159.457 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.07 -170.31 26.64 Favored Glycine 0 CA--C 1.473 -2.567 1 N-CA-C 101.607 -4.597 . . . . 0.0 101.607 179.146 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -83.54 143.4 30.2 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 159.54 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.27 143.57 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.897 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.45 -137.05 0.35 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.498 1.919 . . . . 0.0 106.507 179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -136.88 155.23 76.53 Favored Pre-proline 0 N--CA 1.421 -1.907 1 N-CA-C 95.185 -5.858 . . . . 0.0 95.185 159.822 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -66.3 150.77 84.5 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 0.0 108.423 174.774 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.34 -30.07 33.92 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 128.389 2.676 . . . . 0.0 108.992 6.572 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -164.67 159.36 18.78 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 94.237 -6.209 . . . . 0.0 94.237 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m 167.51 -147.69 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 98.82 -4.511 . . . . 0.0 98.82 174.395 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.91 170.01 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 1 N-CA-C 95.661 -5.681 . . . . 0.0 95.661 170.15 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.39 179.85 6.79 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 167.889 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -119.17 78.06 1.26 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 -179.11 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.3 t -98.77 -170.37 1.93 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -142.63 172.87 5.19 Favored Pre-proline 0 N--CA 1.42 -1.971 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -164.619 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -66.69 50.54 0.32 Allowed 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 123.595 2.864 . . . . 0.0 112.829 162.628 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.46 139.93 5.62 Favored Glycine 0 N--CA 1.423 -2.191 1 N-CA-C 100.437 -5.065 . . . . 0.0 100.437 -178.452 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -94.83 30.37 2.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 -171.969 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -65.86 -57.12 8.64 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.969 1.708 . . . . 0.0 110.836 -166.608 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.17 -28.91 47.7 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.048 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.91 -30.52 71.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.651 1.181 . . . . 0.0 110.859 -172.542 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.45 -58.62 6.5 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.744 0.818 . . . . 0.0 109.945 173.59 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -44.59 96.76 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.157 0.983 . . . . 0.0 113.014 175.833 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.35 -41.85 88.91 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.287 0.565 . . . . 0.0 111.094 -173.283 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -64.25 -40.56 96.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 121.948 -0.47 . . . . 0.0 109.934 179.553 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -66.08 -47.29 74.77 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 122.071 -0.393 . . . . 0.0 111.625 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.18 -20.49 63.12 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.654 -0.654 . . . . 0.0 112.292 -173.747 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.55 -3.23 50.15 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.248 0.619 . . . . 0.0 110.199 176.205 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.32 32.56 8.18 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 165.854 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.82 163.05 13.03 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 105.546 -3.021 . . . . 0.0 105.546 168.774 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -83.72 -43.6 15.33 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.244 1.021 . . . . 0.0 110.038 -169.929 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -160.12 150.92 18.91 Favored 'General case' 0 N--CA 1.418 -2.068 1 N-CA-C 98.759 -4.534 . . . . 0.0 98.759 -157.954 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.9 169.24 38.03 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 100.286 -5.126 . . . . 0.0 100.286 -171.157 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -162.55 -177.98 5.95 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 98.258 -4.719 . . . . 0.0 98.258 -179.494 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.1 m -139.26 162.42 35.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -178.804 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.83 109.1 0.73 Allowed Glycine 0 CA--C 1.487 -1.681 1 N-CA-C 101.748 -4.541 . . . . 0.0 101.748 -178.359 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 41' ' ' VAL . 72.1 t80 -161.14 149.07 15.55 Favored 'General case' 0 CA--C 1.483 -1.617 1 N-CA-C 97.216 -5.105 . . . . 0.0 97.216 -165.595 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -151.12 75.38 1.19 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.666 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.438 ' HB ' ' CE2' ' A' ' 39' ' ' PHE . 49.1 t -126.07 138.52 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 95.671 -5.678 . . . . 0.0 95.671 167.129 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.91 62.99 4.52 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 119.016 0.826 . . . . 0.0 111.621 -163.614 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.5 -51.52 2.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.53 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 -164.19 35.5 Favored Glycine 0 N--CA 1.426 -2.019 1 N-CA-C 96.029 -6.828 . . . . 0.0 96.029 -164.372 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.65 118.63 22.23 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -172.318 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.84 -178.2 5.69 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.068 0.947 . . . . 0.0 110.703 -166.706 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.98 149.62 40.63 Favored 'General case' 0 CA--C 1.489 -1.377 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -174.616 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -96.87 155.17 16.89 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 178.817 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.4 m -147.64 152.14 37.37 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 168.248 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -115.91 144.55 43.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 169.023 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.45 57.3 0.57 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 128.059 2.543 . . . . 0.0 111.651 170.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.09 124.8 48.28 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.574 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 167.04 28.09 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.184 1.923 . . . . 0.0 109.43 174.656 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.77 46.97 1.44 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.52 -0.737 . . . . 0.0 111.618 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -111.91 -6.53 14.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 163.798 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.87 140.86 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 -172.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.65 147.59 18.0 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 103.399 -3.88 . . . . 0.0 103.399 179.407 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.97 -159.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -165.942 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 9.6 mm -69.75 133.12 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -174.655 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.422 -1.834 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 176.806 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.45 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -148.81 179.77 7.59 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 171.558 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -137.02 142.0 42.5 Favored 'General case' 0 CA--C 1.485 -1.532 1 N-CA-C 96.666 -5.309 . . . . 0.0 96.666 179.667 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.53 12.15 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 99.653 -5.379 . . . . 0.0 99.653 165.41 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 94.5 m-85 -82.53 144.03 30.67 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 165.035 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -91.11 139.98 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.401 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.11 -168.14 1.5 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.099 2.959 . . . . 0.0 108.549 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -113.7 161.67 26.41 Favored Pre-proline 0 N--CA 1.428 -1.53 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 170.975 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.2 134.64 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 N-CA-C 106.843 -2.022 . . . . 0.0 106.843 158.205 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -79.31 -58.16 3.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.05 2.14 . . . . 0.0 111.251 14.479 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -166.6 146.24 5.75 Favored 'General case' 0 N--CA 1.426 -1.638 1 N-CA-C 92.384 -6.895 . . . . 0.0 92.384 -178.357 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 21.9 m 159.92 -141.4 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.528 1 N-CA-C 97.771 -4.9 . . . . 0.0 97.771 179.131 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 59' ' ' ILE . 3.0 m -124.26 165.34 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 176.203 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -154.83 0.29 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 162.976 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -141.17 177.37 8.13 Favored 'General case' 0 N--CA 1.425 -1.68 1 N-CA-C 97.177 -5.119 . . . . 0.0 97.177 167.818 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.81 158.81 43.83 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.816 -5.624 . . . . 0.0 95.816 -179.263 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -115.6 113.57 42.67 Favored Pre-proline 0 N--CA 1.422 -1.839 1 N-CA-C 96.197 -5.483 . . . . 0.0 96.197 177.716 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.83 99.2 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 CA-C-N 124.019 2.471 . . . . 0.0 116.082 -156.025 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.93 -166.9 36.42 Favored Glycine 0 N--CA 1.423 -2.219 1 N-CA-C 96.716 -6.554 . . . . 0.0 96.716 -173.746 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -85.97 -41.53 14.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.199 1.0 . . . . 0.0 109.6 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.43 -70.56 0.1 Allowed 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -147.352 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.11 -31.68 54.59 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 121.092 -1.005 . . . . 0.0 111.42 -172.762 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.95 -49.54 44.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.415 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.5 -33.66 76.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.22 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 m -61.48 -50.19 73.73 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.892 172.5 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -42.6 99.76 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.905 0.882 . . . . 0.0 109.968 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -56.48 -47.13 79.86 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.566 1.146 . . . . 0.0 110.714 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.8 -45.5 89.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.886 0.874 . . . . 0.0 110.585 -175.412 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.39 -28.93 62.29 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.845 -0.534 . . . . 0.0 112.163 -176.015 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.6 -18.2 45.59 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.589 -0.694 . . . . 0.0 110.144 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.91 38.16 2.99 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 163.717 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.29 139.25 14.39 Favored Glycine 0 CA--C 1.486 -1.776 1 N-CA-C 101.153 -4.779 . . . . 0.0 101.153 164.099 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -81.84 -29.06 32.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 118.032 0.916 . . . . 0.0 110.065 -162.629 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.47 -176.86 5.84 Favored 'General case' 0 N--CA 1.423 -1.783 1 N-CA-C 98.313 -4.699 . . . . 0.0 98.313 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.25 -160.97 24.99 Favored Glycine 0 N--CA 1.414 -2.783 1 N-CA-C 100.618 -4.993 . . . . 0.0 100.618 -167.378 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -163.62 -159.73 0.53 Allowed 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 96.899 -5.223 . . . . 0.0 96.899 -172.346 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -136.11 170.26 16.29 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 100.584 -3.858 . . . . 0.0 100.584 173.955 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 -177.31 47.92 Favored Glycine 0 N--CA 1.422 -2.283 1 N-CA-C 101.32 -4.712 . . . . 0.0 101.32 177.695 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -113.56 139.97 48.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -177.435 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -110.71 91.09 3.52 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.679 -3.082 . . . . 0.0 102.679 173.054 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 t -68.27 124.98 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -171.168 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -47.53 1.01 Allowed Glycine 0 CA--C 1.483 -1.922 0 N-CA-C 104.539 -3.424 . . . . 0.0 104.539 -173.019 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -100.44 -60.3 1.55 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.001 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.43 -170.63 39.67 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.633 -2.587 . . . . 0.0 106.633 -174.037 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.15 137.68 35.92 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 102.904 -2.998 . . . . 0.0 102.904 177.493 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.93 -174.51 3.68 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -164.165 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.9 t -114.62 153.84 29.43 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 178.3 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.9 t-105 -119.48 149.78 41.32 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -177.299 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -143.15 156.13 44.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.73 144.2 50.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 102.691 -3.078 . . . . 0.0 102.691 170.021 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.64 52.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.758 2.023 . . . . 0.0 111.415 171.832 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.65 130.66 36.18 Favored Pre-proline 0 CA--C 1.501 -0.934 0 N-CA-C 104.951 -2.241 . . . . 0.0 104.951 173.877 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -74.22 176.07 10.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.451 2.1 . . . . 0.0 110.741 175.268 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -86.15 19.69 2.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.988 -174.216 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -95.15 -7.01 40.51 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.446 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.01 169.0 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -179.155 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -148.68 151.26 23.47 Favored Glycine 0 CA--C 1.479 -2.179 1 N-CA-C 97.533 -6.227 . . . . 0.0 97.533 173.755 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.3 -147.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -155.416 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.38 -27.71 43.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 126.173 1.789 . . . . 0.0 113.312 -169.654 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.613 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.539 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.279 0.562 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.36 170.95 9.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 160.489 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -129.96 132.69 46.4 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 93.509 -6.478 . . . . 0.0 93.509 158.314 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -178.01 35.39 Favored Glycine 0 CA--C 1.47 -2.736 0 N-CA-C 104.015 -3.634 . . . . 0.0 104.015 -175.647 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -83.71 140.65 31.99 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 162.442 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -90.39 137.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.005 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.31 -145.03 0.3 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.198 174.993 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.7 142.8 45.11 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 92.939 -6.689 . . . . 0.0 92.939 166.926 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.82 146.34 47.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.693 1.998 . . . . 0.0 107.974 -177.172 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.23 -21.69 17.71 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 126.098 1.759 . . . . 0.0 108.504 13.404 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -158.48 151.68 22.81 Favored 'General case' 0 N--CA 1.415 -2.2 1 N-CA-C 95.945 -5.576 . . . . 0.0 95.945 172.182 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 166.54 -155.93 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 -177.707 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 43' ' ' HIS . 15.3 m -127.4 164.81 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 1 N-CA-C 96.798 -5.26 . . . . 0.0 96.798 161.953 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.11 171.75 8.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 161.658 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -108.56 116.33 31.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -177.67 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 t -92.39 150.43 20.82 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.44 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.36 122.02 28.98 Favored Pre-proline 0 N--CA 1.422 -1.855 1 N-CA-C 97.65 -4.945 . . . . 0.0 97.65 -179.341 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.57 137.49 74.04 Favored 'Trans proline' 0 CA--C 1.505 -0.962 0 CA-C-N 123.456 2.27 . . . . 0.0 110.987 -176.371 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.36 -57.95 0.57 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -158.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m 105.51 -14.72 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 128.901 2.881 . . . . 0.0 110.533 173.137 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -46.44 -51.05 15.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.685 1.994 . . . . 0.0 114.806 -162.974 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.84 -39.77 75.56 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 121.507 -0.746 . . . . 0.0 111.517 -177.231 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.04 -22.1 22.02 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.068 -1.254 . . . . 0.0 110.748 -169.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.47 94.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.878 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -62.49 -45.05 94.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.161 -0.962 . . . . 0.0 110.983 172.797 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.94 -41.24 97.73 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.518 -0.739 . . . . 0.0 111.926 177.532 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.22 -44.39 75.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.35 1.46 . . . . 0.0 110.345 174.771 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.59 -45.85 88.52 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.853 -0.529 . . . . 0.0 111.554 -177.322 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.75 -7.63 51.52 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.36 -0.837 . . . . 0.0 112.669 -177.096 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -102.79 -3.78 25.89 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 121.704 -0.622 . . . . 0.0 109.813 174.497 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.56 28.35 11.53 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 169.945 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.34 129.71 9.99 Favored Glycine 0 CA--C 1.483 -1.917 0 N-CA-C 104.259 -3.536 . . . . 0.0 104.259 169.079 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -36.25 74.19 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.509 -165.763 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -160.56 175.33 12.83 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 170.642 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.49 -178.72 48.78 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 98.516 -5.833 . . . . 0.0 98.516 -169.694 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -164.08 -175.82 4.2 Favored 'General case' 0 N--CA 1.434 -1.24 1 N-CA-C 99.067 -4.42 . . . . 0.0 99.067 -177.946 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.4 m -84.4 168.67 15.33 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.317 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.47 -178.35 41.82 Favored Glycine 0 CA--C 1.487 -1.671 1 N-CA-C 96.9 -6.48 . . . . 0.0 96.9 172.562 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -152.6 132.72 13.48 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 100.478 -3.897 . . . . 0.0 100.478 179.629 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -139.66 40.25 2.02 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.261 2.2 t 57.11 -134.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.17 1.788 . . . . 0.0 107.606 -172.328 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -122.48 7.58 Favored Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 179.55 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.433 ' HB2' HG13 ' A' ' 13' ' ' VAL . 13.8 m170 -118.15 5.12 11.97 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.126 0.57 . . . . 0.0 109.711 -166.939 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.22 -172.87 34.74 Favored Glycine 0 CA--C 1.483 -1.947 1 N-CA-C 100.413 -5.075 . . . . 0.0 100.413 -178.046 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.25 98.46 11.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.028 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.38 177.71 7.74 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 125.634 1.574 . . . . 0.0 110.93 -172.791 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -126.69 160.03 31.96 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.411 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -96.61 154.66 17.15 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 177.69 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.0 m -142.37 140.68 32.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.764 -3.791 . . . . 0.0 100.764 165.53 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.75 27.97 8.9 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.482 0.658 . . . . 0.0 109.631 -170.026 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.27 147.95 0.74 Allowed 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 93.605 -6.443 . . . . 0.0 93.605 167.794 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -150.86 142.83 15.77 Favored Pre-proline 0 CA--C 1.487 -1.468 1 N-CA-C 97.711 -4.922 . . . . 0.0 97.711 153.076 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.86 171.73 17.28 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.265 1.977 . . . . 0.0 109.598 176.498 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.54 -4.97 37.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -92.98 3.65 55.37 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 -178.135 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 t -107.76 138.5 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 103.557 -2.756 . . . . 0.0 103.557 -176.3 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.75 147.37 16.41 Favored Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 103.786 -3.726 . . . . 0.0 103.786 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.9 -160.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -164.342 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -73.33 137.46 23.3 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -172.883 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.421 -1.881 1 N-CA-C 95.046 -5.909 . . . . 0.0 95.046 173.54 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 177.71 7.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 172.704 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -129.58 139.76 51.39 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 97.621 -4.955 . . . . 0.0 97.621 171.556 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 179.16 37.5 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 177.58 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -78.04 128.67 34.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 162.411 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 tt -90.76 140.76 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.385 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.65 -162.47 0.96 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.229 3.012 . . . . 0.0 107.755 174.54 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -144.05 170.37 8.51 Favored Pre-proline 0 N--CA 1.42 -1.953 1 N-CA-C 96.886 -5.227 . . . . 0.0 96.886 175.364 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -64.28 152.58 80.76 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.221 1.948 . . . . 0.0 111.314 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.61 -49.21 9.42 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 127.1 2.16 . . . . 0.0 107.544 -1.203 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -146.2 139.49 25.9 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 92.096 -7.002 . . . . 0.0 92.096 169.153 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.2 m -175.83 -158.44 0.06 Allowed 'General case' 0 CA--C 1.488 -1.408 1 N-CA-C 100.024 -4.065 . . . . 0.0 100.024 -174.178 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.479 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.14 155.14 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 N-CA-C 97.509 -4.997 . . . . 0.0 97.509 164.992 . . . . . . . . 4 4 . 1 . 038 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.27 153.22 20.63 Favored 'General case' 0 CA--C 1.494 -1.191 1 N-CA-C 100.136 -4.024 . . . . 0.0 100.136 166.044 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -102.07 -173.13 2.27 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.255 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.4 t -140.24 154.37 46.85 Favored 'General case' 0 N--CA 1.417 -2.093 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 -171.125 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -115.93 121.39 34.08 Favored Pre-proline 0 N--CA 1.419 -1.988 1 N-CA-C 96.816 -5.253 . . . . 0.0 96.816 167.561 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -56.86 129.2 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 122.972 2.097 . . . . 0.0 112.846 -174.429 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.31 -46.78 1.04 Allowed Glycine 0 CA--C 1.491 -1.424 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -164.41 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 m 92.69 2.41 0.08 Allowed 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 127.496 2.318 . . . . 0.0 112.093 171.289 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -34.65 77.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.835 1.198 . . . . 0.0 111.469 -173.795 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.09 -48.89 50.79 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 175.987 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.21 -49.78 76.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.378 1.471 . . . . 0.0 109.182 179.418 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.52 -45.37 73.34 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.345 1.458 . . . . 0.0 111.751 177.516 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 m -63.88 -43.87 94.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.72 -36.47 67.79 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.769 0.795 . . . . 0.0 109.953 -176.218 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -62.61 -46.5 88.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.739 1.216 . . . . 0.0 110.448 173.358 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.18 -45.78 86.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 123.969 0.908 . . . . 0.0 110.051 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -95.33 -4.29 45.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.145 0.978 . . . . 0.0 109.972 179.425 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.02 12.53 31.53 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 168.139 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.91 127.38 8.39 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 177.207 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 p -97.0 5.04 51.18 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.879 -0.777 . . . . 0.0 110.041 -169.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -160.48 158.1 28.74 Favored 'General case' 0 CA--C 1.479 -1.752 1 N-CA-C 99.159 -4.385 . . . . 0.0 99.159 166.898 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.31 168.4 41.41 Favored Glycine 0 N--CA 1.417 -2.633 1 N-CA-C 98.628 -5.789 . . . . 0.0 98.628 -178.541 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -166.77 173.83 9.18 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 97.064 -5.162 . . . . 0.0 97.064 -179.871 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.0 m -94.95 162.28 13.8 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.548 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.11 174.09 40.98 Favored Glycine 0 N--CA 1.421 -2.304 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 178.533 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -117.79 138.14 52.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 101.544 -3.502 . . . . 0.0 101.544 -177.156 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -98.47 -29.14 13.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.18 0.99 . . . . 0.0 109.483 -175.349 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 42' ' ' GLY . 3.5 t 70.62 176.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 105.468 -165.815 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 80.76 -65.42 3.92 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 120.137 -1.602 . . . . 0.0 109.931 172.572 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -91.36 -53.33 4.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 172.131 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.84 -128.46 3.46 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 171.911 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.47 127.42 32.67 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.435 2.694 . . . . 0.0 106.665 -177.598 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.36 176.88 7.6 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -166.941 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.8 t -117.55 158.96 23.66 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 100.301 -3.962 . . . . 0.0 100.301 174.038 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -124.07 150.34 45.11 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.444 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.2 m -140.07 152.75 46.43 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.623 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.17 138.35 51.34 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 169.671 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.71 50.13 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.942 2.097 . . . . 0.0 111.072 166.852 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.1 133.29 32.14 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.95 176.12 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.321 2.014 . . . . 0.0 110.715 176.496 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.4 2.44 25.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.075 0.95 . . . . 0.0 112.732 -170.734 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -95.93 5.26 51.66 Favored 'General case' 0 CA--C 1.503 -0.849 0 O-C-N 121.098 -1.001 . . . . 0.0 108.847 175.694 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.49 167.39 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 175.76 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.61 163.1 29.54 Favored Glycine 0 CA--C 1.485 -1.827 1 N-CA-C 98.319 -5.912 . . . . 0.0 98.319 -177.039 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -154.12 -164.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 -161.834 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -65.4 121.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 123.979 0.912 . . . . 0.0 111.013 -163.977 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.308 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.223 0.535 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 176.68 5.28 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 159.294 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -129.75 144.34 51.25 Favored 'General case' 0 CA--C 1.481 -1.675 1 N-CA-C 95.169 -5.863 . . . . 0.0 95.169 171.903 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 -178.24 35.47 Favored Glycine 0 CA--C 1.473 -2.593 0 N-CA-C 103.957 -3.657 . . . . 0.0 103.957 175.879 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 33.3 m-85 -76.73 137.75 39.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 156.68 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 tt -90.52 137.82 20.79 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.357 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -108.36 -154.62 0.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 127.245 2.218 . . . . 0.0 107.946 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.7 148.77 54.3 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 95.604 -5.702 . . . . 0.0 95.604 170.138 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -68.96 145.57 62.22 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 122.691 1.997 . . . . 0.0 109.025 -176.761 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -89.07 -42.52 11.68 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.881 2.472 . . . . 0.0 110.085 12.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -153.97 140.09 18.41 Favored 'General case' 0 N--CA 1.424 -1.746 1 N-CA-C 92.212 -6.959 . . . . 0.0 92.212 178.459 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -178.35 -151.53 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 95.515 -5.735 . . . . 0.0 95.515 178.321 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.91 -178.34 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 163.177 . . . . . . . . 4 4 . 1 . 039 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -152.67 0.32 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 166.758 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -143.18 161.2 38.85 Favored 'General case' 0 N--CA 1.422 -1.846 1 N-CA-C 94.601 -6.074 . . . . 0.0 94.601 153.005 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -160.54 -157.7 0.56 Allowed 'General case' 0 N--CA 1.42 -1.974 1 N-CA-C 96.077 -5.527 . . . . 0.0 96.077 -176.682 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -147.1 172.4 5.24 Favored Pre-proline 0 N--CA 1.418 -2.045 1 N-CA-C 99.865 -4.124 . . . . 0.0 99.865 -161.317 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.92 63.55 4.03 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 124.311 2.575 . . . . 0.0 111.386 170.574 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.87 148.65 5.68 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 101.578 -4.609 . . . . 0.0 101.578 174.181 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -83.98 60.97 6.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 118.166 0.983 . . . . 0.0 108.675 178.18 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -69.94 -65.21 0.75 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -173.905 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.8 -22.42 57.95 Favored Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 177.084 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -79.48 -10.74 59.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.261 -1.141 . . . . 0.0 110.992 -174.139 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.4 -51.99 67.53 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 120.428 1.467 . . . . 0.0 108.649 174.746 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -72.28 -40.76 67.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.151 -177.405 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.27 -42.93 96.42 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 118.659 0.663 . . . . 0.0 112.565 179.055 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.31 -44.39 91.72 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -69.29 -43.47 73.75 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 121.439 -0.788 . . . . 0.0 111.679 -178.711 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -69.42 -28.49 66.18 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 119.544 1.065 . . . . 0.0 112.829 -177.675 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -87.51 -4.01 58.99 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.664 0.665 . . . . 0.0 110.558 175.609 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.91 29.4 8.11 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 162.217 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.21 149.32 17.89 Favored Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 171.1 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 p -79.33 -50.45 10.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.174 0.988 . . . . 0.0 109.88 -167.836 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -160.17 176.83 11.32 Favored 'General case' 0 N--CA 1.422 -1.844 1 N-CA-C 98.699 -4.556 . . . . 0.0 98.699 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.27 46.22 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 103.68 -3.768 . . . . 0.0 103.68 -169.585 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -146.98 -177.77 5.84 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.754 -4.906 . . . . 0.0 97.754 -169.252 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.3 m -136.96 160.75 37.97 Favored 'General case' 0 CA--C 1.479 -1.766 1 N-CA-C 99.549 -4.241 . . . . 0.0 99.549 171.529 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.09 179.26 47.37 Favored Glycine 0 N--CA 1.424 -2.136 1 N-CA-C 99.841 -5.304 . . . . 0.0 99.841 -174.318 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -93.18 150.58 20.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 -172.449 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -118.15 116.09 26.13 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 170.838 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.36 128.57 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.45 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -16.57 26.09 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -175.723 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -127.52 -85.49 0.59 Allowed 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.8 -162.56 34.9 Favored Glycine 0 N--CA 1.426 -1.971 1 N-CA-C 102.91 -4.076 . . . . 0.0 102.91 -169.685 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.18 147.73 52.9 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.152 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.79 -176.08 5.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -165.26 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -128.18 166.13 19.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 175.869 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 16.2 t-105 -125.71 143.27 51.11 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 177.799 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.3 m -135.83 139.9 43.79 Favored 'General case' 0 CA--C 1.487 -1.465 1 N-CA-C 99.898 -4.112 . . . . 0.0 99.898 175.045 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -104.49 30.98 4.95 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.105 0.955 . . . . 0.0 108.929 -168.054 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.62 146.95 1.75 Allowed 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 94.036 -6.283 . . . . 0.0 94.036 165.911 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.53 151.67 64.3 Favored Pre-proline 0 N--CA 1.427 -1.591 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 141.79 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.41 174.01 13.28 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 122.158 1.905 . . . . 0.0 110.168 164.775 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -65.04 -11.66 41.73 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 126.454 1.902 . . . . 0.0 115.116 -172.259 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.3 -0.08 57.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.255 -0.903 . . . . 0.0 111.036 -175.543 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.29 142.51 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 -176.488 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.49 155.19 16.5 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 104.679 -3.368 . . . . 0.0 104.679 -176.668 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 pt -143.44 -155.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -161.583 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -83.57 154.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -172.88 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.628 1 N-CA-C 96.763 -5.273 . . . . 0.0 96.763 171.208 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.34 169.68 10.36 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 176.109 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -134.83 137.0 42.91 Favored 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 96.437 -5.394 . . . . 0.0 96.437 169.735 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.49 23.03 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 105.312 -3.115 . . . . 0.0 105.312 172.823 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 72.2 m-85 -82.38 137.41 34.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 163.272 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 58' ' ' ILE . 20.9 tt -91.65 140.89 15.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.873 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB2' HG12 ' A' ' 59' ' ' ILE . . . -95.7 -155.09 0.46 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.215 3.406 . . . . 0.0 110.406 -177.766 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -132.92 154.03 81.24 Favored Pre-proline 0 N--CA 1.429 -1.512 1 N-CA-C 96.211 -5.478 . . . . 0.0 96.211 165.511 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -67.25 135.12 35.9 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.889 2.393 . . . . 0.0 107.884 168.011 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -90.57 -55.14 3.7 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 121.881 2.128 . . . . 0.0 110.752 20.227 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -149.3 132.6 16.5 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 92.971 -6.678 . . . . 0.0 92.971 177.667 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -169.01 0.26 Allowed 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 -174.799 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.75 160.95 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 167.775 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -161.26 0.32 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 162.522 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.79 158.7 43.37 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.39 -5.411 . . . . 0.0 96.39 165.11 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.39 168.06 18.23 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 -167.908 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -114.02 114.18 46.37 Favored Pre-proline 0 N--CA 1.42 -1.942 1 N-CA-C 99.576 -4.231 . . . . 0.0 99.576 174.309 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -57.89 125.72 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.576 2.184 . . . . 0.0 112.268 -176.161 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.15 -56.93 0.67 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 100.357 -5.097 . . . . 0.0 100.357 -162.419 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m 117.7 -34.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 129.48 3.112 . . . . 0.0 107.676 173.466 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.37 -51.22 2.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.86 2.864 . . . . 0.0 116.238 -159.375 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.48 -43.94 75.28 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.559 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.34 -23.08 26.35 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -170.695 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.79 -37.65 85.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.353 1.061 . . . . 0.0 108.522 168.964 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.9 m -69.46 -40.21 77.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.799 -0.563 . . . . 0.0 109.981 174.58 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.89 -38.03 89.63 Favored 'General case' 0 C--N 1.359 1.012 0 O-C-N 121.277 -0.889 . . . . 0.0 111.404 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -52.85 -48.56 66.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.01 1.324 . . . . 0.0 110.357 170.008 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -65.15 -41.85 94.36 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.463 -0.773 . . . . 0.0 112.446 -175.05 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.34 -9.44 58.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.137 -0.977 . . . . 0.0 111.906 -177.301 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -103.43 7.3 38.02 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.245 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.7 20.26 34.88 Favored Glycine 0 CA--C 1.491 -1.466 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.922 167.238 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.37 148.26 22.87 Favored Glycine 0 CA--C 1.49 -1.531 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 170.077 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.5 m -88.79 -32.72 17.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -168.583 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.7 m -160.69 -177.88 6.48 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 98.783 -4.525 . . . . 0.0 98.783 170.357 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.42 -169.87 37.67 Favored Glycine 0 CA--C 1.466 -3.031 1 N-CA-C 102.247 -4.341 . . . . 0.0 102.247 -172.471 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.41 -160.43 0.77 Allowed 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 98.835 -4.506 . . . . 0.0 98.835 -169.942 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.04 170.96 17.65 Favored 'General case' 0 CA--C 1.472 -2.047 1 N-CA-C 99.085 -4.413 . . . . 0.0 99.085 175.328 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.45 -170.8 41.02 Favored Glycine 0 N--CA 1.419 -2.487 1 N-CA-C 98.031 -6.027 . . . . 0.0 98.031 -173.751 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -124.08 150.04 45.46 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 100.765 -3.791 . . . . 0.0 100.765 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -123.05 98.99 6.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 173.763 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.86 122.93 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.69 -40.57 1.53 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -165.385 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -124.43 -63.59 1.18 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.508 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.24 -158.91 31.04 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -172.239 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.43 146.62 53.02 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.566 2.347 . . . . 0.0 105.523 176.748 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.66 -177.22 6.23 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -170.894 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.9 m -122.66 173.73 7.54 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 102.115 -3.291 . . . . 0.0 102.115 170.669 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 7.6 t-105 -131.33 148.17 52.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -175.104 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.4 m -134.11 149.06 51.07 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.248 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.6 134.15 55.17 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 171.284 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.26 71.82 0.54 Allowed 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.345 2.258 . . . . 0.0 111.514 174.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.9 135.56 19.41 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 170.905 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -72.78 176.86 8.35 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 122.65 1.982 . . . . 0.0 112.253 177.01 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.61 9.84 3.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.743 0.817 . . . . 0.0 112.752 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -95.89 -0.81 50.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 121.241 -0.912 . . . . 0.0 108.566 176.025 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.2 170.37 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 -178.384 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.02 163.14 28.37 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.009 -6.036 . . . . 0.0 98.009 177.233 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.0 pt -159.28 -170.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.391 -3.929 . . . . 0.0 100.391 -160.491 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 7' ' ' ALA . 3.5 mt -76.15 116.32 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 126.28 1.832 . . . . 0.0 111.517 -162.975 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 160.546 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.468 0.651 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.6 165.93 12.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.161 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -137.02 132.47 34.29 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 97.452 -5.018 . . . . 0.0 97.452 171.988 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -168.5 24.01 Favored Glycine 0 CA--C 1.48 -2.098 1 N-CA-C 102.755 -4.138 . . . . 0.0 102.755 175.015 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.06 142.42 34.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 159.182 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.45 150.92 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.232 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.32 176.39 12.21 Favored 'General case' 0 N--CA 1.421 -1.887 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 179.12 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -84.2 159.93 58.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 171.009 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 80.0 Cg_exo -61.76 110.98 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.468 2.779 . . . . 0.0 110.594 171.416 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 63.4 mm-40 -131.76 131.21 42.77 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 129.178 2.991 . . . . 0.0 104.378 2.539 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 67.39 16.43 10.04 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.905 1.336 . . . . 0.0 111.573 171.451 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.1 m -96.19 88.99 4.98 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 179.654 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.29 159.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -159.899 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -166.57 1.49 Allowed 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.628 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -150.45 177.47 9.97 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 96.31 -5.441 . . . . 0.0 96.31 172.456 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -157.25 157.59 34.55 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.626 -5.694 . . . . 0.0 95.626 -175.038 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -118.61 122.08 30.29 Favored Pre-proline 0 N--CA 1.426 -1.674 0 N-CA-C 100.424 -3.917 . . . . 0.0 100.424 -175.654 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.95 130.05 38.2 Favored 'Trans proline' 0 CA--C 1.507 -0.837 0 C-N-CA 122.474 2.116 . . . . 0.0 112.994 -174.723 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.06 -48.61 0.95 Allowed Glycine 0 CA--C 1.492 -1.402 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -159.941 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.253 15.0 m 96.26 -12.43 0.09 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 128.551 2.74 . . . . 0.0 111.603 172.577 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -44.85 -48.12 11.09 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 127.377 2.271 . . . . 0.0 115.904 -166.793 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.87 -38.36 41.88 Favored Glycine 0 C--N 1.351 1.389 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -174.913 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.39 -23.92 50.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.137 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.11 -47.6 80.67 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.785 0.834 . . . . 0.0 109.35 173.43 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -47.2 86.7 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.034 -1.041 . . . . 0.0 112.77 172.104 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.03 -42.36 97.11 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 122.039 0.923 . . . . 0.0 111.297 -175.169 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.38 -42.99 97.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.19 0.996 . . . . 0.0 109.998 178.831 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -63.9 -43.5 95.77 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 117.954 0.343 . . . . 0.0 111.449 -179.474 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -76.61 -20.5 56.69 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 118.554 0.616 . . . . 0.0 111.888 -175.779 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -84.53 -14.5 48.78 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.243 0.617 . . . . 0.0 110.499 172.962 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 27.29 5.97 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 166.575 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.66 134.73 12.31 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 175.053 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 p -103.99 12.94 33.59 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 -167.15 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.38 156.44 26.16 Favored 'General case' 0 CA--C 1.482 -1.644 1 N-CA-C 98.929 -4.471 . . . . 0.0 98.929 161.1 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.41 162.51 32.8 Favored Glycine 0 CA--C 1.47 -2.772 1 N-CA-C 98.675 -5.77 . . . . 0.0 98.675 -179.056 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -174.83 175.36 2.4 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 -174.479 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.3 m -87.0 160.0 18.79 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.333 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.95 172.0 44.81 Favored Glycine 0 N--CA 1.425 -2.035 1 N-CA-C 96.73 -6.548 . . . . 0.0 96.73 176.622 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -154.73 148.64 25.65 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 98.098 -4.778 . . . . 0.0 98.098 174.208 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -179.01 47.84 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 100.367 -3.938 . . . . 0.0 100.367 163.952 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -171.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -164.96 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.14 64.93 0.39 Allowed Glycine 0 CA--C 1.489 -1.569 1 N-CA-C 102.126 -4.389 . . . . 0.0 102.126 179.011 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -160.7 -165.72 1.46 Allowed 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.391 -5.411 . . . . 0.0 96.391 -177.434 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.94 -48.32 33.95 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -177.486 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -174.29 1.65 Allowed 'General case' 0 N--CA 1.432 -1.351 1 N-CA-C 96.748 -5.278 . . . . 0.0 96.748 171.709 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.2 168.28 20.91 Favored 'General case' 0 CA--C 1.49 -1.332 1 N-CA-C 96.554 -5.35 . . . . 0.0 96.554 177.701 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.5 t -125.1 157.97 35.01 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 -171.353 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -93.82 148.9 21.7 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.378 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 m -141.31 148.76 40.27 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 167.35 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 137.55 54.0 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 -176.491 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.57 55.38 0.63 Allowed 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.677 1.591 . . . . 0.0 110.741 174.16 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 mt -92.58 135.77 26.07 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.393 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.45 166.27 30.3 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.803 2.336 . . . . 0.0 108.965 177.318 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -87.42 41.29 0.97 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -171.979 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.83 -0.12 12.36 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 169.666 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.47 151.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 -178.228 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.78 147.66 18.99 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 98.282 -5.927 . . . . 0.0 98.282 -179.772 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 pt -145.3 -138.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -156.961 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 7' ' ' ALA . 13.5 mm -73.44 146.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.459 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.431 -1.387 2 N-CA-C 94.158 -6.238 . . . . 0.0 94.158 172.521 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.894 0.378 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.557 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -137.62 -176.87 4.56 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.803 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -133.61 143.51 48.68 Favored 'General case' 0 CA--C 1.49 -1.354 1 N-CA-C 97.492 -5.003 . . . . 0.0 97.492 176.454 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 177.45 37.88 Favored Glycine 0 CA--C 1.48 -2.107 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 178.233 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -79.28 127.91 32.66 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 156.601 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.441 ' HA ' HG22 ' A' ' 58' ' ' ILE . 12.5 tt -89.67 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -172.599 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -95.1 -146.49 0.27 Allowed 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 126.824 2.577 . . . . 0.0 109.438 178.111 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -149.81 167.75 12.39 Favored Pre-proline 0 N--CA 1.424 -1.761 1 N-CA-C 95.989 -5.56 . . . . 0.0 95.989 175.153 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.96 151.14 86.84 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.298 2.666 . . . . 0.0 107.686 158.187 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.87 -51.13 8.41 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 128.12 2.568 . . . . 0.0 109.033 7.181 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -145.66 147.59 32.17 Favored 'General case' 0 N--CA 1.421 -1.914 1 N-CA-C 92.149 -6.982 . . . . 0.0 92.149 162.598 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.49 -164.41 0.22 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -173.641 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -125.75 161.76 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 1 N-CA-C 96.718 -5.29 . . . . 0.0 96.718 161.509 . . . . . . . . 4 4 . 1 . 042 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -151.93 0.07 Allowed 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 163.501 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -139.35 177.72 7.72 Favored 'General case' 0 CA--C 1.478 -1.813 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 163.825 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.9 t -138.14 162.4 34.33 Favored 'General case' 0 N--CA 1.415 -2.198 1 N-CA-C 97.347 -5.057 . . . . 0.0 97.347 -174.424 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -116.1 112.67 41.97 Favored Pre-proline 0 N--CA 1.418 -2.053 1 N-CA-C 96.031 -5.544 . . . . 0.0 96.031 172.296 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -70.45 49.53 0.87 Allowed 'Trans proline' 0 CA--C 1.517 -0.374 0 CA-C-N 124.402 2.608 . . . . 0.0 115.351 -173.663 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.31 16.78 6.67 Favored Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 168.607 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m 74.24 -52.82 0.69 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 127.362 2.265 . . . . 0.0 112.12 172.42 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.05 -41.52 59.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.317 2.247 . . . . 0.0 115.815 -170.955 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.82 60.88 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.154 -0.966 . . . . 0.0 111.496 -176.393 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.76 -47.87 24.13 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.128 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -56.58 -43.21 79.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.255 0.622 . . . . 0.0 110.193 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -57.14 -47.71 80.46 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.077 -1.014 . . . . 0.0 112.164 176.333 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.3 mt -65.38 -43.03 91.97 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-O 121.834 0.826 . . . . 0.0 110.206 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -57.42 -45.98 84.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.162 0.985 . . . . 0.0 110.762 176.422 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.95 -44.33 80.87 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 122.717 0.407 . . . . 0.0 110.322 -176.186 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.31 -30.51 66.32 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 118.381 0.537 . . . . 0.0 111.96 -177.049 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -77.74 -33.51 52.87 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.515 -0.741 . . . . 0.0 109.965 176.219 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.22 43.05 0.49 Allowed Glycine 0 CA--C 1.489 -1.589 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 161.492 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.31 139.94 14.67 Favored Glycine 0 C--N 1.353 1.528 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 164.778 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 p -96.24 -1.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.038 0.923 . . . . 0.0 109.96 -168.04 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -160.34 168.19 25.81 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 97.528 -4.99 . . . . 0.0 97.528 171.404 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.36 -177.83 37.35 Favored Glycine 0 CA--C 1.468 -2.869 1 N-CA-C 100.329 -5.108 . . . . 0.0 100.329 -175.655 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -159.0 -176.78 6.06 Favored 'General case' 0 N--CA 1.423 -1.799 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 -175.885 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -139.91 150.29 44.39 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 95.853 -5.61 . . . . 0.0 95.853 -176.755 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.97 -176.89 46.32 Favored Glycine 0 N--CA 1.423 -2.177 1 N-CA-C 102.127 -4.389 . . . . 0.0 102.127 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -118.16 141.48 48.45 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 99.803 -4.147 . . . . 0.0 99.803 -178.24 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -94.83 -28.98 14.96 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.692 1.234 . . . . 0.0 108.915 -177.574 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.6 t 72.04 -166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 129.895 3.278 . . . . 0.0 103.372 -165.158 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 75.74 -69.98 2.04 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 120.387 -1.446 . . . . 0.0 110.505 176.818 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.65 -57.33 2.17 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.047 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.09 -138.83 5.54 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 118.576 -1.773 . . . . 0.0 110.588 -178.047 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 tp -80.74 144.36 32.22 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -177.477 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.14 -179.9 7.39 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 102.9 -3.0 . . . . 0.0 102.9 -170.118 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -115.88 165.49 13.03 Favored 'General case' 0 CA--C 1.496 -1.1 1 N-CA-C 98.945 -4.465 . . . . 0.0 98.945 175.49 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -129.67 150.87 50.8 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 54.4 m -142.57 149.53 39.17 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.24 138.99 51.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 172.283 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.17 67.65 0.72 Allowed 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.884 2.473 . . . . 0.0 110.539 179.164 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.91 139.64 21.42 Favored Pre-proline 0 CA--C 1.496 -1.112 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 171.108 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -70.32 162.38 42.57 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.279 1.986 . . . . 0.0 110.567 165.166 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.16 -37.54 72.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.9 2.08 . . . . 0.0 115.164 -163.966 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -83.61 -5.86 59.29 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.869 -1.144 . . . . 0.0 110.591 -172.638 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.54 99.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 178.061 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.557 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -83.49 166.27 43.5 Favored Glycine 0 CA--C 1.489 -1.569 0 CA-C-O 122.036 0.798 . . . . 0.0 112.163 -161.823 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 6' ' ' ILE . 31.9 pt -147.35 -178.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 -164.67 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.2 mm -69.29 103.91 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 124.819 1.248 . . . . 0.0 110.216 -166.841 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 101.527 -3.509 . . . . 0.0 101.527 167.163 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.139 0.495 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.487 HH21 ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.2 -178.79 6.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -128.9 132.06 47.66 Favored 'General case' 0 CA--C 1.494 -1.175 1 N-CA-C 99.008 -4.441 . . . . 0.0 99.008 171.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 175.41 38.17 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -77.26 128.04 33.66 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -91.0 139.93 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.6 -129.13 0.24 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.443 -1.708 . . . . 0.0 107.915 169.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -145.34 154.47 53.46 Favored Pre-proline 0 N--CA 1.415 -2.206 1 N-CA-C 95.337 -5.801 . . . . 0.0 95.337 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 82.2 Cg_exo -68.64 110.14 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.837 2.358 . . . . 0.0 110.551 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 52.9 mm-40 -145.64 162.16 38.15 Favored 'General case' 0 CA--C 1.484 -1.564 1 N-CA-C 98.039 -4.8 . . . . 0.0 98.039 4.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.17 27.05 0.91 Allowed 'General case' 0 C--N 1.359 0.985 0 CA-C-O 123.169 1.462 . . . . 0.0 108.887 162.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.9 m -118.99 -158.19 0.72 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.06 168.07 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 1 N-CA-C 95.594 -5.706 . . . . 0.0 95.594 161.161 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.15 -170.3 2.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -131.76 151.65 51.5 Favored 'General case' 0 CA--C 1.478 -1.799 1 N-CA-C 97.244 -5.095 . . . . 0.0 97.244 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' H ' HD22 ' A' ' 45' ' ' LEU . 9.1 t -116.65 163.4 16.18 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 -171.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -113.43 112.87 48.67 Favored Pre-proline 0 N--CA 1.419 -2.017 1 N-CA-C 98.034 -4.802 . . . . 0.0 98.034 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.74 130.72 40.04 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.293 1.996 . . . . 0.0 111.88 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.56 -56.72 0.73 Allowed Glycine 0 CA--C 1.484 -1.852 1 N-CA-C 101.659 -4.576 . . . . 0.0 101.659 -163.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m 119.42 -23.87 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.98 2.912 . . . . 0.0 107.134 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -61.77 0.74 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.381 2.272 . . . . 0.0 115.763 -154.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.56 -39.68 60.46 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.916 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -29.29 51.83 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 117.643 0.721 . . . . 0.0 109.593 -168.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.55 -49.41 77.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.63 1.172 . . . . 0.0 109.861 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -63.87 -34.34 77.72 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.75 -0.594 . . . . 0.0 112.228 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.16 -40.84 94.87 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.043 0.925 . . . . 0.0 110.685 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.03 -44.63 94.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.592 0.757 . . . . 0.0 110.612 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.36 -21.44 56.09 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 119.239 0.927 . . . . 0.0 111.567 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -84.13 -41.3 17.23 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.605 -0.685 . . . . 0.0 109.39 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.08 48.0 0.1 OUTLIER Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.6 137.81 13.88 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 104.781 -3.328 . . . . 0.0 104.781 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -0.07 56.79 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.323 1.049 . . . . 0.0 110.768 -168.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 m -159.38 164.2 34.89 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 100.012 -4.07 . . . . 0.0 100.012 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.05 169.66 39.02 Favored Glycine 0 N--CA 1.424 -2.16 1 N-CA-C 98.043 -6.023 . . . . 0.0 98.043 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -164.55 -171.42 2.33 Favored 'General case' 0 N--CA 1.438 -1.072 1 N-CA-C 100.043 -4.058 . . . . 0.0 100.043 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.8 m -98.9 174.58 6.3 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 166.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.05 43.28 Favored Glycine 0 N--CA 1.427 -1.933 1 N-CA-C 102.025 -4.43 . . . . 0.0 102.025 168.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -134.84 142.45 46.64 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.741 -4.54 . . . . 0.0 98.741 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -126.22 107.36 10.29 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.14 124.04 25.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.9 -81.27 0.22 Allowed Glycine 0 CA--C 1.482 -2.003 1 N-CA-C 100.92 -4.872 . . . . 0.0 100.92 -164.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -87.34 -59.25 2.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.99 -140.38 7.23 Favored Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -65.69 143.57 57.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.974 2.109 . . . . 0.0 106.271 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.25 -174.58 4.86 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.71 -179.99 4.91 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -132.43 151.24 51.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 -175.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.44 136.4 33.0 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -105.96 135.7 46.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.03 40.58 3.96 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.934 1.693 . . . . 0.0 112.031 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 tp -81.92 138.89 46.31 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 165.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -70.19 165.53 31.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.262 1.975 . . . . 0.0 110.833 170.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.41 -5.2 57.65 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 123.93 0.892 . . . . 0.0 110.989 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.66 16.73 10.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.244 1.017 . . . . 0.0 109.837 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.57 162.21 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 N-CA-C 95.134 -5.876 . . . . 0.0 95.134 170.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.99 -177.41 35.96 Favored Glycine 0 CA--C 1.475 -2.44 0 C-N-CA 115.877 -3.059 . . . . 0.0 107.699 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.487 ' CG2' HH21 ' A' ' 2' ' ' ARG . 46.7 pt -142.26 -152.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 114.694 -0.753 . . . . 0.0 110.873 -141.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -75.25 132.56 33.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t -145.76 160.82 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 1 N-CA-C 94.813 -5.995 . . . . 0.0 94.813 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -142.66 151.15 41.1 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 98.114 -4.773 . . . . 0.0 98.114 160.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.23 -42.86 0.68 Allowed Glycine 0 N--CA 1.428 -1.894 1 N-CA-C 102.115 -4.394 . . . . 0.0 102.115 -166.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 64' ' ' LYS . 2.1 tm-20 -104.71 -92.95 0.36 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 63' ' ' GLU . 15.3 tptt 165.77 177.78 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.221 1 N-CA-C 95.918 -5.586 . . . . 0.0 95.918 -172.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.9 t -80.74 152.2 28.46 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -110.54 -132.59 0.33 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 135.85 57.84 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 127.586 2.354 . . . . 0.0 109.723 170.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.273 0 O-C-N 123.444 0.465 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 175.89 12.51 Favored 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.274 -5.454 . . . . 0.0 96.274 169.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -125.15 141.81 51.88 Favored 'General case' 0 CA--C 1.487 -1.475 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -176.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.26 179.02 36.96 Favored Glycine 0 CA--C 1.47 -2.766 0 N-CA-C 103.996 -3.642 . . . . 0.0 103.996 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -81.8 129.79 34.85 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.0 tt -79.25 129.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.88 -169.63 1.49 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 112.055 -2.339 . . . . 0.0 107.615 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.75 151.94 37.64 Favored Pre-proline 0 N--CA 1.434 -1.243 1 N-CA-C 99.601 -4.222 . . . . 0.0 99.601 167.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.34 140.83 78.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 162.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.49 -42.31 10.34 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 121.604 2.002 . . . . 0.0 108.744 12.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -151.97 142.74 22.9 Favored 'General case' 0 N--CA 1.417 -2.077 1 N-CA-C 93.663 -6.421 . . . . 0.0 93.663 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 23.2 m -179.79 -155.41 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.269 -4.345 . . . . 0.0 99.269 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.72 HG12 HD12 ' A' ' 59' ' ' ILE . 15.9 m -131.42 167.96 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 1 N-CA-C 97.011 -5.181 . . . . 0.0 97.011 160.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.93 -166.37 1.37 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 163.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.29 166.95 20.07 Favored 'General case' 0 CA--C 1.484 -1.595 1 N-CA-C 98.067 -4.79 . . . . 0.0 98.067 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.15 167.24 28.36 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -128.7 129.7 23.5 Favored Pre-proline 0 N--CA 1.423 -1.818 1 N-CA-C 99.835 -4.135 . . . . 0.0 99.835 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -54.59 123.68 14.27 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.778 2.319 . . . . 0.0 112.696 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.48 -46.69 1.06 Allowed Glycine 0 CA--C 1.488 -1.61 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 -166.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m 92.11 0.09 0.13 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 127.492 2.317 . . . . 0.0 113.238 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -44.43 81.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.563 1.945 . . . . 0.0 112.905 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.18 -46.27 44.07 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -79.31 -22.03 45.15 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.823 1.312 . . . . 0.0 110.717 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -55.17 -41.51 71.98 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.229 0.922 . . . . 0.0 109.829 166.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 m -63.35 -45.7 89.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.816 -0.553 . . . . 0.0 110.205 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.29 -41.23 96.99 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 122.717 1.246 . . . . 0.0 110.039 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.62 -41.27 98.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 109.946 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -71.77 -37.15 70.53 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.14 -31.16 62.62 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.719 -0.613 . . . . 0.0 111.267 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -85.91 -16.9 37.02 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.537 -0.727 . . . . 0.0 111.073 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 43.07 2.24 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 165.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.57 142.74 16.19 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 167.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -34.01 66.86 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 129.123 2.969 . . . . 0.0 110.504 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 m -160.12 165.95 30.72 Favored 'General case' 0 N--CA 1.421 -1.922 1 N-CA-C 97.944 -4.836 . . . . 0.0 97.944 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.31 165.47 37.02 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.945 -6.062 . . . . 0.0 97.945 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -166.91 178.95 5.52 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.576 -4.602 . . . . 0.0 98.576 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.14 161.4 26.49 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.71 40.48 Favored Glycine 0 N--CA 1.421 -2.321 1 N-CA-C 98.463 -5.855 . . . . 0.0 98.463 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.85 165.46 32.22 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 96.932 -5.21 . . . . 0.0 96.932 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -114.36 -9.28 12.79 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.216 1.006 . . . . 0.0 108.998 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t 73.38 132.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 107.126 -160.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.06 -104.98 0.29 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -69.51 -77.27 0.08 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.076 0.951 . . . . 0.0 112.909 -169.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.39 -50.61 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.516 0 O-C-N 120.285 -1.509 . . . . 0.0 109.769 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -158.78 -167.47 2.13 Favored 'General case' 0 N--CA 1.43 -1.447 1 N-CA-C 95.481 -5.748 . . . . 0.0 95.481 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 -165.62 1.85 Allowed 'General case' 0 CA--C 1.486 -1.484 1 N-CA-C 97.961 -4.829 . . . . 0.0 97.961 167.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 -176.5 4.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 102.128 -3.286 . . . . 0.0 102.128 158.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -117.48 155.38 29.82 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 m -146.44 139.85 25.84 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 100.375 -3.935 . . . . 0.0 100.375 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 30.19 6.59 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.287 0.565 . . . . 0.0 110.073 -168.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 177.5 151.02 0.2 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 93.979 -6.304 . . . . 0.0 93.979 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -153.36 151.92 26.61 Favored Pre-proline 0 CA--C 1.487 -1.47 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 149.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.72 170.95 16.48 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.08 1.853 . . . . 0.0 110.515 171.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.37 16.93 1.16 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -98.55 -6.25 30.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 120.51 -1.369 . . . . 0.0 108.287 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.73 168.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.41 177.36 27.65 Favored Glycine 0 CA--C 1.483 -1.952 1 N-CA-C 102.033 -4.427 . . . . 0.0 102.033 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 6' ' ' ILE . 6.4 pt -154.82 -171.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -158.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.721 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.3 mm -68.76 133.05 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 t -113.95 115.21 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 101.792 -3.411 . . . . 0.0 101.792 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 61.83 -117.63 0.65 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.457 1.503 . . . . 0.0 109.672 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.71 59.61 0.1 Allowed Glycine 0 CA--C 1.485 -1.841 1 N-CA-C 99.334 -5.506 . . . . 0.0 99.334 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 -74.2 0.62 Allowed 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.451 -161.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -126.26 171.97 10.48 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -162.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 15.3 t -137.35 134.9 36.52 Favored 'General case' 0 N--CA 1.422 -1.826 1 N-CA-C 97.624 -4.954 . . . . 0.0 97.624 170.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -149.87 109.53 4.04 Favored 'General case' 0 N--CA 1.427 -1.599 1 N-CA-C 100.114 -4.032 . . . . 0.0 100.114 169.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -81.51 119.3 23.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.017 0 O-C-N 123.463 0.477 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.063 0.459 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -100.99 157.82 16.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -127.53 125.9 41.23 Favored 'General case' 0 CA--C 1.486 -1.482 1 N-CA-C 94.315 -6.18 . . . . 0.0 94.315 159.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.38 29.01 Favored Glycine 0 CA--C 1.474 -2.512 0 N-CA-C 104.021 -3.632 . . . . 0.0 104.021 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -83.54 140.35 32.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.87 148.23 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.3 -177.17 6.07 Favored 'General case' 0 N--CA 1.415 -2.204 1 N-CA-C 98.329 -4.693 . . . . 0.0 98.329 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -105.06 157.54 34.04 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -66.56 144.62 73.46 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.654 2.236 . . . . 0.0 109.226 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -103.14 80.02 1.8 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 128.027 2.531 . . . . 0.0 106.336 -5.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.8 t30 84.66 44.19 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 124.932 1.293 . . . . 0.0 108.392 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.85 127.76 47.64 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.445 ' HA ' ' HB1' ' A' ' 7' ' ' ALA 0.254 5.4 m -70.64 165.04 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 141.87 51.36 Favored 'General case' 0 N--CA 1.423 -1.817 1 N-CA-C 94.455 -6.128 . . . . 0.0 94.455 -176.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -117.31 160.73 20.65 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -167.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 t -115.18 169.27 9.24 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.53 124.68 23.61 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 98.423 -4.658 . . . . 0.0 98.423 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -57.59 111.84 0.95 Allowed 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.965 2.443 . . . . 0.0 113.261 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.79 -51.37 0.52 Allowed Glycine 0 CA--C 1.484 -1.85 1 N-CA-C 100.367 -5.093 . . . . 0.0 100.367 -168.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 6.8 m 106.12 -0.84 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 127.984 2.513 . . . . 0.0 111.852 169.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -46.97 -45.4 20.83 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.567 1.547 . . . . 0.0 113.806 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.37 -59.99 7.65 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.904 0.764 . . . . 0.0 111.955 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.3 m -70.68 -27.56 64.11 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.869 -1.371 . . . . 0.0 113.263 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.84 -45.19 93.74 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.4 m -66.08 -40.97 91.28 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.748 0.819 . . . . 0.0 110.4 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.21 -42.33 94.9 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.703 0.801 . . . . 0.0 109.74 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -38.64 82.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.541 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.24 -42.25 84.3 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.925 -0.484 . . . . 0.0 111.455 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.35 -30.3 37.98 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.726 -0.609 . . . . 0.0 111.019 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -84.66 -22.29 29.92 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 118.363 0.529 . . . . 0.0 109.949 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.49 45.95 1.61 Allowed Glycine 0 CA--C 1.488 -1.594 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 162.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.26 172.8 17.38 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 104.26 -3.536 . . . . 0.0 104.26 167.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 p -75.39 -56.71 4.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.987 0.899 . . . . 0.0 108.651 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -160.65 -176.76 5.75 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 98.832 -4.506 . . . . 0.0 98.832 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.19 -176.73 41.93 Favored Glycine 0 N--CA 1.414 -2.769 1 N-CA-C 98.612 -5.795 . . . . 0.0 98.612 -168.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -166.79 178.08 6.1 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 -172.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.34 168.09 20.66 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.773 0.797 . . . . 0.0 110.465 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.84 -171.01 37.9 Favored Glycine 0 N--CA 1.419 -2.463 1 N-CA-C 97.05 -6.42 . . . . 0.0 97.05 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -146.54 161.91 39.46 Favored 'General case' 0 N--CA 1.422 -1.828 1 N-CA-C 95.325 -5.805 . . . . 0.0 95.325 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -152.44 167.08 29.93 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 97.458 -5.015 . . . . 0.0 97.458 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.76 149.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 1 N-CA-C 96.152 -5.499 . . . . 0.0 96.152 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 -23.02 23.29 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 106.274 -2.731 . . . . 0.0 106.274 -168.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -135.62 -76.36 0.44 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 167.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.41 -150.76 22.13 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 98.289 -5.924 . . . . 0.0 98.289 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.28 115.26 2.37 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.339 2.656 . . . . 0.0 108.689 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.99 158.35 44.07 Favored 'General case' 0 CA--C 1.482 -1.657 1 N-CA-C 96.871 -5.233 . . . . 0.0 96.871 -166.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.8 p -138.61 174.36 10.62 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 116.349 -2.141 . . . . 0.0 108.548 -167.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -104.86 156.64 17.83 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -164.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -152.12 151.1 30.64 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 167.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -113.17 145.71 40.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 104.475 -2.416 . . . . 0.0 104.475 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.94 46.43 0.25 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.098 2.159 . . . . 0.0 112.227 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.33 130.97 33.88 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.95 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.071 1.847 . . . . 0.0 110.656 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -60.69 -20.15 60.31 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.77 1.628 . . . . 0.0 114.762 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -82.29 -12.76 57.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.652 -0.655 . . . . 0.0 110.414 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.52 112.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.46 143.74 17.45 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 104.894 -3.282 . . . . 0.0 104.894 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.9 pt -143.66 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 -160.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mm -68.08 122.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t -132.49 164.29 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -161.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 60.61 -129.96 0.89 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.162 1.785 . . . . 0.0 110.562 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.13 53.67 0.1 OUTLIER Glycine 0 CA--C 1.485 -1.821 1 N-CA-C 97.971 -6.052 . . . . 0.0 97.971 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 64' ' ' LYS . 70.1 tt0 -165.7 -174.56 3.13 Favored 'General case' 0 N--CA 1.423 -1.776 1 N-CA-C 96.251 -5.462 . . . . 0.0 96.251 -168.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 53.0 tttt -106.74 -150.74 0.45 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.81 158.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -169.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.74 174.57 11.47 Favored 'General case' 0 N--CA 1.425 -1.7 1 N-CA-C 96.881 -5.229 . . . . 0.0 96.881 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -177.61 176.16 1.29 Allowed 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.943 0 O-C-N 124.256 0.973 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.27 162.5 14.02 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 164.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -125.59 131.85 52.63 Favored 'General case' 0 CA--C 1.486 -1.501 1 N-CA-C 94.287 -6.19 . . . . 0.0 94.287 161.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.81 29.57 Favored Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 100.912 -4.875 . . . . 0.0 100.912 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.91 137.24 33.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.01 142.52 12.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -135.53 -129.78 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.88 2.872 . . . . 0.0 106.385 175.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -154.16 166.51 15.67 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -172.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -65.39 139.14 58.19 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.346 2.697 . . . . 0.0 111.017 166.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -109.4 -16.26 14.05 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.571 2.348 . . . . 0.0 108.768 9.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -160.22 146.67 15.69 Favored 'General case' 0 CA--C 1.48 -1.72 1 N-CA-C 94.154 -6.239 . . . . 0.0 94.154 165.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.08 -161.97 0.29 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 169.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.74 166.78 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 1 N-CA-C 97.536 -4.987 . . . . 0.0 97.536 157.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -166.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 163.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -127.46 161.89 27.67 Favored 'General case' 0 CA--C 1.473 -1.99 1 N-CA-C 99.245 -4.354 . . . . 0.0 99.245 169.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.0 t -124.83 147.87 48.51 Favored 'General case' 0 N--CA 1.419 -1.996 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -102.41 119.72 55.37 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 96.935 -5.209 . . . . 0.0 96.935 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -57.34 103.97 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 CA-C-N 124.491 2.64 . . . . 0.0 114.726 -165.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.68 -175.8 37.36 Favored Glycine 0 N--CA 1.419 -2.455 1 N-CA-C 97.248 -6.341 . . . . 0.0 97.248 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -92.0 -30.75 15.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.627 0.713 . . . . 0.0 109.276 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -43.97 91.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.561 2.344 . . . . 0.0 115.319 -157.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.25 -50.46 45.04 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -68.96 -41.76 77.53 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.057 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -48.2 -54.11 14.61 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.437 1.495 . . . . 0.0 110.291 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 m -58.72 -54.08 51.07 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.967 0.907 . . . . 0.0 111.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -67.14 -40.77 86.79 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-O 122.36 1.076 . . . . 0.0 110.339 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -64.93 -45.09 87.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.334 1.054 . . . . 0.0 110.304 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -68.56 -40.41 80.62 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 121.27 -0.894 . . . . 0.0 110.945 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -68.26 -14.89 63.32 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.49 7.84 20.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 118.344 0.52 . . . . 0.0 110.433 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 32.75 8.27 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.395 165.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.71 142.05 16.06 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -85.64 -21.63 28.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.461 1.504 . . . . 0.0 109.063 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 m -157.06 156.26 32.53 Favored 'General case' 0 N--CA 1.424 -1.761 1 N-CA-C 98.782 -4.525 . . . . 0.0 98.782 169.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -148.41 141.81 9.43 Favored Glycine 0 CA--C 1.468 -2.885 1 N-CA-C 99.681 -5.368 . . . . 0.0 99.681 -170.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -145.83 -167.65 2.77 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 101.373 -3.565 . . . . 0.0 101.373 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.81 168.36 27.44 Favored 'General case' 0 N--CA 1.427 -1.582 1 N-CA-C 96.882 -5.229 . . . . 0.0 96.882 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.55 91.57 1.06 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 103.112 -3.995 . . . . 0.0 103.112 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -156.61 156.55 33.72 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 171.71 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -138.88 18.87 2.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 42' ' ' GLY . 1.6 t -146.69 -157.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 101.686 -3.45 . . . . 0.0 101.686 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 98.68 -95.1 1.54 Allowed Glycine 0 CA--C 1.474 -2.475 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.49 -54.34 1.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.236 -3.616 . . . . 0.0 101.236 175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.09 64.68 0.24 Allowed Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 173.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE 0.57 0.0 OUTLIER 73.36 171.75 0.3 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.513 1.925 . . . . 0.0 110.306 -171.511 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.67 -173.17 3.62 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -109.97 156.33 20.61 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -106.64 148.58 28.17 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 32.0 m -138.74 148.85 44.39 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 172.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.73 128.11 49.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.88 76.89 0.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 126.94 2.096 . . . . 0.0 111.557 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.47 141.97 23.75 Favored Pre-proline 0 CA--C 1.496 -1.128 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.15 166.33 23.52 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.603 2.202 . . . . 0.0 110.648 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -86.68 15.19 5.91 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.926 -1.109 . . . . 0.0 111.485 -165.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.11 11.17 21.96 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.09 140.61 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 101.637 -3.468 . . . . 0.0 101.637 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.36 143.28 15.65 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.16 -156.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -164.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.7 mm -70.52 125.01 27.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.2 t -90.66 -54.54 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.76 154.13 34.58 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 66.89 3.82 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 106.949 -2.46 . . . . 0.0 106.949 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -123.87 -95.63 0.47 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -143.96 149.63 37.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 -167.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 30.4 t -85.79 154.62 21.46 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 126.694 1.998 . . . . 0.0 106.231 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -165.94 169.62 14.57 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -152.98 164.24 38.32 Favored 'General case' 0 N--CA 1.423 -1.82 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.881 0 O-C-N 124.247 0.967 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -101.73 157.65 16.68 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.44 127.44 45.42 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 94.201 -6.222 . . . . 0.0 94.201 157.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -173.73 30.98 Favored Glycine 0 CA--C 1.475 -2.444 0 N-CA-C 103.532 -3.827 . . . . 0.0 103.532 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 35.4 m-85 -78.98 140.92 37.9 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 163.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tt -90.98 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.859 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -144.62 171.54 14.24 Favored 'General case' 0 N--CA 1.42 -1.964 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 177.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.78 158.24 68.26 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 92.3 Cg_exo -61.89 111.17 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.681 2.921 . . . . 0.0 110.633 170.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 68.9 mm-40 -125.69 132.07 52.47 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 1.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.495 HD21 ' HA ' ' A' ' 61' ' ' GLU . 43.9 t30 63.47 33.99 13.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 162.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.45 121.65 24.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.16 153.96 4.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -163.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.22 120.35 41.62 Favored 'General case' 0 N--CA 1.424 -1.732 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -89.18 128.33 35.8 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.5 t -80.01 159.31 26.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.59 115.18 46.92 Favored Pre-proline 0 N--CA 1.426 -1.659 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.8 113.19 1.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 123.048 2.499 . . . . 0.0 113.117 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.23 -49.54 0.69 Allowed Glycine 0 CA--C 1.489 -1.592 1 N-CA-C 101.045 -4.822 . . . . 0.0 101.045 -164.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m 99.64 -12.77 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 129.073 2.949 . . . . 0.0 109.662 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -50.75 -48.9 59.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.275 2.23 . . . . 0.0 115.213 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.13 -31.47 59.58 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.0 t -75.12 -24.53 58.06 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -49.63 77.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.635 -0.665 . . . . 0.0 111.865 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.8 -42.87 97.61 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 122.559 1.171 . . . . 0.0 111.148 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.0 t -63.2 -44.01 96.56 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 125.371 1.469 . . . . 0.0 108.899 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.61 -45.93 90.62 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 122.965 0.506 . . . . 0.0 110.557 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.95 -23.69 55.42 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -81.57 -21.08 38.67 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.62 38.39 2.23 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 164.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.51 134.72 12.11 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 103.315 -3.914 . . . . 0.0 103.315 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.3 p -102.83 4.95 38.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.859 0.838 . . . . 0.0 109.499 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 m -160.38 164.63 32.26 Favored 'General case' 0 CA--C 1.478 -1.804 1 N-CA-C 97.99 -4.819 . . . . 0.0 97.99 167.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.34 171.75 36.62 Favored Glycine 0 N--CA 1.414 -2.821 1 N-CA-C 99.261 -5.536 . . . . 0.0 99.261 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -160.92 -167.65 1.88 Allowed 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 96.609 -5.33 . . . . 0.0 96.609 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.5 m -154.75 176.1 12.88 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 97.487 -5.005 . . . . 0.0 97.487 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.99 -169.0 41.21 Favored Glycine 0 N--CA 1.42 -2.406 1 N-CA-C 96.805 -6.518 . . . . 0.0 96.805 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.84 173.48 6.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 101.702 -3.444 . . . . 0.0 101.702 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -157.31 163.04 39.11 Favored 'General case' 0 N--CA 1.42 -1.967 1 N-CA-C 95.81 -5.626 . . . . 0.0 95.81 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.31 158.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 1 N-CA-C 97.607 -4.961 . . . . 0.0 97.607 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 -43.89 1.6 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -118.61 -83.41 0.65 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.85 -148.69 18.09 Favored Glycine 0 CA--C 1.478 -2.278 1 N-CA-C 99.384 -5.487 . . . . 0.0 99.384 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.95 131.33 48.32 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 126.597 1.959 . . . . 0.0 107.936 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.75 175.76 11.31 Favored 'General case' 0 CA--C 1.482 -1.646 1 N-CA-C 98.846 -4.501 . . . . 0.0 98.846 -162.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.67 168.4 15.09 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 28.1 t-105 -119.9 150.06 41.1 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.0 m -141.05 149.1 41.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 101.178 -3.638 . . . . 0.0 101.178 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.27 130.48 53.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 103.171 -2.9 . . . . 0.0 103.171 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.44 54.79 0.16 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.674 1.989 . . . . 0.0 110.998 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.26 132.8 32.95 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.18 172.46 13.0 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.436 2.091 . . . . 0.0 110.003 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.11 23.99 1.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.602 -0.686 . . . . 0.0 111.948 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.46 -7.48 28.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.23 143.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.78 146.41 17.94 Favored Glycine 0 CA--C 1.476 -2.368 1 N-CA-C 101.44 -4.664 . . . . 0.0 101.44 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.4 pt -142.31 -146.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 -165.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 7' ' ' ALA . 14.5 mm -69.68 123.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.259 1.0 OUTLIER -135.93 22.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 -167.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.495 ' HA ' HD21 ' A' ' 11' ' ' ASN . 33.5 tt0 -65.92 127.41 31.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 127.331 2.252 . . . . 0.0 109.496 -175.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.64 -46.92 0.99 Allowed Glycine 0 N--CA 1.433 -1.524 1 N-CA-C 98.318 -5.913 . . . . 0.0 98.318 -150.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 13.5 tp10 -95.26 -153.3 0.39 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 157.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 41.7 tptt -149.98 -170.73 3.72 Favored 'General case' 0 N--CA 1.434 -1.252 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 -178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 64' ' ' LYS . 41.8 t -59.0 128.47 37.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.675 2.39 . . . . 0.0 111.966 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.331 91.4 m-70 66.76 -147.31 0.17 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 127.965 2.506 . . . . 0.0 111.913 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -77.95 58.92 2.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 124.09 0.956 . . . . 0.0 111.736 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.081 0 CA-C-N 116.366 -0.379 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.537 0.684 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 171.68 8.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -136.11 140.26 43.58 Favored 'General case' 0 CA--C 1.488 -1.44 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -177.31 34.78 Favored Glycine 0 CA--C 1.475 -2.419 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -79.27 134.25 36.64 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 102.04 -3.319 . . . . 0.0 102.04 157.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -90.16 133.83 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.5 -147.94 0.36 Allowed 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 111.057 -2.792 . . . . 0.0 108.978 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -138.09 148.76 61.35 Favored Pre-proline 0 N--CA 1.42 -1.937 1 N-CA-C 94.691 -6.04 . . . . 0.0 94.691 170.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -76.01 151.77 35.46 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 122.052 1.769 . . . . 0.0 108.428 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.16 -12.18 19.82 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 127.446 2.299 . . . . 0.0 108.204 9.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -160.96 141.89 11.57 Favored 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 95.647 -5.686 . . . . 0.0 95.647 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.05 -159.79 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -128.14 165.09 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 N-CA-C 98.597 -4.594 . . . . 0.0 98.597 160.98 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 -157.44 0.46 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -138.97 -177.86 5.08 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 98.673 -4.566 . . . . 0.0 98.673 168.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.44 163.54 35.34 Favored 'General case' 0 N--CA 1.419 -1.999 1 N-CA-C 95.913 -5.588 . . . . 0.0 95.913 -175.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.28 119.26 31.97 Favored Pre-proline 0 N--CA 1.421 -1.883 1 N-CA-C 98.584 -4.599 . . . . 0.0 98.584 172.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -57.37 111.49 0.83 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.905 2.403 . . . . 0.0 113.14 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.6 -37.87 1.25 Allowed Glycine 0 CA--C 1.49 -1.506 1 N-CA-C 101.148 -4.781 . . . . 0.0 101.148 -162.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m 86.09 -5.43 0.79 Allowed 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 125.678 1.591 . . . . 0.0 112.242 158.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -61.79 -42.38 98.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.156 1.782 . . . . 0.0 112.531 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.22 -31.97 63.26 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -71.57 -50.04 34.89 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.96 -38.12 89.81 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 118.766 0.712 . . . . 0.0 110.602 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.5 m -59.58 -50.04 75.44 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.367 -0.833 . . . . 0.0 111.674 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.82 -43.96 91.39 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.861 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.1 t -54.1 -46.41 72.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.391 1.076 . . . . 0.0 110.91 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -65.5 -49.15 70.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.483 0.713 . . . . 0.0 110.596 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.96 -20.22 61.77 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.774 -0.579 . . . . 0.0 112.56 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -87.66 -6.61 58.17 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 118.615 0.643 . . . . 0.0 110.24 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 27.82 9.43 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.32 146.74 18.34 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 p -75.57 -37.23 60.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.511 -0.993 . . . . 0.0 110.726 -164.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 m -160.88 -177.5 6.18 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.723 -4.918 . . . . 0.0 97.723 165.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.39 -176.72 41.34 Favored Glycine 0 N--CA 1.414 -2.805 1 N-CA-C 98.614 -5.794 . . . . 0.0 98.614 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.57 180.0 6.84 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 97.015 -5.18 . . . . 0.0 97.015 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.2 m -103.52 165.41 11.05 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.5 171.42 39.98 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 97.923 -6.071 . . . . 0.0 97.923 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -103.39 145.43 30.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -116.99 96.15 5.32 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.32 127.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -42.45 1.43 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -169.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -119.27 -68.68 0.9 Allowed 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.31 -160.36 33.98 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 -172.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.64 136.51 51.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 -173.94 3.82 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.35 158.77 27.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 101.166 -3.642 . . . . 0.0 101.166 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -120.57 153.06 37.28 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -146.87 155.38 42.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -118.76 143.94 46.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 166.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.24 56.96 0.11 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 127.237 2.215 . . . . 0.0 111.197 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -96.23 133.37 25.11 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -71.84 174.94 10.38 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 122.206 1.824 . . . . 0.0 111.43 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.32 16.34 1.66 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -98.34 -5.27 33.2 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.87 169.68 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.35 160.23 27.84 Favored Glycine 0 CA--C 1.48 -2.106 1 N-CA-C 99.414 -5.475 . . . . 0.0 99.414 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 pt -144.88 -164.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 -163.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -70.89 128.54 34.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.44 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.24 -124.15 0.72 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.402 1.881 . . . . 0.0 108.569 -171.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.84 42.13 0.32 Allowed Glycine 0 CA--C 1.486 -1.775 1 N-CA-C 102.216 -4.353 . . . . 0.0 102.216 169.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -85.64 -51.82 6.22 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.487 0.715 . . . . 0.0 109.499 -168.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -163.23 -168.64 1.77 Allowed 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 101.35 -3.574 . . . . 0.0 101.35 -171.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.26 148.93 42.58 Favored 'General case' 0 N--CA 1.429 -1.477 1 N-CA-C 96.887 -5.227 . . . . 0.0 96.887 171.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 103.52 4.43 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 99.93 -4.1 . . . . 0.0 99.93 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 m -65.0 128.26 35.0 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.331 1.052 . . . . 0.0 110.263 -172.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.362 1.125 0 O-C-N 123.115 0.26 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.002 0.429 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.97 162.67 12.84 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -132.08 130.45 41.28 Favored 'General case' 0 CA--C 1.489 -1.375 1 N-CA-C 95.077 -5.897 . . . . 0.0 95.077 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.95 -169.16 24.89 Favored Glycine 0 CA--C 1.477 -2.306 0 N-CA-C 104.025 -3.63 . . . . 0.0 104.025 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.28 140.26 30.97 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 159.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.71 150.3 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -155.23 174.74 14.79 Favored 'General case' 0 N--CA 1.415 -2.221 1 N-CA-C 98.535 -4.617 . . . . 0.0 98.535 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -85.67 158.54 56.7 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 34.7 Cg_exo -64.54 113.46 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.019 2.479 . . . . 0.0 110.785 164.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.7 mm-40 -126.64 114.04 17.51 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 127.45 2.3 . . . . 0.0 106.636 1.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.543 HD21 ' HA ' ' A' ' 61' ' ' GLU . 61.4 t30 80.63 31.99 0.16 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.582 1.153 . . . . 0.0 109.126 156.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -123.04 123.03 39.95 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.82 158.26 6.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 CA-C-N 120.106 1.321 . . . . 0.0 114.028 -159.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 135.9 42.74 Favored 'General case' 0 CA--C 1.483 -1.604 1 N-CA-C 97.291 -5.077 . . . . 0.0 97.291 178.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -90.96 165.9 13.31 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -164.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -151.8 175.95 11.92 Favored 'General case' 0 N--CA 1.406 -2.647 1 N-CA-C 94.815 -5.994 . . . . 0.0 94.815 -170.202 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -149.43 176.56 2.2 Favored Pre-proline 0 N--CA 1.408 -2.573 1 N-CA-C 95.026 -5.916 . . . . 0.0 95.026 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.46 55.0 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.122 2.865 . . . . 0.0 110.607 161.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.96 150.43 11.77 Favored Glycine 0 CA--C 1.481 -2.032 1 N-CA-C 99.391 -5.484 . . . . 0.0 99.391 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -106.91 15.09 25.8 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 117.533 0.667 . . . . 0.0 111.239 -161.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -62.11 -61.0 2.78 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.934 1.293 . . . . 0.0 111.759 -166.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.56 -41.14 77.04 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 t -57.89 -58.41 8.51 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.585 1.154 . . . . 0.0 111.288 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.63 -33.57 75.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.066 0.546 . . . . 0.0 109.806 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.0 m -61.2 -50.02 74.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.402 0.681 . . . . 0.0 110.869 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.45 -37.5 68.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.643 0.777 . . . . 0.0 110.04 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.26 -46.26 83.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 110.112 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -62.28 -49.2 76.63 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.133 0.573 . . . . 0.0 110.995 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.28 -21.07 60.68 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.527 -0.733 . . . . 0.0 112.687 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -94.28 3.04 55.76 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.793 -0.567 . . . . 0.0 110.083 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.96 33.06 7.54 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 161.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.91 147.22 18.53 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 104.326 -3.51 . . . . 0.0 104.326 167.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -78.37 -37.14 44.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 117.99 0.895 . . . . 0.0 110.277 -166.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 m -160.52 -179.64 7.82 Favored 'General case' 0 N--CA 1.426 -1.655 1 N-CA-C 99.06 -4.422 . . . . 0.0 99.06 169.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.59 178.7 43.76 Favored Glycine 0 N--CA 1.423 -2.23 1 N-CA-C 99.52 -5.432 . . . . 0.0 99.52 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -167.19 -179.81 4.74 Favored 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 99.287 -4.338 . . . . 0.0 99.287 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.5 m -126.64 158.42 36.36 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.18 102.75 0.34 Allowed Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 105.015 -3.234 . . . . 0.0 105.015 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 174.07 5.31 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.07 26.04 0.01 OUTLIER 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.76 132.41 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -160.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.28 -95.44 2.1 Favored Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -83.58 -51.43 7.32 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.47 46.43 Favored Glycine 0 N--CA 1.42 -2.432 1 N-CA-C 97.694 -6.162 . . . . 0.0 97.694 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.377 0.2 OUTLIER -76.64 143.17 40.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.977 0.388 . . . . 0.0 110.755 173.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.0 9.06 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 101.956 -3.35 . . . . 0.0 101.956 -163.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.48 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 1.9 t -113.2 153.59 28.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 -170.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -97.64 155.65 16.89 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.72 148.85 32.41 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.03 142.62 46.73 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 101.883 -3.376 . . . . 0.0 101.883 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.19 59.21 1.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.356 2.262 . . . . 0.0 112.11 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.6 mt -93.55 133.34 28.32 Favored Pre-proline 0 CA--C 1.495 -1.163 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.92 170.9 15.68 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.403 2.069 . . . . 0.0 110.611 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.86 32.59 0.59 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.726 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.19 -3.37 14.66 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.43 162.66 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 -175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.52 150.71 21.53 Favored Glycine 0 CA--C 1.481 -2.038 1 N-CA-C 98.552 -5.819 . . . . 0.0 98.552 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.6 pt -150.55 -150.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -159.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.6 mm -69.04 128.02 31.84 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.92 18.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -170.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.543 ' HA ' HD21 ' A' ' 11' ' ' ASN . 78.0 tt0 -62.5 133.2 54.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 125.585 1.554 . . . . 0.0 112.184 -168.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.73 -46.42 0.77 Allowed Glycine 0 N--CA 1.432 -1.6 1 N-CA-C 98.69 -5.764 . . . . 0.0 98.69 -157.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -94.4 -149.32 0.28 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 154.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -149.85 -172.98 4.29 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 101.277 -3.601 . . . . 0.0 101.277 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.2 135.7 55.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.909 1.684 . . . . 0.0 109.077 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -157.52 174.34 15.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -67.78 122.55 18.35 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.964 1.306 . . . . 0.0 107.993 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 122.989 0.18 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 167.69 21.58 Favored 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 164.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -127.99 132.04 49.2 Favored 'General case' 0 CA--C 1.48 -1.731 1 N-CA-C 94.017 -6.29 . . . . 0.0 94.017 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.77 36.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 105.551 -3.019 . . . . 0.0 105.551 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.46 134.15 40.92 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.39 148.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.22 -176.88 5.89 Favored 'General case' 0 N--CA 1.413 -2.294 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 -173.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -101.74 168.31 9.26 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 41.1 Cg_exo -61.33 130.33 31.66 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.37 2.046 . . . . 0.0 110.395 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 43.6 mt-10 -128.47 117.98 22.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 -7.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 70.91 19.54 5.71 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.385 1.074 . . . . 0.0 109.837 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.3 m -103.63 91.77 4.16 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 7' ' ' ALA 0.287 27.2 m -59.4 154.86 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -165.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.56 175.58 5.43 Favored 'General case' 0 N--CA 1.421 -1.903 1 N-CA-C 98.175 -4.75 . . . . 0.0 98.175 175.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -136.39 152.81 51.02 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 97.128 -5.138 . . . . 0.0 97.128 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.05 175.58 6.06 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.32 119.45 33.14 Favored Pre-proline 0 N--CA 1.426 -1.654 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 173.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.47 101.24 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.819 2.346 . . . . 0.0 111.497 -170.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.89 -44.92 0.51 Allowed Glycine 0 CA--C 1.481 -2.092 1 N-CA-C 102.504 -4.238 . . . . 0.0 102.504 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m 121.75 -48.48 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 129.006 2.922 . . . . 0.0 107.299 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -39.94 -45.41 1.86 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.068 2.947 . . . . 0.0 118.097 -155.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -41.57 49.46 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 121.235 -0.916 . . . . 0.0 111.33 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 t -82.92 -25.73 32.12 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.81 -29.16 69.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.742 0.817 . . . . 0.0 110.396 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.7 m -70.52 -43.44 69.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.119 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.73 -39.91 95.55 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 122.075 0.941 . . . . 0.0 109.9 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -54.14 -45.68 72.05 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.531 1.132 . . . . 0.0 110.743 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -61.7 -48.97 78.36 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.31 -18.87 59.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.49 -22.7 24.74 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.634 0.652 . . . . 0.0 109.756 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.9 28.13 3.51 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 167.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.44 121.96 7.18 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.04 -2.824 . . . . 0.0 106.04 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -93.59 1.57 56.64 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 122.046 0.927 . . . . 0.0 109.959 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -160.19 160.69 33.12 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 98.121 -4.77 . . . . 0.0 98.121 169.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.83 178.57 46.55 Favored Glycine 0 CA--C 1.481 -2.089 1 N-CA-C 101.318 -4.713 . . . . 0.0 101.318 -171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -166.71 179.95 5.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.663 -3.829 . . . . 0.0 100.663 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.9 m -93.87 173.81 7.48 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.25 -172.72 31.08 Favored Glycine 0 CA--C 1.482 -2.019 1 N-CA-C 98.32 -5.912 . . . . 0.0 98.32 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -127.65 149.21 50.3 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.21 -4.367 . . . . 0.0 99.21 170.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -126.72 101.2 6.52 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.44 120.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.59 -42.03 1.38 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -118.05 -64.51 1.28 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.43 -138.09 5.9 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 105.254 -3.138 . . . . 0.0 105.254 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp -81.23 133.41 35.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.8 162.83 37.08 Favored 'General case' 0 N--CA 1.433 -1.288 1 N-CA-C 97.975 -4.824 . . . . 0.0 97.975 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -113.02 -176.49 2.91 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 121.162 1.801 . . . . 0.0 106.494 -169.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -126.47 147.88 49.75 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 m -141.86 142.18 33.11 Favored 'General case' 0 N--CA 1.433 -1.278 1 N-CA-C 100.096 -4.039 . . . . 0.0 100.096 170.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.1 22.35 16.07 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -165.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.8 2.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 94.542 -6.095 . . . . 0.0 94.542 173.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -150.22 154.14 35.95 Favored Pre-proline 0 N--CA 1.427 -1.602 1 N-CA-C 96.024 -5.547 . . . . 0.0 96.024 152.102 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.09 166.3 30.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 122.156 1.806 . . . . 0.0 109.165 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.64 -10.92 56.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -86.09 -1.34 57.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.517 0.727 . . . . 0.0 110.082 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG11 ' HG ' ' A' ' 52' ' ' LEU . 6.0 t -100.28 142.52 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.13 13.25 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 99.65 -5.38 . . . . 0.0 99.65 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.401 HG21 HD23 ' A' ' 52' ' ' LEU . 15.1 pt -130.09 -129.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -163.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 7' ' ' ALA . 6.1 mm -72.89 118.78 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.39 112.18 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 73.48 -178.3 0.19 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 128.037 2.535 . . . . 0.0 109.544 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.12 0.25 Allowed Glycine 0 CA--C 1.486 -1.777 1 N-CA-C 100.983 -4.847 . . . . 0.0 100.983 169.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -137.37 -124.14 0.14 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 101.408 -3.553 . . . . 0.0 101.408 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -157.16 -174.97 5.16 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 97.835 -4.876 . . . . 0.0 97.835 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.38 123.37 19.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 126.044 1.738 . . . . 0.0 107.61 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -144.02 179.88 6.92 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -171.27 172.29 5.32 Favored 'General case' 0 N--CA 1.428 -1.544 1 N-CA-C 96.226 -5.472 . . . . 0.0 96.226 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.032 0 CA-C-N 119.345 0.975 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 162.71 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -128.6 134.16 48.51 Favored 'General case' 0 CA--C 1.487 -1.463 1 N-CA-C 94.955 -5.943 . . . . 0.0 94.955 165.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.19 -175.14 32.9 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 105.576 -3.009 . . . . 0.0 105.576 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -76.06 132.89 40.38 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.8 137.17 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.52 -150.52 0.42 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.64 -2.527 . . . . 0.0 108.872 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -135.1 152.35 76.92 Favored Pre-proline 0 N--CA 1.421 -1.902 1 N-CA-C 94.612 -6.07 . . . . 0.0 94.612 161.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -67.41 157.55 61.21 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 CA-C-N 123.391 2.247 . . . . 0.0 108.439 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.74 -25.12 17.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 128.153 2.581 . . . . 0.0 110.278 5.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -156.76 106.1 2.25 Favored 'General case' 0 N--CA 1.434 -1.241 1 N-CA-C 99.612 -4.218 . . . . 0.0 99.612 -173.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -163.06 -168.23 1.69 Allowed 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 120.092 1.315 . . . . 0.0 107.648 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -129.18 164.6 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 160.536 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 -164.59 1.01 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.9 167.92 20.3 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 96.314 -5.439 . . . . 0.0 96.314 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.42 156.41 48.59 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 98.231 -4.729 . . . . 0.0 98.231 -167.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.05 116.15 45.01 Favored Pre-proline 0 N--CA 1.424 -1.752 1 N-CA-C 96.304 -5.443 . . . . 0.0 96.304 164.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -63.59 102.41 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 125.025 2.83 . . . . 0.0 114.788 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.98 -172.47 45.47 Favored Glycine 0 N--CA 1.418 -2.507 1 N-CA-C 96.184 -6.767 . . . . 0.0 96.184 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -38.24 23.86 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 118.437 1.119 . . . . 0.0 108.675 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.51 -60.02 2.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.337 2.655 . . . . 0.0 116.124 -165.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.56 -54.37 10.51 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -166.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.29 -47.52 79.17 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 122.292 -0.534 . . . . 0.0 110.971 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -64.69 -40.98 96.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 m -64.8 -44.62 89.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.492 -0.755 . . . . 0.0 111.035 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.88 -38.53 91.27 Favored 'General case' 0 C--N 1.358 0.964 0 CA-C-O 122.342 1.068 . . . . 0.0 109.985 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -58.93 -50.24 74.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.512 1.125 . . . . 0.0 110.572 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -68.76 -35.8 77.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.12 -29.29 54.7 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.264 -0.897 . . . . 0.0 111.806 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -77.29 -35.06 55.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.739 0.7 . . . . 0.0 109.419 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.61 43.32 0.82 Allowed Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.07 157.09 21.0 Favored Glycine 0 CA--C 1.484 -1.897 1 N-CA-C 102.263 -4.335 . . . . 0.0 102.263 159.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.8 m -81.3 -38.05 27.4 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -168.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.2 m -160.5 168.79 24.33 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 99.929 -4.1 . . . . 0.0 99.929 175.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.11 178.55 45.92 Favored Glycine 0 N--CA 1.421 -2.355 1 N-CA-C 99.969 -5.252 . . . . 0.0 99.969 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -169.66 -175.49 2.15 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -171.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.89 145.98 29.12 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.84 167.96 38.84 Favored Glycine 0 N--CA 1.419 -2.486 1 N-CA-C 99.18 -5.568 . . . . 0.0 99.18 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -164.37 -168.04 1.44 Allowed 'General case' 0 N--CA 1.42 -1.971 1 N-CA-C 95.997 -5.557 . . . . 0.0 95.997 170.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 99.59 61.4 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 131.324 3.85 . . . . 0.0 102.244 -167.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.7 t -141.41 166.95 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 1 N-CA-C 99.627 -4.212 . . . . 0.0 99.627 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.32 80.23 0.27 Allowed Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.54 -3.024 . . . . 0.0 105.54 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -173.34 -145.16 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 94.47 -6.122 . . . . 0.0 94.47 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.86 120.15 1.87 Allowed Glycine 0 CA--C 1.484 -1.902 1 N-CA-C 101.349 -4.701 . . . . 0.0 101.349 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tp 73.88 175.53 0.26 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.608 1.963 . . . . 0.0 108.962 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.79 -173.78 0.42 Allowed 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 98.183 -4.747 . . . . 0.0 98.183 171.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.3 m -125.83 176.48 6.92 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 100.499 -3.889 . . . . 0.0 100.499 159.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -113.94 152.52 30.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -145.63 149.94 35.43 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -116.47 137.73 51.94 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.25 61.05 0.23 Allowed 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.345 2.258 . . . . 0.0 110.517 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.36 131.0 26.99 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.61 178.02 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.986 2.457 . . . . 0.0 110.714 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -74.61 -1.54 22.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -89.81 -1.22 57.94 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 120.937 -1.102 . . . . 0.0 109.761 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.93 170.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.98 152.01 24.11 Favored Glycine 0 CA--C 1.478 -2.269 1 N-CA-C 97.719 -6.152 . . . . 0.0 97.719 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.46 -149.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 10.8 mm -68.28 134.98 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.15 158.16 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 1 N-CA-C 93.188 -6.597 . . . . 0.0 93.188 169.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -148.89 158.69 44.36 Favored 'General case' 0 CA--C 1.477 -1.839 1 N-CA-C 96.606 -5.331 . . . . 0.0 96.606 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.19 -39.63 1.11 Allowed Glycine 0 CA--C 1.485 -1.817 1 N-CA-C 102.255 -4.338 . . . . 0.0 102.255 -163.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -104.29 -98.63 0.31 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -174.01 -161.66 0.13 Allowed 'General case' 0 N--CA 1.427 -1.583 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 -169.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 10.4 t -79.89 119.58 22.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 162.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -75.13 174.12 9.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.557 1.17 . . . . 0.0 110.574 -167.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.7 m -170.81 -179.4 2.83 Favored 'General case' 0 N--CA 1.421 -1.891 1 N-CA-C 95.778 -5.638 . . . . 0.0 95.778 173.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.928 0 O-C-N 124.438 1.086 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.031 0.443 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 169.3 9.08 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -128.2 144.38 51.12 Favored 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 94.587 -6.079 . . . . 0.0 94.587 166.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 178.06 37.52 Favored Glycine 0 CA--C 1.475 -2.409 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -81.7 129.91 34.88 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 159.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 14.6 tt -90.52 140.16 16.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.48 -149.76 0.42 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 127.097 2.159 . . . . 0.0 108.285 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.59 165.58 24.22 Favored Pre-proline 0 N--CA 1.418 -2.07 1 N-CA-C 95.229 -5.841 . . . . 0.0 95.229 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.01 152.17 83.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.22 1.947 . . . . 0.0 108.706 167.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -88.27 -51.76 5.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.21 2.204 . . . . 0.0 108.095 1.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.84 121.85 14.6 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 89.567 -7.938 . . . . 0.0 89.567 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 17.8 m -163.57 -166.32 1.19 Allowed 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 102.252 -3.24 . . . . 0.0 102.252 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.07 166.03 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 97.796 -4.89 . . . . 0.0 97.796 160.96 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -161.62 0.66 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 162.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -137.76 167.36 21.87 Favored 'General case' 0 CA--C 1.484 -1.581 1 N-CA-C 97.257 -5.09 . . . . 0.0 97.257 164.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.3 t -108.42 163.58 13.09 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -110.29 106.0 57.64 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 97.712 -4.921 . . . . 0.0 97.712 162.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -53.14 104.62 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 124.045 2.48 . . . . 0.0 118.245 -161.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.01 -162.64 33.77 Favored Glycine 0 N--CA 1.423 -2.193 1 N-CA-C 97.569 -6.212 . . . . 0.0 97.569 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 4.6 p -88.86 -34.03 17.14 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -39.47 -59.64 1.06 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 128.568 2.747 . . . . 0.0 116.643 -160.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -53.65 11.08 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.71 -43.04 98.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 122.115 -0.638 . . . . 0.0 111.621 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -44.5 97.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.818 0.847 . . . . 0.0 109.988 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -63.09 -43.88 97.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.395 -0.815 . . . . 0.0 110.515 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.08 -40.61 90.97 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 122.422 1.106 . . . . 0.0 110.215 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.31 -44.39 95.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.817 1.247 . . . . 0.0 109.658 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -74.98 -28.79 60.69 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -78.39 -24.33 46.38 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.971 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -78.0 -58.18 3.4 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.82 45.52 0.07 OUTLIER Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.85 159.07 14.15 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 104.215 -3.554 . . . . 0.0 104.215 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 m -91.97 -31.14 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.653 0.74 . . . . 0.0 109.757 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -146.22 154.78 42.13 Favored 'General case' 0 CA--C 1.476 -1.896 1 N-CA-C 99.837 -4.134 . . . . 0.0 99.837 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.97 155.69 26.57 Favored Glycine 0 N--CA 1.417 -2.591 1 N-CA-C 98.427 -5.869 . . . . 0.0 98.427 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 8.3 p80 -166.51 -172.99 2.34 Favored 'General case' 0 N--CA 1.424 -1.736 1 N-CA-C 96.863 -5.236 . . . . 0.0 96.863 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 18' ' ' PRO . 28.2 m -72.86 179.57 3.63 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 122.699 1.237 . . . . 0.0 110.817 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.24 174.08 39.48 Favored Glycine 0 N--CA 1.41 -3.07 1 N-CA-C 98.17 -5.972 . . . . 0.0 98.17 168.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -137.45 132.74 33.82 Favored 'General case' 0 N--CA 1.427 -1.584 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 172.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -117.23 105.28 12.04 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.98 125.18 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.35 -32.07 3.47 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -124.35 -67.55 0.91 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.6 -148.92 19.49 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.295 -3.122 . . . . 0.0 105.295 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 tp -58.87 143.76 46.61 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.648 2.379 . . . . 0.0 107.942 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.11 -172.66 4.18 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -170.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.6 m -117.46 170.81 8.43 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 165.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.8 t-105 -124.32 156.83 36.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.2 m -145.03 147.54 32.72 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -113.6 136.73 52.5 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.55 69.73 0.46 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.358 2.663 . . . . 0.0 111.644 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 mt -105.06 139.11 19.79 Favored Pre-proline 0 CA--C 1.503 -0.837 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -68.52 167.44 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.657 2.238 . . . . 0.0 111.596 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -67.49 -21.0 65.53 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.342 1.057 . . . . 0.0 113.742 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -84.02 2.37 39.38 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 110.847 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.29 125.89 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.36 152.27 20.15 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 105.842 -2.903 . . . . 0.0 105.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.1 pt -140.46 -147.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 -166.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.2 mm -72.71 135.5 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.06 149.04 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 1 N-CA-C 93.569 -6.456 . . . . 0.0 93.569 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 46.26 -117.18 0.69 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.615 1.966 . . . . 0.0 112.422 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.88 48.82 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -86.46 -60.04 2.11 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -166.89 -171.68 1.88 Allowed 'General case' 0 N--CA 1.424 -1.734 1 N-CA-C 99.14 -4.392 . . . . 0.0 99.14 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 15.6 t -107.18 119.75 40.25 Favored 'General case' 0 N--CA 1.426 -1.656 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 165.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.256 83.7 m-70 78.55 -164.45 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 128.183 2.593 . . . . 0.0 108.189 -170.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 p -87.42 107.78 18.7 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -170.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.048 0 O-C-N 123.533 0.52 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.3 0.571 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.4 171.29 7.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -131.71 144.14 50.77 Favored 'General case' 0 CA--C 1.485 -1.549 1 N-CA-C 95.694 -5.669 . . . . 0.0 95.694 165.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.78 36.6 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.709 -2.956 . . . . 0.0 105.709 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.37 133.41 35.91 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.37 135.17 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.21 -150.0 0.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 111.328 -2.669 . . . . 0.0 107.026 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 9.2 pt20 -142.14 164.36 34.16 Favored Pre-proline 0 N--CA 1.42 -1.926 1 N-CA-C 96.017 -5.549 . . . . 0.0 96.017 169.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -66.97 149.27 82.88 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 CA-C-N 122.4 1.893 . . . . 0.0 109.698 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -81.86 -22.72 36.78 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.491 2.316 . . . . 0.0 107.844 -1.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -177.49 155.53 1.09 Allowed 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 94.094 -6.261 . . . . 0.0 94.094 -171.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 73.2 m 161.22 -149.33 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.116 1 N-CA-C 97.971 -4.825 . . . . 0.0 97.971 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -117.57 164.7 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 1 N-CA-C 98.802 -4.518 . . . . 0.0 98.802 160.646 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -155.46 0.24 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 161.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -134.82 -179.5 5.65 Favored 'General case' 0 CA--C 1.482 -1.641 1 N-CA-C 98.919 -4.474 . . . . 0.0 98.919 164.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.2 t -139.1 174.01 10.96 Favored 'General case' 0 N--CA 1.416 -2.127 1 N-CA-C 96.817 -5.253 . . . . 0.0 96.817 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -128.04 132.67 24.47 Favored Pre-proline 0 N--CA 1.416 -2.174 1 N-CA-C 97.639 -4.948 . . . . 0.0 97.639 173.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -55.38 118.37 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.109 2.54 . . . . 0.0 112.773 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.81 -44.16 1.21 Allowed Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 25.4 m 91.87 -13.78 0.2 Allowed 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 127.784 2.434 . . . . 0.0 112.917 175.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -47.14 -48.28 23.34 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.54 -28.89 56.67 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 111.241 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.21 -45.47 60.15 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.25 -47.49 78.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.854 1.262 . . . . 0.0 109.163 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -59.78 -45.67 91.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.606 0.762 . . . . 0.0 112.07 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 mt -66.65 -40.13 88.53 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.887 -1.133 . . . . 0.0 110.54 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.29 -43.45 83.18 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.648 1.179 . . . . 0.0 110.779 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -59.37 -53.31 59.67 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.35 0.66 . . . . 0.0 110.679 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.31 -16.97 61.36 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.622 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -91.22 -5.2 55.19 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.794 -0.566 . . . . 0.0 109.895 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.18 27.92 7.95 Favored Glycine 0 CA--C 1.49 -1.5 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.036 166.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.9 146.29 17.42 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -78.87 -27.93 44.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.318 -1.107 . . . . 0.0 111.06 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 m -161.07 174.73 13.3 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 99.674 -4.195 . . . . 0.0 99.674 166.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.06 172.56 43.91 Favored Glycine 0 N--CA 1.423 -2.222 1 N-CA-C 98.82 -5.712 . . . . 0.0 98.82 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -159.63 174.76 14.09 Favored 'General case' 0 CA--C 1.491 -1.3 1 N-CA-C 99.521 -4.252 . . . . 0.0 99.521 -173.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.8 m -71.82 163.4 27.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 119.818 1.19 . . . . 0.0 110.429 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.25 171.81 37.35 Favored Glycine 0 N--CA 1.424 -2.139 1 N-CA-C 99.568 -5.413 . . . . 0.0 99.568 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -120.79 134.59 55.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -110.85 106.42 15.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.34 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.4 -21.87 10.51 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -132.07 -74.02 0.51 Allowed 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.34 -160.62 34.0 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.68 135.54 57.66 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 127.253 2.221 . . . . 0.0 107.167 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.47 -173.45 3.77 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -170.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.7 t -122.58 155.56 36.04 Favored 'General case' 0 CA--C 1.494 -1.181 1 N-CA-C 99.986 -4.079 . . . . 0.0 99.986 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -114.24 151.29 33.05 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.7 m -146.3 149.15 33.28 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.77 138.89 53.06 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 103.385 -2.82 . . . . 0.0 103.385 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.65 58.54 0.1 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 127.67 2.388 . . . . 0.0 111.473 171.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.17 132.68 23.02 Favored Pre-proline 0 CA--C 1.501 -0.911 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.34 171.68 17.79 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.283 1.851 . . . . 0.0 110.965 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.76 -18.23 62.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.672 1.989 . . . . 0.0 114.753 -169.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -86.73 -5.72 59.04 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.278 0.631 . . . . 0.0 109.842 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.17 138.54 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.3 152.52 17.19 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 pt -131.37 -150.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -160.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 HD12 HG12 ' A' ' 13' ' ' VAL . 6.0 mm -76.39 113.49 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.79 95.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -81.01 141.2 34.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.14 -38.44 3.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -83.63 -29.67 27.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.917 0.887 . . . . 0.0 109.049 -175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . 0.311 51.1 tttm 94.83 -117.31 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 125.095 1.358 . . . . 0.0 108.718 173.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 51.0 t -133.63 128.85 35.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 -174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.95 -142.73 0.56 Allowed 'General case' 0 CA--C 1.498 -1.058 0 C-N-CA 126.033 1.733 . . . . 0.0 110.135 -170.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -76.25 56.36 1.04 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.554 1.542 . . . . 0.0 110.995 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.053 0 CA-C-N 115.621 -0.718 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 165.87 26.14 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -134.17 130.07 36.74 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 94.465 -6.124 . . . . 0.0 94.465 166.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.99 -174.1 31.47 Favored Glycine 0 CA--C 1.471 -2.695 0 N-CA-C 103.278 -3.929 . . . . 0.0 103.278 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.94 134.91 37.79 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 163.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 47' ' ' CYS . 8.2 tt -90.9 143.56 10.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.25 -153.66 0.51 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 126.842 2.057 . . . . 0.0 105.618 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.83 66.02 Favored Pre-proline 0 N--CA 1.424 -1.764 1 N-CA-C 94.199 -6.223 . . . . 0.0 94.199 165.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.16 150.57 59.94 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.277 1.984 . . . . 0.0 108.407 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -85.98 -35.59 20.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.914 1.686 . . . . 0.0 109.402 10.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -159.26 145.31 16.38 Favored 'General case' 0 N--CA 1.419 -2.02 1 N-CA-C 94.773 -6.01 . . . . 0.0 94.773 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.4 m 175.37 -155.3 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.433 1 N-CA-C 96.642 -5.318 . . . . 0.0 96.642 172.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.641 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -127.07 165.38 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 1 N-CA-C 96.913 -5.217 . . . . 0.0 96.913 161.042 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.78 -166.91 1.55 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 164.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -135.73 151.19 49.9 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 101.619 -3.474 . . . . 0.0 101.619 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.0 t -124.31 156.94 36.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.36 118.29 47.73 Favored Pre-proline 0 N--CA 1.42 -1.927 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -176.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 108.28 0.45 Allowed 'Trans proline' 0 CA--C 1.506 -0.914 0 C-N-CA 122.999 2.466 . . . . 0.0 111.892 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.78 0.54 Allowed Glycine 0 CA--C 1.482 -1.97 1 N-CA-C 100.374 -5.09 . . . . 0.0 100.374 -164.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.252 6.8 m 114.49 -35.79 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 108.714 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -39.46 -52.06 2.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.999 2.519 . . . . 0.0 117.118 -157.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.62 -41.51 75.16 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 121.033 -1.042 . . . . 0.0 112.066 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -90.14 -21.76 22.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.934 -1.333 . . . . 0.0 109.176 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.6 -43.08 93.82 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 166.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.59 -47.21 87.2 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.572 -0.705 . . . . 0.0 110.763 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.3 mt -58.87 -43.97 90.98 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 123.676 0.79 . . . . 0.0 111.027 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.7 t -54.07 -47.51 71.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.997 1.319 . . . . 0.0 110.863 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -69.24 -40.62 77.79 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.48 0.312 . . . . 0.0 111.391 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.82 -25.32 48.75 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 118.01 0.368 . . . . 0.0 111.469 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -72.76 -54.37 9.08 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.03 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 167.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.66 136.75 13.82 Favored Glycine 0 CA--C 1.49 -1.515 1 N-CA-C 102.696 -4.162 . . . . 0.0 102.696 165.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -101.58 11.1 39.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.778 0.799 . . . . 0.0 110.098 -163.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.5 m -160.01 159.97 32.71 Favored 'General case' 0 CA--C 1.484 -1.582 1 N-CA-C 98.032 -4.803 . . . . 0.0 98.032 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.58 42.57 Favored Glycine 0 CA--C 1.479 -2.184 1 N-CA-C 99.672 -5.371 . . . . 0.0 99.672 -168.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -167.34 -167.26 0.88 Allowed 'General case' 0 N--CA 1.435 -1.195 1 N-CA-C 98.055 -4.794 . . . . 0.0 98.055 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.9 m -99.19 177.25 5.27 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.22 179.73 42.86 Favored Glycine 0 N--CA 1.423 -2.207 1 N-CA-C 102.569 -4.213 . . . . 0.0 102.569 -175.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 37.9 t80 -143.95 148.52 35.46 Favored 'General case' 0 CA--C 1.486 -1.505 1 N-CA-C 97.248 -5.093 . . . . 0.0 97.248 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -133.39 112.79 11.89 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.34 124.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.82 -31.56 3.89 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 104.702 -3.359 . . . . 0.0 104.702 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -113.47 -70.88 0.78 Allowed 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.3 -153.15 24.33 Favored Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 2.9 tt -72.39 144.38 48.22 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.3 -168.96 2.4 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.2 m -123.61 -179.87 4.52 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -130.78 152.98 49.53 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.9 m -148.25 150.89 34.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.33 140.58 49.38 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 170.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.53 0.82 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.331 2.253 . . . . 0.0 111.03 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -91.17 146.52 33.71 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -66.53 162.83 35.05 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.521 2.147 . . . . 0.0 111.001 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.64 -19.1 62.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.381 0.672 . . . . 0.0 112.449 -168.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -82.2 -1.26 48.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.865 1.266 . . . . 0.0 110.975 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.56 129.22 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.02 20.83 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.62 -154.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 -167.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -77.4 139.69 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 t -147.67 164.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 1 N-CA-C 95.266 -5.828 . . . . 0.0 95.266 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -158.39 157.49 32.42 Favored 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 96.812 -5.255 . . . . 0.0 96.812 166.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.88 -42.87 1.49 Allowed Glycine 0 CA--C 1.494 -1.243 1 N-CA-C 101.249 -4.741 . . . . 0.0 101.249 -163.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 12.2 tp10 -96.56 -147.79 0.3 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 155.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 25.8 tttp -167.79 -162.75 0.45 Allowed 'General case' 0 N--CA 1.425 -1.718 1 N-CA-C 96.216 -5.476 . . . . 0.0 96.216 176.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.8 127.49 31.68 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 127.0 2.12 . . . . 0.0 110.374 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -149.97 93.94 2.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 m -78.38 118.54 20.65 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.052 0 O-C-N 123.0 0.188 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -102.51 152.74 20.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -120.76 119.87 34.01 Favored 'General case' 0 CA--C 1.487 -1.473 1 N-CA-C 95.336 -5.801 . . . . 0.0 95.336 159.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.67 -177.88 35.12 Favored Glycine 0 CA--C 1.472 -2.607 1 N-CA-C 102.747 -4.141 . . . . 0.0 102.747 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.79 144.36 27.79 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -90.76 148.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.809 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -164.14 1.48 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 146.94 32.17 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 101.429 -3.545 . . . . 0.0 101.429 161.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.6 Cg_endo -64.91 113.39 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.176 2.584 . . . . 0.0 107.754 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.3 tt0 -142.96 162.54 35.2 Favored 'General case' 0 CA--C 1.473 -2.011 1 N-CA-C 99.407 -4.294 . . . . 0.0 99.407 5.487 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 83.14 -5.51 1.24 Allowed 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.087 0.867 . . . . 0.0 110.922 162.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -90.65 -143.83 0.17 Allowed 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 125.366 1.466 . . . . 0.0 107.715 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.514 HG11 ' H ' ' A' ' 43' ' ' HIS . 34.8 m -141.75 -179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 1 N-CA-C 98.366 -4.679 . . . . 0.0 98.366 160.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.7 156.28 39.58 Favored 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 94.494 -6.113 . . . . 0.0 94.494 162.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -96.0 123.14 39.48 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 t -94.36 143.3 26.52 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -111.82 121.22 40.31 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.94 120.6 8.49 Favored 'Trans proline' 0 CA--C 1.506 -0.901 0 CA-C-N 123.565 2.309 . . . . 0.0 111.454 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.73 -55.61 0.68 Allowed Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.819 -5.312 . . . . 0.0 99.819 -160.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 m 113.27 -27.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 129.676 3.19 . . . . 0.0 109.839 167.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.29 -49.65 2.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.673 2.389 . . . . 0.0 117.147 -160.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.2 -49.01 69.07 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 121.669 -0.644 . . . . 0.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.7 t -85.91 -23.9 26.83 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.621 -0.929 . . . . 0.0 110.026 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.82 -36.92 85.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.572 -0.705 . . . . 0.0 109.124 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.8 m -66.41 -41.04 89.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.947 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.83 -44.5 95.99 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.632 0.773 . . . . 0.0 109.833 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 t -52.6 -50.14 63.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.406 1.482 . . . . 0.0 110.272 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -60.73 -47.69 85.17 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.721 0.409 . . . . 0.0 112.04 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.09 -31.79 66.39 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.487 -0.758 . . . . 0.0 112.783 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -78.48 -25.23 45.68 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.788 0.722 . . . . 0.0 109.784 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.97 42.57 0.77 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 161.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.68 135.37 12.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.879 -2.888 . . . . 0.0 105.879 170.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -84.02 -16.14 45.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.648 0.779 . . . . 0.0 109.928 -166.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t -158.8 169.98 23.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.99 175.39 46.64 Favored Glycine 0 N--CA 1.425 -2.046 1 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 p80 179.2 -176.45 0.26 Allowed 'General case' 0 N--CA 1.435 -1.193 1 N-CA-C 99.513 -4.255 . . . . 0.0 99.513 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.67 173.84 7.49 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.02 -171.05 40.99 Favored Glycine 0 CA--C 1.483 -1.953 1 N-CA-C 97.322 -6.311 . . . . 0.0 97.322 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.29 160.86 40.28 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 97.256 -5.09 . . . . 0.0 97.256 171.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -160.01 36.88 0.18 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.263 2.2 t 58.53 -143.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -157.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.92 -126.19 6.38 Favored Glycine 0 CA--C 1.48 -2.133 1 N-CA-C 99.548 -5.421 . . . . 0.0 99.548 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' H ' HG11 ' A' ' 13' ' ' VAL . 57.1 m-70 -121.13 -20.32 6.83 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 125.611 1.565 . . . . 0.0 108.192 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.39 -173.89 45.78 Favored Glycine 0 N--CA 1.421 -2.318 1 N-CA-C 96.481 -6.647 . . . . 0.0 96.481 -165.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.03 102.07 10.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 118.271 1.035 . . . . 0.0 108.232 -168.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.99 -179.83 7.54 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 125.231 1.413 . . . . 0.0 109.005 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 155.64 39.47 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 -170.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -90.95 154.36 19.52 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.9 m -141.95 144.02 33.52 Favored 'General case' 0 CA--C 1.479 -1.783 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 161.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -112.5 121.93 46.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.17 75.94 0.16 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 126.424 1.89 . . . . 0.0 110.085 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.5 mt -99.74 140.19 21.39 Favored Pre-proline 0 CA--C 1.497 -1.088 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.66 171.3 17.52 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.502 2.135 . . . . 0.0 109.943 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -78.56 -3.88 45.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -163.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -91.14 1.31 57.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.939 0.896 . . . . 0.0 109.917 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.95 140.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.56 148.58 18.91 Favored Glycine 0 CA--C 1.482 -1.997 1 N-CA-C 102.598 -4.201 . . . . 0.0 102.598 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HB ' ' H ' ' A' ' 59' ' ' ILE . 19.1 pt -144.53 -153.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -161.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.2 mm -72.53 139.46 19.59 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -148.36 141.01 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 1 N-CA-C 92.91 -6.7 . . . . 0.0 92.91 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 41.18 -108.86 0.1 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 126.238 1.815 . . . . 0.0 111.612 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.95 70.45 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 104.127 -3.589 . . . . 0.0 104.127 164.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.42 -66.6 0.31 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 -168.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -96.7 163.87 12.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.57 130.53 55.3 Favored 'General case' 0 CA--C 1.496 -1.111 1 N-CA-C 100.048 -4.056 . . . . 0.0 100.048 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.277 17.0 m80 69.48 -168.33 0.17 Allowed 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.841 1.656 . . . . 0.0 110.356 -163.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 m -68.71 105.35 2.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 1.214 0 O-C-N 123.031 0.207 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.698 0.761 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HE ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -123.71 157.15 34.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 174.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -132.52 127.84 36.03 Favored 'General case' 0 CA--C 1.488 -1.423 1 N-CA-C 98.113 -4.773 . . . . 0.0 98.113 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -167.23 22.25 Favored Glycine 0 CA--C 1.475 -2.421 1 N-CA-C 102.017 -4.433 . . . . 0.0 102.017 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.47 135.34 39.37 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 161.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -85.16 135.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -138.24 0.09 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.492 -2.595 . . . . 0.0 106.577 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -151.56 164.03 21.63 Favored Pre-proline 0 N--CA 1.422 -1.829 1 N-CA-C 95.329 -5.804 . . . . 0.0 95.329 162.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -65.22 148.4 88.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.845 2.052 . . . . 0.0 109.328 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.53 -51.01 6.15 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 127.97 2.508 . . . . 0.0 109.463 5.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -142.3 143.38 32.77 Favored 'General case' 0 CA--C 1.479 -1.767 1 N-CA-C 92.615 -6.809 . . . . 0.0 92.615 169.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.2 m -172.83 -158.85 0.11 Allowed 'General case' 0 N--CA 1.435 -1.179 1 N-CA-C 100.133 -4.025 . . . . 0.0 100.133 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 59' ' ' ILE . 2.9 m -124.26 166.37 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 96.612 -5.329 . . . . 0.0 96.612 159.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.16 -170.48 3.06 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -130.09 145.21 51.67 Favored 'General case' 0 CA--C 1.472 -2.027 1 N-CA-C 93.075 -6.639 . . . . 0.0 93.075 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -160.44 -165.37 1.42 Allowed 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 94.863 -5.977 . . . . 0.0 94.863 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -144.42 171.91 6.12 Favored Pre-proline 0 N--CA 1.416 -2.154 1 N-CA-C 99.821 -4.14 . . . . 0.0 99.821 -161.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.88 60.3 2.26 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.304 2.669 . . . . 0.0 110.049 164.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.59 124.43 0.81 Allowed Glycine 0 N--CA 1.422 -2.251 1 N-CA-C 100.948 -4.861 . . . . 0.0 100.948 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.37 38.21 0.35 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.088 1.755 . . . . 0.0 112.276 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -70.08 -63.96 0.98 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.369 1.468 . . . . 0.0 110.127 -161.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -23.46 61.93 Favored Glycine 0 CA--C 1.495 -1.19 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -79.65 -14.66 58.63 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.724 -0.655 . . . . 0.0 111.4 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.7 -55.35 23.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 119.714 1.143 . . . . 0.0 109.735 168.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.32 90.88 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.004 1.322 . . . . 0.0 112.767 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.53 -40.49 89.16 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.574 0.702 . . . . 0.0 111.219 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.6 -42.87 98.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -64.1 -46.38 84.49 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 122.465 0.306 . . . . 0.0 110.935 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.32 -15.94 61.89 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.128 -0.982 . . . . 0.0 112.495 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -92.67 -6.87 48.36 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.02 0.528 . . . . 0.0 109.878 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 32.11 11.14 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.81 18.92 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 103.858 -3.697 . . . . 0.0 103.858 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -82.13 -43.33 17.93 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 121.828 -0.807 . . . . 0.0 109.761 -167.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -160.71 -179.76 7.88 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.72 -4.548 . . . . 0.0 98.72 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.01 -176.39 42.39 Favored Glycine 0 N--CA 1.418 -2.503 1 N-CA-C 99.313 -5.515 . . . . 0.0 99.313 -167.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -160.33 -176.6 5.71 Favored 'General case' 0 CA--C 1.488 -1.409 1 N-CA-C 98.511 -4.625 . . . . 0.0 98.511 -174.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.7 m -140.32 161.64 37.2 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.06 109.73 0.95 Allowed Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 104.571 -3.411 . . . . 0.0 104.571 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -171.84 -179.75 2.53 Favored 'General case' 0 N--CA 1.43 -1.425 1 N-CA-C 98.138 -4.764 . . . . 0.0 98.138 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -153.78 148.74 26.68 Favored 'General case' 0 N--CA 1.433 -1.319 1 N-CA-C 95.849 -5.612 . . . . 0.0 95.849 163.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.52 173.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 N-CA-C 97.814 -4.884 . . . . 0.0 97.814 173.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.29 75.89 1.98 Allowed Glycine 0 C--N 1.351 1.372 0 N-CA-C 105.163 -3.175 . . . . 0.0 105.163 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.38 -50.29 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.35 1 N-CA-C 99.928 -4.101 . . . . 0.0 99.928 -170.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.02 -92.41 0.12 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.59 174.16 8.01 Favored 'General case' 0 N--CA 1.427 -1.597 1 N-CA-C 95.838 -5.616 . . . . 0.0 95.838 -173.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.44 -174.62 4.57 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.9 t -118.01 158.3 25.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 101.742 -3.429 . . . . 0.0 101.742 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -97.17 153.98 17.65 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 m -145.63 152.17 39.22 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 101.444 -3.539 . . . . 0.0 101.444 163.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.87 143.15 48.08 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.84 51.58 0.57 Allowed 'General case' 0 CA--C 1.498 -1.019 0 C-N-CA 126.928 2.091 . . . . 0.0 111.986 171.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -93.0 133.04 29.49 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.97 172.94 11.91 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.542 2.161 . . . . 0.0 110.283 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.71 26.33 1.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -97.31 -7.91 30.94 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -101.81 -176.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -151.17 166.65 30.57 Favored Glycine 0 CA--C 1.479 -2.181 1 N-CA-C 98.11 -5.996 . . . . 0.0 98.11 -174.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.416 HG12 ' HE ' ' A' ' 2' ' ' ARG . 23.3 pt -153.8 -168.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.478 -1.807 1 N-CA-C 99.282 -4.34 . . . . 0.0 99.282 -168.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.429 HD12 HG12 ' A' ' 13' ' ' VAL . 14.5 mm -64.17 111.65 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -83.89 -45.17 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -162.49 168.2 22.29 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 95.583 -5.71 . . . . 0.0 95.583 172.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.72 45.37 1.73 Allowed Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.81 -48.5 9.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.923 -167.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -153.24 167.28 29.86 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 28.6 t -133.63 136.6 44.92 Favored 'General case' 0 CA--C 1.482 -1.671 1 N-CA-C 97.769 -4.9 . . . . 0.0 97.769 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -158.31 144.77 17.38 Favored 'General case' 0 CA--C 1.479 -1.758 1 N-CA-C 98.858 -4.497 . . . . 0.0 98.858 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -159.5 167.7 28.0 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 95.435 -5.765 . . . . 0.0 95.435 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.09 0.869 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -104.47 166.42 10.41 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -130.46 134.33 47.01 Favored 'General case' 0 CA--C 1.491 -1.289 1 N-CA-C 94.574 -6.084 . . . . 0.0 94.574 158.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 -179.69 36.78 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -79.21 132.38 36.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 159.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.62 138.06 20.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.84 -156.88 0.57 Allowed 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 127.71 2.404 . . . . 0.0 107.913 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -121.89 142.94 37.36 Favored Pre-proline 0 N--CA 1.424 -1.774 1 N-CA-C 94.846 -5.983 . . . . 0.0 94.846 165.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -63.36 138.03 63.72 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.034 2.489 . . . . 0.0 107.592 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -79.97 -49.45 11.83 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 127.291 2.236 . . . . 0.0 111.469 12.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -156.58 145.08 19.86 Favored 'General case' 0 N--CA 1.417 -2.08 1 N-CA-C 94.538 -6.097 . . . . 0.0 94.538 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 12.0 m 172.11 -157.65 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 59' ' ' ILE . 5.6 m -125.83 159.04 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 1 N-CA-C 97.143 -5.132 . . . . 0.0 97.143 162.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.85 -175.74 5.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 162.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.03 170.62 14.68 Favored 'General case' 0 CA--C 1.481 -1.682 1 N-CA-C 96.638 -5.319 . . . . 0.0 96.638 176.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -160.42 169.04 23.89 Favored 'General case' 0 N--CA 1.412 -2.364 1 N-CA-C 98.754 -4.535 . . . . 0.0 98.754 -170.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.27 104.21 22.42 Favored Pre-proline 0 N--CA 1.416 -2.136 1 N-CA-C 93.085 -6.635 . . . . 0.0 93.085 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.95 101.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.306 0 CA-C-N 124.987 2.817 . . . . 0.0 118.138 -141.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.97 8.33 79.32 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -91.87 170.65 9.7 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -49.57 -36.69 24.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.704 2.002 . . . . 0.0 115.209 -169.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.33 -59.84 10.01 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 123.115 0.388 . . . . 0.0 112.642 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -79.57 -13.71 59.34 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 118.792 1.296 . . . . 0.0 109.611 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.21 -49.53 76.79 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -42.84 99.43 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.65 -38.86 90.54 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.856 1.207 . . . . 0.0 110.597 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -62.57 -48.78 77.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -57.76 -50.05 74.52 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.896 0.878 . . . . 0.0 112.268 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.4 -10.33 57.5 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -4.07 28.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.634 0.774 . . . . 0.0 110.016 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.14 37.91 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.51 114.99 4.28 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 m -101.9 -5.59 24.55 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.85 169.32 24.62 Favored 'General case' 0 N--CA 1.435 -1.197 1 N-CA-C 97.462 -5.014 . . . . 0.0 97.462 163.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.88 -177.8 42.45 Favored Glycine 0 CA--C 1.479 -2.181 0 N-CA-C 103.797 -3.721 . . . . 0.0 103.797 -174.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -163.48 -166.56 1.25 Allowed 'General case' 0 N--CA 1.433 -1.286 1 N-CA-C 97.229 -5.1 . . . . 0.0 97.229 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.8 m -154.71 163.28 40.47 Favored 'General case' 0 CA--C 1.484 -1.568 1 N-CA-C 98.938 -4.468 . . . . 0.0 98.938 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.55 -176.48 47.68 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 103.274 -3.93 . . . . 0.0 103.274 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.42 143.11 29.87 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 97.178 -5.119 . . . . 0.0 97.178 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -164.42 53.84 0.14 Allowed 'General case' 0 CA--C 1.491 -1.312 1 N-CA-C 97.357 -5.053 . . . . 0.0 97.357 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.301 1.5 t 57.76 -146.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 C-N-CA 125.628 1.571 . . . . 0.0 107.95 -160.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.04 -127.63 6.9 Favored Glycine 0 N--CA 1.424 -2.111 1 N-CA-C 98.915 -5.674 . . . . 0.0 98.915 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' H ' HG11 ' A' ' 13' ' ' VAL . 31.9 m170 -119.23 -10.02 9.83 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.19 -169.86 42.93 Favored Glycine 0 N--CA 1.423 -2.196 1 N-CA-C 98.168 -5.973 . . . . 0.0 98.168 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.59 128.63 36.86 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.91 171.37 8.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.1 t -113.46 166.91 11.04 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 100.856 -3.757 . . . . 0.0 100.856 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -132.15 148.78 52.49 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.4 m -142.18 154.05 44.52 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -120.25 136.03 54.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.72 56.19 0.18 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.588 2.355 . . . . 0.0 109.896 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.95 135.98 25.31 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -66.5 169.1 14.82 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.112 1.875 . . . . 0.0 112.098 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.8 -6.71 50.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -93.6 1.97 56.51 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 123.01 0.524 . . . . 0.0 110.061 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.06 133.85 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.04 151.55 19.49 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 105.766 -2.934 . . . . 0.0 105.766 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 pt -140.7 -166.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -72.47 140.56 17.79 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -172.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.26 160.8 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 1 N-CA-C 94.982 -5.933 . . . . 0.0 94.982 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.44 157.13 36.51 Favored 'General case' 0 N--CA 1.425 -1.696 1 N-CA-C 97.151 -5.129 . . . . 0.0 97.151 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.27 -45.05 1.17 Allowed Glycine 0 CA--C 1.491 -1.439 1 N-CA-C 100.132 -5.187 . . . . 0.0 100.132 -163.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' LYS . 26.0 tt0 -97.92 -143.74 0.3 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 101.18 -3.637 . . . . 0.0 101.18 155.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 40.8 tttp -169.06 -155.27 0.14 Allowed 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.266 -5.457 . . . . 0.0 96.266 173.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 42.2 t -60.05 134.64 57.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 125.762 1.625 . . . . 0.0 110.067 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -82.58 -163.26 0.67 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.083 0.944 . . . . 0.0 108.691 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.2 m -167.66 171.83 9.84 Favored 'General case' 0 N--CA 1.424 -1.759 1 N-CA-C 96.215 -5.476 . . . . 0.0 96.215 172.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.923 0 O-C-N 124.426 1.078 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 178.19 7.5 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -135.83 131.77 35.81 Favored 'General case' 0 CA--C 1.492 -1.274 1 N-CA-C 96.781 -5.266 . . . . 0.0 96.781 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -177.89 35.21 Favored Glycine 0 CA--C 1.479 -2.204 0 N-CA-C 103.909 -3.677 . . . . 0.0 103.909 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -74.73 131.71 41.05 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.5 130.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -99.22 -153.0 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 111.418 -2.628 . . . . 0.0 108.275 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -130.79 152.27 80.26 Favored Pre-proline 0 N--CA 1.422 -1.873 1 N-CA-C 95.834 -5.617 . . . . 0.0 95.834 174.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -70.87 151.39 62.7 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 CA-C-N 122.338 1.871 . . . . 0.0 109.841 -171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -96.31 -20.64 18.35 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 127.771 2.428 . . . . 0.0 106.662 3.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -154.01 148.11 25.74 Favored 'General case' 0 N--CA 1.407 -2.585 1 N-CA-C 95.509 -5.737 . . . . 0.0 95.509 172.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.78 -154.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -136.53 173.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 N-CA-C 97.566 -4.976 . . . . 0.0 97.566 166.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -161.39 0.81 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 167.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -136.75 151.87 49.7 Favored 'General case' 0 N--CA 1.418 -2.057 1 N-CA-C 95.023 -5.918 . . . . 0.0 95.023 167.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -160.77 -167.6 1.89 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.74 -5.652 . . . . 0.0 95.74 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.6 166.35 17.85 Favored Pre-proline 0 N--CA 1.415 -2.204 1 N-CA-C 98.05 -4.796 . . . . 0.0 98.05 -161.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -68.34 68.68 1.02 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 CA-C-N 124.094 2.498 . . . . 0.0 112.199 165.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.1 -179.83 46.98 Favored Glycine 0 N--CA 1.417 -2.567 1 N-CA-C 97.661 -6.176 . . . . 0.0 97.661 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -128.82 9.02 5.8 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -55.03 -43.53 73.81 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.891 1.676 . . . . 0.0 114.205 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.95 -49.69 5.52 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -50.36 -43.23 54.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.042 1.737 . . . . 0.0 113.177 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.9 -32.23 70.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.695 0.798 . . . . 0.0 110.593 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -78.97 -45.8 19.6 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 109.004 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.24 -41.15 86.1 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -63.06 -41.8 99.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.464 -0.773 . . . . 0.0 110.684 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.86 -35.17 67.14 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.277 -0.889 . . . . 0.0 111.49 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.59 -30.35 61.66 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.564 -0.71 . . . . 0.0 111.077 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -90.37 -6.82 54.56 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.213 0.605 . . . . 0.0 110.534 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.7 37.18 4.55 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 160.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.29 163.7 16.81 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 104.653 -3.379 . . . . 0.0 104.653 164.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.4 p -68.53 -56.13 9.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.515 1.15 . . . . 0.0 109.854 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -160.67 -172.62 3.59 Favored 'General case' 0 N--CA 1.424 -1.775 1 N-CA-C 98.904 -4.48 . . . . 0.0 98.904 168.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.04 -178.83 40.2 Favored Glycine 0 N--CA 1.415 -2.764 1 N-CA-C 98.529 -5.828 . . . . 0.0 98.529 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -161.56 -175.74 4.93 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.726 -4.916 . . . . 0.0 97.726 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -139.19 157.77 45.35 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 103.811 -2.662 . . . . 0.0 103.811 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.55 166.44 34.24 Favored Glycine 0 N--CA 1.429 -1.774 1 N-CA-C 95.847 -6.901 . . . . 0.0 95.847 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.95 132.08 56.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -129.67 36.08 4.12 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 42' ' ' GLY 0.284 11.5 t 70.1 -171.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -163.25 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.751 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 147.34 -130.37 3.54 Favored Glycine 0 N--CA 1.42 -2.386 1 N-CA-C 97.122 -6.391 . . . . 0.0 97.122 -168.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -114.5 -48.7 2.86 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.45 -178.74 23.83 Favored Glycine 0 N--CA 1.425 -2.083 1 N-CA-C 97.895 -6.082 . . . . 0.0 97.895 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 103.37 7.43 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.423 1.489 . . . . 0.0 107.294 -171.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.11 -166.46 1.5 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -117.49 151.79 36.39 Favored 'General case' 0 CA--C 1.489 -1.386 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -101.32 158.74 15.83 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.8 m -145.78 143.41 29.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.8 123.6 50.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 172.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.23 65.26 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.778 2.431 . . . . 0.0 109.315 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.95 138.68 20.67 Favored Pre-proline 0 CA--C 1.492 -1.271 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.534 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -66.48 161.3 41.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.749 2.299 . . . . 0.0 110.606 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.6 -15.21 59.89 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.059 0.543 . . . . 0.0 111.127 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -92.27 12.36 22.71 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 110.391 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.08 -158.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 101.439 -3.541 . . . . 0.0 101.439 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.03 163.39 33.75 Favored Glycine 0 CA--C 1.466 -3.001 1 N-CA-C 102.539 -4.224 . . . . 0.0 102.539 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -152.78 -170.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 101.168 -3.641 . . . . 0.0 101.168 -163.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 13' ' ' VAL . 4.0 mm -71.22 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.95 159.51 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -160.71 171.27 19.17 Favored 'General case' 0 N--CA 1.432 -1.347 1 N-CA-C 96.874 -5.232 . . . . 0.0 96.874 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.3 29.72 48.73 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 105.342 -3.103 . . . . 0.0 105.342 -152.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 175.07 -170.18 0.05 OUTLIER 'General case' 0 N--CA 1.423 -1.807 1 N-CA-C 95.293 -5.817 . . . . 0.0 95.293 -158.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -156.49 -176.67 6.09 Favored 'General case' 0 N--CA 1.435 -1.18 1 N-CA-C 96.94 -5.207 . . . . 0.0 96.94 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.83 130.71 48.12 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.68 1.582 . . . . 0.0 108.076 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -149.93 150.12 31.42 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 t -171.7 -179.93 2.64 Favored 'General case' 0 N--CA 1.421 -1.923 1 N-CA-C 96.316 -5.439 . . . . 0.0 96.316 -174.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 0.981 0 O-C-N 125.171 1.545 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 174.87 5.73 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.54 145.77 51.02 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 95.451 -5.759 . . . . 0.0 95.451 165.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 175.66 38.13 Favored Glycine 0 CA--C 1.479 -2.215 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 66.5 m-85 -80.4 131.64 35.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 155.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.87 138.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -106.75 -138.18 0.37 Allowed 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 127.493 2.317 . . . . 0.0 107.085 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -141.34 148.82 52.54 Favored Pre-proline 0 N--CA 1.415 -2.196 1 N-CA-C 94.553 -6.092 . . . . 0.0 94.553 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -67.52 143.8 64.4 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.641 2.228 . . . . 0.0 107.548 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -84.29 -33.06 24.05 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 127.897 2.479 . . . . 0.0 109.332 9.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -160.42 158.32 29.26 Favored 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 94.312 -6.181 . . . . 0.0 94.312 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 171.18 -152.5 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 1 N-CA-C 98.382 -4.673 . . . . 0.0 98.382 167.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.32 167.72 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 N-CA-C 96.287 -5.449 . . . . 0.0 96.287 158.891 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.87 -150.48 0.11 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -139.29 -175.36 4.15 Favored 'General case' 0 CA--C 1.484 -1.571 1 N-CA-C 96.619 -5.326 . . . . 0.0 96.619 163.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -147.93 173.81 12.5 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 96.608 -5.33 . . . . 0.0 96.608 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -129.65 126.11 22.55 Favored Pre-proline 0 N--CA 1.413 -2.317 1 N-CA-C 92.376 -6.898 . . . . 0.0 92.376 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -60.13 98.33 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 125.164 2.88 . . . . 0.0 114.855 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -167.01 35.33 Favored Glycine 0 N--CA 1.422 -2.249 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 p -91.44 -45.36 8.59 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -39.68 -70.62 0.1 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.218 2.207 . . . . 0.0 116.912 -151.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.58 -37.35 62.07 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.799 -1.188 . . . . 0.0 111.068 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -64.88 -51.47 61.77 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.914 1.286 . . . . 0.0 108.795 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.16 -41.39 96.68 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.896 0.878 . . . . 0.0 109.587 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.6 m -59.0 -47.7 84.24 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 121.333 -0.854 . . . . 0.0 111.756 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 mt -65.98 -42.3 90.03 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 123.387 0.675 . . . . 0.0 110.476 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.13 -49.53 73.65 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.38 1.472 . . . . 0.0 109.902 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -69.72 -35.57 75.14 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.27 -0.894 . . . . 0.0 111.339 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -74.76 -2.69 27.6 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.319 -0.863 . . . . 0.0 112.884 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.5 7.53 28.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.379 -0.825 . . . . 0.0 109.212 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.39 26.38 18.3 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.82 132.97 11.43 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 m -94.05 -15.88 24.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -166.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -160.61 179.19 8.78 Favored 'General case' 0 CA--C 1.493 -1.248 1 N-CA-C 99.337 -4.32 . . . . 0.0 99.337 168.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.5 -173.87 39.4 Favored Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 103.104 -3.998 . . . . 0.0 103.104 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -161.08 -162.31 0.9 Allowed 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 -174.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.9 t -136.17 164.92 26.92 Favored 'General case' 0 CA--C 1.489 -1.374 1 N-CA-C 96.202 -5.481 . . . . 0.0 96.202 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.04 -168.19 37.75 Favored Glycine 0 N--CA 1.425 -2.099 1 N-CA-C 102.053 -4.419 . . . . 0.0 102.053 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -148.14 144.68 27.95 Favored 'General case' 0 N--CA 1.428 -1.546 1 N-CA-C 96.368 -5.419 . . . . 0.0 96.368 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -126.89 109.96 12.53 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.73 136.12 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.57 -34.16 4.2 Favored Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 105.414 -3.074 . . . . 0.0 105.414 -170.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.34 -70.62 0.78 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.95 -153.03 23.81 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 106.819 -2.512 . . . . 0.0 106.819 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.64 137.89 55.95 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.164 2.186 . . . . 0.0 106.273 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.35 178.21 8.08 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 101.349 -3.574 . . . . 0.0 101.349 -168.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.22 165.94 13.2 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.651 -4.203 . . . . 0.0 99.651 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 6.4 t-105 -127.89 146.87 50.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -134.98 149.22 50.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.67 136.63 53.81 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 172.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.7 76.37 0.28 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 126.799 2.039 . . . . 0.0 111.522 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.16 141.22 22.11 Favored Pre-proline 0 CA--C 1.501 -0.913 0 N-CA-C 101.819 -3.4 . . . . 0.0 101.819 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.7 165.16 31.84 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.38 2.054 . . . . 0.0 109.595 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.8 -1.65 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.438 -0.789 . . . . 0.0 112.726 -160.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.49 -1.99 58.35 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.051 0.94 . . . . 0.0 109.533 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.65 134.41 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.96 148.44 16.55 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 104.295 -3.522 . . . . 0.0 104.295 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 pt -132.27 -150.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.6 mm -73.64 131.37 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.7 t -120.5 155.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 99.313 -4.329 . . . . 0.0 99.313 172.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -160.14 161.61 33.74 Favored 'General case' 0 CA--C 1.483 -1.615 1 N-CA-C 98.604 -4.591 . . . . 0.0 98.604 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.52 32.84 45.31 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 -147.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -178.07 -172.32 0.32 Allowed 'General case' 0 N--CA 1.424 -1.727 1 N-CA-C 96.167 -5.494 . . . . 0.0 96.167 -161.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.41 176.15 9.31 Favored 'General case' 0 N--CA 1.428 -1.557 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 -175.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 30.1 t -60.11 133.01 55.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 128.338 2.655 . . . . 0.0 111.14 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.321 96.4 m-70 60.68 -137.27 0.62 Allowed 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.942 2.097 . . . . 0.0 109.731 -164.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -77.56 59.79 2.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.326 0.65 . . . . 0.0 111.09 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.062 0 CA-C-N 116.022 -0.535 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -174.57 4.56 Favored 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 98.192 -4.744 . . . . 0.0 98.192 172.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -133.74 143.17 48.3 Favored 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.143 -4.762 . . . . 0.0 98.143 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.32 23.86 Favored Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -81.87 136.65 35.34 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 163.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 tt -90.55 146.83 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.333 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.09 178.19 10.3 Favored 'General case' 0 N--CA 1.401 -2.88 1 N-CA-C 96.949 -5.204 . . . . 0.0 96.949 -163.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -93.21 161.01 32.24 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -64.07 116.85 3.95 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.089 1.859 . . . . 0.0 109.812 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -145.52 139.2 26.6 Favored 'General case' 0 CA--C 1.481 -1.703 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 2.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 65' ' ' CYS . 27.8 t-20 86.1 -26.95 0.09 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 127.162 2.185 . . . . 0.0 110.138 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.2 m -87.24 111.63 21.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -157.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.04 171.97 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-O 124.544 2.116 . . . . 0.0 114.654 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.76 -154.78 0.49 Allowed 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.533 -2.576 . . . . 0.0 104.337 -173.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.9 177.61 8.23 Favored 'General case' 0 N--CA 1.417 -2.12 1 N-CA-C 95.756 -5.646 . . . . 0.0 95.756 162.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' HD22 ' A' ' 45' ' ' LEU . 11.5 t -142.7 159.21 42.68 Favored 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 95.153 -5.869 . . . . 0.0 95.153 -174.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.0 121.42 25.44 Favored Pre-proline 0 N--CA 1.415 -2.18 1 N-CA-C 93.235 -6.58 . . . . 0.0 93.235 168.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -68.29 67.69 1.03 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 CA-C-N 123.604 2.323 . . . . 0.0 114.787 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.93 161.5 32.73 Favored Glycine 0 N--CA 1.424 -2.159 1 N-CA-C 100.031 -5.228 . . . . 0.0 100.031 175.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 m -63.3 -39.76 95.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.919 0.887 . . . . 0.0 112.156 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -62.33 -27.16 68.85 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -168.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -77.19 1.33 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 168.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.19 -37.29 79.79 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.855 0.862 . . . . 0.0 113.238 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -73.26 -46.79 47.97 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 m -54.86 -46.0 74.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.829 0.851 . . . . 0.0 111.383 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.13 -35.23 79.28 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 123.49 0.716 . . . . 0.0 111.637 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -69.98 -48.85 56.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 109.207 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -60.95 -45.59 94.12 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 121.822 -0.549 . . . . 0.0 110.865 -174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.73 -13.84 62.64 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -0.1 37.53 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.66 26.42 13.28 Favored Glycine 0 CA--C 1.491 -1.442 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.012 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.78 138.53 14.43 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.7 p -84.46 -29.67 25.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.764 0.793 . . . . 0.0 109.589 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.45 158.53 29.55 Favored 'General case' 0 N--CA 1.421 -1.889 1 N-CA-C 98.726 -4.546 . . . . 0.0 98.726 -166.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.33 -177.43 47.85 Favored Glycine 0 N--CA 1.424 -2.104 1 N-CA-C 100.346 -5.102 . . . . 0.0 100.346 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -173.17 -176.73 1.42 Allowed 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 100.311 -3.959 . . . . 0.0 100.311 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.3 t -90.22 163.46 14.79 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.77 -175.04 37.93 Favored Glycine 0 CA--C 1.479 -2.168 1 N-CA-C 99.308 -5.517 . . . . 0.0 99.308 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -131.0 148.25 52.73 Favored 'General case' 0 N--CA 1.433 -1.289 1 N-CA-C 99.437 -4.282 . . . . 0.0 99.437 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -115.65 94.38 4.67 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.81 120.2 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.63 -22.83 7.66 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -121.83 -72.11 0.7 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.03 -159.54 32.64 Favored Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 105.706 -2.958 . . . . 0.0 105.706 -169.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 16' ' ' CYS . 1.8 mt -78.26 150.73 33.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.385 -2.821 . . . . 0.0 103.385 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.33 173.84 15.66 Favored 'General case' 0 CA--C 1.485 -1.554 1 N-CA-C 98.69 -4.559 . . . . 0.0 98.69 -174.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -116.14 164.6 14.23 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -106.34 146.56 30.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 m -141.92 147.44 37.07 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.7 138.8 47.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.43 68.98 0.77 Allowed 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.788 2.035 . . . . 0.0 112.326 169.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mt -99.57 148.86 35.3 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -66.64 167.97 17.82 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.591 2.194 . . . . 0.0 112.366 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -81.76 4.08 23.37 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -103.21 13.4 34.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.83 152.77 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 167.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.41 158.26 27.61 Favored Glycine 0 CA--C 1.48 -2.099 1 N-CA-C 98.304 -5.918 . . . . 0.0 98.304 -176.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.19 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 -151.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.8 mm -68.26 131.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.62 136.87 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 1 N-CA-C 90.335 -7.654 . . . . 0.0 90.335 -174.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -164.2 166.22 21.3 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 98.771 -4.529 . . . . 0.0 98.771 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.42 27.71 42.58 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 104.879 -3.288 . . . . 0.0 104.879 -146.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -176.21 -169.93 0.34 Allowed 'General case' 0 N--CA 1.424 -1.769 1 N-CA-C 95.879 -5.6 . . . . 0.0 95.879 -168.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -156.05 -179.69 8.39 Favored 'General case' 0 N--CA 1.427 -1.619 1 N-CA-C 96.87 -5.233 . . . . 0.0 96.87 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.1 t -55.39 129.4 38.45 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 127.333 2.253 . . . . 0.0 111.779 -170.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -154.27 160.63 41.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 m -78.11 56.98 1.72 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.07 1.348 . . . . 0.0 112.996 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.001 0 CA-C-N 116.435 -0.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.185 0.517 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 179.12 7.05 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 169.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -133.09 140.51 47.7 Favored 'General case' 0 CA--C 1.49 -1.335 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -176.18 33.77 Favored Glycine 0 CA--C 1.482 -2.008 0 N-CA-C 106.547 -2.621 . . . . 0.0 106.547 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -77.36 130.7 37.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 161.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.254 15.5 tt -90.41 136.2 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.41 -168.39 2.09 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 129.149 2.98 . . . . 0.0 109.383 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -145.91 158.63 48.69 Favored Pre-proline 0 N--CA 1.423 -1.819 1 N-CA-C 95.85 -5.611 . . . . 0.0 95.85 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.18 146.59 90.73 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 123.065 2.13 . . . . 0.0 112.26 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.63 -53.22 4.9 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 126.621 1.968 . . . . 0.0 107.721 7.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -142.74 137.67 29.96 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 91.947 -7.057 . . . . 0.0 91.947 168.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 9.6 m -177.47 -162.76 0.07 Allowed 'General case' 0 CA--C 1.483 -1.628 1 N-CA-C 98.735 -4.543 . . . . 0.0 98.735 -169.33 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -117.92 163.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 1 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 166.45 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -169.21 1.95 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 159.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -135.01 167.53 20.78 Favored 'General case' 0 CA--C 1.477 -1.86 1 N-CA-C 97.104 -5.147 . . . . 0.0 97.104 173.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -136.58 160.94 37.28 Favored 'General case' 0 N--CA 1.421 -1.92 1 N-CA-C 96.517 -5.364 . . . . 0.0 96.517 -165.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -112.73 116.54 47.76 Favored Pre-proline 0 N--CA 1.422 -1.858 1 N-CA-C 95.067 -5.901 . . . . 0.0 95.067 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -59.37 101.76 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.676 0 CA-C-N 125.004 2.823 . . . . 0.0 115.32 -161.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.15 -171.3 37.15 Favored Glycine 0 N--CA 1.42 -2.387 1 N-CA-C 98.308 -5.917 . . . . 0.0 98.308 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 -35.99 14.6 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.445 0.622 . . . . 0.0 110.499 -172.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -53.25 35.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.496 2.319 . . . . 0.0 116.034 -159.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.75 -42.38 31.73 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.5 -42.79 86.82 Favored 'General case' 0 CA--C 1.482 -1.644 0 O-C-N 122.148 -0.619 . . . . 0.0 110.988 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.36 -39.33 93.67 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.2 m -63.05 -47.21 83.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.818 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -40.07 95.78 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.783 0.801 . . . . 0.0 110.1 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.39 -42.81 82.94 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.26 1.024 . . . . 0.0 110.823 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.86 -47.79 84.77 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 122.878 0.471 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.95 -14.9 60.24 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -96.26 -6.84 37.03 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.733 -0.605 . . . . 0.0 111.061 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.44 27.25 12.03 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.51 151.87 19.09 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.726 -3.349 . . . . 0.0 104.726 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.0 p -84.85 -34.42 22.67 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -169.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.55 152.84 34.75 Favored 'General case' 0 N--CA 1.423 -1.8 1 N-CA-C 99.992 -4.077 . . . . 0.0 99.992 -161.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.89 42.18 Favored Glycine 0 CA--C 1.475 -2.444 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -166.49 -158.74 0.33 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 101.49 -3.522 . . . . 0.0 101.49 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.98 161.18 21.35 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -178.86 41.91 Favored Glycine 0 N--CA 1.422 -2.246 1 N-CA-C 102.214 -4.354 . . . . 0.0 102.214 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -138.07 139.64 39.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 100.389 -3.93 . . . . 0.0 100.389 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -115.48 99.02 7.06 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.82 120.05 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.14 -32.22 3.16 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.782 -2.927 . . . . 0.0 105.782 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.21 -70.3 0.81 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.15 -159.81 32.69 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 104.973 -3.251 . . . . 0.0 104.973 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.53 140.64 58.89 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.453 2.301 . . . . 0.0 106.849 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.86 -179.77 6.13 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -171.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.4 m -113.24 168.2 9.93 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 101.451 -3.537 . . . . 0.0 101.451 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.2 t-105 -121.93 148.38 44.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.07 150.02 45.25 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.14 147.2 43.57 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 103.233 -2.876 . . . . 0.0 103.233 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.02 51.47 0.95 Allowed 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 126.953 2.101 . . . . 0.0 110.972 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.84 133.71 28.69 Favored Pre-proline 0 CA--C 1.499 -0.984 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.0 175.5 11.32 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.266 1.978 . . . . 0.0 110.444 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.08 4.63 16.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -95.86 3.62 53.5 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.182 -0.948 . . . . 0.0 108.813 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -104.58 178.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -155.58 164.13 31.96 Favored Glycine 0 CA--C 1.482 -1.974 1 N-CA-C 98.412 -5.875 . . . . 0.0 98.412 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 pt -155.62 -172.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -163.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER -68.9 118.87 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 CA-C-O 122.077 0.942 . . . . 0.0 111.937 -160.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.76 155.18 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 166.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -147.87 153.63 39.37 Favored 'General case' 0 N--CA 1.426 -1.651 1 N-CA-C 96.686 -5.301 . . . . 0.0 96.686 171.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.41 -43.74 1.31 Allowed Glycine 0 CA--C 1.489 -1.551 1 N-CA-C 100.145 -5.182 . . . . 0.0 100.145 -161.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.81 -143.76 0.32 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 155.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -162.98 -141.69 0.06 Allowed 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 98.22 -4.733 . . . . 0.0 98.22 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 40.4 t -84.34 125.36 32.21 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -138.69 143.14 39.01 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 171.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 t -173.49 -179.98 1.98 Allowed 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 96.357 -5.423 . . . . 0.0 96.357 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.884 0 O-C-N 124.767 1.292 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.627 0.727 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -116.96 154.6 30.59 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -137.89 128.59 26.81 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 97.425 -5.028 . . . . 0.0 97.425 168.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -170.99 27.45 Favored Glycine 0 CA--C 1.476 -2.363 1 N-CA-C 102.306 -4.318 . . . . 0.0 102.306 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.57 135.46 39.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 160.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.51 141.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.44 -138.89 0.36 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.582 -2.099 . . . . 0.0 107.029 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 64.0 mt-30 -140.93 161.19 55.19 Favored Pre-proline 0 N--CA 1.423 -1.783 1 N-CA-C 95.526 -5.731 . . . . 0.0 95.526 169.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -67.31 144.5 68.41 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 122.765 2.023 . . . . 0.0 108.588 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.62 -42.36 8.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.455 2.302 . . . . 0.0 107.744 7.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.62 146.02 37.41 Favored 'General case' 0 N--CA 1.419 -1.986 1 N-CA-C 92.92 -6.696 . . . . 0.0 92.92 173.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -177.75 -163.98 0.08 Allowed 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.561 HG11 ' H ' ' A' ' 43' ' ' HIS . 3.5 m -128.65 164.11 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.729 1 N-CA-C 96.789 -5.263 . . . . 0.0 96.789 156.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -173.47 4.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 160.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -134.96 147.1 49.66 Favored 'General case' 0 CA--C 1.466 -2.256 1 N-CA-C 93.823 -6.362 . . . . 0.0 93.823 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -160.57 -165.82 1.5 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.081 -5.896 . . . . 0.0 95.081 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -141.22 173.18 5.11 Favored Pre-proline 0 N--CA 1.418 -2.04 1 N-CA-C 99.974 -4.084 . . . . 0.0 99.974 -161.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.52 55.51 3.7 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 C-N-CA 123.035 2.49 . . . . 0.0 110.754 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.69 141.11 4.57 Favored Glycine 0 N--CA 1.42 -2.375 1 N-CA-C 99.363 -5.495 . . . . 0.0 99.363 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 24.93 0.5 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.809 1.644 . . . . 0.0 112.667 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -59.16 -49.46 77.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.663 1.985 . . . . 0.0 112.492 -161.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.87 -25.83 26.12 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -82.85 -8.94 59.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.538 -0.977 . . . . 0.0 110.853 -167.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.46 -57.21 10.61 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.324 1.05 . . . . 0.0 108.98 166.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -52.1 67.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.465 1.106 . . . . 0.0 112.419 171.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.89 -43.25 93.52 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.801 0.81 . . . . 0.0 111.856 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.0 t -62.8 -43.13 99.6 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 108.957 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -78.59 -27.48 45.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.398 -0.814 . . . . 0.0 111.601 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.85 -20.13 53.61 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.182 -0.949 . . . . 0.0 111.334 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -88.06 -22.48 24.16 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.76 33.48 2.42 Favored Glycine 0 CA--C 1.488 -1.595 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 163.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.21 150.83 19.74 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -96.96 -17.92 19.78 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.671 0.748 . . . . 0.0 109.833 -165.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 m -160.75 168.27 25.14 Favored 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 98.979 -4.452 . . . . 0.0 98.979 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.37 176.66 44.57 Favored Glycine 0 N--CA 1.419 -2.452 1 N-CA-C 100.855 -4.898 . . . . 0.0 100.855 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -168.93 -168.77 0.89 Allowed 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 97.35 -5.056 . . . . 0.0 97.35 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -142.43 166.05 25.74 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.44 -176.61 44.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 103.135 -3.986 . . . . 0.0 103.135 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -130.95 121.96 26.05 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 99.539 -4.245 . . . . 0.0 99.539 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -139.33 59.81 1.59 Allowed 'General case' 0 CA--C 1.487 -1.444 1 N-CA-C 99.404 -4.295 . . . . 0.0 99.404 171.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 42' ' ' GLY 0.293 1.5 t 56.47 -152.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 127.512 2.325 . . . . 0.0 108.204 -165.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 119.82 -128.76 7.69 Favored Glycine 0 N--CA 1.425 -2.072 1 N-CA-C 100.065 -5.214 . . . . 0.0 100.065 -170.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.561 ' H ' HG11 ' A' ' 13' ' ' VAL . 2.0 m-70 -118.55 -19.65 8.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 125.452 1.501 . . . . 0.0 107.307 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.86 -174.14 46.59 Favored Glycine 0 N--CA 1.426 -1.995 1 N-CA-C 97.625 -6.19 . . . . 0.0 97.625 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -69.16 132.71 46.97 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.06 -169.7 2.03 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -163.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.6 t -123.25 159.51 28.56 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -113.41 151.43 31.37 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.8 m -144.5 150.87 38.3 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -110.53 144.15 39.81 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.79 54.96 4.88 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.748 2.419 . . . . 0.0 112.682 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.18 144.62 38.84 Favored Pre-proline 0 CA--C 1.499 -0.991 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -64.9 162.82 30.62 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.576 2.184 . . . . 0.0 112.209 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.97 -28.03 63.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.103 1.761 . . . . 0.0 114.101 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -98.24 15.82 23.32 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.23 1.012 . . . . 0.0 110.652 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 138.83 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 151.53 18.21 Favored Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 104.31 -3.516 . . . . 0.0 104.31 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.82 -159.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 13' ' ' VAL . 2.0 mm -72.54 130.78 35.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.147 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.13 134.93 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 100.86 -3.756 . . . . 0.0 100.86 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 58.6 -129.72 1.31 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.904 1.281 . . . . 0.0 108.811 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -157.96 55.58 0.37 Allowed Glycine 0 CA--C 1.482 -2.017 1 N-CA-C 98.986 -5.646 . . . . 0.0 98.986 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -98.48 -103.92 0.2 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -166.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -155.37 170.31 22.2 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 -164.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 54.0 t -96.3 150.38 20.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -154.47 153.22 31.15 Favored 'General case' 0 CA--C 1.486 -1.511 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 168.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.3 m -152.47 163.38 39.66 Favored 'General case' 0 N--CA 1.421 -1.876 1 N-CA-C 95.662 -5.681 . . . . 0.0 95.662 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.923 0 O-C-N 124.402 1.064 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.59 165.38 11.86 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 171.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.15 137.91 53.62 Favored 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 94.305 -6.183 . . . . 0.0 94.305 153.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -176.7 34.23 Favored Glycine 0 CA--C 1.474 -2.496 1 N-CA-C 102.956 -4.058 . . . . 0.0 102.956 177.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 41.9 m-85 -76.86 135.52 38.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 161.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -90.4 138.44 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -176.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.57 -135.91 0.34 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.425 -1.716 . . . . 0.0 106.931 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -136.34 159.08 72.11 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 96.156 -5.498 . . . . 0.0 96.156 169.065 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -69.14 148.57 69.37 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.011 1.807 . . . . 0.0 109.421 174.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -82.15 -29.19 31.74 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 127.42 2.288 . . . . 0.0 108.315 -3.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -155.57 165.34 36.88 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 178.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 157.62 -147.0 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.58 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.571 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 59' ' ' ILE . 17.3 m -135.0 166.9 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 1 N-CA-C 98.352 -4.684 . . . . 0.0 98.352 161.842 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -170.9 2.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 165.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -136.24 149.54 48.57 Favored 'General case' 0 CA--C 1.479 -1.757 1 N-CA-C 98.53 -4.618 . . . . 0.0 98.53 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -125.59 162.65 24.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 101.922 -3.362 . . . . 0.0 101.922 -168.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -114.06 112.81 46.96 Favored Pre-proline 0 N--CA 1.421 -1.898 1 N-CA-C 98.765 -4.531 . . . . 0.0 98.765 168.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.53 118.53 5.46 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 CA-C-N 123.314 2.219 . . . . 0.0 111.47 -171.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.28 -45.73 0.57 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 99.874 -5.291 . . . . 0.0 99.874 -165.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m 115.17 -35.33 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 129.362 3.065 . . . . 0.0 107.003 168.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -40.15 -53.78 2.4 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.326 2.65 . . . . 0.0 116.459 -156.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.16 -36.7 56.05 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 121.369 -0.832 . . . . 0.0 111.607 -176.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -86.29 -26.13 25.11 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 120.963 -1.316 . . . . 0.0 109.072 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.65 -36.48 84.38 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.999 0.919 . . . . 0.0 108.83 170.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 m -66.23 -42.21 88.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.382 -0.824 . . . . 0.0 110.336 173.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.46 -38.97 92.89 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 121.002 -1.061 . . . . 0.0 110.869 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 t -54.28 -42.78 70.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.515 1.126 . . . . 0.0 111.009 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.71 -44.85 92.42 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 122.022 -0.424 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.22 -28.39 63.14 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.487 0.585 . . . . 0.0 111.91 -176.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.91 -19.04 49.04 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.853 -0.53 . . . . 0.0 110.435 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.47 35.46 2.86 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 164.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.22 138.45 13.91 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 167.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 p -98.05 3.14 49.36 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.851 -0.794 . . . . 0.0 110.036 -168.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -160.36 166.46 29.33 Favored 'General case' 0 CA--C 1.48 -1.716 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.98 175.75 46.48 Favored Glycine 0 CA--C 1.469 -2.831 1 N-CA-C 99.73 -5.348 . . . . 0.0 99.73 -177.272 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -168.91 -153.78 0.12 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 96.269 -5.456 . . . . 0.0 96.269 -172.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -149.98 166.15 30.51 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.57 -4.974 . . . . 0.0 97.57 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.2 171.41 41.92 Favored Glycine 0 CA--C 1.48 -2.126 1 N-CA-C 96.154 -6.778 . . . . 0.0 96.154 176.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -146.5 137.32 24.12 Favored 'General case' 0 CA--C 1.483 -1.607 1 N-CA-C 99.251 -4.352 . . . . 0.0 99.251 -175.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -158.57 56.18 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.32 1.4 t 55.62 -144.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 125.859 1.664 . . . . 0.0 108.215 -158.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.41 -131.04 5.36 Favored Glycine 0 CA--C 1.474 -2.492 1 N-CA-C 94.86 -7.296 . . . . 0.0 94.86 -169.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.54 ' H ' HG11 ' A' ' 13' ' ' VAL . 51.2 m170 -123.34 10.82 9.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.98 -49.18 0.29 Allowed Glycine 0 CA--C 1.486 -1.737 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -171.33 -176.52 1.89 Allowed 'General case' 0 N--CA 1.437 -1.096 1 N-CA-C 95.848 -5.612 . . . . 0.0 95.848 -175.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.92 174.98 4.59 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 99.089 -4.412 . . . . 0.0 99.089 174.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 29.6 m -123.31 -174.16 2.89 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 171.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 18.4 t-105 -132.01 152.62 51.04 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -177.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.7 m -145.13 155.11 43.11 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -119.27 140.77 49.72 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 172.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.19 55.77 1.07 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 127.356 2.262 . . . . 0.0 111.38 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.35 130.99 37.68 Favored Pre-proline 0 CA--C 1.496 -1.123 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -70.69 176.2 7.81 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.339 2.026 . . . . 0.0 111.069 177.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -84.68 19.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -99.53 -6.16 27.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.2 t -99.06 173.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -145.58 156.86 27.15 Favored Glycine 0 CA--C 1.48 -2.141 1 N-CA-C 97.914 -6.075 . . . . 0.0 97.914 -175.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 pt -150.76 -167.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 101.926 -3.361 . . . . 0.0 101.926 -166.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.738 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -70.03 133.97 30.92 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -171.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.92 126.4 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 162.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -96.47 -44.12 7.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 118.646 0.657 . . . . 0.0 111.515 -168.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 62.32 4.37 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -170.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -162.23 -66.28 0.05 Allowed 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 -176.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.8 tptt 127.92 -139.79 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 96.545 -5.354 . . . . 0.0 96.545 -170.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.75 148.18 24.67 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.67 130.05 39.61 Favored 'General case' 0 CA--C 1.483 -1.601 1 N-CA-C 92.975 -6.676 . . . . 0.0 92.975 168.309 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 p -88.12 -67.21 0.84 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 1.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.139 0.495 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.88 171.39 7.93 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 172.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -135.82 133.72 38.15 Favored 'General case' 0 CA--C 1.489 -1.379 1 N-CA-C 96.421 -5.399 . . . . 0.0 96.421 168.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.8 -177.26 34.71 Favored Glycine 0 CA--C 1.478 -2.277 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 36.2 m-85 -73.91 133.75 43.14 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.19 136.89 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.81 -146.14 0.3 Allowed 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 126.718 2.007 . . . . 0.0 107.295 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -133.86 147.14 63.02 Favored Pre-proline 0 N--CA 1.423 -1.8 1 N-CA-C 94.408 -6.145 . . . . 0.0 94.408 164.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.54 145.1 63.27 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 CA-C-N 123.21 2.182 . . . . 0.0 108.089 177.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.57 -44.43 15.87 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 120.902 1.683 . . . . 0.0 111.79 7.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -152.92 149.59 28.39 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 94.489 -6.115 . . . . 0.0 94.489 177.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.32 -158.9 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.437 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 -179.006 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -123.76 161.1 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 1 N-CA-C 98.739 -4.541 . . . . 0.0 98.739 161.758 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -162.36 0.6 Allowed 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 162.143 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -137.87 166.49 23.9 Favored 'General case' 0 N--CA 1.426 -1.669 1 N-CA-C 96.89 -5.226 . . . . 0.0 96.89 162.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.4 t -119.95 169.82 9.83 Favored 'General case' 0 N--CA 1.419 -1.978 1 N-CA-C 99.041 -4.429 . . . . 0.0 99.041 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.24 131.0 24.02 Favored Pre-proline 0 N--CA 1.421 -1.911 1 N-CA-C 98.03 -4.804 . . . . 0.0 98.03 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -69.08 37.62 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 123.145 2.563 . . . . 0.0 114.715 174.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.86 142.8 9.45 Favored Glycine 0 N--CA 1.426 -2.007 1 N-CA-C 96.084 -6.806 . . . . 0.0 96.084 177.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.1 -41.69 98.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.928 1.291 . . . . 0.0 113.962 -157.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -53.38 9.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 128.407 2.683 . . . . 0.0 115.592 -163.214 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -50.78 32.21 Favored Glycine 0 C--N 1.349 1.288 0 O-C-N 121.945 -0.472 . . . . 0.0 112.14 -166.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.12 -18.91 55.05 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -58.34 -53.72 55.16 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -39.31 93.99 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.32 -37.95 86.55 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.922 0.783 . . . . 0.0 111.261 -179.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -65.9 -45.78 80.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.614 -0.679 . . . . 0.0 109.98 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -65.15 -41.32 94.85 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.957 -0.464 . . . . 0.0 111.916 -178.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.9 -17.35 63.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.166 -0.959 . . . . 0.0 112.188 -175.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -95.72 -6.29 40.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.66 0.784 . . . . 0.0 110.046 176.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.89 32.7 17.3 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.0 151.15 17.96 Favored Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 104.066 -3.614 . . . . 0.0 104.066 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.7 p -73.45 -55.07 6.83 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.029 0.919 . . . . 0.0 109.999 -168.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -160.63 -177.03 5.91 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 98.184 -4.746 . . . . 0.0 98.184 166.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.56 176.44 44.1 Favored Glycine 0 N--CA 1.416 -2.684 1 N-CA-C 99.838 -5.305 . . . . 0.0 99.838 -171.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -146.31 178.49 8.2 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 100.466 -3.902 . . . . 0.0 100.466 -172.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.6 m -83.79 171.76 12.84 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 119.14 0.882 . . . . 0.0 109.771 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.12 -179.07 45.45 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 103.13 -3.988 . . . . 0.0 103.13 -172.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -147.72 152.71 38.23 Favored 'General case' 0 N--CA 1.427 -1.598 1 N-CA-C 97.298 -5.075 . . . . 0.0 97.298 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -136.84 106.07 6.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 172.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.43 122.29 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.72 -40.69 1.43 Allowed Glycine 0 CA--C 1.482 -2.005 1 N-CA-C 102.62 -4.192 . . . . 0.0 102.62 -166.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -123.76 -67.6 0.92 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.95 -157.51 30.02 Favored Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 -169.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -70.71 139.03 51.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.3 -173.46 3.34 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -167.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -129.4 177.3 7.29 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.815 -3.772 . . . . 0.0 100.815 169.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 30.1 t-105 -122.3 160.48 25.23 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.5 m -148.65 151.77 35.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 167.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.97 129.92 56.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.31 66.89 0.1 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 127.64 2.376 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.5 mt -103.11 137.96 19.41 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.12 170.86 18.81 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.745 2.296 . . . . 0.0 110.402 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.75 -5.68 42.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 124.164 0.986 . . . . 0.0 113.583 -168.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -88.91 3.7 50.49 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.288 -0.883 . . . . 0.0 109.551 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.05 136.05 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.33 154.94 18.54 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.347 -2.301 . . . . 0.0 107.347 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.89 -171.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 -172.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -73.86 141.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 123.395 0.678 . . . . 0.0 109.581 -169.222 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.45 155.11 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 1 N-CA-C 98.089 -4.782 . . . . 0.0 98.089 178.69 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -144.14 152.92 41.56 Favored 'General case' 0 N--CA 1.426 -1.663 1 N-CA-C 95.3 -5.815 . . . . 0.0 95.3 166.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.96 -42.0 1.6 Allowed Glycine 0 CA--C 1.489 -1.586 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -163.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -99.36 -136.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 153.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -163.66 -165.2 1.0 Allowed 'General case' 0 N--CA 1.427 -1.61 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.74 125.17 22.6 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -143.72 154.22 43.25 Favored 'General case' 0 CA--C 1.475 -1.928 1 N-CA-C 97.19 -5.115 . . . . 0.0 97.19 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m 179.78 174.53 0.84 Allowed 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 96.132 -5.507 . . . . 0.0 96.132 179.348 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.903 0 CA-C-N 119.341 0.973 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.254 0.55 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 178.8 4.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 167.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -128.74 148.02 50.81 Favored 'General case' 0 N--CA 1.431 -1.397 1 N-CA-C 95.245 -5.835 . . . . 0.0 95.245 166.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.31 170.59 37.13 Favored Glycine 0 CA--C 1.48 -2.133 0 C-N-CA 117.845 -2.121 . . . . 0.0 109.017 -175.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -82.11 121.82 27.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 159.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 tt -90.5 143.27 11.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.089 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -174.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -115.59 -154.52 0.55 Allowed 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 128.995 2.918 . . . . 0.0 108.858 -175.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.32 165.58 30.72 Favored Pre-proline 0 N--CA 1.425 -1.708 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 170.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 44.0 Cg_exo -62.19 126.49 18.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.748 2.965 . . . . 0.0 112.871 -173.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 3.2 mm-40 -133.77 138.07 45.52 Favored 'General case' 0 CA--C 1.467 -2.24 1 N-CA-C 96.33 -5.433 . . . . 0.0 96.33 -10.685 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.6 t30 68.36 30.25 5.54 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 119.351 0.978 . . . . 0.0 111.626 175.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.23 -159.9 0.76 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 168.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -133.95 162.84 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 1 N-CA-C 96.55 -5.352 . . . . 0.0 96.55 170.563 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -168.02 2.09 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 162.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -138.08 146.09 42.51 Favored 'General case' 0 CA--C 1.469 -2.161 1 N-CA-C 96.214 -5.476 . . . . 0.0 96.214 168.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.55 175.2 6.84 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -112.29 130.49 23.28 Favored Pre-proline 0 N--CA 1.421 -1.882 1 N-CA-C 93.976 -6.305 . . . . 0.0 93.976 165.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.92 37.98 0.11 Allowed 'Trans proline' 0 C--N 1.331 -0.369 0 CA-C-N 125.679 3.064 . . . . 0.0 116.024 177.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.55 108.97 0.49 Allowed Glycine 0 N--CA 1.422 -2.243 1 N-CA-C 94.734 -7.346 . . . . 0.0 94.734 170.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -52.42 -36.8 55.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.313 2.245 . . . . 0.0 115.042 -157.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -44.79 -39.35 5.18 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.854 2.462 . . . . 0.0 116.659 -170.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.41 -46.13 87.31 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 120.776 -1.202 . . . . 0.0 112.05 -177.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.65 -25.09 28.75 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 122.18 -0.6 . . . . 0.0 109.621 -175.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.82 -39.25 91.12 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.096 0.558 . . . . 0.0 109.971 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -63.81 -41.97 97.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.464 175.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.0 mt -63.94 -40.44 96.43 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 121.953 0.883 . . . . 0.0 110.667 177.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.6 t -57.86 -47.38 82.88 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.208 1.403 . . . . 0.0 110.575 175.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.04 -42.41 80.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 122.681 0.393 . . . . 0.0 111.024 -176.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.02 -23.6 60.63 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.727 -0.608 . . . . 0.0 111.928 -175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.95 -49.21 11.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.073 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.92 48.81 0.16 Allowed Glycine 0 CA--C 1.49 -1.518 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 168.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.13 143.55 15.79 Favored Glycine 0 CA--C 1.487 -1.673 1 N-CA-C 101.35 -4.7 . . . . 0.0 101.35 157.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 p -75.12 -28.6 60.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 118.385 1.092 . . . . 0.0 110.77 -164.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.9 m -160.56 173.42 15.55 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.92 -176.96 42.75 Favored Glycine 0 N--CA 1.418 -2.542 1 N-CA-C 98.786 -5.726 . . . . 0.0 98.786 -172.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -171.16 -174.71 1.54 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 -170.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.4 m -81.03 169.71 17.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 119.153 0.888 . . . . 0.0 109.134 -178.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.88 164.51 34.25 Favored Glycine 0 N--CA 1.416 -2.693 1 N-CA-C 98.465 -5.854 . . . . 0.0 98.465 175.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -135.8 154.77 51.1 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 97.21 -5.108 . . . . 0.0 97.21 177.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.92 179.21 9.29 Favored 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 97.503 -4.999 . . . . 0.0 97.503 174.935 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.63 163.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 1 N-CA-C 97.968 -4.827 . . . . 0.0 97.968 178.173 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.39 -46.85 1.1 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 102.564 -4.214 . . . . 0.0 102.564 -170.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -119.46 -79.65 0.6 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 170.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.22 -147.26 12.82 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 103.28 -3.928 . . . . 0.0 103.28 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.59 132.91 54.64 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.51 2.324 . . . . 0.0 108.066 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.11 -173.34 3.7 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 102.201 -3.259 . . . . 0.0 102.201 -164.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.31 172.05 9.41 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 169.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -129.31 147.9 51.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.7 m -143.28 146.97 34.06 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -114.69 145.46 42.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.5 55.44 0.5 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 126.578 1.951 . . . . 0.0 111.064 172.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.05 138.69 20.35 Favored Pre-proline 0 CA--C 1.501 -0.908 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -66.42 165.95 23.23 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.45 2.1 . . . . 0.0 111.773 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -73.86 -19.1 60.83 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.328 0.651 . . . . 0.0 112.27 -169.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -92.29 18.55 8.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 109.73 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.05 133.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 100.533 -3.877 . . . . 0.0 100.533 167.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.92 146.57 18.64 Favored Glycine 0 CA--C 1.479 -2.172 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.69 -141.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -156.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.8 120.62 28.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 169.14 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.9 -33.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -163.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 35.0 tt0 -155.43 -136.98 0.06 Allowed 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 96.542 -5.355 . . . . 0.0 96.542 176.178 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . -168.55 52.08 0.22 Allowed Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 103.535 -3.826 . . . . 0.0 103.535 171.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.73 -57.51 2.02 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -172.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -158.14 157.04 31.98 Favored 'General case' 0 N--CA 1.423 -1.788 1 N-CA-C 97.195 -5.113 . . . . 0.0 97.195 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.8 t -86.7 149.83 24.61 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.334 39.9 m80 85.09 -163.31 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.517 0 C-N-CA 130.01 3.324 . . . . 0.0 106.273 -173.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -84.31 67.04 9.67 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 119.158 0.89 . . . . 0.0 108.959 -170.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.093 0 CA-C-N 115.949 -0.569 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.115 0.483 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.29 167.7 12.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 171.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -130.46 140.03 50.55 Favored 'General case' 0 CA--C 1.485 -1.545 1 N-CA-C 94.703 -6.036 . . . . 0.0 94.703 165.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.45 29.27 Favored Glycine 0 CA--C 1.472 -2.608 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 178.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.58 138.72 34.15 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 101.453 -3.536 . . . . 0.0 101.453 157.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -89.99 132.82 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -177.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.26 -148.86 0.43 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 111.949 -2.387 . . . . 0.0 107.09 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.94 148.46 65.06 Favored Pre-proline 0 N--CA 1.424 -1.773 1 N-CA-C 95.509 -5.738 . . . . 0.0 95.509 174.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.64 149.86 39.18 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.787 2.031 . . . . 0.0 107.847 -177.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 -5.33 16.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.468 2.307 . . . . 0.0 109.263 13.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -162.38 146.55 12.0 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 94.417 -6.142 . . . . 0.0 94.417 163.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.08 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 177.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 59' ' ' ILE . 16.2 m -135.15 170.42 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 97.164 -5.124 . . . . 0.0 97.164 163.048 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.85 -168.16 1.59 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -125.72 163.64 22.39 Favored 'General case' 0 CA--C 1.474 -1.96 1 N-CA-C 99.603 -4.221 . . . . 0.0 99.603 171.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.28 152.71 47.47 Favored 'General case' 0 N--CA 1.417 -2.076 1 N-CA-C 96.158 -5.497 . . . . 0.0 96.158 -166.07 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.52 115.76 39.47 Favored Pre-proline 0 N--CA 1.419 -1.996 1 N-CA-C 97.36 -5.052 . . . . 0.0 97.36 171.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.3 107.49 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 123.347 2.231 . . . . 0.0 112.043 -176.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.81 -41.26 0.83 Allowed Glycine 0 CA--C 1.491 -1.455 1 N-CA-C 101.472 -4.651 . . . . 0.0 101.472 -161.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m 84.76 3.81 0.68 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 125.351 1.46 . . . . 0.0 113.222 157.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.75 -40.82 80.6 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.417 1.887 . . . . 0.0 110.752 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.91 -41.29 93.47 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.906 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.5 m -68.89 -42.94 76.26 Favored 'General case' 0 CA--C 1.484 -1.559 0 CA-C-N 117.959 0.879 . . . . 0.0 110.164 -175.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.98 -49.69 74.97 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.905 0.882 . . . . 0.0 109.255 176.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -57.5 -50.11 74.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 111.443 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.7 -43.78 98.19 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.035 0.921 . . . . 0.0 110.152 -178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.1 -43.05 95.86 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.284 0.634 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.86 -39.74 83.72 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.802 -0.561 . . . . 0.0 111.477 -178.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.71 -21.21 52.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.613 -0.679 . . . . 0.0 111.702 -175.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -89.51 -28.78 19.4 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.592 -0.693 . . . . 0.0 109.691 175.07 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.21 44.62 0.85 Allowed Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 164.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.73 141.23 16.32 Favored Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 p -99.62 7.42 45.24 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 123.488 0.715 . . . . 0.0 110.034 -167.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.3 m -160.18 150.89 18.77 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 100.28 -3.97 . . . . 0.0 100.28 166.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -166.94 162.67 36.45 Favored Glycine 0 CA--C 1.463 -3.205 1 N-CA-C 99.537 -5.425 . . . . 0.0 99.537 -177.415 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -162.34 -157.68 0.48 Allowed 'General case' 0 N--CA 1.428 -1.529 1 N-CA-C 99.714 -4.18 . . . . 0.0 99.714 -168.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.4 t -155.6 167.04 31.68 Favored 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 95.954 -5.573 . . . . 0.0 95.954 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.82 73.95 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.568 1 N-CA-C 100.27 -5.132 . . . . 0.0 100.27 -176.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -157.84 157.39 33.18 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 176.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -148.39 166.76 27.13 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 94.16 -6.237 . . . . 0.0 94.16 159.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 42' ' ' GLY 0.332 50.1 t 84.19 -167.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -172.132 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.775 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 89.67 -93.24 1.86 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 107.174 -2.371 . . . . 0.0 107.174 -177.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -137.96 -52.47 0.62 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 100.589 -3.856 . . . . 0.0 100.589 178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.8 61.95 0.22 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 172.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.461 0.0 OUTLIER 76.36 167.82 0.26 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 109.164 -175.717 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.55 -179.65 8.37 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -175.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.78 160.97 15.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 176.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 t-105 -107.79 150.52 26.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 9.4 m -147.55 150.92 35.42 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.38 143.15 48.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.21 54.13 0.43 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 126.544 1.938 . . . . 0.0 110.602 168.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.6 mt -95.7 135.34 23.07 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 175.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.99 171.8 16.79 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.432 2.088 . . . . 0.0 110.434 177.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -67.61 -17.17 64.52 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -79.37 -6.78 57.56 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.818 -0.551 . . . . 0.0 110.448 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.61 127.3 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.71 157.09 17.54 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 105.16 -3.176 . . . . 0.0 105.16 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -136.75 -158.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 105.925 -1.879 . . . . 0.0 105.925 -163.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -74.76 123.09 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -178.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.86 -47.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -173.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -159.94 158.83 31.46 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 98.666 -4.568 . . . . 0.0 98.666 -176.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.27 55.54 4.93 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 174.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -92.49 -68.65 0.79 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -172.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -171.53 -164.72 0.34 Allowed 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.188 -4.745 . . . . 0.0 98.188 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 38.3 t -115.82 157.43 24.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -178.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -154.17 138.56 16.72 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 166.09 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 m -83.07 120.41 25.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -169.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.007 0 O-C-N 123.242 0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.395 0.617 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 173.08 6.95 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.33 137.92 39.42 Favored 'General case' 0 N--CA 1.431 -1.405 1 N-CA-C 95.412 -5.773 . . . . 0.0 95.412 170.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.94 -177.58 35.12 Favored Glycine 0 CA--C 1.471 -2.662 1 N-CA-C 103.06 -4.016 . . . . 0.0 103.06 176.042 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -77.44 134.39 38.39 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 159.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.48 138.28 19.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.14 -157.18 0.56 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 129.045 2.938 . . . . 0.0 110.557 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.42 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 36.9 mt-30 -148.65 165.74 17.21 Favored Pre-proline 0 N--CA 1.426 -1.664 1 N-CA-C 97.116 -5.142 . . . . 0.0 97.116 176.782 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -68.96 149.9 72.46 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.688 2.259 . . . . 0.0 109.974 176.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -82.21 -47.37 12.55 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 127.48 2.312 . . . . 0.0 107.231 -1.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -150.26 140.38 22.1 Favored 'General case' 0 N--CA 1.42 -1.972 1 N-CA-C 92.332 -6.914 . . . . 0.0 92.332 173.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.8 m 179.9 -161.05 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 97.336 -5.061 . . . . 0.0 97.336 -174.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 59' ' ' ILE . 1.2 m -119.77 163.55 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 100.365 -3.939 . . . . 0.0 100.365 167.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.6 -165.63 1.01 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 158.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -138.34 168.52 19.57 Favored 'General case' 0 N--CA 1.415 -2.179 1 N-CA-C 96.399 -5.408 . . . . 0.0 96.399 167.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -129.55 -176.41 3.89 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 96.68 -5.304 . . . . 0.0 96.68 -176.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.77 131.17 23.67 Favored Pre-proline 0 N--CA 1.42 -1.95 1 N-CA-C 95.385 -5.783 . . . . 0.0 95.385 174.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.79 40.71 0.17 Allowed 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.298 3.332 . . . . 0.0 116.401 -174.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.13 92.9 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 93.609 -7.796 . . . . 0.0 93.609 174.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -78.79 30.86 0.2 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -148.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -70.18 -35.98 74.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 110.32 -170.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.19 -33.44 69.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -81.69 -11.83 58.9 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.189 -0.595 . . . . 0.0 109.969 -177.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.01 -50.08 75.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.039 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -50.58 73.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.867 0.867 . . . . 0.0 112.466 170.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.63 -41.52 99.06 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 121.593 0.711 . . . . 0.0 112.135 -173.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 t -65.12 -45.83 83.51 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -67.86 -37.17 81.48 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.669 -0.644 . . . . 0.0 112.358 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.16 -7.86 53.27 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.054 -1.029 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -106.22 1.61 26.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.98 29.67 37.39 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 140.83 15.27 Favored Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -92.94 -54.73 3.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -164.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 m -106.46 147.63 29.11 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 102.895 -3.002 . . . . 0.0 102.895 174.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.64 154.76 25.81 Favored Glycine 0 CA--C 1.469 -2.785 1 N-CA-C 100.468 -5.053 . . . . 0.0 100.468 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -171.97 179.02 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 98.016 -4.809 . . . . 0.0 98.016 -175.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.7 m -78.05 173.93 11.67 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 119.796 1.18 . . . . 0.0 111.044 -177.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.92 164.17 37.75 Favored Glycine 0 N--CA 1.418 -2.528 1 N-CA-C 98.688 -5.765 . . . . 0.0 98.688 175.69 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -126.72 131.57 51.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -115.76 105.49 12.78 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.72 140.23 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -172.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.09 -36.14 4.6 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -104.17 -66.39 0.96 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -177.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.33 -150.31 22.23 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 104.963 -3.255 . . . . 0.0 104.963 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.43 136.48 54.75 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.84 -162.48 1.1 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 101.998 -3.334 . . . . 0.0 101.998 -176.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.8 171.55 11.64 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 158.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -129.7 148.76 51.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.2 m -142.36 146.67 35.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -116.64 140.63 49.18 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 170.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 63.98 0.31 Allowed 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 126.342 1.857 . . . . 0.0 109.893 176.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 mt -103.09 133.88 20.09 Favored Pre-proline 0 CA--C 1.503 -0.833 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 169.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -72.52 174.64 11.31 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.624 2.216 . . . . 0.0 111.248 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -76.03 -2.08 28.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -165.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -90.49 -5.89 55.49 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.266 -0.896 . . . . 0.0 110.065 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.03 138.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -174.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.72 149.92 17.8 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 pt -146.78 -175.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -168.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.0 OUTLIER -72.42 127.75 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 121.723 0.773 . . . . 0.0 111.74 -159.637 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.07 159.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 100.833 -3.766 . . . . 0.0 100.833 168.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -143.93 158.61 43.59 Favored 'General case' 0 N--CA 1.426 -1.653 1 N-CA-C 96.208 -5.479 . . . . 0.0 96.208 164.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.03 -33.47 3.86 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -167.358 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -93.8 -101.74 0.14 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 172.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 tptm 175.16 -167.86 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.527 1 N-CA-C 97.677 -4.934 . . . . 0.0 97.677 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -94.97 134.66 37.4 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 168.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -157.47 150.61 23.53 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 102.129 -3.286 . . . . 0.0 102.129 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -153.97 162.07 41.49 Favored 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 96.155 -5.498 . . . . 0.0 96.155 -177.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.437 1.086 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.33 163.27 13.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -130.76 127.93 39.74 Favored 'General case' 0 CA--C 1.491 -1.301 1 N-CA-C 95.564 -5.717 . . . . 0.0 95.564 158.11 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.05 -169.83 25.95 Favored Glycine 0 CA--C 1.478 -2.261 1 N-CA-C 102.808 -4.117 . . . . 0.0 102.808 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 76.0 m-85 -80.55 142.33 34.23 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 163.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.92 141.64 14.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.971 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.702 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -119.77 -153.25 0.53 Allowed 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 128.029 2.531 . . . . 0.0 106.701 -175.376 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -128.84 147.46 64.65 Favored Pre-proline 0 N--CA 1.419 -1.992 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 173.656 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.98 146.8 59.89 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.614 1.969 . . . . 0.0 107.31 175.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -80.93 -41.67 22.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.403 2.281 . . . . 0.0 109.845 11.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -154.02 151.87 29.85 Favored 'General case' 0 N--CA 1.417 -2.095 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 -176.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 57.7 m 173.97 -154.01 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 97.091 -5.151 . . . . 0.0 97.091 169.704 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.15 170.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 1 N-CA-C 97.412 -5.032 . . . . 0.0 97.412 161.536 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -161.77 0.72 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 164.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -142.35 163.54 32.58 Favored 'General case' 0 N--CA 1.417 -2.101 1 N-CA-C 94.463 -6.125 . . . . 0.0 94.463 165.355 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -160.64 -156.89 0.5 Allowed 'General case' 0 N--CA 1.414 -2.257 1 N-CA-C 94.656 -6.053 . . . . 0.0 94.656 -174.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -145.61 169.71 9.28 Favored Pre-proline 0 N--CA 1.414 -2.25 1 N-CA-C 97.837 -4.875 . . . . 0.0 97.837 -167.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -77.33 68.4 7.49 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 CA-C-N 124.14 2.514 . . . . 0.0 111.873 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.82 165.94 34.59 Favored Glycine 0 CA--C 1.479 -2.166 1 N-CA-C 99.778 -5.329 . . . . 0.0 99.778 171.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -83.25 11.17 6.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 118.085 0.942 . . . . 0.0 111.32 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.91 -57.02 8.32 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 128.56 2.744 . . . . 0.0 114.485 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.51 -29.66 18.38 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -85.03 -5.06 59.36 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.779 -0.836 . . . . 0.0 110.873 -165.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.96 -53.04 62.89 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -52.63 64.65 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.486 1.115 . . . . 0.0 112.423 171.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.88 -41.08 97.83 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 118.603 0.638 . . . . 0.0 110.998 -173.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -65.47 -42.3 92.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 121.231 -0.918 . . . . 0.0 108.78 -177.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -69.61 -40.28 76.71 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.896 -0.502 . . . . 0.0 111.136 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -72.65 -30.13 64.03 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 118.535 0.607 . . . . 0.0 112.324 -178.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.69 -24.56 36.13 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.216 0.462 . . . . 0.0 109.89 176.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.61 37.92 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 159.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.89 136.86 13.87 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 104.773 -3.331 . . . . 0.0 104.773 173.031 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -106.34 9.64 31.84 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.74 0.781 . . . . 0.0 108.978 -165.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.6 m -160.21 157.83 28.96 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 98.886 -4.487 . . . . 0.0 98.886 163.292 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 170.98 44.04 Favored Glycine 0 N--CA 1.421 -2.339 1 N-CA-C 100.799 -4.92 . . . . 0.0 100.799 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -168.12 -174.44 2.33 Favored 'General case' 0 N--CA 1.432 -1.334 1 N-CA-C 97.303 -5.073 . . . . 0.0 97.303 -179.377 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.45 159.89 33.99 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.75 -179.22 48.49 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 100.721 -4.951 . . . . 0.0 100.721 -173.147 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -102.9 146.97 27.51 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -171.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -119.17 113.27 20.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 101.458 -3.534 . . . . 0.0 101.458 171.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.03 132.3 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -173.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.83 15.65 33.27 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -171.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -152.4 -79.48 0.11 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.66 -168.88 39.78 Favored Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 -165.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.96 142.15 42.04 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.87 -164.08 1.43 Allowed 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -166.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.6 t -127.62 165.93 19.03 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.2 -4.0 . . . . 0.0 100.2 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 13.6 t-105 -123.33 148.04 46.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 178.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.51 152.3 40.38 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 175.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -115.99 140.84 48.86 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 172.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.1 42.29 0.14 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.145 2.178 . . . . 0.0 111.197 166.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 mt -85.11 134.76 40.38 Favored Pre-proline 0 CA--C 1.5 -0.97 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.32 172.92 15.36 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.127 1.885 . . . . 0.0 110.135 -178.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.66 -9.38 58.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -167.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -91.24 5.3 49.69 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -178.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -103.81 147.79 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 176.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.01 143.83 18.21 Favored Glycine 0 CA--C 1.478 -2.274 1 N-CA-C 101.111 -4.796 . . . . 0.0 101.111 175.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 -149.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -167.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.3 mp -67.4 119.78 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 174.389 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -91.51 -48.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -162.43 164.31 27.22 Favored 'General case' 0 CA--C 1.486 -1.517 1 N-CA-C 100.146 -4.02 . . . . 0.0 100.146 174.62 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.15 68.29 3.55 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 172.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -113.93 -61.8 1.69 Allowed 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -172.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 65' ' ' CYS . 16.8 tptm -157.84 -155.03 0.47 Allowed 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -172.023 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 3.0 t -143.31 133.91 25.02 Favored 'General case' 0 N--CA 1.417 -2.083 1 N-CA-C 93.604 -6.443 . . . . 0.0 93.604 -176.654 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 68.1 m80 54.76 29.88 12.57 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 127.762 2.425 . . . . 0.0 114.535 -169.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -172.87 167.93 5.07 Favored 'General case' 0 N--CA 1.428 -1.548 1 N-CA-C 96.766 -5.272 . . . . 0.0 96.766 172.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.968 0 O-C-N 124.27 0.981 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.122 0.487 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -112.59 167.92 10.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 164.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.85 123.79 33.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 94.856 -5.979 . . . . 0.0 94.856 159.596 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.69 -169.75 25.44 Favored Glycine 0 CA--C 1.485 -1.791 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -172.066 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.01 138.8 31.7 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 164.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 tt -90.93 144.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.71 -138.16 0.36 Allowed 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 127.874 2.47 . . . . 0.0 107.115 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -139.62 154.04 70.88 Favored Pre-proline 0 N--CA 1.426 -1.647 1 N-CA-C 95.597 -5.705 . . . . 0.0 95.597 166.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.87 155.4 53.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 122.836 2.049 . . . . 0.0 109.016 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -83.71 -27.63 28.84 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 126.764 2.025 . . . . 0.0 107.824 -1.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -158.61 152.91 24.08 Favored 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 95.123 -5.881 . . . . 0.0 95.123 175.316 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m 170.27 -153.55 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.662 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.32 170.4 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 1 N-CA-C 96.715 -5.291 . . . . 0.0 96.715 166.67 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -156.95 0.34 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 161.453 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -138.4 143.07 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 167.02 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 t -160.1 -174.44 4.55 Favored 'General case' 0 N--CA 1.419 -2.011 1 N-CA-C 96.878 -5.23 . . . . 0.0 96.878 178.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.17 173.52 5.53 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 -159.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.79 61.74 2.31 Favored 'Trans proline' 0 C--N 1.328 -0.552 0 C-N-CA 123.117 2.545 . . . . 0.0 110.108 161.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.86 138.56 2.7 Favored Glycine 0 N--CA 1.428 -1.843 1 N-CA-C 100.024 -5.231 . . . . 0.0 100.024 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -85.9 -11.48 53.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 123.918 0.887 . . . . 0.0 112.976 -165.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -39.29 -53.42 1.94 Allowed 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 127.963 2.505 . . . . 0.0 117.632 -153.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.94 -40.94 7.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -174.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -82.09 -14.81 55.24 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.586 -0.949 . . . . 0.0 110.306 -169.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.66 -45.11 93.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.792 0.837 . . . . 0.0 109.253 169.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -46.82 86.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.299 1.039 . . . . 0.0 111.513 172.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.32 -39.29 89.18 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-O 121.801 0.81 . . . . 0.0 111.435 -176.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.91 -44.57 67.06 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.116 1.766 . . . . 0.0 110.776 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.8 -54.26 47.37 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 123.196 0.598 . . . . 0.0 110.961 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.95 -20.42 62.45 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.323 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -88.74 -7.68 55.83 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.581 0.628 . . . . 0.0 110.413 172.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.99 5.2 Favored Glycine 0 CA--C 1.486 -1.758 0 CA-C-O 119.192 -0.782 . . . . 0.0 111.81 160.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.72 20.33 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 p -86.94 -84.2 0.18 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.5 m -81.54 161.26 23.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.27 168.35 35.83 Favored Glycine 0 N--CA 1.42 -2.416 1 N-CA-C 99.172 -5.571 . . . . 0.0 99.172 -177.596 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -165.03 -179.8 5.94 Favored 'General case' 0 N--CA 1.433 -1.318 1 N-CA-C 97.758 -4.904 . . . . 0.0 97.758 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.6 m -143.92 161.22 39.27 Favored 'General case' 0 CA--C 1.487 -1.45 1 N-CA-C 98.376 -4.676 . . . . 0.0 98.376 165.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.52 177.43 35.53 Favored Glycine 0 CA--C 1.488 -1.629 1 N-CA-C 97.081 -6.408 . . . . 0.0 97.081 -175.033 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -113.43 103.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 120.374 2.087 . . . . 0.0 108.559 -174.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -130.38 81.9 2.03 Favored 'General case' 0 CA--C 1.497 -1.091 1 N-CA-C 99.215 -4.365 . . . . 0.0 99.215 156.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.39 -177.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 1 N-CA-C 100.177 -4.008 . . . . 0.0 100.177 -174.65 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.51 54.61 0.37 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -157.47 -67.18 0.1 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 -178.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.85 42.47 Favored Glycine 0 CA--C 1.477 -2.285 1 N-CA-C 98.533 -5.827 . . . . 0.0 98.533 -178.105 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -76.69 140.88 41.05 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -175.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.91 -172.75 4.12 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 100.882 -3.747 . . . . 0.0 100.882 -162.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.39 155.33 32.16 Favored 'General case' 0 CA--C 1.479 -1.773 0 C-N-CA 117.542 -1.663 . . . . 0.0 106.658 -165.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -97.49 150.4 21.11 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 176.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 46.8 m -145.14 146.69 31.89 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 168.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.64 145.47 33.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 170.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.64 38.04 1.33 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 126.065 1.746 . . . . 0.0 111.85 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.57 133.97 62.33 Favored Pre-proline 0 CA--C 1.5 -0.952 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -65.22 166.75 18.11 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.5 2.134 . . . . 0.0 111.331 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.45 -5.49 52.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.969 -0.457 . . . . 0.0 112.16 -168.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -90.38 -0.57 57.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.69 -0.631 . . . . 0.0 109.861 177.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 t -95.74 123.74 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 177.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.86 145.75 16.82 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -147.13 -171.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -158.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 7' ' ' ALA . 35.1 mm -54.44 111.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.939 0 C-N-CA 126.912 2.085 . . . . 0.0 112.562 -170.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.15 162.12 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 166.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.82 162.69 38.43 Favored 'General case' 0 N--CA 1.428 -1.571 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 -175.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.18 -1.31 76.88 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -172.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -119.18 -92.89 0.53 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -171.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -174.18 -169.36 0.46 Allowed 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -161.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.73 146.01 45.34 Favored 'General case' 0 N--CA 1.432 -1.328 1 N-CA-C 93.099 -6.63 . . . . 0.0 93.099 169.678 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -103.68 177.18 4.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.832 1.301 . . . . 0.0 108.698 -171.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 m -177.16 173.97 1.72 Allowed 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 95.355 -5.794 . . . . 0.0 95.355 -178.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.865 0 O-C-N 124.478 1.111 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.27 0.557 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -179.55 6.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 172.204 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -130.95 146.17 52.27 Favored 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 99.33 -4.322 . . . . 0.0 99.33 -174.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.63 -179.65 36.44 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -177.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.51 123.34 28.0 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 58' ' ' ILE 0.273 11.9 tt -90.67 140.9 15.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 120.752 1.615 . . . . 0.0 109.453 -176.413 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.98 169.07 10.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 110.95 -2.841 . . . . 0.0 112.092 177.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 14' ' ' TYR 0.252 26.6 tt0 -95.9 151.22 38.21 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 174.745 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -63.03 132.34 36.34 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.978 2.452 . . . . 0.0 109.336 165.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.94 -50.86 9.83 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 122.001 2.182 . . . . 0.0 110.843 14.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -168.06 156.28 8.79 Favored 'General case' 0 N--CA 1.425 -1.708 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 167.356 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 18.7 m 158.52 -144.84 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.428 1 N-CA-C 97.985 -4.821 . . . . 0.0 97.985 -176.968 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 59' ' ' ILE . 3.6 m -106.02 165.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 165.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -91.0 -167.93 1.94 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 162.787 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -136.73 161.75 35.07 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 168.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.9 t -132.41 163.97 27.54 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 101.341 -3.577 . . . . 0.0 101.341 -160.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -109.43 126.95 28.1 Favored Pre-proline 0 N--CA 1.423 -1.775 1 N-CA-C 99.554 -4.239 . . . . 0.0 99.554 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.91 41.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.485 0 C-N-CA 123.843 3.029 . . . . 0.0 116.617 174.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.93 115.41 0.66 Allowed Glycine 0 N--CA 1.423 -2.217 1 N-CA-C 94.436 -7.466 . . . . 0.0 94.436 171.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -60.48 -32.76 71.73 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 m -41.18 -43.88 2.43 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 127.807 2.443 . . . . 0.0 116.373 -168.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -55.89 26.91 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 121.116 -0.99 . . . . 0.0 112.017 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -21.61 36.55 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.642 -0.916 . . . . 0.0 110.091 -173.583 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.11 -35.32 78.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.542 0.737 . . . . 0.0 109.641 169.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 m -70.61 -40.1 73.37 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 177.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.75 -39.61 94.71 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.242 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -57.17 -42.57 81.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.652 1.181 . . . . 0.0 111.176 177.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.55 -51.85 67.68 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.833 0.453 . . . . 0.0 110.821 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.88 -18.94 62.67 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.31 -2.32 57.99 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.802 -0.561 . . . . 0.0 111.325 174.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 24.91 12.74 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 121.601 -0.687 . . . . 0.0 111.754 170.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.03 157.89 21.15 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 172.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 p -81.43 -40.86 22.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.41 157.5 27.87 Favored 'General case' 0 N--CA 1.418 -2.028 1 N-CA-C 98.524 -4.621 . . . . 0.0 98.524 -164.025 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.14 173.87 45.29 Favored Glycine 0 CA--C 1.475 -2.449 1 N-CA-C 102.085 -4.406 . . . . 0.0 102.085 -176.082 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -170.72 -143.98 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.5 m -121.36 -175.37 3.06 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 -170.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.49 -168.58 33.29 Favored Glycine 0 N--CA 1.417 -2.624 1 N-CA-C 96.845 -6.502 . . . . 0.0 96.845 172.594 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -141.97 157.87 44.44 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 96.884 -5.228 . . . . 0.0 96.884 172.328 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -162.55 177.84 9.1 Favored 'General case' 0 N--CA 1.423 -1.784 1 N-CA-C 96.036 -5.542 . . . . 0.0 96.036 172.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.41 171.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 1 N-CA-C 96.283 -5.451 . . . . 0.0 96.283 179.119 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.03 -49.53 0.85 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 104.005 -3.638 . . . . 0.0 104.005 -173.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.43 -70.19 0.81 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.33 -159.9 32.98 Favored Glycine 0 CA--C 1.482 -1.979 0 N-CA-C 103.367 -3.893 . . . . 0.0 103.367 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.06 136.27 58.03 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.761 2.024 . . . . 0.0 106.831 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.49 168.32 20.06 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -161.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.79 179.05 4.39 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -140.37 146.82 38.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.845 -3.02 . . . . 0.0 102.845 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.73 151.18 49.89 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -112.12 137.69 49.83 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 173.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 56.9 71.88 0.55 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 127.753 2.421 . . . . 0.0 113.253 174.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.6 mt -103.77 143.59 26.95 Favored Pre-proline 0 CA--C 1.504 -0.809 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 172.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -69.21 173.39 10.55 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.251 1.967 . . . . 0.0 113.288 174.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.06 -17.64 61.4 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.067 1.347 . . . . 0.0 111.549 -174.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -94.3 18.91 10.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.592 0.757 . . . . 0.0 109.485 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.97 164.74 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 1 N-CA-C 98.773 -4.528 . . . . 0.0 98.773 167.025 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.06 175.1 30.91 Favored Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.783 -5.327 . . . . 0.0 99.783 -175.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -159.22 -170.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 -156.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 13' ' ' VAL . 17.5 mm -38.9 -43.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 129.844 3.258 . . . . 0.0 118.908 -147.27 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.84 -57.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.472 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 75.63 -95.88 0.02 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.565 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -154.1 33.38 0.72 Allowed Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 103.209 -3.957 . . . . 0.0 103.209 168.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -123.14 -105.66 0.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 35.9 tttp 179.33 -157.24 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.419 -3.178 . . . . 0.0 102.419 -169.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.431 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -137.55 135.35 36.61 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 94.775 -6.009 . . . . 0.0 94.775 -176.072 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -167.26 156.52 10.35 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -176.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -179.32 176.82 0.81 Allowed 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 95.915 -5.587 . . . . 0.0 95.915 -176.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.901 0 O-C-N 124.112 0.883 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.93 0.871 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -117.73 164.44 14.98 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -139.91 136.51 33.96 Favored 'General case' 0 CA--C 1.485 -1.536 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 167.296 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.13 35.57 Favored Glycine 0 CA--C 1.476 -2.399 0 N-CA-C 104.165 -3.574 . . . . 0.0 104.165 174.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -75.02 130.8 39.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.359 -3.201 . . . . 0.0 102.359 157.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -84.1 135.84 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.68 -136.61 0.34 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 110.711 -2.949 . . . . 0.0 109.256 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -146.43 159.24 45.5 Favored Pre-proline 0 N--CA 1.423 -1.79 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 172.678 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.11 141.89 44.99 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.37 2.047 . . . . 0.0 108.484 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.22 -32.42 13.04 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 127.962 2.505 . . . . 0.0 107.601 7.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -150.34 147.21 27.32 Favored 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 94.126 -6.25 . . . . 0.0 94.126 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -159.47 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.606 HG12 HD12 ' A' ' 59' ' ' ILE . 2.4 m -133.58 157.8 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 162.273 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 -155.16 0.27 Allowed 'General case' 0 C--N 1.358 0.936 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 161.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -138.63 154.97 48.68 Favored 'General case' 0 CA--C 1.473 -2.004 1 N-CA-C 97.496 -5.002 . . . . 0.0 97.496 177.364 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.25 175.31 6.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -158.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.89 85.58 57.42 Favored Pre-proline 0 N--CA 1.411 -2.419 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -175.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -78.0 -4.39 14.36 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.133 1.889 . . . . 0.0 109.63 165.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.27 141.09 10.84 Favored Glycine 0 CA--C 1.484 -1.901 1 N-CA-C 96.815 -6.514 . . . . 0.0 96.815 174.169 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -68.06 -55.13 13.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -153.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -63.47 5.95 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -155.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.17 -93.05 1.31 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 169.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.92 -17.86 62.06 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.521 1.128 . . . . 0.0 111.61 -166.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -62.31 -49.84 74.04 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 121.082 1.765 . . . . 0.0 109.499 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.72 89.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.812 2.045 . . . . 0.0 111.884 173.112 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.33 -44.09 88.91 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.815 0.817 . . . . 0.0 110.968 -178.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.9 t -58.67 -43.88 90.01 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 125.182 1.393 . . . . 0.0 109.03 177.216 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -53.51 54.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.099 0.96 . . . . 0.0 111.262 -178.583 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.28 -26.39 66.52 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.785 -0.572 . . . . 0.0 112.474 -175.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -79.86 -13.12 59.63 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 123.39 0.676 . . . . 0.0 110.498 177.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.31 23.87 8.74 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.87 119.87 6.13 Favored Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.134 -3.187 . . . . 0.0 105.134 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 p -82.45 -11.97 58.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.695 0.759 . . . . 0.0 110.087 -172.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.97 149.01 17.54 Favored 'General case' 0 N--CA 1.415 -2.207 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -160.094 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.62 47.24 Favored Glycine 0 CA--C 1.476 -2.397 1 N-CA-C 97.963 -6.055 . . . . 0.0 97.963 -178.024 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -165.79 168.54 15.92 Favored 'General case' 0 N--CA 1.425 -1.676 1 N-CA-C 98.191 -4.744 . . . . 0.0 98.191 179.377 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.8 t -100.33 166.16 11.11 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.1 -170.27 40.05 Favored Glycine 0 N--CA 1.425 -2.054 1 N-CA-C 97.754 -6.138 . . . . 0.0 97.754 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.77 154.39 51.61 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 100.237 -3.986 . . . . 0.0 100.237 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -150.29 149.82 30.65 Favored 'General case' 0 N--CA 1.426 -1.652 1 N-CA-C 94.231 -6.211 . . . . 0.0 94.231 172.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.97 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.57 -71.64 1.12 Allowed Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 108.204 -1.959 . . . . 0.0 108.204 171.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 m170 -99.59 -42.31 6.96 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.87 -70.79 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.942 0 C-N-CA 118.274 -1.917 . . . . 0.0 108.74 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 tp -158.68 161.95 37.17 Favored 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 95.535 -5.728 . . . . 0.0 95.535 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.35 172.99 16.33 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 -171.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -128.55 167.41 17.15 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 100.98 -3.711 . . . . 0.0 100.98 -175.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -116.7 145.2 43.61 Favored 'General case' 0 C--N 1.364 1.2 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 176.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.6 m -133.94 143.82 48.44 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 170.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -127.38 121.7 31.67 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 -172.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.43 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 127.942 2.497 . . . . 0.0 108.076 -177.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.49 135.44 20.64 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-O 117.084 -1.436 . . . . 0.0 107.433 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.88 165.91 26.34 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.434 2.089 . . . . 0.0 112.653 176.444 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.84 -13.94 62.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.252 1.021 . . . . 0.0 112.484 -174.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -91.44 5.58 48.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.85 0.86 . . . . 0.0 110.995 -179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -108.38 -174.96 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.71 169.22 33.97 Favored Glycine 0 CA--C 1.482 -2.022 1 N-CA-C 101.877 -4.489 . . . . 0.0 101.877 -170.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 pt -155.53 -168.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 101.722 -3.436 . . . . 0.0 101.722 -162.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 HD12 HG12 ' A' ' 13' ' ' VAL . 1.2 mm -70.79 131.25 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.5 t -111.65 109.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 101.176 -3.639 . . . . 0.0 101.176 176.113 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 62.77 -117.86 0.56 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.188 1.395 . . . . 0.0 107.879 -170.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.1 47.05 0.32 Allowed Glycine 0 N--CA 1.428 -1.896 1 N-CA-C 98.795 -5.722 . . . . 0.0 98.795 165.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.09 -59.99 2.5 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.57 0.7 . . . . 0.0 110.341 -162.117 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -161.09 -178.44 6.76 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.774 -3.787 . . . . 0.0 100.774 -171.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.0 t -123.73 148.04 46.95 Favored 'General case' 0 N--CA 1.427 -1.587 1 N-CA-C 98.594 -4.595 . . . . 0.0 98.594 172.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -167.24 159.81 13.1 Favored 'General case' 0 CA--C 1.482 -1.637 1 N-CA-C 99.662 -4.199 . . . . 0.0 99.662 175.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -150.17 165.08 33.96 Favored 'General case' 0 N--CA 1.423 -1.781 1 N-CA-C 96.598 -5.334 . . . . 0.0 96.598 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.53 1.144 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.7 169.6 9.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 162.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -125.44 146.34 49.67 Favored 'General case' 0 CA--C 1.487 -1.443 1 N-CA-C 93.329 -6.545 . . . . 0.0 93.329 156.092 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 179.31 36.95 Favored Glycine 0 CA--C 1.468 -2.879 0 C-N-CA 116.542 -2.742 . . . . 0.0 107.55 -177.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 40' ' ' LYS . 41.8 m-85 -87.34 132.7 33.86 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 100.832 -3.766 . . . . 0.0 100.832 157.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.62 140.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.64 -138.46 0.36 Allowed 'General case' 0 N--CA 1.426 -1.673 0 O-C-N 126.849 2.593 . . . . 0.0 106.982 -178.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -133.27 153.39 80.62 Favored Pre-proline 0 N--CA 1.421 -1.912 1 N-CA-C 94.915 -5.957 . . . . 0.0 94.915 166.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -64.19 135.31 46.36 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.12 2.15 . . . . 0.0 106.571 163.154 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -94.9 -37.61 11.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 121.952 2.16 . . . . 0.0 109.648 17.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -158.74 148.43 19.28 Favored 'General case' 0 N--CA 1.422 -1.853 1 N-CA-C 94.639 -6.06 . . . . 0.0 94.639 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.3 m 170.73 -158.55 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.939 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 59' ' ' ILE . 1.2 m -122.92 165.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 N-CA-C 99.515 -4.254 . . . . 0.0 99.515 157.859 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -155.48 0.21 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.052 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -139.35 179.31 6.61 Favored 'General case' 0 CA--C 1.482 -1.651 1 N-CA-C 97.853 -4.869 . . . . 0.0 97.853 160.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.56 171.17 14.42 Favored 'General case' 0 N--CA 1.415 -2.194 1 N-CA-C 97.276 -5.083 . . . . 0.0 97.276 -177.658 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -125.75 121.74 24.52 Favored Pre-proline 0 N--CA 1.415 -2.202 1 N-CA-C 97.762 -4.903 . . . . 0.0 97.762 176.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.28 113.96 1.65 Allowed 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.262 2.641 . . . . 0.0 112.661 176.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.22 -43.51 1.05 Allowed Glycine 0 CA--C 1.489 -1.57 1 N-CA-C 101.86 -4.496 . . . . 0.0 101.86 -163.278 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.254 67.6 m 85.47 -7.84 0.84 Allowed 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 127.448 2.299 . . . . 0.0 113.101 172.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -51.32 -49.6 61.04 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.479 1.512 . . . . 0.0 113.595 -171.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -38.98 62.0 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.331 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.32 -47.16 77.5 Favored 'General case' 0 CA--C 1.488 -1.437 0 O-C-N 121.757 -0.849 . . . . 0.0 109.698 -177.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.9 -40.1 94.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.485 0.66 . . . . 0.0 109.792 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 m -63.05 -48.63 77.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.438 0.695 . . . . 0.0 110.929 175.016 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.05 -36.13 83.37 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.132 0.973 . . . . 0.0 111.055 -177.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.4 t -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.724 1.21 . . . . 0.0 110.448 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -68.55 -41.38 79.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.784 -0.573 . . . . 0.0 111.966 -175.495 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.89 -11.77 60.95 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.457 -0.777 . . . . 0.0 112.45 -178.458 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -99.55 -0.69 40.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.443 0.697 . . . . 0.0 109.75 174.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.09 28.36 18.1 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 170.224 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.48 152.4 20.17 Favored Glycine 0 C--N 1.356 1.66 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 170.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -80.9 -38.74 27.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.451 -1.029 . . . . 0.0 110.635 -166.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 m -160.54 173.36 15.65 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 98.805 -4.517 . . . . 0.0 98.805 166.539 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.31 168.88 41.19 Favored Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 99.386 -5.486 . . . . 0.0 99.386 -172.711 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.72 172.53 14.06 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -172.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.49 156.18 39.3 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 119.412 1.006 . . . . 0.0 110.831 -177.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 -179.39 40.63 Favored Glycine 0 N--CA 1.42 -2.378 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 168.517 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -145.14 154.45 42.46 Favored 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.082 -5.525 . . . . 0.0 96.082 -175.206 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -137.49 18.84 2.91 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.976 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 42' ' ' GLY 0.27 2.3 t 61.75 -142.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -167.746 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 76.0 -74.53 1.61 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 124.071 0.843 . . . . 0.0 111.709 168.063 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.08 -76.14 0.59 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.78 -174.28 41.33 Favored Glycine 0 CA--C 1.478 -2.236 1 N-CA-C 100.582 -5.007 . . . . 0.0 100.582 -168.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.0 tp -52.3 134.89 33.55 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 127.245 2.218 . . . . 0.0 108.561 177.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.69 -167.67 1.84 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 -167.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.02 153.73 48.12 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.076 -4.416 . . . . 0.0 99.076 172.449 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -105.65 152.01 23.66 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.52 144.65 33.05 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -103.31 142.26 34.51 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 167.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.68 74.37 0.44 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.013 2.525 . . . . 0.0 112.602 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.2 mt -108.29 134.83 20.06 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.8 170.02 20.61 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.24 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.77 -17.35 64.57 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.213 1.405 . . . . 0.0 114.008 -166.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -84.37 -7.67 59.24 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 124.205 1.002 . . . . 0.0 110.907 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.55 125.95 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 -176.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 143.8 16.74 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 104.486 -3.445 . . . . 0.0 104.486 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.9 pt -130.41 -150.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -165.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.588 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -74.3 117.37 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 177.133 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.39 108.83 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 -176.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 62.5 -125.9 0.68 Allowed 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.46 46.71 0.55 Allowed Glycine 0 CA--C 1.485 -1.807 1 N-CA-C 101.606 -4.598 . . . . 0.0 101.606 165.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -99.08 -61.2 1.4 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -164.018 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -122.42 165.87 15.64 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -160.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.5 t -141.12 136.02 31.49 Favored 'General case' 0 N--CA 1.425 -1.72 1 N-CA-C 96.571 -5.344 . . . . 0.0 96.571 167.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.05 118.52 2.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 169.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -83.2 118.07 23.36 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.363 1.155 0 O-C-N 123.384 0.428 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.467 0.651 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -104.72 155.21 19.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 165.564 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -120.36 126.14 49.75 Favored 'General case' 0 CA--C 1.485 -1.552 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 157.265 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -162.45 13.09 Favored Glycine 0 CA--C 1.481 -2.061 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -174.399 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.58 141.37 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.268 -3.975 . . . . 0.0 100.268 163.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tt -90.42 147.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 173.094 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.826 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -150.62 177.0 10.47 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 98.482 -4.636 . . . . 0.0 98.482 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -86.53 158.37 54.45 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.079 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 61.6 Cg_exo -62.31 118.06 4.94 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.467 2.111 . . . . 0.0 109.589 168.916 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.0 mm-40 -130.87 114.22 15.02 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 127.74 2.416 . . . . 0.0 105.365 2.483 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 65.74 40.15 4.47 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 110.279 169.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.66 125.03 43.46 Favored 'General case' 0 CA--C 1.479 -1.751 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 168.268 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.269 35.0 m -69.58 169.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 122.637 1.208 . . . . 0.0 113.832 -161.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.2 131.21 50.71 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 92.062 -7.014 . . . . 0.0 92.062 -178.478 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 16' ' ' CYS . 59.4 m80 -92.88 -146.32 0.23 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -170.389 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 15' ' ' HIS . 3.8 t -151.09 155.45 39.0 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 93.821 -6.363 . . . . 0.0 93.821 -174.539 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -108.98 112.8 59.87 Favored Pre-proline 0 N--CA 1.43 -1.431 1 N-CA-C 99.037 -4.431 . . . . 0.0 99.037 168.366 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.92 106.12 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.448 2.765 . . . . 0.0 117.665 -166.343 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.57 -166.46 38.48 Favored Glycine 0 N--CA 1.421 -2.343 1 N-CA-C 94.561 -7.416 . . . . 0.0 94.561 179.258 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 m -79.56 -29.19 41.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.722 1.761 . . . . 0.0 107.778 170.461 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -40.28 -57.44 1.74 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.505 3.922 . . . . 0.0 115.414 -168.711 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.92 -34.94 55.11 Favored Glycine 0 CA--C 1.492 -1.39 0 O-C-N 120.767 -1.208 . . . . 0.0 112.132 -168.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.86 -36.93 35.95 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.36 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.4 -49.76 71.51 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 123.79 0.836 . . . . 0.0 109.207 173.076 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 m -58.17 -54.96 41.12 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.456 0.702 . . . . 0.0 111.35 175.831 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.97 -46.52 90.4 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.669 1.188 . . . . 0.0 111.51 -174.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.39 -42.95 92.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -175.827 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.35 -42.77 74.81 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.171 0.442 . . . . 0.0 111.706 -179.19 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -72.11 -22.79 61.28 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.42 -0.8 . . . . 0.0 111.973 -173.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -46.62 9.18 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.676 -0.64 . . . . 0.0 109.558 172.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.01 48.66 0.18 Allowed Glycine 0 CA--C 1.487 -1.711 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 168.759 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.24 149.9 18.53 Favored Glycine 0 CA--C 1.488 -1.626 1 N-CA-C 102.114 -4.394 . . . . 0.0 102.114 163.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -89.16 -62.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.011 0.906 . . . . 0.0 109.129 -169.241 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -94.34 150.57 20.16 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.269 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.13 167.24 39.71 Favored Glycine 0 CA--C 1.478 -2.225 1 N-CA-C 100.826 -4.909 . . . . 0.0 100.826 176.902 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -170.04 172.76 6.3 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 100.249 -3.982 . . . . 0.0 100.249 -178.087 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 m -113.15 145.26 41.26 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.052 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.8 90.92 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.739 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -174.14 176.93 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 97.933 -4.839 . . . . 0.0 97.933 178.197 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp 170.25 49.96 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 170.57 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.49 140.31 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -172.812 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.66 -63.64 3.55 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.525 -0.734 . . . . 0.0 111.304 161.496 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -107.59 -52.51 2.75 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -176.85 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.25 -146.88 11.14 Favored Glycine 0 N--CA 1.42 -2.401 1 N-CA-C 95.024 -7.23 . . . . 0.0 95.024 -174.582 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 162.92 20.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.155 0.977 . . . . 0.0 108.63 171.386 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.16 169.57 17.36 Favored 'General case' 0 CA--C 1.485 -1.555 1 N-CA-C 98.395 -4.668 . . . . 0.0 98.395 -178.096 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 141.0 42.51 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 -170.202 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -88.37 150.07 23.39 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.9 m -149.23 138.5 21.5 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.894 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -108.27 136.49 47.84 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 170.246 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.67 56.36 0.14 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 126.187 1.795 . . . . 0.0 110.559 168.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.33 132.81 34.55 Favored Pre-proline 0 CA--C 1.498 -1.023 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 170.193 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 172.42 14.2 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.116 2.544 . . . . 0.0 110.169 177.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.0 -20.06 63.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.694 1.598 . . . . 0.0 113.824 -169.554 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -82.77 -4.45 57.96 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.511 -0.743 . . . . 0.0 111.486 -172.014 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -101.3 126.73 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -175.132 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.27 148.8 18.52 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 103.204 -3.958 . . . . 0.0 103.204 176.146 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.7 pt -148.03 -146.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 -159.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.826 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.6 mm -71.27 118.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.144 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.32 162.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -159.303 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 77.89 -112.27 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 127.895 2.478 . . . . 0.0 106.52 -173.104 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.53 59.58 0.04 OUTLIER Glycine 0 CA--C 1.479 -2.18 1 N-CA-C 97.672 -6.171 . . . . 0.0 97.672 -177.508 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 10.7 tp10 -170.06 -162.36 0.31 Allowed 'General case' 0 N--CA 1.421 -1.909 1 N-CA-C 98.262 -4.718 . . . . 0.0 98.262 -162.341 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 32.7 tttp -113.56 -146.32 0.41 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.8 t -79.93 146.28 32.2 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 125.725 1.61 . . . . 0.0 109.403 -169.022 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -151.86 167.8 27.14 Favored 'General case' 0 N--CA 1.423 -1.819 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 174.527 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 m -75.51 58.08 1.0 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.054 1.342 . . . . 0.0 112.424 -171.31 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.944 0 CA-C-N 116.543 -0.299 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.192 0.52 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -101.08 159.31 15.34 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 165.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -126.33 122.77 36.39 Favored 'General case' 0 CA--C 1.484 -1.588 1 N-CA-C 94.19 -6.226 . . . . 0.0 94.19 159.793 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.63 38.15 Favored Glycine 0 CA--C 1.473 -2.581 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -173.915 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -79.64 131.4 35.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 165.511 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.4 tt -90.39 141.57 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -176.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.22 -141.81 0.37 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -178.493 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -131.95 150.9 77.45 Favored Pre-proline 0 N--CA 1.419 -2.02 1 N-CA-C 94.586 -6.079 . . . . 0.0 94.586 166.011 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.7 144.01 58.31 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 N-CA-C 106.629 -2.104 . . . . 0.0 106.629 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.57 -36.64 13.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.635 1.974 . . . . 0.0 109.165 12.795 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.88 150.08 28.93 Favored 'General case' 0 N--CA 1.418 -2.056 1 N-CA-C 94.707 -6.034 . . . . 0.0 94.707 175.816 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.55 -160.66 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -176.316 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.638 HG12 HD12 ' A' ' 59' ' ' ILE . 16.0 m -129.33 165.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 96.568 -5.345 . . . . 0.0 96.568 152.64 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.32 158.41 19.68 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 100.235 -3.987 . . . . 0.0 100.235 163.341 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -107.71 147.22 31.04 Favored 'General case' 0 CA--C 1.47 -2.103 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 -177.997 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -159.41 -177.99 6.83 Favored 'General case' 0 N--CA 1.409 -2.484 1 N-CA-C 95.763 -5.643 . . . . 0.0 95.763 -168.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -139.76 171.46 7.89 Favored Pre-proline 0 N--CA 1.414 -2.227 1 N-CA-C 98.867 -4.494 . . . . 0.0 98.867 -156.964 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.15 42.92 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 123.967 3.112 . . . . 0.0 114.308 169.962 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.83 129.52 1.49 Allowed Glycine 0 N--CA 1.423 -2.229 1 N-CA-C 100.203 -5.159 . . . . 0.0 100.203 -176.398 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.25 33.69 1.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.673 1.589 . . . . 0.0 111.083 -171.063 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -56.48 -43.63 79.81 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 126.437 1.895 . . . . 0.0 113.133 -173.237 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -33.29 8.97 Favored Glycine 0 C--N 1.352 1.431 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.691 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.0 t -61.72 -36.71 81.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.018 1.327 . . . . 0.0 111.408 -170.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.97 -53.84 43.92 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.121 0.968 . . . . 0.0 110.588 176.379 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -36.84 84.89 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.629 1.172 . . . . 0.0 112.884 177.061 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.02 -39.78 87.1 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 122.076 0.941 . . . . 0.0 109.733 -179.602 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -61.36 -42.87 99.4 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.444 0.697 . . . . 0.0 110.792 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -60.65 -47.79 84.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.785 0.834 . . . . 0.0 111.033 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.37 -17.55 62.41 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.211 -0.931 . . . . 0.0 112.739 -174.003 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -96.3 -5.17 40.75 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.208 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.35 11.85 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.009 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.35 159.48 19.29 Favored Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 105.721 -2.951 . . . . 0.0 105.721 168.907 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -71.51 -60.74 2.07 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.758 1.266 . . . . 0.0 108.747 -170.7 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.96 -171.05 2.92 Favored 'General case' 0 N--CA 1.425 -1.711 1 N-CA-C 97.323 -5.065 . . . . 0.0 97.323 169.438 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.99 -158.18 16.68 Favored Glycine 0 N--CA 1.419 -2.453 1 N-CA-C 101.732 -4.547 . . . . 0.0 101.732 -175.769 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -163.11 -170.2 2.24 Favored 'General case' 0 N--CA 1.429 -1.501 1 N-CA-C 97.467 -5.012 . . . . 0.0 97.467 -171.188 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.9 m -128.61 165.58 20.52 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 174.171 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.72 -170.92 43.03 Favored Glycine 0 N--CA 1.42 -2.383 1 N-CA-C 96.847 -6.501 . . . . 0.0 96.847 -176.353 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -139.46 161.85 36.48 Favored 'General case' 0 N--CA 1.431 -1.406 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 -174.485 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 150.4 40.54 Favored 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 94.237 -6.208 . . . . 0.0 94.237 159.88 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 t -75.99 126.57 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 119.539 1.063 . . . . 0.0 108.326 -165.005 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.87 -78.23 0.05 OUTLIER Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 104.382 -3.487 . . . . 0.0 104.382 178.348 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -108.3 -105.32 0.35 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.375 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.6 98.21 0.18 Allowed Glycine 0 CA--C 1.489 -1.58 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 -171.741 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.333 0.2 OUTLIER 59.33 -166.91 0.17 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.764 2.425 . . . . 0.0 110.712 -170.322 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -164.98 -179.47 5.77 Favored 'General case' 0 N--CA 1.427 -1.605 1 N-CA-C 99.878 -4.119 . . . . 0.0 99.878 168.661 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -122.55 152.99 39.83 Favored 'General case' 0 CA--C 1.494 -1.186 1 N-CA-C 98.078 -4.786 . . . . 0.0 98.078 175.282 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -104.87 156.01 18.4 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 176.688 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.01 141.78 32.87 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 165.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -108.18 122.31 46.65 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 177.317 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.62 82.3 0.14 Allowed 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 127.188 2.195 . . . . 0.0 109.924 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.8 mt -106.67 135.12 19.56 Favored Pre-proline 0 CA--C 1.49 -1.342 0 N-CA-C 103.417 -2.809 . . . . 0.0 103.417 170.155 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.88 170.49 16.6 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.078 1.852 . . . . 0.0 110.385 171.216 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -82.1 7.06 14.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -162.053 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -90.08 -8.03 52.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.737 0.815 . . . . 0.0 108.961 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 t -99.13 138.17 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -174.171 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.43 148.11 16.65 Favored Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 103.976 -3.649 . . . . 0.0 103.976 178.7 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 pt -134.6 -156.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -167.861 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -72.59 128.51 35.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -121.34 114.01 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 178.527 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 60.3 -128.67 1.0 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.513 1.125 . . . . 0.0 108.167 -174.183 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -159.9 45.98 0.42 Allowed Glycine 0 N--CA 1.432 -1.608 1 N-CA-C 101.135 -4.786 . . . . 0.0 101.135 164.828 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -76.56 -58.5 3.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 -164.302 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER -165.01 -168.36 1.41 Allowed 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 100.096 -4.038 . . . . 0.0 100.096 -176.174 . . . . . . . . 4 4 . 1 . 032 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 64' ' ' LYS . 15.1 t -127.3 153.53 46.04 Favored 'General case' 0 N--CA 1.424 -1.751 1 N-CA-C 99.266 -4.346 . . . . 0.0 99.266 178.42 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -153.4 119.72 5.51 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 164.103 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 m -75.97 117.45 17.7 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.742 0.817 . . . . 0.0 108.837 -174.55 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.059 0 CA-C-N 116.236 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 170.7 9.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 171.14 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -130.32 133.74 46.67 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 95.862 -5.607 . . . . 0.0 95.862 168.433 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -176.07 33.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 118.527 -1.797 . . . . 0.0 109.627 -175.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -86.74 125.03 33.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 169.334 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.66 146.26 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 119.348 0.977 . . . . 0.0 108.44 -174.594 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.64 -163.98 0.89 Allowed 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 127.477 2.311 . . . . 0.0 105.998 -175.82 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -128.51 159.01 69.99 Favored Pre-proline 0 N--CA 1.422 -1.846 1 N-CA-C 96.44 -5.393 . . . . 0.0 96.44 169.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -68.57 155.77 67.85 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 CA-C-N 122.621 1.972 . . . . 0.0 109.189 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -99.21 -19.97 16.85 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 128.901 2.88 . . . . 0.0 108.502 4.596 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -149.72 151.57 33.87 Favored 'General case' 0 CA--C 1.479 -1.761 1 N-CA-C 92.592 -6.818 . . . . 0.0 92.592 158.079 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.07 -163.69 0.11 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 171.442 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 HD12 ' A' ' 59' ' ' ILE . 5.7 m -128.75 160.3 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 1 N-CA-C 95.904 -5.591 . . . . 0.0 95.904 160.648 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -164.47 0.7 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.513 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -137.86 168.62 19.32 Favored 'General case' 0 N--CA 1.418 -2.063 1 N-CA-C 95.186 -5.857 . . . . 0.0 95.186 176.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -142.85 155.88 44.84 Favored 'General case' 0 CA--C 1.474 -1.966 1 N-CA-C 96.973 -5.195 . . . . 0.0 96.973 -166.277 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -114.46 119.35 40.12 Favored Pre-proline 0 N--CA 1.421 -1.921 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 167.21 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.91 95.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 124.728 2.724 . . . . 0.0 117.444 -162.795 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.19 -173.15 41.69 Favored Glycine 0 N--CA 1.422 -2.293 1 N-CA-C 97.787 -6.125 . . . . 0.0 97.787 -179.388 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -89.67 -13.9 35.98 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 118.173 0.987 . . . . 0.0 109.455 178.636 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.41 -60.56 1.89 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.557 3.143 . . . . 0.0 116.566 -161.32 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 -36.49 23.09 Favored Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.4 m -80.47 -16.1 55.16 Favored 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 123.141 0.576 . . . . 0.0 110.793 -174.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.89 -51.68 68.61 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.955 0.798 . . . . 0.0 108.951 168.451 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.49 81.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.73 0.812 . . . . 0.0 112.661 174.077 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.23 -38.69 85.65 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.129 0.966 . . . . 0.0 111.645 -174.191 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.4 -34.7 78.54 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.311 -0.868 . . . . 0.0 110.28 178.56 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -40.54 89.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.374 0.669 . . . . 0.0 111.477 -177.177 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.54 -28.77 59.17 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 122.159 -0.338 . . . . 0.0 110.978 -177.883 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.02 -27.41 24.82 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.951 -0.468 . . . . 0.0 110.768 179.422 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.28 42.62 1.06 Allowed Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 163.729 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.96 157.33 15.06 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 162.224 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -94.08 -9.9 35.12 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 122.178 -0.601 . . . . 0.0 110.559 -163.662 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 m -149.5 149.62 31.04 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.78 138.61 9.94 Favored Glycine 0 CA--C 1.475 -2.409 1 N-CA-C 98.847 -5.701 . . . . 0.0 98.847 -178.048 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -141.45 -162.64 1.41 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 -177.328 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.77 169.15 9.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 -170.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.65 -177.97 41.69 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 102.469 -4.252 . . . . 0.0 102.469 -177.094 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -152.16 159.74 43.54 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 97.665 -4.939 . . . . 0.0 97.665 178.03 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -151.96 171.01 18.47 Favored 'General case' 0 CA--C 1.491 -1.309 1 N-CA-C 98.974 -4.454 . . . . 0.0 98.974 167.909 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.92 168.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -177.768 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.92 29.22 52.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -169.011 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m170 163.45 -154.13 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 94.471 -6.122 . . . . 0.0 94.471 -174.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.08 150.16 21.39 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 98.715 -5.754 . . . . 0.0 98.715 170.41 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tp 74.16 176.84 0.24 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.003 1.721 . . . . 0.0 108.519 175.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -178.46 -169.35 0.18 Allowed 'General case' 0 CA--C 1.483 -1.62 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 173.922 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.35 178.25 6.96 Favored 'General case' 0 CA--C 1.484 -1.559 1 N-CA-C 100.137 -4.023 . . . . 0.0 100.137 154.524 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -126.85 146.59 50.22 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.06 156.09 46.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 179.665 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -125.65 142.44 51.51 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.735 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.97 55.67 1.13 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 128.542 2.737 . . . . 0.0 111.783 172.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.52 132.85 25.58 Favored Pre-proline 0 CA--C 1.505 -0.777 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.042 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -73.54 174.76 11.66 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.513 2.142 . . . . 0.0 111.75 174.015 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.15 -19.07 62.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 126.548 1.939 . . . . 0.0 114.787 -173.885 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -79.62 -15.26 57.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 121.686 -0.634 . . . . 0.0 109.704 -177.23 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.55 129.92 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -178.537 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.84 149.53 18.73 Favored Glycine 0 CA--C 1.48 -2.153 1 N-CA-C 101.402 -4.679 . . . . 0.0 101.402 -179.481 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -133.18 -143.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -162.051 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG12 ' A' ' 13' ' ' VAL . 3.9 mm -67.19 120.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.659 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.13 -51.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.2 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -162.72 163.08 27.03 Favored 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 98.402 -4.666 . . . . 0.0 98.402 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 74.17 2.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 173.115 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -121.64 -67.11 0.99 Allowed 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -165.659 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -162.99 172.58 14.81 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 98.633 -4.58 . . . . 0.0 98.633 -169.434 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.4 t -129.41 153.3 48.05 Favored 'General case' 0 CA--C 1.485 -1.531 1 N-CA-C 97.15 -5.13 . . . . 0.0 97.15 178.862 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -158.31 152.37 23.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 94.975 -5.935 . . . . 0.0 94.975 176.941 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -154.9 163.28 40.51 Favored 'General case' 0 N--CA 1.421 -1.894 1 N-CA-C 95.599 -5.704 . . . . 0.0 95.599 -177.991 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.929 0 O-C-N 124.419 1.074 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.686 0.755 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 161.83 34.65 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.415 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.78 137.67 51.66 Favored 'General case' 0 CA--C 1.485 -1.548 1 N-CA-C 94.977 -5.934 . . . . 0.0 94.977 171.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.84 -172.56 29.39 Favored Glycine 0 CA--C 1.472 -2.618 0 N-CA-C 104.866 -3.294 . . . . 0.0 104.866 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.03 138.69 32.96 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 102.051 -3.314 . . . . 0.0 102.051 158.352 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.0 tt -90.84 141.33 14.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.31 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -112.46 -160.31 0.71 Allowed 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 128.395 2.678 . . . . 0.0 108.099 -176.213 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.44 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 53.5 mt-30 -136.17 164.78 40.53 Favored Pre-proline 0 N--CA 1.419 -1.977 1 N-CA-C 96.601 -5.333 . . . . 0.0 96.601 174.86 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -65.32 151.53 84.95 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.67 2.246 . . . . 0.0 109.764 169.291 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.52 -54.58 4.1 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 127.75 2.42 . . . . 0.0 107.917 5.266 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -133.35 135.69 44.91 Favored 'General case' 0 N--CA 1.42 -1.925 1 N-CA-C 90.729 -7.508 . . . . 0.0 90.729 169.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 m -168.19 -166.41 0.7 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 178.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.06 164.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 165.804 . . . . . . . . 4 4 . 1 . 034 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.34 -158.42 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 162.079 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -137.45 168.7 19.13 Favored 'General case' 0 CA--C 1.476 -1.9 1 N-CA-C 96.668 -5.308 . . . . 0.0 96.668 165.852 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.5 t -130.86 158.59 39.78 Favored 'General case' 0 CA--C 1.478 -1.818 1 N-CA-C 97.402 -5.036 . . . . 0.0 97.402 -170.374 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -109.84 112.43 58.17 Favored Pre-proline 0 N--CA 1.425 -1.694 1 N-CA-C 96.596 -5.335 . . . . 0.0 96.596 167.915 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.3 101.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.543 0 CA-C-N 124.491 2.64 . . . . 0.0 116.177 -161.175 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -172.57 36.9 Favored Glycine 0 N--CA 1.427 -1.935 1 N-CA-C 97.092 -6.403 . . . . 0.0 97.092 -172.628 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p -92.58 -28.75 16.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 118.993 1.396 . . . . 0.0 109.893 -177.933 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.16 -63.92 0.56 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.775 2.43 . . . . 0.0 116.152 -161.899 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.65 -45.45 52.93 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -176.142 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 m -64.47 -45.77 85.98 Favored 'General case' 0 CA--C 1.486 -1.495 0 O-C-N 122.229 -0.571 . . . . 0.0 111.776 -174.162 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.36 -35.97 78.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -60.85 -48.43 81.82 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.713 173.764 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.38 -41.95 99.04 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-O 121.799 0.809 . . . . 0.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -60.69 -45.3 94.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.87 0.868 . . . . 0.0 110.432 179.395 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.81 -42.37 81.64 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.392 0.277 . . . . 0.0 110.792 -176.781 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.44 -27.08 56.09 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.799 -0.563 . . . . 0.0 111.552 -176.049 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -76.49 -49.23 17.06 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.22 51.6 0.18 Allowed Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 169.318 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.04 16.15 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 104.913 -3.275 . . . . 0.0 104.913 159.636 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.4 p -92.92 -3.59 54.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 117.777 0.788 . . . . 0.0 110.7 -166.091 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.479 -1.778 1 N-CA-C 98.427 -4.657 . . . . 0.0 98.427 174.096 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -167.17 163.71 37.33 Favored Glycine 0 CA--C 1.465 -3.058 1 N-CA-C 101.065 -4.814 . . . . 0.0 101.065 -173.539 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -156.66 -155.34 0.53 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.814 -3.772 . . . . 0.0 100.814 -170.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 t -145.03 161.71 38.74 Favored 'General case' 0 N--CA 1.429 -1.51 1 N-CA-C 96.534 -5.358 . . . . 0.0 96.534 -173.825 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.92 -172.57 45.18 Favored Glycine 0 N--CA 1.42 -2.409 1 N-CA-C 99.024 -5.63 . . . . 0.0 99.024 -176.439 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -135.38 142.47 45.7 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 97.048 -5.168 . . . . 0.0 97.048 -177.426 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -112.46 108.82 18.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.1 121.38 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.553 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -13.54 8.09 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -168.1 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -136.68 -77.26 0.41 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.528 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.04 -163.45 36.82 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 -165.1 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.8 141.26 57.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.79 2.436 . . . . 0.0 106.044 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.32 178.3 8.52 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 -168.223 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 m -110.44 162.16 14.95 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 170.886 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -119.23 146.56 45.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 14.6 m -141.8 150.91 42.3 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -120.71 142.09 49.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 173.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 60.05 62.44 1.64 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 127.495 2.318 . . . . 0.0 111.374 174.277 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.18 145.5 30.17 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 171.428 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -64.73 160.58 39.8 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.973 2.448 . . . . 0.0 110.886 174.353 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -66.51 -24.53 66.41 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.867 0.867 . . . . 0.0 112.626 -168.087 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -81.48 -2.75 50.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.473 1.109 . . . . 0.0 111.162 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.87 122.88 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 177.776 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.75 145.57 17.71 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -136.72 -153.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -165.538 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -66.65 131.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.365 1.265 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.107 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 t -119.55 151.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 177.409 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 7.5 tp10 51.11 -142.16 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.796 2.038 . . . . 0.0 112.191 168.678 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -150.66 110.79 0.48 Allowed Glycine 0 CA--C 1.479 -2.196 1 N-CA-C 92.352 -8.299 . . . . 0.0 92.352 158.079 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -147.61 -82.33 0.12 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -165.79 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 35.6 tttm -165.4 -175.25 3.5 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 99.559 -4.237 . . . . 0.0 99.559 -173.186 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.431 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 1.7 t -132.15 134.19 45.13 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 95.879 -5.601 . . . . 0.0 95.879 177.931 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -162.06 158.56 25.06 Favored 'General case' 0 CA--C 1.485 -1.54 1 N-CA-C 99.356 -4.312 . . . . 0.0 99.356 -176.161 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -153.4 164.03 38.89 Favored 'General case' 0 N--CA 1.423 -1.807 1 N-CA-C 95.811 -5.626 . . . . 0.0 95.811 -177.253 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.926 0 O-C-N 124.435 1.085 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 159.91 15.92 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.37 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -130.69 130.09 43.42 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.558 -6.09 . . . . 0.0 94.558 159.457 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.07 -170.31 26.64 Favored Glycine 0 CA--C 1.473 -2.567 1 N-CA-C 101.607 -4.597 . . . . 0.0 101.607 179.146 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -83.54 143.4 30.2 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 159.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.27 143.57 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.897 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.45 -137.05 0.35 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.498 1.919 . . . . 0.0 106.507 179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -136.88 155.23 76.53 Favored Pre-proline 0 N--CA 1.421 -1.907 1 N-CA-C 95.185 -5.858 . . . . 0.0 95.185 159.822 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -66.3 150.77 84.5 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 0.0 108.423 174.774 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.34 -30.07 33.92 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 128.389 2.676 . . . . 0.0 108.992 6.572 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -164.67 159.36 18.78 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 94.237 -6.209 . . . . 0.0 94.237 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m 167.51 -147.69 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 98.82 -4.511 . . . . 0.0 98.82 174.395 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.91 170.01 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 1 N-CA-C 95.661 -5.681 . . . . 0.0 95.661 170.15 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.39 179.85 6.79 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 167.889 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -119.17 78.06 1.26 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 -179.11 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.3 t -98.77 -170.37 1.93 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -142.63 172.87 5.19 Favored Pre-proline 0 N--CA 1.42 -1.971 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -164.619 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -66.69 50.54 0.32 Allowed 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 123.595 2.864 . . . . 0.0 112.829 162.628 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.46 139.93 5.62 Favored Glycine 0 N--CA 1.423 -2.191 1 N-CA-C 100.437 -5.065 . . . . 0.0 100.437 -178.452 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -94.83 30.37 2.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 -171.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -65.86 -57.12 8.64 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.969 1.708 . . . . 0.0 110.836 -166.608 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.17 -28.91 47.7 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.048 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.91 -30.52 71.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.651 1.181 . . . . 0.0 110.859 -172.542 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.45 -58.62 6.5 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.744 0.818 . . . . 0.0 109.945 173.59 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -44.59 96.76 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.157 0.983 . . . . 0.0 113.014 175.833 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.35 -41.85 88.91 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.287 0.565 . . . . 0.0 111.094 -173.283 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -64.25 -40.56 96.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 121.948 -0.47 . . . . 0.0 109.934 179.553 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -66.08 -47.29 74.77 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 122.071 -0.393 . . . . 0.0 111.625 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.18 -20.49 63.12 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.654 -0.654 . . . . 0.0 112.292 -173.747 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.55 -3.23 50.15 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.248 0.619 . . . . 0.0 110.199 176.205 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.32 32.56 8.18 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 165.854 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.82 163.05 13.03 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 105.546 -3.021 . . . . 0.0 105.546 168.774 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -83.72 -43.6 15.33 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.244 1.021 . . . . 0.0 110.038 -169.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -160.12 150.92 18.91 Favored 'General case' 0 N--CA 1.418 -2.068 1 N-CA-C 98.759 -4.534 . . . . 0.0 98.759 -157.954 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.9 169.24 38.03 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 100.286 -5.126 . . . . 0.0 100.286 -171.157 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -162.55 -177.98 5.95 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 98.258 -4.719 . . . . 0.0 98.258 -179.494 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.1 m -139.26 162.42 35.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -178.804 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.83 109.1 0.73 Allowed Glycine 0 CA--C 1.487 -1.681 1 N-CA-C 101.748 -4.541 . . . . 0.0 101.748 -178.359 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 41' ' ' VAL . 72.1 t80 -161.14 149.07 15.55 Favored 'General case' 0 CA--C 1.483 -1.617 1 N-CA-C 97.216 -5.105 . . . . 0.0 97.216 -165.595 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -151.12 75.38 1.19 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.666 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.438 ' HB ' ' CE2' ' A' ' 39' ' ' PHE . 49.1 t -126.07 138.52 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 95.671 -5.678 . . . . 0.0 95.671 167.129 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.91 62.99 4.52 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 119.016 0.826 . . . . 0.0 111.621 -163.614 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.5 -51.52 2.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.53 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 -164.19 35.5 Favored Glycine 0 N--CA 1.426 -2.019 1 N-CA-C 96.029 -6.828 . . . . 0.0 96.029 -164.372 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.65 118.63 22.23 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -172.318 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.84 -178.2 5.69 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.068 0.947 . . . . 0.0 110.703 -166.706 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.98 149.62 40.63 Favored 'General case' 0 CA--C 1.489 -1.377 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -174.616 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -96.87 155.17 16.89 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 178.817 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.4 m -147.64 152.14 37.37 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 168.248 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -115.91 144.55 43.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 169.023 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.45 57.3 0.57 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 128.059 2.543 . . . . 0.0 111.651 170.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.09 124.8 48.28 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.574 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 167.04 28.09 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.184 1.923 . . . . 0.0 109.43 174.656 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.77 46.97 1.44 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.52 -0.737 . . . . 0.0 111.618 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -111.91 -6.53 14.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 163.798 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.87 140.86 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 -172.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.65 147.59 18.0 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 103.399 -3.88 . . . . 0.0 103.399 179.407 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.97 -159.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -165.942 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 9.6 mm -69.75 133.12 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -174.655 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.58 160.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 176.806 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -161.76 162.8 29.75 Favored 'General case' 0 N--CA 1.428 -1.543 1 N-CA-C 96.754 -5.276 . . . . 0.0 96.754 171.733 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.07 35.59 26.94 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 104.841 -3.304 . . . . 0.0 104.841 -150.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -179.04 -163.61 0.06 Allowed 'General case' 0 N--CA 1.424 -1.731 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 -166.292 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 21.1 ttpp -156.98 -169.01 2.82 Favored 'General case' 0 N--CA 1.43 -1.431 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 179.707 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.458 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 8.7 t -72.52 134.32 45.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.881 2.072 . . . . 0.0 106.086 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.293 98.2 m-70 57.91 -132.68 1.23 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 126.089 1.756 . . . . 0.0 109.535 -161.41 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.5 m -79.65 55.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 177.101 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.081 0 CA-C-N 116.23 -0.441 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.45 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -148.81 179.77 7.59 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 171.558 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -137.02 142.0 42.5 Favored 'General case' 0 CA--C 1.485 -1.532 1 N-CA-C 96.666 -5.309 . . . . 0.0 96.666 179.667 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.53 12.15 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 99.653 -5.379 . . . . 0.0 99.653 165.41 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 94.5 m-85 -82.53 144.03 30.67 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 165.035 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -91.11 139.98 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.401 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.11 -168.14 1.5 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.099 2.959 . . . . 0.0 108.549 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -113.7 161.67 26.41 Favored Pre-proline 0 N--CA 1.428 -1.53 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 170.975 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.2 134.64 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 N-CA-C 106.843 -2.022 . . . . 0.0 106.843 158.205 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -79.31 -58.16 3.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.05 2.14 . . . . 0.0 111.251 14.479 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -166.6 146.24 5.75 Favored 'General case' 0 N--CA 1.426 -1.638 1 N-CA-C 92.384 -6.895 . . . . 0.0 92.384 -178.357 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 21.9 m 159.92 -141.4 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.528 1 N-CA-C 97.771 -4.9 . . . . 0.0 97.771 179.131 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 59' ' ' ILE . 3.0 m -124.26 165.34 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 176.203 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -154.83 0.29 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 162.976 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -141.17 177.37 8.13 Favored 'General case' 0 N--CA 1.425 -1.68 1 N-CA-C 97.177 -5.119 . . . . 0.0 97.177 167.818 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.81 158.81 43.83 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.816 -5.624 . . . . 0.0 95.816 -179.263 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -115.6 113.57 42.67 Favored Pre-proline 0 N--CA 1.422 -1.839 1 N-CA-C 96.197 -5.483 . . . . 0.0 96.197 177.716 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.83 99.2 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 CA-C-N 124.019 2.471 . . . . 0.0 116.082 -156.025 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.93 -166.9 36.42 Favored Glycine 0 N--CA 1.423 -2.219 1 N-CA-C 96.716 -6.554 . . . . 0.0 96.716 -173.746 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -85.97 -41.53 14.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.199 1.0 . . . . 0.0 109.6 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.43 -70.56 0.1 Allowed 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -147.352 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.11 -31.68 54.59 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 121.092 -1.005 . . . . 0.0 111.42 -172.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.95 -49.54 44.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.415 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.5 -33.66 76.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.22 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 m -61.48 -50.19 73.73 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.892 172.5 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -42.6 99.76 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.905 0.882 . . . . 0.0 109.968 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -56.48 -47.13 79.86 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.566 1.146 . . . . 0.0 110.714 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.8 -45.5 89.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.886 0.874 . . . . 0.0 110.585 -175.412 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.39 -28.93 62.29 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.845 -0.534 . . . . 0.0 112.163 -176.015 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.6 -18.2 45.59 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.589 -0.694 . . . . 0.0 110.144 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.91 38.16 2.99 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 163.717 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.29 139.25 14.39 Favored Glycine 0 CA--C 1.486 -1.776 1 N-CA-C 101.153 -4.779 . . . . 0.0 101.153 164.099 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -81.84 -29.06 32.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 118.032 0.916 . . . . 0.0 110.065 -162.629 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.47 -176.86 5.84 Favored 'General case' 0 N--CA 1.423 -1.783 1 N-CA-C 98.313 -4.699 . . . . 0.0 98.313 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.25 -160.97 24.99 Favored Glycine 0 N--CA 1.414 -2.783 1 N-CA-C 100.618 -4.993 . . . . 0.0 100.618 -167.378 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -163.62 -159.73 0.53 Allowed 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 96.899 -5.223 . . . . 0.0 96.899 -172.346 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -136.11 170.26 16.29 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 100.584 -3.858 . . . . 0.0 100.584 173.955 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 -177.31 47.92 Favored Glycine 0 N--CA 1.422 -2.283 1 N-CA-C 101.32 -4.712 . . . . 0.0 101.32 177.695 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -113.56 139.97 48.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -177.435 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -110.71 91.09 3.52 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.679 -3.082 . . . . 0.0 102.679 173.054 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 t -68.27 124.98 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -171.168 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -47.53 1.01 Allowed Glycine 0 CA--C 1.483 -1.922 0 N-CA-C 104.539 -3.424 . . . . 0.0 104.539 -173.019 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -100.44 -60.3 1.55 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.001 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.43 -170.63 39.67 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.633 -2.587 . . . . 0.0 106.633 -174.037 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.15 137.68 35.92 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 102.904 -2.998 . . . . 0.0 102.904 177.493 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.93 -174.51 3.68 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -164.165 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.9 t -114.62 153.84 29.43 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 178.3 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.9 t-105 -119.48 149.78 41.32 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -177.299 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -143.15 156.13 44.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.73 144.2 50.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 102.691 -3.078 . . . . 0.0 102.691 170.021 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.64 52.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.758 2.023 . . . . 0.0 111.415 171.832 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.65 130.66 36.18 Favored Pre-proline 0 CA--C 1.501 -0.934 0 N-CA-C 104.951 -2.241 . . . . 0.0 104.951 173.877 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -74.22 176.07 10.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.451 2.1 . . . . 0.0 110.741 175.268 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -86.15 19.69 2.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.988 -174.216 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -95.15 -7.01 40.51 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.446 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.01 169.0 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -179.155 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -148.68 151.26 23.47 Favored Glycine 0 CA--C 1.479 -2.179 1 N-CA-C 97.533 -6.227 . . . . 0.0 97.533 173.755 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.3 -147.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -155.416 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.38 -27.71 43.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 126.173 1.789 . . . . 0.0 113.312 -169.654 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 167.4 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.539 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -171.98 -173.84 1.2 Allowed 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 94.978 -5.934 . . . . 0.0 94.978 -170.061 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.42 69.92 2.9 Favored Glycine 0 CA--C 1.495 -1.195 0 N-CA-C 105.007 -3.237 . . . . 0.0 105.007 164.334 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -169.5 -170.91 1.14 Allowed 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 96.739 -5.282 . . . . 0.0 96.739 -172.033 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -164.19 172.1 14.11 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.73 -4.544 . . . . 0.0 98.73 -175.125 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 18.2 t -73.16 125.48 27.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 127.506 2.322 . . . . 0.0 109.106 -172.168 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -165.04 172.92 12.09 Favored 'General case' 0 N--CA 1.426 -1.659 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 173.466 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m 177.47 178.69 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 95.746 -5.649 . . . . 0.0 95.746 171.221 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.937 0 CA-C-N 119.022 0.828 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.279 0.562 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.36 170.95 9.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 160.489 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -129.96 132.69 46.4 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 93.509 -6.478 . . . . 0.0 93.509 158.314 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -178.01 35.39 Favored Glycine 0 CA--C 1.47 -2.736 0 N-CA-C 104.015 -3.634 . . . . 0.0 104.015 -175.647 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -83.71 140.65 31.99 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 162.442 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -90.39 137.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.005 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.31 -145.03 0.3 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.198 174.993 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.7 142.8 45.11 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 92.939 -6.689 . . . . 0.0 92.939 166.926 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.82 146.34 47.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.693 1.998 . . . . 0.0 107.974 -177.172 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.23 -21.69 17.71 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 126.098 1.759 . . . . 0.0 108.504 13.404 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -158.48 151.68 22.81 Favored 'General case' 0 N--CA 1.415 -2.2 1 N-CA-C 95.945 -5.576 . . . . 0.0 95.945 172.182 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 166.54 -155.93 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 -177.707 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 43' ' ' HIS . 15.3 m -127.4 164.81 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 1 N-CA-C 96.798 -5.26 . . . . 0.0 96.798 161.953 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.11 171.75 8.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 161.658 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -108.56 116.33 31.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -177.67 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 t -92.39 150.43 20.82 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.44 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.36 122.02 28.98 Favored Pre-proline 0 N--CA 1.422 -1.855 1 N-CA-C 97.65 -4.945 . . . . 0.0 97.65 -179.341 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.57 137.49 74.04 Favored 'Trans proline' 0 CA--C 1.505 -0.962 0 CA-C-N 123.456 2.27 . . . . 0.0 110.987 -176.371 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.36 -57.95 0.57 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -158.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m 105.51 -14.72 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 128.901 2.881 . . . . 0.0 110.533 173.137 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -46.44 -51.05 15.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.685 1.994 . . . . 0.0 114.806 -162.974 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.84 -39.77 75.56 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 121.507 -0.746 . . . . 0.0 111.517 -177.231 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.04 -22.1 22.02 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.068 -1.254 . . . . 0.0 110.748 -169.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.47 94.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.878 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -62.49 -45.05 94.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.161 -0.962 . . . . 0.0 110.983 172.797 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.94 -41.24 97.73 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.518 -0.739 . . . . 0.0 111.926 177.532 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.22 -44.39 75.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.35 1.46 . . . . 0.0 110.345 174.771 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.59 -45.85 88.52 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.853 -0.529 . . . . 0.0 111.554 -177.322 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.75 -7.63 51.52 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.36 -0.837 . . . . 0.0 112.669 -177.096 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -102.79 -3.78 25.89 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 121.704 -0.622 . . . . 0.0 109.813 174.497 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.56 28.35 11.53 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 169.945 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.34 129.71 9.99 Favored Glycine 0 CA--C 1.483 -1.917 0 N-CA-C 104.259 -3.536 . . . . 0.0 104.259 169.079 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -36.25 74.19 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.509 -165.763 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -160.56 175.33 12.83 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 170.642 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.49 -178.72 48.78 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 98.516 -5.833 . . . . 0.0 98.516 -169.694 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -164.08 -175.82 4.2 Favored 'General case' 0 N--CA 1.434 -1.24 1 N-CA-C 99.067 -4.42 . . . . 0.0 99.067 -177.946 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.4 m -84.4 168.67 15.33 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.317 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.47 -178.35 41.82 Favored Glycine 0 CA--C 1.487 -1.671 1 N-CA-C 96.9 -6.48 . . . . 0.0 96.9 172.562 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -152.6 132.72 13.48 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 100.478 -3.897 . . . . 0.0 100.478 179.629 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -139.66 40.25 2.02 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.261 2.2 t 57.11 -134.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.17 1.788 . . . . 0.0 107.606 -172.328 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -122.48 7.58 Favored Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 179.55 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.433 ' HB2' HG13 ' A' ' 13' ' ' VAL . 13.8 m170 -118.15 5.12 11.97 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.126 0.57 . . . . 0.0 109.711 -166.939 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.22 -172.87 34.74 Favored Glycine 0 CA--C 1.483 -1.947 1 N-CA-C 100.413 -5.075 . . . . 0.0 100.413 -178.046 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.25 98.46 11.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.028 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.38 177.71 7.74 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 125.634 1.574 . . . . 0.0 110.93 -172.791 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -126.69 160.03 31.96 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.411 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -96.61 154.66 17.15 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 177.69 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.0 m -142.37 140.68 32.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.764 -3.791 . . . . 0.0 100.764 165.53 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.75 27.97 8.9 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.482 0.658 . . . . 0.0 109.631 -170.026 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.27 147.95 0.74 Allowed 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 93.605 -6.443 . . . . 0.0 93.605 167.794 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -150.86 142.83 15.77 Favored Pre-proline 0 CA--C 1.487 -1.468 1 N-CA-C 97.711 -4.922 . . . . 0.0 97.711 153.076 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.86 171.73 17.28 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.265 1.977 . . . . 0.0 109.598 176.498 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.54 -4.97 37.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -92.98 3.65 55.37 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 -178.135 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 t -107.76 138.5 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 103.557 -2.756 . . . . 0.0 103.557 -176.3 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.75 147.37 16.41 Favored Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 103.786 -3.726 . . . . 0.0 103.786 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.9 -160.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -164.342 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -73.33 137.46 23.3 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -172.883 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.88 153.41 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 1 N-CA-C 95.046 -5.909 . . . . 0.0 95.046 173.54 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.73 153.04 30.62 Favored 'General case' 0 N--CA 1.427 -1.62 1 N-CA-C 96.717 -5.29 . . . . 0.0 96.717 168.251 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.94 -42.87 1.43 Allowed Glycine 0 CA--C 1.49 -1.529 1 N-CA-C 100.651 -4.98 . . . . 0.0 100.651 -160.786 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.94 -145.19 0.28 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.159 -3.274 . . . . 0.0 102.159 157.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 51.9 tttm -157.48 -170.77 3.34 Favored 'General case' 0 N--CA 1.428 -1.554 1 N-CA-C 97.513 -4.995 . . . . 0.0 97.513 -174.378 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 34.7 t -65.52 147.35 53.56 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 126.284 1.834 . . . . 0.0 110.031 -178.486 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -156.03 102.69 2.17 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 167.688 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -66.63 125.09 24.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 124.693 1.197 . . . . 0.0 110.137 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.062 0 O-C-N 123.424 0.453 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 177.71 7.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 172.704 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -129.58 139.76 51.39 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 97.621 -4.955 . . . . 0.0 97.621 171.556 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 179.16 37.5 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 177.58 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -78.04 128.67 34.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 162.411 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 tt -90.76 140.76 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.385 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.65 -162.47 0.96 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.229 3.012 . . . . 0.0 107.755 174.54 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -144.05 170.37 8.51 Favored Pre-proline 0 N--CA 1.42 -1.953 1 N-CA-C 96.886 -5.227 . . . . 0.0 96.886 175.364 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -64.28 152.58 80.76 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.221 1.948 . . . . 0.0 111.314 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.61 -49.21 9.42 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 127.1 2.16 . . . . 0.0 107.544 -1.203 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -146.2 139.49 25.9 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 92.096 -7.002 . . . . 0.0 92.096 169.153 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.2 m -175.83 -158.44 0.06 Allowed 'General case' 0 CA--C 1.488 -1.408 1 N-CA-C 100.024 -4.065 . . . . 0.0 100.024 -174.178 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.479 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.14 155.14 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 N-CA-C 97.509 -4.997 . . . . 0.0 97.509 164.992 . . . . . . . . 4 4 . 1 . 038 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.27 153.22 20.63 Favored 'General case' 0 CA--C 1.494 -1.191 1 N-CA-C 100.136 -4.024 . . . . 0.0 100.136 166.044 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -102.07 -173.13 2.27 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.255 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.4 t -140.24 154.37 46.85 Favored 'General case' 0 N--CA 1.417 -2.093 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 -171.125 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -115.93 121.39 34.08 Favored Pre-proline 0 N--CA 1.419 -1.988 1 N-CA-C 96.816 -5.253 . . . . 0.0 96.816 167.561 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -56.86 129.2 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 122.972 2.097 . . . . 0.0 112.846 -174.429 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.31 -46.78 1.04 Allowed Glycine 0 CA--C 1.491 -1.424 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -164.41 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 m 92.69 2.41 0.08 Allowed 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 127.496 2.318 . . . . 0.0 112.093 171.289 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -34.65 77.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.835 1.198 . . . . 0.0 111.469 -173.795 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.09 -48.89 50.79 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 175.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.21 -49.78 76.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.378 1.471 . . . . 0.0 109.182 179.418 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.52 -45.37 73.34 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.345 1.458 . . . . 0.0 111.751 177.516 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 m -63.88 -43.87 94.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.72 -36.47 67.79 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.769 0.795 . . . . 0.0 109.953 -176.218 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -62.61 -46.5 88.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.739 1.216 . . . . 0.0 110.448 173.358 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.18 -45.78 86.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 123.969 0.908 . . . . 0.0 110.051 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -95.33 -4.29 45.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.145 0.978 . . . . 0.0 109.972 179.425 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.02 12.53 31.53 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 168.139 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.91 127.38 8.39 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 177.207 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 p -97.0 5.04 51.18 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.879 -0.777 . . . . 0.0 110.041 -169.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -160.48 158.1 28.74 Favored 'General case' 0 CA--C 1.479 -1.752 1 N-CA-C 99.159 -4.385 . . . . 0.0 99.159 166.898 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.31 168.4 41.41 Favored Glycine 0 N--CA 1.417 -2.633 1 N-CA-C 98.628 -5.789 . . . . 0.0 98.628 -178.541 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -166.77 173.83 9.18 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 97.064 -5.162 . . . . 0.0 97.064 -179.871 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.0 m -94.95 162.28 13.8 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.548 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.11 174.09 40.98 Favored Glycine 0 N--CA 1.421 -2.304 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 178.533 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -117.79 138.14 52.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 101.544 -3.502 . . . . 0.0 101.544 -177.156 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -98.47 -29.14 13.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.18 0.99 . . . . 0.0 109.483 -175.349 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 42' ' ' GLY . 3.5 t 70.62 176.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 105.468 -165.815 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 80.76 -65.42 3.92 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 120.137 -1.602 . . . . 0.0 109.931 172.572 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -91.36 -53.33 4.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 172.131 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.84 -128.46 3.46 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 171.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.47 127.42 32.67 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.435 2.694 . . . . 0.0 106.665 -177.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.36 176.88 7.6 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -166.941 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.8 t -117.55 158.96 23.66 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 100.301 -3.962 . . . . 0.0 100.301 174.038 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.4 t-105 -124.07 150.34 45.11 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.444 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.2 m -140.07 152.75 46.43 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.623 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.17 138.35 51.34 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 169.671 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.71 50.13 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.942 2.097 . . . . 0.0 111.072 166.852 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.1 133.29 32.14 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.95 176.12 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.321 2.014 . . . . 0.0 110.715 176.496 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.4 2.44 25.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.075 0.95 . . . . 0.0 112.732 -170.734 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -95.93 5.26 51.66 Favored 'General case' 0 CA--C 1.503 -0.849 0 O-C-N 121.098 -1.001 . . . . 0.0 108.847 175.694 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.49 167.39 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 175.76 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.61 163.1 29.54 Favored Glycine 0 CA--C 1.485 -1.827 1 N-CA-C 98.319 -5.912 . . . . 0.0 98.319 -177.039 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -154.12 -164.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 -161.834 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -65.4 121.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 123.979 0.912 . . . . 0.0 111.013 -163.977 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.64 155.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.308 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -157.41 167.93 28.82 Favored 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 96.855 -5.239 . . . . 0.0 96.855 177.624 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 24.68 52.43 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -151.368 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 176.48 -165.33 0.03 OUTLIER 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 94.276 -6.194 . . . . 0.0 94.276 -167.392 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -165.81 -153.3 0.17 Allowed 'General case' 0 N--CA 1.432 -1.374 1 N-CA-C 99.079 -4.415 . . . . 0.0 99.079 177.967 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.9 t -82.34 142.74 31.78 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 125.832 1.653 . . . . 0.0 107.202 -176.064 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -157.61 153.31 26.62 Favored 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 172.548 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.5 m 1.67 68.14 0.0 OUTLIER 'General case' 0 C--N 1.358 0.961 0 C-N-CA 130.646 3.579 . . . . 0.0 117.353 -169.89 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.362 1.13 0 CA-C-N 116.766 -0.197 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.223 0.535 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 176.68 5.28 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 159.294 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -129.75 144.34 51.25 Favored 'General case' 0 CA--C 1.481 -1.675 1 N-CA-C 95.169 -5.863 . . . . 0.0 95.169 171.903 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 -178.24 35.47 Favored Glycine 0 CA--C 1.473 -2.593 0 N-CA-C 103.957 -3.657 . . . . 0.0 103.957 175.879 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 33.3 m-85 -76.73 137.75 39.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 156.68 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 tt -90.52 137.82 20.79 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.357 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -108.36 -154.62 0.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 127.245 2.218 . . . . 0.0 107.946 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -122.7 148.77 54.3 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 95.604 -5.702 . . . . 0.0 95.604 170.138 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -68.96 145.57 62.22 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 122.691 1.997 . . . . 0.0 109.025 -176.761 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -89.07 -42.52 11.68 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.881 2.472 . . . . 0.0 110.085 12.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -153.97 140.09 18.41 Favored 'General case' 0 N--CA 1.424 -1.746 1 N-CA-C 92.212 -6.959 . . . . 0.0 92.212 178.459 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -178.35 -151.53 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 95.515 -5.735 . . . . 0.0 95.515 178.321 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.91 -178.34 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 163.177 . . . . . . . . 4 4 . 1 . 039 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -152.67 0.32 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 166.758 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -143.18 161.2 38.85 Favored 'General case' 0 N--CA 1.422 -1.846 1 N-CA-C 94.601 -6.074 . . . . 0.0 94.601 153.005 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -160.54 -157.7 0.56 Allowed 'General case' 0 N--CA 1.42 -1.974 1 N-CA-C 96.077 -5.527 . . . . 0.0 96.077 -176.682 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -147.1 172.4 5.24 Favored Pre-proline 0 N--CA 1.418 -2.045 1 N-CA-C 99.865 -4.124 . . . . 0.0 99.865 -161.317 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.92 63.55 4.03 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 124.311 2.575 . . . . 0.0 111.386 170.574 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.87 148.65 5.68 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 101.578 -4.609 . . . . 0.0 101.578 174.181 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -83.98 60.97 6.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 118.166 0.983 . . . . 0.0 108.675 178.18 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -69.94 -65.21 0.75 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -173.905 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.8 -22.42 57.95 Favored Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 177.084 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -79.48 -10.74 59.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.261 -1.141 . . . . 0.0 110.992 -174.139 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.4 -51.99 67.53 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 120.428 1.467 . . . . 0.0 108.649 174.746 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -72.28 -40.76 67.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.151 -177.405 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.27 -42.93 96.42 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 118.659 0.663 . . . . 0.0 112.565 179.055 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.31 -44.39 91.72 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -69.29 -43.47 73.75 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 121.439 -0.788 . . . . 0.0 111.679 -178.711 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -69.42 -28.49 66.18 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 119.544 1.065 . . . . 0.0 112.829 -177.675 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -87.51 -4.01 58.99 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.664 0.665 . . . . 0.0 110.558 175.609 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.91 29.4 8.11 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 162.217 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.21 149.32 17.89 Favored Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 171.1 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 p -79.33 -50.45 10.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.174 0.988 . . . . 0.0 109.88 -167.836 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -160.17 176.83 11.32 Favored 'General case' 0 N--CA 1.422 -1.844 1 N-CA-C 98.699 -4.556 . . . . 0.0 98.699 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.27 46.22 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 103.68 -3.768 . . . . 0.0 103.68 -169.585 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -146.98 -177.77 5.84 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.754 -4.906 . . . . 0.0 97.754 -169.252 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.3 m -136.96 160.75 37.97 Favored 'General case' 0 CA--C 1.479 -1.766 1 N-CA-C 99.549 -4.241 . . . . 0.0 99.549 171.529 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.09 179.26 47.37 Favored Glycine 0 N--CA 1.424 -2.136 1 N-CA-C 99.841 -5.304 . . . . 0.0 99.841 -174.318 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -93.18 150.58 20.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 -172.449 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -118.15 116.09 26.13 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 170.838 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.36 128.57 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.45 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -16.57 26.09 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -175.723 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -127.52 -85.49 0.59 Allowed 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.8 -162.56 34.9 Favored Glycine 0 N--CA 1.426 -1.971 1 N-CA-C 102.91 -4.076 . . . . 0.0 102.91 -169.685 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.18 147.73 52.9 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.152 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.79 -176.08 5.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -165.26 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -128.18 166.13 19.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 175.869 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 16.2 t-105 -125.71 143.27 51.11 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 177.799 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.3 m -135.83 139.9 43.79 Favored 'General case' 0 CA--C 1.487 -1.465 1 N-CA-C 99.898 -4.112 . . . . 0.0 99.898 175.045 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -104.49 30.98 4.95 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.105 0.955 . . . . 0.0 108.929 -168.054 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.62 146.95 1.75 Allowed 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 94.036 -6.283 . . . . 0.0 94.036 165.911 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.53 151.67 64.3 Favored Pre-proline 0 N--CA 1.427 -1.591 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 141.79 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.41 174.01 13.28 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 122.158 1.905 . . . . 0.0 110.168 164.775 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -65.04 -11.66 41.73 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 126.454 1.902 . . . . 0.0 115.116 -172.259 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.3 -0.08 57.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.255 -0.903 . . . . 0.0 111.036 -175.543 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.29 142.51 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 -176.488 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.49 155.19 16.5 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 104.679 -3.368 . . . . 0.0 104.679 -176.668 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 pt -143.44 -155.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -161.583 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -83.57 154.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -172.88 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.2 173.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.628 1 N-CA-C 96.763 -5.273 . . . . 0.0 96.763 171.208 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -156.91 158.7 37.16 Favored 'General case' 0 N--CA 1.43 -1.472 1 N-CA-C 98.108 -4.775 . . . . 0.0 98.108 168.929 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 -40.61 2.42 Favored Glycine 0 CA--C 1.495 -1.197 1 N-CA-C 102.211 -4.356 . . . . 0.0 102.211 -162.989 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 7.0 tp10 -91.74 -153.39 0.33 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 157.752 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 2.1 tmtm? -168.85 -167.75 0.79 Allowed 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 98.748 -4.538 . . . . 0.0 98.748 -175.677 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.5 t -71.41 125.27 26.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.553 1.541 . . . . 0.0 107.77 -176.077 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.51 145.96 21.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 m -160.72 175.57 12.48 Favored 'General case' 0 N--CA 1.428 -1.564 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 -176.012 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.037 0 O-C-N 124.007 0.817 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.34 169.68 10.36 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 176.109 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -134.83 137.0 42.91 Favored 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 96.437 -5.394 . . . . 0.0 96.437 169.735 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.49 23.03 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 105.312 -3.115 . . . . 0.0 105.312 172.823 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 72.2 m-85 -82.38 137.41 34.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 163.272 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 58' ' ' ILE . 20.9 tt -91.65 140.89 15.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.873 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB2' HG12 ' A' ' 59' ' ' ILE . . . -95.7 -155.09 0.46 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.215 3.406 . . . . 0.0 110.406 -177.766 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -132.92 154.03 81.24 Favored Pre-proline 0 N--CA 1.429 -1.512 1 N-CA-C 96.211 -5.478 . . . . 0.0 96.211 165.511 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -67.25 135.12 35.9 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.889 2.393 . . . . 0.0 107.884 168.011 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -90.57 -55.14 3.7 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 121.881 2.128 . . . . 0.0 110.752 20.227 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -149.3 132.6 16.5 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 92.971 -6.678 . . . . 0.0 92.971 177.667 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -176.59 -169.01 0.26 Allowed 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 -174.799 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.75 160.95 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 167.775 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -161.26 0.32 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 162.522 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.79 158.7 43.37 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.39 -5.411 . . . . 0.0 96.39 165.11 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.39 168.06 18.23 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 -167.908 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -114.02 114.18 46.37 Favored Pre-proline 0 N--CA 1.42 -1.942 1 N-CA-C 99.576 -4.231 . . . . 0.0 99.576 174.309 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -57.89 125.72 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.576 2.184 . . . . 0.0 112.268 -176.161 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.15 -56.93 0.67 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 100.357 -5.097 . . . . 0.0 100.357 -162.419 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m 117.7 -34.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 129.48 3.112 . . . . 0.0 107.676 173.466 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.37 -51.22 2.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.86 2.864 . . . . 0.0 116.238 -159.375 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.48 -43.94 75.28 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.559 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.34 -23.08 26.35 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -170.695 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.79 -37.65 85.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.353 1.061 . . . . 0.0 108.522 168.964 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.9 m -69.46 -40.21 77.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.799 -0.563 . . . . 0.0 109.981 174.58 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.89 -38.03 89.63 Favored 'General case' 0 C--N 1.359 1.012 0 O-C-N 121.277 -0.889 . . . . 0.0 111.404 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -52.85 -48.56 66.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.01 1.324 . . . . 0.0 110.357 170.008 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -65.15 -41.85 94.36 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.463 -0.773 . . . . 0.0 112.446 -175.05 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.34 -9.44 58.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.137 -0.977 . . . . 0.0 111.906 -177.301 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -103.43 7.3 38.02 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.245 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.7 20.26 34.88 Favored Glycine 0 CA--C 1.491 -1.466 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.922 167.238 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.37 148.26 22.87 Favored Glycine 0 CA--C 1.49 -1.531 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 170.077 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.5 m -88.79 -32.72 17.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -168.583 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.7 m -160.69 -177.88 6.48 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 98.783 -4.525 . . . . 0.0 98.783 170.357 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.42 -169.87 37.67 Favored Glycine 0 CA--C 1.466 -3.031 1 N-CA-C 102.247 -4.341 . . . . 0.0 102.247 -172.471 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.41 -160.43 0.77 Allowed 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 98.835 -4.506 . . . . 0.0 98.835 -169.942 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.04 170.96 17.65 Favored 'General case' 0 CA--C 1.472 -2.047 1 N-CA-C 99.085 -4.413 . . . . 0.0 99.085 175.328 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.45 -170.8 41.02 Favored Glycine 0 N--CA 1.419 -2.487 1 N-CA-C 98.031 -6.027 . . . . 0.0 98.031 -173.751 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -124.08 150.04 45.46 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 100.765 -3.791 . . . . 0.0 100.765 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -123.05 98.99 6.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 173.763 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.86 122.93 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.69 -40.57 1.53 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -165.385 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -124.43 -63.59 1.18 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.508 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.24 -158.91 31.04 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -172.239 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.43 146.62 53.02 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.566 2.347 . . . . 0.0 105.523 176.748 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.66 -177.22 6.23 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -170.894 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.9 m -122.66 173.73 7.54 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 102.115 -3.291 . . . . 0.0 102.115 170.669 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 7.6 t-105 -131.33 148.17 52.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -175.104 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.4 m -134.11 149.06 51.07 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.248 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.6 134.15 55.17 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 171.284 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.26 71.82 0.54 Allowed 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.345 2.258 . . . . 0.0 111.514 174.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.9 135.56 19.41 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 170.905 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -72.78 176.86 8.35 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 122.65 1.982 . . . . 0.0 112.253 177.01 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.61 9.84 3.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.743 0.817 . . . . 0.0 112.752 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -95.89 -0.81 50.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 121.241 -0.912 . . . . 0.0 108.566 176.025 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.2 170.37 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 -178.384 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.02 163.14 28.37 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.009 -6.036 . . . . 0.0 98.009 177.233 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.0 pt -159.28 -170.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.391 -3.929 . . . . 0.0 100.391 -160.491 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 7' ' ' ALA . 3.5 mt -76.15 116.32 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 126.28 1.832 . . . . 0.0 111.517 -162.975 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.7 163.85 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 160.546 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.04 158.62 43.59 Favored 'General case' 0 CA--C 1.484 -1.591 1 N-CA-C 97.906 -4.85 . . . . 0.0 97.906 173.539 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.77 -30.85 5.57 Favored Glycine 0 CA--C 1.493 -1.323 0 N-CA-C 104.835 -3.306 . . . . 0.0 104.835 -163.236 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -96.96 -106.68 0.17 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.352 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 58.5 tttt -169.18 -163.97 0.44 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 -171.678 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 39.4 t -123.89 120.76 33.48 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 98.722 -4.548 . . . . 0.0 98.722 178.736 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -148.11 106.46 3.76 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 179.435 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 m -83.08 137.59 34.04 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.876 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.468 0.651 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.6 165.93 12.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.161 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -137.02 132.47 34.29 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 97.452 -5.018 . . . . 0.0 97.452 171.988 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -168.5 24.01 Favored Glycine 0 CA--C 1.48 -2.098 1 N-CA-C 102.755 -4.138 . . . . 0.0 102.755 175.015 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.06 142.42 34.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 159.182 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.45 150.92 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.232 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.32 176.39 12.21 Favored 'General case' 0 N--CA 1.421 -1.887 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 179.12 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -84.2 159.93 58.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 171.009 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 80.0 Cg_exo -61.76 110.98 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.468 2.779 . . . . 0.0 110.594 171.416 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 63.4 mm-40 -131.76 131.21 42.77 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 129.178 2.991 . . . . 0.0 104.378 2.539 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 67.39 16.43 10.04 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.905 1.336 . . . . 0.0 111.573 171.451 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.1 m -96.19 88.99 4.98 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 179.654 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.29 159.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -159.899 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -166.57 1.49 Allowed 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.628 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -150.45 177.47 9.97 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 96.31 -5.441 . . . . 0.0 96.31 172.456 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -157.25 157.59 34.55 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.626 -5.694 . . . . 0.0 95.626 -175.038 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -118.61 122.08 30.29 Favored Pre-proline 0 N--CA 1.426 -1.674 0 N-CA-C 100.424 -3.917 . . . . 0.0 100.424 -175.654 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.95 130.05 38.2 Favored 'Trans proline' 0 CA--C 1.507 -0.837 0 C-N-CA 122.474 2.116 . . . . 0.0 112.994 -174.723 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.06 -48.61 0.95 Allowed Glycine 0 CA--C 1.492 -1.402 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -159.941 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.253 15.0 m 96.26 -12.43 0.09 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 128.551 2.74 . . . . 0.0 111.603 172.577 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -44.85 -48.12 11.09 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 127.377 2.271 . . . . 0.0 115.904 -166.793 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.87 -38.36 41.88 Favored Glycine 0 C--N 1.351 1.389 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -174.913 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.39 -23.92 50.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.137 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.11 -47.6 80.67 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.785 0.834 . . . . 0.0 109.35 173.43 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -47.2 86.7 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.034 -1.041 . . . . 0.0 112.77 172.104 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.03 -42.36 97.11 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 122.039 0.923 . . . . 0.0 111.297 -175.169 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.38 -42.99 97.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.19 0.996 . . . . 0.0 109.998 178.831 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -63.9 -43.5 95.77 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 117.954 0.343 . . . . 0.0 111.449 -179.474 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -76.61 -20.5 56.69 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 118.554 0.616 . . . . 0.0 111.888 -175.779 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -84.53 -14.5 48.78 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.243 0.617 . . . . 0.0 110.499 172.962 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 27.29 5.97 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 166.575 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.66 134.73 12.31 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 175.053 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 p -103.99 12.94 33.59 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 -167.15 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.38 156.44 26.16 Favored 'General case' 0 CA--C 1.482 -1.644 1 N-CA-C 98.929 -4.471 . . . . 0.0 98.929 161.1 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.41 162.51 32.8 Favored Glycine 0 CA--C 1.47 -2.772 1 N-CA-C 98.675 -5.77 . . . . 0.0 98.675 -179.056 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -174.83 175.36 2.4 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 -174.479 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.3 m -87.0 160.0 18.79 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.333 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.95 172.0 44.81 Favored Glycine 0 N--CA 1.425 -2.035 1 N-CA-C 96.73 -6.548 . . . . 0.0 96.73 176.622 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -154.73 148.64 25.65 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 98.098 -4.778 . . . . 0.0 98.098 174.208 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -179.01 47.84 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 100.367 -3.938 . . . . 0.0 100.367 163.952 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -171.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -164.96 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.14 64.93 0.39 Allowed Glycine 0 CA--C 1.489 -1.569 1 N-CA-C 102.126 -4.389 . . . . 0.0 102.126 179.011 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -160.7 -165.72 1.46 Allowed 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.391 -5.411 . . . . 0.0 96.391 -177.434 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.94 -48.32 33.95 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -177.486 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -174.29 1.65 Allowed 'General case' 0 N--CA 1.432 -1.351 1 N-CA-C 96.748 -5.278 . . . . 0.0 96.748 171.709 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.2 168.28 20.91 Favored 'General case' 0 CA--C 1.49 -1.332 1 N-CA-C 96.554 -5.35 . . . . 0.0 96.554 177.701 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.5 t -125.1 157.97 35.01 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 -171.353 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -93.82 148.9 21.7 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.378 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 m -141.31 148.76 40.27 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 167.35 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 137.55 54.0 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 -176.491 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.57 55.38 0.63 Allowed 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.677 1.591 . . . . 0.0 110.741 174.16 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 mt -92.58 135.77 26.07 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.393 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.45 166.27 30.3 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.803 2.336 . . . . 0.0 108.965 177.318 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -87.42 41.29 0.97 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -171.979 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.83 -0.12 12.36 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 169.666 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.47 151.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 -178.228 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.78 147.66 18.99 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 98.282 -5.927 . . . . 0.0 98.282 -179.772 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 pt -145.3 -138.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -156.961 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 7' ' ' ALA . 13.5 mm -73.44 146.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.459 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.07 160.7 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 2 N-CA-C 94.158 -6.238 . . . . 0.0 94.158 172.521 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 24.7 tt0 -164.36 178.03 7.79 Favored 'General case' 0 CA--C 1.488 -1.439 1 N-CA-C 99.597 -4.223 . . . . 0.0 99.597 169.978 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . 88.35 23.45 37.16 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 105.428 -3.069 . . . . 0.0 105.428 -153.266 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -176.83 -159.61 0.06 Allowed 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 97.43 -5.026 . . . . 0.0 97.43 -166.798 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.75 -167.23 2.53 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.732 -4.544 . . . . 0.0 98.732 -176.3 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.38 127.84 33.75 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 126.384 1.873 . . . . 0.0 108.807 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -149.32 159.06 44.6 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 101.669 -3.456 . . . . 0.0 101.669 176.917 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 t -169.16 -176.98 2.74 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 178.182 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.894 0 O-C-N 124.937 1.398 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.894 0.378 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.557 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -137.62 -176.87 4.56 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.803 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -133.61 143.51 48.68 Favored 'General case' 0 CA--C 1.49 -1.354 1 N-CA-C 97.492 -5.003 . . . . 0.0 97.492 176.454 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 177.45 37.88 Favored Glycine 0 CA--C 1.48 -2.107 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 178.233 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -79.28 127.91 32.66 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 156.601 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' HA ' HG22 ' A' ' 58' ' ' ILE . 12.5 tt -89.67 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -172.599 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -95.1 -146.49 0.27 Allowed 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 126.824 2.577 . . . . 0.0 109.438 178.111 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -149.81 167.75 12.39 Favored Pre-proline 0 N--CA 1.424 -1.761 1 N-CA-C 95.989 -5.56 . . . . 0.0 95.989 175.153 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.96 151.14 86.84 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.298 2.666 . . . . 0.0 107.686 158.187 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HG3' ' CE1' ' A' ' 66' ' ' HIS . 57.3 mm-40 -81.87 -51.13 8.41 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 128.12 2.568 . . . . 0.0 109.033 7.181 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -145.66 147.59 32.17 Favored 'General case' 0 N--CA 1.421 -1.914 1 N-CA-C 92.149 -6.982 . . . . 0.0 92.149 162.598 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.49 -164.41 0.22 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -173.641 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -125.75 161.76 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 1 N-CA-C 96.718 -5.29 . . . . 0.0 96.718 161.509 . . . . . . . . 4 4 . 1 . 042 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -151.93 0.07 Allowed 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 163.501 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -139.35 177.72 7.72 Favored 'General case' 0 CA--C 1.478 -1.813 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 163.825 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.9 t -138.14 162.4 34.33 Favored 'General case' 0 N--CA 1.415 -2.198 1 N-CA-C 97.347 -5.057 . . . . 0.0 97.347 -174.424 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -116.1 112.67 41.97 Favored Pre-proline 0 N--CA 1.418 -2.053 1 N-CA-C 96.031 -5.544 . . . . 0.0 96.031 172.296 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -70.45 49.53 0.87 Allowed 'Trans proline' 0 CA--C 1.517 -0.374 0 CA-C-N 124.402 2.608 . . . . 0.0 115.351 -173.663 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.31 16.78 6.67 Favored Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 168.607 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m 74.24 -52.82 0.69 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 127.362 2.265 . . . . 0.0 112.12 172.42 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.05 -41.52 59.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.317 2.247 . . . . 0.0 115.815 -170.955 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.82 60.88 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.154 -0.966 . . . . 0.0 111.496 -176.393 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.76 -47.87 24.13 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.128 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -56.58 -43.21 79.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.255 0.622 . . . . 0.0 110.193 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -57.14 -47.71 80.46 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.077 -1.014 . . . . 0.0 112.164 176.333 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.3 mt -65.38 -43.03 91.97 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-O 121.834 0.826 . . . . 0.0 110.206 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -57.42 -45.98 84.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.162 0.985 . . . . 0.0 110.762 176.422 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.95 -44.33 80.87 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 122.717 0.407 . . . . 0.0 110.322 -176.186 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.31 -30.51 66.32 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 118.381 0.537 . . . . 0.0 111.96 -177.049 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -77.74 -33.51 52.87 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.515 -0.741 . . . . 0.0 109.965 176.219 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.22 43.05 0.49 Allowed Glycine 0 CA--C 1.489 -1.589 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 161.492 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.31 139.94 14.67 Favored Glycine 0 C--N 1.353 1.528 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 164.778 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 p -96.24 -1.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.038 0.923 . . . . 0.0 109.96 -168.04 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -160.34 168.19 25.81 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 97.528 -4.99 . . . . 0.0 97.528 171.404 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.36 -177.83 37.35 Favored Glycine 0 CA--C 1.468 -2.869 1 N-CA-C 100.329 -5.108 . . . . 0.0 100.329 -175.655 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -159.0 -176.78 6.06 Favored 'General case' 0 N--CA 1.423 -1.799 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 -175.885 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -139.91 150.29 44.39 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 95.853 -5.61 . . . . 0.0 95.853 -176.755 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.97 -176.89 46.32 Favored Glycine 0 N--CA 1.423 -2.177 1 N-CA-C 102.127 -4.389 . . . . 0.0 102.127 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -118.16 141.48 48.45 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 99.803 -4.147 . . . . 0.0 99.803 -178.24 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -94.83 -28.98 14.96 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.692 1.234 . . . . 0.0 108.915 -177.574 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.6 t 72.04 -166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 129.895 3.278 . . . . 0.0 103.372 -165.158 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 75.74 -69.98 2.04 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 120.387 -1.446 . . . . 0.0 110.505 176.818 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.65 -57.33 2.17 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.047 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.09 -138.83 5.54 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 118.576 -1.773 . . . . 0.0 110.588 -178.047 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 tp -80.74 144.36 32.22 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -177.477 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.14 -179.9 7.39 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 102.9 -3.0 . . . . 0.0 102.9 -170.118 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -115.88 165.49 13.03 Favored 'General case' 0 CA--C 1.496 -1.1 1 N-CA-C 98.945 -4.465 . . . . 0.0 98.945 175.49 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -129.67 150.87 50.8 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 54.4 m -142.57 149.53 39.17 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.24 138.99 51.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 172.283 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.17 67.65 0.72 Allowed 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.884 2.473 . . . . 0.0 110.539 179.164 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.91 139.64 21.42 Favored Pre-proline 0 CA--C 1.496 -1.112 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 171.108 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -70.32 162.38 42.57 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.279 1.986 . . . . 0.0 110.567 165.166 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.16 -37.54 72.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.9 2.08 . . . . 0.0 115.164 -163.966 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -83.61 -5.86 59.29 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.869 -1.144 . . . . 0.0 110.591 -172.638 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.54 99.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 178.061 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.557 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -83.49 166.27 43.5 Favored Glycine 0 CA--C 1.489 -1.569 0 CA-C-O 122.036 0.798 . . . . 0.0 112.163 -161.823 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 6' ' ' ILE . 31.9 pt -147.35 -178.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 -164.67 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.2 mm -69.29 103.91 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 124.819 1.248 . . . . 0.0 110.216 -166.841 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.05 170.92 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 101.527 -3.509 . . . . 0.0 101.527 167.163 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.2 163.67 39.87 Favored 'General case' 0 N--CA 1.427 -1.601 1 N-CA-C 97.768 -4.901 . . . . 0.0 97.768 174.833 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.87 -33.87 4.42 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 103.923 -3.671 . . . . 0.0 103.923 -162.385 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.02 -115.54 0.22 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 175.637 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -176.47 -153.8 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.475 1 N-CA-C 97.48 -5.007 . . . . 0.0 97.48 -171.368 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 34.8 t -120.39 123.6 43.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 -179.896 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 10' ' ' GLU . 14.8 p80 -149.77 150.2 31.67 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 171.177 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t -170.46 -175.6 1.94 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 96.08 -5.526 . . . . 0.0 96.08 -172.17 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.906 0 O-C-N 125.062 1.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.139 0.495 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.487 HH21 ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.2 -178.79 6.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -128.9 132.06 47.66 Favored 'General case' 0 CA--C 1.494 -1.175 1 N-CA-C 99.008 -4.441 . . . . 0.0 99.008 171.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 175.41 38.17 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -77.26 128.04 33.66 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -91.0 139.93 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.6 -129.13 0.24 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.443 -1.708 . . . . 0.0 107.915 169.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -145.34 154.47 53.46 Favored Pre-proline 0 N--CA 1.415 -2.206 1 N-CA-C 95.337 -5.801 . . . . 0.0 95.337 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 82.2 Cg_exo -68.64 110.14 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.837 2.358 . . . . 0.0 110.551 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 52.9 mm-40 -145.64 162.16 38.15 Favored 'General case' 0 CA--C 1.484 -1.564 1 N-CA-C 98.039 -4.8 . . . . 0.0 98.039 4.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.17 27.05 0.91 Allowed 'General case' 0 C--N 1.359 0.985 0 CA-C-O 123.169 1.462 . . . . 0.0 108.887 162.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.9 m -118.99 -158.19 0.72 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.06 168.07 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 1 N-CA-C 95.594 -5.706 . . . . 0.0 95.594 161.161 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.15 -170.3 2.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -131.76 151.65 51.5 Favored 'General case' 0 CA--C 1.478 -1.799 1 N-CA-C 97.244 -5.095 . . . . 0.0 97.244 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' H ' HD22 ' A' ' 45' ' ' LEU . 9.1 t -116.65 163.4 16.18 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 -171.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -113.43 112.87 48.67 Favored Pre-proline 0 N--CA 1.419 -2.017 1 N-CA-C 98.034 -4.802 . . . . 0.0 98.034 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.74 130.72 40.04 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.293 1.996 . . . . 0.0 111.88 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.56 -56.72 0.73 Allowed Glycine 0 CA--C 1.484 -1.852 1 N-CA-C 101.659 -4.576 . . . . 0.0 101.659 -163.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m 119.42 -23.87 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.98 2.912 . . . . 0.0 107.134 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -61.77 0.74 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.381 2.272 . . . . 0.0 115.763 -154.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.56 -39.68 60.46 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.916 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -29.29 51.83 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 117.643 0.721 . . . . 0.0 109.593 -168.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.55 -49.41 77.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.63 1.172 . . . . 0.0 109.861 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -63.87 -34.34 77.72 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.75 -0.594 . . . . 0.0 112.228 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.16 -40.84 94.87 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.043 0.925 . . . . 0.0 110.685 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.03 -44.63 94.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.592 0.757 . . . . 0.0 110.612 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.36 -21.44 56.09 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 119.239 0.927 . . . . 0.0 111.567 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -84.13 -41.3 17.23 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.605 -0.685 . . . . 0.0 109.39 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.08 48.0 0.1 OUTLIER Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.6 137.81 13.88 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 104.781 -3.328 . . . . 0.0 104.781 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -0.07 56.79 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.323 1.049 . . . . 0.0 110.768 -168.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 m -159.38 164.2 34.89 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 100.012 -4.07 . . . . 0.0 100.012 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.05 169.66 39.02 Favored Glycine 0 N--CA 1.424 -2.16 1 N-CA-C 98.043 -6.023 . . . . 0.0 98.043 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -164.55 -171.42 2.33 Favored 'General case' 0 N--CA 1.438 -1.072 1 N-CA-C 100.043 -4.058 . . . . 0.0 100.043 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.8 m -98.9 174.58 6.3 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 166.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.05 43.28 Favored Glycine 0 N--CA 1.427 -1.933 1 N-CA-C 102.025 -4.43 . . . . 0.0 102.025 168.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -134.84 142.45 46.64 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.741 -4.54 . . . . 0.0 98.741 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -126.22 107.36 10.29 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.14 124.04 25.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.9 -81.27 0.22 Allowed Glycine 0 CA--C 1.482 -2.003 1 N-CA-C 100.92 -4.872 . . . . 0.0 100.92 -164.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -87.34 -59.25 2.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.99 -140.38 7.23 Favored Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -65.69 143.57 57.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.974 2.109 . . . . 0.0 106.271 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.25 -174.58 4.86 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.71 -179.99 4.91 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -132.43 151.24 51.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 -175.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.44 136.4 33.0 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -105.96 135.7 46.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.03 40.58 3.96 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.934 1.693 . . . . 0.0 112.031 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 tp -81.92 138.89 46.31 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 165.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -70.19 165.53 31.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.262 1.975 . . . . 0.0 110.833 170.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.41 -5.2 57.65 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 123.93 0.892 . . . . 0.0 110.989 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.66 16.73 10.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.244 1.017 . . . . 0.0 109.837 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.57 162.21 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 N-CA-C 95.134 -5.876 . . . . 0.0 95.134 170.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.99 -177.41 35.96 Favored Glycine 0 CA--C 1.475 -2.44 0 C-N-CA 115.877 -3.059 . . . . 0.0 107.699 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.487 ' CG2' HH21 ' A' ' 2' ' ' ARG . 46.7 pt -142.26 -152.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 114.694 -0.753 . . . . 0.0 110.873 -141.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -75.25 132.56 33.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 N--CA 1.423 -1.802 1 N-CA-C 94.813 -5.995 . . . . 0.0 94.813 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 175.89 12.51 Favored 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.274 -5.454 . . . . 0.0 96.274 169.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -125.15 141.81 51.88 Favored 'General case' 0 CA--C 1.487 -1.475 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -176.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.26 179.02 36.96 Favored Glycine 0 CA--C 1.47 -2.766 0 N-CA-C 103.996 -3.642 . . . . 0.0 103.996 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -81.8 129.79 34.85 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.0 tt -79.25 129.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.88 -169.63 1.49 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 112.055 -2.339 . . . . 0.0 107.615 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.75 151.94 37.64 Favored Pre-proline 0 N--CA 1.434 -1.243 1 N-CA-C 99.601 -4.222 . . . . 0.0 99.601 167.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.34 140.83 78.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 162.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.49 -42.31 10.34 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 121.604 2.002 . . . . 0.0 108.744 12.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -151.97 142.74 22.9 Favored 'General case' 0 N--CA 1.417 -2.077 1 N-CA-C 93.663 -6.421 . . . . 0.0 93.663 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.2 m -179.79 -155.41 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.269 -4.345 . . . . 0.0 99.269 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.72 HG12 HD12 ' A' ' 59' ' ' ILE . 15.9 m -131.42 167.96 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 1 N-CA-C 97.011 -5.181 . . . . 0.0 97.011 160.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.93 -166.37 1.37 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 163.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.29 166.95 20.07 Favored 'General case' 0 CA--C 1.484 -1.595 1 N-CA-C 98.067 -4.79 . . . . 0.0 98.067 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.15 167.24 28.36 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -128.7 129.7 23.5 Favored Pre-proline 0 N--CA 1.423 -1.818 1 N-CA-C 99.835 -4.135 . . . . 0.0 99.835 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -54.59 123.68 14.27 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.778 2.319 . . . . 0.0 112.696 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.48 -46.69 1.06 Allowed Glycine 0 CA--C 1.488 -1.61 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 -166.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m 92.11 0.09 0.13 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 127.492 2.317 . . . . 0.0 113.238 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -44.43 81.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.563 1.945 . . . . 0.0 112.905 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.18 -46.27 44.07 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -79.31 -22.03 45.15 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.823 1.312 . . . . 0.0 110.717 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -55.17 -41.51 71.98 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.229 0.922 . . . . 0.0 109.829 166.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 m -63.35 -45.7 89.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.816 -0.553 . . . . 0.0 110.205 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.29 -41.23 96.99 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 122.717 1.246 . . . . 0.0 110.039 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.62 -41.27 98.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 109.946 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -71.77 -37.15 70.53 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.14 -31.16 62.62 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.719 -0.613 . . . . 0.0 111.267 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -85.91 -16.9 37.02 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.537 -0.727 . . . . 0.0 111.073 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 43.07 2.24 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 165.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.57 142.74 16.19 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 167.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -34.01 66.86 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 129.123 2.969 . . . . 0.0 110.504 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 m -160.12 165.95 30.72 Favored 'General case' 0 N--CA 1.421 -1.922 1 N-CA-C 97.944 -4.836 . . . . 0.0 97.944 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.31 165.47 37.02 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.945 -6.062 . . . . 0.0 97.945 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -166.91 178.95 5.52 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.576 -4.602 . . . . 0.0 98.576 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.14 161.4 26.49 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.71 40.48 Favored Glycine 0 N--CA 1.421 -2.321 1 N-CA-C 98.463 -5.855 . . . . 0.0 98.463 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.85 165.46 32.22 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 96.932 -5.21 . . . . 0.0 96.932 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -114.36 -9.28 12.79 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.216 1.006 . . . . 0.0 108.998 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t 73.38 132.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 107.126 -160.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.06 -104.98 0.29 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -69.51 -77.27 0.08 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.076 0.951 . . . . 0.0 112.909 -169.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.39 -50.61 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.516 0 O-C-N 120.285 -1.509 . . . . 0.0 109.769 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -158.78 -167.47 2.13 Favored 'General case' 0 N--CA 1.43 -1.447 1 N-CA-C 95.481 -5.748 . . . . 0.0 95.481 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 -165.62 1.85 Allowed 'General case' 0 CA--C 1.486 -1.484 1 N-CA-C 97.961 -4.829 . . . . 0.0 97.961 167.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 -176.5 4.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 102.128 -3.286 . . . . 0.0 102.128 158.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -117.48 155.38 29.82 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 m -146.44 139.85 25.84 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 100.375 -3.935 . . . . 0.0 100.375 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 30.19 6.59 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.287 0.565 . . . . 0.0 110.073 -168.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 177.5 151.02 0.2 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 93.979 -6.304 . . . . 0.0 93.979 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -153.36 151.92 26.61 Favored Pre-proline 0 CA--C 1.487 -1.47 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 149.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.72 170.95 16.48 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.08 1.853 . . . . 0.0 110.515 171.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.37 16.93 1.16 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -98.55 -6.25 30.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 120.51 -1.369 . . . . 0.0 108.287 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.73 168.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.41 177.36 27.65 Favored Glycine 0 CA--C 1.483 -1.952 1 N-CA-C 102.033 -4.427 . . . . 0.0 102.033 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 6' ' ' ILE . 6.4 pt -154.82 -171.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -158.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.721 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.3 mm -68.76 133.05 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.431 -1.379 0 N-CA-C 101.792 -3.411 . . . . 0.0 101.792 171.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.063 0.459 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -100.99 157.82 16.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -127.53 125.9 41.23 Favored 'General case' 0 CA--C 1.486 -1.482 1 N-CA-C 94.315 -6.18 . . . . 0.0 94.315 159.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.38 29.01 Favored Glycine 0 CA--C 1.474 -2.512 0 N-CA-C 104.021 -3.632 . . . . 0.0 104.021 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -83.54 140.35 32.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.87 148.23 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.3 -177.17 6.07 Favored 'General case' 0 N--CA 1.415 -2.204 1 N-CA-C 98.329 -4.693 . . . . 0.0 98.329 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -105.06 157.54 34.04 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -66.56 144.62 73.46 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.654 2.236 . . . . 0.0 109.226 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -103.14 80.02 1.8 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 128.027 2.531 . . . . 0.0 106.336 -5.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.8 t30 84.66 44.19 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 124.932 1.293 . . . . 0.0 108.392 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.85 127.76 47.64 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 15' ' ' HIS 0.254 5.4 m -70.64 165.04 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 141.87 51.36 Favored 'General case' 0 N--CA 1.423 -1.817 1 N-CA-C 94.455 -6.128 . . . . 0.0 94.455 -176.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CE1' HG23 ' A' ' 13' ' ' VAL . 46.9 m80 -117.31 160.73 20.65 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -167.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 t -115.18 169.27 9.24 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.53 124.68 23.61 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 98.423 -4.658 . . . . 0.0 98.423 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -57.59 111.84 0.95 Allowed 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.965 2.443 . . . . 0.0 113.261 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.79 -51.37 0.52 Allowed Glycine 0 CA--C 1.484 -1.85 1 N-CA-C 100.367 -5.093 . . . . 0.0 100.367 -168.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 6.8 m 106.12 -0.84 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 127.984 2.513 . . . . 0.0 111.852 169.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -46.97 -45.4 20.83 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.567 1.547 . . . . 0.0 113.806 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.37 -59.99 7.65 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.904 0.764 . . . . 0.0 111.955 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.3 m -70.68 -27.56 64.11 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.869 -1.371 . . . . 0.0 113.263 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.84 -45.19 93.74 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.4 m -66.08 -40.97 91.28 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.748 0.819 . . . . 0.0 110.4 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.21 -42.33 94.9 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.703 0.801 . . . . 0.0 109.74 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -38.64 82.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.541 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.24 -42.25 84.3 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.925 -0.484 . . . . 0.0 111.455 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.35 -30.3 37.98 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.726 -0.609 . . . . 0.0 111.019 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -84.66 -22.29 29.92 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 118.363 0.529 . . . . 0.0 109.949 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.49 45.95 1.61 Allowed Glycine 0 CA--C 1.488 -1.594 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 162.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.26 172.8 17.38 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 104.26 -3.536 . . . . 0.0 104.26 167.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 p -75.39 -56.71 4.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.987 0.899 . . . . 0.0 108.651 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -160.65 -176.76 5.75 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 98.832 -4.506 . . . . 0.0 98.832 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.19 -176.73 41.93 Favored Glycine 0 N--CA 1.414 -2.769 1 N-CA-C 98.612 -5.795 . . . . 0.0 98.612 -168.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -166.79 178.08 6.1 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 -172.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.34 168.09 20.66 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.773 0.797 . . . . 0.0 110.465 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.84 -171.01 37.9 Favored Glycine 0 N--CA 1.419 -2.463 1 N-CA-C 97.05 -6.42 . . . . 0.0 97.05 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -146.54 161.91 39.46 Favored 'General case' 0 N--CA 1.422 -1.828 1 N-CA-C 95.325 -5.805 . . . . 0.0 95.325 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -152.44 167.08 29.93 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 97.458 -5.015 . . . . 0.0 97.458 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.76 149.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 1 N-CA-C 96.152 -5.499 . . . . 0.0 96.152 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 -23.02 23.29 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 106.274 -2.731 . . . . 0.0 106.274 -168.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -135.62 -76.36 0.44 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 167.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.41 -150.76 22.13 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 98.289 -5.924 . . . . 0.0 98.289 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.28 115.26 2.37 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.339 2.656 . . . . 0.0 108.689 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.99 158.35 44.07 Favored 'General case' 0 CA--C 1.482 -1.657 1 N-CA-C 96.871 -5.233 . . . . 0.0 96.871 -166.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.8 p -138.61 174.36 10.62 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 116.349 -2.141 . . . . 0.0 108.548 -167.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -104.86 156.64 17.83 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -164.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -152.12 151.1 30.64 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 167.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -113.17 145.71 40.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 104.475 -2.416 . . . . 0.0 104.475 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.94 46.43 0.25 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.098 2.159 . . . . 0.0 112.227 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.33 130.97 33.88 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.95 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.071 1.847 . . . . 0.0 110.656 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -60.69 -20.15 60.31 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.77 1.628 . . . . 0.0 114.762 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -82.29 -12.76 57.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.652 -0.655 . . . . 0.0 110.414 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.52 112.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.46 143.74 17.45 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 104.894 -3.282 . . . . 0.0 104.894 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.9 pt -143.66 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 -160.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mm -68.08 122.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -161.431 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.27 162.5 14.02 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 164.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -125.59 131.85 52.63 Favored 'General case' 0 CA--C 1.486 -1.501 1 N-CA-C 94.287 -6.19 . . . . 0.0 94.287 161.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.81 29.57 Favored Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 100.912 -4.875 . . . . 0.0 100.912 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.91 137.24 33.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.01 142.52 12.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -135.53 -129.78 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.88 2.872 . . . . 0.0 106.385 175.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -154.16 166.51 15.67 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -172.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -65.39 139.14 58.19 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.346 2.697 . . . . 0.0 111.017 166.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -109.4 -16.26 14.05 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.571 2.348 . . . . 0.0 108.768 9.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -160.22 146.67 15.69 Favored 'General case' 0 CA--C 1.48 -1.72 1 N-CA-C 94.154 -6.239 . . . . 0.0 94.154 165.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.08 -161.97 0.29 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 169.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.74 166.78 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 1 N-CA-C 97.536 -4.987 . . . . 0.0 97.536 157.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -166.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 163.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -127.46 161.89 27.67 Favored 'General case' 0 CA--C 1.473 -1.99 1 N-CA-C 99.245 -4.354 . . . . 0.0 99.245 169.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.0 t -124.83 147.87 48.51 Favored 'General case' 0 N--CA 1.419 -1.996 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -102.41 119.72 55.37 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 96.935 -5.209 . . . . 0.0 96.935 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -57.34 103.97 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 CA-C-N 124.491 2.64 . . . . 0.0 114.726 -165.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.68 -175.8 37.36 Favored Glycine 0 N--CA 1.419 -2.455 1 N-CA-C 97.248 -6.341 . . . . 0.0 97.248 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -92.0 -30.75 15.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.627 0.713 . . . . 0.0 109.276 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -43.97 91.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.561 2.344 . . . . 0.0 115.319 -157.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.25 -50.46 45.04 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -68.96 -41.76 77.53 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.057 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -48.2 -54.11 14.61 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.437 1.495 . . . . 0.0 110.291 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 m -58.72 -54.08 51.07 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.967 0.907 . . . . 0.0 111.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -67.14 -40.77 86.79 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-O 122.36 1.076 . . . . 0.0 110.339 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -64.93 -45.09 87.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.334 1.054 . . . . 0.0 110.304 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -68.56 -40.41 80.62 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 121.27 -0.894 . . . . 0.0 110.945 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -68.26 -14.89 63.32 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.49 7.84 20.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 118.344 0.52 . . . . 0.0 110.433 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 32.75 8.27 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.395 165.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.71 142.05 16.06 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -85.64 -21.63 28.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.461 1.504 . . . . 0.0 109.063 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 m -157.06 156.26 32.53 Favored 'General case' 0 N--CA 1.424 -1.761 1 N-CA-C 98.782 -4.525 . . . . 0.0 98.782 169.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -148.41 141.81 9.43 Favored Glycine 0 CA--C 1.468 -2.885 1 N-CA-C 99.681 -5.368 . . . . 0.0 99.681 -170.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -145.83 -167.65 2.77 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 101.373 -3.565 . . . . 0.0 101.373 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.81 168.36 27.44 Favored 'General case' 0 N--CA 1.427 -1.582 1 N-CA-C 96.882 -5.229 . . . . 0.0 96.882 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.55 91.57 1.06 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 103.112 -3.995 . . . . 0.0 103.112 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -156.61 156.55 33.72 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 171.71 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -138.88 18.87 2.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 42' ' ' GLY . 1.6 t -146.69 -157.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 101.686 -3.45 . . . . 0.0 101.686 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 98.68 -95.1 1.54 Allowed Glycine 0 CA--C 1.474 -2.475 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -129.49 -54.34 1.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.236 -3.616 . . . . 0.0 101.236 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.09 64.68 0.24 Allowed Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 173.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE 0.57 0.0 OUTLIER 73.36 171.75 0.3 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.513 1.925 . . . . 0.0 110.306 -171.511 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.67 -173.17 3.62 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -109.97 156.33 20.61 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -106.64 148.58 28.17 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 32.0 m -138.74 148.85 44.39 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 172.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.73 128.11 49.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.88 76.89 0.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 126.94 2.096 . . . . 0.0 111.557 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.47 141.97 23.75 Favored Pre-proline 0 CA--C 1.496 -1.128 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.15 166.33 23.52 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.603 2.202 . . . . 0.0 110.648 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -86.68 15.19 5.91 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.926 -1.109 . . . . 0.0 111.485 -165.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.11 11.17 21.96 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.09 140.61 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 101.637 -3.468 . . . . 0.0 101.637 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.36 143.28 15.65 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.16 -156.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -164.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.7 mm -70.52 125.01 27.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.437 -1.116 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 174.093 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -101.73 157.65 16.68 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.44 127.44 45.42 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 94.201 -6.222 . . . . 0.0 94.201 157.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -173.73 30.98 Favored Glycine 0 CA--C 1.475 -2.444 0 N-CA-C 103.532 -3.827 . . . . 0.0 103.532 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 35.4 m-85 -78.98 140.92 37.9 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 163.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tt -90.98 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.859 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -144.62 171.54 14.24 Favored 'General case' 0 N--CA 1.42 -1.964 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 177.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.78 158.24 68.26 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 92.3 Cg_exo -61.89 111.17 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.681 2.921 . . . . 0.0 110.633 170.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 68.9 mm-40 -125.69 132.07 52.47 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 1.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.9 t30 63.47 33.99 13.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 162.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.45 121.65 24.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.16 153.96 4.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -163.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.22 120.35 41.62 Favored 'General case' 0 N--CA 1.424 -1.732 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -89.18 128.33 35.8 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.5 t -80.01 159.31 26.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.59 115.18 46.92 Favored Pre-proline 0 N--CA 1.426 -1.659 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.8 113.19 1.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 123.048 2.499 . . . . 0.0 113.117 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.23 -49.54 0.69 Allowed Glycine 0 CA--C 1.489 -1.592 1 N-CA-C 101.045 -4.822 . . . . 0.0 101.045 -164.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m 99.64 -12.77 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 129.073 2.949 . . . . 0.0 109.662 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -50.75 -48.9 59.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.275 2.23 . . . . 0.0 115.213 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.13 -31.47 59.58 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.0 t -75.12 -24.53 58.06 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -49.63 77.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.635 -0.665 . . . . 0.0 111.865 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.8 -42.87 97.61 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 122.559 1.171 . . . . 0.0 111.148 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.0 t -63.2 -44.01 96.56 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 125.371 1.469 . . . . 0.0 108.899 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.61 -45.93 90.62 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 122.965 0.506 . . . . 0.0 110.557 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.95 -23.69 55.42 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -81.57 -21.08 38.67 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.62 38.39 2.23 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 164.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.51 134.72 12.11 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 103.315 -3.914 . . . . 0.0 103.315 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.3 p -102.83 4.95 38.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.859 0.838 . . . . 0.0 109.499 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 m -160.38 164.63 32.26 Favored 'General case' 0 CA--C 1.478 -1.804 1 N-CA-C 97.99 -4.819 . . . . 0.0 97.99 167.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.34 171.75 36.62 Favored Glycine 0 N--CA 1.414 -2.821 1 N-CA-C 99.261 -5.536 . . . . 0.0 99.261 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -160.92 -167.65 1.88 Allowed 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 96.609 -5.33 . . . . 0.0 96.609 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.5 m -154.75 176.1 12.88 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 97.487 -5.005 . . . . 0.0 97.487 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.99 -169.0 41.21 Favored Glycine 0 N--CA 1.42 -2.406 1 N-CA-C 96.805 -6.518 . . . . 0.0 96.805 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.84 173.48 6.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 101.702 -3.444 . . . . 0.0 101.702 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -157.31 163.04 39.11 Favored 'General case' 0 N--CA 1.42 -1.967 1 N-CA-C 95.81 -5.626 . . . . 0.0 95.81 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.31 158.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 1 N-CA-C 97.607 -4.961 . . . . 0.0 97.607 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 -43.89 1.6 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -118.61 -83.41 0.65 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.85 -148.69 18.09 Favored Glycine 0 CA--C 1.478 -2.278 1 N-CA-C 99.384 -5.487 . . . . 0.0 99.384 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.95 131.33 48.32 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 126.597 1.959 . . . . 0.0 107.936 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.75 175.76 11.31 Favored 'General case' 0 CA--C 1.482 -1.646 1 N-CA-C 98.846 -4.501 . . . . 0.0 98.846 -162.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.67 168.4 15.09 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 28.1 t-105 -119.9 150.06 41.1 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.0 m -141.05 149.1 41.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 101.178 -3.638 . . . . 0.0 101.178 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.27 130.48 53.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 103.171 -2.9 . . . . 0.0 103.171 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.44 54.79 0.16 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.674 1.989 . . . . 0.0 110.998 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.26 132.8 32.95 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.18 172.46 13.0 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.436 2.091 . . . . 0.0 110.003 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.11 23.99 1.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.602 -0.686 . . . . 0.0 111.948 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.46 -7.48 28.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.23 143.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.78 146.41 17.94 Favored Glycine 0 CA--C 1.476 -2.368 1 N-CA-C 101.44 -4.664 . . . . 0.0 101.44 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.4 pt -142.31 -146.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 -165.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 7' ' ' ALA . 14.5 mm -69.68 123.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.259 1.0 OUTLIER . . . . . 0 N--CA 1.438 -1.04 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 -167.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.537 0.684 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 171.68 8.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -136.11 140.26 43.58 Favored 'General case' 0 CA--C 1.488 -1.44 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -177.31 34.78 Favored Glycine 0 CA--C 1.475 -2.419 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -79.27 134.25 36.64 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 102.04 -3.319 . . . . 0.0 102.04 157.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -90.16 133.83 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.5 -147.94 0.36 Allowed 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 111.057 -2.792 . . . . 0.0 108.978 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -138.09 148.76 61.35 Favored Pre-proline 0 N--CA 1.42 -1.937 1 N-CA-C 94.691 -6.04 . . . . 0.0 94.691 170.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -76.01 151.77 35.46 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 122.052 1.769 . . . . 0.0 108.428 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.16 -12.18 19.82 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 127.446 2.299 . . . . 0.0 108.204 9.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -160.96 141.89 11.57 Favored 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 95.647 -5.686 . . . . 0.0 95.647 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.05 -159.79 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -128.14 165.09 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 N-CA-C 98.597 -4.594 . . . . 0.0 98.597 160.98 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 -157.44 0.46 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -138.97 -177.86 5.08 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 98.673 -4.566 . . . . 0.0 98.673 168.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.44 163.54 35.34 Favored 'General case' 0 N--CA 1.419 -1.999 1 N-CA-C 95.913 -5.588 . . . . 0.0 95.913 -175.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.28 119.26 31.97 Favored Pre-proline 0 N--CA 1.421 -1.883 1 N-CA-C 98.584 -4.599 . . . . 0.0 98.584 172.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -57.37 111.49 0.83 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.905 2.403 . . . . 0.0 113.14 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.6 -37.87 1.25 Allowed Glycine 0 CA--C 1.49 -1.506 1 N-CA-C 101.148 -4.781 . . . . 0.0 101.148 -162.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m 86.09 -5.43 0.79 Allowed 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 125.678 1.591 . . . . 0.0 112.242 158.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -61.79 -42.38 98.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.156 1.782 . . . . 0.0 112.531 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.22 -31.97 63.26 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -71.57 -50.04 34.89 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.96 -38.12 89.81 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 118.766 0.712 . . . . 0.0 110.602 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.5 m -59.58 -50.04 75.44 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.367 -0.833 . . . . 0.0 111.674 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.82 -43.96 91.39 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.861 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.1 t -54.1 -46.41 72.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.391 1.076 . . . . 0.0 110.91 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -65.5 -49.15 70.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.483 0.713 . . . . 0.0 110.596 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.96 -20.22 61.77 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.774 -0.579 . . . . 0.0 112.56 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -87.66 -6.61 58.17 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 118.615 0.643 . . . . 0.0 110.24 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 27.82 9.43 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.32 146.74 18.34 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 p -75.57 -37.23 60.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.511 -0.993 . . . . 0.0 110.726 -164.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 m -160.88 -177.5 6.18 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.723 -4.918 . . . . 0.0 97.723 165.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.39 -176.72 41.34 Favored Glycine 0 N--CA 1.414 -2.805 1 N-CA-C 98.614 -5.794 . . . . 0.0 98.614 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.57 180.0 6.84 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 97.015 -5.18 . . . . 0.0 97.015 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.2 m -103.52 165.41 11.05 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.5 171.42 39.98 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 97.923 -6.071 . . . . 0.0 97.923 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -103.39 145.43 30.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -116.99 96.15 5.32 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.32 127.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -42.45 1.43 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -169.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -119.27 -68.68 0.9 Allowed 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.31 -160.36 33.98 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 -172.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.64 136.51 51.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 -173.94 3.82 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.35 158.77 27.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 101.166 -3.642 . . . . 0.0 101.166 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -120.57 153.06 37.28 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -146.87 155.38 42.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -118.76 143.94 46.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 166.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.24 56.96 0.11 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 127.237 2.215 . . . . 0.0 111.197 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -96.23 133.37 25.11 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -71.84 174.94 10.38 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 122.206 1.824 . . . . 0.0 111.43 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.32 16.34 1.66 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -98.34 -5.27 33.2 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.87 169.68 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.35 160.23 27.84 Favored Glycine 0 CA--C 1.48 -2.106 1 N-CA-C 99.414 -5.475 . . . . 0.0 99.414 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 pt -144.88 -164.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 -163.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -70.89 128.54 34.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.002 0.429 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.97 162.67 12.84 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -132.08 130.45 41.28 Favored 'General case' 0 CA--C 1.489 -1.375 1 N-CA-C 95.077 -5.897 . . . . 0.0 95.077 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.95 -169.16 24.89 Favored Glycine 0 CA--C 1.477 -2.306 0 N-CA-C 104.025 -3.63 . . . . 0.0 104.025 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.28 140.26 30.97 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 159.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.71 150.3 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -155.23 174.74 14.79 Favored 'General case' 0 N--CA 1.415 -2.221 1 N-CA-C 98.535 -4.617 . . . . 0.0 98.535 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -85.67 158.54 56.7 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 34.7 Cg_exo -64.54 113.46 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.019 2.479 . . . . 0.0 110.785 164.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.7 mm-40 -126.64 114.04 17.51 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 127.45 2.3 . . . . 0.0 106.636 1.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 61.4 t30 80.63 31.99 0.16 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.582 1.153 . . . . 0.0 109.126 156.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -123.04 123.03 39.95 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.82 158.26 6.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 CA-C-N 120.106 1.321 . . . . 0.0 114.028 -159.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 135.9 42.74 Favored 'General case' 0 CA--C 1.483 -1.604 1 N-CA-C 97.291 -5.077 . . . . 0.0 97.291 178.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -90.96 165.9 13.31 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -164.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -151.8 175.95 11.92 Favored 'General case' 0 N--CA 1.406 -2.647 1 N-CA-C 94.815 -5.994 . . . . 0.0 94.815 -170.202 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -149.43 176.56 2.2 Favored Pre-proline 0 N--CA 1.408 -2.573 1 N-CA-C 95.026 -5.916 . . . . 0.0 95.026 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.46 55.0 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.122 2.865 . . . . 0.0 110.607 161.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.96 150.43 11.77 Favored Glycine 0 CA--C 1.481 -2.032 1 N-CA-C 99.391 -5.484 . . . . 0.0 99.391 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -106.91 15.09 25.8 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 117.533 0.667 . . . . 0.0 111.239 -161.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -62.11 -61.0 2.78 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.934 1.293 . . . . 0.0 111.759 -166.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.56 -41.14 77.04 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 t -57.89 -58.41 8.51 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.585 1.154 . . . . 0.0 111.288 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.63 -33.57 75.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.066 0.546 . . . . 0.0 109.806 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.0 m -61.2 -50.02 74.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.402 0.681 . . . . 0.0 110.869 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.45 -37.5 68.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.643 0.777 . . . . 0.0 110.04 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.26 -46.26 83.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 110.112 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -62.28 -49.2 76.63 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.133 0.573 . . . . 0.0 110.995 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.28 -21.07 60.68 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.527 -0.733 . . . . 0.0 112.687 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -94.28 3.04 55.76 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.793 -0.567 . . . . 0.0 110.083 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.96 33.06 7.54 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 161.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.91 147.22 18.53 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 104.326 -3.51 . . . . 0.0 104.326 167.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -78.37 -37.14 44.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 117.99 0.895 . . . . 0.0 110.277 -166.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 m -160.52 -179.64 7.82 Favored 'General case' 0 N--CA 1.426 -1.655 1 N-CA-C 99.06 -4.422 . . . . 0.0 99.06 169.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.59 178.7 43.76 Favored Glycine 0 N--CA 1.423 -2.23 1 N-CA-C 99.52 -5.432 . . . . 0.0 99.52 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -167.19 -179.81 4.74 Favored 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 99.287 -4.338 . . . . 0.0 99.287 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.5 m -126.64 158.42 36.36 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.18 102.75 0.34 Allowed Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 105.015 -3.234 . . . . 0.0 105.015 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 174.07 5.31 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.07 26.04 0.01 OUTLIER 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.76 132.41 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -160.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.28 -95.44 2.1 Favored Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -83.58 -51.43 7.32 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.47 46.43 Favored Glycine 0 N--CA 1.42 -2.432 1 N-CA-C 97.694 -6.162 . . . . 0.0 97.694 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.377 0.2 OUTLIER -76.64 143.17 40.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.977 0.388 . . . . 0.0 110.755 173.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.0 9.06 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 101.956 -3.35 . . . . 0.0 101.956 -163.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.48 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 1.9 t -113.2 153.59 28.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 -170.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -97.64 155.65 16.89 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.72 148.85 32.41 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.03 142.62 46.73 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 101.883 -3.376 . . . . 0.0 101.883 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.19 59.21 1.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.356 2.262 . . . . 0.0 112.11 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.6 mt -93.55 133.34 28.32 Favored Pre-proline 0 CA--C 1.495 -1.163 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.92 170.9 15.68 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.403 2.069 . . . . 0.0 110.611 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.86 32.59 0.59 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.726 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.19 -3.37 14.66 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.43 162.66 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 -175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.52 150.71 21.53 Favored Glycine 0 CA--C 1.481 -2.038 1 N-CA-C 98.552 -5.819 . . . . 0.0 98.552 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.6 pt -150.55 -150.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -159.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.6 mm -69.04 128.02 31.84 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -170.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 167.69 21.58 Favored 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 164.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -127.99 132.04 49.2 Favored 'General case' 0 CA--C 1.48 -1.731 1 N-CA-C 94.017 -6.29 . . . . 0.0 94.017 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.77 36.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 105.551 -3.019 . . . . 0.0 105.551 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.46 134.15 40.92 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.39 148.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.22 -176.88 5.89 Favored 'General case' 0 N--CA 1.413 -2.294 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 -173.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -101.74 168.31 9.26 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 41.1 Cg_exo -61.33 130.33 31.66 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.37 2.046 . . . . 0.0 110.395 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 43.6 mt-10 -128.47 117.98 22.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 -7.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 70.91 19.54 5.71 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.385 1.074 . . . . 0.0 109.837 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.3 m -103.63 91.77 4.16 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 7' ' ' ALA 0.287 27.2 m -59.4 154.86 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -165.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.56 175.58 5.43 Favored 'General case' 0 N--CA 1.421 -1.903 1 N-CA-C 98.175 -4.75 . . . . 0.0 98.175 175.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -136.39 152.81 51.02 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 97.128 -5.138 . . . . 0.0 97.128 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.05 175.58 6.06 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.32 119.45 33.14 Favored Pre-proline 0 N--CA 1.426 -1.654 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 173.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.47 101.24 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.819 2.346 . . . . 0.0 111.497 -170.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.89 -44.92 0.51 Allowed Glycine 0 CA--C 1.481 -2.092 1 N-CA-C 102.504 -4.238 . . . . 0.0 102.504 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m 121.75 -48.48 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 129.006 2.922 . . . . 0.0 107.299 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -39.94 -45.41 1.86 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.068 2.947 . . . . 0.0 118.097 -155.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -41.57 49.46 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 121.235 -0.916 . . . . 0.0 111.33 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 t -82.92 -25.73 32.12 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.81 -29.16 69.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.742 0.817 . . . . 0.0 110.396 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.7 m -70.52 -43.44 69.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.119 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.73 -39.91 95.55 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 122.075 0.941 . . . . 0.0 109.9 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -54.14 -45.68 72.05 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.531 1.132 . . . . 0.0 110.743 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -61.7 -48.97 78.36 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.31 -18.87 59.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.49 -22.7 24.74 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.634 0.652 . . . . 0.0 109.756 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.9 28.13 3.51 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 167.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.44 121.96 7.18 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.04 -2.824 . . . . 0.0 106.04 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -93.59 1.57 56.64 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 122.046 0.927 . . . . 0.0 109.959 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -160.19 160.69 33.12 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 98.121 -4.77 . . . . 0.0 98.121 169.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.83 178.57 46.55 Favored Glycine 0 CA--C 1.481 -2.089 1 N-CA-C 101.318 -4.713 . . . . 0.0 101.318 -171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -166.71 179.95 5.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.663 -3.829 . . . . 0.0 100.663 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.9 m -93.87 173.81 7.48 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.25 -172.72 31.08 Favored Glycine 0 CA--C 1.482 -2.019 1 N-CA-C 98.32 -5.912 . . . . 0.0 98.32 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -127.65 149.21 50.3 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.21 -4.367 . . . . 0.0 99.21 170.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -126.72 101.2 6.52 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.44 120.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.59 -42.03 1.38 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -118.05 -64.51 1.28 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.43 -138.09 5.9 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 105.254 -3.138 . . . . 0.0 105.254 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp -81.23 133.41 35.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.8 162.83 37.08 Favored 'General case' 0 N--CA 1.433 -1.288 1 N-CA-C 97.975 -4.824 . . . . 0.0 97.975 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -113.02 -176.49 2.91 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 121.162 1.801 . . . . 0.0 106.494 -169.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -126.47 147.88 49.75 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 m -141.86 142.18 33.11 Favored 'General case' 0 N--CA 1.433 -1.278 1 N-CA-C 100.096 -4.039 . . . . 0.0 100.096 170.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.1 22.35 16.07 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -165.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.8 2.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 94.542 -6.095 . . . . 0.0 94.542 173.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -150.22 154.14 35.95 Favored Pre-proline 0 N--CA 1.427 -1.602 1 N-CA-C 96.024 -5.547 . . . . 0.0 96.024 152.102 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.09 166.3 30.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 122.156 1.806 . . . . 0.0 109.165 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.64 -10.92 56.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -86.09 -1.34 57.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.517 0.727 . . . . 0.0 110.082 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG11 ' HG ' ' A' ' 52' ' ' LEU . 6.0 t -100.28 142.52 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.13 13.25 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 99.65 -5.38 . . . . 0.0 99.65 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.401 HG21 HD23 ' A' ' 52' ' ' LEU . 15.1 pt -130.09 -129.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -163.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 7' ' ' ALA . 6.1 mm -72.89 118.78 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -166.472 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 162.71 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -128.6 134.16 48.51 Favored 'General case' 0 CA--C 1.487 -1.463 1 N-CA-C 94.955 -5.943 . . . . 0.0 94.955 165.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.19 -175.14 32.9 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 105.576 -3.009 . . . . 0.0 105.576 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -76.06 132.89 40.38 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.8 137.17 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.52 -150.52 0.42 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.64 -2.527 . . . . 0.0 108.872 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -135.1 152.35 76.92 Favored Pre-proline 0 N--CA 1.421 -1.902 1 N-CA-C 94.612 -6.07 . . . . 0.0 94.612 161.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -67.41 157.55 61.21 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 CA-C-N 123.391 2.247 . . . . 0.0 108.439 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.74 -25.12 17.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 128.153 2.581 . . . . 0.0 110.278 5.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.76 106.1 2.25 Favored 'General case' 0 N--CA 1.434 -1.241 1 N-CA-C 99.612 -4.218 . . . . 0.0 99.612 -173.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.06 -168.23 1.69 Allowed 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 120.092 1.315 . . . . 0.0 107.648 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -129.18 164.6 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 160.536 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 -164.59 1.01 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.9 167.92 20.3 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 96.314 -5.439 . . . . 0.0 96.314 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.42 156.41 48.59 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 98.231 -4.729 . . . . 0.0 98.231 -167.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.05 116.15 45.01 Favored Pre-proline 0 N--CA 1.424 -1.752 1 N-CA-C 96.304 -5.443 . . . . 0.0 96.304 164.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -63.59 102.41 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 125.025 2.83 . . . . 0.0 114.788 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.98 -172.47 45.47 Favored Glycine 0 N--CA 1.418 -2.507 1 N-CA-C 96.184 -6.767 . . . . 0.0 96.184 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -38.24 23.86 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 118.437 1.119 . . . . 0.0 108.675 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.51 -60.02 2.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.337 2.655 . . . . 0.0 116.124 -165.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.56 -54.37 10.51 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -166.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.29 -47.52 79.17 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 122.292 -0.534 . . . . 0.0 110.971 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -64.69 -40.98 96.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 m -64.8 -44.62 89.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.492 -0.755 . . . . 0.0 111.035 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.88 -38.53 91.27 Favored 'General case' 0 C--N 1.358 0.964 0 CA-C-O 122.342 1.068 . . . . 0.0 109.985 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -58.93 -50.24 74.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.512 1.125 . . . . 0.0 110.572 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -68.76 -35.8 77.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.12 -29.29 54.7 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.264 -0.897 . . . . 0.0 111.806 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -77.29 -35.06 55.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.739 0.7 . . . . 0.0 109.419 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.61 43.32 0.82 Allowed Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.07 157.09 21.0 Favored Glycine 0 CA--C 1.484 -1.897 1 N-CA-C 102.263 -4.335 . . . . 0.0 102.263 159.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.8 m -81.3 -38.05 27.4 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -168.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.2 m -160.5 168.79 24.33 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 99.929 -4.1 . . . . 0.0 99.929 175.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.11 178.55 45.92 Favored Glycine 0 N--CA 1.421 -2.355 1 N-CA-C 99.969 -5.252 . . . . 0.0 99.969 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -169.66 -175.49 2.15 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -171.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.89 145.98 29.12 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.84 167.96 38.84 Favored Glycine 0 N--CA 1.419 -2.486 1 N-CA-C 99.18 -5.568 . . . . 0.0 99.18 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -164.37 -168.04 1.44 Allowed 'General case' 0 N--CA 1.42 -1.971 1 N-CA-C 95.997 -5.557 . . . . 0.0 95.997 170.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 99.59 61.4 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 131.324 3.85 . . . . 0.0 102.244 -167.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.7 t -141.41 166.95 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 1 N-CA-C 99.627 -4.212 . . . . 0.0 99.627 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.32 80.23 0.27 Allowed Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.54 -3.024 . . . . 0.0 105.54 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.413 ' CD2' HG13 ' A' ' 13' ' ' VAL . 36.8 m-70 -173.34 -145.16 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 94.47 -6.122 . . . . 0.0 94.47 -177.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.86 120.15 1.87 Allowed Glycine 0 CA--C 1.484 -1.902 1 N-CA-C 101.349 -4.701 . . . . 0.0 101.349 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tp 73.88 175.53 0.26 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.608 1.963 . . . . 0.0 108.962 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.79 -173.78 0.42 Allowed 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 98.183 -4.747 . . . . 0.0 98.183 171.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.3 m -125.83 176.48 6.92 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 100.499 -3.889 . . . . 0.0 100.499 159.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -113.94 152.52 30.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -145.63 149.94 35.43 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -116.47 137.73 51.94 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.25 61.05 0.23 Allowed 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.345 2.258 . . . . 0.0 110.517 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.36 131.0 26.99 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.61 178.02 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.986 2.457 . . . . 0.0 110.714 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -74.61 -1.54 22.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -89.81 -1.22 57.94 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 120.937 -1.102 . . . . 0.0 109.761 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.93 170.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.98 152.01 24.11 Favored Glycine 0 CA--C 1.478 -2.269 1 N-CA-C 97.719 -6.152 . . . . 0.0 97.719 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.46 -149.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 10.8 mm -68.28 134.98 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.421 -1.924 1 N-CA-C 93.188 -6.597 . . . . 0.0 93.188 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.031 0.443 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 169.3 9.08 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -128.2 144.38 51.12 Favored 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 94.587 -6.079 . . . . 0.0 94.587 166.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 178.06 37.52 Favored Glycine 0 CA--C 1.475 -2.409 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -81.7 129.91 34.88 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 159.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 14.6 tt -90.52 140.16 16.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.48 -149.76 0.42 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 127.097 2.159 . . . . 0.0 108.285 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.59 165.58 24.22 Favored Pre-proline 0 N--CA 1.418 -2.07 1 N-CA-C 95.229 -5.841 . . . . 0.0 95.229 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.01 152.17 83.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.22 1.947 . . . . 0.0 108.706 167.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -88.27 -51.76 5.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.21 2.204 . . . . 0.0 108.095 1.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.84 121.85 14.6 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 89.567 -7.938 . . . . 0.0 89.567 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.8 m -163.57 -166.32 1.19 Allowed 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 102.252 -3.24 . . . . 0.0 102.252 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.07 166.03 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 97.796 -4.89 . . . . 0.0 97.796 160.96 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -161.62 0.66 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 162.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -137.76 167.36 21.87 Favored 'General case' 0 CA--C 1.484 -1.581 1 N-CA-C 97.257 -5.09 . . . . 0.0 97.257 164.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.3 t -108.42 163.58 13.09 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -110.29 106.0 57.64 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 97.712 -4.921 . . . . 0.0 97.712 162.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -53.14 104.62 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 124.045 2.48 . . . . 0.0 118.245 -161.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.01 -162.64 33.77 Favored Glycine 0 N--CA 1.423 -2.193 1 N-CA-C 97.569 -6.212 . . . . 0.0 97.569 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 4.6 p -88.86 -34.03 17.14 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -39.47 -59.64 1.06 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 128.568 2.747 . . . . 0.0 116.643 -160.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -53.65 11.08 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.71 -43.04 98.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 122.115 -0.638 . . . . 0.0 111.621 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -44.5 97.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.818 0.847 . . . . 0.0 109.988 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -63.09 -43.88 97.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.395 -0.815 . . . . 0.0 110.515 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.08 -40.61 90.97 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 122.422 1.106 . . . . 0.0 110.215 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.31 -44.39 95.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.817 1.247 . . . . 0.0 109.658 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -74.98 -28.79 60.69 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -78.39 -24.33 46.38 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.971 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -78.0 -58.18 3.4 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.82 45.52 0.07 OUTLIER Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.85 159.07 14.15 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 104.215 -3.554 . . . . 0.0 104.215 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 m -91.97 -31.14 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.653 0.74 . . . . 0.0 109.757 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -146.22 154.78 42.13 Favored 'General case' 0 CA--C 1.476 -1.896 1 N-CA-C 99.837 -4.134 . . . . 0.0 99.837 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.97 155.69 26.57 Favored Glycine 0 N--CA 1.417 -2.591 1 N-CA-C 98.427 -5.869 . . . . 0.0 98.427 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 18.0 p-80 -166.51 -172.99 2.34 Favored 'General case' 0 N--CA 1.424 -1.736 1 N-CA-C 96.863 -5.236 . . . . 0.0 96.863 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 18' ' ' PRO . 28.2 m -72.86 179.57 3.63 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 122.699 1.237 . . . . 0.0 110.817 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.24 174.08 39.48 Favored Glycine 0 N--CA 1.41 -3.07 1 N-CA-C 98.17 -5.972 . . . . 0.0 98.17 168.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -137.45 132.74 33.82 Favored 'General case' 0 N--CA 1.427 -1.584 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 172.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -117.23 105.28 12.04 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.98 125.18 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.35 -32.07 3.47 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -124.35 -67.55 0.91 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.6 -148.92 19.49 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.295 -3.122 . . . . 0.0 105.295 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 tp -58.87 143.76 46.61 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.648 2.379 . . . . 0.0 107.942 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.11 -172.66 4.18 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -170.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.6 m -117.46 170.81 8.43 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 165.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.8 t-105 -124.32 156.83 36.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.2 m -145.03 147.54 32.72 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -113.6 136.73 52.5 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.55 69.73 0.46 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.358 2.663 . . . . 0.0 111.644 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 mt -105.06 139.11 19.79 Favored Pre-proline 0 CA--C 1.503 -0.837 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -68.52 167.44 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.657 2.238 . . . . 0.0 111.596 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -67.49 -21.0 65.53 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.342 1.057 . . . . 0.0 113.742 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -84.02 2.37 39.38 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 110.847 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.29 125.89 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.36 152.27 20.15 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 105.842 -2.903 . . . . 0.0 105.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.1 pt -140.46 -147.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 -166.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.2 mm -72.71 135.5 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.412 -2.349 1 N-CA-C 93.569 -6.456 . . . . 0.0 93.569 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.3 0.571 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.4 171.29 7.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -131.71 144.14 50.77 Favored 'General case' 0 CA--C 1.485 -1.549 1 N-CA-C 95.694 -5.669 . . . . 0.0 95.694 165.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.78 36.6 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.709 -2.956 . . . . 0.0 105.709 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.37 133.41 35.91 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.37 135.17 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.21 -150.0 0.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 111.328 -2.669 . . . . 0.0 107.026 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 9.2 pt20 -142.14 164.36 34.16 Favored Pre-proline 0 N--CA 1.42 -1.926 1 N-CA-C 96.017 -5.549 . . . . 0.0 96.017 169.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -66.97 149.27 82.88 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 CA-C-N 122.4 1.893 . . . . 0.0 109.698 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -81.86 -22.72 36.78 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.491 2.316 . . . . 0.0 107.844 -1.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -177.49 155.53 1.09 Allowed 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 94.094 -6.261 . . . . 0.0 94.094 -171.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.419 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 73.2 m 161.22 -149.33 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.116 1 N-CA-C 97.971 -4.825 . . . . 0.0 97.971 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -117.57 164.7 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 1 N-CA-C 98.802 -4.518 . . . . 0.0 98.802 160.646 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -155.46 0.24 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 161.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -134.82 -179.5 5.65 Favored 'General case' 0 CA--C 1.482 -1.641 1 N-CA-C 98.919 -4.474 . . . . 0.0 98.919 164.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.2 t -139.1 174.01 10.96 Favored 'General case' 0 N--CA 1.416 -2.127 1 N-CA-C 96.817 -5.253 . . . . 0.0 96.817 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -128.04 132.67 24.47 Favored Pre-proline 0 N--CA 1.416 -2.174 1 N-CA-C 97.639 -4.948 . . . . 0.0 97.639 173.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -55.38 118.37 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.109 2.54 . . . . 0.0 112.773 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.81 -44.16 1.21 Allowed Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 25.4 m 91.87 -13.78 0.2 Allowed 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 127.784 2.434 . . . . 0.0 112.917 175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -47.14 -48.28 23.34 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.54 -28.89 56.67 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 111.241 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.21 -45.47 60.15 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.25 -47.49 78.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.854 1.262 . . . . 0.0 109.163 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -59.78 -45.67 91.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.606 0.762 . . . . 0.0 112.07 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 mt -66.65 -40.13 88.53 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.887 -1.133 . . . . 0.0 110.54 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.29 -43.45 83.18 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.648 1.179 . . . . 0.0 110.779 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -59.37 -53.31 59.67 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.35 0.66 . . . . 0.0 110.679 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.31 -16.97 61.36 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.622 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -91.22 -5.2 55.19 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.794 -0.566 . . . . 0.0 109.895 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.18 27.92 7.95 Favored Glycine 0 CA--C 1.49 -1.5 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.036 166.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.9 146.29 17.42 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -78.87 -27.93 44.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.318 -1.107 . . . . 0.0 111.06 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 m -161.07 174.73 13.3 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 99.674 -4.195 . . . . 0.0 99.674 166.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.06 172.56 43.91 Favored Glycine 0 N--CA 1.423 -2.222 1 N-CA-C 98.82 -5.712 . . . . 0.0 98.82 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -159.63 174.76 14.09 Favored 'General case' 0 CA--C 1.491 -1.3 1 N-CA-C 99.521 -4.252 . . . . 0.0 99.521 -173.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.8 m -71.82 163.4 27.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 119.818 1.19 . . . . 0.0 110.429 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.25 171.81 37.35 Favored Glycine 0 N--CA 1.424 -2.139 1 N-CA-C 99.568 -5.413 . . . . 0.0 99.568 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -120.79 134.59 55.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -110.85 106.42 15.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.34 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.4 -21.87 10.51 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -132.07 -74.02 0.51 Allowed 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.34 -160.62 34.0 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.68 135.54 57.66 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 127.253 2.221 . . . . 0.0 107.167 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.47 -173.45 3.77 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -170.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.7 t -122.58 155.56 36.04 Favored 'General case' 0 CA--C 1.494 -1.181 1 N-CA-C 99.986 -4.079 . . . . 0.0 99.986 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -114.24 151.29 33.05 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.7 m -146.3 149.15 33.28 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.77 138.89 53.06 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 103.385 -2.82 . . . . 0.0 103.385 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.65 58.54 0.1 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 127.67 2.388 . . . . 0.0 111.473 171.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.17 132.68 23.02 Favored Pre-proline 0 CA--C 1.501 -0.911 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.34 171.68 17.79 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.283 1.851 . . . . 0.0 110.965 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.76 -18.23 62.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.672 1.989 . . . . 0.0 114.753 -169.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -86.73 -5.72 59.04 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.278 0.631 . . . . 0.0 109.842 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.17 138.54 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.3 152.52 17.19 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 pt -131.37 -150.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -160.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 HD12 HG12 ' A' ' 13' ' ' VAL . 6.0 mm -76.39 113.49 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 176.561 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 165.87 26.14 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -134.17 130.07 36.74 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 94.465 -6.124 . . . . 0.0 94.465 166.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.99 -174.1 31.47 Favored Glycine 0 CA--C 1.471 -2.695 0 N-CA-C 103.278 -3.929 . . . . 0.0 103.278 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.94 134.91 37.79 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 163.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 47' ' ' CYS . 8.2 tt -90.9 143.56 10.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.25 -153.66 0.51 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 126.842 2.057 . . . . 0.0 105.618 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.83 66.02 Favored Pre-proline 0 N--CA 1.424 -1.764 1 N-CA-C 94.199 -6.223 . . . . 0.0 94.199 165.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.16 150.57 59.94 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.277 1.984 . . . . 0.0 108.407 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -85.98 -35.59 20.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.914 1.686 . . . . 0.0 109.402 10.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -159.26 145.31 16.38 Favored 'General case' 0 N--CA 1.419 -2.02 1 N-CA-C 94.773 -6.01 . . . . 0.0 94.773 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.4 m 175.37 -155.3 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.433 1 N-CA-C 96.642 -5.318 . . . . 0.0 96.642 172.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.641 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -127.07 165.38 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 1 N-CA-C 96.913 -5.217 . . . . 0.0 96.913 161.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.78 -166.91 1.55 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 164.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -135.73 151.19 49.9 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 101.619 -3.474 . . . . 0.0 101.619 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.0 t -124.31 156.94 36.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.36 118.29 47.73 Favored Pre-proline 0 N--CA 1.42 -1.927 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -176.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 108.28 0.45 Allowed 'Trans proline' 0 CA--C 1.506 -0.914 0 C-N-CA 122.999 2.466 . . . . 0.0 111.892 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.78 0.54 Allowed Glycine 0 CA--C 1.482 -1.97 1 N-CA-C 100.374 -5.09 . . . . 0.0 100.374 -164.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.252 6.8 m 114.49 -35.79 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 108.714 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -39.46 -52.06 2.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.999 2.519 . . . . 0.0 117.118 -157.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.62 -41.51 75.16 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 121.033 -1.042 . . . . 0.0 112.066 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -90.14 -21.76 22.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.934 -1.333 . . . . 0.0 109.176 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.6 -43.08 93.82 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 166.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.59 -47.21 87.2 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.572 -0.705 . . . . 0.0 110.763 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.3 mt -58.87 -43.97 90.98 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 123.676 0.79 . . . . 0.0 111.027 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.7 t -54.07 -47.51 71.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.997 1.319 . . . . 0.0 110.863 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -69.24 -40.62 77.79 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.48 0.312 . . . . 0.0 111.391 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.82 -25.32 48.75 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 118.01 0.368 . . . . 0.0 111.469 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -72.76 -54.37 9.08 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.03 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 167.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.66 136.75 13.82 Favored Glycine 0 CA--C 1.49 -1.515 1 N-CA-C 102.696 -4.162 . . . . 0.0 102.696 165.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -101.58 11.1 39.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.778 0.799 . . . . 0.0 110.098 -163.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.5 m -160.01 159.97 32.71 Favored 'General case' 0 CA--C 1.484 -1.582 1 N-CA-C 98.032 -4.803 . . . . 0.0 98.032 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.58 42.57 Favored Glycine 0 CA--C 1.479 -2.184 1 N-CA-C 99.672 -5.371 . . . . 0.0 99.672 -168.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -167.34 -167.26 0.88 Allowed 'General case' 0 N--CA 1.435 -1.195 1 N-CA-C 98.055 -4.794 . . . . 0.0 98.055 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.9 m -99.19 177.25 5.27 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.22 179.73 42.86 Favored Glycine 0 N--CA 1.423 -2.207 1 N-CA-C 102.569 -4.213 . . . . 0.0 102.569 -175.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 37.9 t80 -143.95 148.52 35.46 Favored 'General case' 0 CA--C 1.486 -1.505 1 N-CA-C 97.248 -5.093 . . . . 0.0 97.248 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -133.39 112.79 11.89 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.34 124.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.82 -31.56 3.89 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 104.702 -3.359 . . . . 0.0 104.702 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -113.47 -70.88 0.78 Allowed 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.3 -153.15 24.33 Favored Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 2.9 tt -72.39 144.38 48.22 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.3 -168.96 2.4 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.2 m -123.61 -179.87 4.52 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -130.78 152.98 49.53 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.9 m -148.25 150.89 34.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.33 140.58 49.38 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 170.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.53 0.82 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.331 2.253 . . . . 0.0 111.03 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -91.17 146.52 33.71 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -66.53 162.83 35.05 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.521 2.147 . . . . 0.0 111.001 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.64 -19.1 62.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.381 0.672 . . . . 0.0 112.449 -168.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -82.2 -1.26 48.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.865 1.266 . . . . 0.0 110.975 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.56 129.22 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.02 20.83 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.62 -154.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 -167.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -77.4 139.69 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.422 -1.852 1 N-CA-C 95.266 -5.828 . . . . 0.0 95.266 -173.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -102.51 152.74 20.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -120.76 119.87 34.01 Favored 'General case' 0 CA--C 1.487 -1.473 1 N-CA-C 95.336 -5.801 . . . . 0.0 95.336 159.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.67 -177.88 35.12 Favored Glycine 0 CA--C 1.472 -2.607 1 N-CA-C 102.747 -4.141 . . . . 0.0 102.747 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.79 144.36 27.79 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -90.76 148.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.809 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -164.14 1.48 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 146.94 32.17 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 101.429 -3.545 . . . . 0.0 101.429 161.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.6 Cg_endo -64.91 113.39 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.176 2.584 . . . . 0.0 107.754 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.3 tt0 -142.96 162.54 35.2 Favored 'General case' 0 CA--C 1.473 -2.011 1 N-CA-C 99.407 -4.294 . . . . 0.0 99.407 5.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.492 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER 83.14 -5.51 1.24 Allowed 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.087 0.867 . . . . 0.0 110.922 162.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -90.65 -143.83 0.17 Allowed 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 125.366 1.466 . . . . 0.0 107.715 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.514 HG11 ' H ' ' A' ' 43' ' ' HIS . 34.8 m -141.75 -179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 1 N-CA-C 98.366 -4.679 . . . . 0.0 98.366 160.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.7 156.28 39.58 Favored 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 94.494 -6.113 . . . . 0.0 94.494 162.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -96.0 123.14 39.48 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 t -94.36 143.3 26.52 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -111.82 121.22 40.31 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.94 120.6 8.49 Favored 'Trans proline' 0 CA--C 1.506 -0.901 0 CA-C-N 123.565 2.309 . . . . 0.0 111.454 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.73 -55.61 0.68 Allowed Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.819 -5.312 . . . . 0.0 99.819 -160.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 m 113.27 -27.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 129.676 3.19 . . . . 0.0 109.839 167.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.29 -49.65 2.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.673 2.389 . . . . 0.0 117.147 -160.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.2 -49.01 69.07 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 121.669 -0.644 . . . . 0.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.7 t -85.91 -23.9 26.83 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.621 -0.929 . . . . 0.0 110.026 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.82 -36.92 85.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.572 -0.705 . . . . 0.0 109.124 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.8 m -66.41 -41.04 89.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.947 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.83 -44.5 95.99 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.632 0.773 . . . . 0.0 109.833 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 t -52.6 -50.14 63.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.406 1.482 . . . . 0.0 110.272 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -60.73 -47.69 85.17 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.721 0.409 . . . . 0.0 112.04 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.09 -31.79 66.39 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.487 -0.758 . . . . 0.0 112.783 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -78.48 -25.23 45.68 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.788 0.722 . . . . 0.0 109.784 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.97 42.57 0.77 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 161.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.68 135.37 12.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.879 -2.888 . . . . 0.0 105.879 170.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -84.02 -16.14 45.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.648 0.779 . . . . 0.0 109.928 -166.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t -158.8 169.98 23.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.99 175.39 46.64 Favored Glycine 0 N--CA 1.425 -2.046 1 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 p80 179.2 -176.45 0.26 Allowed 'General case' 0 N--CA 1.435 -1.193 1 N-CA-C 99.513 -4.255 . . . . 0.0 99.513 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.67 173.84 7.49 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.02 -171.05 40.99 Favored Glycine 0 CA--C 1.483 -1.953 1 N-CA-C 97.322 -6.311 . . . . 0.0 97.322 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.29 160.86 40.28 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 97.256 -5.09 . . . . 0.0 97.256 171.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -160.01 36.88 0.18 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.263 2.2 t 58.53 -143.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -157.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.92 -126.19 6.38 Favored Glycine 0 CA--C 1.48 -2.133 1 N-CA-C 99.548 -5.421 . . . . 0.0 99.548 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' H ' HG11 ' A' ' 13' ' ' VAL . 66.9 m80 -121.13 -20.32 6.83 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 125.611 1.565 . . . . 0.0 108.192 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.39 -173.89 45.78 Favored Glycine 0 N--CA 1.421 -2.318 1 N-CA-C 96.481 -6.647 . . . . 0.0 96.481 -165.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.03 102.07 10.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 118.271 1.035 . . . . 0.0 108.232 -168.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.99 -179.83 7.54 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 125.231 1.413 . . . . 0.0 109.005 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 155.64 39.47 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 -170.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -90.95 154.36 19.52 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.9 m -141.95 144.02 33.52 Favored 'General case' 0 CA--C 1.479 -1.783 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 161.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -112.5 121.93 46.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.17 75.94 0.16 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 126.424 1.89 . . . . 0.0 110.085 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.5 mt -99.74 140.19 21.39 Favored Pre-proline 0 CA--C 1.497 -1.088 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.66 171.3 17.52 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.502 2.135 . . . . 0.0 109.943 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -78.56 -3.88 45.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -163.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -91.14 1.31 57.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.939 0.896 . . . . 0.0 109.917 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.95 140.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.56 148.58 18.91 Favored Glycine 0 CA--C 1.482 -1.997 1 N-CA-C 102.598 -4.201 . . . . 0.0 102.598 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HB ' ' H ' ' A' ' 59' ' ' ILE . 19.1 pt -144.53 -153.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -161.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.2 mm -72.53 139.46 19.59 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.423 -1.824 1 N-CA-C 92.91 -6.7 . . . . 0.0 92.91 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.698 0.761 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HE ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -123.71 157.15 34.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 174.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -132.52 127.84 36.03 Favored 'General case' 0 CA--C 1.488 -1.423 1 N-CA-C 98.113 -4.773 . . . . 0.0 98.113 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -167.23 22.25 Favored Glycine 0 CA--C 1.475 -2.421 1 N-CA-C 102.017 -4.433 . . . . 0.0 102.017 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.47 135.34 39.37 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 161.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -85.16 135.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -138.24 0.09 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.492 -2.595 . . . . 0.0 106.577 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -151.56 164.03 21.63 Favored Pre-proline 0 N--CA 1.422 -1.829 1 N-CA-C 95.329 -5.804 . . . . 0.0 95.329 162.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -65.22 148.4 88.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.845 2.052 . . . . 0.0 109.328 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.53 -51.01 6.15 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 127.97 2.508 . . . . 0.0 109.463 5.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -142.3 143.38 32.77 Favored 'General case' 0 CA--C 1.479 -1.767 1 N-CA-C 92.615 -6.809 . . . . 0.0 92.615 169.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.2 m -172.83 -158.85 0.11 Allowed 'General case' 0 N--CA 1.435 -1.179 1 N-CA-C 100.133 -4.025 . . . . 0.0 100.133 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 59' ' ' ILE . 2.9 m -124.26 166.37 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 96.612 -5.329 . . . . 0.0 96.612 159.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.16 -170.48 3.06 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -130.09 145.21 51.67 Favored 'General case' 0 CA--C 1.472 -2.027 1 N-CA-C 93.075 -6.639 . . . . 0.0 93.075 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -160.44 -165.37 1.42 Allowed 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 94.863 -5.977 . . . . 0.0 94.863 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -144.42 171.91 6.12 Favored Pre-proline 0 N--CA 1.416 -2.154 1 N-CA-C 99.821 -4.14 . . . . 0.0 99.821 -161.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.88 60.3 2.26 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.304 2.669 . . . . 0.0 110.049 164.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.59 124.43 0.81 Allowed Glycine 0 N--CA 1.422 -2.251 1 N-CA-C 100.948 -4.861 . . . . 0.0 100.948 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.37 38.21 0.35 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.088 1.755 . . . . 0.0 112.276 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -70.08 -63.96 0.98 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.369 1.468 . . . . 0.0 110.127 -161.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -23.46 61.93 Favored Glycine 0 CA--C 1.495 -1.19 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -79.65 -14.66 58.63 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.724 -0.655 . . . . 0.0 111.4 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.7 -55.35 23.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 119.714 1.143 . . . . 0.0 109.735 168.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.32 90.88 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.004 1.322 . . . . 0.0 112.767 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.53 -40.49 89.16 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.574 0.702 . . . . 0.0 111.219 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.6 -42.87 98.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -64.1 -46.38 84.49 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 122.465 0.306 . . . . 0.0 110.935 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.32 -15.94 61.89 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.128 -0.982 . . . . 0.0 112.495 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -92.67 -6.87 48.36 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.02 0.528 . . . . 0.0 109.878 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 32.11 11.14 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.81 18.92 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 103.858 -3.697 . . . . 0.0 103.858 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -82.13 -43.33 17.93 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 121.828 -0.807 . . . . 0.0 109.761 -167.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -160.71 -179.76 7.88 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.72 -4.548 . . . . 0.0 98.72 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.01 -176.39 42.39 Favored Glycine 0 N--CA 1.418 -2.503 1 N-CA-C 99.313 -5.515 . . . . 0.0 99.313 -167.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -160.33 -176.6 5.71 Favored 'General case' 0 CA--C 1.488 -1.409 1 N-CA-C 98.511 -4.625 . . . . 0.0 98.511 -174.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.7 m -140.32 161.64 37.2 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.06 109.73 0.95 Allowed Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 104.571 -3.411 . . . . 0.0 104.571 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -171.84 -179.75 2.53 Favored 'General case' 0 N--CA 1.43 -1.425 1 N-CA-C 98.138 -4.764 . . . . 0.0 98.138 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -153.78 148.74 26.68 Favored 'General case' 0 N--CA 1.433 -1.319 1 N-CA-C 95.849 -5.612 . . . . 0.0 95.849 163.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.52 173.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 N-CA-C 97.814 -4.884 . . . . 0.0 97.814 173.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.29 75.89 1.98 Allowed Glycine 0 C--N 1.351 1.372 0 N-CA-C 105.163 -3.175 . . . . 0.0 105.163 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.38 -50.29 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.35 1 N-CA-C 99.928 -4.101 . . . . 0.0 99.928 -170.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.02 -92.41 0.12 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.59 174.16 8.01 Favored 'General case' 0 N--CA 1.427 -1.597 1 N-CA-C 95.838 -5.616 . . . . 0.0 95.838 -173.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.44 -174.62 4.57 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.9 t -118.01 158.3 25.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 101.742 -3.429 . . . . 0.0 101.742 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -97.17 153.98 17.65 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 m -145.63 152.17 39.22 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 101.444 -3.539 . . . . 0.0 101.444 163.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.87 143.15 48.08 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.84 51.58 0.57 Allowed 'General case' 0 CA--C 1.498 -1.019 0 C-N-CA 126.928 2.091 . . . . 0.0 111.986 171.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -93.0 133.04 29.49 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.97 172.94 11.91 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.542 2.161 . . . . 0.0 110.283 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.71 26.33 1.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -97.31 -7.91 30.94 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -101.81 -176.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -151.17 166.65 30.57 Favored Glycine 0 CA--C 1.479 -2.181 1 N-CA-C 98.11 -5.996 . . . . 0.0 98.11 -174.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.416 HG12 ' HE ' ' A' ' 2' ' ' ARG . 23.3 pt -153.8 -168.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.478 -1.807 1 N-CA-C 99.282 -4.34 . . . . 0.0 99.282 -168.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.429 HD12 HG12 ' A' ' 13' ' ' VAL . 14.5 mm -64.17 111.65 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.118 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -104.47 166.42 10.41 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -130.46 134.33 47.01 Favored 'General case' 0 CA--C 1.491 -1.289 1 N-CA-C 94.574 -6.084 . . . . 0.0 94.574 158.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 -179.69 36.78 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -79.21 132.38 36.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 159.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.62 138.06 20.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.84 -156.88 0.57 Allowed 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 127.71 2.404 . . . . 0.0 107.913 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -121.89 142.94 37.36 Favored Pre-proline 0 N--CA 1.424 -1.774 1 N-CA-C 94.846 -5.983 . . . . 0.0 94.846 165.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -63.36 138.03 63.72 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.034 2.489 . . . . 0.0 107.592 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -79.97 -49.45 11.83 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 127.291 2.236 . . . . 0.0 111.469 12.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -156.58 145.08 19.86 Favored 'General case' 0 N--CA 1.417 -2.08 1 N-CA-C 94.538 -6.097 . . . . 0.0 94.538 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 m 172.11 -157.65 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 59' ' ' ILE . 5.6 m -125.83 159.04 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 1 N-CA-C 97.143 -5.132 . . . . 0.0 97.143 162.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.85 -175.74 5.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 162.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -132.03 170.62 14.68 Favored 'General case' 0 CA--C 1.481 -1.682 1 N-CA-C 96.638 -5.319 . . . . 0.0 96.638 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -160.42 169.04 23.89 Favored 'General case' 0 N--CA 1.412 -2.364 1 N-CA-C 98.754 -4.535 . . . . 0.0 98.754 -170.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.27 104.21 22.42 Favored Pre-proline 0 N--CA 1.416 -2.136 1 N-CA-C 93.085 -6.635 . . . . 0.0 93.085 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.95 101.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.306 0 CA-C-N 124.987 2.817 . . . . 0.0 118.138 -141.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.97 8.33 79.32 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -91.87 170.65 9.7 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -49.57 -36.69 24.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.704 2.002 . . . . 0.0 115.209 -169.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.33 -59.84 10.01 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 123.115 0.388 . . . . 0.0 112.642 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -79.57 -13.71 59.34 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 118.792 1.296 . . . . 0.0 109.611 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.21 -49.53 76.79 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -42.84 99.43 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.65 -38.86 90.54 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.856 1.207 . . . . 0.0 110.597 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -62.57 -48.78 77.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -57.76 -50.05 74.52 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.896 0.878 . . . . 0.0 112.268 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.4 -10.33 57.5 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -4.07 28.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.634 0.774 . . . . 0.0 110.016 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.14 37.91 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.51 114.99 4.28 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 m -101.9 -5.59 24.55 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.85 169.32 24.62 Favored 'General case' 0 N--CA 1.435 -1.197 1 N-CA-C 97.462 -5.014 . . . . 0.0 97.462 163.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.88 -177.8 42.45 Favored Glycine 0 CA--C 1.479 -2.181 0 N-CA-C 103.797 -3.721 . . . . 0.0 103.797 -174.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -163.48 -166.56 1.25 Allowed 'General case' 0 N--CA 1.433 -1.286 1 N-CA-C 97.229 -5.1 . . . . 0.0 97.229 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.8 m -154.71 163.28 40.47 Favored 'General case' 0 CA--C 1.484 -1.568 1 N-CA-C 98.938 -4.468 . . . . 0.0 98.938 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.55 -176.48 47.68 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 103.274 -3.93 . . . . 0.0 103.274 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.42 143.11 29.87 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 97.178 -5.119 . . . . 0.0 97.178 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -164.42 53.84 0.14 Allowed 'General case' 0 CA--C 1.491 -1.312 1 N-CA-C 97.357 -5.053 . . . . 0.0 97.357 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.301 1.5 t 57.76 -146.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 C-N-CA 125.628 1.571 . . . . 0.0 107.95 -160.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.04 -127.63 6.9 Favored Glycine 0 N--CA 1.424 -2.111 1 N-CA-C 98.915 -5.674 . . . . 0.0 98.915 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.484 ' H ' HG11 ' A' ' 13' ' ' VAL . 31.9 m170 -119.23 -10.02 9.83 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.19 -169.86 42.93 Favored Glycine 0 N--CA 1.423 -2.196 1 N-CA-C 98.168 -5.973 . . . . 0.0 98.168 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.59 128.63 36.86 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.91 171.37 8.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.1 t -113.46 166.91 11.04 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 100.856 -3.757 . . . . 0.0 100.856 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -132.15 148.78 52.49 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.4 m -142.18 154.05 44.52 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -120.25 136.03 54.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.72 56.19 0.18 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.588 2.355 . . . . 0.0 109.896 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.95 135.98 25.31 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -66.5 169.1 14.82 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.112 1.875 . . . . 0.0 112.098 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.8 -6.71 50.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -93.6 1.97 56.51 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 123.01 0.524 . . . . 0.0 110.061 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.06 133.85 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.04 151.55 19.49 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 105.766 -2.934 . . . . 0.0 105.766 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 pt -140.7 -166.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -72.47 140.56 17.79 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -172.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.421 -1.879 1 N-CA-C 94.982 -5.933 . . . . 0.0 94.982 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 178.19 7.5 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -135.83 131.77 35.81 Favored 'General case' 0 CA--C 1.492 -1.274 1 N-CA-C 96.781 -5.266 . . . . 0.0 96.781 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -177.89 35.21 Favored Glycine 0 CA--C 1.479 -2.204 0 N-CA-C 103.909 -3.677 . . . . 0.0 103.909 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -74.73 131.71 41.05 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.5 130.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -99.22 -153.0 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 111.418 -2.628 . . . . 0.0 108.275 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -130.79 152.27 80.26 Favored Pre-proline 0 N--CA 1.422 -1.873 1 N-CA-C 95.834 -5.617 . . . . 0.0 95.834 174.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -70.87 151.39 62.7 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 CA-C-N 122.338 1.871 . . . . 0.0 109.841 -171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -96.31 -20.64 18.35 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 127.771 2.428 . . . . 0.0 106.662 3.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -154.01 148.11 25.74 Favored 'General case' 0 N--CA 1.407 -2.585 1 N-CA-C 95.509 -5.737 . . . . 0.0 95.509 172.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.78 -154.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.605 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -136.53 173.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 N-CA-C 97.566 -4.976 . . . . 0.0 97.566 166.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -161.39 0.81 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 167.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -136.75 151.87 49.7 Favored 'General case' 0 N--CA 1.418 -2.057 1 N-CA-C 95.023 -5.918 . . . . 0.0 95.023 167.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -160.77 -167.6 1.89 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.74 -5.652 . . . . 0.0 95.74 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.6 166.35 17.85 Favored Pre-proline 0 N--CA 1.415 -2.204 1 N-CA-C 98.05 -4.796 . . . . 0.0 98.05 -161.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -68.34 68.68 1.02 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 CA-C-N 124.094 2.498 . . . . 0.0 112.199 165.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.1 -179.83 46.98 Favored Glycine 0 N--CA 1.417 -2.567 1 N-CA-C 97.661 -6.176 . . . . 0.0 97.661 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -128.82 9.02 5.8 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -55.03 -43.53 73.81 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.891 1.676 . . . . 0.0 114.205 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.95 -49.69 5.52 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -50.36 -43.23 54.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.042 1.737 . . . . 0.0 113.177 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.9 -32.23 70.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.695 0.798 . . . . 0.0 110.593 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -78.97 -45.8 19.6 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 109.004 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.24 -41.15 86.1 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -63.06 -41.8 99.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.464 -0.773 . . . . 0.0 110.684 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.86 -35.17 67.14 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.277 -0.889 . . . . 0.0 111.49 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.59 -30.35 61.66 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.564 -0.71 . . . . 0.0 111.077 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -90.37 -6.82 54.56 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.213 0.605 . . . . 0.0 110.534 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.7 37.18 4.55 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 160.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.29 163.7 16.81 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 104.653 -3.379 . . . . 0.0 104.653 164.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.4 p -68.53 -56.13 9.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.515 1.15 . . . . 0.0 109.854 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -160.67 -172.62 3.59 Favored 'General case' 0 N--CA 1.424 -1.775 1 N-CA-C 98.904 -4.48 . . . . 0.0 98.904 168.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.04 -178.83 40.2 Favored Glycine 0 N--CA 1.415 -2.764 1 N-CA-C 98.529 -5.828 . . . . 0.0 98.529 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -161.56 -175.74 4.93 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.726 -4.916 . . . . 0.0 97.726 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -139.19 157.77 45.35 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 103.811 -2.662 . . . . 0.0 103.811 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.55 166.44 34.24 Favored Glycine 0 N--CA 1.429 -1.774 1 N-CA-C 95.847 -6.901 . . . . 0.0 95.847 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.95 132.08 56.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -129.67 36.08 4.12 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 42' ' ' GLY 0.284 11.5 t 70.1 -171.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -163.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.751 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 147.34 -130.37 3.54 Favored Glycine 0 N--CA 1.42 -2.386 1 N-CA-C 97.122 -6.391 . . . . 0.0 97.122 -168.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -114.5 -48.7 2.86 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.45 -178.74 23.83 Favored Glycine 0 N--CA 1.425 -2.083 1 N-CA-C 97.895 -6.082 . . . . 0.0 97.895 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 103.37 7.43 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.423 1.489 . . . . 0.0 107.294 -171.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.11 -166.46 1.5 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -117.49 151.79 36.39 Favored 'General case' 0 CA--C 1.489 -1.386 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -101.32 158.74 15.83 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.8 m -145.78 143.41 29.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.8 123.6 50.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 172.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.23 65.26 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.778 2.431 . . . . 0.0 109.315 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.95 138.68 20.67 Favored Pre-proline 0 CA--C 1.492 -1.271 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.534 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -66.48 161.3 41.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.749 2.299 . . . . 0.0 110.606 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.6 -15.21 59.89 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.059 0.543 . . . . 0.0 111.127 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -92.27 12.36 22.71 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 110.391 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.08 -158.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 101.439 -3.541 . . . . 0.0 101.439 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.03 163.39 33.75 Favored Glycine 0 CA--C 1.466 -3.001 1 N-CA-C 102.539 -4.224 . . . . 0.0 102.539 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -152.78 -170.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 101.168 -3.641 . . . . 0.0 101.168 -163.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 13' ' ' VAL . 4.0 mm -71.22 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.427 -1.583 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 174.87 5.73 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.54 145.77 51.02 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 95.451 -5.759 . . . . 0.0 95.451 165.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 175.66 38.13 Favored Glycine 0 CA--C 1.479 -2.215 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 66.5 m-85 -80.4 131.64 35.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 155.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.87 138.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -106.75 -138.18 0.37 Allowed 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 127.493 2.317 . . . . 0.0 107.085 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -141.34 148.82 52.54 Favored Pre-proline 0 N--CA 1.415 -2.196 1 N-CA-C 94.553 -6.092 . . . . 0.0 94.553 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -67.52 143.8 64.4 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.641 2.228 . . . . 0.0 107.548 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -84.29 -33.06 24.05 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 127.897 2.479 . . . . 0.0 109.332 9.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -160.42 158.32 29.26 Favored 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 94.312 -6.181 . . . . 0.0 94.312 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 171.18 -152.5 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 1 N-CA-C 98.382 -4.673 . . . . 0.0 98.382 167.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.32 167.72 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 N-CA-C 96.287 -5.449 . . . . 0.0 96.287 158.891 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.87 -150.48 0.11 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -139.29 -175.36 4.15 Favored 'General case' 0 CA--C 1.484 -1.571 1 N-CA-C 96.619 -5.326 . . . . 0.0 96.619 163.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -147.93 173.81 12.5 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 96.608 -5.33 . . . . 0.0 96.608 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -129.65 126.11 22.55 Favored Pre-proline 0 N--CA 1.413 -2.317 1 N-CA-C 92.376 -6.898 . . . . 0.0 92.376 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -60.13 98.33 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 125.164 2.88 . . . . 0.0 114.855 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -167.01 35.33 Favored Glycine 0 N--CA 1.422 -2.249 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 p -91.44 -45.36 8.59 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -39.68 -70.62 0.1 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.218 2.207 . . . . 0.0 116.912 -151.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.58 -37.35 62.07 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.799 -1.188 . . . . 0.0 111.068 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -64.88 -51.47 61.77 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.914 1.286 . . . . 0.0 108.795 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.16 -41.39 96.68 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.896 0.878 . . . . 0.0 109.587 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.6 m -59.0 -47.7 84.24 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 121.333 -0.854 . . . . 0.0 111.756 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 mt -65.98 -42.3 90.03 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 123.387 0.675 . . . . 0.0 110.476 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.13 -49.53 73.65 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.38 1.472 . . . . 0.0 109.902 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -69.72 -35.57 75.14 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.27 -0.894 . . . . 0.0 111.339 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -74.76 -2.69 27.6 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.319 -0.863 . . . . 0.0 112.884 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.5 7.53 28.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.379 -0.825 . . . . 0.0 109.212 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.39 26.38 18.3 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.82 132.97 11.43 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 m -94.05 -15.88 24.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -166.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -160.61 179.19 8.78 Favored 'General case' 0 CA--C 1.493 -1.248 1 N-CA-C 99.337 -4.32 . . . . 0.0 99.337 168.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.5 -173.87 39.4 Favored Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 103.104 -3.998 . . . . 0.0 103.104 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -161.08 -162.31 0.9 Allowed 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 -174.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.9 t -136.17 164.92 26.92 Favored 'General case' 0 CA--C 1.489 -1.374 1 N-CA-C 96.202 -5.481 . . . . 0.0 96.202 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.04 -168.19 37.75 Favored Glycine 0 N--CA 1.425 -2.099 1 N-CA-C 102.053 -4.419 . . . . 0.0 102.053 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -148.14 144.68 27.95 Favored 'General case' 0 N--CA 1.428 -1.546 1 N-CA-C 96.368 -5.419 . . . . 0.0 96.368 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -126.89 109.96 12.53 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.73 136.12 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.57 -34.16 4.2 Favored Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 105.414 -3.074 . . . . 0.0 105.414 -170.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.34 -70.62 0.78 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.95 -153.03 23.81 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 106.819 -2.512 . . . . 0.0 106.819 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.64 137.89 55.95 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.164 2.186 . . . . 0.0 106.273 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.35 178.21 8.08 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 101.349 -3.574 . . . . 0.0 101.349 -168.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.22 165.94 13.2 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.651 -4.203 . . . . 0.0 99.651 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 6.4 t-105 -127.89 146.87 50.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -134.98 149.22 50.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.67 136.63 53.81 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 172.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.7 76.37 0.28 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 126.799 2.039 . . . . 0.0 111.522 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.16 141.22 22.11 Favored Pre-proline 0 CA--C 1.501 -0.913 0 N-CA-C 101.819 -3.4 . . . . 0.0 101.819 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.7 165.16 31.84 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.38 2.054 . . . . 0.0 109.595 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.8 -1.65 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.438 -0.789 . . . . 0.0 112.726 -160.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.49 -1.99 58.35 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.051 0.94 . . . . 0.0 109.533 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.65 134.41 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.96 148.44 16.55 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 104.295 -3.522 . . . . 0.0 104.295 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 pt -132.27 -150.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.6 mm -73.64 131.37 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 99.313 -4.329 . . . . 0.0 99.313 172.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -174.57 4.56 Favored 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 98.192 -4.744 . . . . 0.0 98.192 172.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -133.74 143.17 48.3 Favored 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.143 -4.762 . . . . 0.0 98.143 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.32 23.86 Favored Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -81.87 136.65 35.34 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 163.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 tt -90.55 146.83 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.333 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.09 178.19 10.3 Favored 'General case' 0 N--CA 1.401 -2.88 1 N-CA-C 96.949 -5.204 . . . . 0.0 96.949 -163.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -93.21 161.01 32.24 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -64.07 116.85 3.95 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.089 1.859 . . . . 0.0 109.812 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -145.52 139.2 26.6 Favored 'General case' 0 CA--C 1.481 -1.703 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 2.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.1 -26.95 0.09 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 127.162 2.185 . . . . 0.0 110.138 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.2 m -87.24 111.63 21.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -157.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.04 171.97 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-O 124.544 2.116 . . . . 0.0 114.654 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.76 -154.78 0.49 Allowed 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.533 -2.576 . . . . 0.0 104.337 -173.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.9 177.61 8.23 Favored 'General case' 0 N--CA 1.417 -2.12 1 N-CA-C 95.756 -5.646 . . . . 0.0 95.756 162.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' HD22 ' A' ' 45' ' ' LEU . 11.5 t -142.7 159.21 42.68 Favored 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 95.153 -5.869 . . . . 0.0 95.153 -174.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.0 121.42 25.44 Favored Pre-proline 0 N--CA 1.415 -2.18 1 N-CA-C 93.235 -6.58 . . . . 0.0 93.235 168.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -68.29 67.69 1.03 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 CA-C-N 123.604 2.323 . . . . 0.0 114.787 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.93 161.5 32.73 Favored Glycine 0 N--CA 1.424 -2.159 1 N-CA-C 100.031 -5.228 . . . . 0.0 100.031 175.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 m -63.3 -39.76 95.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.919 0.887 . . . . 0.0 112.156 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -62.33 -27.16 68.85 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -168.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -77.19 1.33 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 168.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.19 -37.29 79.79 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.855 0.862 . . . . 0.0 113.238 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -73.26 -46.79 47.97 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 m -54.86 -46.0 74.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.829 0.851 . . . . 0.0 111.383 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.13 -35.23 79.28 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 123.49 0.716 . . . . 0.0 111.637 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -69.98 -48.85 56.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 109.207 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -60.95 -45.59 94.12 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 121.822 -0.549 . . . . 0.0 110.865 -174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.73 -13.84 62.64 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -0.1 37.53 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.66 26.42 13.28 Favored Glycine 0 CA--C 1.491 -1.442 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.012 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.78 138.53 14.43 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.7 p -84.46 -29.67 25.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.764 0.793 . . . . 0.0 109.589 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.45 158.53 29.55 Favored 'General case' 0 N--CA 1.421 -1.889 1 N-CA-C 98.726 -4.546 . . . . 0.0 98.726 -166.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.33 -177.43 47.85 Favored Glycine 0 N--CA 1.424 -2.104 1 N-CA-C 100.346 -5.102 . . . . 0.0 100.346 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -173.17 -176.73 1.42 Allowed 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 100.311 -3.959 . . . . 0.0 100.311 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.3 t -90.22 163.46 14.79 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.77 -175.04 37.93 Favored Glycine 0 CA--C 1.479 -2.168 1 N-CA-C 99.308 -5.517 . . . . 0.0 99.308 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -131.0 148.25 52.73 Favored 'General case' 0 N--CA 1.433 -1.289 1 N-CA-C 99.437 -4.282 . . . . 0.0 99.437 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -115.65 94.38 4.67 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.81 120.2 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.63 -22.83 7.66 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -121.83 -72.11 0.7 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.03 -159.54 32.64 Favored Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 105.706 -2.958 . . . . 0.0 105.706 -169.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 16' ' ' CYS . 1.8 mt -78.26 150.73 33.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.385 -2.821 . . . . 0.0 103.385 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.33 173.84 15.66 Favored 'General case' 0 CA--C 1.485 -1.554 1 N-CA-C 98.69 -4.559 . . . . 0.0 98.69 -174.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -116.14 164.6 14.23 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -106.34 146.56 30.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 m -141.92 147.44 37.07 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.7 138.8 47.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.43 68.98 0.77 Allowed 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.788 2.035 . . . . 0.0 112.326 169.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mt -99.57 148.86 35.3 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -66.64 167.97 17.82 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.591 2.194 . . . . 0.0 112.366 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -81.76 4.08 23.37 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -103.21 13.4 34.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.83 152.77 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 167.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.41 158.26 27.61 Favored Glycine 0 CA--C 1.48 -2.099 1 N-CA-C 98.304 -5.918 . . . . 0.0 98.304 -176.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.19 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 -151.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.8 mm -68.26 131.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.415 -2.2 1 N-CA-C 90.335 -7.654 . . . . 0.0 90.335 -174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.185 0.517 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 179.12 7.05 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 169.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -133.09 140.51 47.7 Favored 'General case' 0 CA--C 1.49 -1.335 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -176.18 33.77 Favored Glycine 0 CA--C 1.482 -2.008 0 N-CA-C 106.547 -2.621 . . . . 0.0 106.547 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -77.36 130.7 37.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 161.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.254 15.5 tt -90.41 136.2 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.41 -168.39 2.09 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 129.149 2.98 . . . . 0.0 109.383 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -145.91 158.63 48.69 Favored Pre-proline 0 N--CA 1.423 -1.819 1 N-CA-C 95.85 -5.611 . . . . 0.0 95.85 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.18 146.59 90.73 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 123.065 2.13 . . . . 0.0 112.26 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.63 -53.22 4.9 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 126.621 1.968 . . . . 0.0 107.721 7.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -142.74 137.67 29.96 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 91.947 -7.057 . . . . 0.0 91.947 168.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.6 m -177.47 -162.76 0.07 Allowed 'General case' 0 CA--C 1.483 -1.628 1 N-CA-C 98.735 -4.543 . . . . 0.0 98.735 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -117.92 163.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 1 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 166.45 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -169.21 1.95 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 159.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -135.01 167.53 20.78 Favored 'General case' 0 CA--C 1.477 -1.86 1 N-CA-C 97.104 -5.147 . . . . 0.0 97.104 173.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -136.58 160.94 37.28 Favored 'General case' 0 N--CA 1.421 -1.92 1 N-CA-C 96.517 -5.364 . . . . 0.0 96.517 -165.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -112.73 116.54 47.76 Favored Pre-proline 0 N--CA 1.422 -1.858 1 N-CA-C 95.067 -5.901 . . . . 0.0 95.067 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -59.37 101.76 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.676 0 CA-C-N 125.004 2.823 . . . . 0.0 115.32 -161.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.15 -171.3 37.15 Favored Glycine 0 N--CA 1.42 -2.387 1 N-CA-C 98.308 -5.917 . . . . 0.0 98.308 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 -35.99 14.6 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.445 0.622 . . . . 0.0 110.499 -172.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -53.25 35.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.496 2.319 . . . . 0.0 116.034 -159.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.75 -42.38 31.73 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.5 -42.79 86.82 Favored 'General case' 0 CA--C 1.482 -1.644 0 O-C-N 122.148 -0.619 . . . . 0.0 110.988 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.36 -39.33 93.67 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.2 m -63.05 -47.21 83.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.818 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -40.07 95.78 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.783 0.801 . . . . 0.0 110.1 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.39 -42.81 82.94 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.26 1.024 . . . . 0.0 110.823 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.86 -47.79 84.77 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 122.878 0.471 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.95 -14.9 60.24 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -96.26 -6.84 37.03 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.733 -0.605 . . . . 0.0 111.061 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.44 27.25 12.03 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.51 151.87 19.09 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.726 -3.349 . . . . 0.0 104.726 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.0 p -84.85 -34.42 22.67 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -169.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.55 152.84 34.75 Favored 'General case' 0 N--CA 1.423 -1.8 1 N-CA-C 99.992 -4.077 . . . . 0.0 99.992 -161.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.89 42.18 Favored Glycine 0 CA--C 1.475 -2.444 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.489 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 26.1 p-80 -166.49 -158.74 0.33 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 101.49 -3.522 . . . . 0.0 101.49 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.98 161.18 21.35 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -178.86 41.91 Favored Glycine 0 N--CA 1.422 -2.246 1 N-CA-C 102.214 -4.354 . . . . 0.0 102.214 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -138.07 139.64 39.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 100.389 -3.93 . . . . 0.0 100.389 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -115.48 99.02 7.06 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.82 120.05 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.14 -32.22 3.16 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.782 -2.927 . . . . 0.0 105.782 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.21 -70.3 0.81 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.15 -159.81 32.69 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 104.973 -3.251 . . . . 0.0 104.973 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.53 140.64 58.89 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.453 2.301 . . . . 0.0 106.849 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.86 -179.77 6.13 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -171.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.4 m -113.24 168.2 9.93 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 101.451 -3.537 . . . . 0.0 101.451 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 13.2 t-105 -121.93 148.38 44.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.07 150.02 45.25 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.14 147.2 43.57 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 103.233 -2.876 . . . . 0.0 103.233 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.02 51.47 0.95 Allowed 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 126.953 2.101 . . . . 0.0 110.972 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.84 133.71 28.69 Favored Pre-proline 0 CA--C 1.499 -0.984 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.0 175.5 11.32 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.266 1.978 . . . . 0.0 110.444 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.08 4.63 16.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -95.86 3.62 53.5 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.182 -0.948 . . . . 0.0 108.813 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -104.58 178.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -155.58 164.13 31.96 Favored Glycine 0 CA--C 1.482 -1.974 1 N-CA-C 98.412 -5.875 . . . . 0.0 98.412 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 pt -155.62 -172.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -163.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER -68.9 118.87 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 CA-C-O 122.077 0.942 . . . . 0.0 111.937 -160.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.427 -1.58 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 166.235 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.627 0.727 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -116.96 154.6 30.59 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -137.89 128.59 26.81 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 97.425 -5.028 . . . . 0.0 97.425 168.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -170.99 27.45 Favored Glycine 0 CA--C 1.476 -2.363 1 N-CA-C 102.306 -4.318 . . . . 0.0 102.306 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.57 135.46 39.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 160.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.51 141.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.44 -138.89 0.36 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.582 -2.099 . . . . 0.0 107.029 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.432 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 64.0 mt-30 -140.93 161.19 55.19 Favored Pre-proline 0 N--CA 1.423 -1.783 1 N-CA-C 95.526 -5.731 . . . . 0.0 95.526 169.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -67.31 144.5 68.41 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 122.765 2.023 . . . . 0.0 108.588 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.62 -42.36 8.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.455 2.302 . . . . 0.0 107.744 7.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.62 146.02 37.41 Favored 'General case' 0 N--CA 1.419 -1.986 1 N-CA-C 92.92 -6.696 . . . . 0.0 92.92 173.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -177.75 -163.98 0.08 Allowed 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.561 HG11 ' H ' ' A' ' 43' ' ' HIS . 3.5 m -128.65 164.11 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.729 1 N-CA-C 96.789 -5.263 . . . . 0.0 96.789 156.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -173.47 4.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 160.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -134.96 147.1 49.66 Favored 'General case' 0 CA--C 1.466 -2.256 1 N-CA-C 93.823 -6.362 . . . . 0.0 93.823 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -160.57 -165.82 1.5 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.081 -5.896 . . . . 0.0 95.081 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -141.22 173.18 5.11 Favored Pre-proline 0 N--CA 1.418 -2.04 1 N-CA-C 99.974 -4.084 . . . . 0.0 99.974 -161.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.52 55.51 3.7 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 C-N-CA 123.035 2.49 . . . . 0.0 110.754 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.69 141.11 4.57 Favored Glycine 0 N--CA 1.42 -2.375 1 N-CA-C 99.363 -5.495 . . . . 0.0 99.363 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 24.93 0.5 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.809 1.644 . . . . 0.0 112.667 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -59.16 -49.46 77.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.663 1.985 . . . . 0.0 112.492 -161.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.87 -25.83 26.12 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -82.85 -8.94 59.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.538 -0.977 . . . . 0.0 110.853 -167.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.46 -57.21 10.61 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.324 1.05 . . . . 0.0 108.98 166.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -52.1 67.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.465 1.106 . . . . 0.0 112.419 171.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.89 -43.25 93.52 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.801 0.81 . . . . 0.0 111.856 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.0 t -62.8 -43.13 99.6 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 108.957 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -78.59 -27.48 45.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.398 -0.814 . . . . 0.0 111.601 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.85 -20.13 53.61 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.182 -0.949 . . . . 0.0 111.334 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -88.06 -22.48 24.16 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.76 33.48 2.42 Favored Glycine 0 CA--C 1.488 -1.595 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 163.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.21 150.83 19.74 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -96.96 -17.92 19.78 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.671 0.748 . . . . 0.0 109.833 -165.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 m -160.75 168.27 25.14 Favored 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 98.979 -4.452 . . . . 0.0 98.979 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.37 176.66 44.57 Favored Glycine 0 N--CA 1.419 -2.452 1 N-CA-C 100.855 -4.898 . . . . 0.0 100.855 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -168.93 -168.77 0.89 Allowed 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 97.35 -5.056 . . . . 0.0 97.35 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -142.43 166.05 25.74 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.44 -176.61 44.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 103.135 -3.986 . . . . 0.0 103.135 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -130.95 121.96 26.05 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 99.539 -4.245 . . . . 0.0 99.539 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -139.33 59.81 1.59 Allowed 'General case' 0 CA--C 1.487 -1.444 1 N-CA-C 99.404 -4.295 . . . . 0.0 99.404 171.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 42' ' ' GLY 0.293 1.5 t 56.47 -152.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 127.512 2.325 . . . . 0.0 108.204 -165.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 119.82 -128.76 7.69 Favored Glycine 0 N--CA 1.425 -2.072 1 N-CA-C 100.065 -5.214 . . . . 0.0 100.065 -170.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.561 ' H ' HG11 ' A' ' 13' ' ' VAL . 35.5 m170 -118.55 -19.65 8.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 125.452 1.501 . . . . 0.0 107.307 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.86 -174.14 46.59 Favored Glycine 0 N--CA 1.426 -1.995 1 N-CA-C 97.625 -6.19 . . . . 0.0 97.625 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -69.16 132.71 46.97 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.06 -169.7 2.03 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -163.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.6 t -123.25 159.51 28.56 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -113.41 151.43 31.37 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.8 m -144.5 150.87 38.3 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -110.53 144.15 39.81 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.79 54.96 4.88 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.748 2.419 . . . . 0.0 112.682 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.18 144.62 38.84 Favored Pre-proline 0 CA--C 1.499 -0.991 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -64.9 162.82 30.62 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.576 2.184 . . . . 0.0 112.209 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.97 -28.03 63.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.103 1.761 . . . . 0.0 114.101 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -98.24 15.82 23.32 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.23 1.012 . . . . 0.0 110.652 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 138.83 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 151.53 18.21 Favored Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 104.31 -3.516 . . . . 0.0 104.31 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.82 -159.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 13' ' ' VAL . 2.0 mm -72.54 130.78 35.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.147 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 100.86 -3.756 . . . . 0.0 100.86 178.883 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.59 165.38 11.86 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 171.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.15 137.91 53.62 Favored 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 94.305 -6.183 . . . . 0.0 94.305 153.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -176.7 34.23 Favored Glycine 0 CA--C 1.474 -2.496 1 N-CA-C 102.956 -4.058 . . . . 0.0 102.956 177.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 41.9 m-85 -76.86 135.52 38.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 161.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -90.4 138.44 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -176.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.57 -135.91 0.34 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.425 -1.716 . . . . 0.0 106.931 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -136.34 159.08 72.11 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 96.156 -5.498 . . . . 0.0 96.156 169.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -69.14 148.57 69.37 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.011 1.807 . . . . 0.0 109.421 174.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -82.15 -29.19 31.74 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 127.42 2.288 . . . . 0.0 108.315 -3.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -155.57 165.34 36.88 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 178.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 157.62 -147.0 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.58 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.571 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 59' ' ' ILE . 17.3 m -135.0 166.9 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 1 N-CA-C 98.352 -4.684 . . . . 0.0 98.352 161.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -170.9 2.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 165.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -136.24 149.54 48.57 Favored 'General case' 0 CA--C 1.479 -1.757 1 N-CA-C 98.53 -4.618 . . . . 0.0 98.53 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -125.59 162.65 24.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 101.922 -3.362 . . . . 0.0 101.922 -168.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -114.06 112.81 46.96 Favored Pre-proline 0 N--CA 1.421 -1.898 1 N-CA-C 98.765 -4.531 . . . . 0.0 98.765 168.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.53 118.53 5.46 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 CA-C-N 123.314 2.219 . . . . 0.0 111.47 -171.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.28 -45.73 0.57 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 99.874 -5.291 . . . . 0.0 99.874 -165.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m 115.17 -35.33 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 129.362 3.065 . . . . 0.0 107.003 168.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -40.15 -53.78 2.4 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.326 2.65 . . . . 0.0 116.459 -156.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.16 -36.7 56.05 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 121.369 -0.832 . . . . 0.0 111.607 -176.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -86.29 -26.13 25.11 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 120.963 -1.316 . . . . 0.0 109.072 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.65 -36.48 84.38 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.999 0.919 . . . . 0.0 108.83 170.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 m -66.23 -42.21 88.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.382 -0.824 . . . . 0.0 110.336 173.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.46 -38.97 92.89 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 121.002 -1.061 . . . . 0.0 110.869 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 t -54.28 -42.78 70.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.515 1.126 . . . . 0.0 111.009 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.71 -44.85 92.42 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 122.022 -0.424 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.22 -28.39 63.14 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.487 0.585 . . . . 0.0 111.91 -176.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.91 -19.04 49.04 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.853 -0.53 . . . . 0.0 110.435 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.47 35.46 2.86 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 164.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.22 138.45 13.91 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 167.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 p -98.05 3.14 49.36 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.851 -0.794 . . . . 0.0 110.036 -168.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -160.36 166.46 29.33 Favored 'General case' 0 CA--C 1.48 -1.716 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.98 175.75 46.48 Favored Glycine 0 CA--C 1.469 -2.831 1 N-CA-C 99.73 -5.348 . . . . 0.0 99.73 -177.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -168.91 -153.78 0.12 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 96.269 -5.456 . . . . 0.0 96.269 -172.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -149.98 166.15 30.51 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.57 -4.974 . . . . 0.0 97.57 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.2 171.41 41.92 Favored Glycine 0 CA--C 1.48 -2.126 1 N-CA-C 96.154 -6.778 . . . . 0.0 96.154 176.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -146.5 137.32 24.12 Favored 'General case' 0 CA--C 1.483 -1.607 1 N-CA-C 99.251 -4.352 . . . . 0.0 99.251 -175.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -158.57 56.18 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.32 1.4 t 55.62 -144.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 125.859 1.664 . . . . 0.0 108.215 -158.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.41 -131.04 5.36 Favored Glycine 0 CA--C 1.474 -2.492 1 N-CA-C 94.86 -7.296 . . . . 0.0 94.86 -169.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.54 ' H ' HG11 ' A' ' 13' ' ' VAL . 51.2 m170 -123.34 10.82 9.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.98 -49.18 0.29 Allowed Glycine 0 CA--C 1.486 -1.737 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -171.33 -176.52 1.89 Allowed 'General case' 0 N--CA 1.437 -1.096 1 N-CA-C 95.848 -5.612 . . . . 0.0 95.848 -175.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.92 174.98 4.59 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 99.089 -4.412 . . . . 0.0 99.089 174.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 29.6 m -123.31 -174.16 2.89 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 171.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 18.4 t-105 -132.01 152.62 51.04 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -177.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.7 m -145.13 155.11 43.11 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -119.27 140.77 49.72 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 172.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.19 55.77 1.07 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 127.356 2.262 . . . . 0.0 111.38 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.35 130.99 37.68 Favored Pre-proline 0 CA--C 1.496 -1.123 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -70.69 176.2 7.81 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.339 2.026 . . . . 0.0 111.069 177.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -84.68 19.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -99.53 -6.16 27.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.2 t -99.06 173.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -145.58 156.86 27.15 Favored Glycine 0 CA--C 1.48 -2.141 1 N-CA-C 97.914 -6.075 . . . . 0.0 97.914 -175.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 pt -150.76 -167.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 101.926 -3.361 . . . . 0.0 101.926 -166.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.738 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -70.03 133.97 30.92 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -171.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.434 -1.263 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 162.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.139 0.495 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.88 171.39 7.93 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 172.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -135.82 133.72 38.15 Favored 'General case' 0 CA--C 1.489 -1.379 1 N-CA-C 96.421 -5.399 . . . . 0.0 96.421 168.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.8 -177.26 34.71 Favored Glycine 0 CA--C 1.478 -2.277 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 36.2 m-85 -73.91 133.75 43.14 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.19 136.89 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.81 -146.14 0.3 Allowed 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 126.718 2.007 . . . . 0.0 107.295 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -133.86 147.14 63.02 Favored Pre-proline 0 N--CA 1.423 -1.8 1 N-CA-C 94.408 -6.145 . . . . 0.0 94.408 164.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.54 145.1 63.27 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 CA-C-N 123.21 2.182 . . . . 0.0 108.089 177.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.57 -44.43 15.87 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 120.902 1.683 . . . . 0.0 111.79 7.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -152.92 149.59 28.39 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 94.489 -6.115 . . . . 0.0 94.489 177.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.32 -158.9 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.437 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 -179.006 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -123.76 161.1 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 1 N-CA-C 98.739 -4.541 . . . . 0.0 98.739 161.758 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -162.36 0.6 Allowed 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 162.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -137.87 166.49 23.9 Favored 'General case' 0 N--CA 1.426 -1.669 1 N-CA-C 96.89 -5.226 . . . . 0.0 96.89 162.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.4 t -119.95 169.82 9.83 Favored 'General case' 0 N--CA 1.419 -1.978 1 N-CA-C 99.041 -4.429 . . . . 0.0 99.041 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.24 131.0 24.02 Favored Pre-proline 0 N--CA 1.421 -1.911 1 N-CA-C 98.03 -4.804 . . . . 0.0 98.03 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -69.08 37.62 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 123.145 2.563 . . . . 0.0 114.715 174.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.86 142.8 9.45 Favored Glycine 0 N--CA 1.426 -2.007 1 N-CA-C 96.084 -6.806 . . . . 0.0 96.084 177.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.1 -41.69 98.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.928 1.291 . . . . 0.0 113.962 -157.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -53.38 9.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 128.407 2.683 . . . . 0.0 115.592 -163.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -50.78 32.21 Favored Glycine 0 C--N 1.349 1.288 0 O-C-N 121.945 -0.472 . . . . 0.0 112.14 -166.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.12 -18.91 55.05 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -58.34 -53.72 55.16 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -39.31 93.99 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.32 -37.95 86.55 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.922 0.783 . . . . 0.0 111.261 -179.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -65.9 -45.78 80.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.614 -0.679 . . . . 0.0 109.98 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -65.15 -41.32 94.85 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.957 -0.464 . . . . 0.0 111.916 -178.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.9 -17.35 63.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.166 -0.959 . . . . 0.0 112.188 -175.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -95.72 -6.29 40.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.66 0.784 . . . . 0.0 110.046 176.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.89 32.7 17.3 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.0 151.15 17.96 Favored Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 104.066 -3.614 . . . . 0.0 104.066 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.7 p -73.45 -55.07 6.83 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.029 0.919 . . . . 0.0 109.999 -168.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -160.63 -177.03 5.91 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 98.184 -4.746 . . . . 0.0 98.184 166.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.56 176.44 44.1 Favored Glycine 0 N--CA 1.416 -2.684 1 N-CA-C 99.838 -5.305 . . . . 0.0 99.838 -171.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -146.31 178.49 8.2 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 100.466 -3.902 . . . . 0.0 100.466 -172.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.6 m -83.79 171.76 12.84 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 119.14 0.882 . . . . 0.0 109.771 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.12 -179.07 45.45 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 103.13 -3.988 . . . . 0.0 103.13 -172.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -147.72 152.71 38.23 Favored 'General case' 0 N--CA 1.427 -1.598 1 N-CA-C 97.298 -5.075 . . . . 0.0 97.298 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -136.84 106.07 6.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 172.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.43 122.29 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.72 -40.69 1.43 Allowed Glycine 0 CA--C 1.482 -2.005 1 N-CA-C 102.62 -4.192 . . . . 0.0 102.62 -166.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -123.76 -67.6 0.92 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.95 -157.51 30.02 Favored Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 -169.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -70.71 139.03 51.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.3 -173.46 3.34 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -167.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -129.4 177.3 7.29 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.815 -3.772 . . . . 0.0 100.815 169.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 30.1 t-105 -122.3 160.48 25.23 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.5 m -148.65 151.77 35.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 167.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.97 129.92 56.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.31 66.89 0.1 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 127.64 2.376 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.5 mt -103.11 137.96 19.41 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.12 170.86 18.81 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.745 2.296 . . . . 0.0 110.402 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.75 -5.68 42.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 124.164 0.986 . . . . 0.0 113.583 -168.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -88.91 3.7 50.49 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.288 -0.883 . . . . 0.0 109.551 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.05 136.05 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.33 154.94 18.54 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.347 -2.301 . . . . 0.0 107.347 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.89 -171.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 -172.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -73.86 141.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 123.395 0.678 . . . . 0.0 109.581 -169.222 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.424 -1.731 1 N-CA-C 98.089 -4.782 . . . . 0.0 98.089 178.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.254 0.55 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 178.8 4.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 167.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -128.74 148.02 50.81 Favored 'General case' 0 N--CA 1.431 -1.397 1 N-CA-C 95.245 -5.835 . . . . 0.0 95.245 166.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.31 170.59 37.13 Favored Glycine 0 CA--C 1.48 -2.133 0 C-N-CA 117.845 -2.121 . . . . 0.0 109.017 -175.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -82.11 121.82 27.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 159.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 tt -90.5 143.27 11.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.089 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -174.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -115.59 -154.52 0.55 Allowed 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 128.995 2.918 . . . . 0.0 108.858 -175.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.32 165.58 30.72 Favored Pre-proline 0 N--CA 1.425 -1.708 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 170.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 44.0 Cg_exo -62.19 126.49 18.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.748 2.965 . . . . 0.0 112.871 -173.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 3.2 mm-40 -133.77 138.07 45.52 Favored 'General case' 0 CA--C 1.467 -2.24 1 N-CA-C 96.33 -5.433 . . . . 0.0 96.33 -10.685 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.532 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 48.6 t30 68.36 30.25 5.54 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 119.351 0.978 . . . . 0.0 111.626 175.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.23 -159.9 0.76 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 168.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -133.95 162.84 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 1 N-CA-C 96.55 -5.352 . . . . 0.0 96.55 170.563 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -168.02 2.09 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 162.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -138.08 146.09 42.51 Favored 'General case' 0 CA--C 1.469 -2.161 1 N-CA-C 96.214 -5.476 . . . . 0.0 96.214 168.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.55 175.2 6.84 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -112.29 130.49 23.28 Favored Pre-proline 0 N--CA 1.421 -1.882 1 N-CA-C 93.976 -6.305 . . . . 0.0 93.976 165.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.92 37.98 0.11 Allowed 'Trans proline' 0 C--N 1.331 -0.369 0 CA-C-N 125.679 3.064 . . . . 0.0 116.024 177.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.55 108.97 0.49 Allowed Glycine 0 N--CA 1.422 -2.243 1 N-CA-C 94.734 -7.346 . . . . 0.0 94.734 170.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -52.42 -36.8 55.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.313 2.245 . . . . 0.0 115.042 -157.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -44.79 -39.35 5.18 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.854 2.462 . . . . 0.0 116.659 -170.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.41 -46.13 87.31 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 120.776 -1.202 . . . . 0.0 112.05 -177.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.65 -25.09 28.75 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 122.18 -0.6 . . . . 0.0 109.621 -175.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.82 -39.25 91.12 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.096 0.558 . . . . 0.0 109.971 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -63.81 -41.97 97.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.464 175.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.0 mt -63.94 -40.44 96.43 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 121.953 0.883 . . . . 0.0 110.667 177.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.6 t -57.86 -47.38 82.88 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.208 1.403 . . . . 0.0 110.575 175.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.04 -42.41 80.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 122.681 0.393 . . . . 0.0 111.024 -176.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.02 -23.6 60.63 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.727 -0.608 . . . . 0.0 111.928 -175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.95 -49.21 11.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.92 48.81 0.16 Allowed Glycine 0 CA--C 1.49 -1.518 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 168.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.13 143.55 15.79 Favored Glycine 0 CA--C 1.487 -1.673 1 N-CA-C 101.35 -4.7 . . . . 0.0 101.35 157.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 p -75.12 -28.6 60.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 118.385 1.092 . . . . 0.0 110.77 -164.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.9 m -160.56 173.42 15.55 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.92 -176.96 42.75 Favored Glycine 0 N--CA 1.418 -2.542 1 N-CA-C 98.786 -5.726 . . . . 0.0 98.786 -172.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -171.16 -174.71 1.54 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 -170.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.4 m -81.03 169.71 17.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 119.153 0.888 . . . . 0.0 109.134 -178.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.88 164.51 34.25 Favored Glycine 0 N--CA 1.416 -2.693 1 N-CA-C 98.465 -5.854 . . . . 0.0 98.465 175.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -135.8 154.77 51.1 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 97.21 -5.108 . . . . 0.0 97.21 177.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.92 179.21 9.29 Favored 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 97.503 -4.999 . . . . 0.0 97.503 174.935 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.63 163.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 1 N-CA-C 97.968 -4.827 . . . . 0.0 97.968 178.173 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.39 -46.85 1.1 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 102.564 -4.214 . . . . 0.0 102.564 -170.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.532 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 35.1 m170 -119.46 -79.65 0.6 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 170.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.22 -147.26 12.82 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 103.28 -3.928 . . . . 0.0 103.28 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.59 132.91 54.64 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.51 2.324 . . . . 0.0 108.066 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.11 -173.34 3.7 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 102.201 -3.259 . . . . 0.0 102.201 -164.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.31 172.05 9.41 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 169.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -129.31 147.9 51.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.7 m -143.28 146.97 34.06 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -114.69 145.46 42.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.5 55.44 0.5 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 126.578 1.951 . . . . 0.0 111.064 172.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.05 138.69 20.35 Favored Pre-proline 0 CA--C 1.501 -0.908 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -66.42 165.95 23.23 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.45 2.1 . . . . 0.0 111.773 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -73.86 -19.1 60.83 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.328 0.651 . . . . 0.0 112.27 -169.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -92.29 18.55 8.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 109.73 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.05 133.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 100.533 -3.877 . . . . 0.0 100.533 167.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.92 146.57 18.64 Favored Glycine 0 CA--C 1.479 -2.172 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.69 -141.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -156.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.8 120.62 28.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 169.14 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -163.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.115 0.483 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.29 167.7 12.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 171.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -130.46 140.03 50.55 Favored 'General case' 0 CA--C 1.485 -1.545 1 N-CA-C 94.703 -6.036 . . . . 0.0 94.703 165.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.45 29.27 Favored Glycine 0 CA--C 1.472 -2.608 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 178.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.58 138.72 34.15 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 101.453 -3.536 . . . . 0.0 101.453 157.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -89.99 132.82 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -177.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.26 -148.86 0.43 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 111.949 -2.387 . . . . 0.0 107.09 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.94 148.46 65.06 Favored Pre-proline 0 N--CA 1.424 -1.773 1 N-CA-C 95.509 -5.738 . . . . 0.0 95.509 174.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.64 149.86 39.18 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.787 2.031 . . . . 0.0 107.847 -177.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 -5.33 16.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.468 2.307 . . . . 0.0 109.263 13.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -162.38 146.55 12.0 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 94.417 -6.142 . . . . 0.0 94.417 163.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.08 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 177.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 59' ' ' ILE . 16.2 m -135.15 170.42 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 97.164 -5.124 . . . . 0.0 97.164 163.048 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.85 -168.16 1.59 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -125.72 163.64 22.39 Favored 'General case' 0 CA--C 1.474 -1.96 1 N-CA-C 99.603 -4.221 . . . . 0.0 99.603 171.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.28 152.71 47.47 Favored 'General case' 0 N--CA 1.417 -2.076 1 N-CA-C 96.158 -5.497 . . . . 0.0 96.158 -166.07 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.52 115.76 39.47 Favored Pre-proline 0 N--CA 1.419 -1.996 1 N-CA-C 97.36 -5.052 . . . . 0.0 97.36 171.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.3 107.49 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 123.347 2.231 . . . . 0.0 112.043 -176.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.81 -41.26 0.83 Allowed Glycine 0 CA--C 1.491 -1.455 1 N-CA-C 101.472 -4.651 . . . . 0.0 101.472 -161.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m 84.76 3.81 0.68 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 125.351 1.46 . . . . 0.0 113.222 157.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.75 -40.82 80.6 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.417 1.887 . . . . 0.0 110.752 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.91 -41.29 93.47 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.906 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.5 m -68.89 -42.94 76.26 Favored 'General case' 0 CA--C 1.484 -1.559 0 CA-C-N 117.959 0.879 . . . . 0.0 110.164 -175.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.98 -49.69 74.97 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.905 0.882 . . . . 0.0 109.255 176.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -57.5 -50.11 74.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 111.443 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.7 -43.78 98.19 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.035 0.921 . . . . 0.0 110.152 -178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.1 -43.05 95.86 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.284 0.634 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.86 -39.74 83.72 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.802 -0.561 . . . . 0.0 111.477 -178.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.71 -21.21 52.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.613 -0.679 . . . . 0.0 111.702 -175.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -89.51 -28.78 19.4 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.592 -0.693 . . . . 0.0 109.691 175.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.21 44.62 0.85 Allowed Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 164.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.73 141.23 16.32 Favored Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 p -99.62 7.42 45.24 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 123.488 0.715 . . . . 0.0 110.034 -167.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.3 m -160.18 150.89 18.77 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 100.28 -3.97 . . . . 0.0 100.28 166.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -166.94 162.67 36.45 Favored Glycine 0 CA--C 1.463 -3.205 1 N-CA-C 99.537 -5.425 . . . . 0.0 99.537 -177.415 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -162.34 -157.68 0.48 Allowed 'General case' 0 N--CA 1.428 -1.529 1 N-CA-C 99.714 -4.18 . . . . 0.0 99.714 -168.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.4 t -155.6 167.04 31.68 Favored 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 95.954 -5.573 . . . . 0.0 95.954 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.82 73.95 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.568 1 N-CA-C 100.27 -5.132 . . . . 0.0 100.27 -176.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -157.84 157.39 33.18 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 176.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -148.39 166.76 27.13 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 94.16 -6.237 . . . . 0.0 94.16 159.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 42' ' ' GLY 0.332 50.1 t 84.19 -167.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -172.132 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.775 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 89.67 -93.24 1.86 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 107.174 -2.371 . . . . 0.0 107.174 -177.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -137.96 -52.47 0.62 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 100.589 -3.856 . . . . 0.0 100.589 178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.8 61.95 0.22 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 172.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.461 0.0 OUTLIER 76.36 167.82 0.26 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 109.164 -175.717 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.55 -179.65 8.37 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -175.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.78 160.97 15.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 176.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 t-105 -107.79 150.52 26.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 9.4 m -147.55 150.92 35.42 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.38 143.15 48.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.21 54.13 0.43 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 126.544 1.938 . . . . 0.0 110.602 168.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.6 mt -95.7 135.34 23.07 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 175.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.99 171.8 16.79 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.432 2.088 . . . . 0.0 110.434 177.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -67.61 -17.17 64.52 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -79.37 -6.78 57.56 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.818 -0.551 . . . . 0.0 110.448 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.61 127.3 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.71 157.09 17.54 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 105.16 -3.176 . . . . 0.0 105.16 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -136.75 -158.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 105.925 -1.879 . . . . 0.0 105.925 -163.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -74.76 123.09 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -178.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -173.896 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.395 0.617 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 173.08 6.95 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.33 137.92 39.42 Favored 'General case' 0 N--CA 1.431 -1.405 1 N-CA-C 95.412 -5.773 . . . . 0.0 95.412 170.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.94 -177.58 35.12 Favored Glycine 0 CA--C 1.471 -2.662 1 N-CA-C 103.06 -4.016 . . . . 0.0 103.06 176.042 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -77.44 134.39 38.39 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 159.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.48 138.28 19.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.14 -157.18 0.56 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 129.045 2.938 . . . . 0.0 110.557 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.42 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 36.9 mt-30 -148.65 165.74 17.21 Favored Pre-proline 0 N--CA 1.426 -1.664 1 N-CA-C 97.116 -5.142 . . . . 0.0 97.116 176.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -68.96 149.9 72.46 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.688 2.259 . . . . 0.0 109.974 176.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -82.21 -47.37 12.55 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 127.48 2.312 . . . . 0.0 107.231 -1.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -150.26 140.38 22.1 Favored 'General case' 0 N--CA 1.42 -1.972 1 N-CA-C 92.332 -6.914 . . . . 0.0 92.332 173.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.8 m 179.9 -161.05 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 97.336 -5.061 . . . . 0.0 97.336 -174.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 59' ' ' ILE . 1.2 m -119.77 163.55 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 100.365 -3.939 . . . . 0.0 100.365 167.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.6 -165.63 1.01 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 158.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -138.34 168.52 19.57 Favored 'General case' 0 N--CA 1.415 -2.179 1 N-CA-C 96.399 -5.408 . . . . 0.0 96.399 167.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -129.55 -176.41 3.89 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 96.68 -5.304 . . . . 0.0 96.68 -176.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.77 131.17 23.67 Favored Pre-proline 0 N--CA 1.42 -1.95 1 N-CA-C 95.385 -5.783 . . . . 0.0 95.385 174.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.79 40.71 0.17 Allowed 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.298 3.332 . . . . 0.0 116.401 -174.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.13 92.9 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 93.609 -7.796 . . . . 0.0 93.609 174.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -78.79 30.86 0.2 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -148.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -70.18 -35.98 74.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 110.32 -170.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.19 -33.44 69.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -81.69 -11.83 58.9 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.189 -0.595 . . . . 0.0 109.969 -177.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.01 -50.08 75.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -50.58 73.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.867 0.867 . . . . 0.0 112.466 170.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.63 -41.52 99.06 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 121.593 0.711 . . . . 0.0 112.135 -173.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 t -65.12 -45.83 83.51 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -67.86 -37.17 81.48 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.669 -0.644 . . . . 0.0 112.358 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.16 -7.86 53.27 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.054 -1.029 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -106.22 1.61 26.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.98 29.67 37.39 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 140.83 15.27 Favored Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -92.94 -54.73 3.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -164.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 m -106.46 147.63 29.11 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 102.895 -3.002 . . . . 0.0 102.895 174.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.64 154.76 25.81 Favored Glycine 0 CA--C 1.469 -2.785 1 N-CA-C 100.468 -5.053 . . . . 0.0 100.468 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -171.97 179.02 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 98.016 -4.809 . . . . 0.0 98.016 -175.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.7 m -78.05 173.93 11.67 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 119.796 1.18 . . . . 0.0 111.044 -177.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.92 164.17 37.75 Favored Glycine 0 N--CA 1.418 -2.528 1 N-CA-C 98.688 -5.765 . . . . 0.0 98.688 175.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -126.72 131.57 51.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -115.76 105.49 12.78 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.72 140.23 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -172.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.09 -36.14 4.6 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -104.17 -66.39 0.96 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -177.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.33 -150.31 22.23 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 104.963 -3.255 . . . . 0.0 104.963 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.43 136.48 54.75 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.84 -162.48 1.1 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 101.998 -3.334 . . . . 0.0 101.998 -176.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.8 171.55 11.64 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 158.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -129.7 148.76 51.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.2 m -142.36 146.67 35.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -116.64 140.63 49.18 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 170.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 63.98 0.31 Allowed 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 126.342 1.857 . . . . 0.0 109.893 176.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 mt -103.09 133.88 20.09 Favored Pre-proline 0 CA--C 1.503 -0.833 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 169.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -72.52 174.64 11.31 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.624 2.216 . . . . 0.0 111.248 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -76.03 -2.08 28.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -165.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -90.49 -5.89 55.49 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.266 -0.896 . . . . 0.0 110.065 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.03 138.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -174.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.72 149.92 17.8 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 pt -146.78 -175.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -168.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.0 OUTLIER -72.42 127.75 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 121.723 0.773 . . . . 0.0 111.74 -159.637 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 100.833 -3.766 . . . . 0.0 100.833 168.808 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.33 163.27 13.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -130.76 127.93 39.74 Favored 'General case' 0 CA--C 1.491 -1.301 1 N-CA-C 95.564 -5.717 . . . . 0.0 95.564 158.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.05 -169.83 25.95 Favored Glycine 0 CA--C 1.478 -2.261 1 N-CA-C 102.808 -4.117 . . . . 0.0 102.808 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 76.0 m-85 -80.55 142.33 34.23 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 163.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.92 141.64 14.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.971 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.702 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -119.77 -153.25 0.53 Allowed 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 128.029 2.531 . . . . 0.0 106.701 -175.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -128.84 147.46 64.65 Favored Pre-proline 0 N--CA 1.419 -1.992 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 173.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.98 146.8 59.89 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.614 1.969 . . . . 0.0 107.31 175.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -80.93 -41.67 22.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.403 2.281 . . . . 0.0 109.845 11.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -154.02 151.87 29.85 Favored 'General case' 0 N--CA 1.417 -2.095 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 -176.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.7 m 173.97 -154.01 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 97.091 -5.151 . . . . 0.0 97.091 169.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.15 170.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 1 N-CA-C 97.412 -5.032 . . . . 0.0 97.412 161.536 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -161.77 0.72 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 164.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -142.35 163.54 32.58 Favored 'General case' 0 N--CA 1.417 -2.101 1 N-CA-C 94.463 -6.125 . . . . 0.0 94.463 165.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -160.64 -156.89 0.5 Allowed 'General case' 0 N--CA 1.414 -2.257 1 N-CA-C 94.656 -6.053 . . . . 0.0 94.656 -174.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -145.61 169.71 9.28 Favored Pre-proline 0 N--CA 1.414 -2.25 1 N-CA-C 97.837 -4.875 . . . . 0.0 97.837 -167.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -77.33 68.4 7.49 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 CA-C-N 124.14 2.514 . . . . 0.0 111.873 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.82 165.94 34.59 Favored Glycine 0 CA--C 1.479 -2.166 1 N-CA-C 99.778 -5.329 . . . . 0.0 99.778 171.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -83.25 11.17 6.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 118.085 0.942 . . . . 0.0 111.32 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.91 -57.02 8.32 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 128.56 2.744 . . . . 0.0 114.485 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.51 -29.66 18.38 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -85.03 -5.06 59.36 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.779 -0.836 . . . . 0.0 110.873 -165.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.96 -53.04 62.89 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -52.63 64.65 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.486 1.115 . . . . 0.0 112.423 171.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.88 -41.08 97.83 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 118.603 0.638 . . . . 0.0 110.998 -173.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -65.47 -42.3 92.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 121.231 -0.918 . . . . 0.0 108.78 -177.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -69.61 -40.28 76.71 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.896 -0.502 . . . . 0.0 111.136 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -72.65 -30.13 64.03 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 118.535 0.607 . . . . 0.0 112.324 -178.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.69 -24.56 36.13 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.216 0.462 . . . . 0.0 109.89 176.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.61 37.92 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 159.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.89 136.86 13.87 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 104.773 -3.331 . . . . 0.0 104.773 173.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -106.34 9.64 31.84 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.74 0.781 . . . . 0.0 108.978 -165.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.6 m -160.21 157.83 28.96 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 98.886 -4.487 . . . . 0.0 98.886 163.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 170.98 44.04 Favored Glycine 0 N--CA 1.421 -2.339 1 N-CA-C 100.799 -4.92 . . . . 0.0 100.799 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -168.12 -174.44 2.33 Favored 'General case' 0 N--CA 1.432 -1.334 1 N-CA-C 97.303 -5.073 . . . . 0.0 97.303 -179.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.45 159.89 33.99 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.75 -179.22 48.49 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 100.721 -4.951 . . . . 0.0 100.721 -173.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -102.9 146.97 27.51 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -171.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -119.17 113.27 20.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 101.458 -3.534 . . . . 0.0 101.458 171.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.03 132.3 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -173.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.83 15.65 33.27 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -171.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -152.4 -79.48 0.11 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.66 -168.88 39.78 Favored Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 -165.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.96 142.15 42.04 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.87 -164.08 1.43 Allowed 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -166.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.6 t -127.62 165.93 19.03 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.2 -4.0 . . . . 0.0 100.2 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 13.6 t-105 -123.33 148.04 46.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 178.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.51 152.3 40.38 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 175.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -115.99 140.84 48.86 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 172.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.1 42.29 0.14 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.145 2.178 . . . . 0.0 111.197 166.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 mt -85.11 134.76 40.38 Favored Pre-proline 0 CA--C 1.5 -0.97 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.32 172.92 15.36 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.127 1.885 . . . . 0.0 110.135 -178.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.66 -9.38 58.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -167.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -91.24 5.3 49.69 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -178.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -103.81 147.79 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 176.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.01 143.83 18.21 Favored Glycine 0 CA--C 1.478 -2.274 1 N-CA-C 101.111 -4.796 . . . . 0.0 101.111 175.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 -149.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -167.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.3 mp -67.4 119.78 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 174.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.581 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.122 0.487 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -112.59 167.92 10.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 164.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.85 123.79 33.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 94.856 -5.979 . . . . 0.0 94.856 159.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.69 -169.75 25.44 Favored Glycine 0 CA--C 1.485 -1.791 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -172.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.01 138.8 31.7 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 164.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 tt -90.93 144.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.71 -138.16 0.36 Allowed 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 127.874 2.47 . . . . 0.0 107.115 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -139.62 154.04 70.88 Favored Pre-proline 0 N--CA 1.426 -1.647 1 N-CA-C 95.597 -5.705 . . . . 0.0 95.597 166.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.87 155.4 53.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 122.836 2.049 . . . . 0.0 109.016 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -83.71 -27.63 28.84 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 126.764 2.025 . . . . 0.0 107.824 -1.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -158.61 152.91 24.08 Favored 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 95.123 -5.881 . . . . 0.0 95.123 175.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m 170.27 -153.55 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.662 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.32 170.4 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 1 N-CA-C 96.715 -5.291 . . . . 0.0 96.715 166.67 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -156.95 0.34 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 161.453 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -138.4 143.07 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 167.02 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 t -160.1 -174.44 4.55 Favored 'General case' 0 N--CA 1.419 -2.011 1 N-CA-C 96.878 -5.23 . . . . 0.0 96.878 178.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.17 173.52 5.53 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 -159.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.79 61.74 2.31 Favored 'Trans proline' 0 C--N 1.328 -0.552 0 C-N-CA 123.117 2.545 . . . . 0.0 110.108 161.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.86 138.56 2.7 Favored Glycine 0 N--CA 1.428 -1.843 1 N-CA-C 100.024 -5.231 . . . . 0.0 100.024 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -85.9 -11.48 53.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 123.918 0.887 . . . . 0.0 112.976 -165.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -39.29 -53.42 1.94 Allowed 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 127.963 2.505 . . . . 0.0 117.632 -153.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.94 -40.94 7.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -174.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -82.09 -14.81 55.24 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.586 -0.949 . . . . 0.0 110.306 -169.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.66 -45.11 93.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.792 0.837 . . . . 0.0 109.253 169.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -46.82 86.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.299 1.039 . . . . 0.0 111.513 172.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.32 -39.29 89.18 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-O 121.801 0.81 . . . . 0.0 111.435 -176.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.91 -44.57 67.06 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.116 1.766 . . . . 0.0 110.776 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.8 -54.26 47.37 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 123.196 0.598 . . . . 0.0 110.961 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.95 -20.42 62.45 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -88.74 -7.68 55.83 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.581 0.628 . . . . 0.0 110.413 172.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.99 5.2 Favored Glycine 0 CA--C 1.486 -1.758 0 CA-C-O 119.192 -0.782 . . . . 0.0 111.81 160.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.72 20.33 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 p -86.94 -84.2 0.18 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.5 m -81.54 161.26 23.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.27 168.35 35.83 Favored Glycine 0 N--CA 1.42 -2.416 1 N-CA-C 99.172 -5.571 . . . . 0.0 99.172 -177.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -165.03 -179.8 5.94 Favored 'General case' 0 N--CA 1.433 -1.318 1 N-CA-C 97.758 -4.904 . . . . 0.0 97.758 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.6 m -143.92 161.22 39.27 Favored 'General case' 0 CA--C 1.487 -1.45 1 N-CA-C 98.376 -4.676 . . . . 0.0 98.376 165.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.52 177.43 35.53 Favored Glycine 0 CA--C 1.488 -1.629 1 N-CA-C 97.081 -6.408 . . . . 0.0 97.081 -175.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -113.43 103.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 120.374 2.087 . . . . 0.0 108.559 -174.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -130.38 81.9 2.03 Favored 'General case' 0 CA--C 1.497 -1.091 1 N-CA-C 99.215 -4.365 . . . . 0.0 99.215 156.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.39 -177.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 1 N-CA-C 100.177 -4.008 . . . . 0.0 100.177 -174.65 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.51 54.61 0.37 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -157.47 -67.18 0.1 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 -178.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.85 42.47 Favored Glycine 0 CA--C 1.477 -2.285 1 N-CA-C 98.533 -5.827 . . . . 0.0 98.533 -178.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -76.69 140.88 41.05 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -175.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.91 -172.75 4.12 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 100.882 -3.747 . . . . 0.0 100.882 -162.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.39 155.33 32.16 Favored 'General case' 0 CA--C 1.479 -1.773 0 C-N-CA 117.542 -1.663 . . . . 0.0 106.658 -165.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -97.49 150.4 21.11 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 176.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 46.8 m -145.14 146.69 31.89 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 168.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.64 145.47 33.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 170.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.64 38.04 1.33 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 126.065 1.746 . . . . 0.0 111.85 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.57 133.97 62.33 Favored Pre-proline 0 CA--C 1.5 -0.952 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -65.22 166.75 18.11 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.5 2.134 . . . . 0.0 111.331 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.45 -5.49 52.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.969 -0.457 . . . . 0.0 112.16 -168.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -90.38 -0.57 57.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.69 -0.631 . . . . 0.0 109.861 177.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 t -95.74 123.74 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 177.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.86 145.75 16.82 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -147.13 -171.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -158.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 7' ' ' ALA . 35.1 mm -54.44 111.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.939 0 C-N-CA 126.912 2.085 . . . . 0.0 112.562 -170.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.434 -1.272 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 166.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.27 0.557 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -179.55 6.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 172.204 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -130.95 146.17 52.27 Favored 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 99.33 -4.322 . . . . 0.0 99.33 -174.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.63 -179.65 36.44 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -177.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.51 123.34 28.0 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 58' ' ' ILE 0.273 11.9 tt -90.67 140.9 15.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 120.752 1.615 . . . . 0.0 109.453 -176.413 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.98 169.07 10.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 110.95 -2.841 . . . . 0.0 112.092 177.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 14' ' ' TYR 0.252 26.6 tt0 -95.9 151.22 38.21 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 174.745 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -63.03 132.34 36.34 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.978 2.452 . . . . 0.0 109.336 165.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.94 -50.86 9.83 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 122.001 2.182 . . . . 0.0 110.843 14.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -168.06 156.28 8.79 Favored 'General case' 0 N--CA 1.425 -1.708 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 167.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 18.7 m 158.52 -144.84 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.428 1 N-CA-C 97.985 -4.821 . . . . 0.0 97.985 -176.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 59' ' ' ILE . 3.6 m -106.02 165.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 165.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -91.0 -167.93 1.94 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 162.787 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -136.73 161.75 35.07 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 168.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.9 t -132.41 163.97 27.54 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 101.341 -3.577 . . . . 0.0 101.341 -160.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -109.43 126.95 28.1 Favored Pre-proline 0 N--CA 1.423 -1.775 1 N-CA-C 99.554 -4.239 . . . . 0.0 99.554 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.91 41.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.485 0 C-N-CA 123.843 3.029 . . . . 0.0 116.617 174.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.93 115.41 0.66 Allowed Glycine 0 N--CA 1.423 -2.217 1 N-CA-C 94.436 -7.466 . . . . 0.0 94.436 171.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -60.48 -32.76 71.73 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 m -41.18 -43.88 2.43 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 127.807 2.443 . . . . 0.0 116.373 -168.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -55.89 26.91 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 121.116 -0.99 . . . . 0.0 112.017 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -21.61 36.55 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.642 -0.916 . . . . 0.0 110.091 -173.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.11 -35.32 78.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.542 0.737 . . . . 0.0 109.641 169.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 m -70.61 -40.1 73.37 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 177.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.75 -39.61 94.71 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -57.17 -42.57 81.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.652 1.181 . . . . 0.0 111.176 177.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.55 -51.85 67.68 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.833 0.453 . . . . 0.0 110.821 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.88 -18.94 62.67 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.31 -2.32 57.99 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.802 -0.561 . . . . 0.0 111.325 174.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 24.91 12.74 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 121.601 -0.687 . . . . 0.0 111.754 170.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.03 157.89 21.15 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 172.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 p -81.43 -40.86 22.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.41 157.5 27.87 Favored 'General case' 0 N--CA 1.418 -2.028 1 N-CA-C 98.524 -4.621 . . . . 0.0 98.524 -164.025 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.14 173.87 45.29 Favored Glycine 0 CA--C 1.475 -2.449 1 N-CA-C 102.085 -4.406 . . . . 0.0 102.085 -176.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -170.72 -143.98 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.5 m -121.36 -175.37 3.06 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 -170.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.49 -168.58 33.29 Favored Glycine 0 N--CA 1.417 -2.624 1 N-CA-C 96.845 -6.502 . . . . 0.0 96.845 172.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -141.97 157.87 44.44 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 96.884 -5.228 . . . . 0.0 96.884 172.328 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -162.55 177.84 9.1 Favored 'General case' 0 N--CA 1.423 -1.784 1 N-CA-C 96.036 -5.542 . . . . 0.0 96.036 172.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.41 171.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 1 N-CA-C 96.283 -5.451 . . . . 0.0 96.283 179.119 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.03 -49.53 0.85 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 104.005 -3.638 . . . . 0.0 104.005 -173.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -115.43 -70.19 0.81 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.33 -159.9 32.98 Favored Glycine 0 CA--C 1.482 -1.979 0 N-CA-C 103.367 -3.893 . . . . 0.0 103.367 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.06 136.27 58.03 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.761 2.024 . . . . 0.0 106.831 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.49 168.32 20.06 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -161.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.79 179.05 4.39 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -140.37 146.82 38.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.845 -3.02 . . . . 0.0 102.845 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.73 151.18 49.89 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -112.12 137.69 49.83 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 173.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 56.9 71.88 0.55 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 127.753 2.421 . . . . 0.0 113.253 174.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.6 mt -103.77 143.59 26.95 Favored Pre-proline 0 CA--C 1.504 -0.809 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 172.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -69.21 173.39 10.55 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.251 1.967 . . . . 0.0 113.288 174.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.06 -17.64 61.4 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.067 1.347 . . . . 0.0 111.549 -174.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -94.3 18.91 10.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.592 0.757 . . . . 0.0 109.485 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.97 164.74 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 1 N-CA-C 98.773 -4.528 . . . . 0.0 98.773 167.025 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.06 175.1 30.91 Favored Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.783 -5.327 . . . . 0.0 99.783 -175.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -159.22 -170.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 -156.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 13' ' ' VAL . 17.5 mm -38.9 -43.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 129.844 3.258 . . . . 0.0 118.908 -147.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.487 -1.472 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.93 0.871 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -117.73 164.44 14.98 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -139.91 136.51 33.96 Favored 'General case' 0 CA--C 1.485 -1.536 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 167.296 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.13 35.57 Favored Glycine 0 CA--C 1.476 -2.399 0 N-CA-C 104.165 -3.574 . . . . 0.0 104.165 174.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -75.02 130.8 39.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.359 -3.201 . . . . 0.0 102.359 157.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -84.1 135.84 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.68 -136.61 0.34 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 110.711 -2.949 . . . . 0.0 109.256 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -146.43 159.24 45.5 Favored Pre-proline 0 N--CA 1.423 -1.79 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 172.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.11 141.89 44.99 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.37 2.047 . . . . 0.0 108.484 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.22 -32.42 13.04 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 127.962 2.505 . . . . 0.0 107.601 7.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -150.34 147.21 27.32 Favored 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 94.126 -6.25 . . . . 0.0 94.126 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -159.47 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.606 HG12 HD12 ' A' ' 59' ' ' ILE . 2.4 m -133.58 157.8 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 162.273 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 -155.16 0.27 Allowed 'General case' 0 C--N 1.358 0.936 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 161.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -138.63 154.97 48.68 Favored 'General case' 0 CA--C 1.473 -2.004 1 N-CA-C 97.496 -5.002 . . . . 0.0 97.496 177.364 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.25 175.31 6.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -158.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.89 85.58 57.42 Favored Pre-proline 0 N--CA 1.411 -2.419 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -175.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -78.0 -4.39 14.36 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.133 1.889 . . . . 0.0 109.63 165.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.27 141.09 10.84 Favored Glycine 0 CA--C 1.484 -1.901 1 N-CA-C 96.815 -6.514 . . . . 0.0 96.815 174.169 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -68.06 -55.13 13.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -153.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -63.47 5.95 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -155.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.17 -93.05 1.31 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 169.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.92 -17.86 62.06 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.521 1.128 . . . . 0.0 111.61 -166.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -62.31 -49.84 74.04 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 121.082 1.765 . . . . 0.0 109.499 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.72 89.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.812 2.045 . . . . 0.0 111.884 173.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.33 -44.09 88.91 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.815 0.817 . . . . 0.0 110.968 -178.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.9 t -58.67 -43.88 90.01 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 125.182 1.393 . . . . 0.0 109.03 177.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -53.51 54.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.099 0.96 . . . . 0.0 111.262 -178.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.28 -26.39 66.52 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.785 -0.572 . . . . 0.0 112.474 -175.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -79.86 -13.12 59.63 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 123.39 0.676 . . . . 0.0 110.498 177.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.31 23.87 8.74 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.87 119.87 6.13 Favored Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.134 -3.187 . . . . 0.0 105.134 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 p -82.45 -11.97 58.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.695 0.759 . . . . 0.0 110.087 -172.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.97 149.01 17.54 Favored 'General case' 0 N--CA 1.415 -2.207 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -160.094 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.62 47.24 Favored Glycine 0 CA--C 1.476 -2.397 1 N-CA-C 97.963 -6.055 . . . . 0.0 97.963 -178.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.457 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 12.7 p-80 -165.79 168.54 15.92 Favored 'General case' 0 N--CA 1.425 -1.676 1 N-CA-C 98.191 -4.744 . . . . 0.0 98.191 179.377 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.8 t -100.33 166.16 11.11 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.1 -170.27 40.05 Favored Glycine 0 N--CA 1.425 -2.054 1 N-CA-C 97.754 -6.138 . . . . 0.0 97.754 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.77 154.39 51.61 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 100.237 -3.986 . . . . 0.0 100.237 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -150.29 149.82 30.65 Favored 'General case' 0 N--CA 1.426 -1.652 1 N-CA-C 94.231 -6.211 . . . . 0.0 94.231 172.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.97 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.57 -71.64 1.12 Allowed Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 108.204 -1.959 . . . . 0.0 108.204 171.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 m170 -99.59 -42.31 6.96 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.87 -70.79 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.942 0 C-N-CA 118.274 -1.917 . . . . 0.0 108.74 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 tp -158.68 161.95 37.17 Favored 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 95.535 -5.728 . . . . 0.0 95.535 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.35 172.99 16.33 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 -171.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -128.55 167.41 17.15 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 100.98 -3.711 . . . . 0.0 100.98 -175.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.457 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 27.4 t-105 -116.7 145.2 43.61 Favored 'General case' 0 C--N 1.364 1.2 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 176.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.6 m -133.94 143.82 48.44 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 170.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -127.38 121.7 31.67 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 -172.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.43 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 127.942 2.497 . . . . 0.0 108.076 -177.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.49 135.44 20.64 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-O 117.084 -1.436 . . . . 0.0 107.433 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.88 165.91 26.34 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.434 2.089 . . . . 0.0 112.653 176.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.84 -13.94 62.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.252 1.021 . . . . 0.0 112.484 -174.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -91.44 5.58 48.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.85 0.86 . . . . 0.0 110.995 -179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -108.38 -174.96 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.71 169.22 33.97 Favored Glycine 0 CA--C 1.482 -2.022 1 N-CA-C 101.877 -4.489 . . . . 0.0 101.877 -170.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 pt -155.53 -168.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 101.722 -3.436 . . . . 0.0 101.722 -162.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.606 HD12 HG12 ' A' ' 13' ' ' VAL . 1.2 mm -70.79 131.25 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.427 -1.591 0 N-CA-C 101.176 -3.639 . . . . 0.0 101.176 176.113 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.7 169.6 9.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 162.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -125.44 146.34 49.67 Favored 'General case' 0 CA--C 1.487 -1.443 1 N-CA-C 93.329 -6.545 . . . . 0.0 93.329 156.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 179.31 36.95 Favored Glycine 0 CA--C 1.468 -2.879 0 C-N-CA 116.542 -2.742 . . . . 0.0 107.55 -177.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 40' ' ' LYS . 41.8 m-85 -87.34 132.7 33.86 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 100.832 -3.766 . . . . 0.0 100.832 157.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.62 140.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.64 -138.46 0.36 Allowed 'General case' 0 N--CA 1.426 -1.673 0 O-C-N 126.849 2.593 . . . . 0.0 106.982 -178.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -133.27 153.39 80.62 Favored Pre-proline 0 N--CA 1.421 -1.912 1 N-CA-C 94.915 -5.957 . . . . 0.0 94.915 166.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -64.19 135.31 46.36 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.12 2.15 . . . . 0.0 106.571 163.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -94.9 -37.61 11.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 121.952 2.16 . . . . 0.0 109.648 17.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -158.74 148.43 19.28 Favored 'General case' 0 N--CA 1.422 -1.853 1 N-CA-C 94.639 -6.06 . . . . 0.0 94.639 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.3 m 170.73 -158.55 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.939 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 59' ' ' ILE . 1.2 m -122.92 165.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 N-CA-C 99.515 -4.254 . . . . 0.0 99.515 157.859 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -155.48 0.21 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -139.35 179.31 6.61 Favored 'General case' 0 CA--C 1.482 -1.651 1 N-CA-C 97.853 -4.869 . . . . 0.0 97.853 160.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.56 171.17 14.42 Favored 'General case' 0 N--CA 1.415 -2.194 1 N-CA-C 97.276 -5.083 . . . . 0.0 97.276 -177.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -125.75 121.74 24.52 Favored Pre-proline 0 N--CA 1.415 -2.202 1 N-CA-C 97.762 -4.903 . . . . 0.0 97.762 176.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.28 113.96 1.65 Allowed 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.262 2.641 . . . . 0.0 112.661 176.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.22 -43.51 1.05 Allowed Glycine 0 CA--C 1.489 -1.57 1 N-CA-C 101.86 -4.496 . . . . 0.0 101.86 -163.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.254 67.6 m 85.47 -7.84 0.84 Allowed 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 127.448 2.299 . . . . 0.0 113.101 172.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -51.32 -49.6 61.04 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.479 1.512 . . . . 0.0 113.595 -171.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -38.98 62.0 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.32 -47.16 77.5 Favored 'General case' 0 CA--C 1.488 -1.437 0 O-C-N 121.757 -0.849 . . . . 0.0 109.698 -177.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.9 -40.1 94.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.485 0.66 . . . . 0.0 109.792 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 m -63.05 -48.63 77.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.438 0.695 . . . . 0.0 110.929 175.016 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.05 -36.13 83.37 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.132 0.973 . . . . 0.0 111.055 -177.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.4 t -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.724 1.21 . . . . 0.0 110.448 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -68.55 -41.38 79.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.784 -0.573 . . . . 0.0 111.966 -175.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.89 -11.77 60.95 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.457 -0.777 . . . . 0.0 112.45 -178.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -99.55 -0.69 40.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.443 0.697 . . . . 0.0 109.75 174.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.09 28.36 18.1 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 170.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.48 152.4 20.17 Favored Glycine 0 C--N 1.356 1.66 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 170.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -80.9 -38.74 27.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.451 -1.029 . . . . 0.0 110.635 -166.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 m -160.54 173.36 15.65 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 98.805 -4.517 . . . . 0.0 98.805 166.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.31 168.88 41.19 Favored Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 99.386 -5.486 . . . . 0.0 99.386 -172.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -163.72 172.53 14.06 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -172.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.49 156.18 39.3 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 119.412 1.006 . . . . 0.0 110.831 -177.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 -179.39 40.63 Favored Glycine 0 N--CA 1.42 -2.378 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 168.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -145.14 154.45 42.46 Favored 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.082 -5.525 . . . . 0.0 96.082 -175.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -137.49 18.84 2.91 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.976 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 42' ' ' GLY 0.27 2.3 t 61.75 -142.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -167.746 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 76.0 -74.53 1.61 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 124.071 0.843 . . . . 0.0 111.709 168.063 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.08 -76.14 0.59 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.78 -174.28 41.33 Favored Glycine 0 CA--C 1.478 -2.236 1 N-CA-C 100.582 -5.007 . . . . 0.0 100.582 -168.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.0 tp -52.3 134.89 33.55 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 127.245 2.218 . . . . 0.0 108.561 177.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.69 -167.67 1.84 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 -167.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.02 153.73 48.12 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.076 -4.416 . . . . 0.0 99.076 172.449 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -105.65 152.01 23.66 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.52 144.65 33.05 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -103.31 142.26 34.51 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 167.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.68 74.37 0.44 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.013 2.525 . . . . 0.0 112.602 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.2 mt -108.29 134.83 20.06 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.8 170.02 20.61 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.24 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.77 -17.35 64.57 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.213 1.405 . . . . 0.0 114.008 -166.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -84.37 -7.67 59.24 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 124.205 1.002 . . . . 0.0 110.907 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.55 125.95 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 -176.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 143.8 16.74 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 104.486 -3.445 . . . . 0.0 104.486 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.9 pt -130.41 -150.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -165.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.588 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -74.3 117.37 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 177.133 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 -176.932 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.467 0.651 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -104.72 155.21 19.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 165.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -120.36 126.14 49.75 Favored 'General case' 0 CA--C 1.485 -1.552 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 157.265 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -162.45 13.09 Favored Glycine 0 CA--C 1.481 -2.061 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -174.399 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.58 141.37 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.268 -3.975 . . . . 0.0 100.268 163.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tt -90.42 147.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 173.094 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.826 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -150.62 177.0 10.47 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 98.482 -4.636 . . . . 0.0 98.482 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -86.53 158.37 54.45 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.079 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 61.6 Cg_exo -62.31 118.06 4.94 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.467 2.111 . . . . 0.0 109.589 168.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.0 mm-40 -130.87 114.22 15.02 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 127.74 2.416 . . . . 0.0 105.365 2.483 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 65.74 40.15 4.47 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 110.279 169.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.66 125.03 43.46 Favored 'General case' 0 CA--C 1.479 -1.751 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 168.268 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.269 35.0 m -69.58 169.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 122.637 1.208 . . . . 0.0 113.832 -161.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.2 131.21 50.71 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 92.062 -7.014 . . . . 0.0 92.062 -178.478 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 16' ' ' CYS . 59.4 m80 -92.88 -146.32 0.23 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -170.389 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 15' ' ' HIS . 3.8 t -151.09 155.45 39.0 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 93.821 -6.363 . . . . 0.0 93.821 -174.539 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -108.98 112.8 59.87 Favored Pre-proline 0 N--CA 1.43 -1.431 1 N-CA-C 99.037 -4.431 . . . . 0.0 99.037 168.366 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.92 106.12 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.448 2.765 . . . . 0.0 117.665 -166.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.57 -166.46 38.48 Favored Glycine 0 N--CA 1.421 -2.343 1 N-CA-C 94.561 -7.416 . . . . 0.0 94.561 179.258 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 m -79.56 -29.19 41.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.722 1.761 . . . . 0.0 107.778 170.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -40.28 -57.44 1.74 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.505 3.922 . . . . 0.0 115.414 -168.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.92 -34.94 55.11 Favored Glycine 0 CA--C 1.492 -1.39 0 O-C-N 120.767 -1.208 . . . . 0.0 112.132 -168.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.86 -36.93 35.95 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.36 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.4 -49.76 71.51 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 123.79 0.836 . . . . 0.0 109.207 173.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 m -58.17 -54.96 41.12 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.456 0.702 . . . . 0.0 111.35 175.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.97 -46.52 90.4 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.669 1.188 . . . . 0.0 111.51 -174.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.39 -42.95 92.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -175.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.35 -42.77 74.81 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.171 0.442 . . . . 0.0 111.706 -179.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -72.11 -22.79 61.28 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.42 -0.8 . . . . 0.0 111.973 -173.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -46.62 9.18 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.676 -0.64 . . . . 0.0 109.558 172.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.01 48.66 0.18 Allowed Glycine 0 CA--C 1.487 -1.711 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 168.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.24 149.9 18.53 Favored Glycine 0 CA--C 1.488 -1.626 1 N-CA-C 102.114 -4.394 . . . . 0.0 102.114 163.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -89.16 -62.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.011 0.906 . . . . 0.0 109.129 -169.241 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -94.34 150.57 20.16 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.13 167.24 39.71 Favored Glycine 0 CA--C 1.478 -2.225 1 N-CA-C 100.826 -4.909 . . . . 0.0 100.826 176.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -170.04 172.76 6.3 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 100.249 -3.982 . . . . 0.0 100.249 -178.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 m -113.15 145.26 41.26 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.052 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.8 90.92 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.739 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -174.14 176.93 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 97.933 -4.839 . . . . 0.0 97.933 178.197 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp 170.25 49.96 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 170.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.49 140.31 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -172.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.66 -63.64 3.55 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.525 -0.734 . . . . 0.0 111.304 161.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -107.59 -52.51 2.75 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -176.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.25 -146.88 11.14 Favored Glycine 0 N--CA 1.42 -2.401 1 N-CA-C 95.024 -7.23 . . . . 0.0 95.024 -174.582 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 162.92 20.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.155 0.977 . . . . 0.0 108.63 171.386 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.16 169.57 17.36 Favored 'General case' 0 CA--C 1.485 -1.555 1 N-CA-C 98.395 -4.668 . . . . 0.0 98.395 -178.096 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 141.0 42.51 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 -170.202 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -88.37 150.07 23.39 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.9 m -149.23 138.5 21.5 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -108.27 136.49 47.84 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 170.246 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.67 56.36 0.14 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 126.187 1.795 . . . . 0.0 110.559 168.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.33 132.81 34.55 Favored Pre-proline 0 CA--C 1.498 -1.023 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 170.193 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 172.42 14.2 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.116 2.544 . . . . 0.0 110.169 177.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.0 -20.06 63.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.694 1.598 . . . . 0.0 113.824 -169.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -82.77 -4.45 57.96 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.511 -0.743 . . . . 0.0 111.486 -172.014 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -101.3 126.73 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -175.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.27 148.8 18.52 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 103.204 -3.958 . . . . 0.0 103.204 176.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.7 pt -148.03 -146.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 -159.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.826 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.6 mm -71.27 118.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.144 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -159.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.192 0.52 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -101.08 159.31 15.34 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 165.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -126.33 122.77 36.39 Favored 'General case' 0 CA--C 1.484 -1.588 1 N-CA-C 94.19 -6.226 . . . . 0.0 94.19 159.793 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.63 38.15 Favored Glycine 0 CA--C 1.473 -2.581 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -173.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -79.64 131.4 35.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 165.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.4 tt -90.39 141.57 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -176.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.22 -141.81 0.37 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -178.493 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -131.95 150.9 77.45 Favored Pre-proline 0 N--CA 1.419 -2.02 1 N-CA-C 94.586 -6.079 . . . . 0.0 94.586 166.011 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.7 144.01 58.31 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 N-CA-C 106.629 -2.104 . . . . 0.0 106.629 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.57 -36.64 13.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.635 1.974 . . . . 0.0 109.165 12.795 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.88 150.08 28.93 Favored 'General case' 0 N--CA 1.418 -2.056 1 N-CA-C 94.707 -6.034 . . . . 0.0 94.707 175.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.55 -160.66 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -176.316 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.638 HG12 HD12 ' A' ' 59' ' ' ILE . 16.0 m -129.33 165.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 96.568 -5.345 . . . . 0.0 96.568 152.64 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.32 158.41 19.68 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 100.235 -3.987 . . . . 0.0 100.235 163.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -107.71 147.22 31.04 Favored 'General case' 0 CA--C 1.47 -2.103 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 -177.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -159.41 -177.99 6.83 Favored 'General case' 0 N--CA 1.409 -2.484 1 N-CA-C 95.763 -5.643 . . . . 0.0 95.763 -168.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -139.76 171.46 7.89 Favored Pre-proline 0 N--CA 1.414 -2.227 1 N-CA-C 98.867 -4.494 . . . . 0.0 98.867 -156.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.15 42.92 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 123.967 3.112 . . . . 0.0 114.308 169.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.83 129.52 1.49 Allowed Glycine 0 N--CA 1.423 -2.229 1 N-CA-C 100.203 -5.159 . . . . 0.0 100.203 -176.398 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.25 33.69 1.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.673 1.589 . . . . 0.0 111.083 -171.063 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -56.48 -43.63 79.81 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 126.437 1.895 . . . . 0.0 113.133 -173.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -33.29 8.97 Favored Glycine 0 C--N 1.352 1.431 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.0 t -61.72 -36.71 81.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.018 1.327 . . . . 0.0 111.408 -170.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.97 -53.84 43.92 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.121 0.968 . . . . 0.0 110.588 176.379 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -36.84 84.89 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.629 1.172 . . . . 0.0 112.884 177.061 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.02 -39.78 87.1 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 122.076 0.941 . . . . 0.0 109.733 -179.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -61.36 -42.87 99.4 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.444 0.697 . . . . 0.0 110.792 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -60.65 -47.79 84.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.785 0.834 . . . . 0.0 111.033 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.37 -17.55 62.41 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.211 -0.931 . . . . 0.0 112.739 -174.003 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -96.3 -5.17 40.75 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.208 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.35 11.85 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.009 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.35 159.48 19.29 Favored Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 105.721 -2.951 . . . . 0.0 105.721 168.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -71.51 -60.74 2.07 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.758 1.266 . . . . 0.0 108.747 -170.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.96 -171.05 2.92 Favored 'General case' 0 N--CA 1.425 -1.711 1 N-CA-C 97.323 -5.065 . . . . 0.0 97.323 169.438 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.99 -158.18 16.68 Favored Glycine 0 N--CA 1.419 -2.453 1 N-CA-C 101.732 -4.547 . . . . 0.0 101.732 -175.769 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -163.11 -170.2 2.24 Favored 'General case' 0 N--CA 1.429 -1.501 1 N-CA-C 97.467 -5.012 . . . . 0.0 97.467 -171.188 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.9 m -128.61 165.58 20.52 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 174.171 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.72 -170.92 43.03 Favored Glycine 0 N--CA 1.42 -2.383 1 N-CA-C 96.847 -6.501 . . . . 0.0 96.847 -176.353 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -139.46 161.85 36.48 Favored 'General case' 0 N--CA 1.431 -1.406 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 -174.485 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 150.4 40.54 Favored 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 94.237 -6.208 . . . . 0.0 94.237 159.88 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 t -75.99 126.57 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 119.539 1.063 . . . . 0.0 108.326 -165.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.87 -78.23 0.05 OUTLIER Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 104.382 -3.487 . . . . 0.0 104.382 178.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -108.3 -105.32 0.35 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.375 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.6 98.21 0.18 Allowed Glycine 0 CA--C 1.489 -1.58 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 -171.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.333 0.2 OUTLIER 59.33 -166.91 0.17 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.764 2.425 . . . . 0.0 110.712 -170.322 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -164.98 -179.47 5.77 Favored 'General case' 0 N--CA 1.427 -1.605 1 N-CA-C 99.878 -4.119 . . . . 0.0 99.878 168.661 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -122.55 152.99 39.83 Favored 'General case' 0 CA--C 1.494 -1.186 1 N-CA-C 98.078 -4.786 . . . . 0.0 98.078 175.282 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -104.87 156.01 18.4 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 176.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.01 141.78 32.87 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 165.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -108.18 122.31 46.65 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 177.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.62 82.3 0.14 Allowed 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 127.188 2.195 . . . . 0.0 109.924 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.8 mt -106.67 135.12 19.56 Favored Pre-proline 0 CA--C 1.49 -1.342 0 N-CA-C 103.417 -2.809 . . . . 0.0 103.417 170.155 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.88 170.49 16.6 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.078 1.852 . . . . 0.0 110.385 171.216 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -82.1 7.06 14.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -162.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -90.08 -8.03 52.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.737 0.815 . . . . 0.0 108.961 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 t -99.13 138.17 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -174.171 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.43 148.11 16.65 Favored Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 103.976 -3.649 . . . . 0.0 103.976 178.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 pt -134.6 -156.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -167.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -72.59 128.51 35.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 178.527 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 170.7 9.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 171.14 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -130.32 133.74 46.67 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 95.862 -5.607 . . . . 0.0 95.862 168.433 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -176.07 33.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 118.527 -1.797 . . . . 0.0 109.627 -175.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -86.74 125.03 33.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 169.334 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.66 146.26 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 119.348 0.977 . . . . 0.0 108.44 -174.594 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.64 -163.98 0.89 Allowed 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 127.477 2.311 . . . . 0.0 105.998 -175.82 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -128.51 159.01 69.99 Favored Pre-proline 0 N--CA 1.422 -1.846 1 N-CA-C 96.44 -5.393 . . . . 0.0 96.44 169.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -68.57 155.77 67.85 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 CA-C-N 122.621 1.972 . . . . 0.0 109.189 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -99.21 -19.97 16.85 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 128.901 2.88 . . . . 0.0 108.502 4.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -149.72 151.57 33.87 Favored 'General case' 0 CA--C 1.479 -1.761 1 N-CA-C 92.592 -6.818 . . . . 0.0 92.592 158.079 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.07 -163.69 0.11 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 171.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 HD12 ' A' ' 59' ' ' ILE . 5.7 m -128.75 160.3 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 1 N-CA-C 95.904 -5.591 . . . . 0.0 95.904 160.648 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -164.47 0.7 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.513 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -137.86 168.62 19.32 Favored 'General case' 0 N--CA 1.418 -2.063 1 N-CA-C 95.186 -5.857 . . . . 0.0 95.186 176.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -142.85 155.88 44.84 Favored 'General case' 0 CA--C 1.474 -1.966 1 N-CA-C 96.973 -5.195 . . . . 0.0 96.973 -166.277 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -114.46 119.35 40.12 Favored Pre-proline 0 N--CA 1.421 -1.921 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 167.21 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.91 95.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 124.728 2.724 . . . . 0.0 117.444 -162.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.19 -173.15 41.69 Favored Glycine 0 N--CA 1.422 -2.293 1 N-CA-C 97.787 -6.125 . . . . 0.0 97.787 -179.388 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -89.67 -13.9 35.98 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 118.173 0.987 . . . . 0.0 109.455 178.636 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.41 -60.56 1.89 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.557 3.143 . . . . 0.0 116.566 -161.32 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 -36.49 23.09 Favored Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.4 m -80.47 -16.1 55.16 Favored 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 123.141 0.576 . . . . 0.0 110.793 -174.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.89 -51.68 68.61 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.955 0.798 . . . . 0.0 108.951 168.451 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.49 81.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.73 0.812 . . . . 0.0 112.661 174.077 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.23 -38.69 85.65 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.129 0.966 . . . . 0.0 111.645 -174.191 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.4 -34.7 78.54 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.311 -0.868 . . . . 0.0 110.28 178.56 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -40.54 89.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.374 0.669 . . . . 0.0 111.477 -177.177 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.54 -28.77 59.17 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 122.159 -0.338 . . . . 0.0 110.978 -177.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.02 -27.41 24.82 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.951 -0.468 . . . . 0.0 110.768 179.422 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.28 42.62 1.06 Allowed Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 163.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.96 157.33 15.06 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 162.224 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -94.08 -9.9 35.12 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 122.178 -0.601 . . . . 0.0 110.559 -163.662 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 m -149.5 149.62 31.04 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.78 138.61 9.94 Favored Glycine 0 CA--C 1.475 -2.409 1 N-CA-C 98.847 -5.701 . . . . 0.0 98.847 -178.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -141.45 -162.64 1.41 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 -177.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.77 169.15 9.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 -170.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.65 -177.97 41.69 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 102.469 -4.252 . . . . 0.0 102.469 -177.094 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -152.16 159.74 43.54 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 97.665 -4.939 . . . . 0.0 97.665 178.03 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -151.96 171.01 18.47 Favored 'General case' 0 CA--C 1.491 -1.309 1 N-CA-C 98.974 -4.454 . . . . 0.0 98.974 167.909 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.92 168.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -177.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.92 29.22 52.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -169.011 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m170 163.45 -154.13 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 94.471 -6.122 . . . . 0.0 94.471 -174.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.08 150.16 21.39 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 98.715 -5.754 . . . . 0.0 98.715 170.41 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tp 74.16 176.84 0.24 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.003 1.721 . . . . 0.0 108.519 175.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -178.46 -169.35 0.18 Allowed 'General case' 0 CA--C 1.483 -1.62 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 173.922 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.35 178.25 6.96 Favored 'General case' 0 CA--C 1.484 -1.559 1 N-CA-C 100.137 -4.023 . . . . 0.0 100.137 154.524 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -126.85 146.59 50.22 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.06 156.09 46.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 179.665 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -125.65 142.44 51.51 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.97 55.67 1.13 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 128.542 2.737 . . . . 0.0 111.783 172.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.52 132.85 25.58 Favored Pre-proline 0 CA--C 1.505 -0.777 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.042 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -73.54 174.76 11.66 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.513 2.142 . . . . 0.0 111.75 174.015 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.15 -19.07 62.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 126.548 1.939 . . . . 0.0 114.787 -173.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -79.62 -15.26 57.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 121.686 -0.634 . . . . 0.0 109.704 -177.23 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.55 129.92 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -178.537 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.84 149.53 18.73 Favored Glycine 0 CA--C 1.48 -2.153 1 N-CA-C 101.402 -4.679 . . . . 0.0 101.402 -179.481 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -133.18 -143.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -162.051 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG12 ' A' ' 13' ' ' VAL . 3.9 mm -67.19 120.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.659 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 CA--C 1.496 -1.111 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.2 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.686 0.755 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 161.83 34.65 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.78 137.67 51.66 Favored 'General case' 0 CA--C 1.485 -1.548 1 N-CA-C 94.977 -5.934 . . . . 0.0 94.977 171.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.84 -172.56 29.39 Favored Glycine 0 CA--C 1.472 -2.618 0 N-CA-C 104.866 -3.294 . . . . 0.0 104.866 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.03 138.69 32.96 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 102.051 -3.314 . . . . 0.0 102.051 158.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.0 tt -90.84 141.33 14.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.31 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -112.46 -160.31 0.71 Allowed 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 128.395 2.678 . . . . 0.0 108.099 -176.213 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.44 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 53.5 mt-30 -136.17 164.78 40.53 Favored Pre-proline 0 N--CA 1.419 -1.977 1 N-CA-C 96.601 -5.333 . . . . 0.0 96.601 174.86 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -65.32 151.53 84.95 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.67 2.246 . . . . 0.0 109.764 169.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.52 -54.58 4.1 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 127.75 2.42 . . . . 0.0 107.917 5.266 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -133.35 135.69 44.91 Favored 'General case' 0 N--CA 1.42 -1.925 1 N-CA-C 90.729 -7.508 . . . . 0.0 90.729 169.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 m -168.19 -166.41 0.7 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 178.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.06 164.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 165.804 . . . . . . . . 4 4 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.34 -158.42 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 162.079 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -137.45 168.7 19.13 Favored 'General case' 0 CA--C 1.476 -1.9 1 N-CA-C 96.668 -5.308 . . . . 0.0 96.668 165.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.5 t -130.86 158.59 39.78 Favored 'General case' 0 CA--C 1.478 -1.818 1 N-CA-C 97.402 -5.036 . . . . 0.0 97.402 -170.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -109.84 112.43 58.17 Favored Pre-proline 0 N--CA 1.425 -1.694 1 N-CA-C 96.596 -5.335 . . . . 0.0 96.596 167.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.3 101.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.543 0 CA-C-N 124.491 2.64 . . . . 0.0 116.177 -161.175 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -172.57 36.9 Favored Glycine 0 N--CA 1.427 -1.935 1 N-CA-C 97.092 -6.403 . . . . 0.0 97.092 -172.628 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p -92.58 -28.75 16.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 118.993 1.396 . . . . 0.0 109.893 -177.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.16 -63.92 0.56 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.775 2.43 . . . . 0.0 116.152 -161.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.65 -45.45 52.93 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -176.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 m -64.47 -45.77 85.98 Favored 'General case' 0 CA--C 1.486 -1.495 0 O-C-N 122.229 -0.571 . . . . 0.0 111.776 -174.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.36 -35.97 78.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -60.85 -48.43 81.82 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.713 173.764 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.38 -41.95 99.04 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-O 121.799 0.809 . . . . 0.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -60.69 -45.3 94.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.87 0.868 . . . . 0.0 110.432 179.395 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.81 -42.37 81.64 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.392 0.277 . . . . 0.0 110.792 -176.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.44 -27.08 56.09 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.799 -0.563 . . . . 0.0 111.552 -176.049 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -76.49 -49.23 17.06 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.22 51.6 0.18 Allowed Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 169.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.04 16.15 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 104.913 -3.275 . . . . 0.0 104.913 159.636 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.4 p -92.92 -3.59 54.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 117.777 0.788 . . . . 0.0 110.7 -166.091 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.479 -1.778 1 N-CA-C 98.427 -4.657 . . . . 0.0 98.427 174.096 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -167.17 163.71 37.33 Favored Glycine 0 CA--C 1.465 -3.058 1 N-CA-C 101.065 -4.814 . . . . 0.0 101.065 -173.539 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -156.66 -155.34 0.53 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.814 -3.772 . . . . 0.0 100.814 -170.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 t -145.03 161.71 38.74 Favored 'General case' 0 N--CA 1.429 -1.51 1 N-CA-C 96.534 -5.358 . . . . 0.0 96.534 -173.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.92 -172.57 45.18 Favored Glycine 0 N--CA 1.42 -2.409 1 N-CA-C 99.024 -5.63 . . . . 0.0 99.024 -176.439 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -135.38 142.47 45.7 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 97.048 -5.168 . . . . 0.0 97.048 -177.426 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -112.46 108.82 18.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.1 121.38 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.553 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -13.54 8.09 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -168.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -136.68 -77.26 0.41 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.04 -163.45 36.82 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 -165.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.8 141.26 57.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.79 2.436 . . . . 0.0 106.044 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.32 178.3 8.52 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 -168.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 m -110.44 162.16 14.95 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 170.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -119.23 146.56 45.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 14.6 m -141.8 150.91 42.3 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -120.71 142.09 49.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 173.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 60.05 62.44 1.64 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 127.495 2.318 . . . . 0.0 111.374 174.277 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.18 145.5 30.17 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 171.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -64.73 160.58 39.8 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.973 2.448 . . . . 0.0 110.886 174.353 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -66.51 -24.53 66.41 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.867 0.867 . . . . 0.0 112.626 -168.087 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -81.48 -2.75 50.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.473 1.109 . . . . 0.0 111.162 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.87 122.88 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 177.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.75 145.57 17.71 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -136.72 -153.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -165.538 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -66.65 131.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.365 1.265 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.426 -1.65 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 177.409 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 159.91 15.92 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.37 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -130.69 130.09 43.42 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.558 -6.09 . . . . 0.0 94.558 159.457 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.07 -170.31 26.64 Favored Glycine 0 CA--C 1.473 -2.567 1 N-CA-C 101.607 -4.597 . . . . 0.0 101.607 179.146 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -83.54 143.4 30.2 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 159.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.27 143.57 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.45 -137.05 0.35 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.498 1.919 . . . . 0.0 106.507 179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -136.88 155.23 76.53 Favored Pre-proline 0 N--CA 1.421 -1.907 1 N-CA-C 95.185 -5.858 . . . . 0.0 95.185 159.822 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -66.3 150.77 84.5 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 0.0 108.423 174.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.34 -30.07 33.92 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 128.389 2.676 . . . . 0.0 108.992 6.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -164.67 159.36 18.78 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 94.237 -6.209 . . . . 0.0 94.237 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m 167.51 -147.69 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 98.82 -4.511 . . . . 0.0 98.82 174.395 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.91 170.01 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 1 N-CA-C 95.661 -5.681 . . . . 0.0 95.661 170.15 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.39 179.85 6.79 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 167.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -119.17 78.06 1.26 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 -179.11 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.3 t -98.77 -170.37 1.93 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -142.63 172.87 5.19 Favored Pre-proline 0 N--CA 1.42 -1.971 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -164.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -66.69 50.54 0.32 Allowed 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 123.595 2.864 . . . . 0.0 112.829 162.628 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.46 139.93 5.62 Favored Glycine 0 N--CA 1.423 -2.191 1 N-CA-C 100.437 -5.065 . . . . 0.0 100.437 -178.452 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -94.83 30.37 2.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 -171.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -65.86 -57.12 8.64 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.969 1.708 . . . . 0.0 110.836 -166.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.17 -28.91 47.7 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.048 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.91 -30.52 71.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.651 1.181 . . . . 0.0 110.859 -172.542 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.45 -58.62 6.5 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.744 0.818 . . . . 0.0 109.945 173.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -44.59 96.76 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.157 0.983 . . . . 0.0 113.014 175.833 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.35 -41.85 88.91 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.287 0.565 . . . . 0.0 111.094 -173.283 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -64.25 -40.56 96.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 121.948 -0.47 . . . . 0.0 109.934 179.553 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -66.08 -47.29 74.77 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 122.071 -0.393 . . . . 0.0 111.625 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.18 -20.49 63.12 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.654 -0.654 . . . . 0.0 112.292 -173.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.55 -3.23 50.15 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.248 0.619 . . . . 0.0 110.199 176.205 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.32 32.56 8.18 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 165.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.82 163.05 13.03 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 105.546 -3.021 . . . . 0.0 105.546 168.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -83.72 -43.6 15.33 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.244 1.021 . . . . 0.0 110.038 -169.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -160.12 150.92 18.91 Favored 'General case' 0 N--CA 1.418 -2.068 1 N-CA-C 98.759 -4.534 . . . . 0.0 98.759 -157.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.9 169.24 38.03 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 100.286 -5.126 . . . . 0.0 100.286 -171.157 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -162.55 -177.98 5.95 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 98.258 -4.719 . . . . 0.0 98.258 -179.494 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.1 m -139.26 162.42 35.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -178.804 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.83 109.1 0.73 Allowed Glycine 0 CA--C 1.487 -1.681 1 N-CA-C 101.748 -4.541 . . . . 0.0 101.748 -178.359 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 41' ' ' VAL . 72.1 t80 -161.14 149.07 15.55 Favored 'General case' 0 CA--C 1.483 -1.617 1 N-CA-C 97.216 -5.105 . . . . 0.0 97.216 -165.595 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -151.12 75.38 1.19 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.438 ' HB ' ' CE2' ' A' ' 39' ' ' PHE . 49.1 t -126.07 138.52 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 95.671 -5.678 . . . . 0.0 95.671 167.129 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.91 62.99 4.52 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 119.016 0.826 . . . . 0.0 111.621 -163.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.5 -51.52 2.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.53 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 -164.19 35.5 Favored Glycine 0 N--CA 1.426 -2.019 1 N-CA-C 96.029 -6.828 . . . . 0.0 96.029 -164.372 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.65 118.63 22.23 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -172.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.84 -178.2 5.69 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.068 0.947 . . . . 0.0 110.703 -166.706 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.98 149.62 40.63 Favored 'General case' 0 CA--C 1.489 -1.377 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -174.616 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -96.87 155.17 16.89 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 178.817 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.4 m -147.64 152.14 37.37 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 168.248 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -115.91 144.55 43.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 169.023 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.45 57.3 0.57 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 128.059 2.543 . . . . 0.0 111.651 170.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.09 124.8 48.28 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.574 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 167.04 28.09 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.184 1.923 . . . . 0.0 109.43 174.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.77 46.97 1.44 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.52 -0.737 . . . . 0.0 111.618 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -111.91 -6.53 14.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 163.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.87 140.86 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 -172.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.65 147.59 18.0 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 103.399 -3.88 . . . . 0.0 103.399 179.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.97 -159.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -165.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 9.6 mm -69.75 133.12 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -174.655 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.422 -1.834 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 176.806 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.45 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -148.81 179.77 7.59 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 171.558 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -137.02 142.0 42.5 Favored 'General case' 0 CA--C 1.485 -1.532 1 N-CA-C 96.666 -5.309 . . . . 0.0 96.666 179.667 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.53 12.15 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 99.653 -5.379 . . . . 0.0 99.653 165.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 94.5 m-85 -82.53 144.03 30.67 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 165.035 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -91.11 139.98 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.401 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.11 -168.14 1.5 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.099 2.959 . . . . 0.0 108.549 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -113.7 161.67 26.41 Favored Pre-proline 0 N--CA 1.428 -1.53 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 170.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.2 134.64 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 N-CA-C 106.843 -2.022 . . . . 0.0 106.843 158.205 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -79.31 -58.16 3.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.05 2.14 . . . . 0.0 111.251 14.479 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -166.6 146.24 5.75 Favored 'General case' 0 N--CA 1.426 -1.638 1 N-CA-C 92.384 -6.895 . . . . 0.0 92.384 -178.357 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 21.9 m 159.92 -141.4 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.528 1 N-CA-C 97.771 -4.9 . . . . 0.0 97.771 179.131 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 59' ' ' ILE . 3.0 m -124.26 165.34 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 176.203 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -154.83 0.29 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 162.976 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -141.17 177.37 8.13 Favored 'General case' 0 N--CA 1.425 -1.68 1 N-CA-C 97.177 -5.119 . . . . 0.0 97.177 167.818 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.81 158.81 43.83 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.816 -5.624 . . . . 0.0 95.816 -179.263 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -115.6 113.57 42.67 Favored Pre-proline 0 N--CA 1.422 -1.839 1 N-CA-C 96.197 -5.483 . . . . 0.0 96.197 177.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.83 99.2 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 CA-C-N 124.019 2.471 . . . . 0.0 116.082 -156.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.93 -166.9 36.42 Favored Glycine 0 N--CA 1.423 -2.219 1 N-CA-C 96.716 -6.554 . . . . 0.0 96.716 -173.746 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -85.97 -41.53 14.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.199 1.0 . . . . 0.0 109.6 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.43 -70.56 0.1 Allowed 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -147.352 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.11 -31.68 54.59 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 121.092 -1.005 . . . . 0.0 111.42 -172.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.95 -49.54 44.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.415 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.5 -33.66 76.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.22 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 m -61.48 -50.19 73.73 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.892 172.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -42.6 99.76 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.905 0.882 . . . . 0.0 109.968 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -56.48 -47.13 79.86 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.566 1.146 . . . . 0.0 110.714 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.8 -45.5 89.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.886 0.874 . . . . 0.0 110.585 -175.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.39 -28.93 62.29 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.845 -0.534 . . . . 0.0 112.163 -176.015 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.6 -18.2 45.59 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.589 -0.694 . . . . 0.0 110.144 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.91 38.16 2.99 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 163.717 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.29 139.25 14.39 Favored Glycine 0 CA--C 1.486 -1.776 1 N-CA-C 101.153 -4.779 . . . . 0.0 101.153 164.099 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -81.84 -29.06 32.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 118.032 0.916 . . . . 0.0 110.065 -162.629 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.47 -176.86 5.84 Favored 'General case' 0 N--CA 1.423 -1.783 1 N-CA-C 98.313 -4.699 . . . . 0.0 98.313 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.25 -160.97 24.99 Favored Glycine 0 N--CA 1.414 -2.783 1 N-CA-C 100.618 -4.993 . . . . 0.0 100.618 -167.378 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -163.62 -159.73 0.53 Allowed 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 96.899 -5.223 . . . . 0.0 96.899 -172.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -136.11 170.26 16.29 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 100.584 -3.858 . . . . 0.0 100.584 173.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 -177.31 47.92 Favored Glycine 0 N--CA 1.422 -2.283 1 N-CA-C 101.32 -4.712 . . . . 0.0 101.32 177.695 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -113.56 139.97 48.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -177.435 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -110.71 91.09 3.52 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.679 -3.082 . . . . 0.0 102.679 173.054 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 t -68.27 124.98 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -171.168 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -47.53 1.01 Allowed Glycine 0 CA--C 1.483 -1.922 0 N-CA-C 104.539 -3.424 . . . . 0.0 104.539 -173.019 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -100.44 -60.3 1.55 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.001 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.43 -170.63 39.67 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.633 -2.587 . . . . 0.0 106.633 -174.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.15 137.68 35.92 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 102.904 -2.998 . . . . 0.0 102.904 177.493 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.93 -174.51 3.68 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -164.165 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.9 t -114.62 153.84 29.43 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 178.3 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.9 t-105 -119.48 149.78 41.32 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -177.299 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -143.15 156.13 44.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.73 144.2 50.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 102.691 -3.078 . . . . 0.0 102.691 170.021 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.64 52.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.758 2.023 . . . . 0.0 111.415 171.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.65 130.66 36.18 Favored Pre-proline 0 CA--C 1.501 -0.934 0 N-CA-C 104.951 -2.241 . . . . 0.0 104.951 173.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -74.22 176.07 10.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.451 2.1 . . . . 0.0 110.741 175.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -86.15 19.69 2.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.988 -174.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -95.15 -7.01 40.51 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.446 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.01 169.0 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -179.155 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -148.68 151.26 23.47 Favored Glycine 0 CA--C 1.479 -2.179 1 N-CA-C 97.533 -6.227 . . . . 0.0 97.533 173.755 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.3 -147.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -155.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.38 -27.71 43.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 126.173 1.789 . . . . 0.0 113.312 -169.654 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.613 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.539 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.279 0.562 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.36 170.95 9.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 160.489 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -129.96 132.69 46.4 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 93.509 -6.478 . . . . 0.0 93.509 158.314 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -178.01 35.39 Favored Glycine 0 CA--C 1.47 -2.736 0 N-CA-C 104.015 -3.634 . . . . 0.0 104.015 -175.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -83.71 140.65 31.99 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 162.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -90.39 137.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.005 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.31 -145.03 0.3 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.198 174.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.7 142.8 45.11 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 92.939 -6.689 . . . . 0.0 92.939 166.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.82 146.34 47.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.693 1.998 . . . . 0.0 107.974 -177.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.23 -21.69 17.71 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 126.098 1.759 . . . . 0.0 108.504 13.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -158.48 151.68 22.81 Favored 'General case' 0 N--CA 1.415 -2.2 1 N-CA-C 95.945 -5.576 . . . . 0.0 95.945 172.182 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 166.54 -155.93 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 -177.707 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 43' ' ' HIS . 15.3 m -127.4 164.81 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 1 N-CA-C 96.798 -5.26 . . . . 0.0 96.798 161.953 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.11 171.75 8.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 161.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -108.56 116.33 31.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -177.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 t -92.39 150.43 20.82 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.44 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.36 122.02 28.98 Favored Pre-proline 0 N--CA 1.422 -1.855 1 N-CA-C 97.65 -4.945 . . . . 0.0 97.65 -179.341 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.57 137.49 74.04 Favored 'Trans proline' 0 CA--C 1.505 -0.962 0 CA-C-N 123.456 2.27 . . . . 0.0 110.987 -176.371 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.36 -57.95 0.57 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -158.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m 105.51 -14.72 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 128.901 2.881 . . . . 0.0 110.533 173.137 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -46.44 -51.05 15.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.685 1.994 . . . . 0.0 114.806 -162.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.84 -39.77 75.56 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 121.507 -0.746 . . . . 0.0 111.517 -177.231 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.04 -22.1 22.02 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.068 -1.254 . . . . 0.0 110.748 -169.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.47 94.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -62.49 -45.05 94.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.161 -0.962 . . . . 0.0 110.983 172.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.94 -41.24 97.73 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.518 -0.739 . . . . 0.0 111.926 177.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.22 -44.39 75.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.35 1.46 . . . . 0.0 110.345 174.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.59 -45.85 88.52 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.853 -0.529 . . . . 0.0 111.554 -177.322 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.75 -7.63 51.52 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.36 -0.837 . . . . 0.0 112.669 -177.096 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -102.79 -3.78 25.89 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 121.704 -0.622 . . . . 0.0 109.813 174.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.56 28.35 11.53 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 169.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.34 129.71 9.99 Favored Glycine 0 CA--C 1.483 -1.917 0 N-CA-C 104.259 -3.536 . . . . 0.0 104.259 169.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -36.25 74.19 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.509 -165.763 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -160.56 175.33 12.83 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 170.642 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.49 -178.72 48.78 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 98.516 -5.833 . . . . 0.0 98.516 -169.694 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -164.08 -175.82 4.2 Favored 'General case' 0 N--CA 1.434 -1.24 1 N-CA-C 99.067 -4.42 . . . . 0.0 99.067 -177.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.4 m -84.4 168.67 15.33 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.317 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.47 -178.35 41.82 Favored Glycine 0 CA--C 1.487 -1.671 1 N-CA-C 96.9 -6.48 . . . . 0.0 96.9 172.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -152.6 132.72 13.48 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 100.478 -3.897 . . . . 0.0 100.478 179.629 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -139.66 40.25 2.02 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.261 2.2 t 57.11 -134.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.17 1.788 . . . . 0.0 107.606 -172.328 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -122.48 7.58 Favored Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 179.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.433 ' HB2' HG13 ' A' ' 13' ' ' VAL . 13.8 m170 -118.15 5.12 11.97 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.126 0.57 . . . . 0.0 109.711 -166.939 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.22 -172.87 34.74 Favored Glycine 0 CA--C 1.483 -1.947 1 N-CA-C 100.413 -5.075 . . . . 0.0 100.413 -178.046 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.25 98.46 11.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.028 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.38 177.71 7.74 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 125.634 1.574 . . . . 0.0 110.93 -172.791 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -126.69 160.03 31.96 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.411 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -96.61 154.66 17.15 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 177.69 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.0 m -142.37 140.68 32.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.764 -3.791 . . . . 0.0 100.764 165.53 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.75 27.97 8.9 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.482 0.658 . . . . 0.0 109.631 -170.026 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.27 147.95 0.74 Allowed 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 93.605 -6.443 . . . . 0.0 93.605 167.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -150.86 142.83 15.77 Favored Pre-proline 0 CA--C 1.487 -1.468 1 N-CA-C 97.711 -4.922 . . . . 0.0 97.711 153.076 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.86 171.73 17.28 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.265 1.977 . . . . 0.0 109.598 176.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.54 -4.97 37.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -92.98 3.65 55.37 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 -178.135 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 t -107.76 138.5 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 103.557 -2.756 . . . . 0.0 103.557 -176.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.75 147.37 16.41 Favored Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 103.786 -3.726 . . . . 0.0 103.786 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.9 -160.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -164.342 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -73.33 137.46 23.3 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -172.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.421 -1.881 1 N-CA-C 95.046 -5.909 . . . . 0.0 95.046 173.54 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 177.71 7.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 172.704 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -129.58 139.76 51.39 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 97.621 -4.955 . . . . 0.0 97.621 171.556 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 179.16 37.5 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 177.58 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -78.04 128.67 34.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 162.411 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 tt -90.76 140.76 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.385 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.65 -162.47 0.96 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.229 3.012 . . . . 0.0 107.755 174.54 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -144.05 170.37 8.51 Favored Pre-proline 0 N--CA 1.42 -1.953 1 N-CA-C 96.886 -5.227 . . . . 0.0 96.886 175.364 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -64.28 152.58 80.76 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.221 1.948 . . . . 0.0 111.314 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.61 -49.21 9.42 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 127.1 2.16 . . . . 0.0 107.544 -1.203 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -146.2 139.49 25.9 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 92.096 -7.002 . . . . 0.0 92.096 169.153 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.2 m -175.83 -158.44 0.06 Allowed 'General case' 0 CA--C 1.488 -1.408 1 N-CA-C 100.024 -4.065 . . . . 0.0 100.024 -174.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.479 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.14 155.14 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 N-CA-C 97.509 -4.997 . . . . 0.0 97.509 164.992 . . . . . . . . 4 4 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.27 153.22 20.63 Favored 'General case' 0 CA--C 1.494 -1.191 1 N-CA-C 100.136 -4.024 . . . . 0.0 100.136 166.044 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -102.07 -173.13 2.27 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.255 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.4 t -140.24 154.37 46.85 Favored 'General case' 0 N--CA 1.417 -2.093 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 -171.125 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -115.93 121.39 34.08 Favored Pre-proline 0 N--CA 1.419 -1.988 1 N-CA-C 96.816 -5.253 . . . . 0.0 96.816 167.561 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -56.86 129.2 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 122.972 2.097 . . . . 0.0 112.846 -174.429 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.31 -46.78 1.04 Allowed Glycine 0 CA--C 1.491 -1.424 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -164.41 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 m 92.69 2.41 0.08 Allowed 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 127.496 2.318 . . . . 0.0 112.093 171.289 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -34.65 77.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.835 1.198 . . . . 0.0 111.469 -173.795 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.09 -48.89 50.79 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 175.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.21 -49.78 76.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.378 1.471 . . . . 0.0 109.182 179.418 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.52 -45.37 73.34 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.345 1.458 . . . . 0.0 111.751 177.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 m -63.88 -43.87 94.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.72 -36.47 67.79 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.769 0.795 . . . . 0.0 109.953 -176.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -62.61 -46.5 88.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.739 1.216 . . . . 0.0 110.448 173.358 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.18 -45.78 86.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 123.969 0.908 . . . . 0.0 110.051 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -95.33 -4.29 45.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.145 0.978 . . . . 0.0 109.972 179.425 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.02 12.53 31.53 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 168.139 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.91 127.38 8.39 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 177.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 p -97.0 5.04 51.18 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.879 -0.777 . . . . 0.0 110.041 -169.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -160.48 158.1 28.74 Favored 'General case' 0 CA--C 1.479 -1.752 1 N-CA-C 99.159 -4.385 . . . . 0.0 99.159 166.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.31 168.4 41.41 Favored Glycine 0 N--CA 1.417 -2.633 1 N-CA-C 98.628 -5.789 . . . . 0.0 98.628 -178.541 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 8.1 p-80 -166.77 173.83 9.18 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 97.064 -5.162 . . . . 0.0 97.064 -179.871 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.0 m -94.95 162.28 13.8 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.548 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.11 174.09 40.98 Favored Glycine 0 N--CA 1.421 -2.304 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 178.533 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -117.79 138.14 52.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 101.544 -3.502 . . . . 0.0 101.544 -177.156 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -98.47 -29.14 13.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.18 0.99 . . . . 0.0 109.483 -175.349 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 42' ' ' GLY . 3.5 t 70.62 176.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 105.468 -165.815 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 80.76 -65.42 3.92 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 120.137 -1.602 . . . . 0.0 109.931 172.572 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -91.36 -53.33 4.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 172.131 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.84 -128.46 3.46 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 171.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.47 127.42 32.67 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.435 2.694 . . . . 0.0 106.665 -177.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.36 176.88 7.6 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -166.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.8 t -117.55 158.96 23.66 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 100.301 -3.962 . . . . 0.0 100.301 174.038 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 19.4 t-105 -124.07 150.34 45.11 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.444 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.2 m -140.07 152.75 46.43 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.623 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.17 138.35 51.34 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 169.671 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.71 50.13 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.942 2.097 . . . . 0.0 111.072 166.852 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.1 133.29 32.14 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.95 176.12 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.321 2.014 . . . . 0.0 110.715 176.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.4 2.44 25.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.075 0.95 . . . . 0.0 112.732 -170.734 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -95.93 5.26 51.66 Favored 'General case' 0 CA--C 1.503 -0.849 0 O-C-N 121.098 -1.001 . . . . 0.0 108.847 175.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.49 167.39 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 175.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.61 163.1 29.54 Favored Glycine 0 CA--C 1.485 -1.827 1 N-CA-C 98.319 -5.912 . . . . 0.0 98.319 -177.039 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -154.12 -164.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 -161.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -65.4 121.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 123.979 0.912 . . . . 0.0 111.013 -163.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.308 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.223 0.535 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 176.68 5.28 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 159.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -129.75 144.34 51.25 Favored 'General case' 0 CA--C 1.481 -1.675 1 N-CA-C 95.169 -5.863 . . . . 0.0 95.169 171.903 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 -178.24 35.47 Favored Glycine 0 CA--C 1.473 -2.593 0 N-CA-C 103.957 -3.657 . . . . 0.0 103.957 175.879 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 33.3 m-85 -76.73 137.75 39.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 156.68 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 tt -90.52 137.82 20.79 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.357 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -108.36 -154.62 0.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 127.245 2.218 . . . . 0.0 107.946 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -122.7 148.77 54.3 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 95.604 -5.702 . . . . 0.0 95.604 170.138 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -68.96 145.57 62.22 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 122.691 1.997 . . . . 0.0 109.025 -176.761 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -89.07 -42.52 11.68 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.881 2.472 . . . . 0.0 110.085 12.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -153.97 140.09 18.41 Favored 'General case' 0 N--CA 1.424 -1.746 1 N-CA-C 92.212 -6.959 . . . . 0.0 92.212 178.459 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -178.35 -151.53 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 95.515 -5.735 . . . . 0.0 95.515 178.321 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.91 -178.34 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 163.177 . . . . . . . . 4 4 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -152.67 0.32 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 166.758 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -143.18 161.2 38.85 Favored 'General case' 0 N--CA 1.422 -1.846 1 N-CA-C 94.601 -6.074 . . . . 0.0 94.601 153.005 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -160.54 -157.7 0.56 Allowed 'General case' 0 N--CA 1.42 -1.974 1 N-CA-C 96.077 -5.527 . . . . 0.0 96.077 -176.682 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -147.1 172.4 5.24 Favored Pre-proline 0 N--CA 1.418 -2.045 1 N-CA-C 99.865 -4.124 . . . . 0.0 99.865 -161.317 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.92 63.55 4.03 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 124.311 2.575 . . . . 0.0 111.386 170.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.87 148.65 5.68 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 101.578 -4.609 . . . . 0.0 101.578 174.181 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -83.98 60.97 6.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 118.166 0.983 . . . . 0.0 108.675 178.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -69.94 -65.21 0.75 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -173.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.8 -22.42 57.95 Favored Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 177.084 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -79.48 -10.74 59.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.261 -1.141 . . . . 0.0 110.992 -174.139 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.4 -51.99 67.53 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 120.428 1.467 . . . . 0.0 108.649 174.746 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -72.28 -40.76 67.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.151 -177.405 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.27 -42.93 96.42 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 118.659 0.663 . . . . 0.0 112.565 179.055 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.31 -44.39 91.72 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -69.29 -43.47 73.75 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 121.439 -0.788 . . . . 0.0 111.679 -178.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -69.42 -28.49 66.18 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 119.544 1.065 . . . . 0.0 112.829 -177.675 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -87.51 -4.01 58.99 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.664 0.665 . . . . 0.0 110.558 175.609 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.91 29.4 8.11 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 162.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.21 149.32 17.89 Favored Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 171.1 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 p -79.33 -50.45 10.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.174 0.988 . . . . 0.0 109.88 -167.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -160.17 176.83 11.32 Favored 'General case' 0 N--CA 1.422 -1.844 1 N-CA-C 98.699 -4.556 . . . . 0.0 98.699 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.27 46.22 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 103.68 -3.768 . . . . 0.0 103.68 -169.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -146.98 -177.77 5.84 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.754 -4.906 . . . . 0.0 97.754 -169.252 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.3 m -136.96 160.75 37.97 Favored 'General case' 0 CA--C 1.479 -1.766 1 N-CA-C 99.549 -4.241 . . . . 0.0 99.549 171.529 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.09 179.26 47.37 Favored Glycine 0 N--CA 1.424 -2.136 1 N-CA-C 99.841 -5.304 . . . . 0.0 99.841 -174.318 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -93.18 150.58 20.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 -172.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -118.15 116.09 26.13 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 170.838 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.36 128.57 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -16.57 26.09 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -175.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -127.52 -85.49 0.59 Allowed 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.8 -162.56 34.9 Favored Glycine 0 N--CA 1.426 -1.971 1 N-CA-C 102.91 -4.076 . . . . 0.0 102.91 -169.685 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.18 147.73 52.9 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.152 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.79 -176.08 5.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -165.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -128.18 166.13 19.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 175.869 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 16.2 t-105 -125.71 143.27 51.11 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 177.799 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.3 m -135.83 139.9 43.79 Favored 'General case' 0 CA--C 1.487 -1.465 1 N-CA-C 99.898 -4.112 . . . . 0.0 99.898 175.045 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -104.49 30.98 4.95 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.105 0.955 . . . . 0.0 108.929 -168.054 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.62 146.95 1.75 Allowed 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 94.036 -6.283 . . . . 0.0 94.036 165.911 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.53 151.67 64.3 Favored Pre-proline 0 N--CA 1.427 -1.591 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 141.79 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.41 174.01 13.28 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 122.158 1.905 . . . . 0.0 110.168 164.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -65.04 -11.66 41.73 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 126.454 1.902 . . . . 0.0 115.116 -172.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.3 -0.08 57.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.255 -0.903 . . . . 0.0 111.036 -175.543 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.29 142.51 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 -176.488 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.49 155.19 16.5 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 104.679 -3.368 . . . . 0.0 104.679 -176.668 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 pt -143.44 -155.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -161.583 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -83.57 154.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -172.88 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.628 1 N-CA-C 96.763 -5.273 . . . . 0.0 96.763 171.208 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.34 169.68 10.36 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 176.109 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -134.83 137.0 42.91 Favored 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 96.437 -5.394 . . . . 0.0 96.437 169.735 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.49 23.03 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 105.312 -3.115 . . . . 0.0 105.312 172.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 72.2 m-85 -82.38 137.41 34.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 163.272 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 58' ' ' ILE . 20.9 tt -91.65 140.89 15.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB2' HG12 ' A' ' 59' ' ' ILE . . . -95.7 -155.09 0.46 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.215 3.406 . . . . 0.0 110.406 -177.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -132.92 154.03 81.24 Favored Pre-proline 0 N--CA 1.429 -1.512 1 N-CA-C 96.211 -5.478 . . . . 0.0 96.211 165.511 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -67.25 135.12 35.9 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.889 2.393 . . . . 0.0 107.884 168.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -90.57 -55.14 3.7 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 121.881 2.128 . . . . 0.0 110.752 20.227 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -149.3 132.6 16.5 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 92.971 -6.678 . . . . 0.0 92.971 177.667 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -169.01 0.26 Allowed 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 -174.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.75 160.95 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 167.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -161.26 0.32 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 162.522 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.79 158.7 43.37 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.39 -5.411 . . . . 0.0 96.39 165.11 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.39 168.06 18.23 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 -167.908 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -114.02 114.18 46.37 Favored Pre-proline 0 N--CA 1.42 -1.942 1 N-CA-C 99.576 -4.231 . . . . 0.0 99.576 174.309 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -57.89 125.72 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.576 2.184 . . . . 0.0 112.268 -176.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.15 -56.93 0.67 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 100.357 -5.097 . . . . 0.0 100.357 -162.419 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m 117.7 -34.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 129.48 3.112 . . . . 0.0 107.676 173.466 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.37 -51.22 2.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.86 2.864 . . . . 0.0 116.238 -159.375 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.48 -43.94 75.28 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.559 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.34 -23.08 26.35 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -170.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.79 -37.65 85.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.353 1.061 . . . . 0.0 108.522 168.964 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.9 m -69.46 -40.21 77.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.799 -0.563 . . . . 0.0 109.981 174.58 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.89 -38.03 89.63 Favored 'General case' 0 C--N 1.359 1.012 0 O-C-N 121.277 -0.889 . . . . 0.0 111.404 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -52.85 -48.56 66.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.01 1.324 . . . . 0.0 110.357 170.008 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -65.15 -41.85 94.36 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.463 -0.773 . . . . 0.0 112.446 -175.05 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.34 -9.44 58.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.137 -0.977 . . . . 0.0 111.906 -177.301 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -103.43 7.3 38.02 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.245 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.7 20.26 34.88 Favored Glycine 0 CA--C 1.491 -1.466 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.922 167.238 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.37 148.26 22.87 Favored Glycine 0 CA--C 1.49 -1.531 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 170.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.5 m -88.79 -32.72 17.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -168.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.7 m -160.69 -177.88 6.48 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 98.783 -4.525 . . . . 0.0 98.783 170.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.42 -169.87 37.67 Favored Glycine 0 CA--C 1.466 -3.031 1 N-CA-C 102.247 -4.341 . . . . 0.0 102.247 -172.471 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.41 -160.43 0.77 Allowed 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 98.835 -4.506 . . . . 0.0 98.835 -169.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.04 170.96 17.65 Favored 'General case' 0 CA--C 1.472 -2.047 1 N-CA-C 99.085 -4.413 . . . . 0.0 99.085 175.328 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.45 -170.8 41.02 Favored Glycine 0 N--CA 1.419 -2.487 1 N-CA-C 98.031 -6.027 . . . . 0.0 98.031 -173.751 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -124.08 150.04 45.46 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 100.765 -3.791 . . . . 0.0 100.765 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -123.05 98.99 6.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 173.763 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.86 122.93 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.69 -40.57 1.53 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -165.385 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -124.43 -63.59 1.18 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.508 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.24 -158.91 31.04 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -172.239 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.43 146.62 53.02 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.566 2.347 . . . . 0.0 105.523 176.748 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.66 -177.22 6.23 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -170.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.9 m -122.66 173.73 7.54 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 102.115 -3.291 . . . . 0.0 102.115 170.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 7.6 t-105 -131.33 148.17 52.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -175.104 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.4 m -134.11 149.06 51.07 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.248 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.6 134.15 55.17 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 171.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.26 71.82 0.54 Allowed 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.345 2.258 . . . . 0.0 111.514 174.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.9 135.56 19.41 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 170.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -72.78 176.86 8.35 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 122.65 1.982 . . . . 0.0 112.253 177.01 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.61 9.84 3.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.743 0.817 . . . . 0.0 112.752 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -95.89 -0.81 50.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 121.241 -0.912 . . . . 0.0 108.566 176.025 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.2 170.37 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 -178.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.02 163.14 28.37 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.009 -6.036 . . . . 0.0 98.009 177.233 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.0 pt -159.28 -170.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.391 -3.929 . . . . 0.0 100.391 -160.491 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 7' ' ' ALA . 3.5 mt -76.15 116.32 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 126.28 1.832 . . . . 0.0 111.517 -162.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 160.546 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.468 0.651 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.6 165.93 12.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.161 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -137.02 132.47 34.29 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 97.452 -5.018 . . . . 0.0 97.452 171.988 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -168.5 24.01 Favored Glycine 0 CA--C 1.48 -2.098 1 N-CA-C 102.755 -4.138 . . . . 0.0 102.755 175.015 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.06 142.42 34.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 159.182 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.45 150.92 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.232 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.32 176.39 12.21 Favored 'General case' 0 N--CA 1.421 -1.887 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 179.12 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -84.2 159.93 58.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 171.009 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 80.0 Cg_exo -61.76 110.98 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.468 2.779 . . . . 0.0 110.594 171.416 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 63.4 mm-40 -131.76 131.21 42.77 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 129.178 2.991 . . . . 0.0 104.378 2.539 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 67.39 16.43 10.04 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.905 1.336 . . . . 0.0 111.573 171.451 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.1 m -96.19 88.99 4.98 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 179.654 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.29 159.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -159.899 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -166.57 1.49 Allowed 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.628 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -150.45 177.47 9.97 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 96.31 -5.441 . . . . 0.0 96.31 172.456 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -157.25 157.59 34.55 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.626 -5.694 . . . . 0.0 95.626 -175.038 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -118.61 122.08 30.29 Favored Pre-proline 0 N--CA 1.426 -1.674 0 N-CA-C 100.424 -3.917 . . . . 0.0 100.424 -175.654 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.95 130.05 38.2 Favored 'Trans proline' 0 CA--C 1.507 -0.837 0 C-N-CA 122.474 2.116 . . . . 0.0 112.994 -174.723 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.06 -48.61 0.95 Allowed Glycine 0 CA--C 1.492 -1.402 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -159.941 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.253 15.0 m 96.26 -12.43 0.09 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 128.551 2.74 . . . . 0.0 111.603 172.577 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -44.85 -48.12 11.09 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 127.377 2.271 . . . . 0.0 115.904 -166.793 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.87 -38.36 41.88 Favored Glycine 0 C--N 1.351 1.389 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -174.913 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.39 -23.92 50.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.137 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.11 -47.6 80.67 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.785 0.834 . . . . 0.0 109.35 173.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -47.2 86.7 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.034 -1.041 . . . . 0.0 112.77 172.104 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.03 -42.36 97.11 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 122.039 0.923 . . . . 0.0 111.297 -175.169 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.38 -42.99 97.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.19 0.996 . . . . 0.0 109.998 178.831 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -63.9 -43.5 95.77 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 117.954 0.343 . . . . 0.0 111.449 -179.474 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -76.61 -20.5 56.69 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 118.554 0.616 . . . . 0.0 111.888 -175.779 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -84.53 -14.5 48.78 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.243 0.617 . . . . 0.0 110.499 172.962 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 27.29 5.97 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 166.575 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.66 134.73 12.31 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 175.053 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 p -103.99 12.94 33.59 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 -167.15 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.38 156.44 26.16 Favored 'General case' 0 CA--C 1.482 -1.644 1 N-CA-C 98.929 -4.471 . . . . 0.0 98.929 161.1 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.41 162.51 32.8 Favored Glycine 0 CA--C 1.47 -2.772 1 N-CA-C 98.675 -5.77 . . . . 0.0 98.675 -179.056 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -174.83 175.36 2.4 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 -174.479 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.3 m -87.0 160.0 18.79 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.333 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.95 172.0 44.81 Favored Glycine 0 N--CA 1.425 -2.035 1 N-CA-C 96.73 -6.548 . . . . 0.0 96.73 176.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -154.73 148.64 25.65 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 98.098 -4.778 . . . . 0.0 98.098 174.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -179.01 47.84 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 100.367 -3.938 . . . . 0.0 100.367 163.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -171.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -164.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.14 64.93 0.39 Allowed Glycine 0 CA--C 1.489 -1.569 1 N-CA-C 102.126 -4.389 . . . . 0.0 102.126 179.011 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -160.7 -165.72 1.46 Allowed 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.391 -5.411 . . . . 0.0 96.391 -177.434 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.94 -48.32 33.95 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -177.486 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -174.29 1.65 Allowed 'General case' 0 N--CA 1.432 -1.351 1 N-CA-C 96.748 -5.278 . . . . 0.0 96.748 171.709 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.2 168.28 20.91 Favored 'General case' 0 CA--C 1.49 -1.332 1 N-CA-C 96.554 -5.35 . . . . 0.0 96.554 177.701 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.5 t -125.1 157.97 35.01 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 -171.353 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -93.82 148.9 21.7 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.378 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 m -141.31 148.76 40.27 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 167.35 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 137.55 54.0 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 -176.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.57 55.38 0.63 Allowed 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.677 1.591 . . . . 0.0 110.741 174.16 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 mt -92.58 135.77 26.07 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.393 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.45 166.27 30.3 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.803 2.336 . . . . 0.0 108.965 177.318 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -87.42 41.29 0.97 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -171.979 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.83 -0.12 12.36 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 169.666 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.47 151.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 -178.228 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.78 147.66 18.99 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 98.282 -5.927 . . . . 0.0 98.282 -179.772 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 pt -145.3 -138.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -156.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 7' ' ' ALA . 13.5 mm -73.44 146.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.459 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.431 -1.387 2 N-CA-C 94.158 -6.238 . . . . 0.0 94.158 172.521 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.894 0.378 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.557 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -137.62 -176.87 4.56 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.803 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -133.61 143.51 48.68 Favored 'General case' 0 CA--C 1.49 -1.354 1 N-CA-C 97.492 -5.003 . . . . 0.0 97.492 176.454 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 177.45 37.88 Favored Glycine 0 CA--C 1.48 -2.107 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 178.233 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -79.28 127.91 32.66 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 156.601 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.441 ' HA ' HG22 ' A' ' 58' ' ' ILE . 12.5 tt -89.67 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -172.599 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -95.1 -146.49 0.27 Allowed 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 126.824 2.577 . . . . 0.0 109.438 178.111 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -149.81 167.75 12.39 Favored Pre-proline 0 N--CA 1.424 -1.761 1 N-CA-C 95.989 -5.56 . . . . 0.0 95.989 175.153 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.96 151.14 86.84 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.298 2.666 . . . . 0.0 107.686 158.187 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.87 -51.13 8.41 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 128.12 2.568 . . . . 0.0 109.033 7.181 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -145.66 147.59 32.17 Favored 'General case' 0 N--CA 1.421 -1.914 1 N-CA-C 92.149 -6.982 . . . . 0.0 92.149 162.598 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.49 -164.41 0.22 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -173.641 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -125.75 161.76 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 1 N-CA-C 96.718 -5.29 . . . . 0.0 96.718 161.509 . . . . . . . . 4 4 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -151.93 0.07 Allowed 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 163.501 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -139.35 177.72 7.72 Favored 'General case' 0 CA--C 1.478 -1.813 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 163.825 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.9 t -138.14 162.4 34.33 Favored 'General case' 0 N--CA 1.415 -2.198 1 N-CA-C 97.347 -5.057 . . . . 0.0 97.347 -174.424 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -116.1 112.67 41.97 Favored Pre-proline 0 N--CA 1.418 -2.053 1 N-CA-C 96.031 -5.544 . . . . 0.0 96.031 172.296 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -70.45 49.53 0.87 Allowed 'Trans proline' 0 CA--C 1.517 -0.374 0 CA-C-N 124.402 2.608 . . . . 0.0 115.351 -173.663 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.31 16.78 6.67 Favored Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 168.607 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m 74.24 -52.82 0.69 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 127.362 2.265 . . . . 0.0 112.12 172.42 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.05 -41.52 59.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.317 2.247 . . . . 0.0 115.815 -170.955 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.82 60.88 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.154 -0.966 . . . . 0.0 111.496 -176.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.76 -47.87 24.13 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.128 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -56.58 -43.21 79.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.255 0.622 . . . . 0.0 110.193 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -57.14 -47.71 80.46 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.077 -1.014 . . . . 0.0 112.164 176.333 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.3 mt -65.38 -43.03 91.97 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-O 121.834 0.826 . . . . 0.0 110.206 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -57.42 -45.98 84.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.162 0.985 . . . . 0.0 110.762 176.422 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.95 -44.33 80.87 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 122.717 0.407 . . . . 0.0 110.322 -176.186 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.31 -30.51 66.32 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 118.381 0.537 . . . . 0.0 111.96 -177.049 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -77.74 -33.51 52.87 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.515 -0.741 . . . . 0.0 109.965 176.219 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.22 43.05 0.49 Allowed Glycine 0 CA--C 1.489 -1.589 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 161.492 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.31 139.94 14.67 Favored Glycine 0 C--N 1.353 1.528 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 164.778 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 p -96.24 -1.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.038 0.923 . . . . 0.0 109.96 -168.04 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -160.34 168.19 25.81 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 97.528 -4.99 . . . . 0.0 97.528 171.404 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.36 -177.83 37.35 Favored Glycine 0 CA--C 1.468 -2.869 1 N-CA-C 100.329 -5.108 . . . . 0.0 100.329 -175.655 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -159.0 -176.78 6.06 Favored 'General case' 0 N--CA 1.423 -1.799 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 -175.885 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -139.91 150.29 44.39 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 95.853 -5.61 . . . . 0.0 95.853 -176.755 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.97 -176.89 46.32 Favored Glycine 0 N--CA 1.423 -2.177 1 N-CA-C 102.127 -4.389 . . . . 0.0 102.127 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -118.16 141.48 48.45 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 99.803 -4.147 . . . . 0.0 99.803 -178.24 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -94.83 -28.98 14.96 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.692 1.234 . . . . 0.0 108.915 -177.574 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.6 t 72.04 -166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 129.895 3.278 . . . . 0.0 103.372 -165.158 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 75.74 -69.98 2.04 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 120.387 -1.446 . . . . 0.0 110.505 176.818 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -99.65 -57.33 2.17 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.047 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.09 -138.83 5.54 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 118.576 -1.773 . . . . 0.0 110.588 -178.047 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 tp -80.74 144.36 32.22 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -177.477 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.14 -179.9 7.39 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 102.9 -3.0 . . . . 0.0 102.9 -170.118 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -115.88 165.49 13.03 Favored 'General case' 0 CA--C 1.496 -1.1 1 N-CA-C 98.945 -4.465 . . . . 0.0 98.945 175.49 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -129.67 150.87 50.8 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 54.4 m -142.57 149.53 39.17 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.24 138.99 51.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 172.283 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.17 67.65 0.72 Allowed 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.884 2.473 . . . . 0.0 110.539 179.164 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.91 139.64 21.42 Favored Pre-proline 0 CA--C 1.496 -1.112 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 171.108 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -70.32 162.38 42.57 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.279 1.986 . . . . 0.0 110.567 165.166 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.16 -37.54 72.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.9 2.08 . . . . 0.0 115.164 -163.966 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -83.61 -5.86 59.29 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.869 -1.144 . . . . 0.0 110.591 -172.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.54 99.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 178.061 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.557 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -83.49 166.27 43.5 Favored Glycine 0 CA--C 1.489 -1.569 0 CA-C-O 122.036 0.798 . . . . 0.0 112.163 -161.823 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 6' ' ' ILE . 31.9 pt -147.35 -178.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 -164.67 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.2 mm -69.29 103.91 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 124.819 1.248 . . . . 0.0 110.216 -166.841 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 101.527 -3.509 . . . . 0.0 101.527 167.163 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.139 0.495 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.487 HH21 ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.2 -178.79 6.49 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -128.9 132.06 47.66 Favored 'General case' 0 CA--C 1.494 -1.175 1 N-CA-C 99.008 -4.441 . . . . 0.0 99.008 171.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 175.41 38.17 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -77.26 128.04 33.66 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -91.0 139.93 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.6 -129.13 0.24 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.443 -1.708 . . . . 0.0 107.915 169.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -145.34 154.47 53.46 Favored Pre-proline 0 N--CA 1.415 -2.206 1 N-CA-C 95.337 -5.801 . . . . 0.0 95.337 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 82.2 Cg_exo -68.64 110.14 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.837 2.358 . . . . 0.0 110.551 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 52.9 mm-40 -145.64 162.16 38.15 Favored 'General case' 0 CA--C 1.484 -1.564 1 N-CA-C 98.039 -4.8 . . . . 0.0 98.039 4.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 76.17 27.05 0.91 Allowed 'General case' 0 C--N 1.359 0.985 0 CA-C-O 123.169 1.462 . . . . 0.0 108.887 162.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.9 m -118.99 -158.19 0.72 Allowed 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.06 168.07 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 1 N-CA-C 95.594 -5.706 . . . . 0.0 95.594 161.161 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.15 -170.3 2.0 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -131.76 151.65 51.5 Favored 'General case' 0 CA--C 1.478 -1.799 1 N-CA-C 97.244 -5.095 . . . . 0.0 97.244 170.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' H ' HD22 ' A' ' 45' ' ' LEU . 9.1 t -116.65 163.4 16.18 Favored 'General case' 0 CA--C 1.474 -1.97 0 N-CA-C 101.352 -3.573 . . . . 0.0 101.352 -171.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -113.43 112.87 48.67 Favored Pre-proline 0 N--CA 1.419 -2.017 1 N-CA-C 98.034 -4.802 . . . . 0.0 98.034 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.74 130.72 40.04 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 122.293 1.996 . . . . 0.0 111.88 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.56 -56.72 0.73 Allowed Glycine 0 CA--C 1.484 -1.852 1 N-CA-C 101.659 -4.576 . . . . 0.0 101.659 -163.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m 119.42 -23.87 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.98 2.912 . . . . 0.0 107.134 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -61.77 0.74 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.381 2.272 . . . . 0.0 115.763 -154.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.56 -39.68 60.46 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.916 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -29.29 51.83 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 117.643 0.721 . . . . 0.0 109.593 -168.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.55 -49.41 77.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.63 1.172 . . . . 0.0 109.861 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -63.87 -34.34 77.72 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.75 -0.594 . . . . 0.0 112.228 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.16 -40.84 94.87 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 122.043 0.925 . . . . 0.0 110.685 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.03 -44.63 94.5 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 123.592 0.757 . . . . 0.0 110.612 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -69.0 -34.59 75.53 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.36 -21.44 56.09 Favored 'General case' 0 C--N 1.357 0.894 0 CA-C-N 119.239 0.927 . . . . 0.0 111.567 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -84.13 -41.3 17.23 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.605 -0.685 . . . . 0.0 109.39 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.08 48.0 0.1 OUTLIER Glycine 0 CA--C 1.493 -1.302 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.6 137.81 13.88 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 104.781 -3.328 . . . . 0.0 104.781 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.42 -0.07 56.79 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.323 1.049 . . . . 0.0 110.768 -168.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 m -159.38 164.2 34.89 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 100.012 -4.07 . . . . 0.0 100.012 167.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.05 169.66 39.02 Favored Glycine 0 N--CA 1.424 -2.16 1 N-CA-C 98.043 -6.023 . . . . 0.0 98.043 -176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -164.55 -171.42 2.33 Favored 'General case' 0 N--CA 1.438 -1.072 1 N-CA-C 100.043 -4.058 . . . . 0.0 100.043 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.8 m -98.9 174.58 6.3 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 166.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.61 -178.05 43.28 Favored Glycine 0 N--CA 1.427 -1.933 1 N-CA-C 102.025 -4.43 . . . . 0.0 102.025 168.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -134.84 142.45 46.64 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.741 -4.54 . . . . 0.0 98.741 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -126.22 107.36 10.29 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -70.14 124.04 25.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.9 -81.27 0.22 Allowed Glycine 0 CA--C 1.482 -2.003 1 N-CA-C 100.92 -4.872 . . . . 0.0 100.92 -164.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -87.34 -59.25 2.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.99 -140.38 7.23 Favored Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -65.69 143.57 57.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.974 2.109 . . . . 0.0 106.271 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.25 -174.58 4.86 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.71 -179.99 4.91 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -132.43 151.24 51.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 -175.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.44 136.4 33.0 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -105.96 135.7 46.94 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 172.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.03 40.58 3.96 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 125.934 1.693 . . . . 0.0 112.031 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 tp -81.92 138.89 46.31 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 165.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -70.19 165.53 31.15 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.262 1.975 . . . . 0.0 110.833 170.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -81.41 -5.2 57.65 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 123.93 0.892 . . . . 0.0 110.989 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -91.66 16.73 10.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.244 1.017 . . . . 0.0 109.837 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.57 162.21 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 N-CA-C 95.134 -5.876 . . . . 0.0 95.134 170.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.99 -177.41 35.96 Favored Glycine 0 CA--C 1.475 -2.44 0 C-N-CA 115.877 -3.059 . . . . 0.0 107.699 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.487 ' CG2' HH21 ' A' ' 2' ' ' ARG . 46.7 pt -142.26 -152.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 CA-C-N 114.694 -0.753 . . . . 0.0 110.873 -141.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -75.25 132.56 33.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.5 t -145.76 160.82 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 1 N-CA-C 94.813 -5.995 . . . . 0.0 94.813 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -142.66 151.15 41.1 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 98.114 -4.773 . . . . 0.0 98.114 160.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.23 -42.86 0.68 Allowed Glycine 0 N--CA 1.428 -1.894 1 N-CA-C 102.115 -4.394 . . . . 0.0 102.115 -166.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 64' ' ' LYS . 2.1 tm-20 -104.71 -92.95 0.36 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 63' ' ' GLU . 15.3 tptt 165.77 177.78 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.221 1 N-CA-C 95.918 -5.586 . . . . 0.0 95.918 -172.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.9 t -80.74 152.2 28.46 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -110.54 -132.59 0.33 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.35 135.85 57.84 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 127.586 2.354 . . . . 0.0 109.723 170.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.273 0 O-C-N 123.444 0.465 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 175.89 12.51 Favored 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.274 -5.454 . . . . 0.0 96.274 169.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -125.15 141.81 51.88 Favored 'General case' 0 CA--C 1.487 -1.475 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -176.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.26 179.02 36.96 Favored Glycine 0 CA--C 1.47 -2.766 0 N-CA-C 103.996 -3.642 . . . . 0.0 103.996 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -81.8 129.79 34.85 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 167.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.0 tt -79.25 129.37 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -173.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.88 -169.63 1.49 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 112.055 -2.339 . . . . 0.0 107.615 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.75 151.94 37.64 Favored Pre-proline 0 N--CA 1.434 -1.243 1 N-CA-C 99.601 -4.222 . . . . 0.0 99.601 167.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -63.34 140.83 78.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 162.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.49 -42.31 10.34 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 121.604 2.002 . . . . 0.0 108.744 12.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -151.97 142.74 22.9 Favored 'General case' 0 N--CA 1.417 -2.077 1 N-CA-C 93.663 -6.421 . . . . 0.0 93.663 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 23.2 m -179.79 -155.41 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.269 -4.345 . . . . 0.0 99.269 178.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.72 HG12 HD12 ' A' ' 59' ' ' ILE . 15.9 m -131.42 167.96 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 1 N-CA-C 97.011 -5.181 . . . . 0.0 97.011 160.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.93 -166.37 1.37 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 163.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -131.29 166.95 20.07 Favored 'General case' 0 CA--C 1.484 -1.595 1 N-CA-C 98.067 -4.79 . . . . 0.0 98.067 172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.15 167.24 28.36 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -128.7 129.7 23.5 Favored Pre-proline 0 N--CA 1.423 -1.818 1 N-CA-C 99.835 -4.135 . . . . 0.0 99.835 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -54.59 123.68 14.27 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.778 2.319 . . . . 0.0 112.696 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.48 -46.69 1.06 Allowed Glycine 0 CA--C 1.488 -1.61 0 N-CA-C 103.324 -3.91 . . . . 0.0 103.324 -166.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m 92.11 0.09 0.13 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 127.492 2.317 . . . . 0.0 113.238 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -44.43 81.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.563 1.945 . . . . 0.0 112.905 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.18 -46.27 44.07 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.3 t -79.31 -22.03 45.15 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 118.823 1.312 . . . . 0.0 110.717 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -55.17 -41.51 71.98 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 119.229 0.922 . . . . 0.0 109.829 166.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.9 m -63.35 -45.7 89.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.816 -0.553 . . . . 0.0 110.205 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.29 -41.23 96.99 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 122.717 1.246 . . . . 0.0 110.039 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.62 -41.27 98.31 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 109.946 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -71.77 -37.15 70.53 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 121.599 -0.688 . . . . 0.0 111.223 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.14 -31.16 62.62 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.719 -0.613 . . . . 0.0 111.267 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -85.91 -16.9 37.02 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.537 -0.727 . . . . 0.0 111.073 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.36 43.07 2.24 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 165.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.57 142.74 16.19 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 167.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.7 -34.01 66.86 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 129.123 2.969 . . . . 0.0 110.504 -172.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 m -160.12 165.95 30.72 Favored 'General case' 0 N--CA 1.421 -1.922 1 N-CA-C 97.944 -4.836 . . . . 0.0 97.944 174.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.31 165.47 37.02 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.945 -6.062 . . . . 0.0 97.945 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -166.91 178.95 5.52 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.576 -4.602 . . . . 0.0 98.576 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.14 161.4 26.49 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.71 40.48 Favored Glycine 0 N--CA 1.421 -2.321 1 N-CA-C 98.463 -5.855 . . . . 0.0 98.463 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -159.85 165.46 32.22 Favored 'General case' 0 N--CA 1.42 -1.962 1 N-CA-C 96.932 -5.21 . . . . 0.0 96.932 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -114.36 -9.28 12.79 Favored 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 124.216 1.006 . . . . 0.0 108.998 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.6 t 73.38 132.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 128.257 2.623 . . . . 0.0 107.126 -160.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.06 -104.98 0.29 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 105.394 -3.082 . . . . 0.0 105.394 -172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -69.51 -77.27 0.08 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.076 0.951 . . . . 0.0 112.909 -169.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.39 -50.61 0.01 OUTLIER Glycine 0 CA--C 1.49 -1.516 0 O-C-N 120.285 -1.509 . . . . 0.0 109.769 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tp -158.78 -167.47 2.13 Favored 'General case' 0 N--CA 1.43 -1.447 1 N-CA-C 95.481 -5.748 . . . . 0.0 95.481 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 -165.62 1.85 Allowed 'General case' 0 CA--C 1.486 -1.484 1 N-CA-C 97.961 -4.829 . . . . 0.0 97.961 167.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.19 -176.5 4.15 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 102.128 -3.286 . . . . 0.0 102.128 158.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -117.48 155.38 29.82 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 m -146.44 139.85 25.84 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 100.375 -3.935 . . . . 0.0 100.375 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 30.19 6.59 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.287 0.565 . . . . 0.0 110.073 -168.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 177.5 151.02 0.2 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 93.979 -6.304 . . . . 0.0 93.979 170.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -153.36 151.92 26.61 Favored Pre-proline 0 CA--C 1.487 -1.47 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 149.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.72 170.95 16.48 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.08 1.853 . . . . 0.0 110.515 171.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.37 16.93 1.16 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -98.55 -6.25 30.49 Favored 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 120.51 -1.369 . . . . 0.0 108.287 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.73 168.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 N-CA-C 101.397 -3.557 . . . . 0.0 101.397 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.41 177.36 27.65 Favored Glycine 0 CA--C 1.483 -1.952 1 N-CA-C 102.033 -4.427 . . . . 0.0 102.033 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 6' ' ' ILE . 6.4 pt -154.82 -171.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -158.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.721 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.3 mm -68.76 133.05 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 t -113.95 115.21 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 101.792 -3.411 . . . . 0.0 101.792 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 61.83 -117.63 0.65 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.457 1.503 . . . . 0.0 109.672 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.71 59.61 0.1 Allowed Glycine 0 CA--C 1.485 -1.841 1 N-CA-C 99.334 -5.506 . . . . 0.0 99.334 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 -74.2 0.62 Allowed 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.451 -161.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -126.26 171.97 10.48 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 -162.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 15.3 t -137.35 134.9 36.52 Favored 'General case' 0 N--CA 1.422 -1.826 1 N-CA-C 97.624 -4.954 . . . . 0.0 97.624 170.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.87 109.53 4.04 Favored 'General case' 0 N--CA 1.427 -1.599 1 N-CA-C 100.114 -4.032 . . . . 0.0 100.114 169.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -81.51 119.3 23.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.017 0 O-C-N 123.463 0.477 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.063 0.459 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -100.99 157.82 16.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -127.53 125.9 41.23 Favored 'General case' 0 CA--C 1.486 -1.482 1 N-CA-C 94.315 -6.18 . . . . 0.0 94.315 159.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.38 29.01 Favored Glycine 0 CA--C 1.474 -2.512 0 N-CA-C 104.021 -3.632 . . . . 0.0 104.021 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -83.54 140.35 32.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 161.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.87 148.23 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.3 -177.17 6.07 Favored 'General case' 0 N--CA 1.415 -2.204 1 N-CA-C 98.329 -4.693 . . . . 0.0 98.329 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -105.06 157.54 34.04 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -66.56 144.62 73.46 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.654 2.236 . . . . 0.0 109.226 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -103.14 80.02 1.8 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 128.027 2.531 . . . . 0.0 106.336 -5.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.8 t30 84.66 44.19 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 124.932 1.293 . . . . 0.0 108.392 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.85 127.76 47.64 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 103.069 -2.937 . . . . 0.0 103.069 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 15' ' ' HIS 0.254 5.4 m -70.64 165.04 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 141.87 51.36 Favored 'General case' 0 N--CA 1.423 -1.817 1 N-CA-C 94.455 -6.128 . . . . 0.0 94.455 -176.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.462 ' CE1' HG23 ' A' ' 13' ' ' VAL . 46.9 m80 -117.31 160.73 20.65 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -167.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 t -115.18 169.27 9.24 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.53 124.68 23.61 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 98.423 -4.658 . . . . 0.0 98.423 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -57.59 111.84 0.95 Allowed 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.965 2.443 . . . . 0.0 113.261 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.79 -51.37 0.52 Allowed Glycine 0 CA--C 1.484 -1.85 1 N-CA-C 100.367 -5.093 . . . . 0.0 100.367 -168.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 6.8 m 106.12 -0.84 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 127.984 2.513 . . . . 0.0 111.852 169.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -46.97 -45.4 20.83 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.567 1.547 . . . . 0.0 113.806 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.37 -59.99 7.65 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.904 0.764 . . . . 0.0 111.955 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.3 m -70.68 -27.56 64.11 Favored 'General case' 0 CA--C 1.497 -1.086 0 O-C-N 120.869 -1.371 . . . . 0.0 113.263 -171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.84 -45.19 93.74 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.4 m -66.08 -40.97 91.28 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.748 0.819 . . . . 0.0 110.4 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.21 -42.33 94.9 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.703 0.801 . . . . 0.0 109.74 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -38.64 82.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.541 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.24 -42.25 84.3 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 121.925 -0.484 . . . . 0.0 111.455 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.35 -30.3 37.98 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 121.726 -0.609 . . . . 0.0 111.019 -173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -84.66 -22.29 29.92 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 118.363 0.529 . . . . 0.0 109.949 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.49 45.95 1.61 Allowed Glycine 0 CA--C 1.488 -1.594 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 162.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.26 172.8 17.38 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 104.26 -3.536 . . . . 0.0 104.26 167.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.8 p -75.39 -56.71 4.44 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.987 0.899 . . . . 0.0 108.651 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.9 m -160.65 -176.76 5.75 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 98.832 -4.506 . . . . 0.0 98.832 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.19 -176.73 41.93 Favored Glycine 0 N--CA 1.414 -2.769 1 N-CA-C 98.612 -5.795 . . . . 0.0 98.612 -168.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -166.79 178.08 6.1 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 -172.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -75.34 168.09 20.66 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.773 0.797 . . . . 0.0 110.465 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.84 -171.01 37.9 Favored Glycine 0 N--CA 1.419 -2.463 1 N-CA-C 97.05 -6.42 . . . . 0.0 97.05 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -146.54 161.91 39.46 Favored 'General case' 0 N--CA 1.422 -1.828 1 N-CA-C 95.325 -5.805 . . . . 0.0 95.325 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -152.44 167.08 29.93 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 97.458 -5.015 . . . . 0.0 97.458 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.76 149.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 1 N-CA-C 96.152 -5.499 . . . . 0.0 96.152 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 -23.02 23.29 Favored Glycine 0 CA--C 1.493 -1.322 0 N-CA-C 106.274 -2.731 . . . . 0.0 106.274 -168.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -135.62 -76.36 0.44 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 103.096 -2.927 . . . . 0.0 103.096 167.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.41 -150.76 22.13 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 98.289 -5.924 . . . . 0.0 98.289 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.28 115.26 2.37 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.339 2.656 . . . . 0.0 108.689 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.99 158.35 44.07 Favored 'General case' 0 CA--C 1.482 -1.657 1 N-CA-C 96.871 -5.233 . . . . 0.0 96.871 -166.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.8 p -138.61 174.36 10.62 Favored 'General case' 0 CA--C 1.479 -1.763 0 C-N-CA 116.349 -2.141 . . . . 0.0 108.548 -167.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -104.86 156.64 17.83 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -164.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 m -152.12 151.1 30.64 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 167.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -113.17 145.71 40.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 104.475 -2.416 . . . . 0.0 104.475 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.94 46.43 0.25 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.098 2.159 . . . . 0.0 112.227 164.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -93.33 130.97 33.88 Favored Pre-proline 0 CA--C 1.505 -0.786 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -75.95 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.071 1.847 . . . . 0.0 110.656 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -60.69 -20.15 60.31 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.77 1.628 . . . . 0.0 114.762 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -82.29 -12.76 57.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 121.652 -0.655 . . . . 0.0 110.414 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -90.52 112.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.46 143.74 17.45 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 104.894 -3.282 . . . . 0.0 104.894 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.9 pt -143.66 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 -160.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 7' ' ' ALA . 4.1 mm -68.08 122.61 19.65 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t -132.49 164.29 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -161.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 60.61 -129.96 0.89 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.162 1.785 . . . . 0.0 110.562 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.13 53.67 0.1 OUTLIER Glycine 0 CA--C 1.485 -1.821 1 N-CA-C 97.971 -6.052 . . . . 0.0 97.971 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 64' ' ' LYS . 70.1 tt0 -165.7 -174.56 3.13 Favored 'General case' 0 N--CA 1.423 -1.776 1 N-CA-C 96.251 -5.462 . . . . 0.0 96.251 -168.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 53.0 tttt -106.74 -150.74 0.45 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.81 158.96 21.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.84 1.256 . . . . 0.0 108.651 -169.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -163.74 174.57 11.47 Favored 'General case' 0 N--CA 1.425 -1.7 1 N-CA-C 96.881 -5.229 . . . . 0.0 96.881 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -177.61 176.16 1.29 Allowed 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 96.149 -5.5 . . . . 0.0 96.149 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.943 0 O-C-N 124.256 0.973 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.27 162.5 14.02 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 164.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -125.59 131.85 52.63 Favored 'General case' 0 CA--C 1.486 -1.501 1 N-CA-C 94.287 -6.19 . . . . 0.0 94.287 161.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.81 29.57 Favored Glycine 0 CA--C 1.473 -2.532 1 N-CA-C 100.912 -4.875 . . . . 0.0 100.912 176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -83.91 137.24 33.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 164.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.01 142.52 12.79 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -135.53 -129.78 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.88 2.872 . . . . 0.0 106.385 175.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -154.16 166.51 15.67 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 100.236 -3.987 . . . . 0.0 100.236 -172.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -65.39 139.14 58.19 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.346 2.697 . . . . 0.0 111.017 166.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -109.4 -16.26 14.05 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.571 2.348 . . . . 0.0 108.768 9.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -160.22 146.67 15.69 Favored 'General case' 0 CA--C 1.48 -1.72 1 N-CA-C 94.154 -6.239 . . . . 0.0 94.154 165.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.08 -161.97 0.29 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 169.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.74 166.78 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 1 N-CA-C 97.536 -4.987 . . . . 0.0 97.536 157.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -166.89 1.6 Allowed 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 163.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -127.46 161.89 27.67 Favored 'General case' 0 CA--C 1.473 -1.99 1 N-CA-C 99.245 -4.354 . . . . 0.0 99.245 169.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.0 t -124.83 147.87 48.51 Favored 'General case' 0 N--CA 1.419 -1.996 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -102.41 119.72 55.37 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 96.935 -5.209 . . . . 0.0 96.935 169.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -57.34 103.97 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 CA-C-N 124.491 2.64 . . . . 0.0 114.726 -165.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.68 -175.8 37.36 Favored Glycine 0 N--CA 1.419 -2.455 1 N-CA-C 97.248 -6.341 . . . . 0.0 97.248 -171.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -92.0 -30.75 15.9 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.627 0.713 . . . . 0.0 109.276 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -43.97 91.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 127.561 2.344 . . . . 0.0 115.319 -157.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.25 -50.46 45.04 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -68.96 -41.76 77.53 Favored 'General case' 0 CA--C 1.476 -1.879 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.057 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -48.2 -54.11 14.61 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.437 1.495 . . . . 0.0 110.291 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 m -58.72 -54.08 51.07 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.967 0.907 . . . . 0.0 111.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -67.14 -40.77 86.79 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-O 122.36 1.076 . . . . 0.0 110.339 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -64.93 -45.09 87.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.334 1.054 . . . . 0.0 110.304 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -68.56 -40.41 80.62 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 121.27 -0.894 . . . . 0.0 110.945 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -68.26 -14.89 63.32 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -111.49 7.84 20.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 118.344 0.52 . . . . 0.0 110.433 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 32.75 8.27 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.727 -0.485 . . . . 0.0 113.395 165.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.71 142.05 16.06 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.4 m -85.64 -21.63 28.32 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.461 1.504 . . . . 0.0 109.063 -170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 m -157.06 156.26 32.53 Favored 'General case' 0 N--CA 1.424 -1.761 1 N-CA-C 98.782 -4.525 . . . . 0.0 98.782 169.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -148.41 141.81 9.43 Favored Glycine 0 CA--C 1.468 -2.885 1 N-CA-C 99.681 -5.368 . . . . 0.0 99.681 -170.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -145.83 -167.65 2.77 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 101.373 -3.565 . . . . 0.0 101.373 -171.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.81 168.36 27.44 Favored 'General case' 0 N--CA 1.427 -1.582 1 N-CA-C 96.882 -5.229 . . . . 0.0 96.882 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.55 91.57 1.06 Allowed Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 103.112 -3.995 . . . . 0.0 103.112 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -156.61 156.55 33.72 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 171.71 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -138.88 18.87 2.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 42' ' ' GLY . 1.6 t -146.69 -157.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 101.686 -3.45 . . . . 0.0 101.686 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 98.68 -95.1 1.54 Allowed Glycine 0 CA--C 1.474 -2.475 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -129.49 -54.34 1.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.236 -3.616 . . . . 0.0 101.236 175.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.09 64.68 0.24 Allowed Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 105.569 -3.012 . . . . 0.0 105.569 173.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE 0.57 0.0 OUTLIER 73.36 171.75 0.3 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 126.513 1.925 . . . . 0.0 110.306 -171.511 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.67 -173.17 3.62 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -109.97 156.33 20.61 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -106.64 148.58 28.17 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 32.0 m -138.74 148.85 44.39 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 172.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.73 128.11 49.13 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 59.88 76.89 0.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 126.94 2.096 . . . . 0.0 111.557 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.47 141.97 23.75 Favored Pre-proline 0 CA--C 1.496 -1.128 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.15 166.33 23.52 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.603 2.202 . . . . 0.0 110.648 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -86.68 15.19 5.91 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.926 -1.109 . . . . 0.0 111.485 -165.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.11 11.17 21.96 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.09 140.61 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 101.637 -3.468 . . . . 0.0 101.637 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.36 143.28 15.65 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.16 -156.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -164.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.7 mm -70.52 125.01 27.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.234 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.2 t -90.66 -54.54 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.76 154.13 34.58 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.85 66.89 3.82 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 106.949 -2.46 . . . . 0.0 106.949 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -123.87 -95.63 0.47 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -143.96 149.63 37.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 -167.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 30.4 t -85.79 154.62 21.46 Favored 'General case' 0 CA--C 1.495 -1.163 0 C-N-CA 126.694 1.998 . . . . 0.0 106.231 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -165.94 169.62 14.57 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -152.98 164.24 38.32 Favored 'General case' 0 N--CA 1.423 -1.82 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 173.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.881 0 O-C-N 124.247 0.967 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.258 0.551 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -101.73 157.65 16.68 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.44 127.44 45.42 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 94.201 -6.222 . . . . 0.0 94.201 157.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -173.73 30.98 Favored Glycine 0 CA--C 1.475 -2.444 0 N-CA-C 103.532 -3.827 . . . . 0.0 103.532 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 35.4 m-85 -78.98 140.92 37.9 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 163.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tt -90.98 146.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.859 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -144.62 171.54 14.24 Favored 'General case' 0 N--CA 1.42 -1.964 1 N-CA-C 99.719 -4.178 . . . . 0.0 99.719 177.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.78 158.24 68.26 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 92.3 Cg_exo -61.89 111.17 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.681 2.921 . . . . 0.0 110.633 170.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 68.9 mm-40 -125.69 132.07 52.47 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 1.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.495 HD21 ' HA ' ' A' ' 61' ' ' GLU . 43.9 t30 63.47 33.99 13.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 162.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.45 121.65 24.9 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.16 153.96 4.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -163.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.22 120.35 41.62 Favored 'General case' 0 N--CA 1.424 -1.732 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -89.18 128.33 35.8 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.5 t -80.01 159.31 26.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.59 115.18 46.92 Favored Pre-proline 0 N--CA 1.426 -1.659 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.8 113.19 1.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 123.048 2.499 . . . . 0.0 113.117 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.23 -49.54 0.69 Allowed Glycine 0 CA--C 1.489 -1.592 1 N-CA-C 101.045 -4.822 . . . . 0.0 101.045 -164.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m 99.64 -12.77 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 129.073 2.949 . . . . 0.0 109.662 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -50.75 -48.9 59.01 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.275 2.23 . . . . 0.0 115.213 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.13 -31.47 59.58 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.0 t -75.12 -24.53 58.06 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.778 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -49.63 77.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 121.635 -0.665 . . . . 0.0 111.865 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.8 -42.87 97.61 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 122.559 1.171 . . . . 0.0 111.148 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.0 t -63.2 -44.01 96.56 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 125.371 1.469 . . . . 0.0 108.899 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.61 -45.93 90.62 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 122.965 0.506 . . . . 0.0 110.557 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -75.95 -23.69 55.42 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -81.57 -21.08 38.67 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.62 38.39 2.23 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 164.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.51 134.72 12.11 Favored Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 103.315 -3.914 . . . . 0.0 103.315 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.3 p -102.83 4.95 38.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.859 0.838 . . . . 0.0 109.499 -166.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.8 m -160.38 164.63 32.26 Favored 'General case' 0 CA--C 1.478 -1.804 1 N-CA-C 97.99 -4.819 . . . . 0.0 97.99 167.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.34 171.75 36.62 Favored Glycine 0 N--CA 1.414 -2.821 1 N-CA-C 99.261 -5.536 . . . . 0.0 99.261 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -160.92 -167.65 1.88 Allowed 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 96.609 -5.33 . . . . 0.0 96.609 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.5 m -154.75 176.1 12.88 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 97.487 -5.005 . . . . 0.0 97.487 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.99 -169.0 41.21 Favored Glycine 0 N--CA 1.42 -2.406 1 N-CA-C 96.805 -6.518 . . . . 0.0 96.805 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.84 173.48 6.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 101.702 -3.444 . . . . 0.0 101.702 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -157.31 163.04 39.11 Favored 'General case' 0 N--CA 1.42 -1.967 1 N-CA-C 95.81 -5.626 . . . . 0.0 95.81 176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.31 158.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 1 N-CA-C 97.607 -4.961 . . . . 0.0 97.607 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 -43.89 1.6 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 105.141 -3.184 . . . . 0.0 105.141 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -118.61 -83.41 0.65 Allowed 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.85 -148.69 18.09 Favored Glycine 0 CA--C 1.478 -2.278 1 N-CA-C 99.384 -5.487 . . . . 0.0 99.384 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.95 131.33 48.32 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 126.597 1.959 . . . . 0.0 107.936 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.75 175.76 11.31 Favored 'General case' 0 CA--C 1.482 -1.646 1 N-CA-C 98.846 -4.501 . . . . 0.0 98.846 -162.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.67 168.4 15.09 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 28.1 t-105 -119.9 150.06 41.1 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.0 m -141.05 149.1 41.23 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 101.178 -3.638 . . . . 0.0 101.178 172.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.27 130.48 53.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 103.171 -2.9 . . . . 0.0 103.171 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.44 54.79 0.16 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.674 1.989 . . . . 0.0 110.998 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.26 132.8 32.95 Favored Pre-proline 0 CA--C 1.498 -1.046 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.18 172.46 13.0 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.436 2.091 . . . . 0.0 110.003 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.11 23.99 1.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.602 -0.686 . . . . 0.0 111.948 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.46 -7.48 28.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.23 143.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.78 146.41 17.94 Favored Glycine 0 CA--C 1.476 -2.368 1 N-CA-C 101.44 -4.664 . . . . 0.0 101.44 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.4 pt -142.31 -146.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 -165.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.859 HD13 ' HB2' ' A' ' 7' ' ' ALA . 14.5 mm -69.68 123.7 23.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.259 1.0 OUTLIER -135.93 22.26 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 102.495 -3.15 . . . . 0.0 102.495 -167.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.495 ' HA ' HD21 ' A' ' 11' ' ' ASN . 33.5 tt0 -65.92 127.41 31.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 127.331 2.252 . . . . 0.0 109.496 -175.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.64 -46.92 0.99 Allowed Glycine 0 N--CA 1.433 -1.524 1 N-CA-C 98.318 -5.913 . . . . 0.0 98.318 -150.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.527 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 13.5 tp10 -95.26 -153.3 0.39 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 157.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 41.7 tptt -149.98 -170.73 3.72 Favored 'General case' 0 N--CA 1.434 -1.252 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 -178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 64' ' ' LYS . 41.8 t -59.0 128.47 37.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.675 2.39 . . . . 0.0 111.966 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.331 91.4 m-70 66.76 -147.31 0.17 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 127.965 2.506 . . . . 0.0 111.913 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -77.95 58.92 2.03 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 124.09 0.956 . . . . 0.0 111.736 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.081 0 CA-C-N 116.366 -0.379 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.537 0.684 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 171.68 8.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -136.11 140.26 43.58 Favored 'General case' 0 CA--C 1.488 -1.44 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -177.31 34.78 Favored Glycine 0 CA--C 1.475 -2.419 0 N-CA-C 103.187 -3.965 . . . . 0.0 103.187 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -79.27 134.25 36.64 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 102.04 -3.319 . . . . 0.0 102.04 157.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.5 tt -90.16 133.83 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 -176.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.5 -147.94 0.36 Allowed 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 111.057 -2.792 . . . . 0.0 108.978 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -138.09 148.76 61.35 Favored Pre-proline 0 N--CA 1.42 -1.937 1 N-CA-C 94.691 -6.04 . . . . 0.0 94.691 170.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -76.01 151.77 35.46 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 122.052 1.769 . . . . 0.0 108.428 -169.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -100.16 -12.18 19.82 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 127.446 2.299 . . . . 0.0 108.204 9.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -160.96 141.89 11.57 Favored 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 95.647 -5.686 . . . . 0.0 95.647 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.05 -159.79 0.02 OUTLIER 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.519 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -128.14 165.09 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 N-CA-C 98.597 -4.594 . . . . 0.0 98.597 160.98 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 -157.44 0.46 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 161.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -138.97 -177.86 5.08 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 98.673 -4.566 . . . . 0.0 98.673 168.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 t -146.44 163.54 35.34 Favored 'General case' 0 N--CA 1.419 -1.999 1 N-CA-C 95.913 -5.588 . . . . 0.0 95.913 -175.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -119.28 119.26 31.97 Favored Pre-proline 0 N--CA 1.421 -1.883 1 N-CA-C 98.584 -4.599 . . . . 0.0 98.584 172.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -57.37 111.49 0.83 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.905 2.403 . . . . 0.0 113.14 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.6 -37.87 1.25 Allowed Glycine 0 CA--C 1.49 -1.506 1 N-CA-C 101.148 -4.781 . . . . 0.0 101.148 -162.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m 86.09 -5.43 0.79 Allowed 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 125.678 1.591 . . . . 0.0 112.242 158.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -61.79 -42.38 98.93 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.156 1.782 . . . . 0.0 112.531 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.22 -31.97 63.26 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -71.57 -50.04 34.89 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.96 -38.12 89.81 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 118.766 0.712 . . . . 0.0 110.602 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.5 m -59.58 -50.04 75.44 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 121.367 -0.833 . . . . 0.0 111.674 173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.82 -43.96 91.39 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.452 0.701 . . . . 0.0 109.861 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.1 t -54.1 -46.41 72.09 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.391 1.076 . . . . 0.0 110.91 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -65.5 -49.15 70.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 123.483 0.713 . . . . 0.0 110.596 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.96 -20.22 61.77 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.774 -0.579 . . . . 0.0 112.56 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -87.66 -6.61 58.17 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 118.615 0.643 . . . . 0.0 110.24 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.63 27.82 9.43 Favored Glycine 0 CA--C 1.486 -1.729 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 165.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.32 146.74 18.34 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 p -75.57 -37.23 60.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.511 -0.993 . . . . 0.0 110.726 -164.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 m -160.88 -177.5 6.18 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.723 -4.918 . . . . 0.0 97.723 165.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.39 -176.72 41.34 Favored Glycine 0 N--CA 1.414 -2.805 1 N-CA-C 98.614 -5.794 . . . . 0.0 98.614 -173.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -163.57 180.0 6.84 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 97.015 -5.18 . . . . 0.0 97.015 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.2 m -103.52 165.41 11.05 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.5 171.42 39.98 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 97.923 -6.071 . . . . 0.0 97.923 173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -103.39 145.43 30.0 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -116.99 96.15 5.32 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.32 127.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -42.45 1.43 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -169.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -119.27 -68.68 0.9 Allowed 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.31 -160.36 33.98 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 -172.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -69.64 136.51 51.25 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 -173.94 3.82 Favored 'General case' 0 CA--C 1.492 -1.276 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.6 t -121.35 158.77 27.53 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 101.166 -3.642 . . . . 0.0 101.166 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -120.57 153.06 37.28 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -146.87 155.38 42.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -118.76 143.94 46.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 166.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.24 56.96 0.11 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 127.237 2.215 . . . . 0.0 111.197 168.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -96.23 133.37 25.11 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -71.84 174.94 10.38 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 122.206 1.824 . . . . 0.0 111.43 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -81.32 16.34 1.66 Allowed 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -98.34 -5.27 33.2 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.87 169.68 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.35 160.23 27.84 Favored Glycine 0 CA--C 1.48 -2.106 1 N-CA-C 99.414 -5.475 . . . . 0.0 99.414 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 pt -144.88 -164.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 -163.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -70.89 128.54 34.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.44 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 62.24 -124.15 0.72 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.402 1.881 . . . . 0.0 108.569 -171.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.84 42.13 0.32 Allowed Glycine 0 CA--C 1.486 -1.775 1 N-CA-C 102.216 -4.353 . . . . 0.0 102.216 169.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -85.64 -51.82 6.22 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.487 0.715 . . . . 0.0 109.499 -168.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -163.23 -168.64 1.77 Allowed 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 101.35 -3.574 . . . . 0.0 101.35 -171.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.4 t -119.26 148.93 42.58 Favored 'General case' 0 N--CA 1.429 -1.477 1 N-CA-C 96.887 -5.227 . . . . 0.0 96.887 171.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -141.36 103.52 4.43 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 99.93 -4.1 . . . . 0.0 99.93 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 m -65.0 128.26 35.0 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.331 1.052 . . . . 0.0 110.263 -172.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.362 1.125 0 O-C-N 123.115 0.26 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.002 0.429 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.97 162.67 12.84 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -132.08 130.45 41.28 Favored 'General case' 0 CA--C 1.489 -1.375 1 N-CA-C 95.077 -5.897 . . . . 0.0 95.077 156.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.95 -169.16 24.89 Favored Glycine 0 CA--C 1.477 -2.306 0 N-CA-C 104.025 -3.63 . . . . 0.0 104.025 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.28 140.26 30.97 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 159.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.71 150.3 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -155.23 174.74 14.79 Favored 'General case' 0 N--CA 1.415 -2.221 1 N-CA-C 98.535 -4.617 . . . . 0.0 98.535 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -85.67 158.54 56.7 Favored Pre-proline 0 N--CA 1.432 -1.352 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -175.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 34.7 Cg_exo -64.54 113.46 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.019 2.479 . . . . 0.0 110.785 164.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.7 mm-40 -126.64 114.04 17.51 Favored 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 127.45 2.3 . . . . 0.0 106.636 1.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.543 HD21 ' HA ' ' A' ' 61' ' ' GLU . 61.4 t30 80.63 31.99 0.16 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 124.582 1.153 . . . . 0.0 109.126 156.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -123.04 123.03 39.95 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 102.542 -3.133 . . . . 0.0 102.542 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.82 158.26 6.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 CA-C-N 120.106 1.321 . . . . 0.0 114.028 -159.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.96 135.9 42.74 Favored 'General case' 0 CA--C 1.483 -1.604 1 N-CA-C 97.291 -5.077 . . . . 0.0 97.291 178.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -90.96 165.9 13.31 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -164.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -151.8 175.95 11.92 Favored 'General case' 0 N--CA 1.406 -2.647 1 N-CA-C 94.815 -5.994 . . . . 0.0 94.815 -170.202 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -149.43 176.56 2.2 Favored Pre-proline 0 N--CA 1.408 -2.573 1 N-CA-C 95.026 -5.916 . . . . 0.0 95.026 -175.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.46 55.0 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.122 2.865 . . . . 0.0 110.607 161.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.96 150.43 11.77 Favored Glycine 0 CA--C 1.481 -2.032 1 N-CA-C 99.391 -5.484 . . . . 0.0 99.391 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m -106.91 15.09 25.8 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 117.533 0.667 . . . . 0.0 111.239 -161.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -62.11 -61.0 2.78 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 124.934 1.293 . . . . 0.0 111.759 -166.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.56 -41.14 77.04 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 t -57.89 -58.41 8.51 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 124.585 1.154 . . . . 0.0 111.288 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.63 -33.57 75.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 123.066 0.546 . . . . 0.0 109.806 -171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.0 m -61.2 -50.02 74.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.402 0.681 . . . . 0.0 110.869 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.45 -37.5 68.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.643 0.777 . . . . 0.0 110.04 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.1 t -57.26 -46.26 83.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.225 1.01 . . . . 0.0 110.112 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -62.28 -49.2 76.63 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 123.133 0.573 . . . . 0.0 110.995 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.28 -21.07 60.68 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.527 -0.733 . . . . 0.0 112.687 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -94.28 3.04 55.76 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.793 -0.567 . . . . 0.0 110.083 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.96 33.06 7.54 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 161.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.91 147.22 18.53 Favored Glycine 0 CA--C 1.491 -1.436 0 N-CA-C 104.326 -3.51 . . . . 0.0 104.326 167.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -78.37 -37.14 44.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 117.99 0.895 . . . . 0.0 110.277 -166.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 m -160.52 -179.64 7.82 Favored 'General case' 0 N--CA 1.426 -1.655 1 N-CA-C 99.06 -4.422 . . . . 0.0 99.06 169.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.59 178.7 43.76 Favored Glycine 0 N--CA 1.423 -2.23 1 N-CA-C 99.52 -5.432 . . . . 0.0 99.52 -169.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -167.19 -179.81 4.74 Favored 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 99.287 -4.338 . . . . 0.0 99.287 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.5 m -126.64 158.42 36.36 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.18 102.75 0.34 Allowed Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 105.015 -3.234 . . . . 0.0 105.015 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 174.07 5.31 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 97.749 -4.908 . . . . 0.0 97.749 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.07 26.04 0.01 OUTLIER 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 165.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.76 132.41 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -160.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.28 -95.44 2.1 Favored Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 166.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -83.58 -51.43 7.32 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.86 -175.47 46.43 Favored Glycine 0 N--CA 1.42 -2.432 1 N-CA-C 97.694 -6.162 . . . . 0.0 97.694 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.377 0.2 OUTLIER -76.64 143.17 40.32 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.977 0.388 . . . . 0.0 110.755 173.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.0 9.06 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 101.956 -3.35 . . . . 0.0 101.956 -163.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.48 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 1.9 t -113.2 153.59 28.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 103.757 -2.682 . . . . 0.0 103.757 -170.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -97.64 155.65 16.89 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -146.72 148.85 32.41 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.03 142.62 46.73 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 101.883 -3.376 . . . . 0.0 101.883 171.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.19 59.21 1.07 Allowed 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.356 2.262 . . . . 0.0 112.11 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.6 mt -93.55 133.34 28.32 Favored Pre-proline 0 CA--C 1.495 -1.163 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.92 170.9 15.68 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.403 2.069 . . . . 0.0 110.611 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.86 32.59 0.59 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.726 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -112.19 -3.37 14.66 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.43 162.66 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 -175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -139.52 150.71 21.53 Favored Glycine 0 CA--C 1.481 -2.038 1 N-CA-C 98.552 -5.819 . . . . 0.0 98.552 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.6 pt -150.55 -150.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 -159.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.787 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.6 mm -69.04 128.02 31.84 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.92 18.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -170.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.543 ' HA ' HD21 ' A' ' 11' ' ' ASN . 78.0 tt0 -62.5 133.2 54.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 125.585 1.554 . . . . 0.0 112.184 -168.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.73 -46.42 0.77 Allowed Glycine 0 N--CA 1.432 -1.6 1 N-CA-C 98.69 -5.764 . . . . 0.0 98.69 -157.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -94.4 -149.32 0.28 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 154.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -149.85 -172.98 4.29 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 101.277 -3.601 . . . . 0.0 101.277 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.2 135.7 55.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.909 1.684 . . . . 0.0 109.077 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -157.52 174.34 15.52 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.2 m -67.78 122.55 18.35 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 124.964 1.306 . . . . 0.0 107.993 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 122.989 0.18 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 167.69 21.58 Favored 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 164.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -127.99 132.04 49.2 Favored 'General case' 0 CA--C 1.48 -1.731 1 N-CA-C 94.017 -6.29 . . . . 0.0 94.017 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.77 36.11 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 105.551 -3.019 . . . . 0.0 105.551 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.46 134.15 40.92 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.8 tt -91.39 148.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -160.22 -176.88 5.89 Favored 'General case' 0 N--CA 1.413 -2.294 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 -173.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -101.74 168.31 9.26 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 41.1 Cg_exo -61.33 130.33 31.66 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.37 2.046 . . . . 0.0 110.395 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 43.6 mt-10 -128.47 117.98 22.28 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 -7.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 70.91 19.54 5.71 Favored 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.385 1.074 . . . . 0.0 109.837 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.3 m -103.63 91.77 4.16 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 7' ' ' ALA 0.287 27.2 m -59.4 154.86 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -165.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.56 175.58 5.43 Favored 'General case' 0 N--CA 1.421 -1.903 1 N-CA-C 98.175 -4.75 . . . . 0.0 98.175 175.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -136.39 152.81 51.02 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 97.128 -5.138 . . . . 0.0 97.128 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.05 175.58 6.06 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.32 119.45 33.14 Favored Pre-proline 0 N--CA 1.426 -1.654 1 N-CA-C 97.852 -4.87 . . . . 0.0 97.852 173.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.47 101.24 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.819 2.346 . . . . 0.0 111.497 -170.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.89 -44.92 0.51 Allowed Glycine 0 CA--C 1.481 -2.092 1 N-CA-C 102.504 -4.238 . . . . 0.0 102.504 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m 121.75 -48.48 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 129.006 2.922 . . . . 0.0 107.299 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -39.94 -45.41 1.86 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.068 2.947 . . . . 0.0 118.097 -155.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.76 -41.57 49.46 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 121.235 -0.916 . . . . 0.0 111.33 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 t -82.92 -25.73 32.12 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.81 -29.16 69.02 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 123.742 0.817 . . . . 0.0 110.396 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.7 m -70.52 -43.44 69.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.119 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.73 -39.91 95.55 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 122.075 0.941 . . . . 0.0 109.9 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -54.14 -45.68 72.05 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.531 1.132 . . . . 0.0 110.743 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -61.7 -48.97 78.36 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.31 -18.87 59.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.49 -22.7 24.74 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.634 0.652 . . . . 0.0 109.756 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.9 28.13 3.51 Favored Glycine 0 CA--C 1.494 -1.256 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 167.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.44 121.96 7.18 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.04 -2.824 . . . . 0.0 106.04 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 p -93.59 1.57 56.64 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 122.046 0.927 . . . . 0.0 109.959 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -160.19 160.69 33.12 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 98.121 -4.77 . . . . 0.0 98.121 169.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.83 178.57 46.55 Favored Glycine 0 CA--C 1.481 -2.089 1 N-CA-C 101.318 -4.713 . . . . 0.0 101.318 -171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -166.71 179.95 5.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.663 -3.829 . . . . 0.0 100.663 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.9 m -93.87 173.81 7.48 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.25 -172.72 31.08 Favored Glycine 0 CA--C 1.482 -2.019 1 N-CA-C 98.32 -5.912 . . . . 0.0 98.32 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -127.65 149.21 50.3 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.21 -4.367 . . . . 0.0 99.21 170.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -126.72 101.2 6.52 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -69.44 120.04 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.59 -42.03 1.38 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -118.05 -64.51 1.28 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.43 -138.09 5.9 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 105.254 -3.138 . . . . 0.0 105.254 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.3 tp -81.23 133.41 35.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.8 162.83 37.08 Favored 'General case' 0 N--CA 1.433 -1.288 1 N-CA-C 97.975 -4.824 . . . . 0.0 97.975 -170.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 m -113.02 -176.49 2.91 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 121.162 1.801 . . . . 0.0 106.494 -169.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -126.47 147.88 49.75 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.8 m -141.86 142.18 33.11 Favored 'General case' 0 N--CA 1.433 -1.278 1 N-CA-C 100.096 -4.039 . . . . 0.0 100.096 170.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.1 22.35 16.07 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -165.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.01 153.8 2.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 94.542 -6.095 . . . . 0.0 94.542 173.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HG ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -150.22 154.14 35.95 Favored Pre-proline 0 N--CA 1.427 -1.602 1 N-CA-C 96.024 -5.547 . . . . 0.0 96.024 152.102 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.09 166.3 30.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 CA-C-N 122.156 1.806 . . . . 0.0 109.165 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.64 -10.92 56.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -86.09 -1.34 57.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.517 0.727 . . . . 0.0 110.082 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG11 ' HG ' ' A' ' 52' ' ' LEU . 6.0 t -100.28 142.52 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.13 13.25 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 99.65 -5.38 . . . . 0.0 99.65 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.401 HG21 HD23 ' A' ' 52' ' ' LEU . 15.1 pt -130.09 -129.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 -163.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 7' ' ' ALA . 6.1 mm -72.89 118.78 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 166.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.9 t -128.39 112.18 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 -166.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 73.48 -178.3 0.19 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 128.037 2.535 . . . . 0.0 109.544 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.12 0.25 Allowed Glycine 0 CA--C 1.486 -1.777 1 N-CA-C 100.983 -4.847 . . . . 0.0 100.983 169.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -137.37 -124.14 0.14 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 101.408 -3.553 . . . . 0.0 101.408 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -157.16 -174.97 5.16 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 97.835 -4.876 . . . . 0.0 97.835 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.38 123.37 19.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 126.044 1.738 . . . . 0.0 107.61 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -144.02 179.88 6.92 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -171.27 172.29 5.32 Favored 'General case' 0 N--CA 1.428 -1.544 1 N-CA-C 96.226 -5.472 . . . . 0.0 96.226 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.032 0 CA-C-N 119.345 0.975 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.08 162.71 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -128.6 134.16 48.51 Favored 'General case' 0 CA--C 1.487 -1.463 1 N-CA-C 94.955 -5.943 . . . . 0.0 94.955 165.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.19 -175.14 32.9 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 105.576 -3.009 . . . . 0.0 105.576 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -76.06 132.89 40.38 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.2 tt -90.8 137.17 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.52 -150.52 0.42 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.64 -2.527 . . . . 0.0 108.872 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -135.1 152.35 76.92 Favored Pre-proline 0 N--CA 1.421 -1.902 1 N-CA-C 94.612 -6.07 . . . . 0.0 94.612 161.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -67.41 157.55 61.21 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 CA-C-N 123.391 2.247 . . . . 0.0 108.439 170.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.74 -25.12 17.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 128.153 2.581 . . . . 0.0 110.278 5.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.76 106.1 2.25 Favored 'General case' 0 N--CA 1.434 -1.241 1 N-CA-C 99.612 -4.218 . . . . 0.0 99.612 -173.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -163.06 -168.23 1.69 Allowed 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 120.092 1.315 . . . . 0.0 107.648 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -129.18 164.6 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 160.536 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 -164.59 1.01 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -135.9 167.92 20.3 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 96.314 -5.439 . . . . 0.0 96.314 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.42 156.41 48.59 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 98.231 -4.729 . . . . 0.0 98.231 -167.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -114.05 116.15 45.01 Favored Pre-proline 0 N--CA 1.424 -1.752 1 N-CA-C 96.304 -5.443 . . . . 0.0 96.304 164.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -63.59 102.41 0.35 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 125.025 2.83 . . . . 0.0 114.788 -172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.98 -172.47 45.47 Favored Glycine 0 N--CA 1.418 -2.507 1 N-CA-C 96.184 -6.767 . . . . 0.0 96.184 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -38.24 23.86 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 118.437 1.119 . . . . 0.0 108.675 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.51 -60.02 2.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.337 2.655 . . . . 0.0 116.124 -165.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.56 -54.37 10.51 Favored Glycine 0 CA--C 1.489 -1.552 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -166.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 74.4 m -64.29 -47.52 79.17 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 122.292 -0.534 . . . . 0.0 110.971 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -64.69 -40.98 96.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.8 m -64.8 -44.62 89.34 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.492 -0.755 . . . . 0.0 111.035 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.88 -38.53 91.27 Favored 'General case' 0 C--N 1.358 0.964 0 CA-C-O 122.342 1.068 . . . . 0.0 109.985 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -58.93 -50.24 74.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.512 1.125 . . . . 0.0 110.572 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -68.76 -35.8 77.55 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.12 -29.29 54.7 Favored 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.264 -0.897 . . . . 0.0 111.806 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -77.29 -35.06 55.38 Favored 'General case' 0 C--N 1.36 1.055 0 CA-C-N 118.739 0.7 . . . . 0.0 109.419 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.61 43.32 0.82 Allowed Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.07 157.09 21.0 Favored Glycine 0 CA--C 1.484 -1.897 1 N-CA-C 102.263 -4.335 . . . . 0.0 102.263 159.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.8 m -81.3 -38.05 27.4 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -168.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.2 m -160.5 168.79 24.33 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 99.929 -4.1 . . . . 0.0 99.929 175.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.11 178.55 45.92 Favored Glycine 0 N--CA 1.421 -2.355 1 N-CA-C 99.969 -5.252 . . . . 0.0 99.969 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -169.66 -175.49 2.15 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -171.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.9 t -82.89 145.98 29.12 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.84 167.96 38.84 Favored Glycine 0 N--CA 1.419 -2.486 1 N-CA-C 99.18 -5.568 . . . . 0.0 99.18 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -164.37 -168.04 1.44 Allowed 'General case' 0 N--CA 1.42 -1.971 1 N-CA-C 95.997 -5.557 . . . . 0.0 95.997 170.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 99.59 61.4 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 131.324 3.85 . . . . 0.0 102.244 -167.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.7 t -141.41 166.95 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 1 N-CA-C 99.627 -4.212 . . . . 0.0 99.627 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.32 80.23 0.27 Allowed Glycine 0 CA--C 1.487 -1.657 0 N-CA-C 105.54 -3.024 . . . . 0.0 105.54 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.413 ' CD2' HG13 ' A' ' 13' ' ' VAL . 36.8 m-70 -173.34 -145.16 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.378 1 N-CA-C 94.47 -6.122 . . . . 0.0 94.47 -177.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.86 120.15 1.87 Allowed Glycine 0 CA--C 1.484 -1.902 1 N-CA-C 101.349 -4.701 . . . . 0.0 101.349 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tp 73.88 175.53 0.26 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.608 1.963 . . . . 0.0 108.962 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.79 -173.78 0.42 Allowed 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 98.183 -4.747 . . . . 0.0 98.183 171.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.3 m -125.83 176.48 6.92 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 100.499 -3.889 . . . . 0.0 100.499 159.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -113.94 152.52 30.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.4 m -145.63 149.94 35.43 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -116.47 137.73 51.94 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.25 61.05 0.23 Allowed 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.345 2.258 . . . . 0.0 110.517 168.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.3 mt -98.36 131.0 26.99 Favored Pre-proline 0 CA--C 1.5 -0.979 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.61 178.02 8.09 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.986 2.457 . . . . 0.0 110.714 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -74.61 -1.54 22.07 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -89.81 -1.22 57.94 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 120.937 -1.102 . . . . 0.0 109.761 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.93 170.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.98 152.01 24.11 Favored Glycine 0 CA--C 1.478 -2.269 1 N-CA-C 97.719 -6.152 . . . . 0.0 97.719 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.46 -149.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 10.8 mm -68.28 134.98 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.15 158.16 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 1 N-CA-C 93.188 -6.597 . . . . 0.0 93.188 169.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -148.89 158.69 44.36 Favored 'General case' 0 CA--C 1.477 -1.839 1 N-CA-C 96.606 -5.331 . . . . 0.0 96.606 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.19 -39.63 1.11 Allowed Glycine 0 CA--C 1.485 -1.817 1 N-CA-C 102.255 -4.338 . . . . 0.0 102.255 -163.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -104.29 -98.63 0.31 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -174.01 -161.66 0.13 Allowed 'General case' 0 N--CA 1.427 -1.583 1 N-CA-C 95.391 -5.781 . . . . 0.0 95.391 -169.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 10.4 t -79.89 119.58 22.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 103.908 -2.626 . . . . 0.0 103.908 162.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -75.13 174.12 9.85 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.557 1.17 . . . . 0.0 110.574 -167.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.7 m -170.81 -179.4 2.83 Favored 'General case' 0 N--CA 1.421 -1.891 1 N-CA-C 95.778 -5.638 . . . . 0.0 95.778 173.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.928 0 O-C-N 124.438 1.086 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.031 0.443 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.67 169.3 9.08 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -128.2 144.38 51.12 Favored 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 94.587 -6.079 . . . . 0.0 94.587 166.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 178.06 37.52 Favored Glycine 0 CA--C 1.475 -2.409 0 N-CA-C 105.78 -2.928 . . . . 0.0 105.78 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -81.7 129.91 34.88 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 159.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 14.6 tt -90.52 140.16 16.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.48 -149.76 0.42 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 127.097 2.159 . . . . 0.0 108.285 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.59 165.58 24.22 Favored Pre-proline 0 N--CA 1.418 -2.07 1 N-CA-C 95.229 -5.841 . . . . 0.0 95.229 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.01 152.17 83.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.22 1.947 . . . . 0.0 108.706 167.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -88.27 -51.76 5.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.21 2.204 . . . . 0.0 108.095 1.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.84 121.85 14.6 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 89.567 -7.938 . . . . 0.0 89.567 -176.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 17.8 m -163.57 -166.32 1.19 Allowed 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 102.252 -3.24 . . . . 0.0 102.252 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.07 166.03 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 97.796 -4.89 . . . . 0.0 97.796 160.96 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -161.62 0.66 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 162.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -137.76 167.36 21.87 Favored 'General case' 0 CA--C 1.484 -1.581 1 N-CA-C 97.257 -5.09 . . . . 0.0 97.257 164.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.3 t -108.42 163.58 13.09 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -110.29 106.0 57.64 Favored Pre-proline 0 N--CA 1.427 -1.606 1 N-CA-C 97.712 -4.921 . . . . 0.0 97.712 162.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -53.14 104.62 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 124.045 2.48 . . . . 0.0 118.245 -161.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.01 -162.64 33.77 Favored Glycine 0 N--CA 1.423 -2.193 1 N-CA-C 97.569 -6.212 . . . . 0.0 97.569 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 4.6 p -88.86 -34.03 17.14 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -39.47 -59.64 1.06 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 128.568 2.747 . . . . 0.0 116.643 -160.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -53.65 11.08 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 87.9 m -60.71 -43.04 98.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 122.115 -0.638 . . . . 0.0 111.621 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.45 -44.5 97.0 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 123.818 0.847 . . . . 0.0 109.988 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.8 m -63.09 -43.88 97.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 121.395 -0.815 . . . . 0.0 110.515 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.5 mt -66.08 -40.61 90.97 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 122.422 1.106 . . . . 0.0 110.215 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -63.31 -44.39 95.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 124.817 1.247 . . . . 0.0 109.658 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -74.98 -28.79 60.69 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -78.39 -24.33 46.38 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.971 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -78.0 -58.18 3.4 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.82 45.52 0.07 OUTLIER Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.85 159.07 14.15 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 104.215 -3.554 . . . . 0.0 104.215 166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.3 m -91.97 -31.14 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.653 0.74 . . . . 0.0 109.757 -161.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -146.22 154.78 42.13 Favored 'General case' 0 CA--C 1.476 -1.896 1 N-CA-C 99.837 -4.134 . . . . 0.0 99.837 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.97 155.69 26.57 Favored Glycine 0 N--CA 1.417 -2.591 1 N-CA-C 98.427 -5.869 . . . . 0.0 98.427 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 18.0 p-80 -166.51 -172.99 2.34 Favored 'General case' 0 N--CA 1.424 -1.736 1 N-CA-C 96.863 -5.236 . . . . 0.0 96.863 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' SG ' ' HA ' ' A' ' 18' ' ' PRO . 28.2 m -72.86 179.57 3.63 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 122.699 1.237 . . . . 0.0 110.817 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.24 174.08 39.48 Favored Glycine 0 N--CA 1.41 -3.07 1 N-CA-C 98.17 -5.972 . . . . 0.0 98.17 168.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -137.45 132.74 33.82 Favored 'General case' 0 N--CA 1.427 -1.584 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 172.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -117.23 105.28 12.04 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.98 125.18 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.35 -32.07 3.47 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 105.79 -2.924 . . . . 0.0 105.79 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -124.35 -67.55 0.91 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.6 -148.92 19.49 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.295 -3.122 . . . . 0.0 105.295 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 tp -58.87 143.76 46.61 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.648 2.379 . . . . 0.0 107.942 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.11 -172.66 4.18 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 103.1 -2.926 . . . . 0.0 103.1 -170.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.6 m -117.46 170.81 8.43 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.936 -3.727 . . . . 0.0 100.936 165.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.8 t-105 -124.32 156.83 36.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.2 m -145.03 147.54 32.72 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -113.6 136.73 52.5 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.55 69.73 0.46 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.358 2.663 . . . . 0.0 111.644 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.7 mt -105.06 139.11 19.79 Favored Pre-proline 0 CA--C 1.503 -0.837 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -68.52 167.44 22.59 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.657 2.238 . . . . 0.0 111.596 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -67.49 -21.0 65.53 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.342 1.057 . . . . 0.0 113.742 -167.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -84.02 2.37 39.38 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 110.847 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 t -97.29 125.89 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 104.432 -2.432 . . . . 0.0 104.432 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.36 152.27 20.15 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 105.842 -2.903 . . . . 0.0 105.842 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.1 pt -140.46 -147.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 -166.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.2 mm -72.71 135.5 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.107 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.4 t -136.06 149.04 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.349 1 N-CA-C 93.569 -6.456 . . . . 0.0 93.569 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 46.26 -117.18 0.69 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.615 1.966 . . . . 0.0 112.422 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.88 48.82 0.01 OUTLIER Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -86.46 -60.04 2.11 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -166.89 -171.68 1.88 Allowed 'General case' 0 N--CA 1.424 -1.734 1 N-CA-C 99.14 -4.392 . . . . 0.0 99.14 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 15.6 t -107.18 119.75 40.25 Favored 'General case' 0 N--CA 1.426 -1.656 1 N-CA-C 99.165 -4.383 . . . . 0.0 99.165 165.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.256 83.7 m-70 78.55 -164.45 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 128.183 2.593 . . . . 0.0 108.189 -170.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 p -87.42 107.78 18.7 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -170.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.048 0 O-C-N 123.533 0.52 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.3 0.571 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.4 171.29 7.57 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 173.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -131.71 144.14 50.77 Favored 'General case' 0 CA--C 1.485 -1.549 1 N-CA-C 95.694 -5.669 . . . . 0.0 95.694 165.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.71 -179.78 36.6 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 105.709 -2.956 . . . . 0.0 105.709 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.37 133.41 35.91 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -90.37 135.17 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.21 -150.0 0.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 111.328 -2.669 . . . . 0.0 107.026 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' A' ' 12' ' ' CYS . 9.2 pt20 -142.14 164.36 34.16 Favored Pre-proline 0 N--CA 1.42 -1.926 1 N-CA-C 96.017 -5.549 . . . . 0.0 96.017 169.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -66.97 149.27 82.88 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 CA-C-N 122.4 1.893 . . . . 0.0 109.698 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -81.86 -22.72 36.78 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.491 2.316 . . . . 0.0 107.844 -1.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -177.49 155.53 1.09 Allowed 'General case' 0 N--CA 1.415 -2.212 1 N-CA-C 94.094 -6.261 . . . . 0.0 94.094 -171.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 73.2 m 161.22 -149.33 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.116 1 N-CA-C 97.971 -4.825 . . . . 0.0 97.971 176.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -117.57 164.7 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 1 N-CA-C 98.802 -4.518 . . . . 0.0 98.802 160.646 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -155.46 0.24 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 161.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -134.82 -179.5 5.65 Favored 'General case' 0 CA--C 1.482 -1.641 1 N-CA-C 98.919 -4.474 . . . . 0.0 98.919 164.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.2 t -139.1 174.01 10.96 Favored 'General case' 0 N--CA 1.416 -2.127 1 N-CA-C 96.817 -5.253 . . . . 0.0 96.817 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -128.04 132.67 24.47 Favored Pre-proline 0 N--CA 1.416 -2.174 1 N-CA-C 97.639 -4.948 . . . . 0.0 97.639 173.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -55.38 118.37 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.109 2.54 . . . . 0.0 112.773 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.81 -44.16 1.21 Allowed Glycine 0 CA--C 1.493 -1.298 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -167.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 25.4 m 91.87 -13.78 0.2 Allowed 'General case' 0 CA--C 1.495 -1.168 0 C-N-CA 127.784 2.434 . . . . 0.0 112.917 175.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -47.14 -48.28 23.34 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.54 -28.89 56.67 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 111.241 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.21 -45.47 60.15 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.25 -47.49 78.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.854 1.262 . . . . 0.0 109.163 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 m -59.78 -45.67 91.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.606 0.762 . . . . 0.0 112.07 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.4 mt -66.65 -40.13 88.53 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.887 -1.133 . . . . 0.0 110.54 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -57.29 -43.45 83.18 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.648 1.179 . . . . 0.0 110.779 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -59.37 -53.31 59.67 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.35 0.66 . . . . 0.0 110.679 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.31 -16.97 61.36 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 121.675 -0.64 . . . . 0.0 112.622 -172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -91.22 -5.2 55.19 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.794 -0.566 . . . . 0.0 109.895 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.18 27.92 7.95 Favored Glycine 0 CA--C 1.49 -1.5 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.036 166.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.9 146.29 17.42 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.1 p -78.87 -27.93 44.08 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.318 -1.107 . . . . 0.0 111.06 -169.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 m -161.07 174.73 13.3 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 99.674 -4.195 . . . . 0.0 99.674 166.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.06 172.56 43.91 Favored Glycine 0 N--CA 1.423 -2.222 1 N-CA-C 98.82 -5.712 . . . . 0.0 98.82 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -159.63 174.76 14.09 Favored 'General case' 0 CA--C 1.491 -1.3 1 N-CA-C 99.521 -4.252 . . . . 0.0 99.521 -173.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.8 m -71.82 163.4 27.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-N 119.818 1.19 . . . . 0.0 110.429 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.25 171.81 37.35 Favored Glycine 0 N--CA 1.424 -2.139 1 N-CA-C 99.568 -5.413 . . . . 0.0 99.568 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -120.79 134.59 55.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 101.496 -3.52 . . . . 0.0 101.496 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -110.85 106.42 15.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.34 131.8 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.4 -21.87 10.51 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.417 ' HE1' ' O ' ' A' ' 64' ' ' LYS . 9.6 m170 -132.07 -74.02 0.51 Allowed 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.34 -160.62 34.0 Favored Glycine 0 N--CA 1.427 -1.967 0 N-CA-C 105.675 -2.97 . . . . 0.0 105.675 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.68 135.54 57.66 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 127.253 2.221 . . . . 0.0 107.167 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.47 -173.45 3.77 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 -170.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.7 t -122.58 155.56 36.04 Favored 'General case' 0 CA--C 1.494 -1.181 1 N-CA-C 99.986 -4.079 . . . . 0.0 99.986 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -114.24 151.29 33.05 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 10.7 m -146.3 149.15 33.28 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -119.77 138.89 53.06 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 103.385 -2.82 . . . . 0.0 103.385 172.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.65 58.54 0.1 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 127.67 2.388 . . . . 0.0 111.473 171.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.2 mt -99.17 132.68 23.02 Favored Pre-proline 0 CA--C 1.501 -0.911 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -75.34 171.68 17.79 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.283 1.851 . . . . 0.0 110.965 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.76 -18.23 62.27 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.672 1.989 . . . . 0.0 114.753 -169.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -86.73 -5.72 59.04 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 123.278 0.631 . . . . 0.0 109.842 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.17 138.54 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.3 152.52 17.19 Favored Glycine 0 CA--C 1.481 -2.033 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 pt -131.37 -150.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.575 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -160.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 HD12 HG12 ' A' ' 13' ' ' VAL . 6.0 mm -76.39 113.49 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -176.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.79 95.57 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -81.01 141.2 34.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.14 -38.44 3.29 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -83.63 -29.67 27.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.917 0.887 . . . . 0.0 109.049 -175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' O ' ' HE1' ' A' ' 43' ' ' HIS 0.311 51.1 tttm 94.83 -117.31 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 125.095 1.358 . . . . 0.0 108.718 173.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 51.0 t -133.63 128.85 35.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 -174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 59.95 -142.73 0.56 Allowed 'General case' 0 CA--C 1.498 -1.058 0 C-N-CA 126.033 1.733 . . . . 0.0 110.135 -170.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -76.25 56.36 1.04 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.554 1.542 . . . . 0.0 110.995 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.053 0 CA-C-N 115.621 -0.718 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.86 165.87 26.14 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -134.17 130.07 36.74 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 94.465 -6.124 . . . . 0.0 94.465 166.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.99 -174.1 31.47 Favored Glycine 0 CA--C 1.471 -2.695 0 N-CA-C 103.278 -3.929 . . . . 0.0 103.278 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.94 134.91 37.79 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 163.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 47' ' ' CYS . 8.2 tt -90.9 143.56 10.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.25 -153.66 0.51 Allowed 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 126.842 2.057 . . . . 0.0 105.618 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.83 66.02 Favored Pre-proline 0 N--CA 1.424 -1.764 1 N-CA-C 94.199 -6.223 . . . . 0.0 94.199 165.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.16 150.57 59.94 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.277 1.984 . . . . 0.0 108.407 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -85.98 -35.59 20.32 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.914 1.686 . . . . 0.0 109.402 10.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -159.26 145.31 16.38 Favored 'General case' 0 N--CA 1.419 -2.02 1 N-CA-C 94.773 -6.01 . . . . 0.0 94.773 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.4 m 175.37 -155.3 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.433 1 N-CA-C 96.642 -5.318 . . . . 0.0 96.642 172.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.641 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -127.07 165.38 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 1 N-CA-C 96.913 -5.217 . . . . 0.0 96.913 161.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.78 -166.91 1.55 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 164.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -135.73 151.19 49.9 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 101.619 -3.474 . . . . 0.0 101.619 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.0 t -124.31 156.94 36.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -111.36 118.29 47.73 Favored Pre-proline 0 N--CA 1.42 -1.927 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -176.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 108.28 0.45 Allowed 'Trans proline' 0 CA--C 1.506 -0.914 0 C-N-CA 122.999 2.466 . . . . 0.0 111.892 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.78 0.54 Allowed Glycine 0 CA--C 1.482 -1.97 1 N-CA-C 100.374 -5.09 . . . . 0.0 100.374 -164.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.252 6.8 m 114.49 -35.79 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.127 2.971 . . . . 0.0 108.714 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -39.46 -52.06 2.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.999 2.519 . . . . 0.0 117.118 -157.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.62 -41.51 75.16 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 121.033 -1.042 . . . . 0.0 112.066 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -90.14 -21.76 22.07 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 120.934 -1.333 . . . . 0.0 109.176 -173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.6 -43.08 93.82 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 166.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.59 -47.21 87.2 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.572 -0.705 . . . . 0.0 110.763 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.3 mt -58.87 -43.97 90.98 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 123.676 0.79 . . . . 0.0 111.027 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.7 t -54.07 -47.51 71.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.997 1.319 . . . . 0.0 110.863 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -69.24 -40.62 77.79 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.48 0.312 . . . . 0.0 111.391 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.82 -25.32 48.75 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 118.01 0.368 . . . . 0.0 111.469 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -72.76 -54.37 9.08 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.76 49.03 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.75 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 167.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.66 136.75 13.82 Favored Glycine 0 CA--C 1.49 -1.515 1 N-CA-C 102.696 -4.162 . . . . 0.0 102.696 165.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -101.58 11.1 39.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.778 0.799 . . . . 0.0 110.098 -163.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.5 m -160.01 159.97 32.71 Favored 'General case' 0 CA--C 1.484 -1.582 1 N-CA-C 98.032 -4.803 . . . . 0.0 98.032 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.58 42.57 Favored Glycine 0 CA--C 1.479 -2.184 1 N-CA-C 99.672 -5.371 . . . . 0.0 99.672 -168.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -167.34 -167.26 0.88 Allowed 'General case' 0 N--CA 1.435 -1.195 1 N-CA-C 98.055 -4.794 . . . . 0.0 98.055 -174.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.9 m -99.19 177.25 5.27 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.22 179.73 42.86 Favored Glycine 0 N--CA 1.423 -2.207 1 N-CA-C 102.569 -4.213 . . . . 0.0 102.569 -175.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' LEU . 37.9 t80 -143.95 148.52 35.46 Favored 'General case' 0 CA--C 1.486 -1.505 1 N-CA-C 97.248 -5.093 . . . . 0.0 97.248 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -133.39 112.79 11.89 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 171.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.34 124.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 -172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.82 -31.56 3.89 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 104.702 -3.359 . . . . 0.0 104.702 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -113.47 -70.88 0.78 Allowed 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.3 -153.15 24.33 Favored Glycine 0 CA--C 1.487 -1.709 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 2.9 tt -72.39 144.38 48.22 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.3 -168.96 2.4 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.409 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.2 m -123.61 -179.87 4.52 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 165.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -130.78 152.98 49.53 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.9 m -148.25 150.89 34.5 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -117.33 140.58 49.38 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 170.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.53 0.82 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.331 2.253 . . . . 0.0 111.03 170.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -91.17 146.52 33.71 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 170.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -66.53 162.83 35.05 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.521 2.147 . . . . 0.0 111.001 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.64 -19.1 62.15 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 123.381 0.672 . . . . 0.0 112.449 -168.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -82.2 -1.26 48.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.865 1.266 . . . . 0.0 110.975 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.56 129.22 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.5 155.02 20.83 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.62 -154.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 -167.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD12 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -77.4 139.69 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.4 t -147.67 164.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 1 N-CA-C 95.266 -5.828 . . . . 0.0 95.266 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -158.39 157.49 32.42 Favored 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 96.812 -5.255 . . . . 0.0 96.812 166.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.88 -42.87 1.49 Allowed Glycine 0 CA--C 1.494 -1.243 1 N-CA-C 101.249 -4.741 . . . . 0.0 101.249 -163.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 12.2 tp10 -96.56 -147.79 0.3 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 155.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 25.8 tttp -167.79 -162.75 0.45 Allowed 'General case' 0 N--CA 1.425 -1.718 1 N-CA-C 96.216 -5.476 . . . . 0.0 96.216 176.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.8 127.49 31.68 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 127.0 2.12 . . . . 0.0 110.374 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -149.97 93.94 2.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.103 -3.666 . . . . 0.0 101.103 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.9 m -78.38 118.54 20.65 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.052 0 O-C-N 123.0 0.188 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -102.51 152.74 20.79 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 168.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -120.76 119.87 34.01 Favored 'General case' 0 CA--C 1.487 -1.473 1 N-CA-C 95.336 -5.801 . . . . 0.0 95.336 159.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.67 -177.88 35.12 Favored Glycine 0 CA--C 1.472 -2.607 1 N-CA-C 102.747 -4.141 . . . . 0.0 102.747 -171.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -85.79 144.36 27.79 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -90.76 148.32 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.809 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -164.14 1.48 Allowed 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -96.88 146.94 32.17 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 101.429 -3.545 . . . . 0.0 101.429 161.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 18.6 Cg_endo -64.91 113.39 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.176 2.584 . . . . 0.0 107.754 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.3 tt0 -142.96 162.54 35.2 Favored 'General case' 0 CA--C 1.473 -2.011 1 N-CA-C 99.407 -4.294 . . . . 0.0 99.407 5.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.492 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.1 OUTLIER 83.14 -5.51 1.24 Allowed 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 124.087 0.867 . . . . 0.0 110.922 162.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.1 m -90.65 -143.83 0.17 Allowed 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 125.366 1.466 . . . . 0.0 107.715 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.514 HG11 ' H ' ' A' ' 43' ' ' HIS . 34.8 m -141.75 -179.52 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 1 N-CA-C 98.366 -4.679 . . . . 0.0 98.366 160.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.7 156.28 39.58 Favored 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 94.494 -6.113 . . . . 0.0 94.494 162.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -96.0 123.14 39.48 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 t -94.36 143.3 26.52 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -111.82 121.22 40.31 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.94 120.6 8.49 Favored 'Trans proline' 0 CA--C 1.506 -0.901 0 CA-C-N 123.565 2.309 . . . . 0.0 111.454 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.73 -55.61 0.68 Allowed Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.819 -5.312 . . . . 0.0 99.819 -160.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 m 113.27 -27.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 129.676 3.19 . . . . 0.0 109.839 167.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.29 -49.65 2.74 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.673 2.389 . . . . 0.0 117.147 -160.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.2 -49.01 69.07 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 121.669 -0.644 . . . . 0.0 111.697 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.7 t -85.91 -23.9 26.83 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.621 -0.929 . . . . 0.0 110.026 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.82 -36.92 85.48 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.572 -0.705 . . . . 0.0 109.124 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.8 m -66.41 -41.04 89.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.125 -0.985 . . . . 0.0 109.947 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.83 -44.5 95.99 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.632 0.773 . . . . 0.0 109.833 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 t -52.6 -50.14 63.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.406 1.482 . . . . 0.0 110.272 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -60.73 -47.69 85.17 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 122.721 0.409 . . . . 0.0 112.04 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.09 -31.79 66.39 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.487 -0.758 . . . . 0.0 112.783 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -78.48 -25.23 45.68 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.788 0.722 . . . . 0.0 109.784 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.97 42.57 0.77 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 161.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.68 135.37 12.1 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 105.879 -2.888 . . . . 0.0 105.879 170.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -84.02 -16.14 45.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.648 0.779 . . . . 0.0 109.928 -166.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 t -158.8 169.98 23.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 170.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.99 175.39 46.64 Favored Glycine 0 N--CA 1.425 -2.046 1 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.3 p80 179.2 -176.45 0.26 Allowed 'General case' 0 N--CA 1.435 -1.193 1 N-CA-C 99.513 -4.255 . . . . 0.0 99.513 -175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.67 173.84 7.49 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.02 -171.05 40.99 Favored Glycine 0 CA--C 1.483 -1.953 1 N-CA-C 97.322 -6.311 . . . . 0.0 97.322 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.29 160.86 40.28 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 97.256 -5.09 . . . . 0.0 97.256 171.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -160.01 36.88 0.18 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.263 2.2 t 58.53 -143.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -157.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.92 -126.19 6.38 Favored Glycine 0 CA--C 1.48 -2.133 1 N-CA-C 99.548 -5.421 . . . . 0.0 99.548 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' H ' HG11 ' A' ' 13' ' ' VAL . 66.9 m80 -121.13 -20.32 6.83 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 125.611 1.565 . . . . 0.0 108.192 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.39 -173.89 45.78 Favored Glycine 0 N--CA 1.421 -2.318 1 N-CA-C 96.481 -6.647 . . . . 0.0 96.481 -165.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.03 102.07 10.75 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 118.271 1.035 . . . . 0.0 108.232 -168.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.99 -179.83 7.54 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 125.231 1.413 . . . . 0.0 109.005 -174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.06 155.64 39.47 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 -170.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -90.95 154.36 19.52 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.9 m -141.95 144.02 33.52 Favored 'General case' 0 CA--C 1.479 -1.783 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 161.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -112.5 121.93 46.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 103.196 -2.89 . . . . 0.0 103.196 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.17 75.94 0.16 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 126.424 1.89 . . . . 0.0 110.085 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.5 mt -99.74 140.19 21.39 Favored Pre-proline 0 CA--C 1.497 -1.088 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.66 171.3 17.52 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.502 2.135 . . . . 0.0 109.943 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -78.56 -3.88 45.93 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -163.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -91.14 1.31 57.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.939 0.896 . . . . 0.0 109.917 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -100.95 140.57 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.56 148.58 18.91 Favored Glycine 0 CA--C 1.482 -1.997 1 N-CA-C 102.598 -4.201 . . . . 0.0 102.598 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HB ' ' H ' ' A' ' 59' ' ' ILE . 19.1 pt -144.53 -153.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -161.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.2 mm -72.53 139.46 19.59 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -148.36 141.01 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 1 N-CA-C 92.91 -6.7 . . . . 0.0 92.91 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 41.18 -108.86 0.1 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 126.238 1.815 . . . . 0.0 111.612 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.95 70.45 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 104.127 -3.589 . . . . 0.0 104.127 164.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.42 -66.6 0.31 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 -168.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -96.7 163.87 12.82 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.57 130.53 55.3 Favored 'General case' 0 CA--C 1.496 -1.111 1 N-CA-C 100.048 -4.056 . . . . 0.0 100.048 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.277 41.6 m-70 69.48 -168.33 0.17 Allowed 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.841 1.656 . . . . 0.0 110.356 -163.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 m -68.71 105.35 2.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 1.214 0 O-C-N 123.031 0.207 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.698 0.761 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HE ' HG12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -123.71 157.15 34.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 174.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -132.52 127.84 36.03 Favored 'General case' 0 CA--C 1.488 -1.423 1 N-CA-C 98.113 -4.773 . . . . 0.0 98.113 172.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -167.23 22.25 Favored Glycine 0 CA--C 1.475 -2.421 1 N-CA-C 102.017 -4.433 . . . . 0.0 102.017 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -76.47 135.34 39.37 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 161.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -85.16 135.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.14 -138.24 0.09 Allowed 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 111.492 -2.595 . . . . 0.0 106.577 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -151.56 164.03 21.63 Favored Pre-proline 0 N--CA 1.422 -1.829 1 N-CA-C 95.329 -5.804 . . . . 0.0 95.329 162.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -65.22 148.4 88.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 122.845 2.052 . . . . 0.0 109.328 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -87.53 -51.01 6.15 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 127.97 2.508 . . . . 0.0 109.463 5.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -142.3 143.38 32.77 Favored 'General case' 0 CA--C 1.479 -1.767 1 N-CA-C 92.615 -6.809 . . . . 0.0 92.615 169.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 39.2 m -172.83 -158.85 0.11 Allowed 'General case' 0 N--CA 1.435 -1.179 1 N-CA-C 100.133 -4.025 . . . . 0.0 100.133 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 HD12 ' A' ' 59' ' ' ILE . 2.9 m -124.26 166.37 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 96.612 -5.329 . . . . 0.0 96.612 159.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.16 -170.48 3.06 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 162.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -130.09 145.21 51.67 Favored 'General case' 0 CA--C 1.472 -2.027 1 N-CA-C 93.075 -6.639 . . . . 0.0 93.075 173.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -160.44 -165.37 1.42 Allowed 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 94.863 -5.977 . . . . 0.0 94.863 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -144.42 171.91 6.12 Favored Pre-proline 0 N--CA 1.416 -2.154 1 N-CA-C 99.821 -4.14 . . . . 0.0 99.821 -161.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.88 60.3 2.26 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.304 2.669 . . . . 0.0 110.049 164.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.59 124.43 0.81 Allowed Glycine 0 N--CA 1.422 -2.251 1 N-CA-C 100.948 -4.861 . . . . 0.0 100.948 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.37 38.21 0.35 Allowed 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.088 1.755 . . . . 0.0 112.276 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -70.08 -63.96 0.98 Allowed 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 125.369 1.468 . . . . 0.0 110.127 -161.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -23.46 61.93 Favored Glycine 0 CA--C 1.495 -1.19 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -79.65 -14.66 58.63 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.724 -0.655 . . . . 0.0 111.4 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.7 -55.35 23.3 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 119.714 1.143 . . . . 0.0 109.735 168.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -46.32 90.88 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.004 1.322 . . . . 0.0 112.767 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -66.53 -40.49 89.16 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.574 0.702 . . . . 0.0 111.219 -172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.6 -42.87 98.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.665 -0.647 . . . . 0.0 109.794 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -64.1 -46.38 84.49 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 122.465 0.306 . . . . 0.0 110.935 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.32 -15.94 61.89 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.128 -0.982 . . . . 0.0 112.495 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -92.67 -6.87 48.36 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 123.02 0.528 . . . . 0.0 109.878 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 32.11 11.14 Favored Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.81 18.92 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 103.858 -3.697 . . . . 0.0 103.858 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 p -82.13 -43.33 17.93 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 121.828 -0.807 . . . . 0.0 109.761 -167.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.3 m -160.71 -179.76 7.88 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.72 -4.548 . . . . 0.0 98.72 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.01 -176.39 42.39 Favored Glycine 0 N--CA 1.418 -2.503 1 N-CA-C 99.313 -5.515 . . . . 0.0 99.313 -167.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -160.33 -176.6 5.71 Favored 'General case' 0 CA--C 1.488 -1.409 1 N-CA-C 98.511 -4.625 . . . . 0.0 98.511 -174.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.7 m -140.32 161.64 37.2 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.06 109.73 0.95 Allowed Glycine 0 CA--C 1.49 -1.516 0 N-CA-C 104.571 -3.411 . . . . 0.0 104.571 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -171.84 -179.75 2.53 Favored 'General case' 0 N--CA 1.43 -1.425 1 N-CA-C 98.138 -4.764 . . . . 0.0 98.138 -173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -153.78 148.74 26.68 Favored 'General case' 0 N--CA 1.433 -1.319 1 N-CA-C 95.849 -5.612 . . . . 0.0 95.849 163.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.52 173.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 N-CA-C 97.814 -4.884 . . . . 0.0 97.814 173.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.29 75.89 1.98 Allowed Glycine 0 C--N 1.351 1.372 0 N-CA-C 105.163 -3.175 . . . . 0.0 105.163 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.38 -50.29 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.35 1 N-CA-C 99.928 -4.101 . . . . 0.0 99.928 -170.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.02 -92.41 0.12 Allowed Glycine 0 N--CA 1.427 -1.903 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.59 174.16 8.01 Favored 'General case' 0 N--CA 1.427 -1.597 1 N-CA-C 95.838 -5.616 . . . . 0.0 95.838 -173.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.44 -174.62 4.57 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.9 t -118.01 158.3 25.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 101.742 -3.429 . . . . 0.0 101.742 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -97.17 153.98 17.65 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.2 m -145.63 152.17 39.22 Favored 'General case' 0 CA--C 1.479 -1.777 0 N-CA-C 101.444 -3.539 . . . . 0.0 101.444 163.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -119.87 143.15 48.08 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 101.65 -3.463 . . . . 0.0 101.65 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.84 51.58 0.57 Allowed 'General case' 0 CA--C 1.498 -1.019 0 C-N-CA 126.928 2.091 . . . . 0.0 111.986 171.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -93.0 133.04 29.49 Favored Pre-proline 0 CA--C 1.499 -1.0 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -69.97 172.94 11.91 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.542 2.161 . . . . 0.0 110.283 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.71 26.33 1.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -97.31 -7.91 30.94 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -101.81 -176.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -151.17 166.65 30.57 Favored Glycine 0 CA--C 1.479 -2.181 1 N-CA-C 98.11 -5.996 . . . . 0.0 98.11 -174.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.416 HG12 ' HE ' ' A' ' 2' ' ' ARG . 23.3 pt -153.8 -168.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.478 -1.807 1 N-CA-C 99.282 -4.34 . . . . 0.0 99.282 -168.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.429 HD12 HG12 ' A' ' 13' ' ' VAL . 14.5 mm -64.17 111.65 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -83.89 -45.17 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -162.49 168.2 22.29 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 95.583 -5.71 . . . . 0.0 95.583 172.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.72 45.37 1.73 Allowed Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 106.575 -2.61 . . . . 0.0 106.575 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.81 -48.5 9.31 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.923 -167.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -153.24 167.28 29.86 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 28.6 t -133.63 136.6 44.92 Favored 'General case' 0 CA--C 1.482 -1.671 1 N-CA-C 97.769 -4.9 . . . . 0.0 97.769 175.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -158.31 144.77 17.38 Favored 'General case' 0 CA--C 1.479 -1.758 1 N-CA-C 98.858 -4.497 . . . . 0.0 98.858 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -159.5 167.7 28.0 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 95.435 -5.765 . . . . 0.0 95.435 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.09 0.869 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -104.47 166.42 10.41 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -130.46 134.33 47.01 Favored 'General case' 0 CA--C 1.491 -1.289 1 N-CA-C 94.574 -6.084 . . . . 0.0 94.574 158.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 -179.69 36.78 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 105.432 -3.067 . . . . 0.0 105.432 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -79.21 132.38 36.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 159.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -90.62 138.06 20.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.84 -156.88 0.57 Allowed 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 127.71 2.404 . . . . 0.0 107.913 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -121.89 142.94 37.36 Favored Pre-proline 0 N--CA 1.424 -1.774 1 N-CA-C 94.846 -5.983 . . . . 0.0 94.846 165.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -63.36 138.03 63.72 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.034 2.489 . . . . 0.0 107.592 173.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -79.97 -49.45 11.83 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 127.291 2.236 . . . . 0.0 111.469 12.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -156.58 145.08 19.86 Favored 'General case' 0 N--CA 1.417 -2.08 1 N-CA-C 94.538 -6.097 . . . . 0.0 94.538 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 12.0 m 172.11 -157.65 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 98.672 -4.566 . . . . 0.0 98.672 -177.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 59' ' ' ILE . 5.6 m -125.83 159.04 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 1 N-CA-C 97.143 -5.132 . . . . 0.0 97.143 162.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.85 -175.74 5.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 162.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -132.03 170.62 14.68 Favored 'General case' 0 CA--C 1.481 -1.682 1 N-CA-C 96.638 -5.319 . . . . 0.0 96.638 176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -160.42 169.04 23.89 Favored 'General case' 0 N--CA 1.412 -2.364 1 N-CA-C 98.754 -4.535 . . . . 0.0 98.754 -170.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -127.27 104.21 22.42 Favored Pre-proline 0 N--CA 1.416 -2.136 1 N-CA-C 93.085 -6.635 . . . . 0.0 93.085 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.95 101.71 0.09 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.306 0 CA-C-N 124.987 2.817 . . . . 0.0 118.138 -141.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.97 8.33 79.32 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -91.87 170.65 9.7 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -49.57 -36.69 24.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.704 2.002 . . . . 0.0 115.209 -169.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.33 -59.84 10.01 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 123.115 0.388 . . . . 0.0 112.642 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -79.57 -13.71 59.34 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 118.792 1.296 . . . . 0.0 109.611 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -61.21 -49.53 76.79 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -42.84 99.43 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 171.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.65 -38.86 90.54 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.856 1.207 . . . . 0.0 110.597 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -62.57 -48.78 77.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -57.76 -50.05 74.52 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.896 0.878 . . . . 0.0 112.268 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.4 -10.33 57.5 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -4.07 28.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 123.634 0.774 . . . . 0.0 110.016 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.14 37.91 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.51 114.99 4.28 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.2 m -101.9 -5.59 24.55 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -159.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.85 169.32 24.62 Favored 'General case' 0 N--CA 1.435 -1.197 1 N-CA-C 97.462 -5.014 . . . . 0.0 97.462 163.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.88 -177.8 42.45 Favored Glycine 0 CA--C 1.479 -2.181 0 N-CA-C 103.797 -3.721 . . . . 0.0 103.797 -174.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -163.48 -166.56 1.25 Allowed 'General case' 0 N--CA 1.433 -1.286 1 N-CA-C 97.229 -5.1 . . . . 0.0 97.229 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 89.8 m -154.71 163.28 40.47 Favored 'General case' 0 CA--C 1.484 -1.568 1 N-CA-C 98.938 -4.468 . . . . 0.0 98.938 173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.55 -176.48 47.68 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 103.274 -3.93 . . . . 0.0 103.274 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -145.42 143.11 29.87 Favored 'General case' 0 N--CA 1.423 -1.782 1 N-CA-C 97.178 -5.119 . . . . 0.0 97.178 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -164.42 53.84 0.14 Allowed 'General case' 0 CA--C 1.491 -1.312 1 N-CA-C 97.357 -5.053 . . . . 0.0 97.357 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.301 1.5 t 57.76 -146.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 C-N-CA 125.628 1.571 . . . . 0.0 107.95 -160.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.04 -127.63 6.9 Favored Glycine 0 N--CA 1.424 -2.111 1 N-CA-C 98.915 -5.674 . . . . 0.0 98.915 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' H ' HG11 ' A' ' 13' ' ' VAL . 31.9 m170 -119.23 -10.02 9.83 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.19 -169.86 42.93 Favored Glycine 0 N--CA 1.423 -2.196 1 N-CA-C 98.168 -5.973 . . . . 0.0 98.168 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.59 128.63 36.86 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.91 171.37 8.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.1 t -113.46 166.91 11.04 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 100.856 -3.757 . . . . 0.0 100.856 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -132.15 148.78 52.49 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.4 m -142.18 154.05 44.52 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -120.25 136.03 54.79 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.72 56.19 0.18 Allowed 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 127.588 2.355 . . . . 0.0 109.896 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.95 135.98 25.31 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -66.5 169.1 14.82 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.112 1.875 . . . . 0.0 112.098 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.8 -6.71 50.47 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -93.6 1.97 56.51 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 123.01 0.524 . . . . 0.0 110.061 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.06 133.85 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.04 151.55 19.49 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 105.766 -2.934 . . . . 0.0 105.766 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 pt -140.7 -166.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -72.47 140.56 17.79 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -172.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.26 160.8 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.879 1 N-CA-C 94.982 -5.933 . . . . 0.0 94.982 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -155.44 157.13 36.51 Favored 'General case' 0 N--CA 1.425 -1.696 1 N-CA-C 97.151 -5.129 . . . . 0.0 97.151 171.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.27 -45.05 1.17 Allowed Glycine 0 CA--C 1.491 -1.439 1 N-CA-C 100.132 -5.187 . . . . 0.0 100.132 -163.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' LYS . 26.0 tt0 -97.92 -143.74 0.3 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 101.18 -3.637 . . . . 0.0 101.18 155.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 40.8 tttp -169.06 -155.27 0.14 Allowed 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.266 -5.457 . . . . 0.0 96.266 173.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 42.2 t -60.05 134.64 57.23 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 125.762 1.625 . . . . 0.0 110.067 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -82.58 -163.26 0.67 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.083 0.944 . . . . 0.0 108.691 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.2 m -167.66 171.83 9.84 Favored 'General case' 0 N--CA 1.424 -1.759 1 N-CA-C 96.215 -5.476 . . . . 0.0 96.215 172.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.923 0 O-C-N 124.426 1.078 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 178.19 7.5 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 169.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -135.83 131.77 35.81 Favored 'General case' 0 CA--C 1.492 -1.274 1 N-CA-C 96.781 -5.266 . . . . 0.0 96.781 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -177.89 35.21 Favored Glycine 0 CA--C 1.479 -2.204 0 N-CA-C 103.909 -3.677 . . . . 0.0 103.909 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -74.73 131.71 41.05 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 159.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.3 tt -87.5 130.72 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -99.22 -153.0 0.42 Allowed 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 111.418 -2.628 . . . . 0.0 108.275 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -130.79 152.27 80.26 Favored Pre-proline 0 N--CA 1.422 -1.873 1 N-CA-C 95.834 -5.617 . . . . 0.0 95.834 174.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -70.87 151.39 62.7 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 CA-C-N 122.338 1.871 . . . . 0.0 109.841 -171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -96.31 -20.64 18.35 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 127.771 2.428 . . . . 0.0 106.662 3.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -154.01 148.11 25.74 Favored 'General case' 0 N--CA 1.407 -2.585 1 N-CA-C 95.509 -5.737 . . . . 0.0 95.509 172.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.78 -154.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.553 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG12 HD12 ' A' ' 59' ' ' ILE . 1.6 m -136.53 173.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 N-CA-C 97.566 -4.976 . . . . 0.0 97.566 166.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.51 -161.39 0.81 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 167.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -136.75 151.87 49.7 Favored 'General case' 0 N--CA 1.418 -2.057 1 N-CA-C 95.023 -5.918 . . . . 0.0 95.023 167.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -160.77 -167.6 1.89 Allowed 'General case' 0 N--CA 1.411 -2.396 1 N-CA-C 95.74 -5.652 . . . . 0.0 95.74 -173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -145.6 166.35 17.85 Favored Pre-proline 0 N--CA 1.415 -2.204 1 N-CA-C 98.05 -4.796 . . . . 0.0 98.05 -161.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -68.34 68.68 1.02 Allowed 'Trans proline' 0 C--N 1.316 -1.168 0 CA-C-N 124.094 2.498 . . . . 0.0 112.199 165.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.1 -179.83 46.98 Favored Glycine 0 N--CA 1.417 -2.567 1 N-CA-C 97.661 -6.176 . . . . 0.0 97.661 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -128.82 9.02 5.8 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -55.03 -43.53 73.81 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.891 1.676 . . . . 0.0 114.205 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.95 -49.69 5.52 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.0 t -50.36 -43.23 54.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.042 1.737 . . . . 0.0 113.177 -171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.9 -32.23 70.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.695 0.798 . . . . 0.0 110.593 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -78.97 -45.8 19.6 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 109.004 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.24 -41.15 86.1 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -63.06 -41.8 99.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 121.464 -0.773 . . . . 0.0 110.684 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.86 -35.17 67.14 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.277 -0.889 . . . . 0.0 111.49 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.59 -30.35 61.66 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.564 -0.71 . . . . 0.0 111.077 -176.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -90.37 -6.82 54.56 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.213 0.605 . . . . 0.0 110.534 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.7 37.18 4.55 Favored Glycine 0 CA--C 1.489 -1.55 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 160.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.29 163.7 16.81 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 104.653 -3.379 . . . . 0.0 104.653 164.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.4 p -68.53 -56.13 9.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 122.515 1.15 . . . . 0.0 109.854 -173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -160.67 -172.62 3.59 Favored 'General case' 0 N--CA 1.424 -1.775 1 N-CA-C 98.904 -4.48 . . . . 0.0 98.904 168.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.04 -178.83 40.2 Favored Glycine 0 N--CA 1.415 -2.764 1 N-CA-C 98.529 -5.828 . . . . 0.0 98.529 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -161.56 -175.74 4.93 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.726 -4.916 . . . . 0.0 97.726 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -139.19 157.77 45.35 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 103.811 -2.662 . . . . 0.0 103.811 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.55 166.44 34.24 Favored Glycine 0 N--CA 1.429 -1.774 1 N-CA-C 95.847 -6.901 . . . . 0.0 95.847 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.95 132.08 56.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 102.702 -3.073 . . . . 0.0 102.702 -175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -129.67 36.08 4.12 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 42' ' ' GLY 0.284 11.5 t 70.1 -171.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -163.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.751 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 147.34 -130.37 3.54 Favored Glycine 0 N--CA 1.42 -2.386 1 N-CA-C 97.122 -6.391 . . . . 0.0 97.122 -168.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -114.5 -48.7 2.86 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.45 -178.74 23.83 Favored Glycine 0 N--CA 1.425 -2.083 1 N-CA-C 97.895 -6.082 . . . . 0.0 97.895 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.53 103.37 7.43 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.423 1.489 . . . . 0.0 107.294 -171.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.11 -166.46 1.5 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -170.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -117.49 151.79 36.39 Favored 'General case' 0 CA--C 1.489 -1.386 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -101.32 158.74 15.83 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.8 m -145.78 143.41 29.68 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 166.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.8 123.6 50.69 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 172.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.23 65.26 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 127.778 2.431 . . . . 0.0 109.315 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tp -98.95 138.68 20.67 Favored Pre-proline 0 CA--C 1.492 -1.271 0 CA-C-O 117.368 -1.301 . . . . 0.0 108.534 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -66.48 161.3 41.75 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.749 2.299 . . . . 0.0 110.606 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.6 -15.21 59.89 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.059 0.543 . . . . 0.0 111.127 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -92.27 12.36 22.71 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.933 0.893 . . . . 0.0 110.391 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -99.08 -158.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 101.439 -3.541 . . . . 0.0 101.439 167.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.03 163.39 33.75 Favored Glycine 0 CA--C 1.466 -3.001 1 N-CA-C 102.539 -4.224 . . . . 0.0 102.539 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -152.78 -170.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 101.168 -3.641 . . . . 0.0 101.168 -163.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.605 HD12 HG12 ' A' ' 13' ' ' VAL . 4.0 mm -71.22 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.95 159.51 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 1 N-CA-C 99.893 -4.114 . . . . 0.0 99.893 173.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -160.71 171.27 19.17 Favored 'General case' 0 N--CA 1.432 -1.347 1 N-CA-C 96.874 -5.232 . . . . 0.0 96.874 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.3 29.72 48.73 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 105.342 -3.103 . . . . 0.0 105.342 -152.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 175.07 -170.18 0.05 OUTLIER 'General case' 0 N--CA 1.423 -1.807 1 N-CA-C 95.293 -5.817 . . . . 0.0 95.293 -158.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -156.49 -176.67 6.09 Favored 'General case' 0 N--CA 1.435 -1.18 1 N-CA-C 96.94 -5.207 . . . . 0.0 96.94 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.83 130.71 48.12 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.68 1.582 . . . . 0.0 108.076 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -149.93 150.12 31.42 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.8 t -171.7 -179.93 2.64 Favored 'General case' 0 N--CA 1.421 -1.923 1 N-CA-C 96.316 -5.439 . . . . 0.0 96.316 -174.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 0.981 0 O-C-N 125.171 1.545 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.814 0.34 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 174.87 5.73 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.54 145.77 51.02 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 95.451 -5.759 . . . . 0.0 95.451 165.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.57 175.66 38.13 Favored Glycine 0 CA--C 1.479 -2.215 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 66.5 m-85 -80.4 131.64 35.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 155.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.87 138.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -106.75 -138.18 0.37 Allowed 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 127.493 2.317 . . . . 0.0 107.085 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -141.34 148.82 52.54 Favored Pre-proline 0 N--CA 1.415 -2.196 1 N-CA-C 94.553 -6.092 . . . . 0.0 94.553 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -67.52 143.8 64.4 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.641 2.228 . . . . 0.0 107.548 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -84.29 -33.06 24.05 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 127.897 2.479 . . . . 0.0 109.332 9.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -160.42 158.32 29.26 Favored 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 94.312 -6.181 . . . . 0.0 94.312 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 171.18 -152.5 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 1 N-CA-C 98.382 -4.673 . . . . 0.0 98.382 167.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.32 167.72 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 N-CA-C 96.287 -5.449 . . . . 0.0 96.287 158.891 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.87 -150.48 0.11 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -139.29 -175.36 4.15 Favored 'General case' 0 CA--C 1.484 -1.571 1 N-CA-C 96.619 -5.326 . . . . 0.0 96.619 163.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -147.93 173.81 12.5 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 96.608 -5.33 . . . . 0.0 96.608 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -129.65 126.11 22.55 Favored Pre-proline 0 N--CA 1.413 -2.317 1 N-CA-C 92.376 -6.898 . . . . 0.0 92.376 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -60.13 98.33 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 125.164 2.88 . . . . 0.0 114.855 -171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -167.01 35.33 Favored Glycine 0 N--CA 1.422 -2.249 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 p -91.44 -45.36 8.59 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -39.68 -70.62 0.1 Allowed 'General case' 0 C--N 1.353 0.754 0 C-N-CA 127.218 2.207 . . . . 0.0 116.912 -151.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.58 -37.35 62.07 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 120.799 -1.188 . . . . 0.0 111.068 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -64.88 -51.47 61.77 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.914 1.286 . . . . 0.0 108.795 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.16 -41.39 96.68 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.896 0.878 . . . . 0.0 109.587 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.6 m -59.0 -47.7 84.24 Favored 'General case' 0 C--N 1.347 0.49 0 O-C-N 121.333 -0.854 . . . . 0.0 111.756 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 mt -65.98 -42.3 90.03 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 123.387 0.675 . . . . 0.0 110.476 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.13 -49.53 73.65 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.38 1.472 . . . . 0.0 109.902 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -69.72 -35.57 75.14 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.27 -0.894 . . . . 0.0 111.339 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -74.76 -2.69 27.6 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.319 -0.863 . . . . 0.0 112.884 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -107.5 7.53 28.9 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.379 -0.825 . . . . 0.0 109.212 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.39 26.38 18.3 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.82 132.97 11.43 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 m -94.05 -15.88 24.37 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -166.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 m -160.61 179.19 8.78 Favored 'General case' 0 CA--C 1.493 -1.248 1 N-CA-C 99.337 -4.32 . . . . 0.0 99.337 168.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.5 -173.87 39.4 Favored Glycine 0 CA--C 1.473 -2.55 0 N-CA-C 103.104 -3.998 . . . . 0.0 103.104 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -161.08 -162.31 0.9 Allowed 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 -174.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.9 t -136.17 164.92 26.92 Favored 'General case' 0 CA--C 1.489 -1.374 1 N-CA-C 96.202 -5.481 . . . . 0.0 96.202 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.04 -168.19 37.75 Favored Glycine 0 N--CA 1.425 -2.099 1 N-CA-C 102.053 -4.419 . . . . 0.0 102.053 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -148.14 144.68 27.95 Favored 'General case' 0 N--CA 1.428 -1.546 1 N-CA-C 96.368 -5.419 . . . . 0.0 96.368 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -126.89 109.96 12.53 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.73 136.12 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.57 -34.16 4.2 Favored Glycine 0 CA--C 1.487 -1.667 0 N-CA-C 105.414 -3.074 . . . . 0.0 105.414 -170.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -117.34 -70.62 0.78 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 160.95 -153.03 23.81 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 106.819 -2.512 . . . . 0.0 106.819 -172.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.64 137.89 55.95 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 127.164 2.186 . . . . 0.0 106.273 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.35 178.21 8.08 Favored 'General case' 0 CA--C 1.479 -1.778 0 N-CA-C 101.349 -3.574 . . . . 0.0 101.349 -168.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.22 165.94 13.2 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.651 -4.203 . . . . 0.0 99.651 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 6.4 t-105 -127.89 146.87 50.49 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -134.98 149.22 50.17 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.67 136.63 53.81 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 172.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.7 76.37 0.28 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 126.799 2.039 . . . . 0.0 111.522 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.16 141.22 22.11 Favored Pre-proline 0 CA--C 1.501 -0.913 0 N-CA-C 101.819 -3.4 . . . . 0.0 101.819 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.7 165.16 31.84 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.38 2.054 . . . . 0.0 109.595 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -82.8 -1.65 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 121.438 -0.789 . . . . 0.0 112.726 -160.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.49 -1.99 58.35 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 124.051 0.94 . . . . 0.0 109.533 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 t -95.65 134.41 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.96 148.44 16.55 Favored Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 104.295 -3.522 . . . . 0.0 104.295 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 pt -132.27 -150.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.6 mm -73.64 131.37 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.7 t -120.5 155.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 99.313 -4.329 . . . . 0.0 99.313 172.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -160.14 161.61 33.74 Favored 'General case' 0 CA--C 1.483 -1.615 1 N-CA-C 98.604 -4.591 . . . . 0.0 98.604 174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.52 32.84 45.31 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 -147.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -178.07 -172.32 0.32 Allowed 'General case' 0 N--CA 1.424 -1.727 1 N-CA-C 96.167 -5.494 . . . . 0.0 96.167 -161.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.41 176.15 9.31 Favored 'General case' 0 N--CA 1.428 -1.557 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 -175.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 30.1 t -60.11 133.01 55.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 128.338 2.655 . . . . 0.0 111.14 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.321 96.4 m-70 60.68 -137.27 0.62 Allowed 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.942 2.097 . . . . 0.0 109.731 -164.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.0 m -77.56 59.79 2.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.326 0.65 . . . . 0.0 111.09 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.062 0 CA-C-N 116.022 -0.535 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -174.57 4.56 Favored 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 98.192 -4.744 . . . . 0.0 98.192 172.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -133.74 143.17 48.3 Favored 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.143 -4.762 . . . . 0.0 98.143 177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.32 23.86 Favored Glycine 0 CA--C 1.484 -1.9 0 N-CA-C 105.587 -3.005 . . . . 0.0 105.587 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -81.87 136.65 35.34 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 163.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 tt -90.55 146.83 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.333 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.09 178.19 10.3 Favored 'General case' 0 N--CA 1.401 -2.88 1 N-CA-C 96.949 -5.204 . . . . 0.0 96.949 -163.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -93.21 161.01 32.24 Favored Pre-proline 0 N--CA 1.428 -1.536 0 N-CA-C 102.97 -2.974 . . . . 0.0 102.97 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -64.07 116.85 3.95 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.089 1.859 . . . . 0.0 109.812 173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -145.52 139.2 26.6 Favored 'General case' 0 CA--C 1.481 -1.703 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 2.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 65' ' ' CYS . 27.8 t-20 86.1 -26.95 0.09 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 127.162 2.185 . . . . 0.0 110.138 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.2 m -87.24 111.63 21.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -157.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -65.04 171.97 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-O 124.544 2.116 . . . . 0.0 114.654 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.76 -154.78 0.49 Allowed 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.533 -2.576 . . . . 0.0 104.337 -173.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -142.9 177.61 8.23 Favored 'General case' 0 N--CA 1.417 -2.12 1 N-CA-C 95.756 -5.646 . . . . 0.0 95.756 162.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' HD22 ' A' ' 45' ' ' LEU . 11.5 t -142.7 159.21 42.68 Favored 'General case' 0 N--CA 1.411 -2.421 1 N-CA-C 95.153 -5.869 . . . . 0.0 95.153 -174.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -125.0 121.42 25.44 Favored Pre-proline 0 N--CA 1.415 -2.18 1 N-CA-C 93.235 -6.58 . . . . 0.0 93.235 168.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -68.29 67.69 1.03 Allowed 'Trans proline' 0 C--N 1.328 -0.513 0 CA-C-N 123.604 2.323 . . . . 0.0 114.787 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.93 161.5 32.73 Favored Glycine 0 N--CA 1.424 -2.159 1 N-CA-C 100.031 -5.228 . . . . 0.0 100.031 175.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.4 m -63.3 -39.76 95.48 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.919 0.887 . . . . 0.0 112.156 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -62.33 -27.16 68.85 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -168.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -77.19 1.33 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 168.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.19 -37.29 79.79 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.855 0.862 . . . . 0.0 113.238 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -73.26 -46.79 47.97 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 m -54.86 -46.0 74.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.829 0.851 . . . . 0.0 111.383 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.13 -35.23 79.28 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 123.49 0.716 . . . . 0.0 111.637 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -69.98 -48.85 56.58 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.068 0.947 . . . . 0.0 109.207 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -60.95 -45.59 94.12 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 121.822 -0.549 . . . . 0.0 110.865 -174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.73 -13.84 62.64 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -0.1 37.53 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.66 26.42 13.28 Favored Glycine 0 CA--C 1.491 -1.442 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.012 171.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.78 138.53 14.43 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.7 p -84.46 -29.67 25.87 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.764 0.793 . . . . 0.0 109.589 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.45 158.53 29.55 Favored 'General case' 0 N--CA 1.421 -1.889 1 N-CA-C 98.726 -4.546 . . . . 0.0 98.726 -166.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.33 -177.43 47.85 Favored Glycine 0 N--CA 1.424 -2.104 1 N-CA-C 100.346 -5.102 . . . . 0.0 100.346 -173.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -173.17 -176.73 1.42 Allowed 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 100.311 -3.959 . . . . 0.0 100.311 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.3 t -90.22 163.46 14.79 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.77 -175.04 37.93 Favored Glycine 0 CA--C 1.479 -2.168 1 N-CA-C 99.308 -5.517 . . . . 0.0 99.308 171.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -131.0 148.25 52.73 Favored 'General case' 0 N--CA 1.433 -1.289 1 N-CA-C 99.437 -4.282 . . . . 0.0 99.437 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -115.65 94.38 4.67 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.81 120.2 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -169.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.63 -22.83 7.66 Favored Glycine 0 CA--C 1.49 -1.526 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -172.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -121.83 -72.11 0.7 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.03 -159.54 32.64 Favored Glycine 0 CA--C 1.484 -1.883 0 N-CA-C 105.706 -2.958 . . . . 0.0 105.706 -169.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 16' ' ' CYS . 1.8 mt -78.26 150.73 33.33 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.385 -2.821 . . . . 0.0 103.385 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.33 173.84 15.66 Favored 'General case' 0 CA--C 1.485 -1.554 1 N-CA-C 98.69 -4.559 . . . . 0.0 98.69 -174.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.0 m -116.14 164.6 14.23 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -106.34 146.56 30.27 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 m -141.92 147.44 37.07 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.7 138.8 47.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.43 68.98 0.77 Allowed 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 126.788 2.035 . . . . 0.0 112.326 169.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mt -99.57 148.86 35.3 Favored Pre-proline 0 N--CA 1.44 -0.965 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -66.64 167.97 17.82 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.591 2.194 . . . . 0.0 112.366 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -81.76 4.08 23.37 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -103.21 13.4 34.04 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.83 152.77 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 167.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.41 158.26 27.61 Favored Glycine 0 CA--C 1.48 -2.099 1 N-CA-C 98.304 -5.918 . . . . 0.0 98.304 -176.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.7 pt -151.19 -140.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 -151.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' A' ' 7' ' ' ALA . 8.8 mm -68.26 131.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.62 136.87 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 1 N-CA-C 90.335 -7.654 . . . . 0.0 90.335 -174.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -164.2 166.22 21.3 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 98.771 -4.529 . . . . 0.0 98.771 -174.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.42 27.71 42.58 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 104.879 -3.288 . . . . 0.0 104.879 -146.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -176.21 -169.93 0.34 Allowed 'General case' 0 N--CA 1.424 -1.769 1 N-CA-C 95.879 -5.6 . . . . 0.0 95.879 -168.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -156.05 -179.69 8.39 Favored 'General case' 0 N--CA 1.427 -1.619 1 N-CA-C 96.87 -5.233 . . . . 0.0 96.87 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.1 t -55.39 129.4 38.45 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 127.333 2.253 . . . . 0.0 111.779 -170.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -154.27 160.63 41.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 100.998 -3.705 . . . . 0.0 100.998 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 m -78.11 56.98 1.72 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.07 1.348 . . . . 0.0 112.996 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.001 0 CA-C-N 116.435 -0.348 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.185 0.517 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 179.12 7.05 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 169.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -133.09 140.51 47.7 Favored 'General case' 0 CA--C 1.49 -1.335 1 N-CA-C 98.67 -4.567 . . . . 0.0 98.67 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.96 -176.18 33.77 Favored Glycine 0 CA--C 1.482 -2.008 0 N-CA-C 106.547 -2.621 . . . . 0.0 106.547 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -77.36 130.7 37.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 161.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.254 15.5 tt -90.41 136.2 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.41 -168.39 2.09 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 129.149 2.98 . . . . 0.0 109.383 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -145.91 158.63 48.69 Favored Pre-proline 0 N--CA 1.423 -1.819 1 N-CA-C 95.85 -5.611 . . . . 0.0 95.85 -178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.18 146.59 90.73 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 123.065 2.13 . . . . 0.0 112.26 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.63 -53.22 4.9 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 126.621 1.968 . . . . 0.0 107.721 7.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -142.74 137.67 29.96 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 91.947 -7.057 . . . . 0.0 91.947 168.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 9.6 m -177.47 -162.76 0.07 Allowed 'General case' 0 CA--C 1.483 -1.628 1 N-CA-C 98.735 -4.543 . . . . 0.0 98.735 -169.33 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -117.92 163.74 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 1 N-CA-C 98.242 -4.725 . . . . 0.0 98.242 166.45 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.14 -169.21 1.95 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 159.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.7 m170 -135.01 167.53 20.78 Favored 'General case' 0 CA--C 1.477 -1.86 1 N-CA-C 97.104 -5.147 . . . . 0.0 97.104 173.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -136.58 160.94 37.28 Favored 'General case' 0 N--CA 1.421 -1.92 1 N-CA-C 96.517 -5.364 . . . . 0.0 96.517 -165.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -112.73 116.54 47.76 Favored Pre-proline 0 N--CA 1.422 -1.858 1 N-CA-C 95.067 -5.901 . . . . 0.0 95.067 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -59.37 101.76 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.676 0 CA-C-N 125.004 2.823 . . . . 0.0 115.32 -161.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.15 -171.3 37.15 Favored Glycine 0 N--CA 1.42 -2.387 1 N-CA-C 98.308 -5.917 . . . . 0.0 98.308 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 -35.99 14.6 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 117.445 0.622 . . . . 0.0 110.499 -172.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -53.25 35.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.496 2.319 . . . . 0.0 116.034 -159.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.75 -42.38 31.73 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -171.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.5 -42.79 86.82 Favored 'General case' 0 CA--C 1.482 -1.644 0 O-C-N 122.148 -0.619 . . . . 0.0 110.988 -174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.36 -39.33 93.67 Favored 'General case' 0 C--N 1.352 0.709 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.2 m -63.05 -47.21 83.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.818 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -40.07 95.78 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-O 121.783 0.801 . . . . 0.0 110.1 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.39 -42.81 82.94 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 124.26 1.024 . . . . 0.0 110.823 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.86 -47.79 84.77 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 122.878 0.471 . . . . 0.0 110.865 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.95 -14.9 60.24 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -96.26 -6.84 37.03 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.733 -0.605 . . . . 0.0 111.061 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.44 27.25 12.03 Favored Glycine 0 C--N 1.349 1.284 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 169.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.51 151.87 19.09 Favored Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.726 -3.349 . . . . 0.0 104.726 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.0 p -84.85 -34.42 22.67 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -169.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.55 152.84 34.75 Favored 'General case' 0 N--CA 1.423 -1.8 1 N-CA-C 99.992 -4.077 . . . . 0.0 99.992 -161.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.89 42.18 Favored Glycine 0 CA--C 1.475 -2.444 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.489 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 26.1 p-80 -166.49 -158.74 0.33 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 101.49 -3.522 . . . . 0.0 101.49 -175.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.98 161.18 21.35 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 103.26 -2.867 . . . . 0.0 103.26 -167.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.13 -178.86 41.91 Favored Glycine 0 N--CA 1.422 -2.246 1 N-CA-C 102.214 -4.354 . . . . 0.0 102.214 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -138.07 139.64 39.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 100.389 -3.93 . . . . 0.0 100.389 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -115.48 99.02 7.06 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.82 120.05 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.14 -32.22 3.16 Favored Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 105.782 -2.927 . . . . 0.0 105.782 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.21 -70.3 0.81 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.15 -159.81 32.69 Favored Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 104.973 -3.251 . . . . 0.0 104.973 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.53 140.64 58.89 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.453 2.301 . . . . 0.0 106.849 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.86 -179.77 6.13 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 -171.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.4 m -113.24 168.2 9.93 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 101.451 -3.537 . . . . 0.0 101.451 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 13.2 t-105 -121.93 148.38 44.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.7 m -139.07 150.02 45.25 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -118.14 147.2 43.57 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 103.233 -2.876 . . . . 0.0 103.233 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.02 51.47 0.95 Allowed 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 126.953 2.101 . . . . 0.0 110.972 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.84 133.71 28.69 Favored Pre-proline 0 CA--C 1.499 -0.984 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.0 175.5 11.32 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.266 1.978 . . . . 0.0 110.444 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -80.08 4.63 16.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -95.86 3.62 53.5 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 121.182 -0.948 . . . . 0.0 108.813 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.1 t -104.58 178.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -155.58 164.13 31.96 Favored Glycine 0 CA--C 1.482 -1.974 1 N-CA-C 98.412 -5.875 . . . . 0.0 98.412 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 pt -155.62 -172.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 -163.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 13' ' ' VAL . 0.6 OUTLIER -68.9 118.87 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 CA-C-O 122.077 0.942 . . . . 0.0 111.937 -160.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.76 155.18 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 102.293 -3.225 . . . . 0.0 102.293 166.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -147.87 153.63 39.37 Favored 'General case' 0 N--CA 1.426 -1.651 1 N-CA-C 96.686 -5.301 . . . . 0.0 96.686 171.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.41 -43.74 1.31 Allowed Glycine 0 CA--C 1.489 -1.551 1 N-CA-C 100.145 -5.182 . . . . 0.0 100.145 -161.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.81 -143.76 0.32 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 155.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -162.98 -141.69 0.06 Allowed 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 98.22 -4.733 . . . . 0.0 98.22 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 40.4 t -84.34 125.36 32.21 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -138.69 143.14 39.01 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 171.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 t -173.49 -179.98 1.98 Allowed 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 96.357 -5.423 . . . . 0.0 96.357 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.884 0 O-C-N 124.767 1.292 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.627 0.727 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -116.96 154.6 30.59 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -137.89 128.59 26.81 Favored 'General case' 0 CA--C 1.488 -1.436 1 N-CA-C 97.425 -5.028 . . . . 0.0 97.425 168.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -170.99 27.45 Favored Glycine 0 CA--C 1.476 -2.363 1 N-CA-C 102.306 -4.318 . . . . 0.0 102.306 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.57 135.46 39.24 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 103.838 -2.652 . . . . 0.0 103.838 160.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.9 tt -90.51 141.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.44 -138.89 0.36 Allowed 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.582 -2.099 . . . . 0.0 107.029 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 64.0 mt-30 -140.93 161.19 55.19 Favored Pre-proline 0 N--CA 1.423 -1.783 1 N-CA-C 95.526 -5.731 . . . . 0.0 95.526 169.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -67.31 144.5 68.41 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 122.765 2.023 . . . . 0.0 108.588 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.62 -42.36 8.83 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.455 2.302 . . . . 0.0 107.744 7.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.62 146.02 37.41 Favored 'General case' 0 N--CA 1.419 -1.986 1 N-CA-C 92.92 -6.696 . . . . 0.0 92.92 173.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -177.75 -163.98 0.08 Allowed 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 -177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.561 HG11 ' H ' ' A' ' 43' ' ' HIS . 3.5 m -128.65 164.11 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.729 1 N-CA-C 96.789 -5.263 . . . . 0.0 96.789 156.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -173.47 4.74 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 160.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -134.96 147.1 49.66 Favored 'General case' 0 CA--C 1.466 -2.256 1 N-CA-C 93.823 -6.362 . . . . 0.0 93.823 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -160.57 -165.82 1.5 Allowed 'General case' 0 N--CA 1.411 -2.398 1 N-CA-C 95.081 -5.896 . . . . 0.0 95.081 -173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -141.22 173.18 5.11 Favored Pre-proline 0 N--CA 1.418 -2.04 1 N-CA-C 99.974 -4.084 . . . . 0.0 99.974 -161.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.52 55.51 3.7 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 C-N-CA 123.035 2.49 . . . . 0.0 110.754 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.69 141.11 4.57 Favored Glycine 0 N--CA 1.42 -2.375 1 N-CA-C 99.363 -5.495 . . . . 0.0 99.363 177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 24.93 0.5 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.809 1.644 . . . . 0.0 112.667 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -59.16 -49.46 77.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 126.663 1.985 . . . . 0.0 112.492 -161.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.87 -25.83 26.12 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -82.85 -8.94 59.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.538 -0.977 . . . . 0.0 110.853 -167.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -52.46 -57.21 10.61 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.324 1.05 . . . . 0.0 108.98 166.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -52.1 67.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.465 1.106 . . . . 0.0 112.419 171.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.89 -43.25 93.52 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.801 0.81 . . . . 0.0 111.856 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.0 t -62.8 -43.13 99.6 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 108.957 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -78.59 -27.48 45.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.398 -0.814 . . . . 0.0 111.601 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.85 -20.13 53.61 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.182 -0.949 . . . . 0.0 111.334 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -88.06 -22.48 24.16 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.76 33.48 2.42 Favored Glycine 0 CA--C 1.488 -1.595 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 163.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.21 150.83 19.74 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -96.96 -17.92 19.78 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.671 0.748 . . . . 0.0 109.833 -165.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 m -160.75 168.27 25.14 Favored 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 98.979 -4.452 . . . . 0.0 98.979 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.37 176.66 44.57 Favored Glycine 0 N--CA 1.419 -2.452 1 N-CA-C 100.855 -4.898 . . . . 0.0 100.855 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -168.93 -168.77 0.89 Allowed 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 97.35 -5.056 . . . . 0.0 97.35 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -142.43 166.05 25.74 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.44 -176.61 44.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 103.135 -3.986 . . . . 0.0 103.135 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -130.95 121.96 26.05 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 99.539 -4.245 . . . . 0.0 99.539 177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -139.33 59.81 1.59 Allowed 'General case' 0 CA--C 1.487 -1.444 1 N-CA-C 99.404 -4.295 . . . . 0.0 99.404 171.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 42' ' ' GLY 0.293 1.5 t 56.47 -152.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 127.512 2.325 . . . . 0.0 108.204 -165.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 119.82 -128.76 7.69 Favored Glycine 0 N--CA 1.425 -2.072 1 N-CA-C 100.065 -5.214 . . . . 0.0 100.065 -170.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.561 ' H ' HG11 ' A' ' 13' ' ' VAL . 35.5 m170 -118.55 -19.65 8.69 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 125.452 1.501 . . . . 0.0 107.307 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.86 -174.14 46.59 Favored Glycine 0 N--CA 1.426 -1.995 1 N-CA-C 97.625 -6.19 . . . . 0.0 97.625 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -69.16 132.71 46.97 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.06 -169.7 2.03 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -163.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.6 t -123.25 159.51 28.56 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -113.41 151.43 31.37 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.8 m -144.5 150.87 38.3 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -110.53 144.15 39.81 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 58.79 54.96 4.88 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.748 2.419 . . . . 0.0 112.682 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.18 144.62 38.84 Favored Pre-proline 0 CA--C 1.499 -0.991 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -64.9 162.82 30.62 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.576 2.184 . . . . 0.0 112.209 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.97 -28.03 63.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.103 1.761 . . . . 0.0 114.101 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -98.24 15.82 23.32 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 124.23 1.012 . . . . 0.0 110.652 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 138.83 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.048 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 151.53 18.21 Favored Glycine 0 CA--C 1.483 -1.921 0 N-CA-C 104.31 -3.516 . . . . 0.0 104.31 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.82 -159.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -170.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 13' ' ' VAL . 2.0 mm -72.54 130.78 35.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.147 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.13 134.93 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 N-CA-C 100.86 -3.756 . . . . 0.0 100.86 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 58.6 -129.72 1.31 Allowed 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.904 1.281 . . . . 0.0 108.811 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -157.96 55.58 0.37 Allowed Glycine 0 CA--C 1.482 -2.017 1 N-CA-C 98.986 -5.646 . . . . 0.0 98.986 168.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -98.48 -103.92 0.2 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -166.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -155.37 170.31 22.2 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 99.238 -4.356 . . . . 0.0 99.238 -164.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 54.0 t -96.3 150.38 20.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -154.47 153.22 31.15 Favored 'General case' 0 CA--C 1.486 -1.511 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 168.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.3 m -152.47 163.38 39.66 Favored 'General case' 0 N--CA 1.421 -1.876 1 N-CA-C 95.662 -5.681 . . . . 0.0 95.662 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.923 0 O-C-N 124.402 1.064 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -110.59 165.38 11.86 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 171.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -126.15 137.91 53.62 Favored 'General case' 0 CA--C 1.49 -1.361 1 N-CA-C 94.305 -6.183 . . . . 0.0 94.305 153.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -176.7 34.23 Favored Glycine 0 CA--C 1.474 -2.496 1 N-CA-C 102.956 -4.058 . . . . 0.0 102.956 177.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 41.9 m-85 -76.86 135.52 38.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 161.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -90.4 138.44 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -176.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -103.57 -135.91 0.34 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.425 -1.716 . . . . 0.0 106.931 178.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -136.34 159.08 72.11 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 96.156 -5.498 . . . . 0.0 96.156 169.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -69.14 148.57 69.37 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.011 1.807 . . . . 0.0 109.421 174.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -82.15 -29.19 31.74 Favored 'General case' 0 CA--C 1.499 -1.009 0 C-N-CA 127.42 2.288 . . . . 0.0 108.315 -3.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -155.57 165.34 36.88 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.232 -5.84 . . . . 0.0 95.232 178.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 157.62 -147.0 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.58 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.571 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 59' ' ' ILE . 17.3 m -135.0 166.9 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 1 N-CA-C 98.352 -4.684 . . . . 0.0 98.352 161.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.97 -170.9 2.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 165.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -136.24 149.54 48.57 Favored 'General case' 0 CA--C 1.479 -1.757 1 N-CA-C 98.53 -4.618 . . . . 0.0 98.53 179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -125.59 162.65 24.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 101.922 -3.362 . . . . 0.0 101.922 -168.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -114.06 112.81 46.96 Favored Pre-proline 0 N--CA 1.421 -1.898 1 N-CA-C 98.765 -4.531 . . . . 0.0 98.765 168.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.53 118.53 5.46 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 CA-C-N 123.314 2.219 . . . . 0.0 111.47 -171.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.28 -45.73 0.57 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 99.874 -5.291 . . . . 0.0 99.874 -165.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m 115.17 -35.33 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 129.362 3.065 . . . . 0.0 107.003 168.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -40.15 -53.78 2.4 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.326 2.65 . . . . 0.0 116.459 -156.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.16 -36.7 56.05 Favored Glycine 0 C--N 1.346 1.105 0 O-C-N 121.369 -0.832 . . . . 0.0 111.607 -176.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 t -86.29 -26.13 25.11 Favored 'General case' 0 CA--C 1.499 -1.018 0 O-C-N 120.963 -1.316 . . . . 0.0 109.072 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -64.65 -36.48 84.38 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.999 0.919 . . . . 0.0 108.83 170.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 m -66.23 -42.21 88.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 121.382 -0.824 . . . . 0.0 110.336 173.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.46 -38.97 92.89 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 121.002 -1.061 . . . . 0.0 110.869 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.9 t -54.28 -42.78 70.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.515 1.126 . . . . 0.0 111.009 174.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.71 -44.85 92.42 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 122.022 -0.424 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.22 -28.39 63.14 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.487 0.585 . . . . 0.0 111.91 -176.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -79.91 -19.04 49.04 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.853 -0.53 . . . . 0.0 110.435 176.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.47 35.46 2.86 Favored Glycine 0 CA--C 1.487 -1.681 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 164.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.22 138.45 13.91 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 105.171 -3.172 . . . . 0.0 105.171 167.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 p -98.05 3.14 49.36 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 121.851 -0.794 . . . . 0.0 110.036 -168.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -160.36 166.46 29.33 Favored 'General case' 0 CA--C 1.48 -1.716 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.98 175.75 46.48 Favored Glycine 0 CA--C 1.469 -2.831 1 N-CA-C 99.73 -5.348 . . . . 0.0 99.73 -177.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -168.91 -153.78 0.12 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 96.269 -5.456 . . . . 0.0 96.269 -172.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -149.98 166.15 30.51 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.57 -4.974 . . . . 0.0 97.57 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.2 171.41 41.92 Favored Glycine 0 CA--C 1.48 -2.126 1 N-CA-C 96.154 -6.778 . . . . 0.0 96.154 176.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -146.5 137.32 24.12 Favored 'General case' 0 CA--C 1.483 -1.607 1 N-CA-C 99.251 -4.352 . . . . 0.0 99.251 -175.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -158.57 56.18 0.44 Allowed 'General case' 0 CA--C 1.488 -1.442 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 175.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.32 1.4 t 55.62 -144.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 125.859 1.664 . . . . 0.0 108.215 -158.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.41 -131.04 5.36 Favored Glycine 0 CA--C 1.474 -2.492 1 N-CA-C 94.86 -7.296 . . . . 0.0 94.86 -169.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.54 ' H ' HG11 ' A' ' 13' ' ' VAL . 51.2 m170 -123.34 10.82 9.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.98 -49.18 0.29 Allowed Glycine 0 CA--C 1.486 -1.737 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -171.33 -176.52 1.89 Allowed 'General case' 0 N--CA 1.437 -1.096 1 N-CA-C 95.848 -5.612 . . . . 0.0 95.848 -175.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.92 174.98 4.59 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 99.089 -4.412 . . . . 0.0 99.089 174.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 29.6 m -123.31 -174.16 2.89 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 171.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 18.4 t-105 -132.01 152.62 51.04 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -177.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.7 m -145.13 155.11 43.11 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -119.27 140.77 49.72 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 172.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.19 55.77 1.07 Allowed 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 127.356 2.262 . . . . 0.0 111.38 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.35 130.99 37.68 Favored Pre-proline 0 CA--C 1.496 -1.123 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 175.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -70.69 176.2 7.81 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.339 2.026 . . . . 0.0 111.069 177.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -84.68 19.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -99.53 -6.16 27.97 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.2 t -99.06 173.43 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -145.58 156.86 27.15 Favored Glycine 0 CA--C 1.48 -2.141 1 N-CA-C 97.914 -6.075 . . . . 0.0 97.914 -175.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 pt -150.76 -167.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 101.926 -3.361 . . . . 0.0 101.926 -166.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.738 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -70.03 133.97 30.92 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -171.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.92 126.4 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 162.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -96.47 -44.12 7.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 118.646 0.657 . . . . 0.0 111.515 -168.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 62.32 4.37 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -170.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -162.23 -66.28 0.05 Allowed 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 -176.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.8 tptt 127.92 -139.79 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 96.545 -5.354 . . . . 0.0 96.545 -170.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 36.1 t -99.75 148.18 24.67 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.67 130.05 39.61 Favored 'General case' 0 CA--C 1.483 -1.601 1 N-CA-C 92.975 -6.676 . . . . 0.0 92.975 168.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 p -88.12 -67.21 0.84 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -175.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 1.221 0 CA-C-N 115.865 -0.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.139 0.495 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.88 171.39 7.93 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 172.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -135.82 133.72 38.15 Favored 'General case' 0 CA--C 1.489 -1.379 1 N-CA-C 96.421 -5.399 . . . . 0.0 96.421 168.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.8 -177.26 34.71 Favored Glycine 0 CA--C 1.478 -2.277 0 N-CA-C 105.028 -3.229 . . . . 0.0 105.028 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 36.2 m-85 -73.91 133.75 43.14 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.19 136.89 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.81 -146.14 0.3 Allowed 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 126.718 2.007 . . . . 0.0 107.295 178.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -133.86 147.14 63.02 Favored Pre-proline 0 N--CA 1.423 -1.8 1 N-CA-C 94.408 -6.145 . . . . 0.0 94.408 164.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.54 145.1 63.27 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 CA-C-N 123.21 2.182 . . . . 0.0 108.089 177.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.57 -44.43 15.87 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 120.902 1.683 . . . . 0.0 111.79 7.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -152.92 149.59 28.39 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 94.489 -6.115 . . . . 0.0 94.489 177.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 168.32 -158.9 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.437 1 N-CA-C 99.043 -4.428 . . . . 0.0 99.043 -179.006 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -123.76 161.1 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 1 N-CA-C 98.739 -4.541 . . . . 0.0 98.739 161.758 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -162.36 0.6 Allowed 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 162.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -137.87 166.49 23.9 Favored 'General case' 0 N--CA 1.426 -1.669 1 N-CA-C 96.89 -5.226 . . . . 0.0 96.89 162.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.4 t -119.95 169.82 9.83 Favored 'General case' 0 N--CA 1.419 -1.978 1 N-CA-C 99.041 -4.429 . . . . 0.0 99.041 -176.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -116.24 131.0 24.02 Favored Pre-proline 0 N--CA 1.421 -1.911 1 N-CA-C 98.03 -4.804 . . . . 0.0 98.03 173.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -69.08 37.62 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.641 0 C-N-CA 123.145 2.563 . . . . 0.0 114.715 174.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -153.86 142.8 9.45 Favored Glycine 0 N--CA 1.426 -2.007 1 N-CA-C 96.084 -6.806 . . . . 0.0 96.084 177.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.1 -41.69 98.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.928 1.291 . . . . 0.0 113.962 -157.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -53.38 9.34 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 128.407 2.683 . . . . 0.0 115.592 -163.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -50.78 32.21 Favored Glycine 0 C--N 1.349 1.288 0 O-C-N 121.945 -0.472 . . . . 0.0 112.14 -166.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.8 t -78.12 -18.91 55.05 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -58.34 -53.72 55.16 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -39.31 93.99 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.32 -37.95 86.55 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.922 0.783 . . . . 0.0 111.261 -179.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.7 t -65.9 -45.78 80.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.614 -0.679 . . . . 0.0 109.98 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -65.15 -41.32 94.85 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.957 -0.464 . . . . 0.0 111.916 -178.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.9 -17.35 63.34 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.166 -0.959 . . . . 0.0 112.188 -175.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -95.72 -6.29 40.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.66 0.784 . . . . 0.0 110.046 176.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.89 32.7 17.3 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.0 151.15 17.96 Favored Glycine 0 CA--C 1.488 -1.643 0 N-CA-C 104.066 -3.614 . . . . 0.0 104.066 172.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.7 p -73.45 -55.07 6.83 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.029 0.919 . . . . 0.0 109.999 -168.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 m -160.63 -177.03 5.91 Favored 'General case' 0 N--CA 1.424 -1.74 1 N-CA-C 98.184 -4.746 . . . . 0.0 98.184 166.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.56 176.44 44.1 Favored Glycine 0 N--CA 1.416 -2.684 1 N-CA-C 99.838 -5.305 . . . . 0.0 99.838 -171.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -146.31 178.49 8.2 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 100.466 -3.902 . . . . 0.0 100.466 -172.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.6 m -83.79 171.76 12.84 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-N 119.14 0.882 . . . . 0.0 109.771 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.12 -179.07 45.45 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 103.13 -3.988 . . . . 0.0 103.13 -172.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -147.72 152.71 38.23 Favored 'General case' 0 N--CA 1.427 -1.598 1 N-CA-C 97.298 -5.075 . . . . 0.0 97.298 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -136.84 106.07 6.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 102.396 -3.187 . . . . 0.0 102.396 172.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.43 122.29 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -176.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.72 -40.69 1.43 Allowed Glycine 0 CA--C 1.482 -2.005 1 N-CA-C 102.62 -4.192 . . . . 0.0 102.62 -166.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -123.76 -67.6 0.92 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.95 -157.51 30.02 Favored Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 -169.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -70.71 139.03 51.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.3 -173.46 3.34 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -167.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -129.4 177.3 7.29 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.815 -3.772 . . . . 0.0 100.815 169.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 30.1 t-105 -122.3 160.48 25.23 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.5 m -148.65 151.77 35.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 167.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.97 129.92 56.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 176.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.31 66.89 0.1 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 127.64 2.376 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.5 mt -103.11 137.96 19.41 Favored Pre-proline 0 CA--C 1.496 -1.102 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.12 170.86 18.81 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.745 2.296 . . . . 0.0 110.402 175.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.75 -5.68 42.24 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 124.164 0.986 . . . . 0.0 113.583 -168.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -88.91 3.7 50.49 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 121.288 -0.883 . . . . 0.0 109.551 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.05 136.05 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.33 154.94 18.54 Favored Glycine 0 CA--C 1.491 -1.443 0 N-CA-C 107.347 -2.301 . . . . 0.0 107.347 -178.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 pt -139.89 -171.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 -172.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -73.86 141.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 123.395 0.678 . . . . 0.0 109.581 -169.222 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.45 155.11 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 1 N-CA-C 98.089 -4.782 . . . . 0.0 98.089 178.69 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -144.14 152.92 41.56 Favored 'General case' 0 N--CA 1.426 -1.663 1 N-CA-C 95.3 -5.815 . . . . 0.0 95.3 166.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.96 -42.0 1.6 Allowed Glycine 0 CA--C 1.489 -1.586 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -163.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -99.36 -136.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 101.079 -3.674 . . . . 0.0 101.079 153.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -163.66 -165.2 1.0 Allowed 'General case' 0 N--CA 1.427 -1.61 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.2 t -59.74 125.17 22.6 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -143.72 154.22 43.25 Favored 'General case' 0 CA--C 1.475 -1.928 1 N-CA-C 97.19 -5.115 . . . . 0.0 97.19 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m 179.78 174.53 0.84 Allowed 'General case' 0 N--CA 1.428 -1.561 1 N-CA-C 96.132 -5.507 . . . . 0.0 96.132 179.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.903 0 CA-C-N 119.341 0.973 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.254 0.55 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 178.8 4.15 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 167.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -128.74 148.02 50.81 Favored 'General case' 0 N--CA 1.431 -1.397 1 N-CA-C 95.245 -5.835 . . . . 0.0 95.245 166.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.31 170.59 37.13 Favored Glycine 0 CA--C 1.48 -2.133 0 C-N-CA 117.845 -2.121 . . . . 0.0 109.017 -175.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -82.11 121.82 27.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 159.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 tt -90.5 143.27 11.57 Favored 'Isoleucine or valine' 0 C--O 1.25 1.089 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -174.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -115.59 -154.52 0.55 Allowed 'General case' 0 N--CA 1.427 -1.597 0 C-N-CA 128.995 2.918 . . . . 0.0 108.858 -175.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.32 165.58 30.72 Favored Pre-proline 0 N--CA 1.425 -1.708 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 170.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 44.0 Cg_exo -62.19 126.49 18.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.748 2.965 . . . . 0.0 112.871 -173.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 3.2 mm-40 -133.77 138.07 45.52 Favored 'General case' 0 CA--C 1.467 -2.24 1 N-CA-C 96.33 -5.433 . . . . 0.0 96.33 -10.685 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.532 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 48.6 t30 68.36 30.25 5.54 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 119.351 0.978 . . . . 0.0 111.626 175.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 m -96.23 -159.9 0.76 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 168.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG12 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -133.95 162.84 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 1 N-CA-C 96.55 -5.352 . . . . 0.0 96.55 170.563 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -168.02 2.09 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 162.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -138.08 146.09 42.51 Favored 'General case' 0 CA--C 1.469 -2.161 1 N-CA-C 96.214 -5.476 . . . . 0.0 96.214 168.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.55 175.2 6.84 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -112.29 130.49 23.28 Favored Pre-proline 0 N--CA 1.421 -1.882 1 N-CA-C 93.976 -6.305 . . . . 0.0 93.976 165.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.92 37.98 0.11 Allowed 'Trans proline' 0 C--N 1.331 -0.369 0 CA-C-N 125.679 3.064 . . . . 0.0 116.024 177.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.55 108.97 0.49 Allowed Glycine 0 N--CA 1.422 -2.243 1 N-CA-C 94.734 -7.346 . . . . 0.0 94.734 170.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -52.42 -36.8 55.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 127.313 2.245 . . . . 0.0 115.042 -157.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 m -44.79 -39.35 5.18 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.854 2.462 . . . . 0.0 116.659 -170.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.41 -46.13 87.31 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 120.776 -1.202 . . . . 0.0 112.05 -177.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.65 -25.09 28.75 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 122.18 -0.6 . . . . 0.0 109.621 -175.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.82 -39.25 91.12 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.096 0.558 . . . . 0.0 109.971 170.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -63.81 -41.97 97.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.866 -1.146 . . . . 0.0 110.464 175.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.0 mt -63.94 -40.44 96.43 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 121.953 0.883 . . . . 0.0 110.667 177.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.6 t -57.86 -47.38 82.88 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.208 1.403 . . . . 0.0 110.575 175.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -68.04 -42.41 80.58 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 122.681 0.393 . . . . 0.0 111.024 -176.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.02 -23.6 60.63 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.727 -0.608 . . . . 0.0 111.928 -175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.95 -49.21 11.26 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.92 48.81 0.16 Allowed Glycine 0 CA--C 1.49 -1.518 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 168.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.13 143.55 15.79 Favored Glycine 0 CA--C 1.487 -1.673 1 N-CA-C 101.35 -4.7 . . . . 0.0 101.35 157.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 p -75.12 -28.6 60.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 118.385 1.092 . . . . 0.0 110.77 -164.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.9 m -160.56 173.42 15.55 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.92 -176.96 42.75 Favored Glycine 0 N--CA 1.418 -2.542 1 N-CA-C 98.786 -5.726 . . . . 0.0 98.786 -172.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -171.16 -174.71 1.54 Allowed 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 100.641 -3.837 . . . . 0.0 100.641 -170.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.4 m -81.03 169.71 17.15 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 119.153 0.888 . . . . 0.0 109.134 -178.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.88 164.51 34.25 Favored Glycine 0 N--CA 1.416 -2.693 1 N-CA-C 98.465 -5.854 . . . . 0.0 98.465 175.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -135.8 154.77 51.1 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 97.21 -5.108 . . . . 0.0 97.21 177.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.92 179.21 9.29 Favored 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 97.503 -4.999 . . . . 0.0 97.503 174.935 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.63 163.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 1 N-CA-C 97.968 -4.827 . . . . 0.0 97.968 178.173 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.39 -46.85 1.1 Allowed Glycine 0 CA--C 1.486 -1.78 1 N-CA-C 102.564 -4.214 . . . . 0.0 102.564 -170.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.532 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 35.1 m170 -119.46 -79.65 0.6 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 170.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.22 -147.26 12.82 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 103.28 -3.928 . . . . 0.0 103.28 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.59 132.91 54.64 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.51 2.324 . . . . 0.0 108.066 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.11 -173.34 3.7 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 102.201 -3.259 . . . . 0.0 102.201 -164.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.31 172.05 9.41 Favored 'General case' 0 CA--C 1.474 -1.951 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 169.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -129.31 147.9 51.18 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.7 m -143.28 146.97 34.06 Favored 'General case' 0 CA--C 1.492 -1.25 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -114.69 145.46 42.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.5 55.44 0.5 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 126.578 1.951 . . . . 0.0 111.064 172.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.05 138.69 20.35 Favored Pre-proline 0 CA--C 1.501 -0.908 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 176.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -66.42 165.95 23.23 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.45 2.1 . . . . 0.0 111.773 175.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -73.86 -19.1 60.83 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.328 0.651 . . . . 0.0 112.27 -169.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -92.29 18.55 8.14 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.087 0.955 . . . . 0.0 109.73 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.05 133.83 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 100.533 -3.877 . . . . 0.0 100.533 167.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.92 146.57 18.64 Favored Glycine 0 CA--C 1.479 -2.172 1 N-CA-C 102.407 -4.277 . . . . 0.0 102.407 -176.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 pt -135.69 -141.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 103.094 -2.928 . . . . 0.0 103.094 -156.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -77.8 120.62 28.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 169.14 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.9 -33.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -163.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 35.0 tt0 -155.43 -136.98 0.06 Allowed 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 96.542 -5.355 . . . . 0.0 96.542 176.178 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . -168.55 52.08 0.22 Allowed Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 103.535 -3.826 . . . . 0.0 103.535 171.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.73 -57.51 2.02 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -172.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -158.14 157.04 31.98 Favored 'General case' 0 N--CA 1.423 -1.788 1 N-CA-C 97.195 -5.113 . . . . 0.0 97.195 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.8 t -86.7 149.83 24.61 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.334 75.0 m-70 85.09 -163.31 0.01 OUTLIER 'General case' 0 CA--C 1.486 -1.517 0 C-N-CA 130.01 3.324 . . . . 0.0 106.273 -173.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.3 p -84.31 67.04 9.67 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 119.158 0.89 . . . . 0.0 108.959 -170.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.093 0 CA-C-N 115.949 -0.569 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.115 0.483 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.29 167.7 12.93 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 171.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -130.46 140.03 50.55 Favored 'General case' 0 CA--C 1.485 -1.545 1 N-CA-C 94.703 -6.036 . . . . 0.0 94.703 165.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.45 29.27 Favored Glycine 0 CA--C 1.472 -2.608 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 178.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -82.58 138.72 34.15 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 101.453 -3.536 . . . . 0.0 101.453 157.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -89.99 132.82 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -177.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.26 -148.86 0.43 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 111.949 -2.387 . . . . 0.0 107.09 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.94 148.46 65.06 Favored Pre-proline 0 N--CA 1.424 -1.773 1 N-CA-C 95.509 -5.738 . . . . 0.0 95.509 174.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.64 149.86 39.18 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.787 2.031 . . . . 0.0 107.847 -177.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 -5.33 16.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.468 2.307 . . . . 0.0 109.263 13.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -162.38 146.55 12.0 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 94.417 -6.142 . . . . 0.0 94.417 163.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.08 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 177.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 59' ' ' ILE . 16.2 m -135.15 170.42 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 97.164 -5.124 . . . . 0.0 97.164 163.048 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.85 -168.16 1.59 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -125.72 163.64 22.39 Favored 'General case' 0 CA--C 1.474 -1.96 1 N-CA-C 99.603 -4.221 . . . . 0.0 99.603 171.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.28 152.71 47.47 Favored 'General case' 0 N--CA 1.417 -2.076 1 N-CA-C 96.158 -5.497 . . . . 0.0 96.158 -166.07 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.52 115.76 39.47 Favored Pre-proline 0 N--CA 1.419 -1.996 1 N-CA-C 97.36 -5.052 . . . . 0.0 97.36 171.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.3 107.49 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 CA-C-N 123.347 2.231 . . . . 0.0 112.043 -176.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.81 -41.26 0.83 Allowed Glycine 0 CA--C 1.491 -1.455 1 N-CA-C 101.472 -4.651 . . . . 0.0 101.472 -161.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m 84.76 3.81 0.68 Allowed 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 125.351 1.46 . . . . 0.0 113.222 157.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.75 -40.82 80.6 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.417 1.887 . . . . 0.0 110.752 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.91 -41.29 93.47 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.906 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.5 m -68.89 -42.94 76.26 Favored 'General case' 0 CA--C 1.484 -1.559 0 CA-C-N 117.959 0.879 . . . . 0.0 110.164 -175.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.98 -49.69 74.97 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.905 0.882 . . . . 0.0 109.255 176.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.5 m -57.5 -50.11 74.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 111.443 176.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.7 -43.78 98.19 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.035 0.921 . . . . 0.0 110.152 -178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.1 -43.05 95.86 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 123.284 0.634 . . . . 0.0 110.726 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.86 -39.74 83.72 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.802 -0.561 . . . . 0.0 111.477 -178.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.71 -21.21 52.31 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.613 -0.679 . . . . 0.0 111.702 -175.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -89.51 -28.78 19.4 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.592 -0.693 . . . . 0.0 109.691 175.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.21 44.62 0.85 Allowed Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 164.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.73 141.23 16.32 Favored Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 167.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 p -99.62 7.42 45.24 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 123.488 0.715 . . . . 0.0 110.034 -167.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.3 m -160.18 150.89 18.77 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 100.28 -3.97 . . . . 0.0 100.28 166.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -166.94 162.67 36.45 Favored Glycine 0 CA--C 1.463 -3.205 1 N-CA-C 99.537 -5.425 . . . . 0.0 99.537 -177.415 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -162.34 -157.68 0.48 Allowed 'General case' 0 N--CA 1.428 -1.529 1 N-CA-C 99.714 -4.18 . . . . 0.0 99.714 -168.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.4 t -155.6 167.04 31.68 Favored 'General case' 0 N--CA 1.421 -1.908 1 N-CA-C 95.954 -5.573 . . . . 0.0 95.954 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.82 73.95 0.03 OUTLIER Glycine 0 CA--C 1.473 -2.568 1 N-CA-C 100.27 -5.132 . . . . 0.0 100.27 -176.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -157.84 157.39 33.18 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 100.925 -3.731 . . . . 0.0 100.925 176.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -148.39 166.76 27.13 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 94.16 -6.237 . . . . 0.0 94.16 159.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG12 ' H ' ' A' ' 42' ' ' GLY 0.332 50.1 t 84.19 -167.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 -172.132 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.775 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 89.67 -93.24 1.86 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 107.174 -2.371 . . . . 0.0 107.174 -177.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -137.96 -52.47 0.62 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 100.589 -3.856 . . . . 0.0 100.589 178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.8 61.95 0.22 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 172.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.461 0.0 OUTLIER 76.36 167.82 0.26 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.552 1.941 . . . . 0.0 109.164 -175.717 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.55 -179.65 8.37 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -175.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.78 160.97 15.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 176.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 t-105 -107.79 150.52 26.89 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 9.4 m -147.55 150.92 35.42 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.38 143.15 48.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 170.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.21 54.13 0.43 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 126.544 1.938 . . . . 0.0 110.602 168.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.6 mt -95.7 135.34 23.07 Favored Pre-proline 0 CA--C 1.498 -1.056 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 175.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.99 171.8 16.79 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.432 2.088 . . . . 0.0 110.434 177.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -67.61 -17.17 64.52 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -79.37 -6.78 57.56 Favored 'General case' 0 CA--C 1.503 -0.83 0 O-C-N 121.818 -0.551 . . . . 0.0 110.448 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -99.61 127.3 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.71 157.09 17.54 Favored Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 105.16 -3.176 . . . . 0.0 105.16 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -136.75 -158.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 105.925 -1.879 . . . . 0.0 105.925 -163.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.5 mm -74.76 123.09 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -178.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.86 -47.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -173.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -159.94 158.83 31.46 Favored 'General case' 0 CA--C 1.484 -1.563 1 N-CA-C 98.666 -4.568 . . . . 0.0 98.666 -176.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.27 55.54 4.93 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 174.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -92.49 -68.65 0.79 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -172.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -171.53 -164.72 0.34 Allowed 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 98.188 -4.745 . . . . 0.0 98.188 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 38.3 t -115.82 157.43 24.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.382 -3.562 . . . . 0.0 101.382 -178.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -154.17 138.56 16.72 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 166.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 m -83.07 120.41 25.72 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -169.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.007 0 O-C-N 123.242 0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.395 0.617 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 173.08 6.95 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -137.33 137.92 39.42 Favored 'General case' 0 N--CA 1.431 -1.405 1 N-CA-C 95.412 -5.773 . . . . 0.0 95.412 170.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.94 -177.58 35.12 Favored Glycine 0 CA--C 1.471 -2.662 1 N-CA-C 103.06 -4.016 . . . . 0.0 103.06 176.042 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -77.44 134.39 38.39 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 159.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.48 138.28 19.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -96.14 -157.18 0.56 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 129.045 2.938 . . . . 0.0 110.557 178.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.42 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 36.9 mt-30 -148.65 165.74 17.21 Favored Pre-proline 0 N--CA 1.426 -1.664 1 N-CA-C 97.116 -5.142 . . . . 0.0 97.116 176.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -68.96 149.9 72.46 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.688 2.259 . . . . 0.0 109.974 176.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -82.21 -47.37 12.55 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 127.48 2.312 . . . . 0.0 107.231 -1.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -150.26 140.38 22.1 Favored 'General case' 0 N--CA 1.42 -1.972 1 N-CA-C 92.332 -6.914 . . . . 0.0 92.332 173.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.8 m 179.9 -161.05 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 97.336 -5.061 . . . . 0.0 97.336 -174.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 59' ' ' ILE . 1.2 m -119.77 163.55 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 100.365 -3.939 . . . . 0.0 100.365 167.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.6 -165.63 1.01 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 158.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -138.34 168.52 19.57 Favored 'General case' 0 N--CA 1.415 -2.179 1 N-CA-C 96.399 -5.408 . . . . 0.0 96.399 167.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -129.55 -176.41 3.89 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 96.68 -5.304 . . . . 0.0 96.68 -176.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -127.77 131.17 23.67 Favored Pre-proline 0 N--CA 1.42 -1.95 1 N-CA-C 95.385 -5.783 . . . . 0.0 95.385 174.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -66.79 40.71 0.17 Allowed 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.298 3.332 . . . . 0.0 116.401 -174.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.13 92.9 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 93.609 -7.796 . . . . 0.0 93.609 174.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -78.79 30.86 0.2 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -148.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -70.18 -35.98 74.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.058 0.943 . . . . 0.0 110.32 -170.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.19 -33.44 69.14 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -81.69 -11.83 58.9 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.189 -0.595 . . . . 0.0 109.969 -177.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.01 -50.08 75.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -50.58 73.33 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 123.867 0.867 . . . . 0.0 112.466 170.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.9 mt -62.63 -41.52 99.06 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 121.593 0.711 . . . . 0.0 112.135 -173.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 t -65.12 -45.83 83.51 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -67.86 -37.17 81.48 Favored 'General case' 0 CA--C 1.504 -0.808 0 O-C-N 121.669 -0.644 . . . . 0.0 112.358 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -73.16 -7.86 53.27 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.054 -1.029 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -106.22 1.61 26.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.98 29.67 37.39 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 140.83 15.27 Favored Glycine 0 CA--C 1.485 -1.798 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 172.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -92.94 -54.73 3.62 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 -164.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 m -106.46 147.63 29.11 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 102.895 -3.002 . . . . 0.0 102.895 174.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.64 154.76 25.81 Favored Glycine 0 CA--C 1.469 -2.785 1 N-CA-C 100.468 -5.053 . . . . 0.0 100.468 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -171.97 179.02 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 98.016 -4.809 . . . . 0.0 98.016 -175.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.7 m -78.05 173.93 11.67 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 119.796 1.18 . . . . 0.0 111.044 -177.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.92 164.17 37.75 Favored Glycine 0 N--CA 1.418 -2.528 1 N-CA-C 98.688 -5.765 . . . . 0.0 98.688 175.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -126.72 131.57 51.32 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 100.609 -3.849 . . . . 0.0 100.609 177.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -115.76 105.49 12.78 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.72 140.23 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -172.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.09 -36.14 4.6 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -174.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -104.17 -66.39 0.96 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -177.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.33 -150.31 22.23 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 104.963 -3.255 . . . . 0.0 104.963 -175.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.43 136.48 54.75 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.84 -162.48 1.1 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 101.998 -3.334 . . . . 0.0 101.998 -176.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.6 t -127.8 171.55 11.64 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 158.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -129.7 148.76 51.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.2 m -142.36 146.67 35.21 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -116.64 140.63 49.18 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 170.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 63.98 0.31 Allowed 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 126.342 1.857 . . . . 0.0 109.893 176.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 mt -103.09 133.88 20.09 Favored Pre-proline 0 CA--C 1.503 -0.833 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 169.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -72.52 174.64 11.31 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.624 2.216 . . . . 0.0 111.248 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -76.03 -2.08 28.93 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -165.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -90.49 -5.89 55.49 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 121.266 -0.896 . . . . 0.0 110.065 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.03 138.66 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -174.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.72 149.92 17.8 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.3 pt -146.78 -175.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -168.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.0 OUTLIER -72.42 127.75 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 121.723 0.773 . . . . 0.0 111.74 -159.637 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.07 159.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 100.833 -3.766 . . . . 0.0 100.833 168.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -143.93 158.61 43.59 Favored 'General case' 0 N--CA 1.426 -1.653 1 N-CA-C 96.208 -5.479 . . . . 0.0 96.208 164.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.03 -33.47 3.86 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -167.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -93.8 -101.74 0.14 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 172.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.5 tptm 175.16 -167.86 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.527 1 N-CA-C 97.677 -4.934 . . . . 0.0 97.677 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -94.97 134.66 37.4 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 100.851 -3.759 . . . . 0.0 100.851 168.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -157.47 150.61 23.53 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 102.129 -3.286 . . . . 0.0 102.129 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -153.97 162.07 41.49 Favored 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 96.155 -5.498 . . . . 0.0 96.155 -177.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.437 1.086 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -110.33 163.27 13.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -130.76 127.93 39.74 Favored 'General case' 0 CA--C 1.491 -1.301 1 N-CA-C 95.564 -5.717 . . . . 0.0 95.564 158.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.05 -169.83 25.95 Favored Glycine 0 CA--C 1.478 -2.261 1 N-CA-C 102.808 -4.117 . . . . 0.0 102.808 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 76.0 m-85 -80.55 142.33 34.23 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 163.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tt -90.92 141.64 14.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.971 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.702 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -119.77 -153.25 0.53 Allowed 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 128.029 2.531 . . . . 0.0 106.701 -175.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -128.84 147.46 64.65 Favored Pre-proline 0 N--CA 1.419 -1.992 1 N-CA-C 95.429 -5.767 . . . . 0.0 95.429 173.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.98 146.8 59.89 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.614 1.969 . . . . 0.0 107.31 175.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -80.93 -41.67 22.58 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 127.403 2.281 . . . . 0.0 109.845 11.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -154.02 151.87 29.85 Favored 'General case' 0 N--CA 1.417 -2.095 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 -176.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 57.7 m 173.97 -154.01 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 97.091 -5.151 . . . . 0.0 97.091 169.704 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -131.15 170.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 1 N-CA-C 97.412 -5.032 . . . . 0.0 97.412 161.536 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -161.77 0.72 Allowed 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 164.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -142.35 163.54 32.58 Favored 'General case' 0 N--CA 1.417 -2.101 1 N-CA-C 94.463 -6.125 . . . . 0.0 94.463 165.355 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -160.64 -156.89 0.5 Allowed 'General case' 0 N--CA 1.414 -2.257 1 N-CA-C 94.656 -6.053 . . . . 0.0 94.656 -174.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -145.61 169.71 9.28 Favored Pre-proline 0 N--CA 1.414 -2.25 1 N-CA-C 97.837 -4.875 . . . . 0.0 97.837 -167.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -77.33 68.4 7.49 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 CA-C-N 124.14 2.514 . . . . 0.0 111.873 -179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.82 165.94 34.59 Favored Glycine 0 CA--C 1.479 -2.166 1 N-CA-C 99.778 -5.329 . . . . 0.0 99.778 171.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -83.25 11.17 6.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 118.085 0.942 . . . . 0.0 111.32 -178.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.91 -57.02 8.32 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 128.56 2.744 . . . . 0.0 114.485 -163.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.51 -29.66 18.38 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -177.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 t -85.03 -5.06 59.36 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 121.779 -0.836 . . . . 0.0 110.873 -165.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.96 -53.04 62.89 Favored 'General case' 0 C--N 1.354 0.793 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -52.63 64.65 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.486 1.115 . . . . 0.0 112.423 171.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.88 -41.08 97.83 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 118.603 0.638 . . . . 0.0 110.998 -173.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -65.47 -42.3 92.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 121.231 -0.918 . . . . 0.0 108.78 -177.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -69.61 -40.28 76.71 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.896 -0.502 . . . . 0.0 111.136 -175.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -72.65 -30.13 64.03 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 118.535 0.607 . . . . 0.0 112.324 -178.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -81.69 -24.56 36.13 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 118.216 0.462 . . . . 0.0 109.89 176.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.61 37.92 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 159.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.89 136.86 13.87 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 104.773 -3.331 . . . . 0.0 104.773 173.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -106.34 9.64 31.84 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.74 0.781 . . . . 0.0 108.978 -165.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.6 m -160.21 157.83 28.96 Favored 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 98.886 -4.487 . . . . 0.0 98.886 163.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 170.98 44.04 Favored Glycine 0 N--CA 1.421 -2.339 1 N-CA-C 100.799 -4.92 . . . . 0.0 100.799 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -168.12 -174.44 2.33 Favored 'General case' 0 N--CA 1.432 -1.334 1 N-CA-C 97.303 -5.073 . . . . 0.0 97.303 -179.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 94.9 m -128.45 159.89 33.99 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.588 -2.745 . . . . 0.0 103.588 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.75 -179.22 48.49 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 100.721 -4.951 . . . . 0.0 100.721 -173.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -102.9 146.97 27.51 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 -171.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -119.17 113.27 20.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 101.458 -3.534 . . . . 0.0 101.458 171.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.03 132.3 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -173.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.83 15.65 33.27 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -171.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -152.4 -79.48 0.11 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 170.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.66 -168.88 39.78 Favored Glycine 0 N--CA 1.424 -2.124 1 N-CA-C 101.5 -4.64 . . . . 0.0 101.5 -165.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.96 142.15 42.04 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.87 -164.08 1.43 Allowed 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 -166.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.6 t -127.62 165.93 19.03 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 100.2 -4.0 . . . . 0.0 100.2 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 13.6 t-105 -123.33 148.04 46.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 178.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.9 m -144.51 152.3 40.38 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 175.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -115.99 140.84 48.86 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 172.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.1 42.29 0.14 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 127.145 2.178 . . . . 0.0 111.197 166.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.7 mt -85.11 134.76 40.38 Favored Pre-proline 0 CA--C 1.5 -0.97 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 177.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.32 172.92 15.36 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.127 1.885 . . . . 0.0 110.135 -178.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.66 -9.38 58.61 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -167.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -91.24 5.3 49.69 Favored 'General case' 0 CA--C 1.504 -0.818 0 O-C-N 121.544 -0.722 . . . . 0.0 109.948 -178.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -103.81 147.79 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 101.999 -3.334 . . . . 0.0 101.999 176.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.01 143.83 18.21 Favored Glycine 0 CA--C 1.478 -2.274 1 N-CA-C 101.111 -4.796 . . . . 0.0 101.111 175.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 -149.66 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -167.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.3 mp -67.4 119.78 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.031 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 174.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -91.51 -48.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -162.43 164.31 27.22 Favored 'General case' 0 CA--C 1.486 -1.517 1 N-CA-C 100.146 -4.02 . . . . 0.0 100.146 174.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.15 68.29 3.55 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 172.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -113.93 -61.8 1.69 Allowed 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -172.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 65' ' ' CYS . 16.8 tptm -157.84 -155.03 0.47 Allowed 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -172.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 3.0 t -143.31 133.91 25.02 Favored 'General case' 0 N--CA 1.417 -2.083 1 N-CA-C 93.604 -6.443 . . . . 0.0 93.604 -176.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 54.76 29.88 12.57 Favored 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 127.762 2.425 . . . . 0.0 114.535 -169.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -172.87 167.93 5.07 Favored 'General case' 0 N--CA 1.428 -1.548 1 N-CA-C 96.766 -5.272 . . . . 0.0 96.766 172.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.968 0 O-C-N 124.27 0.981 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.122 0.487 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -112.59 167.92 10.08 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 164.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -128.85 123.79 33.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 94.856 -5.979 . . . . 0.0 94.856 159.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.69 -169.75 25.44 Favored Glycine 0 CA--C 1.485 -1.791 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 -172.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.01 138.8 31.7 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 164.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 tt -90.93 144.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.71 -138.16 0.36 Allowed 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 127.874 2.47 . . . . 0.0 107.115 177.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -139.62 154.04 70.88 Favored Pre-proline 0 N--CA 1.426 -1.647 1 N-CA-C 95.597 -5.705 . . . . 0.0 95.597 166.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.87 155.4 53.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 122.836 2.049 . . . . 0.0 109.016 -172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -83.71 -27.63 28.84 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 126.764 2.025 . . . . 0.0 107.824 -1.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -158.61 152.91 24.08 Favored 'General case' 0 N--CA 1.414 -2.273 1 N-CA-C 95.123 -5.881 . . . . 0.0 95.123 175.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m 170.27 -153.55 0.01 OUTLIER 'General case' 0 CA--C 1.482 -1.662 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.32 170.4 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 1 N-CA-C 96.715 -5.291 . . . . 0.0 96.715 166.67 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -156.95 0.34 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 161.453 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -138.4 143.07 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 167.02 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.9 t -160.1 -174.44 4.55 Favored 'General case' 0 N--CA 1.419 -2.011 1 N-CA-C 96.878 -5.23 . . . . 0.0 96.878 178.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.17 173.52 5.53 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 -159.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.79 61.74 2.31 Favored 'Trans proline' 0 C--N 1.328 -0.552 0 C-N-CA 123.117 2.545 . . . . 0.0 110.108 161.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.86 138.56 2.7 Favored Glycine 0 N--CA 1.428 -1.843 1 N-CA-C 100.024 -5.231 . . . . 0.0 100.024 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -85.9 -11.48 53.09 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 123.918 0.887 . . . . 0.0 112.976 -165.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -39.29 -53.42 1.94 Allowed 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 127.963 2.505 . . . . 0.0 117.632 -153.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.94 -40.94 7.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -174.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -82.09 -14.81 55.24 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 121.586 -0.949 . . . . 0.0 110.306 -169.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.66 -45.11 93.01 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.792 0.837 . . . . 0.0 109.253 169.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -46.82 86.03 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 124.299 1.039 . . . . 0.0 111.513 172.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.32 -39.29 89.18 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-O 121.801 0.81 . . . . 0.0 111.435 -176.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.91 -44.57 67.06 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 126.116 1.766 . . . . 0.0 110.776 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.8 -54.26 47.37 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 123.196 0.598 . . . . 0.0 110.961 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.95 -20.42 62.45 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -88.74 -7.68 55.83 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.581 0.628 . . . . 0.0 110.413 172.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.79 25.99 5.2 Favored Glycine 0 CA--C 1.486 -1.758 0 CA-C-O 119.192 -0.782 . . . . 0.0 111.81 160.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.72 20.33 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.7 p -86.94 -84.2 0.18 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.5 m -81.54 161.26 23.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.27 168.35 35.83 Favored Glycine 0 N--CA 1.42 -2.416 1 N-CA-C 99.172 -5.571 . . . . 0.0 99.172 -177.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -165.03 -179.8 5.94 Favored 'General case' 0 N--CA 1.433 -1.318 1 N-CA-C 97.758 -4.904 . . . . 0.0 97.758 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.6 m -143.92 161.22 39.27 Favored 'General case' 0 CA--C 1.487 -1.45 1 N-CA-C 98.376 -4.676 . . . . 0.0 98.376 165.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.52 177.43 35.53 Favored Glycine 0 CA--C 1.488 -1.629 1 N-CA-C 97.081 -6.408 . . . . 0.0 97.081 -175.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -113.43 103.47 11.32 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 120.374 2.087 . . . . 0.0 108.559 -174.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -130.38 81.9 2.03 Favored 'General case' 0 CA--C 1.497 -1.091 1 N-CA-C 99.215 -4.365 . . . . 0.0 99.215 156.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.39 -177.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 1 N-CA-C 100.177 -4.008 . . . . 0.0 100.177 -174.65 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.51 54.61 0.37 Allowed Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -157.47 -67.18 0.1 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 102.611 -3.107 . . . . 0.0 102.611 -178.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.3 173.85 42.47 Favored Glycine 0 CA--C 1.477 -2.285 1 N-CA-C 98.533 -5.827 . . . . 0.0 98.533 -178.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tt -76.69 140.88 41.05 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -175.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.91 -172.75 4.12 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 100.882 -3.747 . . . . 0.0 100.882 -162.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -119.39 155.33 32.16 Favored 'General case' 0 CA--C 1.479 -1.773 0 C-N-CA 117.542 -1.663 . . . . 0.0 106.658 -165.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -97.49 150.4 21.11 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 176.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 46.8 m -145.14 146.69 31.89 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 103.84 -2.652 . . . . 0.0 103.84 168.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -107.64 145.47 33.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 170.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.64 38.04 1.33 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 126.065 1.746 . . . . 0.0 111.85 166.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.2 mt -78.57 133.97 62.33 Favored Pre-proline 0 CA--C 1.5 -0.952 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -65.22 166.75 18.11 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.5 2.134 . . . . 0.0 111.331 175.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.45 -5.49 52.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.969 -0.457 . . . . 0.0 112.16 -168.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -90.38 -0.57 57.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 121.69 -0.631 . . . . 0.0 109.861 177.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 t -95.74 123.74 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 102.45 -3.167 . . . . 0.0 102.45 177.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.86 145.75 16.82 Favored Glycine 0 CA--C 1.481 -2.094 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 pt -147.13 -171.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -158.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 7' ' ' ALA . 35.1 mm -54.44 111.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.939 0 C-N-CA 126.912 2.085 . . . . 0.0 112.562 -170.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.15 162.12 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 166.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -157.82 162.69 38.43 Favored 'General case' 0 N--CA 1.428 -1.571 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 -175.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.18 -1.31 76.88 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -172.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -119.18 -92.89 0.53 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -171.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -174.18 -169.36 0.46 Allowed 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -161.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.73 146.01 45.34 Favored 'General case' 0 N--CA 1.432 -1.328 1 N-CA-C 93.099 -6.63 . . . . 0.0 93.099 169.678 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -103.68 177.18 4.91 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.832 1.301 . . . . 0.0 108.698 -171.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 m -177.16 173.97 1.72 Allowed 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 95.355 -5.794 . . . . 0.0 95.355 -178.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.865 0 O-C-N 124.478 1.111 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 121.27 0.557 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -179.55 6.28 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 172.204 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -130.95 146.17 52.27 Favored 'General case' 0 CA--C 1.489 -1.393 1 N-CA-C 99.33 -4.322 . . . . 0.0 99.33 -174.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.63 -179.65 36.44 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -177.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -80.51 123.34 28.0 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 58' ' ' ILE 0.273 11.9 tt -90.67 140.9 15.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 CA-C-N 120.752 1.615 . . . . 0.0 109.453 -176.413 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.98 169.07 10.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 110.95 -2.841 . . . . 0.0 112.092 177.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 14' ' ' TYR 0.252 26.6 tt0 -95.9 151.22 38.21 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 174.745 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -63.03 132.34 36.34 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.978 2.452 . . . . 0.0 109.336 165.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.94 -50.86 9.83 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 122.001 2.182 . . . . 0.0 110.843 14.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -168.06 156.28 8.79 Favored 'General case' 0 N--CA 1.425 -1.708 1 N-CA-C 95.369 -5.789 . . . . 0.0 95.369 167.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 18.7 m 158.52 -144.84 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.428 1 N-CA-C 97.985 -4.821 . . . . 0.0 97.985 -176.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 59' ' ' ILE . 3.6 m -106.02 165.14 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 165.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -91.0 -167.93 1.94 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 162.787 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -136.73 161.75 35.07 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 168.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.9 t -132.41 163.97 27.54 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 101.341 -3.577 . . . . 0.0 101.341 -160.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -109.43 126.95 28.1 Favored Pre-proline 0 N--CA 1.423 -1.775 1 N-CA-C 99.554 -4.239 . . . . 0.0 99.554 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.91 41.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.485 0 C-N-CA 123.843 3.029 . . . . 0.0 116.617 174.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.93 115.41 0.66 Allowed Glycine 0 N--CA 1.423 -2.217 1 N-CA-C 94.436 -7.466 . . . . 0.0 94.436 171.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -60.48 -32.76 71.73 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -156.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.2 m -41.18 -43.88 2.43 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 127.807 2.443 . . . . 0.0 116.373 -168.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -55.89 26.91 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 121.116 -0.99 . . . . 0.0 112.017 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -21.61 36.55 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 121.642 -0.916 . . . . 0.0 110.091 -173.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.11 -35.32 78.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.542 0.737 . . . . 0.0 109.641 169.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 m -70.61 -40.1 73.37 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 177.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.75 -39.61 94.71 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.7 t -57.17 -42.57 81.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.652 1.181 . . . . 0.0 111.176 177.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -60.55 -51.85 67.68 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.833 0.453 . . . . 0.0 110.821 -179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.88 -18.94 62.67 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.31 -2.32 57.99 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.802 -0.561 . . . . 0.0 111.325 174.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.58 24.91 12.74 Favored Glycine 0 C--N 1.351 1.368 0 O-C-N 121.601 -0.687 . . . . 0.0 111.754 170.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.03 157.89 21.15 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 172.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 p -81.43 -40.86 22.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.41 157.5 27.87 Favored 'General case' 0 N--CA 1.418 -2.028 1 N-CA-C 98.524 -4.621 . . . . 0.0 98.524 -164.025 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.14 173.87 45.29 Favored Glycine 0 CA--C 1.475 -2.449 1 N-CA-C 102.085 -4.406 . . . . 0.0 102.085 -176.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -170.72 -143.98 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 -172.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.5 m -121.36 -175.37 3.06 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 -170.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.49 -168.58 33.29 Favored Glycine 0 N--CA 1.417 -2.624 1 N-CA-C 96.845 -6.502 . . . . 0.0 96.845 172.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -141.97 157.87 44.44 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 96.884 -5.228 . . . . 0.0 96.884 172.328 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -162.55 177.84 9.1 Favored 'General case' 0 N--CA 1.423 -1.784 1 N-CA-C 96.036 -5.542 . . . . 0.0 96.036 172.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.41 171.0 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 1 N-CA-C 96.283 -5.451 . . . . 0.0 96.283 179.119 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.03 -49.53 0.85 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 104.005 -3.638 . . . . 0.0 104.005 -173.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -115.43 -70.19 0.81 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.33 -159.9 32.98 Favored Glycine 0 CA--C 1.482 -1.979 0 N-CA-C 103.367 -3.893 . . . . 0.0 103.367 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.06 136.27 58.03 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.761 2.024 . . . . 0.0 106.831 179.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.49 168.32 20.06 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 102.807 -3.034 . . . . 0.0 102.807 -161.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.79 179.05 4.39 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -140.37 146.82 38.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.845 -3.02 . . . . 0.0 102.845 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.2 m -135.73 151.18 49.89 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 177.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -112.12 137.69 49.83 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 173.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 56.9 71.88 0.55 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 127.753 2.421 . . . . 0.0 113.253 174.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.6 mt -103.77 143.59 26.95 Favored Pre-proline 0 CA--C 1.504 -0.809 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 172.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -69.21 173.39 10.55 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.251 1.967 . . . . 0.0 113.288 174.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.06 -17.64 61.4 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.067 1.347 . . . . 0.0 111.549 -174.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -94.3 18.91 10.19 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.592 0.757 . . . . 0.0 109.485 179.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -118.97 164.74 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 1 N-CA-C 98.773 -4.528 . . . . 0.0 98.773 167.025 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.06 175.1 30.91 Favored Glycine 0 CA--C 1.485 -1.803 1 N-CA-C 99.783 -5.327 . . . . 0.0 99.783 -175.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -159.22 -170.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 -156.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 13' ' ' VAL . 17.5 mm -38.9 -43.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 129.844 3.258 . . . . 0.0 118.908 -147.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.84 -57.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.472 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 75.63 -95.88 0.02 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -154.1 33.38 0.72 Allowed Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 103.209 -3.957 . . . . 0.0 103.209 168.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -123.14 -105.66 0.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 35.9 tttp 179.33 -157.24 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 102.419 -3.178 . . . . 0.0 102.419 -169.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.431 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -137.55 135.35 36.61 Favored 'General case' 0 N--CA 1.426 -1.657 1 N-CA-C 94.775 -6.009 . . . . 0.0 94.775 -176.072 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -167.26 156.52 10.35 Favored 'General case' 0 CA--C 1.487 -1.463 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -176.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -179.32 176.82 0.81 Allowed 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 95.915 -5.587 . . . . 0.0 95.915 -176.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.901 0 O-C-N 124.112 0.883 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.93 0.871 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -117.73 164.44 14.98 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -139.91 136.51 33.96 Favored 'General case' 0 CA--C 1.485 -1.536 1 N-CA-C 96.02 -5.548 . . . . 0.0 96.02 167.296 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.93 -178.13 35.57 Favored Glycine 0 CA--C 1.476 -2.399 0 N-CA-C 104.165 -3.574 . . . . 0.0 104.165 174.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -75.02 130.8 39.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.359 -3.201 . . . . 0.0 102.359 157.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -84.1 135.84 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -102.68 -136.61 0.34 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 110.711 -2.949 . . . . 0.0 109.256 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -146.43 159.24 45.5 Favored Pre-proline 0 N--CA 1.423 -1.79 1 N-CA-C 96.188 -5.486 . . . . 0.0 96.188 172.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.11 141.89 44.99 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.37 2.047 . . . . 0.0 108.484 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.22 -32.42 13.04 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 127.962 2.505 . . . . 0.0 107.601 7.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -150.34 147.21 27.32 Favored 'General case' 0 N--CA 1.412 -2.345 1 N-CA-C 94.126 -6.25 . . . . 0.0 94.126 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -159.47 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.606 HG12 HD12 ' A' ' 59' ' ' ILE . 2.4 m -133.58 157.8 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 98.444 -4.65 . . . . 0.0 98.444 162.273 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 -155.16 0.27 Allowed 'General case' 0 C--N 1.358 0.936 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 161.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -138.63 154.97 48.68 Favored 'General case' 0 CA--C 1.473 -2.004 1 N-CA-C 97.496 -5.002 . . . . 0.0 97.496 177.364 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.25 175.31 6.49 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -158.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.89 85.58 57.42 Favored Pre-proline 0 N--CA 1.411 -2.419 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -175.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -78.0 -4.39 14.36 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.133 1.889 . . . . 0.0 109.63 165.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.27 141.09 10.84 Favored Glycine 0 CA--C 1.484 -1.901 1 N-CA-C 96.815 -6.514 . . . . 0.0 96.815 174.169 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -68.06 -55.13 13.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -153.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -63.47 5.95 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 -155.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.17 -93.05 1.31 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 169.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.92 -17.86 62.06 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.521 1.128 . . . . 0.0 111.61 -166.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -62.31 -49.84 74.04 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 121.082 1.765 . . . . 0.0 109.499 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.72 89.85 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.812 2.045 . . . . 0.0 111.884 173.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.33 -44.09 88.91 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.815 0.817 . . . . 0.0 110.968 -178.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.9 t -58.67 -43.88 90.01 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 125.182 1.393 . . . . 0.0 109.03 177.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -53.51 54.91 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.099 0.96 . . . . 0.0 111.262 -178.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -67.28 -26.39 66.52 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 121.785 -0.572 . . . . 0.0 112.474 -175.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -79.86 -13.12 59.63 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 123.39 0.676 . . . . 0.0 110.498 177.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.31 23.87 8.74 Favored Glycine 0 CA--C 1.49 -1.491 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.87 119.87 6.13 Favored Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 105.134 -3.187 . . . . 0.0 105.134 170.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 p -82.45 -11.97 58.15 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.695 0.759 . . . . 0.0 110.087 -172.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.97 149.01 17.54 Favored 'General case' 0 N--CA 1.415 -2.207 1 N-CA-C 97.605 -4.961 . . . . 0.0 97.605 -160.094 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.45 175.62 47.24 Favored Glycine 0 CA--C 1.476 -2.397 1 N-CA-C 97.963 -6.055 . . . . 0.0 97.963 -178.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.457 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 12.7 p-80 -165.79 168.54 15.92 Favored 'General case' 0 N--CA 1.425 -1.676 1 N-CA-C 98.191 -4.744 . . . . 0.0 98.191 179.377 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.8 t -100.33 166.16 11.11 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 177.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.1 -170.27 40.05 Favored Glycine 0 N--CA 1.425 -2.054 1 N-CA-C 97.754 -6.138 . . . . 0.0 97.754 -173.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -134.77 154.39 51.61 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 100.237 -3.986 . . . . 0.0 100.237 -179.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -150.29 149.82 30.65 Favored 'General case' 0 N--CA 1.426 -1.652 1 N-CA-C 94.231 -6.211 . . . . 0.0 94.231 172.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.97 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.57 -71.64 1.12 Allowed Glycine 0 CA--C 1.487 -1.664 0 N-CA-C 108.204 -1.959 . . . . 0.0 108.204 171.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 m170 -99.59 -42.31 6.96 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.87 -70.79 0.09 OUTLIER Glycine 0 CA--C 1.483 -1.942 0 C-N-CA 118.274 -1.917 . . . . 0.0 108.74 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 tp -158.68 161.95 37.17 Favored 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 95.535 -5.728 . . . . 0.0 95.535 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.35 172.99 16.33 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 -171.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -128.55 167.41 17.15 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 100.98 -3.711 . . . . 0.0 100.98 -175.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.457 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 27.4 t-105 -116.7 145.2 43.61 Favored 'General case' 0 C--N 1.364 1.2 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 176.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.6 m -133.94 143.82 48.44 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 170.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -127.38 121.7 31.67 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 -172.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.43 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 127.942 2.497 . . . . 0.0 108.076 -177.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.49 135.44 20.64 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-O 117.084 -1.436 . . . . 0.0 107.433 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -67.88 165.91 26.34 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.434 2.089 . . . . 0.0 112.653 176.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.84 -13.94 62.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.252 1.021 . . . . 0.0 112.484 -174.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -91.44 5.58 48.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.85 0.86 . . . . 0.0 110.995 -179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -108.38 -174.96 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.71 169.22 33.97 Favored Glycine 0 CA--C 1.482 -2.022 1 N-CA-C 101.877 -4.489 . . . . 0.0 101.877 -170.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.7 pt -155.53 -168.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 101.722 -3.436 . . . . 0.0 101.722 -162.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 HD12 HG12 ' A' ' 13' ' ' VAL . 1.2 mm -70.79 131.25 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -178.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.5 t -111.65 109.6 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 101.176 -3.639 . . . . 0.0 101.176 176.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 62.77 -117.86 0.56 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.188 1.395 . . . . 0.0 107.879 -170.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.1 47.05 0.32 Allowed Glycine 0 N--CA 1.428 -1.896 1 N-CA-C 98.795 -5.722 . . . . 0.0 98.795 165.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.09 -59.99 2.5 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.57 0.7 . . . . 0.0 110.341 -162.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -161.09 -178.44 6.76 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.774 -3.787 . . . . 0.0 100.774 -171.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.0 t -123.73 148.04 46.95 Favored 'General case' 0 N--CA 1.427 -1.587 1 N-CA-C 98.594 -4.595 . . . . 0.0 98.594 172.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -167.24 159.81 13.1 Favored 'General case' 0 CA--C 1.482 -1.637 1 N-CA-C 99.662 -4.199 . . . . 0.0 99.662 175.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -150.17 165.08 33.96 Favored 'General case' 0 N--CA 1.423 -1.781 1 N-CA-C 96.598 -5.334 . . . . 0.0 96.598 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.93 0 O-C-N 124.53 1.144 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.257 0.551 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -98.7 169.6 9.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 162.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -125.44 146.34 49.67 Favored 'General case' 0 CA--C 1.487 -1.443 1 N-CA-C 93.329 -6.545 . . . . 0.0 93.329 156.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.46 179.31 36.95 Favored Glycine 0 CA--C 1.468 -2.879 0 C-N-CA 116.542 -2.742 . . . . 0.0 107.55 -177.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 40' ' ' LYS . 41.8 m-85 -87.34 132.7 33.86 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 100.832 -3.766 . . . . 0.0 100.832 157.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.62 140.54 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -178.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.64 -138.46 0.36 Allowed 'General case' 0 N--CA 1.426 -1.673 0 O-C-N 126.849 2.593 . . . . 0.0 106.982 -178.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -133.27 153.39 80.62 Favored Pre-proline 0 N--CA 1.421 -1.912 1 N-CA-C 94.915 -5.957 . . . . 0.0 94.915 166.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -64.19 135.31 46.36 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 CA-C-N 123.12 2.15 . . . . 0.0 106.571 163.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -94.9 -37.61 11.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 121.952 2.16 . . . . 0.0 109.648 17.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -158.74 148.43 19.28 Favored 'General case' 0 N--CA 1.422 -1.853 1 N-CA-C 94.639 -6.06 . . . . 0.0 94.639 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.3 m 170.73 -158.55 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.939 1 N-CA-C 99.955 -4.091 . . . . 0.0 99.955 176.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 59' ' ' ILE . 1.2 m -122.92 165.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 N-CA-C 99.515 -4.254 . . . . 0.0 99.515 157.859 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -155.48 0.21 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -139.35 179.31 6.61 Favored 'General case' 0 CA--C 1.482 -1.651 1 N-CA-C 97.853 -4.869 . . . . 0.0 97.853 160.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.56 171.17 14.42 Favored 'General case' 0 N--CA 1.415 -2.194 1 N-CA-C 97.276 -5.083 . . . . 0.0 97.276 -177.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -125.75 121.74 24.52 Favored Pre-proline 0 N--CA 1.415 -2.202 1 N-CA-C 97.762 -4.903 . . . . 0.0 97.762 176.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -55.28 113.96 1.65 Allowed 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.262 2.641 . . . . 0.0 112.661 176.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.22 -43.51 1.05 Allowed Glycine 0 CA--C 1.489 -1.57 1 N-CA-C 101.86 -4.496 . . . . 0.0 101.86 -163.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.254 67.6 m 85.47 -7.84 0.84 Allowed 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 127.448 2.299 . . . . 0.0 113.101 172.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -51.32 -49.6 61.04 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.479 1.512 . . . . 0.0 113.595 -171.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -38.98 62.0 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -177.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.32 -47.16 77.5 Favored 'General case' 0 CA--C 1.488 -1.437 0 O-C-N 121.757 -0.849 . . . . 0.0 109.698 -177.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.9 -40.1 94.29 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.485 0.66 . . . . 0.0 109.792 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.6 m -63.05 -48.63 77.9 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.438 0.695 . . . . 0.0 110.929 175.016 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.05 -36.13 83.37 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.132 0.973 . . . . 0.0 111.055 -177.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.4 t -60.23 -43.18 96.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.724 1.21 . . . . 0.0 110.448 175.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -68.55 -41.38 79.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.784 -0.573 . . . . 0.0 111.966 -175.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.89 -11.77 60.95 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.457 -0.777 . . . . 0.0 112.45 -178.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -99.55 -0.69 40.01 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 123.443 0.697 . . . . 0.0 109.75 174.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.09 28.36 18.1 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 170.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.48 152.4 20.17 Favored Glycine 0 C--N 1.356 1.66 0 N-CA-C 106.18 -2.768 . . . . 0.0 106.18 170.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.3 p -80.9 -38.74 27.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 121.451 -1.029 . . . . 0.0 110.635 -166.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 m -160.54 173.36 15.65 Favored 'General case' 0 N--CA 1.427 -1.613 1 N-CA-C 98.805 -4.517 . . . . 0.0 98.805 166.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.31 168.88 41.19 Favored Glycine 0 N--CA 1.424 -2.133 1 N-CA-C 99.386 -5.486 . . . . 0.0 99.386 -172.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -163.72 172.53 14.06 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -172.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -72.49 156.18 39.3 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 119.412 1.006 . . . . 0.0 110.831 -177.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.21 -179.39 40.63 Favored Glycine 0 N--CA 1.42 -2.378 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 168.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -145.14 154.45 42.46 Favored 'General case' 0 N--CA 1.426 -1.672 1 N-CA-C 96.082 -5.525 . . . . 0.0 96.082 -175.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -137.49 18.84 2.91 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.976 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 42' ' ' GLY 0.27 2.3 t 61.75 -142.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -167.746 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 76.0 -74.53 1.61 Allowed Glycine 0 CA--C 1.495 -1.176 0 C-N-CA 124.071 0.843 . . . . 0.0 111.709 168.063 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -113.08 -76.14 0.59 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.78 -174.28 41.33 Favored Glycine 0 CA--C 1.478 -2.236 1 N-CA-C 100.582 -5.007 . . . . 0.0 100.582 -168.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.0 tp -52.3 134.89 33.55 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 127.245 2.218 . . . . 0.0 108.561 177.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.69 -167.67 1.84 Allowed 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 -167.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.02 153.73 48.12 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.076 -4.416 . . . . 0.0 99.076 172.449 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -105.65 152.01 23.66 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.52 144.65 33.05 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -103.31 142.26 34.51 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 167.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.68 74.37 0.44 Allowed 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.013 2.525 . . . . 0.0 112.602 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.2 mt -108.29 134.83 20.06 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.8 170.02 20.61 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.24 179.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.77 -17.35 64.57 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 125.213 1.405 . . . . 0.0 114.008 -166.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -84.37 -7.67 59.24 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 124.205 1.002 . . . . 0.0 110.907 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 t -96.55 125.95 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 -176.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 143.8 16.74 Favored Glycine 0 CA--C 1.482 -1.969 0 N-CA-C 104.486 -3.445 . . . . 0.0 104.486 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.9 pt -130.41 -150.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -165.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.588 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -74.3 117.37 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 177.133 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.39 108.83 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 -176.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 62.5 -125.9 0.68 Allowed 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -173.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.46 46.71 0.55 Allowed Glycine 0 CA--C 1.485 -1.807 1 N-CA-C 101.606 -4.598 . . . . 0.0 101.606 165.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -99.08 -61.2 1.4 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -164.018 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -122.42 165.87 15.64 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -160.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.5 t -141.12 136.02 31.49 Favored 'General case' 0 N--CA 1.425 -1.72 1 N-CA-C 96.571 -5.344 . . . . 0.0 96.571 167.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.05 118.52 2.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 169.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.6 m -83.2 118.07 23.36 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.363 1.155 0 O-C-N 123.384 0.428 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.467 0.651 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -104.72 155.21 19.08 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 165.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -120.36 126.14 49.75 Favored 'General case' 0 CA--C 1.485 -1.552 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 157.265 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -162.45 13.09 Favored Glycine 0 CA--C 1.481 -2.061 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 -174.399 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.58 141.37 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.268 -3.975 . . . . 0.0 100.268 163.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tt -90.42 147.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 173.094 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.826 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -150.62 177.0 10.47 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 98.482 -4.636 . . . . 0.0 98.482 -179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -86.53 158.37 54.45 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.079 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 61.6 Cg_exo -62.31 118.06 4.94 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.467 2.111 . . . . 0.0 109.589 168.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.0 mm-40 -130.87 114.22 15.02 Favored 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 127.74 2.416 . . . . 0.0 105.365 2.483 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 65.74 40.15 4.47 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 110.279 169.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.66 125.03 43.46 Favored 'General case' 0 CA--C 1.479 -1.751 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 168.268 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.269 35.0 m -69.58 169.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 122.637 1.208 . . . . 0.0 113.832 -161.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.2 131.21 50.71 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 92.062 -7.014 . . . . 0.0 92.062 -178.478 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 16' ' ' CYS . 59.4 m80 -92.88 -146.32 0.23 Allowed 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -170.389 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' H ' ' HB3' ' A' ' 15' ' ' HIS . 3.8 t -151.09 155.45 39.0 Favored 'General case' 0 N--CA 1.419 -2.015 1 N-CA-C 93.821 -6.363 . . . . 0.0 93.821 -174.539 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -108.98 112.8 59.87 Favored Pre-proline 0 N--CA 1.43 -1.431 1 N-CA-C 99.037 -4.431 . . . . 0.0 99.037 168.366 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -52.92 106.12 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.448 2.765 . . . . 0.0 117.665 -166.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.57 -166.46 38.48 Favored Glycine 0 N--CA 1.421 -2.343 1 N-CA-C 94.561 -7.416 . . . . 0.0 94.561 179.258 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 m -79.56 -29.19 41.22 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 119.722 1.761 . . . . 0.0 107.778 170.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -40.28 -57.44 1.74 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.505 3.922 . . . . 0.0 115.414 -168.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.92 -34.94 55.11 Favored Glycine 0 CA--C 1.492 -1.39 0 O-C-N 120.767 -1.208 . . . . 0.0 112.132 -168.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.86 -36.93 35.95 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.36 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -55.4 -49.76 71.51 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 123.79 0.836 . . . . 0.0 109.207 173.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 m -58.17 -54.96 41.12 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.456 0.702 . . . . 0.0 111.35 175.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -60.97 -46.52 90.4 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 124.669 1.188 . . . . 0.0 111.51 -174.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -65.39 -42.95 92.11 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -175.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.35 -42.77 74.81 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 118.171 0.442 . . . . 0.0 111.706 -179.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -72.11 -22.79 61.28 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.42 -0.8 . . . . 0.0 111.973 -173.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -46.62 9.18 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.676 -0.64 . . . . 0.0 109.558 172.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.01 48.66 0.18 Allowed Glycine 0 CA--C 1.487 -1.711 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 168.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.24 149.9 18.53 Favored Glycine 0 CA--C 1.488 -1.626 1 N-CA-C 102.114 -4.394 . . . . 0.0 102.114 163.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 p -89.16 -62.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 118.011 0.906 . . . . 0.0 109.129 -169.241 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -94.34 150.57 20.16 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.13 167.24 39.71 Favored Glycine 0 CA--C 1.478 -2.225 1 N-CA-C 100.826 -4.909 . . . . 0.0 100.826 176.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -170.04 172.76 6.3 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 100.249 -3.982 . . . . 0.0 100.249 -178.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.2 m -113.15 145.26 41.26 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -178.052 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.8 90.92 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.739 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -174.14 176.93 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 97.933 -4.839 . . . . 0.0 97.933 178.197 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp 170.25 49.96 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 170.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.49 140.31 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 -172.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.66 -63.64 3.55 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 121.525 -0.734 . . . . 0.0 111.304 161.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -107.59 -52.51 2.75 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -176.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.25 -146.88 11.14 Favored Glycine 0 N--CA 1.42 -2.401 1 N-CA-C 95.024 -7.23 . . . . 0.0 95.024 -174.582 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 162.92 20.33 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.155 0.977 . . . . 0.0 108.63 171.386 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.16 169.57 17.36 Favored 'General case' 0 CA--C 1.485 -1.555 1 N-CA-C 98.395 -4.668 . . . . 0.0 98.395 -178.096 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.46 141.0 42.51 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 -170.202 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -88.37 150.07 23.39 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.9 m -149.23 138.5 21.5 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -108.27 136.49 47.84 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 170.246 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.67 56.36 0.14 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 126.187 1.795 . . . . 0.0 110.559 168.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.33 132.81 34.55 Favored Pre-proline 0 CA--C 1.498 -1.023 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 170.193 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 172.42 14.2 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.116 2.544 . . . . 0.0 110.169 177.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.0 -20.06 63.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 125.694 1.598 . . . . 0.0 113.824 -169.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -82.77 -4.45 57.96 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 121.511 -0.743 . . . . 0.0 111.486 -172.014 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -101.3 126.73 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -175.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.27 148.8 18.52 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 103.204 -3.958 . . . . 0.0 103.204 176.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.7 pt -148.03 -146.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 -159.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.826 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.6 mm -71.27 118.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.144 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.32 162.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -159.303 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 77.89 -112.27 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 127.895 2.478 . . . . 0.0 106.52 -173.104 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.53 59.58 0.04 OUTLIER Glycine 0 CA--C 1.479 -2.18 1 N-CA-C 97.672 -6.171 . . . . 0.0 97.672 -177.508 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 10.7 tp10 -170.06 -162.36 0.31 Allowed 'General case' 0 N--CA 1.421 -1.909 1 N-CA-C 98.262 -4.718 . . . . 0.0 98.262 -162.341 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 32.7 tttp -113.56 -146.32 0.41 Allowed 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 -179.08 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.8 t -79.93 146.28 32.2 Favored 'General case' 0 CA--C 1.494 -1.178 0 C-N-CA 125.725 1.61 . . . . 0.0 109.403 -169.022 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -151.86 167.8 27.14 Favored 'General case' 0 N--CA 1.423 -1.819 1 N-CA-C 99.059 -4.423 . . . . 0.0 99.059 174.527 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 m -75.51 58.08 1.0 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.054 1.342 . . . . 0.0 112.424 -171.31 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.944 0 CA-C-N 116.543 -0.299 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.192 0.52 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -101.08 159.31 15.34 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 165.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -126.33 122.77 36.39 Favored 'General case' 0 CA--C 1.484 -1.588 1 N-CA-C 94.19 -6.226 . . . . 0.0 94.19 159.793 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.63 38.15 Favored Glycine 0 CA--C 1.473 -2.581 0 N-CA-C 104.39 -3.484 . . . . 0.0 104.39 -173.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -79.64 131.4 35.97 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 165.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.4 tt -90.39 141.57 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -176.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -105.22 -141.81 0.37 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -178.493 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -131.95 150.9 77.45 Favored Pre-proline 0 N--CA 1.419 -2.02 1 N-CA-C 94.586 -6.079 . . . . 0.0 94.586 166.011 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.7 144.01 58.31 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 N-CA-C 106.629 -2.104 . . . . 0.0 106.629 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.57 -36.64 13.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.635 1.974 . . . . 0.0 109.165 12.795 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.88 150.08 28.93 Favored 'General case' 0 N--CA 1.418 -2.056 1 N-CA-C 94.707 -6.034 . . . . 0.0 94.707 175.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.55 -160.66 0.02 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -176.316 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.638 HG12 HD12 ' A' ' 59' ' ' ILE . 16.0 m -129.33 165.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 1 N-CA-C 96.568 -5.345 . . . . 0.0 96.568 152.64 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.32 158.41 19.68 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 100.235 -3.987 . . . . 0.0 100.235 163.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -107.71 147.22 31.04 Favored 'General case' 0 CA--C 1.47 -2.103 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 -177.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -159.41 -177.99 6.83 Favored 'General case' 0 N--CA 1.409 -2.484 1 N-CA-C 95.763 -5.643 . . . . 0.0 95.763 -168.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -139.76 171.46 7.89 Favored Pre-proline 0 N--CA 1.414 -2.227 1 N-CA-C 98.867 -4.494 . . . . 0.0 98.867 -156.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -66.15 42.92 0.17 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 123.967 3.112 . . . . 0.0 114.308 169.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.83 129.52 1.49 Allowed Glycine 0 N--CA 1.423 -2.229 1 N-CA-C 100.203 -5.159 . . . . 0.0 100.203 -176.398 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.25 33.69 1.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 125.673 1.589 . . . . 0.0 111.083 -171.063 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 m -56.48 -43.63 79.81 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 126.437 1.895 . . . . 0.0 113.133 -173.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -33.29 8.97 Favored Glycine 0 C--N 1.352 1.431 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.0 t -61.72 -36.71 81.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 125.018 1.327 . . . . 0.0 111.408 -170.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.97 -53.84 43.92 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.121 0.968 . . . . 0.0 110.588 176.379 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -36.84 84.89 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.629 1.172 . . . . 0.0 112.884 177.061 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.02 -39.78 87.1 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 122.076 0.941 . . . . 0.0 109.733 -179.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -61.36 -42.87 99.4 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.444 0.697 . . . . 0.0 110.792 -179.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -60.65 -47.79 84.68 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.785 0.834 . . . . 0.0 111.033 178.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.37 -17.55 62.41 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.211 -0.931 . . . . 0.0 112.739 -174.003 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -96.3 -5.17 40.75 Favored 'General case' 0 CA--C 1.505 -0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.208 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.35 11.85 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.009 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.35 159.48 19.29 Favored Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 105.721 -2.951 . . . . 0.0 105.721 168.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -71.51 -60.74 2.07 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.758 1.266 . . . . 0.0 108.747 -170.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.96 -171.05 2.92 Favored 'General case' 0 N--CA 1.425 -1.711 1 N-CA-C 97.323 -5.065 . . . . 0.0 97.323 169.438 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.99 -158.18 16.68 Favored Glycine 0 N--CA 1.419 -2.453 1 N-CA-C 101.732 -4.547 . . . . 0.0 101.732 -175.769 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -163.11 -170.2 2.24 Favored 'General case' 0 N--CA 1.429 -1.501 1 N-CA-C 97.467 -5.012 . . . . 0.0 97.467 -171.188 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.9 m -128.61 165.58 20.52 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 174.171 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.72 -170.92 43.03 Favored Glycine 0 N--CA 1.42 -2.383 1 N-CA-C 96.847 -6.501 . . . . 0.0 96.847 -176.353 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -139.46 161.85 36.48 Favored 'General case' 0 N--CA 1.431 -1.406 1 N-CA-C 99.759 -4.163 . . . . 0.0 99.759 -174.485 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 150.4 40.54 Favored 'General case' 0 N--CA 1.428 -1.553 1 N-CA-C 94.237 -6.208 . . . . 0.0 94.237 159.88 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.5 t -75.99 126.57 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 119.539 1.063 . . . . 0.0 108.326 -165.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.87 -78.23 0.05 OUTLIER Glycine 0 CA--C 1.483 -1.957 0 N-CA-C 104.382 -3.487 . . . . 0.0 104.382 178.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -108.3 -105.32 0.35 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.375 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.6 98.21 0.18 Allowed Glycine 0 CA--C 1.489 -1.58 0 N-CA-C 105.248 -3.141 . . . . 0.0 105.248 -171.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.333 0.2 OUTLIER 59.33 -166.91 0.17 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 127.764 2.425 . . . . 0.0 110.712 -170.322 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -164.98 -179.47 5.77 Favored 'General case' 0 N--CA 1.427 -1.605 1 N-CA-C 99.878 -4.119 . . . . 0.0 99.878 168.661 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -122.55 152.99 39.83 Favored 'General case' 0 CA--C 1.494 -1.186 1 N-CA-C 98.078 -4.786 . . . . 0.0 98.078 175.282 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -104.87 156.01 18.4 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 176.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.01 141.78 32.87 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 102.438 -3.171 . . . . 0.0 102.438 165.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -108.18 122.31 46.65 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 177.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.62 82.3 0.14 Allowed 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 127.188 2.195 . . . . 0.0 109.924 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.8 mt -106.67 135.12 19.56 Favored Pre-proline 0 CA--C 1.49 -1.342 0 N-CA-C 103.417 -2.809 . . . . 0.0 103.417 170.155 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.88 170.49 16.6 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.078 1.852 . . . . 0.0 110.385 171.216 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -82.1 7.06 14.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -162.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -90.08 -8.03 52.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.737 0.815 . . . . 0.0 108.961 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 t -99.13 138.17 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -174.171 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.43 148.11 16.65 Favored Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 103.976 -3.649 . . . . 0.0 103.976 178.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.1 pt -134.6 -156.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -167.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -72.59 128.51 35.5 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -121.34 114.01 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 101.647 -3.464 . . . . 0.0 101.647 178.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 60.3 -128.67 1.0 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.513 1.125 . . . . 0.0 108.167 -174.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -159.9 45.98 0.42 Allowed Glycine 0 N--CA 1.432 -1.608 1 N-CA-C 101.135 -4.786 . . . . 0.0 101.135 164.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -76.56 -58.5 3.25 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 -164.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER -165.01 -168.36 1.41 Allowed 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 100.096 -4.038 . . . . 0.0 100.096 -176.174 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.408 ' H ' ' HG3' ' A' ' 64' ' ' LYS . 15.1 t -127.3 153.53 46.04 Favored 'General case' 0 N--CA 1.424 -1.751 1 N-CA-C 99.266 -4.346 . . . . 0.0 99.266 178.42 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 119.72 5.51 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 164.103 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 m -75.97 117.45 17.7 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 123.742 0.817 . . . . 0.0 108.837 -174.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.059 0 CA-C-N 116.236 -0.438 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 170.7 9.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 171.14 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -130.32 133.74 46.67 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 95.862 -5.607 . . . . 0.0 95.862 168.433 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.75 -176.07 33.45 Favored Glycine 0 CA--C 1.489 -1.569 0 C-N-CA 118.527 -1.797 . . . . 0.0 109.627 -175.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -86.74 125.03 33.64 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 169.334 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -90.66 146.26 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 119.348 0.977 . . . . 0.0 108.44 -174.594 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -110.64 -163.98 0.89 Allowed 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 127.477 2.311 . . . . 0.0 105.998 -175.82 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -128.51 159.01 69.99 Favored Pre-proline 0 N--CA 1.422 -1.846 1 N-CA-C 96.44 -5.393 . . . . 0.0 96.44 169.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -68.57 155.77 67.85 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 CA-C-N 122.621 1.972 . . . . 0.0 109.189 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -99.21 -19.97 16.85 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 128.901 2.88 . . . . 0.0 108.502 4.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -149.72 151.57 33.87 Favored 'General case' 0 CA--C 1.479 -1.761 1 N-CA-C 92.592 -6.818 . . . . 0.0 92.592 158.079 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -176.07 -163.69 0.11 Allowed 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 171.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.7 HG12 HD12 ' A' ' 59' ' ' ILE . 5.7 m -128.75 160.3 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 1 N-CA-C 95.904 -5.591 . . . . 0.0 95.904 160.648 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.26 -164.47 0.7 Allowed 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.513 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -137.86 168.62 19.32 Favored 'General case' 0 N--CA 1.418 -2.063 1 N-CA-C 95.186 -5.857 . . . . 0.0 95.186 176.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -142.85 155.88 44.84 Favored 'General case' 0 CA--C 1.474 -1.966 1 N-CA-C 96.973 -5.195 . . . . 0.0 96.973 -166.277 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -114.46 119.35 40.12 Favored Pre-proline 0 N--CA 1.421 -1.921 1 N-CA-C 95.319 -5.808 . . . . 0.0 95.319 167.21 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.91 95.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 124.728 2.724 . . . . 0.0 117.444 -162.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.19 -173.15 41.69 Favored Glycine 0 N--CA 1.422 -2.293 1 N-CA-C 97.787 -6.125 . . . . 0.0 97.787 -179.388 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -89.67 -13.9 35.98 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 118.173 0.987 . . . . 0.0 109.455 178.636 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.41 -60.56 1.89 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 129.557 3.143 . . . . 0.0 116.566 -161.32 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 -36.49 23.09 Favored Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.4 m -80.47 -16.1 55.16 Favored 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 123.141 0.576 . . . . 0.0 110.793 -174.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.89 -51.68 68.61 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 118.955 0.798 . . . . 0.0 108.951 168.451 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.49 81.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.73 0.812 . . . . 0.0 112.661 174.077 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -67.23 -38.69 85.65 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 122.129 0.966 . . . . 0.0 111.645 -174.191 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.9 t -66.4 -34.7 78.54 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 121.311 -0.868 . . . . 0.0 110.28 178.56 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -40.54 89.22 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.374 0.669 . . . . 0.0 111.477 -177.177 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.54 -28.77 59.17 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 122.159 -0.338 . . . . 0.0 110.978 -177.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.02 -27.41 24.82 Favored 'General case' 0 C--N 1.355 0.848 0 O-C-N 121.951 -0.468 . . . . 0.0 110.768 179.422 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.28 42.62 1.06 Allowed Glycine 0 CA--C 1.491 -1.423 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 163.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.96 157.33 15.06 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 105.887 -2.885 . . . . 0.0 105.887 162.224 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -94.08 -9.9 35.12 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 122.178 -0.601 . . . . 0.0 110.559 -163.662 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 m -149.5 149.62 31.04 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 179.597 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.78 138.61 9.94 Favored Glycine 0 CA--C 1.475 -2.409 1 N-CA-C 98.847 -5.701 . . . . 0.0 98.847 -178.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -141.45 -162.64 1.41 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 101.663 -3.458 . . . . 0.0 101.663 -177.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.77 169.15 9.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 -170.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.65 -177.97 41.69 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 102.469 -4.252 . . . . 0.0 102.469 -177.094 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -152.16 159.74 43.54 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 97.665 -4.939 . . . . 0.0 97.665 178.03 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -151.96 171.01 18.47 Favored 'General case' 0 CA--C 1.491 -1.309 1 N-CA-C 98.974 -4.454 . . . . 0.0 98.974 167.909 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.92 168.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 101.362 -3.57 . . . . 0.0 101.362 -177.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.92 29.22 52.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -169.011 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.7 m170 163.45 -154.13 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.361 1 N-CA-C 94.471 -6.122 . . . . 0.0 94.471 -174.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.08 150.16 21.39 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 98.715 -5.754 . . . . 0.0 98.715 170.41 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 tp 74.16 176.84 0.24 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.003 1.721 . . . . 0.0 108.519 175.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -178.46 -169.35 0.18 Allowed 'General case' 0 CA--C 1.483 -1.62 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 173.922 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -132.35 178.25 6.96 Favored 'General case' 0 CA--C 1.484 -1.559 1 N-CA-C 100.137 -4.023 . . . . 0.0 100.137 154.524 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -126.85 146.59 50.22 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.06 156.09 46.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 179.665 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -125.65 142.44 51.51 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.97 55.67 1.13 Allowed 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 128.542 2.737 . . . . 0.0 111.783 172.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.9 mt -96.52 132.85 25.58 Favored Pre-proline 0 CA--C 1.505 -0.777 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 176.042 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -73.54 174.76 11.66 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.513 2.142 . . . . 0.0 111.75 174.015 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.15 -19.07 62.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 126.548 1.939 . . . . 0.0 114.787 -173.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -79.62 -15.26 57.94 Favored 'General case' 0 CA--C 1.499 -1.011 0 O-C-N 121.686 -0.634 . . . . 0.0 109.704 -177.23 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.55 129.92 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -178.537 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -116.84 149.53 18.73 Favored Glycine 0 CA--C 1.48 -2.153 1 N-CA-C 101.402 -4.679 . . . . 0.0 101.402 -179.481 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -133.18 -143.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 N-CA-C 103.116 -2.92 . . . . 0.0 103.116 -162.051 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.7 HD12 HG12 ' A' ' 13' ' ' VAL . 3.9 mm -67.19 120.98 15.44 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.659 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -82.13 -51.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -162.72 163.08 27.03 Favored 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 98.402 -4.666 . . . . 0.0 98.402 177.241 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 74.17 2.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 105.468 -3.053 . . . . 0.0 105.468 173.115 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -121.64 -67.11 0.99 Allowed 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -165.659 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -162.99 172.58 14.81 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 98.633 -4.58 . . . . 0.0 98.633 -169.434 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.4 t -129.41 153.3 48.05 Favored 'General case' 0 CA--C 1.485 -1.531 1 N-CA-C 97.15 -5.13 . . . . 0.0 97.15 178.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.31 152.37 23.98 Favored 'General case' 0 N--CA 1.422 -1.873 1 N-CA-C 94.975 -5.935 . . . . 0.0 94.975 176.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.1 m -154.9 163.28 40.51 Favored 'General case' 0 N--CA 1.421 -1.894 1 N-CA-C 95.599 -5.704 . . . . 0.0 95.599 -177.991 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.929 0 O-C-N 124.419 1.074 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 121.686 0.755 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 161.83 34.65 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -128.78 137.67 51.66 Favored 'General case' 0 CA--C 1.485 -1.548 1 N-CA-C 94.977 -5.934 . . . . 0.0 94.977 171.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.84 -172.56 29.39 Favored Glycine 0 CA--C 1.472 -2.618 0 N-CA-C 104.866 -3.294 . . . . 0.0 104.866 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.03 138.69 32.96 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 102.051 -3.314 . . . . 0.0 102.051 158.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.0 tt -90.84 141.33 14.56 Favored 'Isoleucine or valine' 0 C--O 1.249 1.035 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.31 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -112.46 -160.31 0.71 Allowed 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 128.395 2.678 . . . . 0.0 108.099 -176.213 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.44 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 53.5 mt-30 -136.17 164.78 40.53 Favored Pre-proline 0 N--CA 1.419 -1.977 1 N-CA-C 96.601 -5.333 . . . . 0.0 96.601 174.86 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -65.32 151.53 84.95 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.67 2.246 . . . . 0.0 109.764 169.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -88.52 -54.58 4.1 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 127.75 2.42 . . . . 0.0 107.917 5.266 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -133.35 135.69 44.91 Favored 'General case' 0 N--CA 1.42 -1.925 1 N-CA-C 90.729 -7.508 . . . . 0.0 90.729 169.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 m -168.19 -166.41 0.7 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 178.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG12 HD11 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -126.06 164.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 165.804 . . . . . . . . 4 4 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.34 -158.42 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 162.079 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -137.45 168.7 19.13 Favored 'General case' 0 CA--C 1.476 -1.9 1 N-CA-C 96.668 -5.308 . . . . 0.0 96.668 165.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.5 t -130.86 158.59 39.78 Favored 'General case' 0 CA--C 1.478 -1.818 1 N-CA-C 97.402 -5.036 . . . . 0.0 97.402 -170.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -109.84 112.43 58.17 Favored Pre-proline 0 N--CA 1.425 -1.694 1 N-CA-C 96.596 -5.335 . . . . 0.0 96.596 167.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.3 101.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.543 0 CA-C-N 124.491 2.64 . . . . 0.0 116.177 -161.175 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.48 -172.57 36.9 Favored Glycine 0 N--CA 1.427 -1.935 1 N-CA-C 97.092 -6.403 . . . . 0.0 97.092 -172.628 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 p -92.58 -28.75 16.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 118.993 1.396 . . . . 0.0 109.893 -177.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -40.16 -63.92 0.56 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 127.775 2.43 . . . . 0.0 116.152 -161.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.65 -45.45 52.93 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -176.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 m -64.47 -45.77 85.98 Favored 'General case' 0 CA--C 1.486 -1.495 0 O-C-N 122.229 -0.571 . . . . 0.0 111.776 -174.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.36 -35.97 78.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -60.85 -48.43 81.82 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.179 -0.951 . . . . 0.0 110.713 173.764 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.38 -41.95 99.04 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-O 121.799 0.809 . . . . 0.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -60.69 -45.3 94.7 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.87 0.868 . . . . 0.0 110.432 179.395 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.81 -42.37 81.64 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.392 0.277 . . . . 0.0 110.792 -176.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.44 -27.08 56.09 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.799 -0.563 . . . . 0.0 111.552 -176.049 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -76.49 -49.23 17.06 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.22 51.6 0.18 Allowed Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 169.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.08 147.04 16.15 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 104.913 -3.275 . . . . 0.0 104.913 159.636 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.4 p -92.92 -3.59 54.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 117.777 0.788 . . . . 0.0 110.7 -166.091 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.479 -1.778 1 N-CA-C 98.427 -4.657 . . . . 0.0 98.427 174.096 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -167.17 163.71 37.33 Favored Glycine 0 CA--C 1.465 -3.058 1 N-CA-C 101.065 -4.814 . . . . 0.0 101.065 -173.539 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -156.66 -155.34 0.53 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.814 -3.772 . . . . 0.0 100.814 -170.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.9 t -145.03 161.71 38.74 Favored 'General case' 0 N--CA 1.429 -1.51 1 N-CA-C 96.534 -5.358 . . . . 0.0 96.534 -173.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.92 -172.57 45.18 Favored Glycine 0 N--CA 1.42 -2.409 1 N-CA-C 99.024 -5.63 . . . . 0.0 99.024 -176.439 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -135.38 142.47 45.7 Favored 'General case' 0 N--CA 1.427 -1.618 1 N-CA-C 97.048 -5.168 . . . . 0.0 97.048 -177.426 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -112.46 108.82 18.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.1 121.38 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 -176.553 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.87 -13.54 8.09 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -168.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -136.68 -77.26 0.41 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.04 -163.45 36.82 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 104.916 -3.274 . . . . 0.0 104.916 -165.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.8 141.26 57.77 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 127.79 2.436 . . . . 0.0 106.044 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.32 178.3 8.52 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 -168.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 m -110.44 162.16 14.95 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 101.649 -3.463 . . . . 0.0 101.649 170.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -119.23 146.56 45.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 14.6 m -141.8 150.91 42.3 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.239 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -120.71 142.09 49.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 173.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 60.05 62.44 1.64 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 127.495 2.318 . . . . 0.0 111.374 174.277 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.18 145.5 30.17 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 171.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -64.73 160.58 39.8 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.973 2.448 . . . . 0.0 110.886 174.353 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -66.51 -24.53 66.41 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.867 0.867 . . . . 0.0 112.626 -168.087 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -81.48 -2.75 50.85 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.473 1.109 . . . . 0.0 111.162 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 t -87.87 122.88 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 177.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.75 145.57 17.71 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -136.72 -153.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -165.538 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -66.65 131.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.365 1.265 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 t -119.55 151.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 177.409 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 7.5 tp10 51.11 -142.16 0.73 Allowed 'General case' 0 C--N 1.359 0.985 0 C-N-CA 126.796 2.038 . . . . 0.0 112.191 168.678 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.508 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -150.66 110.79 0.48 Allowed Glycine 0 CA--C 1.479 -2.196 1 N-CA-C 92.352 -8.299 . . . . 0.0 92.352 158.079 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -147.61 -82.33 0.12 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -165.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 35.6 tttm -165.4 -175.25 3.5 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 99.559 -4.237 . . . . 0.0 99.559 -173.186 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.431 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 1.7 t -132.15 134.19 45.13 Favored 'General case' 0 N--CA 1.424 -1.773 1 N-CA-C 95.879 -5.601 . . . . 0.0 95.879 177.931 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -162.06 158.56 25.06 Favored 'General case' 0 CA--C 1.485 -1.54 1 N-CA-C 99.356 -4.312 . . . . 0.0 99.356 -176.161 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -153.4 164.03 38.89 Favored 'General case' 0 N--CA 1.423 -1.807 1 N-CA-C 95.811 -5.626 . . . . 0.0 95.811 -177.253 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.926 0 O-C-N 124.435 1.085 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.96 159.91 15.92 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 173.37 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -130.69 130.09 43.42 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.558 -6.09 . . . . 0.0 94.558 159.457 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.07 -170.31 26.64 Favored Glycine 0 CA--C 1.473 -2.567 1 N-CA-C 101.607 -4.597 . . . . 0.0 101.607 179.146 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -83.54 143.4 30.2 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 159.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.27 143.57 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 175.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -104.45 -137.05 0.35 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 126.498 1.919 . . . . 0.0 106.507 179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -136.88 155.23 76.53 Favored Pre-proline 0 N--CA 1.421 -1.907 1 N-CA-C 95.185 -5.858 . . . . 0.0 95.185 159.822 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -66.3 150.77 84.5 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 0.0 108.423 174.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.34 -30.07 33.92 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 128.389 2.676 . . . . 0.0 108.992 6.572 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -164.67 159.36 18.78 Favored 'General case' 0 N--CA 1.418 -2.066 1 N-CA-C 94.237 -6.209 . . . . 0.0 94.237 178.254 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m 167.51 -147.69 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.445 1 N-CA-C 98.82 -4.511 . . . . 0.0 98.82 174.395 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.91 170.01 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 1 N-CA-C 95.661 -5.681 . . . . 0.0 95.661 170.15 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.39 179.85 6.79 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 167.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -119.17 78.06 1.26 Allowed 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 -179.11 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.3 t -98.77 -170.37 1.93 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -142.63 172.87 5.19 Favored Pre-proline 0 N--CA 1.42 -1.971 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -164.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -66.69 50.54 0.32 Allowed 'Trans proline' 0 C--N 1.322 -0.865 0 C-N-CA 123.595 2.864 . . . . 0.0 112.829 162.628 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.46 139.93 5.62 Favored Glycine 0 N--CA 1.423 -2.191 1 N-CA-C 100.437 -5.065 . . . . 0.0 100.437 -178.452 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -94.83 30.37 2.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.104 0.962 . . . . 0.0 110.778 -171.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -65.86 -57.12 8.64 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.969 1.708 . . . . 0.0 110.836 -166.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.17 -28.91 47.7 Favored Glycine 0 C--N 1.348 1.241 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.048 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.91 -30.52 71.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 124.651 1.181 . . . . 0.0 110.859 -172.542 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.45 -58.62 6.5 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.744 0.818 . . . . 0.0 109.945 173.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -44.59 96.76 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 124.157 0.983 . . . . 0.0 113.014 175.833 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.35 -41.85 88.91 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 121.287 0.565 . . . . 0.0 111.094 -173.283 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -64.25 -40.56 96.26 Favored 'General case' 0 N--CA 1.439 -1.02 0 O-C-N 121.948 -0.47 . . . . 0.0 109.934 179.553 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -66.08 -47.29 74.77 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 122.071 -0.393 . . . . 0.0 111.625 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.18 -20.49 63.12 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 121.654 -0.654 . . . . 0.0 112.292 -173.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.55 -3.23 50.15 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.248 0.619 . . . . 0.0 110.199 176.205 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.32 32.56 8.18 Favored Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 165.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.82 163.05 13.03 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 105.546 -3.021 . . . . 0.0 105.546 168.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -83.72 -43.6 15.33 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.244 1.021 . . . . 0.0 110.038 -169.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -160.12 150.92 18.91 Favored 'General case' 0 N--CA 1.418 -2.068 1 N-CA-C 98.759 -4.534 . . . . 0.0 98.759 -157.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -162.9 169.24 38.03 Favored Glycine 0 N--CA 1.421 -2.341 1 N-CA-C 100.286 -5.126 . . . . 0.0 100.286 -171.157 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -162.55 -177.98 5.95 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 98.258 -4.719 . . . . 0.0 98.258 -179.494 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.1 m -139.26 162.42 35.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -178.804 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.83 109.1 0.73 Allowed Glycine 0 CA--C 1.487 -1.681 1 N-CA-C 101.748 -4.541 . . . . 0.0 101.748 -178.359 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' CE2' ' HB ' ' A' ' 41' ' ' VAL . 72.1 t80 -161.14 149.07 15.55 Favored 'General case' 0 CA--C 1.483 -1.617 1 N-CA-C 97.216 -5.105 . . . . 0.0 97.216 -165.595 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -151.12 75.38 1.19 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.438 ' HB ' ' CE2' ' A' ' 39' ' ' PHE . 49.1 t -126.07 138.52 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 1 N-CA-C 95.671 -5.678 . . . . 0.0 95.671 167.129 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.91 62.99 4.52 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 119.016 0.826 . . . . 0.0 111.621 -163.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -112.5 -51.52 2.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.53 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.9 -164.19 35.5 Favored Glycine 0 N--CA 1.426 -2.019 1 N-CA-C 96.029 -6.828 . . . . 0.0 96.029 -164.372 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.65 118.63 22.23 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -172.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.84 -178.2 5.69 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 124.068 0.947 . . . . 0.0 110.703 -166.706 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.98 149.62 40.63 Favored 'General case' 0 CA--C 1.489 -1.377 1 N-CA-C 99.957 -4.09 . . . . 0.0 99.957 -174.616 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -96.87 155.17 16.89 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 178.817 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 7.4 m -147.64 152.14 37.37 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 168.248 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -115.91 144.55 43.9 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 169.023 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.45 57.3 0.57 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 128.059 2.543 . . . . 0.0 111.651 170.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.09 124.8 48.28 Favored Pre-proline 0 CA--C 1.499 -1.007 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.574 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 167.04 28.09 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.184 1.923 . . . . 0.0 109.43 174.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.77 46.97 1.44 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 121.52 -0.737 . . . . 0.0 111.618 -168.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -111.91 -6.53 14.23 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 163.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.87 140.86 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 -172.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.65 147.59 18.0 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 103.399 -3.88 . . . . 0.0 103.399 179.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.97 -159.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -165.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 7' ' ' ALA . 9.6 mm -69.75 133.12 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -174.655 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -135.58 160.28 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 176.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -161.76 162.8 29.75 Favored 'General case' 0 N--CA 1.428 -1.543 1 N-CA-C 96.754 -5.276 . . . . 0.0 96.754 171.733 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.07 35.59 26.94 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 104.841 -3.304 . . . . 0.0 104.841 -150.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -179.04 -163.61 0.06 Allowed 'General case' 0 N--CA 1.424 -1.731 1 N-CA-C 94.771 -6.011 . . . . 0.0 94.771 -166.292 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 21.1 ttpp -156.98 -169.01 2.82 Favored 'General case' 0 N--CA 1.43 -1.431 1 N-CA-C 96.626 -5.324 . . . . 0.0 96.626 179.707 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.458 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 8.7 t -72.52 134.32 45.21 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.881 2.072 . . . . 0.0 106.086 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.293 98.2 m-70 57.91 -132.68 1.23 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 126.089 1.756 . . . . 0.0 109.535 -161.41 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.5 m -79.65 55.43 2.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 177.101 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.081 0 CA-C-N 116.23 -0.441 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.45 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -148.81 179.77 7.59 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 171.558 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -137.02 142.0 42.5 Favored 'General case' 0 CA--C 1.485 -1.532 1 N-CA-C 96.666 -5.309 . . . . 0.0 96.666 179.667 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.13 -161.53 12.15 Favored Glycine 0 CA--C 1.474 -2.483 1 N-CA-C 99.653 -5.379 . . . . 0.0 99.653 165.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 94.5 m-85 -82.53 144.03 30.67 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 165.035 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 tt -91.11 139.98 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.401 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.11 -168.14 1.5 Allowed 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.099 2.959 . . . . 0.0 108.549 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -113.7 161.67 26.41 Favored Pre-proline 0 N--CA 1.428 -1.53 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 170.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.2 134.64 43.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 N-CA-C 106.843 -2.022 . . . . 0.0 106.843 158.205 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -79.31 -58.16 3.35 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 127.05 2.14 . . . . 0.0 111.251 14.479 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -166.6 146.24 5.75 Favored 'General case' 0 N--CA 1.426 -1.638 1 N-CA-C 92.384 -6.895 . . . . 0.0 92.384 -178.357 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' HB3' ' H ' ' A' ' 13' ' ' VAL . 21.9 m 159.92 -141.4 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.528 1 N-CA-C 97.771 -4.9 . . . . 0.0 97.771 179.131 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 59' ' ' ILE . 3.0 m -124.26 165.34 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 176.203 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.25 -154.83 0.29 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 162.976 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -141.17 177.37 8.13 Favored 'General case' 0 N--CA 1.425 -1.68 1 N-CA-C 97.177 -5.119 . . . . 0.0 97.177 167.818 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 t -145.81 158.81 43.83 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.816 -5.624 . . . . 0.0 95.816 -179.263 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -115.6 113.57 42.67 Favored Pre-proline 0 N--CA 1.422 -1.839 1 N-CA-C 96.197 -5.483 . . . . 0.0 96.197 177.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.83 99.2 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.53 0 CA-C-N 124.019 2.471 . . . . 0.0 116.082 -156.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.93 -166.9 36.42 Favored Glycine 0 N--CA 1.423 -2.219 1 N-CA-C 96.716 -6.554 . . . . 0.0 96.716 -173.746 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -85.97 -41.53 14.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.199 1.0 . . . . 0.0 109.6 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.43 -70.56 0.1 Allowed 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -147.352 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.11 -31.68 54.59 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 121.092 -1.005 . . . . 0.0 111.42 -172.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.6 t -70.95 -49.54 44.45 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.415 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -66.5 -33.66 76.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -177.22 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 m -61.48 -50.19 73.73 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.892 172.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -42.6 99.76 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.905 0.882 . . . . 0.0 109.968 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.3 t -56.48 -47.13 79.86 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.566 1.146 . . . . 0.0 110.714 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.8 -45.5 89.39 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 123.886 0.874 . . . . 0.0 110.585 -175.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.39 -28.93 62.29 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.845 -0.534 . . . . 0.0 112.163 -176.015 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -81.6 -18.2 45.59 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.589 -0.694 . . . . 0.0 110.144 176.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.91 38.16 2.99 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 163.717 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.29 139.25 14.39 Favored Glycine 0 CA--C 1.486 -1.776 1 N-CA-C 101.153 -4.779 . . . . 0.0 101.153 164.099 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -81.84 -29.06 32.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 118.032 0.916 . . . . 0.0 110.065 -162.629 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.47 -176.86 5.84 Favored 'General case' 0 N--CA 1.423 -1.783 1 N-CA-C 98.313 -4.699 . . . . 0.0 98.313 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -177.25 -160.97 24.99 Favored Glycine 0 N--CA 1.414 -2.783 1 N-CA-C 100.618 -4.993 . . . . 0.0 100.618 -167.378 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -163.62 -159.73 0.53 Allowed 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 96.899 -5.223 . . . . 0.0 96.899 -172.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -136.11 170.26 16.29 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 100.584 -3.858 . . . . 0.0 100.584 173.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.9 -177.31 47.92 Favored Glycine 0 N--CA 1.422 -2.283 1 N-CA-C 101.32 -4.712 . . . . 0.0 101.32 177.695 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -113.56 139.97 48.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 -177.435 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -110.71 91.09 3.52 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 102.679 -3.082 . . . . 0.0 102.679 173.054 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 t -68.27 124.98 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -171.168 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.28 -47.53 1.01 Allowed Glycine 0 CA--C 1.483 -1.922 0 N-CA-C 104.539 -3.424 . . . . 0.0 104.539 -173.019 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -100.44 -60.3 1.55 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.001 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.43 -170.63 39.67 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.633 -2.587 . . . . 0.0 106.633 -174.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.15 137.68 35.92 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 102.904 -2.998 . . . . 0.0 102.904 177.493 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.93 -174.51 3.68 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -164.165 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.9 t -114.62 153.84 29.43 Favored 'General case' 0 CA--C 1.495 -1.171 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 178.3 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.9 t-105 -119.48 149.78 41.32 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 -177.299 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.0 m -143.15 156.13 44.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 105.121 -2.178 . . . . 0.0 105.121 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.73 144.2 50.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 102.691 -3.078 . . . . 0.0 102.691 170.021 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.64 52.52 0.23 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 126.758 2.023 . . . . 0.0 111.415 171.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 mt -92.65 130.66 36.18 Favored Pre-proline 0 CA--C 1.501 -0.934 0 N-CA-C 104.951 -2.241 . . . . 0.0 104.951 173.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -74.22 176.07 10.08 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.451 2.1 . . . . 0.0 110.741 175.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -86.15 19.69 2.58 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.988 -174.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -95.15 -7.01 40.51 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.446 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.01 169.0 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -179.155 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -148.68 151.26 23.47 Favored Glycine 0 CA--C 1.479 -2.179 1 N-CA-C 97.533 -6.227 . . . . 0.0 97.533 173.755 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 pt -139.3 -147.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -155.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.38 -27.71 43.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 126.173 1.789 . . . . 0.0 113.312 -169.654 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 167.4 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 169.539 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -171.98 -173.84 1.2 Allowed 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 94.978 -5.934 . . . . 0.0 94.978 -170.061 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.42 69.92 2.9 Favored Glycine 0 CA--C 1.495 -1.195 0 N-CA-C 105.007 -3.237 . . . . 0.0 105.007 164.334 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -169.5 -170.91 1.14 Allowed 'General case' 0 N--CA 1.426 -1.646 1 N-CA-C 96.739 -5.282 . . . . 0.0 96.739 -172.033 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -164.19 172.1 14.11 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.73 -4.544 . . . . 0.0 98.73 -175.125 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 18.2 t -73.16 125.48 27.81 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 127.506 2.322 . . . . 0.0 109.106 -172.168 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -165.04 172.92 12.09 Favored 'General case' 0 N--CA 1.426 -1.659 1 N-CA-C 97.706 -4.924 . . . . 0.0 97.706 173.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m 177.47 178.69 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 95.746 -5.649 . . . . 0.0 95.746 171.221 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.937 0 CA-C-N 119.022 0.828 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 121.279 0.562 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -95.36 170.95 9.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 160.489 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -129.96 132.69 46.4 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 93.509 -6.478 . . . . 0.0 93.509 158.314 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.83 -178.01 35.39 Favored Glycine 0 CA--C 1.47 -2.736 0 N-CA-C 104.015 -3.634 . . . . 0.0 104.015 -175.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -83.71 140.65 31.99 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 162.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.2 tt -90.39 137.53 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.005 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.31 -145.03 0.3 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.198 174.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.7 142.8 45.11 Favored Pre-proline 0 N--CA 1.423 -1.787 1 N-CA-C 92.939 -6.689 . . . . 0.0 92.939 166.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.82 146.34 47.81 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 CA-C-N 122.693 1.998 . . . . 0.0 107.974 -177.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.23 -21.69 17.71 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 126.098 1.759 . . . . 0.0 108.504 13.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -158.48 151.68 22.81 Favored 'General case' 0 N--CA 1.415 -2.2 1 N-CA-C 95.945 -5.576 . . . . 0.0 95.945 172.182 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 166.54 -155.93 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 -177.707 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 43' ' ' HIS . 15.3 m -127.4 164.81 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 1 N-CA-C 96.798 -5.26 . . . . 0.0 96.798 161.953 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.11 171.75 8.42 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 101.52 -3.511 . . . . 0.0 101.52 161.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -108.56 116.33 31.77 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -177.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.4 t -92.39 150.43 20.82 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.44 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.36 122.02 28.98 Favored Pre-proline 0 N--CA 1.422 -1.855 1 N-CA-C 97.65 -4.945 . . . . 0.0 97.65 -179.341 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -60.57 137.49 74.04 Favored 'Trans proline' 0 CA--C 1.505 -0.962 0 CA-C-N 123.456 2.27 . . . . 0.0 110.987 -176.371 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.36 -57.95 0.57 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 101.082 -4.807 . . . . 0.0 101.082 -158.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m 105.51 -14.72 0.02 OUTLIER 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 128.901 2.881 . . . . 0.0 110.533 173.137 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -46.44 -51.05 15.92 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.685 1.994 . . . . 0.0 114.806 -162.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.84 -39.77 75.56 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 121.507 -0.746 . . . . 0.0 111.517 -177.231 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.04 -22.1 22.02 Favored 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 121.068 -1.254 . . . . 0.0 110.748 -169.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.47 94.21 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 167.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -62.49 -45.05 94.78 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 121.161 -0.962 . . . . 0.0 110.983 172.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.94 -41.24 97.73 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.518 -0.739 . . . . 0.0 111.926 177.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 49.8 t -55.22 -44.39 75.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.35 1.46 . . . . 0.0 110.345 174.771 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -63.59 -45.85 88.52 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.853 -0.529 . . . . 0.0 111.554 -177.322 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.75 -7.63 51.52 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.36 -0.837 . . . . 0.0 112.669 -177.096 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -102.79 -3.78 25.89 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 121.704 -0.622 . . . . 0.0 109.813 174.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.56 28.35 11.53 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 169.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.34 129.71 9.99 Favored Glycine 0 CA--C 1.483 -1.917 0 N-CA-C 104.259 -3.536 . . . . 0.0 104.259 169.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -36.25 74.19 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.509 -165.763 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.3 m -160.56 175.33 12.83 Favored 'General case' 0 N--CA 1.426 -1.671 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 170.642 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.49 -178.72 48.78 Favored Glycine 0 N--CA 1.418 -2.544 1 N-CA-C 98.516 -5.833 . . . . 0.0 98.516 -169.694 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -164.08 -175.82 4.2 Favored 'General case' 0 N--CA 1.434 -1.24 1 N-CA-C 99.067 -4.42 . . . . 0.0 99.067 -177.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.4 m -84.4 168.67 15.33 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.317 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.47 -178.35 41.82 Favored Glycine 0 CA--C 1.487 -1.671 1 N-CA-C 96.9 -6.48 . . . . 0.0 96.9 172.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -152.6 132.72 13.48 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 100.478 -3.897 . . . . 0.0 100.478 179.629 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -139.66 40.25 2.02 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.261 2.2 t 57.11 -134.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 C-N-CA 126.17 1.788 . . . . 0.0 107.606 -172.328 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.04 -122.48 7.58 Favored Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 104.167 -3.573 . . . . 0.0 104.167 179.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.433 ' HB2' HG13 ' A' ' 13' ' ' VAL . 13.8 m170 -118.15 5.12 11.97 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 123.126 0.57 . . . . 0.0 109.711 -166.939 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.22 -172.87 34.74 Favored Glycine 0 CA--C 1.483 -1.947 1 N-CA-C 100.413 -5.075 . . . . 0.0 100.413 -178.046 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 tt -88.25 98.46 11.59 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -173.028 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.38 177.71 7.74 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 125.634 1.574 . . . . 0.0 110.93 -172.791 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -126.69 160.03 31.96 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -175.411 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -96.61 154.66 17.15 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 177.69 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.0 m -142.37 140.68 32.14 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 100.764 -3.791 . . . . 0.0 100.764 165.53 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.75 27.97 8.9 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.482 0.658 . . . . 0.0 109.631 -170.026 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -176.27 147.95 0.74 Allowed 'General case' 0 N--CA 1.419 -1.98 1 N-CA-C 93.605 -6.443 . . . . 0.0 93.605 167.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -150.86 142.83 15.77 Favored Pre-proline 0 CA--C 1.487 -1.468 1 N-CA-C 97.711 -4.922 . . . . 0.0 97.711 153.076 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.86 171.73 17.28 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.265 1.977 . . . . 0.0 109.598 176.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.54 -4.97 37.24 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -166.939 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -92.98 3.65 55.37 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.578 -0.701 . . . . 0.0 110.228 -178.135 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 t -107.76 138.5 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 N-CA-C 103.557 -2.756 . . . . 0.0 103.557 -176.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.75 147.37 16.41 Favored Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 103.786 -3.726 . . . . 0.0 103.786 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.9 -160.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -164.342 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -73.33 137.46 23.3 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -172.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.88 153.41 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 1 N-CA-C 95.046 -5.909 . . . . 0.0 95.046 173.54 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.73 153.04 30.62 Favored 'General case' 0 N--CA 1.427 -1.62 1 N-CA-C 96.717 -5.29 . . . . 0.0 96.717 168.251 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.94 -42.87 1.43 Allowed Glycine 0 CA--C 1.49 -1.529 1 N-CA-C 100.651 -4.98 . . . . 0.0 100.651 -160.786 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.94 -145.19 0.28 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.159 -3.274 . . . . 0.0 102.159 157.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 51.9 tttm -157.48 -170.77 3.34 Favored 'General case' 0 N--CA 1.428 -1.554 1 N-CA-C 97.513 -4.995 . . . . 0.0 97.513 -174.378 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 34.7 t -65.52 147.35 53.56 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 126.284 1.834 . . . . 0.0 110.031 -178.486 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -156.03 102.69 2.17 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 167.688 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -66.63 125.09 24.69 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 124.693 1.197 . . . . 0.0 110.137 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.062 0 O-C-N 123.424 0.453 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 177.71 7.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 172.704 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -129.58 139.76 51.39 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 97.621 -4.955 . . . . 0.0 97.621 171.556 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.98 179.16 37.5 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 107.025 -2.43 . . . . 0.0 107.025 177.58 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -78.04 128.67 34.21 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 162.411 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 tt -90.76 140.76 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.385 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.65 -162.47 0.96 Allowed 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 129.229 3.012 . . . . 0.0 107.755 174.54 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -144.05 170.37 8.51 Favored Pre-proline 0 N--CA 1.42 -1.953 1 N-CA-C 96.886 -5.227 . . . . 0.0 96.886 175.364 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -64.28 152.58 80.76 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.221 1.948 . . . . 0.0 111.314 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.61 -49.21 9.42 Favored 'General case' 0 CA--C 1.497 -1.092 0 C-N-CA 127.1 2.16 . . . . 0.0 107.544 -1.203 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -146.2 139.49 25.9 Favored 'General case' 0 N--CA 1.42 -1.94 1 N-CA-C 92.096 -7.002 . . . . 0.0 92.096 169.153 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.2 m -175.83 -158.44 0.06 Allowed 'General case' 0 CA--C 1.488 -1.408 1 N-CA-C 100.024 -4.065 . . . . 0.0 100.024 -174.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.479 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.14 155.14 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 N-CA-C 97.509 -4.997 . . . . 0.0 97.509 164.992 . . . . . . . . 4 4 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.27 153.22 20.63 Favored 'General case' 0 CA--C 1.494 -1.191 1 N-CA-C 100.136 -4.024 . . . . 0.0 100.136 166.044 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -102.07 -173.13 2.27 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.255 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.4 t -140.24 154.37 46.85 Favored 'General case' 0 N--CA 1.417 -2.093 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 -171.125 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -115.93 121.39 34.08 Favored Pre-proline 0 N--CA 1.419 -1.988 1 N-CA-C 96.816 -5.253 . . . . 0.0 96.816 167.561 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -56.86 129.2 33.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 122.972 2.097 . . . . 0.0 112.846 -174.429 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.31 -46.78 1.04 Allowed Glycine 0 CA--C 1.491 -1.424 1 N-CA-C 102.505 -4.238 . . . . 0.0 102.505 -164.41 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 m 92.69 2.41 0.08 Allowed 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 127.496 2.318 . . . . 0.0 112.093 171.289 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -34.65 77.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.835 1.198 . . . . 0.0 111.469 -173.795 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.09 -48.89 50.79 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 175.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.21 -49.78 76.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.378 1.471 . . . . 0.0 109.182 179.418 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.52 -45.37 73.34 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.345 1.458 . . . . 0.0 111.751 177.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 m -63.88 -43.87 94.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.198 -0.939 . . . . 0.0 110.78 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.72 -36.47 67.79 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.769 0.795 . . . . 0.0 109.953 -176.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -62.61 -46.5 88.0 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.739 1.216 . . . . 0.0 110.448 173.358 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.18 -45.78 86.87 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 123.969 0.908 . . . . 0.0 110.051 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -95.33 -4.29 45.74 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 124.145 0.978 . . . . 0.0 109.972 179.425 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.02 12.53 31.53 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 168.139 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.91 127.38 8.39 Favored Glycine 0 C--N 1.352 1.471 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 177.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 p -97.0 5.04 51.18 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.879 -0.777 . . . . 0.0 110.041 -169.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -160.48 158.1 28.74 Favored 'General case' 0 CA--C 1.479 -1.752 1 N-CA-C 99.159 -4.385 . . . . 0.0 99.159 166.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.31 168.4 41.41 Favored Glycine 0 N--CA 1.417 -2.633 1 N-CA-C 98.628 -5.789 . . . . 0.0 98.628 -178.541 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 8.1 p-80 -166.77 173.83 9.18 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 97.064 -5.162 . . . . 0.0 97.064 -179.871 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.0 m -94.95 162.28 13.8 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.548 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.11 174.09 40.98 Favored Glycine 0 N--CA 1.421 -2.304 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 178.533 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -117.79 138.14 52.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 101.544 -3.502 . . . . 0.0 101.544 -177.156 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -98.47 -29.14 13.28 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-O 122.18 0.99 . . . . 0.0 109.483 -175.349 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 42' ' ' GLY . 3.5 t 70.62 176.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 128.896 2.878 . . . . 0.0 105.468 -165.815 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 80.76 -65.42 3.92 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 120.137 -1.602 . . . . 0.0 109.931 172.572 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -91.36 -53.33 4.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 172.131 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.84 -128.46 3.46 Favored Glycine 0 C--N 1.354 1.582 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 171.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.47 127.42 32.67 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 128.435 2.694 . . . . 0.0 106.665 -177.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.36 176.88 7.6 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -166.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.8 t -117.55 158.96 23.66 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 100.301 -3.962 . . . . 0.0 100.301 174.038 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 19.4 t-105 -124.07 150.34 45.11 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.444 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.2 m -140.07 152.75 46.43 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.623 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -116.17 138.35 51.34 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 169.671 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 78.71 50.13 0.03 OUTLIER 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 126.942 2.097 . . . . 0.0 111.072 166.852 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.1 133.29 32.14 Favored Pre-proline 0 CA--C 1.495 -1.14 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.95 176.12 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.321 2.014 . . . . 0.0 110.715 176.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.4 2.44 25.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.075 0.95 . . . . 0.0 112.732 -170.734 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -95.93 5.26 51.66 Favored 'General case' 0 CA--C 1.503 -0.849 0 O-C-N 121.098 -1.001 . . . . 0.0 108.847 175.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.49 167.39 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 175.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.61 163.1 29.54 Favored Glycine 0 CA--C 1.485 -1.827 1 N-CA-C 98.319 -5.912 . . . . 0.0 98.319 -177.039 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -154.12 -164.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 -161.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.479 HD12 HG12 ' A' ' 13' ' ' VAL . 1.1 mm -65.4 121.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 123.979 0.912 . . . . 0.0 111.013 -163.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.64 155.58 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 101.657 -3.46 . . . . 0.0 101.657 168.308 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -157.41 167.93 28.82 Favored 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 96.855 -5.239 . . . . 0.0 96.855 177.624 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 24.68 52.43 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 105.356 -3.098 . . . . 0.0 105.356 -151.368 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 176.48 -165.33 0.03 OUTLIER 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 94.276 -6.194 . . . . 0.0 94.276 -167.392 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -165.81 -153.3 0.17 Allowed 'General case' 0 N--CA 1.432 -1.374 1 N-CA-C 99.079 -4.415 . . . . 0.0 99.079 177.967 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 40.9 t -82.34 142.74 31.78 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 125.832 1.653 . . . . 0.0 107.202 -176.064 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -157.61 153.31 26.62 Favored 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 172.548 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.5 m 1.67 68.14 0.0 OUTLIER 'General case' 0 C--N 1.358 0.961 0 C-N-CA 130.646 3.579 . . . . 0.0 117.353 -169.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.362 1.13 0 CA-C-N 116.766 -0.197 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.223 0.535 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 176.68 5.28 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 101.455 -3.535 . . . . 0.0 101.455 159.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -129.75 144.34 51.25 Favored 'General case' 0 CA--C 1.481 -1.675 1 N-CA-C 95.169 -5.863 . . . . 0.0 95.169 171.903 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 -178.24 35.47 Favored Glycine 0 CA--C 1.473 -2.593 0 N-CA-C 103.957 -3.657 . . . . 0.0 103.957 175.879 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 33.3 m-85 -76.73 137.75 39.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 156.68 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.7 tt -90.52 137.82 20.79 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.357 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -108.36 -154.62 0.53 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 127.245 2.218 . . . . 0.0 107.946 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -122.7 148.77 54.3 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 95.604 -5.702 . . . . 0.0 95.604 170.138 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -68.96 145.57 62.22 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 122.691 1.997 . . . . 0.0 109.025 -176.761 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -89.07 -42.52 11.68 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 127.881 2.472 . . . . 0.0 110.085 12.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -153.97 140.09 18.41 Favored 'General case' 0 N--CA 1.424 -1.746 1 N-CA-C 92.212 -6.959 . . . . 0.0 92.212 178.459 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.5 m -178.35 -151.53 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 95.515 -5.735 . . . . 0.0 95.515 178.321 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.51 HG12 HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.91 -178.34 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 N-CA-C 97.685 -4.931 . . . . 0.0 97.685 163.177 . . . . . . . . 4 4 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.52 -152.67 0.32 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 166.758 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -143.18 161.2 38.85 Favored 'General case' 0 N--CA 1.422 -1.846 1 N-CA-C 94.601 -6.074 . . . . 0.0 94.601 153.005 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -160.54 -157.7 0.56 Allowed 'General case' 0 N--CA 1.42 -1.974 1 N-CA-C 96.077 -5.527 . . . . 0.0 96.077 -176.682 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -147.1 172.4 5.24 Favored Pre-proline 0 N--CA 1.418 -2.045 1 N-CA-C 99.865 -4.124 . . . . 0.0 99.865 -161.317 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.92 63.55 4.03 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 124.311 2.575 . . . . 0.0 111.386 170.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.87 148.65 5.68 Favored Glycine 0 N--CA 1.426 -2.014 1 N-CA-C 101.578 -4.609 . . . . 0.0 101.578 174.181 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -83.98 60.97 6.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 118.166 0.983 . . . . 0.0 108.675 178.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -69.94 -65.21 0.75 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -173.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.8 -22.42 57.95 Favored Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 177.084 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -79.48 -10.74 59.86 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.261 -1.141 . . . . 0.0 110.992 -174.139 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.4 -51.99 67.53 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 120.428 1.467 . . . . 0.0 108.649 174.746 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -72.28 -40.76 67.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.151 -177.405 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.27 -42.93 96.42 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 118.659 0.663 . . . . 0.0 112.565 179.055 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.9 t -64.31 -44.39 91.72 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -69.29 -43.47 73.75 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 121.439 -0.788 . . . . 0.0 111.679 -178.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -69.42 -28.49 66.18 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 119.544 1.065 . . . . 0.0 112.829 -177.675 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -87.51 -4.01 58.99 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.664 0.665 . . . . 0.0 110.558 175.609 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.91 29.4 8.11 Favored Glycine 0 CA--C 1.492 -1.398 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 162.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.21 149.32 17.89 Favored Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 171.1 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 p -79.33 -50.45 10.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.174 0.988 . . . . 0.0 109.88 -167.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -160.17 176.83 11.32 Favored 'General case' 0 N--CA 1.422 -1.844 1 N-CA-C 98.699 -4.556 . . . . 0.0 98.699 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.27 46.22 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 103.68 -3.768 . . . . 0.0 103.68 -169.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -146.98 -177.77 5.84 Favored 'General case' 0 N--CA 1.425 -1.685 1 N-CA-C 97.754 -4.906 . . . . 0.0 97.754 -169.252 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.3 m -136.96 160.75 37.97 Favored 'General case' 0 CA--C 1.479 -1.766 1 N-CA-C 99.549 -4.241 . . . . 0.0 99.549 171.529 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.09 179.26 47.37 Favored Glycine 0 N--CA 1.424 -2.136 1 N-CA-C 99.841 -5.304 . . . . 0.0 99.841 -174.318 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -93.18 150.58 20.4 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 -172.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -118.15 116.09 26.13 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 103.714 -2.698 . . . . 0.0 103.714 170.838 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.36 128.57 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.68 -16.57 26.09 Favored Glycine 0 CA--C 1.492 -1.392 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -175.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -127.52 -85.49 0.59 Allowed 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.8 -162.56 34.9 Favored Glycine 0 N--CA 1.426 -1.971 1 N-CA-C 102.91 -4.076 . . . . 0.0 102.91 -169.685 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.18 147.73 52.9 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.152 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.79 -176.08 5.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -165.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -128.18 166.13 19.1 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 175.869 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 16.2 t-105 -125.71 143.27 51.11 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 177.799 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.3 m -135.83 139.9 43.79 Favored 'General case' 0 CA--C 1.487 -1.465 1 N-CA-C 99.898 -4.112 . . . . 0.0 99.898 175.045 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -104.49 30.98 4.95 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 122.105 0.955 . . . . 0.0 108.929 -168.054 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -172.62 146.95 1.75 Allowed 'General case' 0 N--CA 1.411 -2.389 1 N-CA-C 94.036 -6.283 . . . . 0.0 94.036 165.911 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.53 151.67 64.3 Favored Pre-proline 0 N--CA 1.427 -1.591 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 141.79 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.41 174.01 13.28 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 122.158 1.905 . . . . 0.0 110.168 164.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -65.04 -11.66 41.73 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 126.454 1.902 . . . . 0.0 115.116 -172.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.3 -0.08 57.47 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.255 -0.903 . . . . 0.0 111.036 -175.543 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.29 142.51 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 N-CA-C 103.107 -2.923 . . . . 0.0 103.107 -176.488 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.49 155.19 16.5 Favored Glycine 0 CA--C 1.482 -2.001 0 N-CA-C 104.679 -3.368 . . . . 0.0 104.679 -176.668 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 pt -143.44 -155.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -161.583 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -83.57 154.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.047 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -172.88 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.2 173.24 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.628 1 N-CA-C 96.763 -5.273 . . . . 0.0 96.763 171.208 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -156.91 158.7 37.16 Favored 'General case' 0 N--CA 1.43 -1.472 1 N-CA-C 98.108 -4.775 . . . . 0.0 98.108 168.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 -40.61 2.42 Favored Glycine 0 CA--C 1.495 -1.197 1 N-CA-C 102.211 -4.356 . . . . 0.0 102.211 -162.989 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.463 ' HG2' ' CE1' ' A' ' 66' ' ' HIS . 7.0 tp10 -91.74 -153.39 0.33 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 157.752 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 2.1 tmtm? -168.85 -167.75 0.79 Allowed 'General case' 0 N--CA 1.431 -1.393 1 N-CA-C 98.748 -4.538 . . . . 0.0 98.748 -175.677 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.5 t -71.41 125.27 26.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.553 1.541 . . . . 0.0 107.77 -176.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.463 ' CE1' ' HG2' ' A' ' 63' ' ' GLU . 8.2 p-80 -155.51 145.96 21.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 m -160.72 175.57 12.48 Favored 'General case' 0 N--CA 1.428 -1.564 1 N-CA-C 96.026 -5.546 . . . . 0.0 96.026 -176.012 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.037 0 O-C-N 124.007 0.817 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.34 169.68 10.36 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 176.109 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -134.83 137.0 42.91 Favored 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 96.437 -5.394 . . . . 0.0 96.437 169.735 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.49 23.03 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 105.312 -3.115 . . . . 0.0 105.312 172.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 72.2 m-85 -82.38 137.41 34.75 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 103.377 -2.823 . . . . 0.0 103.377 163.272 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 58' ' ' ILE . 20.9 tt -91.65 140.89 15.33 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB2' HG12 ' A' ' 59' ' ' ILE . . . -95.7 -155.09 0.46 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.215 3.406 . . . . 0.0 110.406 -177.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -132.92 154.03 81.24 Favored Pre-proline 0 N--CA 1.429 -1.512 1 N-CA-C 96.211 -5.478 . . . . 0.0 96.211 165.511 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -67.25 135.12 35.9 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.889 2.393 . . . . 0.0 107.884 168.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -90.57 -55.14 3.7 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 121.881 2.128 . . . . 0.0 110.752 20.227 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -149.3 132.6 16.5 Favored 'General case' 0 CA--C 1.481 -1.707 1 N-CA-C 92.971 -6.678 . . . . 0.0 92.971 177.667 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER -176.59 -169.01 0.26 Allowed 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 -174.799 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.75 160.95 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 167.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -161.26 0.32 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 162.522 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -142.79 158.7 43.37 Favored 'General case' 0 CA--C 1.481 -1.699 1 N-CA-C 96.39 -5.411 . . . . 0.0 96.39 165.11 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.8 t -131.39 168.06 18.23 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 101.681 -3.451 . . . . 0.0 101.681 -167.908 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -114.02 114.18 46.37 Favored Pre-proline 0 N--CA 1.42 -1.942 1 N-CA-C 99.576 -4.231 . . . . 0.0 99.576 174.309 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -57.89 125.72 19.5 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.576 2.184 . . . . 0.0 112.268 -176.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.15 -56.93 0.67 Allowed Glycine 0 CA--C 1.486 -1.738 1 N-CA-C 100.357 -5.097 . . . . 0.0 100.357 -162.419 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m 117.7 -34.93 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.413 0 C-N-CA 129.48 3.112 . . . . 0.0 107.676 173.466 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.37 -51.22 2.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 128.86 2.864 . . . . 0.0 116.238 -159.375 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.48 -43.94 75.28 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.559 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 t -86.34 -23.08 26.35 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -170.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -61.79 -37.65 85.15 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.353 1.061 . . . . 0.0 108.522 168.964 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.9 m -69.46 -40.21 77.29 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.799 -0.563 . . . . 0.0 109.981 174.58 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.89 -38.03 89.63 Favored 'General case' 0 C--N 1.359 1.012 0 O-C-N 121.277 -0.889 . . . . 0.0 111.404 179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.6 t -52.85 -48.56 66.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.01 1.324 . . . . 0.0 110.357 170.008 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -65.15 -41.85 94.36 Favored 'General case' 0 CA--C 1.504 -0.82 0 O-C-N 121.463 -0.773 . . . . 0.0 112.446 -175.05 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.34 -9.44 58.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.137 -0.977 . . . . 0.0 111.906 -177.301 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -103.43 7.3 38.02 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.245 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.7 20.26 34.88 Favored Glycine 0 CA--C 1.491 -1.466 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.922 167.238 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.37 148.26 22.87 Favored Glycine 0 CA--C 1.49 -1.531 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 170.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.5 m -88.79 -32.72 17.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -168.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.7 m -160.69 -177.88 6.48 Favored 'General case' 0 CA--C 1.488 -1.411 1 N-CA-C 98.783 -4.525 . . . . 0.0 98.783 170.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.42 -169.87 37.67 Favored Glycine 0 CA--C 1.466 -3.031 1 N-CA-C 102.247 -4.341 . . . . 0.0 102.247 -172.471 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -160.41 -160.43 0.77 Allowed 'General case' 0 N--CA 1.429 -1.523 1 N-CA-C 98.835 -4.506 . . . . 0.0 98.835 -169.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.04 170.96 17.65 Favored 'General case' 0 CA--C 1.472 -2.047 1 N-CA-C 99.085 -4.413 . . . . 0.0 99.085 175.328 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.45 -170.8 41.02 Favored Glycine 0 N--CA 1.419 -2.487 1 N-CA-C 98.031 -6.027 . . . . 0.0 98.031 -173.751 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -124.08 150.04 45.46 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 100.765 -3.791 . . . . 0.0 100.765 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -123.05 98.99 6.14 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 173.763 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.86 122.93 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.69 -40.57 1.53 Allowed Glycine 0 CA--C 1.487 -1.707 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -165.385 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -124.43 -63.59 1.18 Allowed 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.508 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.24 -158.91 31.04 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -172.239 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.2 tp -68.43 146.62 53.02 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.566 2.347 . . . . 0.0 105.523 176.748 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.66 -177.22 6.23 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.611 -3.477 . . . . 0.0 101.611 -170.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.9 m -122.66 173.73 7.54 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 102.115 -3.291 . . . . 0.0 102.115 170.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 7.6 t-105 -131.33 148.17 52.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -175.104 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.4 m -134.11 149.06 51.07 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.248 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.6 134.15 55.17 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 171.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 61.26 71.82 0.54 Allowed 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.345 2.258 . . . . 0.0 111.514 174.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.9 mt -102.9 135.56 19.41 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 170.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -72.78 176.86 8.35 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 122.65 1.982 . . . . 0.0 112.253 177.01 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.61 9.84 3.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.743 0.817 . . . . 0.0 112.752 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -95.89 -0.81 50.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 121.241 -0.912 . . . . 0.0 108.566 176.025 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.2 170.37 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 -178.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.02 163.14 28.37 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.009 -6.036 . . . . 0.0 98.009 177.233 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.0 pt -159.28 -170.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.391 -3.929 . . . . 0.0 100.391 -160.491 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 7' ' ' ALA . 3.5 mt -76.15 116.32 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 126.28 1.832 . . . . 0.0 111.517 -162.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.7 163.85 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 160.546 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -144.04 158.62 43.59 Favored 'General case' 0 CA--C 1.484 -1.591 1 N-CA-C 97.906 -4.85 . . . . 0.0 97.906 173.539 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.77 -30.85 5.57 Favored Glycine 0 CA--C 1.493 -1.323 0 N-CA-C 104.835 -3.306 . . . . 0.0 104.835 -163.236 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -96.96 -106.68 0.17 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.352 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 58.5 tttt -169.18 -163.97 0.44 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 -171.678 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 39.4 t -123.89 120.76 33.48 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 98.722 -4.548 . . . . 0.0 98.722 178.736 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.11 106.46 3.76 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 179.435 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.8 m -83.08 137.59 34.04 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.876 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.067 0 O-C-N 123.518 0.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 121.468 0.651 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.6 165.93 12.47 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.161 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -137.02 132.47 34.29 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 97.452 -5.018 . . . . 0.0 97.452 171.988 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -168.5 24.01 Favored Glycine 0 CA--C 1.48 -2.098 1 N-CA-C 102.755 -4.138 . . . . 0.0 102.755 175.015 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -80.06 142.42 34.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 159.182 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.45 150.92 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.232 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.641 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -159.32 176.39 12.21 Favored 'General case' 0 N--CA 1.421 -1.887 1 N-CA-C 98.291 -4.707 . . . . 0.0 98.291 179.12 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -84.2 159.93 58.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 171.009 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 80.0 Cg_exo -61.76 110.98 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.468 2.779 . . . . 0.0 110.594 171.416 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 63.4 mm-40 -131.76 131.21 42.77 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 129.178 2.991 . . . . 0.0 104.378 2.539 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 67.39 16.43 10.04 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 122.905 1.336 . . . . 0.0 111.573 171.451 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.1 m -96.19 88.99 4.98 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 179.654 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.29 159.03 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -159.899 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -166.57 1.49 Allowed 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 175.628 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -150.45 177.47 9.97 Favored 'General case' 0 N--CA 1.421 -1.883 1 N-CA-C 96.31 -5.441 . . . . 0.0 96.31 172.456 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.0 t -157.25 157.59 34.55 Favored 'General case' 0 N--CA 1.413 -2.299 1 N-CA-C 95.626 -5.694 . . . . 0.0 95.626 -175.038 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -118.61 122.08 30.29 Favored Pre-proline 0 N--CA 1.426 -1.674 0 N-CA-C 100.424 -3.917 . . . . 0.0 100.424 -175.654 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.95 130.05 38.2 Favored 'Trans proline' 0 CA--C 1.507 -0.837 0 C-N-CA 122.474 2.116 . . . . 0.0 112.994 -174.723 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.06 -48.61 0.95 Allowed Glycine 0 CA--C 1.492 -1.402 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -159.941 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.253 15.0 m 96.26 -12.43 0.09 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 128.551 2.74 . . . . 0.0 111.603 172.577 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -44.85 -48.12 11.09 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 127.377 2.271 . . . . 0.0 115.904 -166.793 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.87 -38.36 41.88 Favored Glycine 0 C--N 1.351 1.389 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -174.913 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.39 -23.92 50.63 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.137 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -57.11 -47.6 80.67 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.785 0.834 . . . . 0.0 109.35 173.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -47.2 86.7 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.034 -1.041 . . . . 0.0 112.77 172.104 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.03 -42.36 97.11 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 122.039 0.923 . . . . 0.0 111.297 -175.169 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.9 t -60.38 -42.99 97.02 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.19 0.996 . . . . 0.0 109.998 178.831 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -63.9 -43.5 95.77 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 117.954 0.343 . . . . 0.0 111.449 -179.474 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -76.61 -20.5 56.69 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 118.554 0.616 . . . . 0.0 111.888 -175.779 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -84.53 -14.5 48.78 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.243 0.617 . . . . 0.0 110.499 172.962 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.05 27.29 5.97 Favored Glycine 0 CA--C 1.492 -1.353 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 166.575 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.66 134.73 12.31 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 105.43 -3.068 . . . . 0.0 105.43 175.053 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 p -103.99 12.94 33.59 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 -167.15 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.38 156.44 26.16 Favored 'General case' 0 CA--C 1.482 -1.644 1 N-CA-C 98.929 -4.471 . . . . 0.0 98.929 161.1 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.41 162.51 32.8 Favored Glycine 0 CA--C 1.47 -2.772 1 N-CA-C 98.675 -5.77 . . . . 0.0 98.675 -179.056 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -174.83 175.36 2.4 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 -174.479 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.3 m -87.0 160.0 18.79 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.333 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.95 172.0 44.81 Favored Glycine 0 N--CA 1.425 -2.035 1 N-CA-C 96.73 -6.548 . . . . 0.0 96.73 176.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -154.73 148.64 25.65 Favored 'General case' 0 N--CA 1.425 -1.677 1 N-CA-C 98.098 -4.778 . . . . 0.0 98.098 174.208 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -179.01 47.84 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 100.367 -3.938 . . . . 0.0 100.367 163.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.81 -171.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -164.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.14 64.93 0.39 Allowed Glycine 0 CA--C 1.489 -1.569 1 N-CA-C 102.126 -4.389 . . . . 0.0 102.126 179.011 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -160.7 -165.72 1.46 Allowed 'General case' 0 N--CA 1.426 -1.665 1 N-CA-C 96.391 -5.411 . . . . 0.0 96.391 -177.434 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.94 -48.32 33.95 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -177.486 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.36 -174.29 1.65 Allowed 'General case' 0 N--CA 1.432 -1.351 1 N-CA-C 96.748 -5.278 . . . . 0.0 96.748 171.709 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.2 168.28 20.91 Favored 'General case' 0 CA--C 1.49 -1.332 1 N-CA-C 96.554 -5.35 . . . . 0.0 96.554 177.701 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.5 t -125.1 157.97 35.01 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 -171.353 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -93.82 148.9 21.7 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 178.378 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.6 m -141.31 148.76 40.27 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 167.35 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -125.42 137.55 54.0 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 -176.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.57 55.38 0.63 Allowed 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.677 1.591 . . . . 0.0 110.741 174.16 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.7 mt -92.58 135.77 26.07 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.393 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.45 166.27 30.3 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.803 2.336 . . . . 0.0 108.965 177.318 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -87.42 41.29 0.97 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -171.979 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.83 -0.12 12.36 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 169.666 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 t -103.47 151.24 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 101.651 -3.462 . . . . 0.0 101.651 -178.228 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.78 147.66 18.99 Favored Glycine 0 CA--C 1.479 -2.204 1 N-CA-C 98.282 -5.927 . . . . 0.0 98.282 -179.772 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 pt -145.3 -138.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -156.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 7' ' ' ALA . 13.5 mm -73.44 146.39 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.459 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG11 ' HE1' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -146.07 160.7 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 2 N-CA-C 94.158 -6.238 . . . . 0.0 94.158 172.521 . . . . . . . . 4 4 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 24.7 tt0 -164.36 178.03 7.79 Favored 'General case' 0 CA--C 1.488 -1.439 1 N-CA-C 99.597 -4.223 . . . . 0.0 99.597 169.978 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . 88.35 23.45 37.16 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 105.428 -3.069 . . . . 0.0 105.428 -153.266 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -176.83 -159.61 0.06 Allowed 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 97.43 -5.026 . . . . 0.0 97.43 -166.798 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.75 -167.23 2.53 Favored 'General case' 0 N--CA 1.427 -1.602 1 N-CA-C 98.732 -4.544 . . . . 0.0 98.732 -176.3 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.38 127.84 33.75 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 126.384 1.873 . . . . 0.0 108.807 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.423 ' HE1' HG11 ' A' ' 60' ' ' VAL . 38.9 p-80 -149.32 159.06 44.6 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 101.669 -3.456 . . . . 0.0 101.669 176.917 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 t -169.16 -176.98 2.74 Favored 'General case' 0 N--CA 1.419 -1.981 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 178.182 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.894 0 O-C-N 124.937 1.398 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.894 0.378 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.557 HH21 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -137.62 -176.87 4.56 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.803 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -133.61 143.51 48.68 Favored 'General case' 0 CA--C 1.49 -1.354 1 N-CA-C 97.492 -5.003 . . . . 0.0 97.492 176.454 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.6 177.45 37.88 Favored Glycine 0 CA--C 1.48 -2.107 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 178.233 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -79.28 127.91 32.66 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.803 -3.406 . . . . 0.0 101.803 156.601 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' HA ' HG22 ' A' ' 58' ' ' ILE . 12.5 tt -89.67 135.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -172.599 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -95.1 -146.49 0.27 Allowed 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 126.824 2.577 . . . . 0.0 109.438 178.111 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -149.81 167.75 12.39 Favored Pre-proline 0 N--CA 1.424 -1.761 1 N-CA-C 95.989 -5.56 . . . . 0.0 95.989 175.153 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.96 151.14 86.84 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.298 2.666 . . . . 0.0 107.686 158.187 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HG3' ' CE1' ' A' ' 66' ' ' HIS . 57.3 mm-40 -81.87 -51.13 8.41 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 128.12 2.568 . . . . 0.0 109.033 7.181 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -145.66 147.59 32.17 Favored 'General case' 0 N--CA 1.421 -1.914 1 N-CA-C 92.149 -6.982 . . . . 0.0 92.149 162.598 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.49 -164.41 0.22 Allowed 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -173.641 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -125.75 161.76 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 1 N-CA-C 96.718 -5.29 . . . . 0.0 96.718 161.509 . . . . . . . . 4 4 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -151.93 0.07 Allowed 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 163.501 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -139.35 177.72 7.72 Favored 'General case' 0 CA--C 1.478 -1.813 1 N-CA-C 96.919 -5.215 . . . . 0.0 96.919 163.825 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.9 t -138.14 162.4 34.33 Favored 'General case' 0 N--CA 1.415 -2.198 1 N-CA-C 97.347 -5.057 . . . . 0.0 97.347 -174.424 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -116.1 112.67 41.97 Favored Pre-proline 0 N--CA 1.418 -2.053 1 N-CA-C 96.031 -5.544 . . . . 0.0 96.031 172.296 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -70.45 49.53 0.87 Allowed 'Trans proline' 0 CA--C 1.517 -0.374 0 CA-C-N 124.402 2.608 . . . . 0.0 115.351 -173.663 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.31 16.78 6.67 Favored Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 168.607 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 m 74.24 -52.82 0.69 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 127.362 2.265 . . . . 0.0 112.12 172.42 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 m -51.05 -41.52 59.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.317 2.247 . . . . 0.0 115.815 -170.955 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.28 -31.82 60.88 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 121.154 -0.966 . . . . 0.0 111.496 -176.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -75.76 -47.87 24.13 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 178.128 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -56.58 -43.21 79.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.255 0.622 . . . . 0.0 110.193 178.538 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.7 m -57.14 -47.71 80.46 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 121.077 -1.014 . . . . 0.0 112.164 176.333 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.3 mt -65.38 -43.03 91.97 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-O 121.834 0.826 . . . . 0.0 110.206 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -57.42 -45.98 84.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.162 0.985 . . . . 0.0 110.762 176.422 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.95 -44.33 80.87 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 122.717 0.407 . . . . 0.0 110.322 -176.186 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.31 -30.51 66.32 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 118.381 0.537 . . . . 0.0 111.96 -177.049 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -77.74 -33.51 52.87 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.515 -0.741 . . . . 0.0 109.965 176.219 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.22 43.05 0.49 Allowed Glycine 0 CA--C 1.489 -1.589 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 161.492 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.31 139.94 14.67 Favored Glycine 0 C--N 1.353 1.528 0 N-CA-C 105.593 -3.003 . . . . 0.0 105.593 164.778 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 p -96.24 -1.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.038 0.923 . . . . 0.0 109.96 -168.04 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -160.34 168.19 25.81 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 97.528 -4.99 . . . . 0.0 97.528 171.404 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.36 -177.83 37.35 Favored Glycine 0 CA--C 1.468 -2.869 1 N-CA-C 100.329 -5.108 . . . . 0.0 100.329 -175.655 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -159.0 -176.78 6.06 Favored 'General case' 0 N--CA 1.423 -1.799 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 -175.885 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.5 t -139.91 150.29 44.39 Favored 'General case' 0 CA--C 1.48 -1.712 1 N-CA-C 95.853 -5.61 . . . . 0.0 95.853 -176.755 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.97 -176.89 46.32 Favored Glycine 0 N--CA 1.423 -2.177 1 N-CA-C 102.127 -4.389 . . . . 0.0 102.127 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -118.16 141.48 48.45 Favored 'General case' 0 N--CA 1.431 -1.395 1 N-CA-C 99.803 -4.147 . . . . 0.0 99.803 -178.24 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -94.83 -28.98 14.96 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 122.692 1.234 . . . . 0.0 108.915 -177.574 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.6 t 72.04 -166.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 129.895 3.278 . . . . 0.0 103.372 -165.158 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 75.74 -69.98 2.04 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 120.387 -1.446 . . . . 0.0 110.505 176.818 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -99.65 -57.33 2.17 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.047 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.09 -138.83 5.54 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 118.576 -1.773 . . . . 0.0 110.588 -178.047 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.2 tp -80.74 144.36 32.22 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -177.477 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.14 -179.9 7.39 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 102.9 -3.0 . . . . 0.0 102.9 -170.118 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.6 t -115.88 165.49 13.03 Favored 'General case' 0 CA--C 1.496 -1.1 1 N-CA-C 98.945 -4.465 . . . . 0.0 98.945 175.49 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -129.67 150.87 50.8 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 -179.96 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 54.4 m -142.57 149.53 39.17 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.24 138.99 51.35 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 172.283 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.17 67.65 0.72 Allowed 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.884 2.473 . . . . 0.0 110.539 179.164 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.9 mt -97.91 139.64 21.42 Favored Pre-proline 0 CA--C 1.496 -1.112 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 171.108 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -70.32 162.38 42.57 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.279 1.986 . . . . 0.0 110.567 165.166 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.16 -37.54 72.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.9 2.08 . . . . 0.0 115.164 -163.966 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -83.61 -5.86 59.29 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 120.869 -1.144 . . . . 0.0 110.591 -172.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 t -90.54 99.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 178.061 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.557 ' HA2' HH21 ' A' ' 2' ' ' ARG . . . -83.49 166.27 43.5 Favored Glycine 0 CA--C 1.489 -1.569 0 CA-C-O 122.036 0.798 . . . . 0.0 112.163 -161.823 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.441 HG22 ' HA ' ' A' ' 6' ' ' ILE . 31.9 pt -147.35 -178.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 N-CA-C 103.242 -2.873 . . . . 0.0 103.242 -164.67 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 13' ' ' VAL . 1.2 mm -69.29 103.91 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 C-N-CA 124.819 1.248 . . . . 0.0 110.216 -166.841 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -92.05 170.92 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 101.527 -3.509 . . . . 0.0 101.527 167.163 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.2 163.67 39.87 Favored 'General case' 0 N--CA 1.427 -1.601 1 N-CA-C 97.768 -4.901 . . . . 0.0 97.768 174.833 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.87 -33.87 4.42 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 103.923 -3.671 . . . . 0.0 103.923 -162.385 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.02 -115.54 0.22 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 175.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -176.47 -153.8 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.475 1 N-CA-C 97.48 -5.007 . . . . 0.0 97.48 -171.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 34.8 t -120.39 123.6 43.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 -179.896 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 10' ' ' GLU . 14.8 p80 -149.77 150.2 31.67 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 171.177 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.7 t -170.46 -175.6 1.94 Allowed 'General case' 0 N--CA 1.42 -1.942 1 N-CA-C 96.08 -5.526 . . . . 0.0 96.08 -172.17 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.906 0 O-C-N 125.062 1.476 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_